Citrus Sinensis ID: 035604
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 768 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.924 | 0.850 | 0.384 | 1e-135 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.929 | 0.844 | 0.370 | 1e-130 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.893 | 0.837 | 0.368 | 1e-116 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.535 | 0.513 | 0.472 | 1e-106 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.579 | 0.559 | 0.447 | 1e-103 | |
| Q8GUH1 | 834 | U-box domain-containing p | no | no | 0.876 | 0.806 | 0.324 | 2e-91 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.459 | 0.681 | 0.334 | 3e-54 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.348 | 0.567 | 0.397 | 1e-49 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.346 | 0.608 | 0.394 | 3e-49 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.360 | 0.325 | 0.380 | 3e-49 |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 483 bits (1242), Expect = e-135, Method: Compositional matrix adjust.
Identities = 298/775 (38%), Positives = 439/775 (56%), Gaps = 65/775 (8%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQ-NLTLLHVKQRVSSVPNPSGNSVAISKVNNEVA 71
V VA+ S+Y + WA++ + G LLH+ ++SVP P GN++ IS+V ++V
Sbjct: 22 VVVALSGSSKSKYVVTWAIEKFATEGNVGFKLLHIHPMITSVPTPMGNAIPISEVRDDVV 81
Query: 72 RIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAA 131
Y+Q++ Q++E+ P+ R+++ + +V+E ++A A+ + V+ +I+ +V+G +
Sbjct: 82 TAYRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVAAAIAEEVTRDSIDRIVIGGS 141
Query: 132 SRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVR--SATASVPVRASPGSQLQS 189
SR+ F ++ ADI S +S P++C VYV+ KGK+S VR + + +R GS+ +
Sbjct: 142 SRSFFSRK---ADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIRED-GSERTN 197
Query: 190 QSRQPSHSSDSYESAMTNSQSSRV--------------AISAAERTPPTTSSLINDDVPI 235
S S + M+++ S+ AI+ P TSS+ +D+
Sbjct: 198 SSSGSSGPTSDSSDVMSSAHDSQSRPLSLPVRRMQHFPAIAGQASVPMETSSVGSDETRC 257
Query: 236 KSPFLRGKGSIPKYEPSLPESDISFVSS-GRPSTDRMIYDMDFGMTPWLSTGSDYE---- 290
S L + VSS R STD + W DYE
Sbjct: 258 MS---------------LDAEEARDVSSINRSSTD--------TTSRWTPRRRDYEERKE 294
Query: 291 --SSSFVSLQSGSRSIDRNSS----PDEFSSYSQESGRTSSSSQSQSVEEVEV----EMR 340
SSS + + G+ + S S SQ++ S + QS + +V E+
Sbjct: 295 AMSSSSSNREYGNFGTRFSWSGMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVE 354
Query: 341 RLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERA 400
+LR ELR +MY+ A E A +K EL++ +LEE KLE+ ++ E A LAEKE+
Sbjct: 355 KLRAELRHVQEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQ 414
Query: 401 KCKRAIEAAEAAQRIAELEAQKCKNVEFKALREAKERKAALNSL-TVDLRYRKYSIEEIE 459
++A AE+ + AE E + + E K+ R+ KE++ +L + L+Y+ ++ EEI
Sbjct: 415 NFEKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIM 474
Query: 460 EATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN 519
AT +FS KIG G YG VYK L HT +KVL+ Q QFQQE+E+L IRHP+
Sbjct: 475 AATSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPH 534
Query: 520 MVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
+VLLLGACPE G L+YEYM NGSLEDRLF+ SP LPW RFRIA E+A AL+FLH++K
Sbjct: 535 LVLLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSK 594
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS-VADSVTQYRMTSAAGTFCYIDPE 638
P+P++HRDLKP NILLD N+VSK+ DVGL+ +V ++ T Y+ TS GT CYIDPE
Sbjct: 595 PKPIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPE 654
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE-NGTFDETLDPAVPDWPVE 697
YQ+TG + KSD+YS G++LLQ++TAKP + L H VE +++ N F + LD +WP+E
Sbjct: 655 YQRTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIE 714
Query: 698 EALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSP 752
E LA LAL C ELR KDRPDL ++P L L+ +AE+ A N SG + P
Sbjct: 715 ETRELAALALCCTELRGKDRPDLKDQILPALENLKKVAEK---ARNSFSGVSTQP 766
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1195), Expect = e-130, Method: Compositional matrix adjust.
Identities = 288/778 (37%), Positives = 432/778 (55%), Gaps = 64/778 (8%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRG-QNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVA 71
VAVAI+ K S+Y + WA++ + G + LL+V+ VS +P P G +VA+S++ +V
Sbjct: 24 VAVAINGKKKSKYVVFWALEKFIPEGFTDFKLLYVRPPVSYIPTPMGIAVAVSELREDVV 83
Query: 72 RIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAA 131
YKQ++D A E+ P++ R++++ + ++L+ + A A+ + ++ + LV+G +
Sbjct: 84 SAYKQELDWSANEMLRPYKKMFERRKVQVEVLLLDSLEPAAAIAEEIAGTGVTKLVIGMS 143
Query: 132 SRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVR----SATASVPV-RASPGSQ 186
R GF R D+ S ++ P +C VYVI KGK++SVR A+ S+ R+S S
Sbjct: 144 LR-GFFSR--KIDMSSLIATAVPRFCTVYVISKGKLASVRPSESDASGSIRFERSSSTSG 200
Query: 187 LQSQSRQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIKSPFLRGKGSI 246
R P D + SA++ +QS R P + +L + G ++
Sbjct: 201 STDSPRLPPEYQD-FLSAVSEAQS---------RVSPFSPALKHS---------MGSNAV 241
Query: 247 PKYEPSLPESDISFVSSGR-----------PSTDRMIYDMDFGM-------TPWLSTGSD 288
+ + S +D VS+GR + F M W S D
Sbjct: 242 AQMDTSSSGTDQEEVSTGRGMEIVHSGIEGKKNKDESFSASFPMGTEAYNSMSWTSKWRD 301
Query: 289 YES------------SSFVSLQSGSRSIDRNSSPDEFSSYSQESGRTSSSSQSQSVEEVE 336
+E V++ G+ + N S ++ G S S + + +
Sbjct: 302 HEDRREMRSSSSSNNHDLVNMDWGA-VVPENYSWVSHTASHMSDGLLSVHSITDNQVNLN 360
Query: 337 VEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAE 396
E+ +LR EL+ +MY+ A E + A +K EL++ + EE +KL + + EE A A
Sbjct: 361 FEIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAKDTAS 420
Query: 397 KERAKCKRAIEAAEAAQRIAELEAQKCKNVEFKALREAKERKAALNSL-TVDLRYRKYSI 455
KE+ + + A++ AE + + EA + EFKA R+A+E+ SL + ++Y+ Y+
Sbjct: 421 KEKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQYQHYTW 480
Query: 456 EEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI 515
EEI AT +F+ + KIG G YG VYK L HT A+KVL Q QF QE+E+L I
Sbjct: 481 EEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELEILSKI 540
Query: 516 RHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
RHP++VLLLGACPE GCL+YEYM NGSL+DRL +P +PW RFRIA E+A+AL+FL
Sbjct: 541 RHPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVASALVFL 600
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H++KP P++HRDLKPGNILLD N+VSK+ DVGL+ +V S T ++ TS GT CYI
Sbjct: 601 HKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIFKQTSPVGTLCYI 660
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSI-ENGTFDETLDPAVPDW 694
DPEYQ+TG++ KSDVYSLG+++LQ+ITAKP + + H VE +I ++ F LD W
Sbjct: 661 DPEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILDKKAGSW 720
Query: 695 PVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSP 752
P+ + LA L L C E+RR+DRPDL ++P L LR +A++ A NL S S P
Sbjct: 721 PISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADK---AQNLLSRTPSGP 775
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1077), Expect = e-116, Method: Compositional matrix adjust.
Identities = 284/770 (36%), Positives = 411/770 (53%), Gaps = 84/770 (10%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLS-RGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVA 71
VA+AI S+ ++WA++ S + L+H+ +++++P SGN V+IS+ EVA
Sbjct: 34 VALAISGSIKSKNVIKWALNKFGSDKNVTFKLIHIHPKITTLPTASGNIVSISEELEEVA 93
Query: 72 RIYKQQVDNQAKE-LFVPFRCFCTRKEIKCKEI--------------VLEDTDIAKALID 116
Y+Q+V + KE L PF+ C RK++K E VLE +A A+
Sbjct: 94 AAYRQKVMQETKETLLKPFKKMCERKKLKIDETRFESSLTKVAVELQVLESNSVAVAITK 153
Query: 117 YVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATAS 176
V+ H I L++G +S+ + + DI +++S + C VYV+ G +
Sbjct: 154 EVNQHLISNLIIGRSSQAASSRNY---DITASISASVSNLCTVYVVSNGGVH-------- 202
Query: 177 VPVRASPGSQLQSQSRQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIK 236
+ + + ++ S + S + + +S V +A + P T S+ ++P
Sbjct: 203 ILAKDTSDTERNDTSIESGFERTSSSCSSGSGANSDVMSNALKSNPHTLSNKRMQNLPT- 261
Query: 237 SPFLRGKGSIPKYEPSLPESDISFVSSGRPSTDRMIYDMDFGMTPWLSTGSDYESSSFVS 296
+RG S+P E S ESD + + S+D S S E+S VS
Sbjct: 262 --IVRG-VSVP-METSSTESD----ETKKRSSD---------AAEEASKRSSPETSRSVS 304
Query: 297 LQSGSRSIDRN-------SSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQT 349
R D SS E+ + G + +Q + E+ +LR ELR
Sbjct: 305 WNPQFRDFDERKDAMSSMSSNFEYGNVVTPLGHYFTDNQ-----DTLNEISKLRAELRHA 359
Query: 350 MDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAA 409
+MY+ A E L A +K EL K EE LE E +A E E+ + KR E
Sbjct: 360 HEMYAVAQVETLDASRKLNEL---KFEELTLLEH----ETKGIAKKETEKFEQKRR-EER 411
Query: 410 EAAQRIAELEAQKCKNVEFKALREAKERKAALNSLTV--DLRYRKYSIEEIEEATENFSN 467
EAAQR + E KA EAKE++ S V L+Y++++ EEI AT +FS
Sbjct: 412 EAAQR---------REAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSE 462
Query: 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
KIG G YG VYK L HT A+KVL + QF QE+E+L IRHP++VLLLGAC
Sbjct: 463 DLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGAC 522
Query: 528 PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRD 587
P+ G L+YEYM NGSLEDRLF+ S +PW +R RIA E+A+AL+FLH++KP P++HRD
Sbjct: 523 PDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRD 582
Query: 588 LKPGNILLDRNYVSKISDVGLARLVPPS--VADSVTQYRMTSAAGTFCYIDPEYQQTGML 645
LKP NILL+ N+VSK+ DVGL+ ++ + ++ T Y+ TS GT CYIDPEYQ+TG +
Sbjct: 583 LKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRI 642
Query: 646 GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDE---TLDPAVPDWPVEEALIL 702
KSDVY+ G+++LQ++T + M L + VE ++EN DE LD +WP+EE L
Sbjct: 643 SPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQL 702
Query: 703 AKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSP 752
A LALQC ELR KDRPDL ++P L L+ +A++ A N S A S P
Sbjct: 703 AALALQCTELRSKDRPDLEDQILPVLESLKKVADK---ARNSLSAAPSQP 749
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (995), Expect = e-106, Method: Compositional matrix adjust.
Identities = 196/415 (47%), Positives = 269/415 (64%), Gaps = 4/415 (0%)
Query: 341 RLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERA 400
RL+ EL+ T+ Y AC+E + + K + L L E +++ +A EE A E+
Sbjct: 317 RLKNELQSTVFKYKQACEELFSTQNKVKMLSTEYLNESKRVNNAVEKEELQRNTAALEKE 376
Query: 401 KCKRAIEAAEAAQRIAELEAQKCKNVEFKALREAKERKAALNSLT-VDLRYRKYSIEEIE 459
+ +A++ E A+ + E + + E ALR E+K ++ L D RYRKY+IEEI
Sbjct: 377 RYMKAVKEVETAKALLAREFCQRQIAEVNALRTYLEKKKVIDQLLGTDHRYRKYTIEEIV 436
Query: 460 EATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN 519
ATE FS + IGEGGYG VY+ LD TP A+KV+R D + + +F +EVEVL +RHP+
Sbjct: 437 TATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPH 496
Query: 520 MVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
+VLLLGACPE GCL+YEY+ NGSLE+ +F R P LPW IRFR+ E+A L FLH +K
Sbjct: 497 VVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSK 556
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
PEP+VHRDLKPGNILL+RNYVSKI+DVGLA+LV D+VT YR + AGT YIDPEY
Sbjct: 557 PEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEY 616
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEA 699
+TG + KSD+Y+ GI++LQ++TA+ P G+ VE +++ GT E LD +V DWP+ E
Sbjct: 617 HRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAET 676
Query: 700 LILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSPSY 754
LA++ L+CAE R +DRPDL V+P +L+ L E + +PS+
Sbjct: 677 EELARIGLKCAEFRCRDRPDLKSEVIP---VLKRLVETANSKVKKEGSNLRAPSH 728
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 378 bits (970), Expect = e-103, Method: Compositional matrix adjust.
Identities = 207/463 (44%), Positives = 292/463 (63%), Gaps = 18/463 (3%)
Query: 306 RNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQ 365
R+S +E SS S S TSSSSQ + E+ +L++ELR MY+ A E + A +
Sbjct: 270 RSSQMEEASSSSTYSDPTSSSSQIHK----DFELEKLKIELRHIKGMYAVAQSEVIDASK 325
Query: 366 KARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKN 425
K ++L++ + EE +L++ + EE A + E ER + + A AE + E E ++
Sbjct: 326 KMQDLNQRRSEEATRLKNLTIREEEADEVVEMERERQEDAENEAELVRECIERETEERLE 385
Query: 426 VEFKALREAKERKAALNSLTVD----LRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYK 481
E +A KE++ ++L +Y K+ EEI EAT +FS+ KIG GGYG VY+
Sbjct: 386 AEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYGSVYR 445
Query: 482 SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANG 541
L HT VA+KVL D + QF QE+E+L IRHP+++LLLGACPE G L+YEYM NG
Sbjct: 446 CNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEYMHNG 505
Query: 542 SLEDRLFRRGGS------PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595
SLE+RL +R + P L W RFRIA EIA+AL FLH +P P+VHRDLKP NILL
Sbjct: 506 SLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPANILL 565
Query: 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLG 655
DRN VSKI DVGL+++V + + T + T GTF YIDPEYQ+TG++ +SD+Y+ G
Sbjct: 566 DRNNVSKIGDVGLSKMVNLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPESDIYAFG 625
Query: 656 ILLLQIITAKPPMGLAHQVERSI--ENGTFDETLDPAVPDWPVEEALILAKLALQCAELR 713
I+LLQ++TA+ MGLAH +E+++ + G F E LD DWPV+EA + + L+CAE+R
Sbjct: 626 IILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGLRCAEMR 685
Query: 714 RKDRPDLGKVVVPKLNILRALAE--ETMPAINLASGAGSSPSY 754
++DRPDLGK ++P L L+ +A M A NL ++P++
Sbjct: 686 KRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPTH 728
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 337 bits (864), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 244/753 (32%), Positives = 382/753 (50%), Gaps = 80/753 (10%)
Query: 10 EEAVAVAIDKDKG-SQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNN 68
+E + VA+DK S+ L WA+ + + G+ + L+HV Q +P G + V
Sbjct: 44 DEKIFVAVDKHVAKSKSTLIWALQN--TGGKKICLIHVHQPSQMIP-LMGAKFPVGAVKE 100
Query: 69 EVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVL 128
E R+++++ + + + C ++ ++ +++ +E I ++ +S I LV+
Sbjct: 101 EEVRVFREKEREKVHMILDDYLRICQQRGVRAEKMFIEMESIENGIVQLISELGIRKLVM 160
Query: 129 GAASRTGFVKRFKTADIPSN----VSKGAPDYCNVYVIGKGKISSVRSATASVPVRASPG 184
GAA+ + +R D+ S V + AP C ++ KG + R AT
Sbjct: 161 GAAADRHYSRRM--TDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREATMD-------D 211
Query: 185 SQLQSQSRQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIKSPFLRGKG 244
++ + S +PS S+ + +S IS + T + N +S G+
Sbjct: 212 TESEYASPRPSISASDLLQTFSTPESEHQHISRVQSTDSVQQLVSNGSSTEQS----GR- 266
Query: 245 SIPKYEPSLPESDISFVSSGRPSTDRMIYDMDFGMTPWLSTGSDYESSSFVSLQSGSRSI 304
VS G +TD + D GS+ S+ V S
Sbjct: 267 ----------------VSDGSLNTDEEERESD---------GSEVTGSATVMSSGHSSPS 301
Query: 305 DRNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLE---------LRQTMDMYSA 355
D+ S++ + + +S + S E +RR + E +Q+ YS
Sbjct: 302 SFPDGVDD--SFNVKIRKATSEAHSSKQEAFAETLRRQKAEKNALDAIRRAKQSESAYSE 359
Query: 356 ACK-----EALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIE--- 407
K E AK+K R + K E++ +E+ + A A A+ E + AK +E
Sbjct: 360 ELKRRKDTEIAVAKEKERFI-TIKNEQEVIMEELQSAM-AQKAMLESQIAKSDGTMEKLN 417
Query: 408 -----AAEAAQRIAELEAQKCKNVEFKALREAKERKAALNSLTVDL--RYRKYSIEEIEE 460
A + Q++ + E ++ + +ALREA+E ++ + T+ L + +S EIEE
Sbjct: 418 QKLDIAVKLLQKLRD-EREELQTERDRALREAEELRSHAETSTLQLPQYFTDFSFSEIEE 476
Query: 461 ATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM 520
AT +F ++ KIGEGGYG +Y L HT VAIK+L P+++QG ++QQEV+VL +RHPN+
Sbjct: 477 ATNHFDSTLKIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNI 536
Query: 521 VLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
+ L+GACPE L+YEY+ GSLEDRL + SP L WQ R RIA EI AL+FLH K
Sbjct: 537 ITLIGACPEGWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKA 596
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ 640
LVH DLKP NILLD N VSK+SD G L+ P+ + SV T GT Y+DPE
Sbjct: 597 HSLVHGDLKPANILLDSNLVSKLSDFGTCSLLHPNGSKSVR----TDVTGTVAYLDPEAS 652
Query: 641 QTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEAL 700
+G L KSDVYS GI+LL+++T +P + ++++V+ +++NGT ++ LDP DWP +A
Sbjct: 653 SSGELTPKSDVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAE 712
Query: 701 ILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733
LA+LAL+C E ++RPDLG V L +RA
Sbjct: 713 QLARLALRCCETVSENRPDLGTEVWRVLEPMRA 745
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (544), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 128/383 (33%), Positives = 200/383 (52%), Gaps = 30/383 (7%)
Query: 379 QKLEDARMAEEA-ALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVEFKALREAKER 437
Q + D + EE + + E+E K + + A + K+ A+++ E
Sbjct: 77 QHVCDRKTYEEVRKVHILEEEIVTLKHQADTYLVQKEKAVTAYDQLKHERDNAVQQVNEL 136
Query: 438 KAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPD 497
+ + +D +S +++E+ATE+F N+R++G+ YG YK + + V IK+
Sbjct: 137 RDQSTHIILD-----FSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKL---- 187
Query: 498 AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLP 557
+ + FQQEV +L RHPN++ +G C E L+YE++ NG+LEDR+ S L
Sbjct: 188 -SSSQKLFQQEVSILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLS 246
Query: 558 WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL------ 611
W R +I EI ALLFLH K LVH DL+P NIL+D NY SKI + G++ L
Sbjct: 247 WYNRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGT 306
Query: 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA 671
PP++ + Y+DPE+ TG L SDVYSLG+++L+++T PP+ L+
Sbjct: 307 FPPNLTARLP------------YMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLS 354
Query: 672 HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD-LGKVVVPKLNI 730
+V ++ + + +D + DWP EA LA + L C + RK RPD L +V + +
Sbjct: 355 EKVAEALGSDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPL 414
Query: 731 LRALAEETMPAINLASGAGSSPS 753
R T P + ASG S P+
Sbjct: 415 TRKPPAATWPYLQSASGDSSVPA 437
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 115/289 (39%), Positives = 164/289 (56%), Gaps = 21/289 (7%)
Query: 451 RKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEV 509
R Y++ E+E AT IGEGGYG VY+ L D T VA+K L + Q +F+ EV
Sbjct: 140 RWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEV 199
Query: 510 EVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSLEDRLFRRGG--SPVLPWQIRFRIA 565
EV+ +RH N+V LLG C E + L+Y+++ NG+LE + G SP L W IR I
Sbjct: 200 EVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSP-LTWDIRMNII 258
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM 625
+A L +LH+ +VHRD+K NILLDR + +K+SD GLA+L+ S + Y
Sbjct: 259 LGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLL-----GSESSYVT 313
Query: 626 TSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM---------GLAHQVER 676
T GTF Y+ PEY TGML KSD+YS GIL+++IIT + P+ L ++
Sbjct: 314 TRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKS 373
Query: 677 SIENGTFDETLDPAVPDWPVEEALILAKL-ALQCAELRRKDRPDLGKVV 724
+ N +E +DP +P+ P +AL L AL+C + RP +G ++
Sbjct: 374 MVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHII 422
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 114/289 (39%), Positives = 163/289 (56%), Gaps = 23/289 (7%)
Query: 453 YSIEEIEEATENFSNSRKIGEGGYGPVYKS-YLDHTPVAIKVLRPDAAQGRSQFQQEVEV 511
YS++++E AT FS+ IGEGGYG VY++ + D + A+K L + Q +F+ EVE
Sbjct: 133 YSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEA 192
Query: 512 LCNIRHPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLP--WQIRFRIA 565
+ +RH N+V L+G C + L+YEY+ NG+LE L G PV P W IR +IA
Sbjct: 193 IGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVG-PVSPLTWDIRMKIA 251
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM 625
A L +LH+ +VHRD+K NILLD+ + +K+SD GLA+L+ S T Y
Sbjct: 252 IGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLL-----GSETSYVT 306
Query: 626 TSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP---------MGLAHQVER 676
T GTF Y+ PEY TGML SDVYS G+LL++IIT + P M L +
Sbjct: 307 TRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKG 366
Query: 677 SIENGTFDETLDPAVPDWPVEEALILAKLA-LQCAELRRKDRPDLGKVV 724
+ + +E +DP + P AL A L L+C +L RP +G+++
Sbjct: 367 MVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQII 415
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 113/297 (38%), Positives = 166/297 (55%), Gaps = 20/297 (6%)
Query: 445 TVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKS-YLDHTPVAIKVLRPDAAQGRS 503
T DL EE+ AT NFSN+ K+G+GG+G VYK LD +A+K L + QG
Sbjct: 506 TDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTD 565
Query: 504 QFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIR 561
+F+ EV+++ ++H N+V LL C + G LIYEY+ N SL+ LF + + L WQ+R
Sbjct: 566 EFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMR 625
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621
F I IA LL+LHQ ++HRDLK NILLD+ KISD G+AR+ ++ T
Sbjct: 626 FDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANT 685
Query: 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ-------- 673
+ GT+ Y+ PEY G+ +KSDV+S G+LLL+II++K G +
Sbjct: 686 R----KVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLG 741
Query: 674 -VERSIENGTFDETLDPAVPD----WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725
V R+ + G E +DP + D + E L ++ L C + R +DRP + V++
Sbjct: 742 CVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVIL 798
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 768 | ||||||
| 359484943 | 806 | PREDICTED: U-box domain-containing prote | 0.975 | 0.929 | 0.685 | 0.0 | |
| 147860573 | 826 | hypothetical protein VITISV_012742 [Viti | 0.976 | 0.907 | 0.662 | 0.0 | |
| 356511423 | 786 | PREDICTED: U-box domain-containing prote | 0.919 | 0.898 | 0.656 | 0.0 | |
| 359476012 | 796 | PREDICTED: U-box domain-containing prote | 0.964 | 0.930 | 0.651 | 0.0 | |
| 356527712 | 788 | PREDICTED: U-box domain-containing prote | 0.929 | 0.906 | 0.643 | 0.0 | |
| 255554402 | 802 | ATP binding protein, putative [Ricinus c | 0.970 | 0.928 | 0.631 | 0.0 | |
| 147797909 | 768 | hypothetical protein VITISV_023046 [Viti | 0.921 | 0.921 | 0.626 | 0.0 | |
| 357520633 | 801 | U-box domain-containing protein [Medicag | 0.929 | 0.891 | 0.622 | 0.0 | |
| 255559677 | 780 | ATP binding protein, putative [Ricinus c | 0.957 | 0.942 | 0.602 | 0.0 | |
| 357520637 | 802 | U-box domain-containing protein [Medicag | 0.919 | 0.880 | 0.616 | 0.0 |
| >gi|359484943|ref|XP_002266413.2| PREDICTED: U-box domain-containing protein 35-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1000 bits (2586), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/779 (68%), Positives = 622/779 (79%), Gaps = 30/779 (3%)
Query: 1 MARRNGDKQEEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNS 60
M+R +++ VAVAIDKDKGSQYAL+WAVDHLLS+GQ++TLLH+KQ+ SS+PNP GN
Sbjct: 1 MSRTGYGEKKVEVAVAIDKDKGSQYALKWAVDHLLSKGQSVTLLHIKQKASSIPNPLGNQ 60
Query: 61 VAISKVNNEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSS 120
VAIS VN +VAR YKQQ+DNQA+ELF+PFRCFC RK+I+C E++LE TDI KA+ID+V++
Sbjct: 61 VAISDVNEDVARAYKQQLDNQARELFLPFRCFCMRKDIQCNEVILEGTDITKAIIDFVTA 120
Query: 121 HTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVR 180
+IE LV+GA SR+GF+ RFKT D+PS+V K APD+C VYVI KGKI+SVRSAT VP
Sbjct: 121 SSIEILVVGAPSRSGFI-RFKTTDVPSSVLKAAPDFCTVYVISKGKITSVRSATRPVPNP 179
Query: 181 ASPGSQLQSQSRQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIKSPFL 240
+ P + Q S + D E+ + +++S+R A+ER+ +L +D+ IKSPF
Sbjct: 180 SPPPTASSLHQNQASPTPDPTEAHLKHNRSTR----ASERSSFGLRNL--NDLEIKSPFT 233
Query: 241 RGKGSIPKY--EPSLPESDISFVSSGRPSTDRMI---YD-MDFGMTPWLSTGSDYESS-- 292
RG+ S+ K E S+PE+DISFVSSGRPS D + YD +D GM PWLS S+
Sbjct: 234 RGRASLSKSYGELSVPETDISFVSSGRPSIDHIFPFSYDNLDTGMNPWLSNSSEMNPRLS 293
Query: 293 ---------SFVSLQSGSRSIDRNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLR 343
SF S SG RS + N S D SS S ESGR S +SQS +E+VE EMRRL+
Sbjct: 294 NSSDLNTRLSFAS--SGGRSSELNYSLD-LSSSSNESGRLSWASQS--MEDVEAEMRRLK 348
Query: 344 LELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCK 403
LEL+QTMDMYS ACKEAL+AKQ ARELHRWK+EE Q+L +AR+AEEAALA AE+E+AK K
Sbjct: 349 LELKQTMDMYSTACKEALSAKQTARELHRWKMEEAQRLGEARLAEEAALATAEREKAKAK 408
Query: 404 RAIEAAEAAQRIAELEAQKCKNVEFKALREAKERKAALNSLT-VDLRYRKYSIEEIEEAT 462
A+EAAEA+QRIA+LEAQK N E A++EA+ERK LN+L DLRYRKY+IEEIE AT
Sbjct: 409 AALEAAEASQRIAKLEAQKRINAEMVAIKEAEERKKMLNTLAQTDLRYRKYTIEEIEAAT 468
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVL 522
E FS SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVL IRHPNMVL
Sbjct: 469 ELFSESRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVL 528
Query: 523 LLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
LLGACPE+GCL+YEYMANGSL+D LFRRG +PVLPWQ+RF+IAAEI T LLFLHQTKPEP
Sbjct: 529 LLGACPEYGCLVYEYMANGSLDDHLFRRGNTPVLPWQLRFQIAAEIGTGLLFLHQTKPEP 588
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT 642
LVHRDLKPGNILLDRN+VSKISDVGLARLVPPSVADSVTQY MTS AGTFCYIDPEYQQT
Sbjct: 589 LVHRDLKPGNILLDRNFVSKISDVGLARLVPPSVADSVTQYLMTSTAGTFCYIDPEYQQT 648
Query: 643 GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALIL 702
GMLG+KSD+YSLGI+LLQIITAKPPMGL H VER+IE GTF E LDPAV DWPVEEAL
Sbjct: 649 GMLGIKSDIYSLGIMLLQIITAKPPMGLTHYVERAIEKGTFAEVLDPAVHDWPVEEALKF 708
Query: 703 AKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSPSYSQVSTVQ 761
AKLALQCAELRRKDRPDLG VV+P+LN LR LAEE M +I L S +SP S VS VQ
Sbjct: 709 AKLALQCAELRRKDRPDLGNVVLPELNRLRTLAEENMSSIMLDSTTVASPRKSNVSIVQ 767
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147860573|emb|CAN79719.1| hypothetical protein VITISV_012742 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2580), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/808 (66%), Positives = 625/808 (77%), Gaps = 58/808 (7%)
Query: 1 MARRNGDKQEEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNS 60
M+R +++ VAVAIDKDKGSQYAL+WAVDHLLS+GQ++TLLH+KQ+ SS+PNP GN
Sbjct: 1 MSRTGYGEKKVEVAVAIDKDKGSQYALKWAVDHLLSKGQSVTLLHIKQKASSIPNPLGNQ 60
Query: 61 VAISKVNNEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSS 120
VAIS VN +VAR YKQQ+DNQA+ELF+PFRCFC RK+I+C E++LE TDI KA+ID+V++
Sbjct: 61 VAISDVNEDVARAYKQQLDNQARELFLPFRCFCMRKDIQCNEVILEGTDITKAIIDFVTA 120
Query: 121 HTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVR 180
+IE LV+GA SR+GF++RFKT D+PS+V K APD+C VYVI KGKI+SVRSAT VP
Sbjct: 121 SSIEILVVGAPSRSGFIRRFKTTDVPSSVLKAAPDFCTVYVISKGKITSVRSATRPVPNP 180
Query: 181 ASPGSQLQSQSRQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIKSPFL 240
+ P + Q S + D E+ + +++S+R A+ER+ +L +D+ IKSPF
Sbjct: 181 SPPPTASSLHQNQASPTPDPTEAHLKHNRSTR----ASERSSFGLRNL--NDLEIKSPFT 234
Query: 241 RGKGSIPKY--EPSLPESDISFVSSGRPSTDRMI---YD-MDFGMTPW------------ 282
RG+ S+ K E S+PE+DISFVSSGRPS D + YD +D GM PW
Sbjct: 235 RGRASLSKSYGELSVPETDISFVSSGRPSIDHIFPFSYDNLDTGMNPWLSNSSEMNPRLS 294
Query: 283 ----------------------------LSTGSDYESSSFVSLQSGSRSIDRNSSPDEFS 314
LS GS+ + SF S SG RS + N S D S
Sbjct: 295 NSSDLNTRLSIGSEMNPRLSNSSDLNTRLSNGSELDCRSFAS--SGGRSSELNYSLD-LS 351
Query: 315 SYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWK 374
S S ESGR S + SQS+E+VE EMRRL+LEL+QTMDMYS ACKEAL+AKQ ARELHRWK
Sbjct: 352 SSSNESGRLSWA--SQSMEDVEAEMRRLKLELKQTMDMYSTACKEALSAKQTARELHRWK 409
Query: 375 LEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVEFKALREA 434
+EE Q+L +AR+AEEAALA AE+E+AK K A+EAAEA+QRIA+LEAQK N E A++EA
Sbjct: 410 MEEAQRLGEARLAEEAALATAEREKAKAKAALEAAEASQRIAKLEAQKRINAEMVAIKEA 469
Query: 435 KERKAALNSLT-VDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKV 493
+ERK LN+L DLRYRKY+IEEIE ATE FS SRKIGEGGYGPVYKSYLDHTPVAIKV
Sbjct: 470 EERKKMLNTLAQTDLRYRKYTIEEIEAATELFSESRKIGEGGYGPVYKSYLDHTPVAIKV 529
Query: 494 LRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGS 553
LRPDAAQGRSQFQQEVEVL IRHPNMVLLLGACPE+GCL+YEYMANGSL+D LFRRG +
Sbjct: 530 LRPDAAQGRSQFQQEVEVLSCIRHPNMVLLLGACPEYGCLVYEYMANGSLDDHLFRRGNT 589
Query: 554 PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613
PVLPWQ+RF+IAAEI T LLFLHQTKPEPLVHRDLKPGNILLDRN+VSKISDVGLARLVP
Sbjct: 590 PVLPWQLRFQIAAEIGTGLLFLHQTKPEPLVHRDLKPGNILLDRNFVSKISDVGLARLVP 649
Query: 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ 673
PSVADSVTQY MTS AGTFCYIDPEYQQTGMLG+KSD+YSLGI+LLQIITAKPPMGL H
Sbjct: 650 PSVADSVTQYLMTSTAGTFCYIDPEYQQTGMLGIKSDIYSLGIMLLQIITAKPPMGLTHY 709
Query: 674 VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733
VER+IE GTF E LDPAV DWPVEEAL AKLALQCAELRRKDRPDLG VV+P+LN LR
Sbjct: 710 VERAIEKGTFAEVLDPAVHDWPVEEALKFAKLALQCAELRRKDRPDLGNVVLPELNRLRT 769
Query: 734 LAEETMPAINLASGAGSSPSYSQVSTVQ 761
LAEE M +I L S +SP S VS VQ
Sbjct: 770 LAEENMSSIMLDSTTVASPRKSNVSIVQ 797
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511423|ref|XP_003524426.1| PREDICTED: U-box domain-containing protein 35-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 939 bits (2427), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/734 (65%), Positives = 579/734 (78%), Gaps = 28/734 (3%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
VAVAI+ +K SQYA +WAVD+LL + Q L LLHV+QRVSS+P P+GN V++ N++VAR
Sbjct: 16 VAVAIENNKTSQYAAKWAVDNLLPKDQALLLLHVRQRVSSIPTPTGNLVSLEG-NDDVAR 74
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
Y QQ+DN++KELF FR FC RK I+CKEI+LED DI+K LI+ +S +++E LVLGAAS
Sbjct: 75 AYMQQMDNESKELFASFRVFCNRKSIQCKEILLEDMDISKGLIEGISKYSVELLVLGAAS 134
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVRASPGSQLQSQSR 192
R+G V RF+T+D+PS VSKGAP +C VY+I KGKISSV++ATA P+ A P ++ + +
Sbjct: 135 RSGLV-RFRTSDVPSLVSKGAPPFCTVYIIAKGKISSVKTATA--PLTAKPPAR--NNTM 189
Query: 193 QPSHSSDSYESAMTNSQSSRVAIS---AAERTPPTTSSLINDDVPIKSPFLR-GKGSIPK 248
QP S + E ++Q +R I ++E+ L +D+ I SPF R G+G+
Sbjct: 190 QPQQSLQTPER--MDTQITRNPIPPRPSSEKPSYIVRQLSSDEDEIISPFTRSGRGNYIS 247
Query: 249 YEPSLPESDISFVSSGRPSTDRM---IYD-MDFGMTPWLSTGSDYESSSFVSLQSGSRSI 304
YE S+P+SDISFVSSGRPS DRM +YD MD G T LSTGSD++ SF S SG++SI
Sbjct: 248 YESSIPDSDISFVSSGRPSVDRMFPSMYDDMDSG-TNRLSTGSDFDVRSFGSSFSGAKSI 306
Query: 305 DRNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAK 364
D ++S SQ+SG + SSS +EVE EMRRL+LEL+QTM++YS+ACKEA+ AK
Sbjct: 307 DHG----DYSFSSQDSGTSMSSSMFS--DEVEAEMRRLKLELKQTMELYSSACKEAMTAK 360
Query: 365 QKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCK 424
QKA EL RWK+EE++KLEDAR+AE ALA+AE+E+ KC A+EAAE +++IAELEAQK
Sbjct: 361 QKALELQRWKVEEQRKLEDARLAEGTALAMAEREKVKCMAAMEAAETSRKIAELEAQKRM 420
Query: 425 NVEFKALREAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL 484
+VE A ++K A RYRKY+IEEIEEAT+ FSNS KIGEGGYGPVY+S L
Sbjct: 421 SVE-----SAHKKKNADILSHSPARYRKYTIEEIEEATKFFSNSLKIGEGGYGPVYRSEL 475
Query: 485 DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLE 544
DHTPVAIKVL+PDAAQGRSQFQQEVEVL IRHPNMVLLLGACPEFGCL+YEYMANGSL+
Sbjct: 476 DHTPVAIKVLKPDAAQGRSQFQQEVEVLSCIRHPNMVLLLGACPEFGCLVYEYMANGSLD 535
Query: 545 DRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 604
D LFRRG P LPWQ+RFRIAAEIAT LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS
Sbjct: 536 DCLFRRGNKPALPWQLRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 595
Query: 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA 664
DVGLARLVPP+VAD+VTQYRMTS AGTFCYIDPEYQQTGMLG+KSD+YSLGI+LLQ+ITA
Sbjct: 596 DVGLARLVPPTVADTVTQYRMTSTAGTFCYIDPEYQQTGMLGIKSDIYSLGIMLLQMITA 655
Query: 665 KPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
KPPMGL H V R+IE GTF + LDPAV DWPVE AL AKLAL CAE+RRKDRPDLGKVV
Sbjct: 656 KPPMGLTHHVGRAIEKGTFADMLDPAVEDWPVEHALHFAKLALACAEMRRKDRPDLGKVV 715
Query: 725 VPKLNILRALAEET 738
+P+LN LR AEE
Sbjct: 716 LPELNKLRDFAEEN 729
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476012|ref|XP_003631778.1| PREDICTED: U-box domain-containing protein 35-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/774 (65%), Positives = 597/774 (77%), Gaps = 33/774 (4%)
Query: 1 MARRNGDKQEEA---VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVS-SVPNP 56
+ R N +K+E VAVAIDKDKGSQ AL+WA+D++L+RGQ + L+HVK + S S P
Sbjct: 3 LGRGNTEKKEGGNPLVAVAIDKDKGSQSALKWAIDNILNRGQTVVLIHVKLKQSHSHSYP 62
Query: 57 SGNSVAISKVNNEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALID 116
+G+ VA ++D+ KELF+PFRCFCTRK+I+CK+++LEDTD+ KALI+
Sbjct: 63 TGDEVA--------------KLDHYTKELFLPFRCFCTRKDIQCKDVILEDTDVVKALIE 108
Query: 117 YVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATAS 176
YVS IE LV+GA ++ GF++RFK DIP +++KGAPD+C VYVI KGKISS RSA+ +
Sbjct: 109 YVSHSAIEVLVVGAPAKGGFLRRFKAIDIPGSITKGAPDFCTVYVISKGKISSTRSASRA 168
Query: 177 VPVRASPGSQLQSQ-SRQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDVP- 234
P + +Q+ +Q S +P S A ++ S ISA E+ P +DD
Sbjct: 169 APAISPLRNQIMNQGSIRPDPSDLPIPHAPSSRAISDDPISAVEKPPVEPPRSSHDDFEH 228
Query: 235 IKSPFLRG-KGSIPKY--EPSLPESDISFVSSGRPSTDRMI---YDMDFGM---TPWLST 285
IKSPF RG +G + E SLP+SDISFVSSGRPSTDRM YD + + P LS
Sbjct: 229 IKSPFTRGARGPNGRSYGEISLPDSDISFVSSGRPSTDRMFPPFYDSNIDIIRSNPRLSN 288
Query: 286 GSDYESSSFVSLQSGSRSIDRNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLE 345
SD ++ +F S Q G +S++ S P EF + SQE+ RTS SSQS E+VE EMRRL+LE
Sbjct: 289 SSDMDNQTFESSQMGRKSMEIGSPP-EFLAISQENDRTSWSSQS--AEDVEAEMRRLKLE 345
Query: 346 LRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRA 405
L+QTMDMYS ACKEAL+AKQKAREL RWKLEE+Q+LE+AR+AEEAALA+AE+E+AK + A
Sbjct: 346 LKQTMDMYSTACKEALSAKQKARELQRWKLEEEQRLEEARLAEEAALAIAEREKAKSRAA 405
Query: 406 IEAAEAAQRIAELEAQKCKNVEFKALREAKERKAALNSLT-VDLRYRKYSIEEIEEATEN 464
IE AEAAQRIAELEAQK N E KA++EA+E+K L+SL D+RYRKY+IEEIE ATE
Sbjct: 406 IEHAEAAQRIAELEAQKRINAEMKAIKEAEEKKKVLDSLAQTDVRYRKYTIEEIESATEF 465
Query: 465 FSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLL 524
FS SRKIGEGGYGPVYK LDHT VAIKVLRPDAAQGRSQFQQEVEVL IRHPNMVLLL
Sbjct: 466 FSESRKIGEGGYGPVYKCNLDHTQVAIKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVLLL 525
Query: 525 GACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
GACPE+GCL+YEYMANGSLEDRLFRRG SP L WQ+RFRIAAEI T LLFLHQTKPEPLV
Sbjct: 526 GACPEYGCLVYEYMANGSLEDRLFRRGDSPPLSWQLRFRIAAEIGTGLLFLHQTKPEPLV 585
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM 644
HRDLKP NILLDRNYVSKISDVGLARLVPPSVAD+VTQYRMTS AGTFCYIDPEYQQTGM
Sbjct: 586 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADNVTQYRMTSTAGTFCYIDPEYQQTGM 645
Query: 645 LGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAK 704
LG+KSDVYSLGI+LLQIITAKPPMGL H VER+IE TF+E LDP VPDWP+EEAL AK
Sbjct: 646 LGIKSDVYSLGIMLLQIITAKPPMGLTHLVERAIEKDTFEEMLDPVVPDWPLEEALSFAK 705
Query: 705 LALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSPSYSQVS 758
+ALQCAELRRKDRPDLGK V+P+LN LR L+EE + + S ++SQVS
Sbjct: 706 IALQCAELRRKDRPDLGKAVLPELNRLRELSEEHLDPTMMGGSQYHSTNHSQVS 759
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527712|ref|XP_003532452.1| PREDICTED: U-box domain-containing protein 35-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 927 bits (2395), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/740 (64%), Positives = 580/740 (78%), Gaps = 26/740 (3%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
VAVAI+ +K SQYA +WAVD+LL + Q L L+HV+Q+ SS+P P+GN V++ N++V R
Sbjct: 16 VAVAIENNKTSQYAAKWAVDNLLPKDQALLLVHVRQKASSIPTPTGNLVSLDG-NDDVTR 74
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
Y QQ+DN++KELF FR FC RK I+CKEI+LED DI+K LI+ +S +++E LVLGAAS
Sbjct: 75 AYMQQMDNESKELFASFRVFCNRKSIQCKEILLEDMDISKGLIEGISKYSVELLVLGAAS 134
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVRASPGSQLQSQSR 192
R+G V RF+ +DIPS VSKGAP +C VY+I KGKISSV+++TA P+ A P ++ + +
Sbjct: 135 RSGLV-RFRISDIPSAVSKGAPPFCTVYIIAKGKISSVKTSTA--PLTAKPSTR--NNTM 189
Query: 193 QPSHSSDSYESAMTNSQSSRVAI---SAAERTPPTTSSLINDDVPIKSPFLR-GKGSIPK 248
QP S + E ++Q +R I S+ E+ L +++ I SPF R G+G+ +
Sbjct: 190 QPLQSFQTPER--MDTQITRNPIPPRSSTEKPSYIVRQLPSNEDEIISPFTRPGRGNC-R 246
Query: 249 YEPSLPESDISFVSSGRPSTDR----MIYDMDFGMTPWLSTGSDYESSSFVSLQSGSRSI 304
YE ++P+SDISFVSSGRPS DR M DMD GM LSTGSD++ SF S SG++SI
Sbjct: 247 YESTIPDSDISFVSSGRPSVDRLFPSMYDDMDSGMNTRLSTGSDFDVRSFGSSFSGAKSI 306
Query: 305 DRNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAK 364
D ++S SQ+SG + SSS + EEVE E+RRL+LEL+QTM+MYS+ CKEA AK
Sbjct: 307 DHG----DYSFSSQDSGTSMSSSMFSASEEVEAEVRRLKLELKQTMEMYSSVCKEATTAK 362
Query: 365 QKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCK 424
QKA EL RWK+EE++KLED R+AE ALA+AE+E+ KC A+++AE +++IAELEAQK
Sbjct: 363 QKALELQRWKVEEQRKLEDTRLAEGTALAMAEREKVKCMAAMKSAETSRKIAELEAQKRI 422
Query: 425 NVEFKALREAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL 484
+VE E K++ + S + +RYRKY+IEEIEEAT+ FSNS KIGEGGYGPVY+S L
Sbjct: 423 SVE----SEHKKKNVDILSHS-PVRYRKYTIEEIEEATKFFSNSLKIGEGGYGPVYRSEL 477
Query: 485 DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLE 544
DHTPVAIKVL+PDAAQGRSQFQQEVEVL IRHPNMVLLLGACPEFGCL+YEYMANGSL+
Sbjct: 478 DHTPVAIKVLKPDAAQGRSQFQQEVEVLSCIRHPNMVLLLGACPEFGCLVYEYMANGSLD 537
Query: 545 DRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 604
D LFRRG P LPWQ+RFRIAAEIAT LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS
Sbjct: 538 DCLFRRGNKPALPWQLRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 597
Query: 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA 664
DVGLARLVPP VAD+VTQYRMTS AGTFCYIDPEYQQTGMLG+KSDVYSLGI+LLQ+ITA
Sbjct: 598 DVGLARLVPPKVADTVTQYRMTSTAGTFCYIDPEYQQTGMLGIKSDVYSLGIMLLQMITA 657
Query: 665 KPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
KPPMGL H V RSIENGTF + LDPAV DWPVE AL AKL+L CAE+RRKDRPDLGKVV
Sbjct: 658 KPPMGLTHHVGRSIENGTFADMLDPAVEDWPVEHALHFAKLSLACAEMRRKDRPDLGKVV 717
Query: 725 VPKLNILRALAEETMPAINL 744
+P+LN LR A+E MP + L
Sbjct: 718 LPELNKLRDFADENMPMMML 737
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554402|ref|XP_002518240.1| ATP binding protein, putative [Ricinus communis] gi|223542587|gb|EEF44126.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2343), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/768 (63%), Positives = 583/768 (75%), Gaps = 23/768 (2%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVN----- 67
VAVAIDKDK SQ AL+WA+DH+L +GQ + L+HVK + S+ S S++ ++N
Sbjct: 21 VAVAIDKDKSSQSALKWAIDHILHKGQTVLLIHVK--LKSISMSSAYSLSTPRMNQIADA 78
Query: 68 NEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLV 127
N + + + D+ KELF+PFRCFCTRK+I+CK++VLE+TDIAKAL++Y + IETLV
Sbjct: 79 NGESMLVCRDPDSLTKELFLPFRCFCTRKDIQCKDVVLEETDIAKALVEYATRTAIETLV 138
Query: 128 LGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVRASPGSQL 187
+GA++++G RFK D P +V KGAPD+C VYVI KGKI S RSA+ P + +QL
Sbjct: 139 VGASNKSGLF-RFKATDTPGSVLKGAPDFCTVYVISKGKIQSTRSASRPPPSLSPMHTQL 197
Query: 188 QSQS--RQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDV-PIKSPFLRGKG 244
+Q+ + ++ + N + E+ P N++ +SPF R
Sbjct: 198 VNQNGVKPLPPPTEILLPQIQNPNPTTAFRRVVEKPPLEQPRRSNEESESFRSPFTRRGL 257
Query: 245 SIPKY-EPSLPESDISFVSSGRPSTDRMI---YD-MDFGM-TPWLSTGSDYES-SSFVSL 297
+ Y E S+P++DISFVSSGRPS DRM YD ++ G LS SD +S SF S+
Sbjct: 258 NGKSYGELSIPDTDISFVSSGRPSIDRMFPAFYDVLEMGARNQRLSNVSDIDSIQSFESM 317
Query: 298 QSGSRSIDRN-SSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAA 356
Q G RSID N SP EFSS S +S R S++SQ +++VE EMRRL+LEL+QTM+MYS A
Sbjct: 318 QFGRRSIDINIGSPPEFSSMSYDSDRLSTASQP--MDDVEAEMRRLKLELKQTMEMYSTA 375
Query: 357 CKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIA 416
CKEAL AK+K REL WKLEE+Q+LE+AR+AEE ALA+AEKE+AK K AIEAAEAAQRIA
Sbjct: 376 CKEALTAKEKTRELQLWKLEEEQRLEEARLAEETALAIAEKEKAKSKAAIEAAEAAQRIA 435
Query: 417 ELEAQKCKNVEFKALREAKERKAALNSLT-VDLRYRKYSIEEIEEATENFSNSRKIGEGG 475
ELEAQK + E KALRE++E+K AL++L D+RYRKYSIEEIE ATE FS SRKIGEGG
Sbjct: 436 ELEAQKRVSAEMKALRESQEKKKALDALAHSDIRYRKYSIEEIEAATEFFSESRKIGEGG 495
Query: 476 YGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIY 535
YGPVYK YLDHT VAIKVLRPDAAQGRSQFQQEVEVL IRHPNMVLLLGACPE+GCL+Y
Sbjct: 496 YGPVYKCYLDHTSVAIKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVLLLGACPEYGCLVY 555
Query: 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595
EYMANGSL+DRLFRRG +P L WQ+RFRIAAEI T+LLFLHQTKPEPLVHRDLKP NILL
Sbjct: 556 EYMANGSLDDRLFRRGNTPPLSWQLRFRIAAEIGTSLLFLHQTKPEPLVHRDLKPANILL 615
Query: 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLG 655
DRNYVSKISDVGLARLVPPSVAD+VTQYRMTS AGTFCYIDPEYQQTGMLG+KSD+YSLG
Sbjct: 616 DRNYVSKISDVGLARLVPPSVADNVTQYRMTSTAGTFCYIDPEYQQTGMLGIKSDIYSLG 675
Query: 656 ILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRK 715
I+ LQI+TAKPPMGL H VERS+E TF+E LDPAVPDWPVEEA A+LAL+C+ELRRK
Sbjct: 676 IMFLQILTAKPPMGLTHHVERSLEKDTFEEMLDPAVPDWPVEEAKCFARLALKCSELRRK 735
Query: 716 DRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSPSYSQVSTVQVS 763
DRPDLG VV+P+LN LR+LAEE M SP SQVS VQ++
Sbjct: 736 DRPDLGNVVLPELNRLRSLAEENMHLALPIPSPNHSPRPSQVS-VQLT 782
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147797909|emb|CAN69465.1| hypothetical protein VITISV_023046 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2336), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/779 (62%), Positives = 581/779 (74%), Gaps = 71/779 (9%)
Query: 1 MARRNGDKQEEA---VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVS-SVPNP 56
+ R N +K+E VAVAIDKDKGSQ AL+WA+D++L+RGQ + L+HVK + S S P
Sbjct: 3 LGRGNTEKKEGGNPLVAVAIDKDKGSQSALKWAIDNILNRGQTVVLIHVKLKQSHSHSYP 62
Query: 57 SGNSVAISKVNNEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALID 116
+G+ VA ++D+ KELF+PFRCFCTRK+I+CK+++LEDTD+ KALI+
Sbjct: 63 TGDEVA--------------KLDHYTKELFLPFRCFCTRKDIQCKDVILEDTDVVKALIE 108
Query: 117 YVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATAS 176
YVS IE LV+GA ++ GF++RFK DIP +++KGAPD+C VYVI KGKISS RSA+ +
Sbjct: 109 YVSHSAIEVLVVGAPAKGGFLRRFKAIDIPGSITKGAPDFCTVYVISKGKISSTRSASRA 168
Query: 177 VPVRASPGSQLQSQSRQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPI- 235
P + +Q+ +Q + R P+ D+PI
Sbjct: 169 APAISPLRNQIMNQ--------------------------GSIRPDPS-------DLPIP 195
Query: 236 KSPFLRGKGSIPKYEPSLPES---------DISFVSSGRPSTDRM---IYDMDFGM---T 280
+P RG S+ + E + + ISFVSSGRPSTDRM YD + +
Sbjct: 196 HAPSSRGHHSLEEQEAQMADHMGKFHYRIRYISFVSSGRPSTDRMFPPFYDSNIDIIRSN 255
Query: 281 PWLSTGSDYESSSFVSLQSGSRSIDRNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMR 340
P LS SD ++ +F S Q G +S++ S P EF + SQE+ RTS S SQS E+VE EMR
Sbjct: 256 PRLSNSSDMDNQTFESSQMGRKSMEIGSPP-EFLAISQENDRTSWS--SQSAEDVEAEMR 312
Query: 341 RLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERA 400
RL+LEL+QTMDMYS ACKEAL+AKQKAREL RWKLEE+Q+LE+AR+AEEAALA+AE+E+A
Sbjct: 313 RLKLELKQTMDMYSTACKEALSAKQKARELQRWKLEEEQRLEEARLAEEAALAIAEREKA 372
Query: 401 KCKRAIEAAEAAQRIAELEAQKCKNVEFKALREAKERKAALNSLT-VDLRYRKYSIEEIE 459
K + AIE AEAAQRIAELEAQK N E KA++EA+E+K L+SL D+RYRKY+IEEIE
Sbjct: 373 KSRAAIEHAEAAQRIAELEAQKRINAEMKAIKEAEEKKKVLDSLAQTDVRYRKYTIEEIE 432
Query: 460 EATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN 519
ATE FS SRKIGEGGYGPVYK LDHT VAIKVLRPDAAQGRSQFQQEVEVL IRHPN
Sbjct: 433 SATEFFSESRKIGEGGYGPVYKCNLDHTQVAIKVLRPDAAQGRSQFQQEVEVLSCIRHPN 492
Query: 520 MVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
MVLLLGACPE+GCL+YEYMANGSLEDRLFRRG SP L WQ+RFRIAAEI T LLFLHQTK
Sbjct: 493 MVLLLGACPEYGCLVYEYMANGSLEDRLFRRGDSPPLSWQLRFRIAAEIGTGLLFLHQTK 552
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
PEPLVHRDLKP NILLDRNYVSKISDVGLARLVPPSVAD+VTQYRMTS AGTFCYIDPEY
Sbjct: 553 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADNVTQYRMTSTAGTFCYIDPEY 612
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEA 699
QQTGMLG+KSDVYSLGI+LLQIITAKPPMGL H VER+IE TF+E LDP VPDWP+EEA
Sbjct: 613 QQTGMLGIKSDVYSLGIMLLQIITAKPPMGLTHLVERAIEKDTFEEMLDPVVPDWPLEEA 672
Query: 700 LILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSPSYSQVS 758
L AK+ALQCAELRRKDRPDLGK V+P+LN LR L+EE + + S ++SQVS
Sbjct: 673 LSFAKIALQCAELRRKDRPDLGKAVLPELNRLRELSEEHLDPTMMGGSQYHSTNHSQVS 731
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520633|ref|XP_003630605.1| U-box domain-containing protein [Medicago truncatula] gi|355524627|gb|AET05081.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2335), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/745 (62%), Positives = 573/745 (76%), Gaps = 31/745 (4%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
VAVAI+ +K SQYA +WAVD+LL + Q+L L+HV+Q+ SS+P +G+ V++ N++V R
Sbjct: 16 VAVAIENNKTSQYAAKWAVDNLLPKDQHLLLVHVRQKASSIPTTTGSHVSVD-ANDDVGR 74
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
Y +Q+DN++KELF FR FC RK I CKE++LED D++KA+I+ + ++IE LVLGA S
Sbjct: 75 AYMRQMDNESKELFSSFRVFCNRKNILCKEVLLEDMDVSKAIIEGIREYSIELLVLGAPS 134
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVRASPGSQLQSQSR 192
R+G V+RF+T+D+PS VSKGAP++C VY+I KGKI SV++AT+ + +A P ++ +
Sbjct: 135 RSGLVRRFRTSDVPSLVSKGAPEFCTVYIISKGKIQSVKTATSPLTPKAMP----RNNAL 190
Query: 193 QPSHSSD--SYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIKSPFLRG-KGSIPKY 249
QP S D + + M N + + P + D+ I SPF +G + + Y
Sbjct: 191 QPQQSPDRINVQQLMRNH-----PLRPSNEKPTYLAHRPGDEGEIISPFTKGARPTHRSY 245
Query: 250 EPSLPESDISFVSSGRPSTDRMI------YDMDFGMTPWLSTGSDYESSSFVSLQSGSRS 303
E S+ +SDISFVSSGRPS DRM D G+TP +S SDY+ SF SL SG +S
Sbjct: 246 ESSISDSDISFVSSGRPSIDRMFPSLYEEMDSGNGITPRISGSSDYDLRSFGSLYSGVKS 305
Query: 304 IDRNSSPDEFSSYSQESGRTSSSSQSQS----VEEVEVEMRRLRLELRQTMDMYSAACKE 359
ID N ++S SQ+SGR+ S SQS +EVE EMRRLRLEL+QTM+MYS ACKE
Sbjct: 306 IDHN----DYSFTSQDSGRSGMSMSSQSRISYSDEVEAEMRRLRLELKQTMEMYSTACKE 361
Query: 360 ALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELE 419
AL AK+KA EL RWKL+E++KLED R +EE +L +AEKERAK K A+EAAEA+++IAELE
Sbjct: 362 ALTAKEKALELQRWKLDEQRKLEDTRFSEETSLEVAEKERAKSKAAMEAAEASRKIAELE 421
Query: 420 AQKCKNVEFKALREAKERKAALNS--LTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYG 477
AQK +VE K+ ++ +RK L RYR+Y+IEEIEEAT FSNS KIGEGGYG
Sbjct: 422 AQKRVSVEMKSNSDSDQRKRTFGDSVLNSPARYRRYTIEEIEEATNYFSNSLKIGEGGYG 481
Query: 478 PVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEY 537
PVY++ LDHT VAIKVL+PDAAQGRSQFQQEVEVL +IRHP+MVLLLGACPEFGCL+YE+
Sbjct: 482 PVYRAELDHTAVAIKVLKPDAAQGRSQFQQEVEVLSSIRHPHMVLLLGACPEFGCLVYEH 541
Query: 538 MANGSLEDRLFRRGGS--PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595
M NGSL+D LFRR S PVLPWQ+RFRIAAEIAT LLFLHQTKPEPLVHRDLKPGNILL
Sbjct: 542 MTNGSLDDCLFRRNNSKLPVLPWQLRFRIAAEIATGLLFLHQTKPEPLVHRDLKPGNILL 601
Query: 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLG 655
DRNYVSKISDVGLARLVPPSVAD+VTQYRMT+ AGTFCYIDPEYQQTGMLG KSD+YSLG
Sbjct: 602 DRNYVSKISDVGLARLVPPSVADTVTQYRMTATAGTFCYIDPEYQQTGMLGTKSDIYSLG 661
Query: 656 ILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRK 715
I+LLQ+ITAKPPMGL+H V RSIE GTFDE LDPAV DWP+E+A+ AKLA+QCAE+RRK
Sbjct: 662 IMLLQMITAKPPMGLSHHVARSIEKGTFDEMLDPAVEDWPIEQAMHFAKLAIQCAEMRRK 721
Query: 716 DRPDLGKVVVPKLNILRALAEETMP 740
DRPDLGKV++P+LN LR A+E MP
Sbjct: 722 DRPDLGKVILPELNKLRDFADENMP 746
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559677|ref|XP_002520858.1| ATP binding protein, putative [Ricinus communis] gi|223539989|gb|EEF41567.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 903 bits (2333), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/773 (60%), Positives = 580/773 (75%), Gaps = 38/773 (4%)
Query: 1 MARRNGDKQEEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNS 60
+AR++ + E++ VAIDKDKGSQYAL+WAVD+ L+RGQ++TLLH+ + S + GN
Sbjct: 8 LARKDSETIEDSTVVAIDKDKGSQYALKWAVDNFLNRGQSVTLLHIALKASPPHSQYGN- 66
Query: 61 VAISKVNNEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSS 120
E+ R Y + ++++ ++LF+PFRCFCTRK+IKC EIV+ED DI KA+++YVS+
Sbjct: 67 -------EEITRTYSKNLESEVRDLFLPFRCFCTRKDIKCHEIVIEDVDIPKAILEYVST 119
Query: 121 HTIETLVLGAASRTGFVKR-FKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPV 179
H IE L+LG +R G + R FK+ D+PS VSK AP++CNVY+I K K+SS RSATA +P
Sbjct: 120 HLIENLILGTPTRGGIIARKFKSTDVPSTVSKSAPEFCNVYIINKAKVSSQRSATAQIPA 179
Query: 180 RASPGS---QLQSQSRQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIK 236
R SP + Q+ Q R PS+ + A T + IS T+ + N D +
Sbjct: 180 RHSPPNSSPQIMLQHR-PSNLA----PADTPHGNRHTRISTGR-----TNLITNWD---R 226
Query: 237 SPFLRGKGSIPKYEPSLPESDISFVSSGRP-STDRMIY----DMDFGMTPWLSTGSDYES 291
SPF RG+ S+ KYEP PE DISFVSSGR STDR+ + D G P ++ ++Y+
Sbjct: 227 SPFTRGRSSLNKYEPYTPEMDISFVSSGRSNSTDRIFSPFNDNSDPGTPPRRTSSTEYDY 286
Query: 292 SSFVSLQSGSRSIDRNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMD 351
SF S+ S S D S +S SQESG+T+ S ++++VE EMRRLRLEL+QTMD
Sbjct: 287 RSFGSVHSAGTSTDLGS---HYSGSSQESGQTTW--YSNNMDDVESEMRRLRLELKQTMD 341
Query: 352 MYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEA 411
MYS+ACKEAL+AKQK RE RWKLEE+ + ++AR+AEEAALAL EKE+AKCK AIEAA+A
Sbjct: 342 MYSSACKEALSAKQKTREYQRWKLEEQHRFDEARIAEEAALALIEKEKAKCKAAIEAAQA 401
Query: 412 AQRIAELEAQKCKNVEFKALREAKERKAALNS-LTVDLRYRKYSIEEIEEATENFSNSRK 470
AQ++AELEAQK ++E K+ E++E K S + D+RYR+Y+IEEIE AT +FS+ K
Sbjct: 402 AQKLAELEAQKRMSLETKSSMESEETKKGKESRVPSDIRYRRYTIEEIEAATNDFSDQLK 461
Query: 471 IGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF 530
IGEGGYGPVYK YLDHT VA+KVLR DAAQG SQF QEVEVL IRHPNMVLLLGACPE
Sbjct: 462 IGEGGYGPVYKCYLDHTEVAVKVLRADAAQGMSQFHQEVEVLSCIRHPNMVLLLGACPEH 521
Query: 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKP 590
GCL+YE+M+NGSL+DRLFRRG + LPWQ+RFRIAAEIAT LLFLHQTKPEPLVHRDLKP
Sbjct: 522 GCLVYEHMSNGSLDDRLFRRGNTLPLPWQMRFRIAAEIATGLLFLHQTKPEPLVHRDLKP 581
Query: 591 GNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSD 650
GNILLDRN+VSKISDVGLARLVPPSVADSVTQYRMTS AGTFCYIDPEYQQTGMLG KSD
Sbjct: 582 GNILLDRNFVSKISDVGLARLVPPSVADSVTQYRMTSTAGTFCYIDPEYQQTGMLGTKSD 641
Query: 651 VYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCA 710
+YS G+LLLQIITAK PMGLAHQVE +I+ G+F E LDP +PDWP++E L AKLALQCA
Sbjct: 642 IYSFGVLLLQIITAKSPMGLAHQVESAIDAGSFAEILDPTIPDWPIQETLSFAKLALQCA 701
Query: 711 ELRRKDRPDLGKVVVPKLNILRALAEETMPAINLAS--GAGSSPSYSQVSTVQ 761
ELR+KDRPDLGKV++P+L+ RA E+ P SSP++S +S++Q
Sbjct: 702 ELRKKDRPDLGKVILPQLSRWRAFGEQNTPYPMFGGIFCTTSSPNHSHISSLQ 754
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520637|ref|XP_003630607.1| U-box domain-containing protein [Medicago truncatula] gi|355524629|gb|AET05083.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2317), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/753 (61%), Positives = 569/753 (75%), Gaps = 47/753 (6%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
VAVAI+ +K SQYA +WAVD+LL + Q+L L+HV+Q+ SS+P +G+ V++ NN+V R
Sbjct: 16 VAVAIENNKTSQYAAKWAVDNLLPKDQHLLLVHVRQKASSIPTTTGSHVSVD-ANNDVGR 74
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
Y +Q+DN++KELF FR FC RK I CKE++LED D++KA+I+ + ++IE LVLGA S
Sbjct: 75 AYMRQMDNESKELFSSFRVFCNRKNILCKEVLLEDMDVSKAIIEGIREYSIELLVLGAPS 134
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVRASPGSQLQSQSR 192
R+G V+ T+D+PS VSKGAP++C VY+I KGKI SV++AT+ + ++A P + LQ
Sbjct: 135 RSGLVR---TSDVPSLVSKGAPEFCTVYIISKGKIQSVKTATSPLTLKAMPRNALQP--- 188
Query: 193 QPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSS----------LINDDVPIKSPFLRG 242
+R+ + +R P SS ++ D I SPF RG
Sbjct: 189 ----------PQQPQQSPNRIDVQQQKRNHPLRSSNEKQTYHARRSVDKDEMI-SPFTRG 237
Query: 243 -KGSIPKYEPSLPESDISFVSSGRPSTDRMIY------DMDFGMTPWLSTGSDYESSSFV 295
+ + YE S+ +SDISFVSSGRPS DRM + D G+TP +S SDY+ SF
Sbjct: 238 ARPTHISYESSISDSDISFVSSGRPSIDRMFHSLYEEMDSGNGITPRISGSSDYDLRSFG 297
Query: 296 SLQSGSRSIDRNSSPDEFSSYSQESGRTSSSSQSQS----VEEVEVEMRRLRLELRQTMD 351
SL SG +SID N ++S SQ SGR+ S SQS ++VE EMRRLRLEL+QTM+
Sbjct: 298 SLYSGVKSIDHN----DYSFTSQGSGRSGMSMSSQSRISNSDKVEAEMRRLRLELKQTME 353
Query: 352 MYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEA 411
MYS ACKEAL AKQKA EL RWKL+E++K+ED R EE +LA+AEKERAKCK A+EAAEA
Sbjct: 354 MYSTACKEALTAKQKALELQRWKLDEERKMEDTRFCEETSLAVAEKERAKCKVAMEAAEA 413
Query: 412 AQRIAELEAQKCKNVEFKALREAKERKAALNS--LTVDLRYRKYSIEEIEEATENFSNSR 469
+++IAELEAQK VE K+ ++ +RK L RYR+Y+IEEIEEAT FSNS
Sbjct: 414 SRKIAELEAQKRMKVEIKSNSDSDQRKRTFGDSVLNSPARYRRYTIEEIEEATNYFSNSL 473
Query: 470 KIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE 529
KIGEGGYGPVY++ LDHT VAIKVL+PDAAQGRSQFQQEVEVL +IRHP+MVLLLGACPE
Sbjct: 474 KIGEGGYGPVYRAELDHTAVAIKVLKPDAAQGRSQFQQEVEVLSSIRHPHMVLLLGACPE 533
Query: 530 FGCLIYEYMANGSLEDRLFRRGGS--PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRD 587
FGCL+YE+M NGSL+D LFRR S PVLPWQ+RFRIAAEIAT LLFLHQTKPEPLVHRD
Sbjct: 534 FGCLVYEHMTNGSLDDCLFRRNNSKLPVLPWQLRFRIAAEIATGLLFLHQTKPEPLVHRD 593
Query: 588 LKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGV 647
LKPGNILLDRNYVSKISDVGLARLVPPSVAD+VTQYRMT+ AGTFCYIDPEYQQTGMLG
Sbjct: 594 LKPGNILLDRNYVSKISDVGLARLVPPSVADTVTQYRMTATAGTFCYIDPEYQQTGMLGT 653
Query: 648 KSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLAL 707
KSD+YSLGI+LLQ+ITA+PPMGL+H V RSIE GTFDE LDPAV DWP+E+A+ AKLA+
Sbjct: 654 KSDIYSLGIMLLQMITARPPMGLSHHVARSIEKGTFDEMLDPAVEDWPIEQAMHFAKLAI 713
Query: 708 QCAELRRKDRPDLGKVVVPKLNILRALAEETMP 740
QCAE+RRKDRPDLGKV++P+LN LR A+E MP
Sbjct: 714 QCAEMRRKDRPDLGKVILPELNKLRDFADENMP 746
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 768 | ||||||
| TAIR|locus:2061012 | 788 | AT2G24370 [Arabidopsis thalian | 0.954 | 0.930 | 0.517 | 2.8e-192 | |
| TAIR|locus:2128131 | 764 | AT4G31230 [Arabidopsis thalian | 0.971 | 0.976 | 0.504 | 3e-188 | |
| TAIR|locus:2015656 | 758 | AT1G16760 [Arabidopsis thalian | 0.407 | 0.412 | 0.752 | 1.4e-181 | |
| TAIR|locus:2063601 | 700 | AT2G07020 [Arabidopsis thalian | 0.671 | 0.737 | 0.529 | 1.5e-175 | |
| TAIR|locus:2087610 | 780 | AT3G20200 [Arabidopsis thalian | 0.402 | 0.396 | 0.706 | 8.8e-171 | |
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.511 | 0.560 | 0.649 | 1.5e-165 | |
| TAIR|locus:2180677 | 703 | AT5G26150 [Arabidopsis thalian | 0.496 | 0.541 | 0.678 | 6.7e-163 | |
| TAIR|locus:2182613 | 731 | AT5G35380 [Arabidopsis thalian | 0.661 | 0.694 | 0.558 | 9.9e-142 | |
| TAIR|locus:2007908 | 728 | AT1G17540 [Arabidopsis thalian | 0.414 | 0.436 | 0.636 | 9.1e-141 | |
| TAIR|locus:2030245 | 697 | AT1G72760 [Arabidopsis thalian | 0.375 | 0.413 | 0.687 | 5e-140 |
| TAIR|locus:2061012 AT2G24370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1863 (660.9 bits), Expect = 2.8e-192, P = 2.8e-192
Identities = 397/767 (51%), Positives = 495/767 (64%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRXXXXXXXXXXXXAISKVNNEVAR 72
VAVAIDKDK SQ+AL+WAVD+LL RGQ++ L+HVK R + +K++ + +
Sbjct: 20 VAVAIDKDKSSQHALKWAVDNLLQRGQSVILVHVKLRPSPLNNSASLHASSAKLSQDSSL 79
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
+ + + +KE+F+PFRCFCTRK+I+C++++LE++D+AKAL++YV+ IE LV+G++S
Sbjct: 80 VCRDP-EGISKEIFLPFRCFCTRKDIQCQDVLLEESDVAKALVEYVNQAAIEVLVVGSSS 138
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVRAXXXXXX----- 187
+ GF++ K DIP +++K APD+C VY+I KGKI ++RSA+ S P+ A
Sbjct: 139 KGGFLRFNKPTDIPGSITKNAPDFCTVYIISKGKIQTMRSASRSAPMTAPLRSSVQPPSL 198
Query: 188 -------XXXXXXXXXXXXXYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIKSPFL 240
+ES S + S ++ S+ + +SPF
Sbjct: 199 KPPQPMPSTSANSLRADRRSFESNQRRSVEDQQRRSMEDQQ---RRSIDDQSESFRSPFT 255
Query: 241 RGKGSIPKY-EPSLPESDISFVSSGRPSTDRM---IYDM-DFGMTP-WLSTGSDYESSSF 294
R +G+ Y + ++PESDISF+SSGRPS DR+ +YD D TP LS SD + SS
Sbjct: 256 R-RGNGRSYGDLTVPESDISFISSGRPSIDRIFPSLYDNNDPSRTPPRLSNFSDMDYSSS 314
Query: 295 VSLQS--GSRSIDRNSSPDEFXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQTMDM 352
+ S G RS+D NS P +F QTM+M
Sbjct: 315 LDQSSNYGRRSVDMNS-PTDFESERFSSASQSIDDVEAEMRRLKLELK-------QTMEM 366
Query: 353 YSAACKEALAAKQKARELHRWKLEEKQKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 412
YS ACKEAL AKQKA EL RWKLEE++K
Sbjct: 367 YSTACKEALTAKQKATELQRWKLEEERKLEEARNAEEAALAIAEKEKAKSKAAMEAAEAA 426
Query: 413 XXXXXXXXQKCKNVEFXXXXXXXXXXXXXNSLT-VDLRYRKYSIEEIEEATENFSNSRKI 471
+K N E +L D+RYRKYSIE+IE ATE F+ KI
Sbjct: 427 QRIAELEAKKRVNAEMKALKESEEKTKALTALANSDVRYRKYSIEDIELATEFFAEKYKI 486
Query: 472 GEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG 531
GEGGYGPVYK YLDHTPVA+KVLRPDAAQGRSQFQQEVEVL IRHPNMVLLLGACPE G
Sbjct: 487 GEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVLLLGACPECG 546
Query: 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPG 591
CL+YE+MANGSLEDRLFR G SP L WQ+RFRIAAEI T LLFLHQ KPEPLVHRDLKPG
Sbjct: 547 CLVYEFMANGSLEDRLFRLGNSPPLSWQMRFRIAAEIGTGLLFLHQAKPEPLVHRDLKPG 606
Query: 592 NILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDV 651
NILLDRN+VSKISDVGLARLVPP+VAD+VTQYRMTS AGTFCYIDPEYQQTGMLGVKSD+
Sbjct: 607 NILLDRNFVSKISDVGLARLVPPTVADTVTQYRMTSTAGTFCYIDPEYQQTGMLGVKSDI 666
Query: 652 YSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAE 711
YSLGI+ LQ+ITAKPPMGL H VER++E GT + LDP V DWP+E+ AKLAL+CAE
Sbjct: 667 YSLGIMFLQLITAKPPMGLTHYVERALEKGTLVDLLDPVVSDWPMEDTEEFAKLALKCAE 726
Query: 712 LRRKDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSPSYSQVS 758
LRRKDRPDL KV++P+LN LR LA+E+ ++ + + SP+ SQ S
Sbjct: 727 LRRKDRPDLAKVILPELNRLRTLADESSHSVVVGNSPLPSPTGSQSS 773
|
|
| TAIR|locus:2128131 AT4G31230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1825 (647.5 bits), Expect = 3.0e-188, P = 3.0e-188
Identities = 386/765 (50%), Positives = 483/765 (63%)
Query: 3 RRNGDKQEEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRXXXXXXXXXXXXA 62
R G + VAVAID+DK SQ AL+WAVD+LL +GQ + L+HVK R
Sbjct: 8 RDGGFGVDGLVAVAIDRDKNSQGALKWAVDNLLQKGQTVVLVHVKPRASSLSTNPSINSN 67
Query: 63 ISKVN--NEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSS 120
SK + N + + + + K+LF+PFRC C+RK+I+CK+++LE++D+A+AL++Y +
Sbjct: 68 SSKTSQINGDSSLVCGEPEGSYKQLFLPFRCLCSRKDIQCKDVLLEESDVARALVEYANQ 127
Query: 121 HTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVR 180
IE LV+G++S+ GF++ K DIP ++K APD+C VY I KGK+S+ ++A+ + P
Sbjct: 128 VMIEVLVVGSSSKGGFLRFNKPIDIPGAITKTAPDFCTVYAITKGKLSTKKTASRAAP-- 185
Query: 181 AXXXXXXXXXXXXXXXXXXXYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIKSPF- 239
SA TN+++ R + + R SL + + P+
Sbjct: 186 -SVSPLRIQLQQNGLKPHPPLPSATTNTRAERQSFESQHRR-----SLDDQSDSFRPPYN 239
Query: 240 LRGKGSIPKYEPSLPESDISFVSSGRPSTDR---MIYD-MDFGMTP-WLSTGSDYESSSF 294
RG E S+P+S+ISF SSGRPS +R +YD D TP LS SD + SF
Sbjct: 240 KRGLTGRSYGELSIPDSEISFNSSGRPSIERNSPSLYDNSDPNRTPPRLSNFSDVDYCSF 299
Query: 295 VSLQSGSRSIDRNSSPDEFXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQTMDMYS 354
S+ G RS+D SSP F QTM+MYS
Sbjct: 300 ESMTFGRRSMDL-SSPTAFSTGSFENERFSSASQGGDDVEAEMRRLKLELK--QTMEMYS 356
Query: 355 AACKEALAAKQKARELHRWKLEEKQKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 414
ACKEAL AK KA EL RWKL E++K
Sbjct: 357 TACKEALTAKHKATELQRWKLAEERKFEEAKLAEEAALAIAEKEKAKSKAAMEAAEAAQR 416
Query: 415 XXXXXXQKCKNVEFXXXXXXXXXXXXXNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEG 474
+K + E N+L D+RYRKYSIEEIE+ATE F + KIGEG
Sbjct: 417 IADIESRKRVDAETKALKESEARTKAVNALAKDVRYRKYSIEEIEDATEFFDDKYKIGEG 476
Query: 475 GYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLI 534
YGPVYK YLDHTPVA+K LRPDAAQGRSQFQ+EVEVLC+IRHPNMVLLLGACPE GCL+
Sbjct: 477 SYGPVYKCYLDHTPVAVKALRPDAAQGRSQFQKEVEVLCSIRHPNMVLLLGACPECGCLV 536
Query: 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNIL 594
YE+MANGSLEDRLFR+G SP L WQ RFRIAAEI T LLFLHQTKPEPLVHRDLKP NIL
Sbjct: 537 YEFMANGSLEDRLFRQGDSPALSWQTRFRIAAEIGTVLLFLHQTKPEPLVHRDLKPANIL 596
Query: 595 LDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSL 654
LDRN+VSK++DVGLARLVPPSVA++VTQY MTS AGTFCYIDPEYQQTGMLGVKSD+YSL
Sbjct: 597 LDRNFVSKLADVGLARLVPPSVANTVTQYHMTSTAGTFCYIDPEYQQTGMLGVKSDIYSL 656
Query: 655 GILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRR 714
GI+ LQ+IT KPPMGL H VER++E G + LDPAV DWPVE+ AKLAL+CAE+RR
Sbjct: 657 GIMFLQLITGKPPMGLTHYVERALEKGNLKDLLDPAVSDWPVEDTTEFAKLALKCAEIRR 716
Query: 715 KDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSPSYSQVST 759
KDRPDL KV++P+LN LR LAEE+ A + + +G +P+ SQ S+
Sbjct: 717 KDRPDLSKVILPELNRLRVLAEESTQAAVVINSSGPTPTESQTSS 761
|
|
| TAIR|locus:2015656 AT1G16760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1243 (442.6 bits), Expect = 1.4e-181, Sum P(3) = 1.4e-181
Identities = 237/315 (75%), Positives = 276/315 (87%)
Query: 448 LRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQ 507
+RYRKYS++EIEE T NF+ SRK+GEGGYGPV++ +LDHT VA+KVLRPDAAQGRSQF +
Sbjct: 433 VRYRKYSVQEIEEGTANFAESRKVGEGGYGPVFRGHLDHTSVAVKVLRPDAAQGRSQFHK 492
Query: 508 EVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
EVEVL IRHPNMVLLLGACPE+G L+YEYMA GSL+DRLFRRG +P + WQ+RFRIAAE
Sbjct: 493 EVEVLSCIRHPNMVLLLGACPEYGILVYEYMARGSLDDRLFRRGNTPPISWQLRFRIAAE 552
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
IAT LLFLHQTKPEP+VHRDLKPGN+LLD NYVSKISDVGLARLVP +VA++VTQYR+TS
Sbjct: 553 IATGLLFLHQTKPEPIVHRDLKPGNVLLDHNYVSKISDVGLARLVP-AVAENVTQYRVTS 611
Query: 628 AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETL 687
AAGTFCYIDPEYQQTGMLGVKSDVYSLGI+LLQ++TAK PMGLA+ VE++IE GT + L
Sbjct: 612 AAGTFCYIDPEYQQTGMLGVKSDVYSLGIMLLQLLTAKQPMGLAYYVEQAIEEGTLKDML 671
Query: 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASG 747
DPAVPDWP+EEAL LAKL+LQCAELRRKDRPDLGK V+P+L+ LR + EE++ ++ A G
Sbjct: 672 DPAVPDWPLEEALSLAKLSLQCAELRRKDRPDLGKEVMPELSRLREIGEESLDSVYYA-G 730
Query: 748 AGSSPSYSQVSTVQV 762
G S SQVS V
Sbjct: 731 QGRSSHPSQVSYTSV 745
|
|
| TAIR|locus:2063601 AT2G07020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1312 (466.9 bits), Expect = 1.5e-175, Sum P(2) = 1.5e-175
Identities = 284/536 (52%), Positives = 333/536 (62%)
Query: 206 TNSQSSRVAISAAERTPPTTSSLINDDVPIKSPFLRGKGSIPKYEPSLPESDISFVSSGR 265
+N+ ++ + A R S I D++ IKSP+LR + Y+ + +SD+SFVSS R
Sbjct: 176 SNANNNNFSPRAQRRLQSVQS--IQDEIEIKSPYLRKEYDQGTYQALVSDSDLSFVSSDR 233
Query: 266 PSTDRMIYDMDFGMTPWLSTG-SDYESSSFVSLQSGSRSIDRNSSPDEFXXXXXXXXXXX 324
PS D W S+Y +SS S +SID SS F
Sbjct: 234 PSMD------------WFEDNRSNYATSSS---SSEKQSIDLCSSYSAFSTSSQESGRLS 278
Query: 325 XXXXXXXXXXXXXXXXXXXXXXXQTMDMYSAACKEALAAKQKARELHRWKLEEKQKXXXX 384
TMDMY++ACKEA+AAK+ ELH+WK E K K
Sbjct: 279 SLSMYSQDDVESEMRRLKLELKY-TMDMYNSACKEAIAAKKTTIELHKWKEERKHKLEEA 337
Query: 385 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQKCKNVEFXXXXXXXXXXXXXNSL 444
QK K +E ++L
Sbjct: 338 ILAKEAAMAIAENEKAKSRAAMEALEAAHRMAETEAQKRKQIETAALREVEHENKAMHAL 397
Query: 445 TVDLR-YRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRS 503
R YRKY+IEEIE+ T FS+S KIGEG YG VYK LD+TPVAIKV+RPDA QGRS
Sbjct: 398 PHSNRMYRKYTIEEIEQGTTKFSDSHKIGEGSYGTVYKGTLDYTPVAIKVVRPDATQGRS 457
Query: 504 QFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR 563
QFQQEVEVL IRHPNMVLLLGAC E+GCL+YEYM+NGSL+D L RRG SPVL WQ+RFR
Sbjct: 458 QFQQEVEVLTCIRHPNMVLLLGACAEYGCLVYEYMSNGSLDDCLLRRGNSPVLSWQLRFR 517
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623
IAAEIAT+L FLHQ KPEPLVHRDLKP NILLD++ VSKISDVGLARLVPP++ D T Y
Sbjct: 518 IAAEIATSLNFLHQLKPEPLVHRDLKPANILLDQHMVSKISDVGLARLVPPTIDDIATHY 577
Query: 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTF 683
RMTS AGT CYIDPEYQQTGMLG KSD+YS GI+LLQI+TAK PMGL +QVE++IE G F
Sbjct: 578 RMTSTAGTLCYIDPEYQQTGMLGTKSDIYSFGIVLLQILTAKTPMGLTNQVEKAIEEGNF 637
Query: 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETM 739
+ LDP V DWP+EEALILAK+ LQCAELRRKDRPDLG VV+P L L LAEE M
Sbjct: 638 AKILDPLVTDWPIEEALILAKIGLQCAELRRKDRPDLGTVVLPGLKRLMNLAEENM 693
|
|
| TAIR|locus:2087610 AT3G20200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1153 (410.9 bits), Expect = 8.8e-171, Sum P(2) = 8.8e-171
Identities = 221/313 (70%), Positives = 265/313 (84%)
Query: 448 LRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQ 507
LRYR+Y I EIEEAT +F + KIGEGGYGPVYK YLDHTPVAIK L+ DA QGRSQFQ+
Sbjct: 436 LRYRRYVIGEIEEATNSFDKANKIGEGGYGPVYKGYLDHTPVAIKALKADAVQGRSQFQR 495
Query: 508 EVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
EVEVL IRHP+MVLL+GACPE+G L+YEYMA GSL DRL++ G +P L W++RFRIAAE
Sbjct: 496 EVEVLSCIRHPHMVLLIGACPEYGVLVYEYMAKGSLADRLYKYGNTPPLSWELRFRIAAE 555
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
+AT LLFLHQTKPEP+VHRDLKPGNIL+D+NYVSKI DVGLA+LVP +VA++VTQ ++S
Sbjct: 556 VATGLLFLHQTKPEPIVHRDLKPGNILIDQNYVSKIGDVGLAKLVP-AVAENVTQCHVSS 614
Query: 628 AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETL 687
AGTFCYIDPEYQQTGMLGVKSDVYS GILLL+++TAK P GLA+ VE+++E G F + L
Sbjct: 615 TAGTFCYIDPEYQQTGMLGVKSDVYSFGILLLELLTAKRPTGLAYTVEQAMEQGKFKDML 674
Query: 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMP--AINLA 745
DPAVP+WPVEEA+ LAK+AL+CA+LRRKDRPDLGK V+P+LN LRA A+ M NL+
Sbjct: 675 DPAVPNWPVEEAMSLAKIALKCAQLRRKDRPDLGKEVLPELNKLRARADTNMEWMMFNLS 734
Query: 746 SGAGSSPSYSQVS 758
G +P++SQVS
Sbjct: 735 RGR-LTPNHSQVS 746
|
|
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1302 (463.4 bits), Expect = 1.5e-165, Sum P(3) = 1.5e-165
Identities = 256/394 (64%), Positives = 294/394 (74%)
Query: 348 QTMDMYSAACKEALAAKQKARELHRWKLEEKQKXXXXXXXXXXXXXXXXXXXXXXXXXXX 407
QTMDMYS+ACKEAL AK+KA EL++WK+EE ++
Sbjct: 304 QTMDMYSSACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAVAEMEKAKCRAALE 363
Query: 408 XXXXXXXXXXXXXQKCKNVEFXXXXXXXXXXXXXNSLTV-DLRYRKYSIEEIEEATENFS 466
Q+ K E ++L D+RYRKYSI+EIE ATE F+
Sbjct: 364 AAEKAQRMAELEGQRRKQAEMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVATERFA 423
Query: 467 NSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
N+RKIGEGGYGPVY LDHTPVAIKVLRPDAAQG+ QFQQEVEVL +IRHP+MVLLLGA
Sbjct: 424 NNRKIGEGGYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLLGA 483
Query: 527 CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
CPE+GCL+YE+M NGSLEDRLFRRG SP L W+ RF+IAAEIATAL FLHQ KPEPLVHR
Sbjct: 484 CPEYGCLVYEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLVHR 543
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLG 646
DLKP NILLD+NYVSKISDVGLARLVP SVA++VTQY MTSAAGTFCYIDPEYQQTG L
Sbjct: 544 DLKPANILLDKNYVSKISDVGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGKLT 603
Query: 647 VKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLA 706
KSD++SLGI+LLQIITAK PMGLAH V R+I+ GTF + LDP VPDWPVEEAL AKL
Sbjct: 604 TKSDIFSLGIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAKLC 663
Query: 707 LQCAELRRKDRPDLGKVVVPKLNILRALAEETMP 740
L+CAELR++DRPDLGK +VP+L LR L ++ P
Sbjct: 664 LRCAELRKRDRPDLGKEIVPELLRLRNLGKDNEP 697
|
|
| TAIR|locus:2180677 AT5G26150 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1318 (469.0 bits), Expect = 6.7e-163, Sum P(3) = 6.7e-163
Identities = 259/382 (67%), Positives = 286/382 (74%)
Query: 348 QTMDMYSAACKEALAAKQKARELHRWKLEEKQKXXXXXXXXXXXXXXXXXXXXXXXXXXX 407
QTMDMYS+ACKEAL AK+KA EL++WK+EE +K
Sbjct: 304 QTMDMYSSACKEALTAKRKANELNQWKIEEARKFEKARLSEEAALAVAEIEKAKCRTAVE 363
Query: 408 XXXXXXXXXXXXXQKCKNVEFXXXXXXXXXXXXXNSLTV-DLRYRKYSIEEIEEATENFS 466
Q+ K E ++L D+RYRKYSIEEIEEATE F+
Sbjct: 364 AAEKAQRMAELEGQRRKQAEMKAVSEEKDKDRAVSALAHNDVRYRKYSIEEIEEATERFA 423
Query: 467 NSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
N RKIGEGGYGPVY LDHTPVAIKVLRPDAAQG+ QFQQEVEVLC+IRHP+MVLLLGA
Sbjct: 424 NHRKIGEGGYGPVYNGELDHTPVAIKVLRPDAAQGKKQFQQEVEVLCSIRHPHMVLLLGA 483
Query: 527 CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
CPE+GCL+YE+M NGSLEDRLFR G SP L W+ RF IAAEIATAL FLHQ KPEPLVHR
Sbjct: 484 CPEYGCLVYEFMENGSLEDRLFRTGNSPPLSWRKRFEIAAEIATALSFLHQAKPEPLVHR 543
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLG 646
DLKP NILLD+NYVSKISDVGLARLVP S+ADSVTQ+ MTSAAGTFCYIDPEYQQTGML
Sbjct: 544 DLKPANILLDKNYVSKISDVGLARLVPASIADSVTQFHMTSAAGTFCYIDPEYQQTGMLT 603
Query: 647 VKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLA 706
KSDVYSLGILLLQIIT +PPMGLAHQV R+I GTF E LDP VPDWPV+EA A LA
Sbjct: 604 TKSDVYSLGILLLQIITGRPPMGLAHQVSRAISKGTFKEMLDPVVPDWPVQEAQSFATLA 663
Query: 707 LQCAELRRKDRPDLGKVVVPKL 728
L+CAELR++DRPDLGK VVP L
Sbjct: 664 LKCAELRKRDRPDLGKEVVPHL 685
|
|
| TAIR|locus:2182613 AT5G35380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1386 (493.0 bits), Expect = 9.9e-142, P = 9.9e-142
Identities = 298/534 (55%), Positives = 354/534 (66%)
Query: 235 IKSPFLRGKGSIPKYEPSLPESDISFVSSGRPSTDRM---IYDMDFGMTPWLSTGSDYES 291
IK RG + Y+PS+ +SDISFVSSGRPS D+M +YD D + P LS S+Y
Sbjct: 195 IKIEIKRGYEGV--YQPSITDSDISFVSSGRPSVDQMFPSLYD-DVDV-PRLSVTSEYGE 250
Query: 292 S--SFVSLQSGSRSIDRNS--SPDEFXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 347
+ SF + S +SID S +P+
Sbjct: 251 NRLSFATTYS-KQSIDLGSPYAPNS----STSFESGRQSFSLQGQDELETEMRRLKMELK 305
Query: 348 QTMDMYSAACKEALAAKQKARELHRWKLEEKQKXXXXXXXXXXXXXXXXXXXXXXXXXXX 407
TM+MY++ACKEA++AK+ A EL +WK E++ K
Sbjct: 306 HTMEMYNSACKEAISAKKAANELLKWKAEKEHKLEEVRLSKEAAMAMAEREKEKSRAAME 365
Query: 408 XXXXXXXXXXXXXQKCKNVEFXXXXXXXXXXXXXNSLTVDLRYRKYSIEEIEEATENFSN 467
+K K++E LRYRKY+IEEIEEATE+FS
Sbjct: 366 AAVAAQKLSDLEAEKRKHIE---------TVDEKKRAVSSLRYRKYTIEEIEEATEDFSP 416
Query: 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
SRK+GEGGYGPVYK LD+T VAIKVLRPDAAQGRSQFQ+EVEVL +RHPNMVLLLGAC
Sbjct: 417 SRKVGEGGYGPVYKGTLDYTKVAIKVLRPDAAQGRSQFQREVEVLTCMRHPNMVLLLGAC 476
Query: 528 PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRD 587
PE+GCL+YEYMANGSL+D LFRRG SP+L WQ+RFRIA+EIAT L FLHQ KPEPLVHRD
Sbjct: 477 PEYGCLVYEYMANGSLDDCLFRRGNSPILSWQLRFRIASEIATGLHFLHQMKPEPLVHRD 536
Query: 588 LKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGV 647
LKPGNILLD+++VSKISDVGLARLVPPSVAD+ TQYRMTS AGTF YIDPEYQQTGMLG
Sbjct: 537 LKPGNILLDQHFVSKISDVGLARLVPPSVADTATQYRMTSTAGTFFYIDPEYQQTGMLGT 596
Query: 648 KSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLAL 707
KSD+YS GI+LLQI+TAKPPMGL H VE++IE GTF E LDPAVPDWP EEAL AKLAL
Sbjct: 597 KSDIYSFGIMLLQILTAKPPMGLTHHVEKAIEKGTFAEMLDPAVPDWPFEEALAAAKLAL 656
Query: 708 QCAELRRKDRPDLGKVVVPKLNILRALAEETMP-AINLASGAGSSPSYSQVSTV 760
QCA+LRRKDRPDLG +V+P+L LR LAEE++ + S SS S + + +
Sbjct: 657 QCAKLRRKDRPDLGNIVLPELKKLRDLAEESIKFGVRQPSPIRSSGSATSIQEI 710
|
|
| TAIR|locus:2007908 AT1G17540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 9.1e-141, Sum P(2) = 9.1e-141
Identities = 203/319 (63%), Positives = 250/319 (78%)
Query: 448 LRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQ 507
+ YR+YSI ++E AT+ FS++ KIGEGGYGPVYK+ L++T VAIK+L+ D +QG QF Q
Sbjct: 392 ISYRRYSIRDVEGATDGFSDALKIGEGGYGPVYKAVLENTSVAIKLLKSDVSQGLKQFNQ 451
Query: 508 EVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
E+EVL +RHPNMV+LLGACPE+GCL+YEYM NG+LEDRLF + +P L W+ RFRIAAE
Sbjct: 452 EIEVLSCMRHPNMVILLGACPEYGCLVYEYMENGTLEDRLFCKDNTPPLSWRARFRIAAE 511
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
IAT LLFLHQ KPEPLVHRDLKP NIL+DR++ SKISDVGLARLVP +VADS + Y MT+
Sbjct: 512 IATGLLFLHQAKPEPLVHRDLKPANILIDRHFTSKISDVGLARLVPAAVADSFSNYHMTA 571
Query: 628 AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETL 687
AAGTFCYIDPEYQQTGMLGVKSD+YS G++LLQIITA P MGL+H+VE++IE E L
Sbjct: 572 AAGTFCYIDPEYQQTGMLGVKSDLYSFGVVLLQIITAMPAMGLSHRVEKAIEKKKLREVL 631
Query: 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASG 747
DP + DWP EE ++LA+LALQC ELR+KDRPDL V++P L+ LR A E N
Sbjct: 632 DPKISDWPEEETMVLAQLALQCCELRKKDRPDLASVLLPALSKLREFATEDHEVHNSDRT 691
Query: 748 AGSSPSYSQVSTVQVS-CQ 765
S +++ V +S CQ
Sbjct: 692 FHVSRAHNLVPLSPISSCQ 710
|
|
| TAIR|locus:2030245 AT1G72760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 5.0e-140, Sum P(3) = 5.0e-140
Identities = 198/288 (68%), Positives = 238/288 (82%)
Query: 450 YRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEV 509
YR+YSI+++E+AT FS++ KIGEGGYGPVYK+ LD+T VAIK+L+ +G QFQQE+
Sbjct: 367 YRRYSIKDVEDATYGFSDALKIGEGGYGPVYKAVLDYTSVAIKILKSGITEGLKQFQQEI 426
Query: 510 EVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIA 569
EVL ++RHPNMV+LLGACPE+GCL+YEYM NG+LEDRLF + +P L W+ RFRIA+EIA
Sbjct: 427 EVLSSMRHPNMVILLGACPEYGCLVYEYMENGTLEDRLFCKNNTPPLSWRARFRIASEIA 486
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
T LLFLHQ KPEPLVHRDLKP NILLD++ KISDVGLARLVPP+VAD+ + Y MTSAA
Sbjct: 487 TGLLFLHQAKPEPLVHRDLKPANILLDKHLTCKISDVGLARLVPPAVADTYSNYHMTSAA 546
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDP 689
GTFCYIDPEYQQTGMLGVKSD+YS G++LLQIITA+P MGL H+VE ++EN E LDP
Sbjct: 547 GTFCYIDPEYQQTGMLGVKSDLYSFGVVLLQIITAQPAMGLGHKVEMAVENNNLREILDP 606
Query: 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737
V +WP EE L LAKLALQC ELR+KDRPDL V++P LN L+ A E
Sbjct: 607 TVSEWPEEETLELAKLALQCCELRKKDRPDLALVLLPALNRLKEFATE 654
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 6.3.2 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 768 | |||
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 1e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-41 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| COG1842 | 225 | COG1842, PspA, Phage shock protein A (IM30), suppr | 4e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-06 | |
| cd05151 | 170 | cd05151, ChoK, Choline Kinase (ChoK) | 4e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| pfam13868 | 349 | pfam13868, Trichoplein, Tumour suppressor, Mitosta | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| COG3064 | 387 | COG3064, TolA, Membrane protein involved in colici | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 4e-04 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 5e-04 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 7e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| PRK00409 | 782 | PRK00409, PRK00409, recombination and DNA strand e | 0.002 | |
| pfam04012 | 220 | pfam04012, PspA_IM30, PspA/IM30 family | 0.002 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 0.002 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 0.003 | |
| COG3064 | 387 | COG3064, TolA, Membrane protein involved in colici | 0.004 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 0.004 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.004 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 1e-64
Identities = 76/153 (49%), Positives = 112/153 (73%), Gaps = 8/153 (5%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
VAVA+DKDK S+ AL+WA+D+L ++GQ + L+HV ++S+P+ SG EVA
Sbjct: 2 VAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGK--------LEVAS 53
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
YKQ+ D +AKEL +P+RCFC+RK ++C+++VLED D+AKA+++YV+ H I LV+GA+S
Sbjct: 54 AYKQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASS 113
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165
F +FK +D+ S+V K APD+C VYV+ KG
Sbjct: 114 DNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 66/198 (33%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 471 IGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNMVLLLGAC 527
+GEGG+G VY + VAIK+++ + + + +E+E+L + HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 528 --PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
L+ EY GSL+D L G L RI +I L +LH ++H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 586 RDLKPGNILLD-RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-YQQTG 643
RDLKP NILLD N K++D GL++L+ + + + GT Y+ PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD------KSLLKTIVGTPAYMAPEVLLGKG 169
Query: 644 MLGVKSDVYSLGILLLQI 661
KSD++SLG++L ++
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 78/243 (32%), Positives = 119/243 (48%), Gaps = 19/243 (7%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNMVLLLG 525
K+GEG +G VY + VAIKV++ + R + +E+++L ++HPN+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 526 AC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
+ L+ EY G L D L +RG + RF +I +AL +LH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLS--EDEARF-YLRQILSALEYLHSKG---I 118
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG 643
VHRDLKP NILLD + K++D GLAR + P ++T+ GT Y+ PE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGE-------KLTTFVGTPEYMAPEVLLGK 171
Query: 644 MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN-GTFDETLDPAVPDWPVEEALIL 702
G D++SLG++L +++T KPP Q+ + G P D E ++
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI 231
Query: 703 AKL 705
KL
Sbjct: 232 RKL 234
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 87/263 (33%), Positives = 125/263 (47%), Gaps = 31/263 (11%)
Query: 469 RKIGEGGYGPVYKSYLD------HTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMV 521
+K+GEG +G VYK L T VA+K L+ A+ + R +F +E ++ + HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 522 LLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
LLG C + ++ EYM G L D L + G L ++ A +IA + +L
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM--ALQIAKGMEYLESKN 122
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT-FCYIDPE 638
VHRDL N L+ N V KISD GL+R + YR ++ PE
Sbjct: 123 ---FVHRDLAARNCLVTENLVVKISDFGLSRDIYED-----DYYRKRGGGKLPIKWMAPE 174
Query: 639 YQQTGMLGVKSDVYSLGILLLQIIT--AKP-PMGLAHQVERSIENGTFDETLDPAVPDWP 695
+ G KSDV+S G+LL +I T +P P +V +E+G L P + P
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG---YRL-PRPENCP 230
Query: 696 VEEALILAKLALQCAELRRKDRP 718
E L +L LQC +DRP
Sbjct: 231 DE----LYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 3e-43
Identities = 86/265 (32%), Positives = 120/265 (45%), Gaps = 30/265 (11%)
Query: 466 SNSRKIGEGGYGPVYKSYLDHTP------VAIKVLRPDA-AQGRSQFQQEVEVLCNIRHP 518
+ +K+GEG +G VYK L VA+K L+ DA Q +F +E ++ + HP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 519 NMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V LLG C E ++ EYM G L L R P L A +IA + +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ +HRDL N L+ N V KISD GL+R + YR ++
Sbjct: 120 S---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYRKRGGKLPIRWMA 171
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVPD 693
PE + G KSDV+S G+LL +I T +P G+ +V ++NG L P
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQ--PP 226
Query: 694 WPVEEALILAKLALQCAELRRKDRP 718
E L L LQC +DRP
Sbjct: 227 NCPPE---LYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 83/265 (31%), Positives = 121/265 (45%), Gaps = 29/265 (10%)
Query: 466 SNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHP 518
+ +K+GEG +G VYK L VA+K L+ DA Q +F +E ++ + HP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 519 NMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V LLG C E ++ EYM G L D L R+ L A +IA + +L
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ +HRDL N L+ N V KISD GL+R + Y++ ++
Sbjct: 121 S---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYKVKGGKLPIRWMA 172
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVPD 693
PE + G KSDV+S G+LL +I T +P G+ +V ++ G P+
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPE 232
Query: 694 WPVEEALILAKLALQCAELRRKDRP 718
L KL LQC +DRP
Sbjct: 233 --------LYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 92/277 (33%), Positives = 124/277 (44%), Gaps = 50/277 (18%)
Query: 469 RKIGEGGYGPVYKSYLD-----HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVL 522
+K+GEG +G VYK L T VA+K L+ DA + R F +E V+ + HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 523 LLGACPEFG--CLIYEYMANGSLEDRL------FRRGGSPVLPWQIRFRIAAEIATALLF 574
LLG C E L+ EYM G L D L F L + A +IA + +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA------ 628
L + VHRDL N L+ + V KISD GL+R V YR +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV-----YDDDYYRKKTGGKLPIR 172
Query: 629 --AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTF 683
A PE + G+ KSDV+S G+LL +I T A P GL +V + G
Sbjct: 173 WMA-------PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR 225
Query: 684 DETLDPAVPDW-PVEEALILAKLALQCAELRRKDRPD 719
P++ P E L +L L C +L +DRP
Sbjct: 226 -----LPKPEYCPDE----LYELMLSCWQLDPEDRPT 253
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 5e-41
Identities = 82/264 (31%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNM 520
+ RK+G G +G VYK+ T VA+K+L+ + + ++E+ +L + HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 521 VLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
V L+ A + L+ EY G L D L R G L +IA +I L +LH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHS- 116
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
++HRDLKP NILLD N V KI+D GLA+ + + +T+ GT Y+ PE
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKL------LKSSSSLTTFVGTPWYMAPE 168
Query: 639 -YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVP-DWPV 696
G K DV+SLG++L +++T KPP + + + L P + D P
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLTGKPP--FSGENILD-QLQLIRRILGPPLEFDEPK 225
Query: 697 EEALI--LAKLALQCAELRRKDRP 718
+ L +C RP
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 80/271 (29%), Positives = 123/271 (45%), Gaps = 20/271 (7%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRS---QFQQEVEVLCNIRHPNM 520
++ RK+GEG +G VY + D VA+KVL +F +E+++L ++ HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 521 V---LLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+ L+ EY+ GSLED L + G L I A+I +AL +LH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 578 TKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ ++HRD+KP NILLDR+ V K+ D GLA+L+P + S +++ GT Y+
Sbjct: 120 ---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 637 PEY---QQTGMLGVKSDVYSLGILLLQIITAKPP------MGLAHQVERSIENGTFDETL 687
PE SD++SLGI L +++T PP Q + I
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 688 DPAVPDWPVEEALILAKLALQCAELRRKDRP 718
P P P + + L + K+R
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 465 FSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVL 522
F KIG+GG+G VYK+ VAIKV++ ++ + + + E+++L +HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 523 LLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
G+ + ++ E+ + GSL+D L + + QI + + E+ L +LH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKELLKGLEYLHSNG- 118
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ 640
++HRD+K NILL + K+ D GL+ ++D+ + M GT ++ PE
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLSA----QLSDTKARNTM---VGTPYWMAPEVI 169
Query: 641 QTGMLGVKSDVYSLGILLLQIITAKPPM 668
K+D++SLGI +++ KPP
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 34/269 (12%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLR--PDAAQGRSQFQQEVEVLCNIRHPN 519
++ +G G +G VY + T +A+K + D+ + ++E+ +L +++HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 520 MVLLLGAC--PEFGCL-IY-EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
+V G+ E L I+ EY++ GSL L + G P IR + +I L +L
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP--EPVIR-KYTRQILEGLAYL 117
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H +VHRD+K NIL+D + V K++D G A+ + D T S GT ++
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAK----RLGDIETGEGTGSVRGTPYWM 170
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIENGTFDETLDPAVP 692
PE + G +D++SLG ++++ T KPP +G I G+ E P +P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI--GSSGEP--PEIP 226
Query: 693 DWPVEEAL-ILAKLALQCAELRR--KDRP 718
+ EEA L K C LRR K RP
Sbjct: 227 EHLSEEAKDFLRK----C--LRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 89/259 (34%), Positives = 121/259 (46%), Gaps = 30/259 (11%)
Query: 469 RKIGEGGYGPVYKS-YLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
RK+G G +G V+ + T VA+K L+P F QE +++ +RH +V L C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 528 PEFGCLIY---EYMANGSLEDRLFRRGGSPV-LPWQIRFRIAAEIATALLFLHQTKPEPL 583
E IY EYM+ GSL D L G + LP + AA+IA + +L
Sbjct: 71 SE-EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYLESRN---Y 124
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG 643
+HRDL NIL+ N V KI+D GLARL + D R A + PE G
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARL----IEDDEYTARE-GAKFPIKWTAPEAANYG 179
Query: 644 MLGVKSDVYSLGILLLQIIT----AKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEA 699
+KSDV+S GILL +I+T P M +V +E G P P+ P E
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMT-NREVLEQVERG----YRMPRPPNCPEE-- 232
Query: 700 LILAKLALQCAELRRKDRP 718
L L LQC + ++RP
Sbjct: 233 --LYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 463 ENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLR-PDAAQGRSQFQQEVEVLCNIRHPN 519
+ + +G+G G VYK A+K + + R Q +E++ L + P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 520 MVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V GA + G ++ EYM GSL D L + G +P + IA +I L +LH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYLHT 117
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
+ ++HRD+KP N+L++ KI+D G+++++ T + + GT Y+ P
Sbjct: 118 KRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLEN------TLDQCNTFVGTVTYMSP 169
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
E Q +D++SLG+ LL+ K P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 72/216 (33%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKS-YLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH 517
E E F+ RK+G G +G V++ + + VAIK+L+ D + FQ+EV+ L +RH
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 518 PNMVLLLGAC----PEFGCLIYEYMANGSLEDRLFRRGGSP---VLPWQIRFRIAAEIAT 570
+++ L C P + +I E M GSL L SP VLP +A ++A
Sbjct: 62 KHLISLFAVCSVGEPVY--IITELMEKGSLLAFL----RSPEGQVLPVASLIDMACQVAE 115
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV---ADSVTQYRMTS 627
+ +L + +HRDL NIL+ + V K++D GLARL+ V +D Y+ T+
Sbjct: 116 GMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA 172
Query: 628 AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
PE G KSDV+S GILL ++ T
Sbjct: 173 ---------PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP------VAIKVLRPDA-AQGRSQFQQEVEVLCNI 515
+ +++GEG +G V D VA+K L Q RS F++E+E+L +
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 516 RHPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
H N+V G C + G LI EY+ +GSL D L R L + F +++I
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF--SSQICKG 121
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
+ +L + +HRDL NIL++ + KISD GLA+++P + S
Sbjct: 122 MDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI-- 176
Query: 632 FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
F Y PE +T SDV+S G+ L ++ T
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 75/259 (28%), Positives = 125/259 (48%), Gaps = 30/259 (11%)
Query: 469 RKIGEGGYGPVYKS-YLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
RK+G G +G V++ + + TPVA+K L+P F E +++ +RHP ++ L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 528 ----PEFGCLIYEYMANGSLEDRLFRRGGSPV-LPWQIRFRIAAEIATALLFLHQTKPEP 582
P + ++ E M GSL + L G + LP I +AA++A+ + +L +
Sbjct: 71 TLEEPIY--IVTELMKYGSLLEYLQGGAGRALKLPQLID--MAAQVASGMAYLEA---QN 123
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT 642
+HRDL N+L+ N + K++D GLAR++ + ++ + + PE
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK-----WTAPEAALY 178
Query: 643 GMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDWPVEEA 699
+KSDV+S GILL +I+T P G+ +V + ++ G P P P E
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG----YRMPCPPGCPKE-- 232
Query: 700 LILAKLALQCAELRRKDRP 718
L + L C + DRP
Sbjct: 233 --LYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVL--RPDAAQGRSQF-QQEVEVLCNI-R 516
++F + IGEG + V + T AIK+L R + + ++ + E EVL +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 517 HPNMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
HP ++ L + L + EY NG L + + G RF AAEI AL +
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK--CTRF-YAAEILLALEY 117
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP----------SVADSVTQYR 624
LH ++HRDLKP NILLD++ KI+D G A+++ P + +
Sbjct: 118 LHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 625 MTSAAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+F Y+ PE G SD+++LG ++ Q++T KPP
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 79/261 (30%), Positives = 122/261 (46%), Gaps = 35/261 (13%)
Query: 470 KIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
K+G G YG VY+ VA+K L+ D + +F +E V+ I+HPN+V LLG C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 528 ---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
P F +I E+M G+L D L R + + +A +I++A+ +L + +
Sbjct: 72 TREPPF-YIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID---PEYQQ 641
HRDL N L+ N++ K++D GL+RL +T T+ AG I PE
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFPIKWTAPESLA 178
Query: 642 TGMLGVKSDVYSLGILLLQIIT----AKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697
+KSDV++ G+LL +I T P + L+ V +E G E + P
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPPK---- 233
Query: 698 EALILAKLALQCAELRRKDRP 718
+ +L C + DRP
Sbjct: 234 ----VYELMRACWQWNPSDRP 250
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 79/261 (30%), Positives = 116/261 (44%), Gaps = 33/261 (12%)
Query: 471 IGEGGYGPVYKSYLDHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
IG+G +G V VA+K L+ D AAQ F E V+ +RHPN+V LLG
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 529 EFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
+ L + EYMA GSL D L RG + V+ + A ++ + +L + VHR
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLG 646
DL N+L+ + V+K+SD GLA+ + T+ PE +
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTA---------PEALREKKFS 177
Query: 647 VKSDVYSLGILLLQIIT----AKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALIL 702
KSDV+S GILL +I + P + L V +E G E + P+ +
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHVEKGYRMEAPEGCPPE--------V 228
Query: 703 AKLALQCAELRRKDRPDLGKV 723
K+ C EL RP ++
Sbjct: 229 YKVMKDCWELDPAKRPTFKQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 73/243 (30%), Positives = 116/243 (47%), Gaps = 38/243 (15%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYL------DH-TPVAIKVLRPDAA-QGRSQFQQEVE 510
E ++GEG +G VYK L T VAIK L+ +A + + +F+QE E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 511 VLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRR--------------GGSP 554
++ +++HPN+V LLG C + C+++EY+A+G L + L R S
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 555 VLPWQIRF-RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613
+ F IA +IA + +L VHRDL N L+ KISD GL+R +
Sbjct: 121 L--DCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 614 PSVADSVTQYRMTSAAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL 670
S YR+ S + ++ PE G +SD++S G++L +I + +P G
Sbjct: 176 -----SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230
Query: 671 AHQ 673
++Q
Sbjct: 231 SNQ 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 41/279 (14%)
Query: 469 RKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNM 520
R++G+G +G VY+ T VAIK + +A+ R +F E V+ ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 521 VLLLGAC----PEFGCLIYEYMANGSLEDRLFRR-------GGSPVLPWQIRFRIAAEIA 569
V LLG P ++ E MA G L+ L R G Q ++AAEIA
Sbjct: 72 VRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS-A 628
+ +L K VHRDL N ++ + KI D G+ R + + YR
Sbjct: 130 DGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET-----DYYRKGGKG 181
Query: 629 AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAH-QVERSIENGTFDE 685
++ PE + G+ KSDV+S G++L ++ T +P GL++ +V + +
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV------- 234
Query: 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+D D P L +L C + K RP ++V
Sbjct: 235 -IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRP--DAAQGRSQFQQEVEVLCNIRHPN 519
N+ IG G +G VYK T VAIK + + QE+++L N++HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 520 MVLLLGACP--EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V +G+ + +I EY NGSL + + G P + ++ L +LH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP---FPESLVAVYVYQVLQGLAYLHE 117
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
+ ++HRD+K NIL ++ V K++D G+A + + V++ S GT ++ P
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVA-----TKLNDVSKDD-ASVVGTPYWMAP 168
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
E + SD++SLG +++++T PP
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKV--LRPDAAQGRSQFQQEVEVLCNIRHPNMVLLL 524
++IG+G +G VY + D +K L + + R EV++L + HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 525 GACPEFGCL--IYEYMANGSLEDRL--FRRGGSP-----VLPWQIRFRIAAEIATALLFL 575
+ E G L + EY G L ++ ++ G P +L W F ++ AL +L
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---F---VQLCLALKYL 119
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H K ++HRD+KP NI L N + K+ D G+++++ +V + T GT Y+
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV------VGTPYYL 170
Query: 636 DPE------YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
PE Y KSD++SLG +L ++ T K P
Sbjct: 171 SPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 83/261 (31%), Positives = 123/261 (47%), Gaps = 34/261 (13%)
Query: 471 IGEGGYGPVYKSY--LDHTPVAIKV--LRPDAAQGR---SQFQQEVEVLCNIRHPNMVLL 523
+G G +G VY+ D A+K L D G+ Q +QE+ +L ++HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 524 LGACPEFGCL-IY-EYMANGSLEDRLFRRGGS---PVLPWQIRFRIAAEIATALLFLHQT 578
LG E L I+ E + GSL +L ++ GS PV+ R +I L +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDR 121
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
VHRD+K NIL+D N V K++D G+A+ V V S G+ ++ PE
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAKQV-------VEFSFAKSFKGSPYWMAPE 171
Query: 639 Y-QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697
Q G G+ +D++SLG +L++ T KPP V + G E P +PD +
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--PPIPDHLSD 229
Query: 698 EALILAKLALQCAELRRKDRP 718
EA L+C + RP
Sbjct: 230 EA---KDFILKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 78/265 (29%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 469 RKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNMVLLLGA 526
KIG+G +G VYK L +T VA+K R + +F QE E+L HPN+V L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 527 CPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
C + + + E + GSL F R L + +++ + A + +L +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLT--FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPP---SVADSVTQYRMTSAAGTFCYIDPEYQQ 641
HRDL N L+ N V KISD G++R +V+D + Q + A PE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA-------PEALN 168
Query: 642 TGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQVERS-IENGTFDETLDPAVPDWPVEE 698
G +SDV+S GILL + + P G+++Q R IE+G P+
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQ-LCPEE---- 223
Query: 699 ALILAKLALQCAELRRKDRPDLGKV 723
+ +L LQC ++RP ++
Sbjct: 224 ---IYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 68/205 (33%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 471 IGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLLLG 525
+G+G +G V + A+KVL+ R + + E +L I HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 526 A--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
A E L+ EY G L L + G + RF AAEI AL +LH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARF-YAAEIVLALEYLHS---LGI 114
Query: 584 VHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT 642
++RDLKP NILLD + ++ K++D GLA+ S R + GT Y+ PE
Sbjct: 115 IYRDLKPENILLDADGHI-KLTDFGLAK------ELSSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 643 GMLGVKSDVYSLGILLLQIITAKPP 667
G D +SLG+LL +++T KPP
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 4e-23
Identities = 71/237 (29%), Positives = 113/237 (47%), Gaps = 40/237 (16%)
Query: 469 RKIGEGGYGPVYK-------SYLDHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNM 520
R IG+G +G V++ Y T VA+K+L+ +A A ++ FQ+E ++ HPN+
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 521 VLLLGACPEFG--CLIYEYMANGSLEDRLFRR-------------------GGSPVLPWQ 559
V LLG C CL++EYMA G L + L R L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 560 IRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619
+ IA ++A + +L + K VHRDL N L+ N V KI+D GL+R + S
Sbjct: 131 EQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY-----S 182
Query: 620 VTQYRMT-SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQ 673
Y+ + + A ++ PE +SDV++ G++L +I + +P G+AH+
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 469 RKIGEGGYGPVYKSYLDHTP----VAIKVLR--PDAAQGRSQFQQEVEVLCNIRHPNMVL 522
++G G G V K H P +A+K +R + A + Q +E+++L P +V
Sbjct: 7 GELGAGNSGVVSKVL--HRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVG 63
Query: 523 LLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
GA G + EYM GSL+ + +P +I +IA + L +LH+
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ 640
++HRD+KP NIL++ K+ D G++ + S+A + GT Y+ PE
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF--------VGTSSYMAPERI 171
Query: 641 QTGMLGVKSDVYSLGILLLQIITAKPP 667
Q VKSD++SLG+ L+++ T + P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 468 SRKIGEGGYGPVYKSY-LD-HTPVAIKVLRPDAAQGRS--QFQQEVEVLCNIRHPNMVLL 523
KIG G +G VY + LD +A+K +R ++ + E++VL ++HPN+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 524 LGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
G E + EY + G+LE+ L G +L + ++ L +LH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL--EHGR-ILDEHVIRVYTLQLLEGLAYLHSHG-- 119
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLA-RLVPPSVADSVTQY--RMTSAAGTFCYIDPE 638
+VHRD+KP NI LD N V K+ D G A +L + T + S AGT Y+ PE
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT-----TTMGEEVQSLAGTPAYMAPE 173
Query: 639 YQ----QTGMLGVKSDVYSLGILLLQIITAKPP 667
G +D++SLG ++L++ T K P
Sbjct: 174 VITGGKGKGHGRA-ADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 470 KIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
+IG G YG VYK+ T VAIKV++ + QQE+ +L RHPN+V G+
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 528 PEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
L + EY GSL+D +++ P+ QI + + E L +LH+T +H
Sbjct: 70 LRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAY-VCRETLKGLAYLHETG---KIH 124
Query: 586 RDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML 645
RD+K NILL + K++D G++ + ++A + S GT ++ PE
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLTATIA------KRKSFIGTPYWMAPEVAAVERK 178
Query: 646 G---VKSDVYSLGILLLQIITAKPPM 668
G K D+++LGI +++ +PPM
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 83/262 (31%), Positives = 123/262 (46%), Gaps = 25/262 (9%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLD-HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
E +K+G G +G V+ Y + HT VAIK L+ + F E ++ ++HP +V
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLV 64
Query: 522 LLLGACP-EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
L E +I EYM NGSL D L G L +AA+IA + F+ +
Sbjct: 65 RLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKN- 122
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG-TFCYIDPEY 639
+HRDL+ NIL+ KI+D GLARL+ +Y A + PE
Sbjct: 123 --YIHRDLRAANILVSETLCCKIADFGLARLI------EDNEYTAREGAKFPIKWTAPEA 174
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAK--PPMGLAH-QVERSIENGTFDETLDPAVPDWPV 696
G +KSDV+S GILL +I+T P G+ + +V +++E G PD
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-----YRMPRPDNCP 229
Query: 697 EEALILAKLALQCAELRRKDRP 718
EE L +L C + + ++RP
Sbjct: 230 EE---LYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 469 RKIGEGGYGPV-YKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
+++G G +G V + VAIK++R + A F +E +V+ + HPN+V L G C
Sbjct: 10 KELGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 528 PEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
+ ++ EYMANG L + L R G L + + +++ A+ +L +H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 586 RDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID---PEYQQT 642
RDL N L+ + V K+SD GLAR V + D QY TS+ GT + PE
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYV---LDD---QY--TSSQGTKFPVKWAPPEVFDY 175
Query: 643 GMLGVKSDVYSLGILLLQIIT 663
KSDV+S G+L+ ++ +
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 80/260 (30%), Positives = 121/260 (46%), Gaps = 31/260 (11%)
Query: 470 KIGEGGYGPVYKSYLDHTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
IGEG +G V + VA+K ++ D AQ F +E V+ + H N+V LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 529 EFGC-LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRD 587
G ++ E M+ G+L + L RG + V Q+ + + ++A + +L K LVHRD
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLESKK---LVHRD 125
Query: 588 LKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGV 647
L NIL+ + V+K+SD GLAR+ V +S + T+ PE +
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA---------PEALKHKKFSS 176
Query: 648 KSDVYSLGILLLQIIT----AKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILA 703
KSDV+S G+LL ++ + P M L +V+ +E G E + D V
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECVEKGYRMEPPEGCPADVYV------- 228
Query: 704 KLALQCAELRRKDRPDLGKV 723
L C E K RP K+
Sbjct: 229 -LMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 38/270 (14%)
Query: 471 IGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLL 524
IG G +G V + L VAIK L+ + + R F E ++ HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 525 GACP--EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
G +I EYM NGSL D+ R Q+ + IA+ + +L +
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQL-VGMLRGIASGMKYLSEMN--- 126
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ-----YRMTSAAGTFCYIDP 637
VHRDL NIL++ N V K+SD GL+R + S A T+ R T+ P
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA---------P 177
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQ-VERSIENGTFDETLDPAVPDW 694
E SDV+S GI++ ++++ +P +++Q V +++E+G L P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPP----- 229
Query: 695 PVEEALILAKLALQCAELRRKDRPDLGKVV 724
P++ L +L L C + R +RP ++V
Sbjct: 230 PMDCPSALYQLMLDCWQKDRNERPTFSQIV 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 468 SRKIGEGGYGPVYKSY-LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
++IG G +G V+ Y L+ VAIK +R + A F +E +V+ + HP +V L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 527 CPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
C E CL++E+M +G L D L + G + + ++ + +L + ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT---FCYIDPEYQQ 641
HRDL N L+ N V K+SD G+ R V QY TS+ GT + PE
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDD------QY--TSSTGTKFPVKWSSPEVFS 174
Query: 642 TGMLGVKSDVYSLGILLLQIIT 663
KSDV+S G+L+ ++ +
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 464 NFSNSRKIGEGGYGPVYK--SYLDHTPVAIKV--LRPDAAQGRSQFQQEVEVLCNIRHPN 519
+F +K+G+G YG VYK D+ A+K L + + R E+ +L ++ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 520 MV-----LLLGACPEFGCLIYEYMANGSLEDRLFRRGGSP-VLPWQIRFRIAAEIATALL 573
++ L G C++ EY G L + +R ++P Q +RI ++ L
Sbjct: 61 IISYKEAFLDG---NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
LH+ K ++HRDLK NILL N + KI D+G+++++ ++A + GT
Sbjct: 118 ALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--------GTPH 166
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
Y+ PE + KSD++SLG LL ++ T PP
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQ----EVEVLCNIRHPNMVL 522
+IGEG YG VYK+ T VA+K +R + + F E+++L +RHPN+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 523 LLGACPEFGC----LIYEYMANGSLED--RLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
L G +++EYM + D L QI+ ++ L +LH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH----DLTGLLDSPEVKFTESQIKC-YMKQLLEGLQYLH 117
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
++HRD+K NIL++ + V K++D GLAR T+ T Y
Sbjct: 118 SNG---ILHRDIKGSNILINNDGVLKLADFGLARPY-----TKRNSADYTNRVITLWYRP 169
Query: 637 PEYQQTGMLGVKS-----DVYSLGILLLQIITAKPPM 668
PE +LG D++S+G +L ++ KP
Sbjct: 170 PEL----LLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 75/264 (28%), Positives = 112/264 (42%), Gaps = 26/264 (9%)
Query: 464 NFSNSRKIGEGGYGPVYKSY--LDHTPVAIKV--LRPDAAQGRSQFQQEVEVLCNIRHPN 519
+F KIG+G +G V+K D A+K L + R + E VL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 520 MVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
++ + + G ++ EY NG L L + G P LP +R +I L LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP-LPEDQVWRFFIQILLGLAHLHS 119
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
K ++HRD+K N+ LD KI D+G+A+L+ + T + T GT Y+ P
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-----TNFANT-IVGTPYYLSP 170
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDWP 695
E + KSDV++LG++L + T K P +Q I G F
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQ-- 228
Query: 696 VEEALILAKLALQCAELRRKDRPD 719
LA+L QC + RPD
Sbjct: 229 ------LAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 469 RKIGEGGYGPVYKSYLDH-------TPVAIKVLR-PDAAQGRSQFQQEVEVLCNIRHPNM 520
R++GEG +G V+ H VA+K L+ + R F++E E+L N +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 521 VLLLGACPEFGCL--IYEYMANGSLEDRLFRRG---------GSPVLPWQIR--FRIAAE 567
V G C E ++EYM +G L L G SP+ + +IA +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
IA+ +++L VHRDL N L+ + V KI D G++R V + V + M
Sbjct: 131 IASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 628 AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGT 682
++ PE +SDV+S G++L +I T +P GL+ +V I G
Sbjct: 188 IR----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 84/264 (31%), Positives = 133/264 (50%), Gaps = 29/264 (10%)
Query: 463 ENFSNSRKIGEGGYGPVY-KSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
E+ +K+G G +G V+ +Y HT VA+K ++P + F E V+ ++H +V
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLV 64
Query: 522 LLLGACP-EFGCLIYEYMANGSLEDRLFRRGGSPV-LPWQIRFRIAAEIATALLFLHQTK 579
L E +I E+MA GSL D L GS LP I F +A+IA + F+ Q
Sbjct: 65 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIEQRN 122
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS--VADSVTQYRMTSAAGTFCYIDP 637
+HRDL+ NIL+ + V KI+D GLAR++ + A ++ + A P
Sbjct: 123 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA-------P 172
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAH-QVERSIENGTFDETLDPAVPDW 694
E G +KSDV+S GILL++I+T P G+++ +V R++E G +
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC---- 228
Query: 695 PVEEALILAKLALQCAELRRKDRP 718
P E L + ++C + R ++RP
Sbjct: 229 PEE----LYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 84/259 (32%), Positives = 123/259 (47%), Gaps = 33/259 (12%)
Query: 470 KIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
K+G+G +G V+ ++ T VAIK L+P + F QE +V+ +RH +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 529 EFGC-LIYEYMANGSLEDRLFRRGGSPV-LPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
E ++ EYM+ GSL D L G + LP + AA+IA+ + ++ + VHR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQIASGMAYVERMN---YVHR 126
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLG 646
DL+ NIL+ N V K++D GLARL + D+ R A + PE G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL----IEDNEYTARQ-GAKFPIKWTAPEAALYGRFT 181
Query: 647 VKSDVYSLGILLLQIITAK--PPMGLAH-----QVERSIENGTFDETLDPAVPDWPVEEA 699
+KSDV+S GILL ++ T P G+ + QVER P P+ P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------PCPPECPES-- 231
Query: 700 LILAKLALQCAELRRKDRP 718
L L QC ++RP
Sbjct: 232 --LHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 16/210 (7%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN 519
E + N KIGEG G VYK+ T VAIK +R Q + E+ ++ + +HPN
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V + L + EYM GSL D + + + QI + + E+ L +LH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAY-VCREVLQGLEYLHS 134
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
++HRD+K NILL ++ K++D G A + + + + S GT ++ P
Sbjct: 135 QN---VIHRDIKSDNILLSKDGSVKLADFGFAAQL------TKEKSKRNSVVGTPYWMAP 185
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
E + G K D++SLGI+ +++ +PP
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 23/223 (10%)
Query: 470 KIGEGGYGPVYK-----SYLDHTPVAIKVLRPDAAQGRSQ-FQQEVEVLCNIRHPNMVLL 523
K+G+G +G V + S PVA+K L+ D F +E ++ ++ H N++ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 524 LG---ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
G P ++ E GSL DRL R+ A +IA + +L +
Sbjct: 62 YGVVLTHPLM--MVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKR- 117
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT-FCYIDPEY 639
+HRDL NILL + KI D GL R +P + Y M F + PE
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALP----QNEDHYVMEEHLKVPFAWCAPES 171
Query: 640 QQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIE 679
+T SDV+ G+ L ++ T +P GL Q+ + I+
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID 214
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 79/268 (29%), Positives = 132/268 (49%), Gaps = 28/268 (10%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH 517
E E+ +K+G G +G V+ Y ++ T VA+K L+P ++ F +E ++ ++H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQH 60
Query: 518 PNMVLLLGACP--EFGCLIYEYMANGSLEDRLFRRGGSPV-LPWQIRFRIAAEIATALLF 574
+V L E +I EYMA GSL D L G V LP I F +A+IA + +
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF--SAQIAEGMAY 118
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG-TFC 633
+ + +HRDL+ N+L+ + + KI+D GLAR++ + +Y A
Sbjct: 119 IERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN------EYTAREGAKFPIK 169
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAK--PPMGLAH-QVERSIENGTFDETLDPA 690
+ PE G +KSDV+S GILL +I+T P G+++ V +++ G P
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG----YRMPR 225
Query: 691 VPDWPVEEALILAKLALQCAELRRKDRP 718
+ + P E L + C + + ++RP
Sbjct: 226 MENCPDE----LYDIMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQ----EVEVLCNIRHP 518
+ K+GEG YG VYK+ T VA+K +R D E+ +L ++HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58
Query: 519 NMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V LL L++EY L+ + + P+ P I+ I ++ L + H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLK-KYLDKRPGPLSPNLIK-SIMYQLLRGLAYCH 115
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ ++HRDLKP NIL++R+ V K++D GLAR + T T Y
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAF------GIPLRTYTHEVVTLWYRA 166
Query: 637 PEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
PE +LG K D++S+G + ++IT KP
Sbjct: 167 PEI----LLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 50/291 (17%)
Query: 470 KIGEGGYGPVY--------------KSYLDHTP--VAIKVLRPDAAQ-GRSQFQQEVEVL 512
K+GEG +G V+ D P VA+K+LR D + R+ F +E++++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 513 CNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRR---------GGSPVLPWQIR 561
+++PN++ LLG C C+I EYM NG L L +R P +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621
+A +IA+ + +L VHRDL N L+ +Y KI+D G++R + S
Sbjct: 132 LYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLY-----SGD 183
Query: 622 QYRMTS-AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQVERSI 678
YR+ A ++ E G SDV++ G+ L ++ T + P L E+ I
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-EQVI 242
Query: 679 EN-GTF-----DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKV 723
EN G F + P P + KL ++C KDRP K+
Sbjct: 243 ENTGEFFRNQGRQIYLSQTPLCPSP----VFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 82/269 (30%), Positives = 127/269 (47%), Gaps = 31/269 (11%)
Query: 459 EEATENFSNSRKIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH 517
E E+ +K+G G +G V+ ++ +T VA+K L+P S F +E +++ +RH
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRH 60
Query: 518 PNMVLLLGACPEFGC-LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
+V L E ++ EYM+ GSL D L + G L +AA++A + ++
Sbjct: 61 DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ +HRDL+ NIL+ V KI+D GLARL + D+ R A +
Sbjct: 120 RMN---YIHRDLRSANILVGDGLVCKIADFGLARL----IEDNEYTARQ-GAKFPIKWTA 171
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAK----PPMG---LAHQVERSIENGTFDETLDP 689
PE G +KSDV+S GILL +++T P M + QVER P
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM--------P 223
Query: 690 AVPDWPVEEALILAKLALQCAELRRKDRP 718
D P+ L +L LQC + ++RP
Sbjct: 224 CPQDCPIS----LHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 70/265 (26%), Positives = 115/265 (43%), Gaps = 25/265 (9%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLR-----PDAAQGRSQFQQEVEVLCNIR 516
N+ + +G+G +G VY Y T +A+K + P+ + + + E+++L N++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 517 HPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
H +V G E + EYM GS++D+L G L + + +I + +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEY 119
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA-RLVPPSVADSVTQYRMTSAAGTFC 633
LH +VHRD+K NIL D K+ D G + RL ++ S T M S GT
Sbjct: 120 LHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTG--MKSVTGTPY 172
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD 693
++ PE G K+DV+S+G +++++T KPP E F P P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA-----EFEAMAAIFKIATQPTNPQ 227
Query: 694 WPVEEALILAKLALQCAELRRKDRP 718
P + + K RP
Sbjct: 228 LPSHVSPDARNFLRRTFVENAKKRP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 56/172 (32%), Positives = 79/172 (45%), Gaps = 32/172 (18%)
Query: 468 SRKIGEGGYGPVYKSYLDHTP------------------VAIKVLRPDAAQ-GRSQFQQE 508
K+GEG +G V+ D VA+KVLRPDA+ R F +E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 509 VEVLCNIRHPNMVLLLGACP--EFGCLIYEYMANGSLEDRLFRR--------GGSPVLPW 558
V++L + PN+ LLG C C+I EYM NG L L + S L +
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 559 QIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+A +IA+ + +L VHRDL N L+ +NY KI+D G++R
Sbjct: 130 STLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 470 KIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
K+G+G +G V+ ++ T VAIK L+P + F QE +++ +RH +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 529 EFGC-LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRD 587
E ++ E+M GSL D L + G L +AA+IA + ++ + +HRD
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 588 LKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGV 647
L+ NIL+ N V KI+D GLARL + D+ R A + PE G +
Sbjct: 128 LRAANILVGDNLVCKIADFGLARL----IEDNEYTARQ-GAKFPIKWTAPEAALYGRFTI 182
Query: 648 KSDVYSLGILLLQIIT 663
KSDV+S GILL +++T
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 471 IGEGGYGPVYKSYLDHTP----VAIKVLRPDAAQGR-SQFQQEVEVLCNIRH---PNMVL 522
IG G YG VY+ H P VA+K++ D S Q+EV +L +R PN+
Sbjct: 9 IGRGAYGAVYRGK--HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 523 LLGAC---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR--IAAEIATALLFLHQ 577
G+ P +I EY GS+ R + G P ++ I E+ AL ++H+
Sbjct: 67 YYGSYLKGPRL-WIIMEYAEGGSV--RTLMKAG----PIAEKYISVIIREVLVALKYIHK 119
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
++HRD+K NIL+ K+ D G+A L+ + + R T GT ++ P
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNSSKRST-FVGTPYWMAP 170
Query: 638 EYQQTG-MLGVKSDVYSLGILLLQIITAKPPM 668
E G K+D++SLGI + ++ T PP
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 471 IGEGGYGPVY----KSYLDHTPVAIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLL 523
I +G YG V+ KS D AIKV++ ++Q Q E ++L + P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 524 LGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
+ + L+ EY+ G L L GS L + AEI AL +LH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLA-SLLENVGS--LDEDVARIYIAEIVLALEYLHSNG-- 113
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLAR--LVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
++HRDLKP NIL+D N K++D GL++ LV + + + GT YI PE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 640 ---QQTGMLGVKSDVYSLGILLLQIITAKPP 667
Q D +SLG +L + + PP
Sbjct: 173 ILGQGHSK---TVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 30/227 (13%)
Query: 471 IGEGGYGPVYKSYL------DHTPVAIKVLRPDAAQGRSQ-FQQEVEVLCNIRHPNMVLL 523
+G G +G VYK PVAIKVLR + + ++ E V+ ++ HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 524 LGACP-EFGCLIYEYMANGSLEDRLF----RRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
LG C LI + M G L D + G +L W +IA + +L +
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEEK 128
Query: 579 KPEPLVHRDLKPGNILLD-RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
+ LVHRDL N+L+ +V KI+D GLA+L+ D +Y ++
Sbjct: 129 R---LVHRDLAARNVLVKTPQHV-KITDFGLAKLLDV---DE-KEYHAEGGKVPIKWMAL 180
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENG 681
E + KSDV+S G+ + +++T AKP G+ A ++ +E G
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 35/270 (12%)
Query: 471 IGEGGYGPVYKSYLDH-----TPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLL 524
IG G +G V + L VAIK L+ + R F E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 525 G----ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
G + P +I E+M NG+L D R+ Q+ + IA + +L +
Sbjct: 72 GVVTKSRPVM--IITEFMENGAL-DSFLRQNDGQFTVIQL-VGMLRGIAAGMKYLSEMN- 126
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG---TFCYIDP 637
VHRDL NIL++ N V K+SD GL+R + +D TS+ G + P
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT----YTSSLGGKIPIRWTAP 180
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQ-VERSIENGTFDETLDPAVPDW 694
E SDV+S GI++ ++++ +P +++Q V +IE D L P D
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---DYRL-PPPMDC 236
Query: 695 PVEEALILAKLALQCAELRRKDRPDLGKVV 724
P L +L L C + R RP G++V
Sbjct: 237 PT----ALHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVL--RPDAAQGRSQFQQEVEVLCNIRHP 518
+ +GEG YG V K T VAIK D + +EV+VL +RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 519 NMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V L A G L++EY+ LE GG LP ++ A+ + H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCH 117
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS--AAGTFCY 634
++HRD+KP NIL+ + V K+ D G AR + A +T Y T A
Sbjct: 118 SHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIITAKP 666
D Y G DV+++G ++ +++ +P
Sbjct: 175 GDTNY------GKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 79/256 (30%), Positives = 113/256 (44%), Gaps = 33/256 (12%)
Query: 471 IGEGGYGPVYKSYLDHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE 529
IG+G +G V VA+K ++ DA AQ F E V+ +RH N+V LLG E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 530 FGCLIY---EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
+Y EYMA GSL D L RG S VL + + ++ A+ +L VHR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLG 646
DL N+L+ + V+K+SD GL + + + T+ PE +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------PEALREKKFS 177
Query: 647 VKSDVYSLGILLLQIIT----AKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALIL 702
KSDV+S GILL +I + P + L V R +E G + D P ++
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPP--------VV 228
Query: 703 AKLALQCAELRRKDRP 718
+ QC L RP
Sbjct: 229 YDVMKQCWHLDAATRP 244
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 465 FSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQ--QEVEVLCNIRHPNM 520
+ KIGEG YG VYK+ L VAIK ++ +E+++L + HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 521 VLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
+ LL G L++E+M + L + + I+ ++ L F H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKS-YLYQLLQGLAFCHSH 117
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
++HRDLKP N+L++ V K++D GLAR T T Y PE
Sbjct: 118 G---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP------VRPYTHYVVTRWYRAPE 168
Query: 639 YQQT-GMLGVKSDVYSLGILLLQIITAKP 666
D++S+G + ++++ +P
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 37/275 (13%)
Query: 464 NFSNSRKIGEGGYGPVY--KSYLDHTPVAIKV--LRPDAAQGRSQFQQEVEVLCNIRHPN 519
+ +KIGEG +G +Y K+ D IK L + + ++EV +L ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGG-----SPVLPWQIRFRIAAEIATAL 572
+V + E G L + EY G L R+ R+ G +L W + +I+ L
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV------QISLGL 114
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
+H K ++HRD+K NI L +N V+K+ D G+AR + S+ + T GT
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT------CVGT 165
Query: 632 FCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM--GLAHQVERSIENGTFDETLDP 689
Y+ PE Q K+D++SLG +L ++ T K P HQ+ I G F P
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF----AP 221
Query: 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
P++ + L L Q ++ +DRP + ++
Sbjct: 222 ISPNFSRD----LRSLISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 79/264 (29%), Positives = 122/264 (46%), Gaps = 33/264 (12%)
Query: 469 RKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVL 522
+++G G +G V K VA+K L+ + A G+ +F +E V+ + HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 523 LLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
L+G C L+ E G L L +R PV + +A ++A + +L
Sbjct: 61 LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESKH- 115
Query: 581 EPLVHRDLKPGNILL-DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG-TFCYIDPE 638
VHRDL N+LL +R+ KISD G++R + A S YR T+A + PE
Sbjct: 116 --FVHRDLAARNVLLVNRHQA-KISDFGMSRALG---AGS-DYYRATTAGRWPLKWYAPE 168
Query: 639 YQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVPDWP 695
G KSDV+S G+ L + + AKP + +V +E+G E L P + P
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---ERL-PRPEECP 224
Query: 696 VEEALILAKLALQCAELRRKDRPD 719
E + + L C + R +DRP
Sbjct: 225 QE----IYSIMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 471 IGEGGYGPVYKSYL-----DHTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLL 524
IG G +G V++ L VAIK L+P + R F E ++ H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 525 GACPEF--GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
G +F +I EYM NG+L D+ R +Q+ + IA + +L
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRG-IAAGMKYLSDMN--- 127
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT 642
VHRDL NIL++ N K+SD GL+R++ D Y + + PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLED---DPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 643 GMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDWPVEEA 699
SDV+S GI++ ++++ +P ++ H+V ++I +G PA D P
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG----FRLPAPMDCPSA-- 238
Query: 700 LILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734
+ +L LQC + R RP +V N+L L
Sbjct: 239 --VYQLMLQCWQQDRARRPRFVDIV----NLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 22/212 (10%)
Query: 469 RKIGEGGYGPVYKSYLDHTP----VAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNMVLL 523
+G G G V K + H P +A KV+ A R Q +E++++ R P +V
Sbjct: 11 SDLGAGNGGSVSK--VKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 524 LGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
GA C+ E+M GSL DR++++GG +P +I +IA + L +L+
Sbjct: 69 YGAFLNENNICMCMEFMDCGSL-DRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNV--H 123
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ 641
++HRD+KP NIL++ K+ D G++ + S+AD+ GT Y+ PE Q
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV--------GTSTYMSPERIQ 175
Query: 642 TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ 673
G VKSDV+SLGI ++++ K P ++
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 464 NFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR 516
N R++GEG +G V+ + D VA+K L+ + R F +E E+L N++
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 517 HPNMVLLLGACPEFGCLI--YEYMANGSLEDRLFRRGGSPVL------PWQIR----FRI 564
H ++V G C E LI +EYM +G L L G VL P ++ I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 565 AAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYR 624
A +IA +++L + VHRDL N L+ N + KI D G++R V + V +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 625 MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
M ++ PE +SDV+SLG++L +I T
Sbjct: 183 MLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQ---EVEVLCNIRH 517
++F + +G G +G V + A+K+L Q + E +L +IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 518 PNMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
P +V L G+ + L + EY+ G L L R+ G P RF AA++ AL +L
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEP-VARF-YAAQVVLALEYL 117
Query: 576 HQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
H +V+RDLKP N+LLD + Y+ KI+D G A+ V R + GT Y
Sbjct: 118 HSLD---IVYRDLKPENLLLDSDGYI-KITDFGFAKRVKG---------RTYTLCGTPEY 164
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+ PE + G D ++LGIL+ +++ PP
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 464 NFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPN 519
+ R +G G +G V+ + D V IK + + R Q E +VL + HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
++ E L + EY G+L + + +R S +L +I AL +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHT 119
Query: 578 TKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
++HRDLK NILLD++ V KI D G+++++ ++ + + GT CYI
Sbjct: 120 KL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVVGTPCYIS 169
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPDW 694
PE + KSD+++LG +L ++ + K A+ + I +GTF D PD
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD- 228
Query: 695 PVEEALILAKLALQCAELRRKDRPDLGKVV 724
L +L L L RP L +++
Sbjct: 229 -------LRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQF-QQEVEVLCNIRHPNMV 521
F+ IG+G +G VYK+ T VAIKV+ + A+ + QQE++ L R P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 522 LLLGACPEFGC---LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
G+ + G +I EY GS D L + G L I E+ L +LH+
Sbjct: 63 KYYGSFLK-GSKLWIIMEYCGGGSCLD-LLKPGK---LDETYIAFILREVLLGLEYLHE- 116
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
E +HRD+K NILL K++D G++ + + T + + GT ++ PE
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFGVSGQL------TSTMSKRNTFVGTPFWMAPE 168
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
+ K+D++SLGI +++ +PP+
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 39/217 (17%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIK-VLRPDAAQGRSQFQQEVEVLCNIRHPN 519
E ++GEG G V K L +T A+K + + Q +E+E+ + + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 520 MVLLLGAC-PEFGCLIY---EYMANGSLE---DRLFRRGGSPVLPWQIRFRIAAEIATAL 572
+V GA E I EY GSL+ ++ +RGG +I ++ +IA ++
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG------RIGEKVLGKIAESV 114
Query: 573 L----FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
L +LH K ++HRD+KP NILL R K+ D G V+ + S
Sbjct: 115 LKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFG------------VSGELVNSL 159
Query: 629 AGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQI 661
AGTF Y+ PE Q + SDV+SLG+ LL++
Sbjct: 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 34/230 (14%)
Query: 470 KIGEGGYGPVYKSYL-----DHTP-VAIKVLRP-DAAQGRSQFQQEVEVLCNIRHPNMVL 522
++GE +G +YK +L DH VAIK L+ + Q +FQQE ++ + HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 523 LLGACPEFG--CLIYEYMANGSLEDRLFRR------GGSPVLPWQIR--------FRIAA 566
LLG + C+++EY+ G L + L R G S ++ IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+IA + +L VH+DL NIL+ KISD+GL+R + S YR+
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY-----SADYYRVQ 183
Query: 627 SAA-GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQ 673
+ ++ PE G SD++S G++L +I + +P G ++Q
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
R++GEG +G V+ + D VA+K L+ R FQ+E E+L N++H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 522 LLLGACPEFGCLI--YEYMANGSLEDRLFRRGGSPVL-----PWQIR--------FRIAA 566
G C + LI +EYM +G L L G ++ P Q + IA+
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+IA+ +++L + VHRDL N L+ N + KI D G++R V + V + M
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
++ PE +SDV+S G++L +I T
Sbjct: 188 PIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVL---CNIRHPNMVLLLG 525
IGEG YG VYK+ T VAIK++ + + ++E +L N HPN+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN--HPNIATFYG 70
Query: 526 AC---PEFGC-----LIYEYMANGSLED--RLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
A G L+ E GS+ D + R+ G + I + I E L +L
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-ILRETLRGLAYL 129
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H+ K ++HRD+K NILL +N K+ D G++ + DS T R + GT ++
Sbjct: 130 HENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL-----DS-TLGRRNTFIGTPYWM 180
Query: 636 DPE-----YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672
PE Q +SDV+SLGI +++ KPP+ H
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 72/269 (26%), Positives = 119/269 (44%), Gaps = 35/269 (13%)
Query: 469 RKIGEGGYGPV--YKSYLDHTPVAIKVL--RPDAAQGRSQFQQEVEVLCNIRHPNMVLLL 524
R +G+G YG V + D IK L R + + R +QE ++L ++HPN+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 525 GACPEFGCLIYEYMA---NGSLEDRLFRRGG-----SPVLPWQIRFRIAAEIATALLFLH 576
+ L+Y M G L +L + G + V+ W + +IA AL +LH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV------QIAMALQYLH 119
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA-AGTFCYI 635
+ + ++HRDLK N+ L R + K+ D+G+AR++ Q M S GT Y+
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-------NQCDMASTLIGTPYYM 169
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWP 695
PE KSDV++LG + ++ T L H N ++ +P P
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMAT------LKHAFNAKDMNSLVYRIIEGKLPPMP 223
Query: 696 VEEALILAKLALQCAELRRKDRPDLGKVV 724
+ + L +L R + RP + ++
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 470 KIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQF-QQEVEVLCNIRHPNMVLLLGA 526
IG G VY + ++ VAIK + + Q ++EV+ + HPN+V +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 527 CPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
L + Y++ GSL D + L I + E+ L +LH +
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QI 124
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV--TQYRMTSAAGTFCYIDPE--YQ 640
HRD+K GNILL + KI+D G V S+AD T+ + GT C++ PE Q
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFG----VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 641 QTGMLGVKSDVYSLGILLLQIITAKPP 667
G K+D++S GI +++ T P
Sbjct: 181 VHGY-DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 471 IGEGGYGPVYKSYLDHTP-------VAIKVLRPDAA-QGRSQFQQEVEVLCNI-RHPNMV 521
+GEG +G V K+ VA+K+L+ DA + S E+E++ I +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 522 LLLGACPEFGCL--IYEYMANGSLEDRLFRR-----GGSPVLPWQIRFRI--------AA 566
LLG C + G L + EY A+G+L D L R SP P + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
++A + FL K +HRDL N+L+ ++V KI+D GLAR + + YR T
Sbjct: 140 QVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHIDYYRKT 191
Query: 627 SAAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
+ ++ PE + +SDV+S G+LL +I T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 465 FSNSRKIGEGGYGP--VYKSYLDHTPVAIKVLRPDAAQG--RSQFQQEVEVLCNIRHPNM 520
+ +KIGEG +G + KS D IK + R + ++EV VL N++HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 521 VLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSP-----VLPWQIRFRIAAEIATALL 573
V + E G L + +Y G L ++ + G +L W + +I AL
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV------QICLALK 115
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
+H K ++HRD+K NI L ++ K+ D G+AR++ +V + T GT
Sbjct: 116 HVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART------CIGTPY 166
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAK 665
Y+ PE + KSD+++LG +L ++ T K
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 57/214 (26%), Positives = 86/214 (40%), Gaps = 26/214 (12%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHTP--------VAIKVLRPDAAQGRSQFQQEVEVLCNI 515
+F R IG+G +G V T K + + + E +L +
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR---NVLNERRILQEL 57
Query: 516 RHPNMVLLLGA-CPEFGC-LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
HP +V L + E L+ + + G L L ++ Q++F EI AL
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKF-WICEIVLALE 114
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
+LH ++HRD+KP NILLD I+D +A V P TS +GT
Sbjct: 115 YLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-------LTTSTSGTPG 164
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Y+ PE V D +SLG+ + + K P
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 471 IGEGGYGPVYKSYLDHTP-VAIK--VLRP---DAAQGRSQ-FQQEVEVLCNIRHPNMVLL 523
+G+G YG VY + +A+K L AA+ + Q+EV++L +++H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 524 LGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
LG C + + E++ GS+ L R G LP + + +I + +LH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNC-- 122
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM-TSAAGTFCYIDPEYQ 640
+VHRD+K N++L N + K+ D G AR + V T M S GT ++ PE
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRL-AWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 641 QTGMLGVKSDVYSLGILLLQIITAKPPM 668
G KSD++S+G + ++ T KPP+
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 40/178 (22%)
Query: 470 KIGEGGYGPVYKSYLDHTP------------------VAIKVLRPDAAQ-GRSQFQQEVE 510
K+GEG +G V+ + + VA+K+LRPDA + R+ F +EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 511 VLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRR----------------GG 552
+L ++ PN++ LLG C + C+I EYM NG L L
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 553 SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
P + + +A +IA+ + +L VHRDL N L+ N KI+D G++R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 43/283 (15%)
Query: 470 KIGEGGYGPVY-----------KSYLDHTP-------VAIKVLRPDAAQ-GRSQFQQEVE 510
K+GEG +G V+ VA+K+LR DA + R+ F +E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 511 VLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFR--------RGGSPVLPWQI 560
++ ++ PN++ LL C C+I EYM NG L L R + + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 561 RFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620
+A +IA+ + +L VHRDL N L+ +NY KI+D G++R + S
Sbjct: 132 LIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLY-----SG 183
Query: 621 TQYRMTS-AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV-ERSI 678
YR+ A ++ E G SDV++ G+ L +I+T + E+ I
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243
Query: 679 EN-GTF--DETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
EN G F D+ +P P L KL L C K+RP
Sbjct: 244 ENTGEFFRDQGRQVYLPK-PALCPDSLYKLMLSCWRRNAKERP 285
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 37/227 (16%)
Query: 507 QEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQ--IRF 562
+E+ ++ + HP+++ +LGA E L E+MA GS+ L + G ++ +
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVII 106
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLA-RLVPPSVADSV 620
++ L +LH+ + ++HRD+K N+L+D +I+D G A RL
Sbjct: 107 NYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMG---------LA 671
Q ++ GT ++ PE + G DV+S+G +++++ TAKPP L
Sbjct: 164 FQGQLL---GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
Query: 672 HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
++ + + E L P + D + L+C EL+ +DRP
Sbjct: 221 FKIASATTAPSIPEHLSPGLRD-----------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 67/217 (30%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 471 IGEGGYGPVYKSYL--------DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMV 521
+G G +G VY+ VA+K LR A Q + +F +E ++ N HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 522 LLLGAC----PEFGCLIYEYMANGS----LEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
LLG C P++ +I E M G L D R G P+L + I ++A +
Sbjct: 63 KLLGVCLLNEPQY--IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 574 FLHQTKPEPLVHRDLKPGNILL-----DRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
+L Q +HRDL N L+ D + V KI D GLAR + S Y
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS------DYYRKEG 171
Query: 629 AGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
G ++ PE G +SDV+S G+L+ +I+T
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 31/214 (14%)
Query: 471 IGEGGYGPVYKSYL----DHTPVAIKVLRPDAAQG-RSQFQQEVEVLCNI-RHPNMVLLL 524
IGEG +G V ++ + AIK+L+ A++ F E+EVLC + HPN++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 525 GACPEFGCL--IYEYMANGSLEDRLFR-------------RGGSPVLPWQIRFRIAAEIA 569
GAC G L EY G+L D L + G + L Q + A+++A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
T + +L + + +HRDL N+L+ N SKI+D GL+R V ++ + +
Sbjct: 130 TGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR--- 183
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
++ E + KSDV+S G+LL +I++
Sbjct: 184 ----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 77/267 (28%), Positives = 119/267 (44%), Gaps = 27/267 (10%)
Query: 469 RKIGEGGYGPVYKSYLD-----HTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVL 522
+ IG G +G V L PVAIK L+ + R F E ++ HPN++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 523 LLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
L G + ++ EYM NGSL D R+ Q+ + IA+ + +L
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQL-VGMLRGIASGMKYLSDMG- 126
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ 640
VHRDL NIL++ N V K+SD GL+R++ D Y + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLED---DPEAAYTTRGGKIPIRWTAPEAI 181
Query: 641 QTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQ-VERSIENGTFDETLDPAVPDWPVE 697
SDV+S GI++ ++++ +P +++Q V ++IE G PA D P
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG----YRLPAPMDCPA- 236
Query: 698 EALILAKLALQCAELRRKDRPDLGKVV 724
L +L L C + R +RP ++V
Sbjct: 237 ---ALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 469 RKIGEGGYGPVYK-SYLDHTP----VAIKVL-RPDAAQGRSQFQQEVEVLCNIRHPNMVL 522
R IG+G +G VY + +D A+K L R + QF +E ++ + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 523 LLGAC-PEFGC--LIYEYMANGSLEDRLFRRGGS--PVLPWQIRFRIAAEIATALLFLHQ 577
LLG C P G ++ YM +G L R F R + P + I F + ++A + +L
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDL--RNFIRSETHNPTVKDLIGFGL--QVAKGMEYLAS 116
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
K VHRDL N +LD ++ K++D GLAR + SV + T A ++
Sbjct: 117 KK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH--TGAKLPVKWMAL 171
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIIT-AKPP 667
E QT KSDV+S G+LL +++T PP
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 202
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 32/274 (11%)
Query: 464 NFSNSRKIGEGGYGPVYKS--YLDHTPVAIK---VLRPDAAQGRSQFQQEVEVLCNIRHP 518
NF +KIG G + VY++ LD PVA+K + A+ R+ +E+++L + HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 519 NMVLLLGACPEFGCL-IYEYMANGSLEDRLFR--RGGSPVLPWQIRFRIAAEIATALLFL 575
N++ + E L I +A+ R+ + + ++P + ++ ++ +AL +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H + ++HRD+KP N+ + V K+ D+GL R + S GT Y+
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA------HSLVGTPYYM 173
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPP-----MGLAHQVERSIENGTFDETLDPA 690
PE KSD++SLG LL ++ + P M L + + + IE + P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCDY-----PP 227
Query: 691 VP-DWPVEEALILAKLALQCAELRRKDRPDLGKV 723
+P D EE L +L C + RPD+ V
Sbjct: 228 LPSDHYSEE---LRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 22/196 (11%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIK--VLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLL 524
+IGEG +G V+K+ T VA+K LR +Q +E++ L +HP +V LL
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 525 GACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
P L+ EYM L + L R P+ Q++ + + ++H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVK-SYMRMLLKGVAYMHANG--- 119
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY--- 639
++HRDLKP N+L+ + V KI+D GLARL + T Y PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLF-----SEEEPRLYSHQVATRWYRAPELLYG 174
Query: 640 QQTGMLGVKSDVYSLG 655
+ GV D++++G
Sbjct: 175 ARKYDPGV--DLWAVG 188
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 470 KIGEGGYGPVYKS-YLD-HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
K+GEG YG VYK+ + + VAIKV+ + + +E+ +L P +V
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIV------ 61
Query: 528 PEFGC--------LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
+G ++ EY GS+ D + + + +I I + L +LH K
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAA-ILYQTLKGLEYLHSNK 119
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
+HRD+K GNILL+ +K++D G++ + + T + + GT ++ PE
Sbjct: 120 ---KIHRDIKAGNILLNEEGQAKLADFGVSGQL------TDTMAKRNTVIGTPFWMAPEV 170
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKPP 667
Q K+D++SLGI +++ KPP
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 469 RKIGEGGYGPVYKSYLDHTPV----AIKVL---RPDAAQGRSQFQQEVEVLCNIRHPNMV 521
+IG G G VYK + H P A+KV+ D R Q +E+E+L ++ HPN+V
Sbjct: 80 NRIGSGAGGTVYK--VIHRPTGRLYALKVIYGNHEDTV--RRQICREIEILRDVNHPNVV 135
Query: 522 LLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAEIATALLFLHQ 577
G + + E+M GSLE +F +A +I + + +LH+
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHI---------ADEQFLADVARQILSGIAYLHR 186
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
+VHRD+KP N+L++ KI+D G++R++ + T S+ GT Y+ P
Sbjct: 187 RH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL------AQTMDPCNSSVGTIAYMSP 237
Query: 638 EYQQT----GML-GVKSDVYSLGILLLQIITAKPPMGLAHQ 673
E T G G D++SLG+ +L+ + P G+ Q
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278
|
Length = 353 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 77/267 (28%), Positives = 115/267 (43%), Gaps = 35/267 (13%)
Query: 470 KIGEGGYGPVYKSYL--DHTPVAIKVLR----PDAAQGRSQFQQEVEVLCNIRHPNMVLL 523
+IG G +G V+ L D+TPVA+K R PD +++F QE +L HPN+V L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRL 58
Query: 524 LGAC----PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
+G C P + ++ E + G F R P L + ++ A + +L +
Sbjct: 59 IGVCTQKQPIY--IVMELVQGGDFLT--FLRTEGPRLKVKELIQMVENAAAGMEYL---E 111
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
+ +HRDL N L+ V KISD G++R V S + T PE
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT----APEA 167
Query: 640 QQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQVER-SIENGTFDETLDPAVPDWPV 696
G +SDV+S GILL + + A P L++Q R +IE G P+
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP-----CPELCP 222
Query: 697 EEALILAKLALQCAELRRKDRPDLGKV 723
+ +L +C E RP V
Sbjct: 223 DAVY---RLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 469 RKIGEGGYGPV----YKSYLDHTP--VAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMV 521
R +GEG +G V Y D T VA+K L+ + Q S +++E+ +L + H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 522 LLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
G C E G LI EY+ GSL D L + + L + F A +I + +LH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN--LAQLLLF--AQQICEGMAYLHS 125
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT--FCYI 635
+HRDL N+LLD + + KI D GLA+ VP + YR+ + F Y
Sbjct: 126 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWYA 178
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIIT 663
E + SDV+S G+ L +++T
Sbjct: 179 -VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 469 RKIGEGGYGPV-YKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
+++G G +G V Y + VAIK+++ + + +F +E +V+ + H +V L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 528 ----PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
P + ++ EYM+NG L + L R G P Q+ + ++ + +L +
Sbjct: 69 TKQRPIY--IVTEYMSNGCLLNYL-REHGKRFQPSQL-LEMCKDVCEGMAYLESKQ---F 121
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT---FCYIDPEYQ 640
+HRDL N L+D K+SD GL+R V + D +Y TS+ G+ + PE
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYV---LDD---EY--TSSVGSKFPVRWSPPEVL 173
Query: 641 QTGMLGVKSDVYSLGILLLQIIT 663
KSDV++ G+L+ ++ +
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 471 IGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
+G+G +G VYK+ T + A K+++ ++ + F E+++L +HPN+V L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 529 EFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
L + E+ G+L D + + QIR+ + ++ AL FLH K ++HR
Sbjct: 73 YENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRY-VCRQMLEALNFLHSHK---VIHR 127
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML- 645
DLK GNILL + K++D G+ S + T + + GT ++ PE
Sbjct: 128 DLKAGNILLTLDGDVKLADFGV------SAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 646 ----GVKSDVYSLGILLLQIITAKPP 667
K+D++SLGI L+++ +PP
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 35/268 (13%)
Query: 471 IGEGGYGPVYKSYLDHTPVAIKV----LRPDAAQGRSQFQQ--------EVEVLCNIRHP 518
IG+G YG VY + T + V L A Q+ E+E L ++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 519 NMVLLLG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V LG E+ + EY+ GS+ R G +RF ++ L +LH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYG-RFEEQLVRF-FTEQVLEGLAYLH 125
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ ++HRDLK N+L+D + + KISD G+++ D + S G+ ++
Sbjct: 126 S---KGILHRDLKADNLLVDADGICKISDFGISK----KSDDIYDNDQNMSMQGSVFWMA 178
Query: 637 PEYQQTGMLG--VKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDW 694
PE + G K D++SLG ++L++ + P + + G + P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN-----KRSAPPI 233
Query: 695 PVEEALILAKLALQ----CAELRRKDRP 718
P + ++ L+ +AL C + +RP
Sbjct: 234 PPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 462 TENFSNSRKIGEGGYGPVYKS--YLDHTPVA---IKVLRPDAAQGRSQFQQEVEVLCNIR 516
NF +KIG+G + VYK+ LD VA +++ A+ R +E+++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 517 HPNMVLLLGACPEFGCLIYEYMANGSLE-------DRL---FRRGGSPVLPWQIRFRIAA 566
HPN++ L + I N LE R+ F++ +P + ++
Sbjct: 61 HPNVIKYLAS------FIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFV 113
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
++ +AL +H + ++HRD+KP N+ + V K+ D+GL R S
Sbjct: 114 QLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAH 164
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
S GT Y+ PE KSD++SLG LL ++ + P
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 470 KIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVL 522
++GEG +G V+ + D VA+K L+ + R FQ+E E+L ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 523 LLGACPEFGCLI--YEYMANGSLEDRLFR---------RGGSPVLPWQIR----FRIAAE 567
G C E L+ +EYM +G L +R R GG V P Q+ IA++
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
IA+ +++L VHRDL N L+ + V KI D G++R + S YR+
Sbjct: 131 IASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-----STDYYRVGG 182
Query: 628 AAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
++ PE +SD++S G++L +I T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 471 IGEGGYGPVYKSYLDHTPV----AIKVLRPDAAQG-RSQFQQEVEVLCNI-RHPNMVLLL 524
IGEG +G V K+ + + AIK ++ A++ F E+EVLC + HPN++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 525 GACPEFGCL--IYEYMANGSLEDRL-----------FRR--GGSPVLPWQIRFRIAAEIA 569
GAC G L EY +G+L D L F + L Q AA++A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
+ +L Q + +HRDL NIL+ NYV+KI+D GL+R V ++ + +
Sbjct: 123 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 176
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
++ E + SDV+S G+LL +I++
Sbjct: 177 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-15
Identities = 60/190 (31%), Positives = 95/190 (50%), Gaps = 16/190 (8%)
Query: 489 VAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVLLL--GAC-PEFGCLIYEYMANGS 542
VAIK+LR DA + R++F++E + + HPN+V LL G P ++EY+ +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 543 LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNY 599
L + L G LP R+ ++ AL H + +VHRDLKP NI++
Sbjct: 66 LREVLAADG---ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119
Query: 600 VSKISDVGLARLVPPS-VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658
+K+ D G+ L+P AD T R T GT Y PE + + SD+Y+ G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 659 LQIITAKPPM 668
L+ +T + +
Sbjct: 180 LECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-15
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 515 IRHPNMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
++HPN+V L+G C LI+EY+ +L + L R L W+ R +IA IA AL
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RN----LSWERRRKIAIGIAKAL 793
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
FLH +V +L P I++D + RL P + + T+ ++SA
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSA---- 843
Query: 633 CYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSI--------ENGTFD 684
Y+ PE ++T + KSD+Y G++L++++T K P V SI + D
Sbjct: 844 -YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902
Query: 685 ETLDPAVP-DWPVEEALIL--AKLALQCAELRRKDRP 718
+DP++ D V + I+ LAL C RP
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM 520
E+F ++IG G YG VYK+ +T AIKV++ + + + QQE+ ++ + +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 521 VLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
V G+ L E+ GSL+D G P+ QI + ++ E L +LH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAY-VSRETLQGLYYLHSK 125
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
+HRD+K NILL N K++D G++ + ++A + S GT ++ PE
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIA------KRKSFIGTPYWMAPE 176
Query: 639 ---YQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
++ G D++++GI +++ +PPM
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGR-SQFQQEVEVLCNIRHPN 519
E F+ +IG+G +G V+K + T VAIK++ + A+ QQE+ VL P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+ G+ + L I EY+ GS D L R G P +QI + EI L +LH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAG--PFDEFQIA-TMLKEILKGLDYLHS 119
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
K +HRD+K N+LL K++D G+A + + TQ + + GT ++ P
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL------TDTQIKRNTFVGTPFWMAP 170
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672
E Q K+D++SLGI +++ +PP H
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-15
Identities = 37/150 (24%), Positives = 62/150 (41%), Gaps = 21/150 (14%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
+ VA+D + S+ ALRWA G L LLHV S
Sbjct: 2 ILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAE---------------- 45
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
+ ++ +A+ L R +K + +VLE D A+A+++ + +V+G+
Sbjct: 46 -LAELLEEEARALLEALREALAEAGVKVETVVLEG-DPAEAILEAAEELGADLIVMGSRG 103
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162
R+G +R + V + AP C V V+
Sbjct: 104 RSGL-RRLLLGSVAERVLRHAP--CPVLVV 130
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPNMVLLLG 525
+G+GG+G V + T A K L R +G E ++L + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 526 A--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
A + CL+ M G L+ ++ G P P AA+I L LHQ +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRI 116
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG 643
V+RDLKP N+LLD + +ISD+GLA + ++ AGT Y+ PE Q
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELK-------GGKKIKGRAGTPGYMAPEVLQGE 169
Query: 644 MLGVKSDVYSLGILLLQIITAKPP 667
+ D ++LG L ++I + P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 40/217 (18%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVL----RPDAAQG--RSQFQQEVEVLCNIRHPNM 520
+K+GEG Y VYK+ VAIK + R +A G + + E+++L ++HPN+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNI 64
Query: 521 VLLLGACPEFG-----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
+ LL FG L++E+M LE ++ + + P I+ L +L
Sbjct: 65 IGLLDV---FGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIK-SYMLMTLRGLEYL 118
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP-PSVADSVTQYRMTSAAGTFCY 634
H ++HRDLKP N+L+ + V K++D GLAR P+ +MT T Y
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-------KMTHQVVTRWY 168
Query: 635 IDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
PE + G + D++S+G + +++ P
Sbjct: 169 RAPEL----LFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 29/262 (11%)
Query: 471 IGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNMVLLLGACP 528
+G+G +G V+K L D TPVA+K + D Q + +F E +L HPN+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 529 EFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
+ ++ E + G L ++ ++F + A A + +L +HR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDA--AAGMAYLESKN---CIHR 117
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADS--VTQYRMTSAAGTFCYIDPEYQQTGM 644
DL N L+ N V KISD G++R + S + Q + A PE G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTA-------PEALNYGR 170
Query: 645 LGVKSDVYSLGILLLQIITAK--PPMGLAHQVER-SIENGTFDETLDPAVPDWPVEEALI 701
+SDV+S GILL + + P G+ +Q R +E G + P ++
Sbjct: 171 YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-----YRMSCPQKCPDD--- 222
Query: 702 LAKLALQCAELRRKDRPDLGKV 723
+ K+ +C + + ++RP ++
Sbjct: 223 VYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 38/277 (13%)
Query: 464 NFSNSRKIGEGGYGPVYKS--YLDHTPVAIK---VLRPDAAQGRSQFQQEVEVLCNIRHP 518
NF +KIG G + VY++ LD PVA+K + A+ R +E+++L + HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 519 NMVLLLGACPEFGCL--IYEYMANGSLEDRL-FRRGGSPVLPWQIRFRIAAEIATALLFL 575
N++ L + E L + E G L + + + ++P + ++ ++ +A+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H + ++HRD+KP N+ + V K+ D+GL R + S GT Y+
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA------HSLVGTPYYM 173
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPP--------MGLAHQVERSIENGTFDETL 687
PE KSD++SLG LL ++ + P L ++E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC---------- 223
Query: 688 DPAVPDWPVEE-ALILAKLALQCAELRRKDRPDLGKV 723
P P E + L +L C RPD+G V
Sbjct: 224 --DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 471 IGEGGYGPVYKSYLD----HTPVAIKVLRPDAAQG-RSQFQQEVEVLCNI-RHPNMVLLL 524
IGEG +G V K+ + AIK ++ A++ F E+EVLC + HPN++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 525 GACPEFGCLIY--EYMANGSLEDRLFR-------------RGGSPVLPWQIRFRIAAEIA 569
GAC G L EY +G+L D L + + L Q AA++A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
+ +L Q + +HRDL NIL+ NYV+KI+D GL+R V ++ + +
Sbjct: 135 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 188
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
++ E + SDV+S G+LL +I++
Sbjct: 189 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM 520
++ +++G G YG VYK+ HT A+K+++ + S QQE+ ++ +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 521 VLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
V G+ E + EY GSL+D G P+ QI + + E L +LH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAY-VCRETLQGLAYLHSK 125
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
+HRD+K NILL N K++D G+A + ++A + S GT ++ PE
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIA------KRKSFIGTPYWMAPE 176
Query: 639 ---YQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
++ G D++++GI +++ +PPM
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 72/219 (32%), Positives = 100/219 (45%), Gaps = 36/219 (16%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQ---QEVEVLCNIRHPN 519
F++ R+IG G +G VY + T VAIK + Q ++Q +EV L +RHPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 520 MVLLLGACPEF-GCLIYEYMA-------NGSLEDRL--FRRGGSPVLPWQIRFRIAAEIA 569
+ E+ GC + E+ A GS D L ++ V IAA
Sbjct: 77 TI-------EYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEV-------EIAAICH 122
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
AL L +HRD+K GNILL K++D G A LV P+ + T Y M A
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWM--AP 180
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
+D E Q G K DV+SLGI +++ KPP+
Sbjct: 181 EVILAMD-EGQYDG----KVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 49/244 (20%)
Query: 444 LTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQG 501
LT+D + + ++E N +IG G G VYK T A+K +R
Sbjct: 3 LTIDGQKYPADLNDLE-------NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR------ 49
Query: 502 RSQFQQEVE-VLCNIRHPNMVLLLGACPE----FGCLIY--------EYMANGSLEDRLF 548
R+ ++E + +L ++ +VL CP +G I E M+ + D+L
Sbjct: 50 RTGNKEENKRILMDLD---VVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLL 104
Query: 549 RRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608
+R P+ P I ++ I AL +L + ++HRD+KP NILLD + K+ D G+
Sbjct: 105 KRIQGPI-PEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI 161
Query: 609 A-RLVPPSVADSVTQYRMTSAAGTFCYIDPEY----QQTGMLGVKSDVYSLGILLLQIIT 663
+ RLV DS + T +AG Y+ PE +++DV+SLGI L+++ T
Sbjct: 162 SGRLV-----DSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213
Query: 664 AKPP 667
+ P
Sbjct: 214 GQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 38/285 (13%)
Query: 469 RKIGEGGYGPVYKSYL---DHTP--VAIKVLRPDAAQGR--SQFQQEVEVLCNIRHPNMV 521
+ +GEG +G V + L D + VA+K ++ D +F E + + HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 522 LLLGACPEFGCL--------IYEYMANGSLEDRLF--RRGGSPV-LPWQIRFRIAAEIAT 570
L+G C E L I +M +G L L R GG P LP Q + +IA
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
+ +L +HRDL N +L + ++D GL++ + S YR A
Sbjct: 125 GMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIY-----SGDYYRQGRIAK 176
Query: 631 T-FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDET 686
+I E + KSDV++ G+ + +I T P G+ H++ + +G
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--RL 234
Query: 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731
P D E L L C KDRP K+ NIL
Sbjct: 235 KQP--EDCLDE----LYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 67/255 (26%), Positives = 108/255 (42%), Gaps = 52/255 (20%)
Query: 463 ENFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLR-PDAAQGRS--QFQQEVEVLCNIRH 517
++ + +G G +G V+ + + A+KV+ P+ + + E VL + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 518 PNMVLLLGACPE--FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR------IAAEIA 569
P ++ L + F ++ EY+ G L L G RF A+EI
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---------RFSNSTGLFYASEIV 111
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
AL +LH + +V+RDLKP NILLD+ K++D G A+ + D R +
Sbjct: 112 CALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK----KLRD-----RTWTLC 159
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMG-----------LAHQVERSI 678
GT Y+ PE Q+ D ++LGIL+ +++ PP LA ++E
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE--- 216
Query: 679 ENGTFDETLDPAVPD 693
F LD D
Sbjct: 217 ----FPRHLDLYAKD 227
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 41/240 (17%)
Query: 470 KIGEGGYGPVYK----SYLDHTPVAIKVL--RPDAAQGRSQFQQEVEVLCNIRHPNMV-- 521
IG+G +G V K S D + K + + + Q EV +L ++HPN+V
Sbjct: 7 TIGKGSFGTVRKVRRKS--DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 522 ----------LLLGACPEFGCLIYEYMANGSLED--RLFRRGGSPVLPWQIRFRIAAEIA 569
L ++ EY G L + ++ + + +RI ++
Sbjct: 65 YDRIIDRSNQTLY--------IVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLL 115
Query: 570 TALLFLH-QTKPEPLV-HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
AL H ++ P V HRDLKP NI LD N K+ D GLA+++ +
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD------SSFAKT 169
Query: 628 AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDE 685
GT Y+ PE KSD++SLG L+ ++ PP +Q++ I+ G F
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 463 ENFSNSRKIGEGGYGPVYKSY---LDHT----PVAIKVLRPDA-AQGRSQFQQEVEVLCN 514
N S + +G G +G V ++ L + VA+K+L+P A + R E++++ +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 515 I-RHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
+ H N+V LLGAC G +I EY G L + L RR L + + ++A
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
+ FL + +HRDL N+LL + KI D GLAR D +
Sbjct: 154 MAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-------DIMNDSNYVVKGNA 203
Query: 632 FC---YIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
++ PE + +SDV+S GILL +I +
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 470 KIGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
++G+G +G VYK+ T V A KV+ + + + E+++L + HPN+V LL A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 528 PEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
L + E+ A G++ D + P+ QIR + + AL +LH+ K ++H
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRV-VCKQTLEALNYLHENK---IIH 126
Query: 586 RDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY-----Q 640
RDLK GNIL + K++D G+ S ++ T R S GT ++ PE
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV------SAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 641 QTGMLGVKSDVYSLGILLLQIITAKPP 667
+ K+DV+SLGI L+++ +PP
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGR-SQFQQEVEVLCNIRHPN 519
E F+ +IG+G +G VYK + T VAIK++ + A+ QQE+ VL P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+ G+ + L I EY+ GS D L + G P+ I I EI L +LH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG--PLEETYIA-TILREILKGLDYLHS 119
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
E +HRD+K N+LL K++D G+A + + TQ + + GT ++ P
Sbjct: 120 ---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL------TDTQIKRNTFVGTPFWMAP 170
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672
E + K+D++SLGI +++ +PP H
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 54/233 (23%)
Query: 471 IGEGGYGPVYKSY--LDHTPVAIKVLR-PDAAQGRSQFQQ-------------EVEVLCN 514
+GEG YG V K+Y L VAIK ++ + + ++ +Q E++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 515 IRHPN-MVLLLGACPE-FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR------IAA 566
I+H N M L+ F L+ + MA L+ ++ R +IR I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLK-KVVDR--------KIRLTESQVKCILL 126
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR------LVPPSVADSV 620
+I L LH+ +HRDL P NI ++ + KI+D GLAR D
Sbjct: 127 QILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 621 TQYR--MTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
Q R MTS T Y PE ++G + D++S+G + +++T KP
Sbjct: 184 MQRREEMTSKVVTLWYRAPEL----LMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 464 NFSNSRKIGEGGYGPVYKSY-------LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR 516
N+ + +G+G +G VY Y L V P+ ++ S + E+++L N++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 517 HPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
H +V G + + EYM GS++D+L G L + + +I +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGM 119
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
+LH +VHRD+K NIL D K+ D G ++ + ++ S T R S GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICMSGTGIR--SVTGTP 173
Query: 633 CYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
++ PE G K+DV+SLG +++++T KPP
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 78/288 (27%), Positives = 127/288 (44%), Gaps = 39/288 (13%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDAA-QGRSQFQQEVE 510
E A E + SR++G+G +G VY+ T VAIK + A+ + R +F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 511 VLCNIRHPNMVLLLGACPEF--GCLIYEYMANGSLEDRLF----RRGGSPVL---PWQIR 561
V+ ++V LLG + +I E M G L+ L +PV +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621
++A EIA + +L+ K VHRDL N ++ ++ KI D G+ R + T
Sbjct: 122 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE------T 172
Query: 622 QYRMTSAAGTFC--YIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAH-QVER 676
Y G ++ PE + G+ SDV+S G++L +I T +P G+++ QV R
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
Query: 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+ G + D PD +L +L C + K RP +++
Sbjct: 233 FVMEGGLLDKPD-NCPD-------MLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 469 RKIGEGGYGP--VYKSYLDHTPVAIKV--LRPDAAQGRSQFQQEVEVLCNIRHPNMVLLL 524
R +G+G +G +Y+ D + V K L + + R E+ +L ++HPN++
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 525 GACPEFGCLI--YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
+ L+ EY G+L D++ R+ G + ++ +I +A+ ++H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ-LFEEEMVLWYLFQIVSAVSYIHK---AG 121
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT-SAAGTFCYIDPEYQQ 641
++HRD+K NI L + + K+ D G+++++ ++Y M + GT Y+ PE Q
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-------SEYSMAETVVGTPYYMSPELCQ 174
Query: 642 TGMLGVKSDVYSLGILLLQIITAK 665
KSD+++LG +L +++T K
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 20/234 (8%)
Query: 458 IEEATENFSNSRKIGEGGYGPVYKS-YLDHT----PVAIKVLRPDAAQGRSQ-FQQEVEV 511
E E+ + R IGEG +G VY+ Y+ VA+K + + + F QE +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 512 LCNIRHPNMVLLLGACPEFGC-LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIAT 570
+ HP++V L+G E ++ E G L L S L + +++T
Sbjct: 61 MRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYS--LDLASLILYSYQLST 118
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
AL +L + VHRD+ N+L+ K+ D GL+R + + + Y+ +
Sbjct: 119 ALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL-----EDESYYKASKGKL 170
Query: 631 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQ-VERSIENG 681
++ PE SDV+ G+ + +I+ KP G+ + V IENG
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG 224
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 22/242 (9%)
Query: 471 IGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQ---------FQQEVEVLCNIRHPN 519
IG G +G VY + +A+K + + S+ +E+ +L ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 520 MVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V LG+ + + EY+ GS+ L G + +I L +LH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHN 124
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
++HRD+K NIL+D KISD G+++ + + + T S G+ ++ P
Sbjct: 125 RG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697
E + K+D++SLG L+++++T K P Q++ + G E P +P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---ENASPEIPSNISS 238
Query: 698 EA 699
EA
Sbjct: 239 EA 240
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 40/236 (16%)
Query: 471 IGEGGYGPVYKSYLDH-------TPVAIKVLRPDAAQGR-SQFQQEVEVLCNIRHPNMVL 522
+GEG +G V K+ T VA+K+L+ +A+ E +L + HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 523 LLGACPEFG--CLIYEYMANGSLED--RLFRR-GGSPVLPWQIR---------------- 561
L GAC + G LI EY GSL R R+ G S + R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 562 --FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619
A +I+ + +L + K LVHRDL N+L+ KISD GL+R V +
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSR----DVYEE 180
Query: 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQ 673
+ + + ++ E + +SDV+S G+LL +I+T P G+A +
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 18/218 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGR-SQFQQEVEVLCNIRHPN 519
E F+ KIG+G +G V+K + T VAIK++ + A+ QQE+ VL P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+ G+ + L I EY+ GS D L G P+ QI I EI L +LH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIA-TILREILKGLDYLHS 119
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
K +HRD+K N+LL + K++D G+A + + TQ + + GT ++ P
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL------TDTQIKRNTFVGTPFWMAP 170
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE 675
E + K+D++SLGI +++ +PP H ++
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 33/226 (14%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEV 511
+I + + + ++ KIG+G G VY + T VAIK + + E+ V
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 512 LCNIRHPNMVLLLGA---CPEFGCLIYEYMANGSLEDRL----FRRGGSPVLPWQIRFRI 564
+ +HPN+V L + E ++ EY+A GSL D + G +I
Sbjct: 70 MRENKHPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETCMDEG-----------QI 117
Query: 565 AA---EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621
AA E AL FLH + ++HRD+K NILL + K++D G + P
Sbjct: 118 AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------ 168
Query: 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Q + ++ GT ++ PE G K D++SLGI+ ++++ +PP
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 469 RKIGEGGYGPVY-KSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
+++G G +G V+ + VAIK + + A F +E +V+ + HP +V L G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 528 ----PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
P + ++ E+M NG L + L +R G L + + ++ + +L +
Sbjct: 69 TQQKPLY--IVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---F 121
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG-TFCYIDPEYQQT 642
+HRDL N L+ V K+SD G+ R V + D +Y +S A + PE
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYV---LDD---EYTSSSGAKFPVKWSPPEVFNF 175
Query: 643 GMLGVKSDVYSLGILLLQIIT 663
KSDV+S G+L+ ++ T
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 24/160 (15%)
Query: 469 RKIGEGGYGPVYK--SYLDHTPVAIKVLR------PDAAQGRSQFQQEVEVLCNI-RHPN 519
+++G+G +G VY + VAIK ++ + R EV+ L + HPN
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-----EVKSLRKLNEHPN 59
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L E L ++EYM G+L + R G P IR I +I L +H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRS-IIYQILQGLAHIHK 117
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV---PP 614
HRDLKP N+L+ V KI+D GLAR + PP
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 63/221 (28%), Positives = 89/221 (40%), Gaps = 50/221 (22%)
Query: 471 IGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLG 525
+G GG+G V K + A+K ++ Q E E+L HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIV---- 56
Query: 526 ACPEFGCL---------IY---EYMANGSLEDRLFRRGGSPVLP-WQIRFRIAAEIATAL 572
L IY EY G L L RG + + RF A + A
Sbjct: 57 ------KLYRTFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARF-YIACVVLAF 106
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
+LH +++RDLKP N+LLD N K+ D G A+ + + T TF
Sbjct: 107 EYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAK--------KLKSGQKTW---TF 152
Query: 633 C----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMG 669
C Y+ PE D +SLGILL +++T +PP G
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM 520
N KIGEG G V + T VA+K + Q R EV ++ + +HPN+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 521 VLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE-IAT------- 570
V + + + ++ E++ G+L D + R+ E IAT
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIV------------THTRMNEEQIATVCLAVLK 126
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
AL FLH ++HRD+K +ILL + K+SD G V+ V + + S G
Sbjct: 127 ALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC----AQVSKEVPRRK--SLVG 177
Query: 631 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
T ++ PE G + D++SLGI++++++ +PP
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 471 IGEGGYGPVYKSYLDHTP----VAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLG 525
+G G G VYK+Y H +A+KV+ D + + Q E+E+L P ++ G
Sbjct: 9 LGHGNGGTVYKAY--HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 526 A--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
A + E+M GSL+ ++R+ +P + RIA + L +L K +
Sbjct: 67 AFFVENRISICTEFMDGGSLD--VYRK-----IPEHVLGRIAVAVVKGLTYLWSLK---I 116
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG 643
+HRD+KP N+L++ K+ D G++ + S+A + GT Y+ PE
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--------KTYVGTNAYMAPERISGE 168
Query: 644 MLGVKSDVYSLGILLLQIITAKPP 667
G+ SDV+SLGI +++ + P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 34/225 (15%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHT-------PVAIKVLRPDAA-QGRSQFQQEVE 510
E ++ + R +G G +G VY+ VA+K L + Q S F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 511 VLCNIRHPNMVLLLGAC----PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR--- 563
++ H N+V L+G P F ++ E MA G L+ L P P + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 564 -IAAEIATALLFLHQTKPEPLVHRDLKPGNILL-----DRNYVSKISDVGLARLVPPSVA 617
A ++A +L + +HRD+ N LL R V+KI+D G+AR + +
Sbjct: 120 FCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGR--VAKIADFGMARDIYRA-- 172
Query: 618 DSVTQYRMTSAAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQI 661
+ YR A ++ PE G+ K+DV+S G+LL +I
Sbjct: 173 ---SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623
I ++ AL +LH+ K +VHRDL P NI+L + I+D GLA+ P +
Sbjct: 118 IFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-------ES 168
Query: 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP------MGLAHQVERS 677
++TS GT Y PE + G K+DV++ G +L Q+ T +PP + LA +
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK---- 224
Query: 678 IENGTFDETLDPAVPDWPVEEALILAKLAL---QCAELRRKDRPDLGKV 723
I ++ P+ E + + C + RPD+ +V
Sbjct: 225 IVEAVYE----------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 29/212 (13%)
Query: 471 IGEGGYGPVYKSYLDHTP----VAIKVLRPDAAQGRSQFQ--QEVEVLCNIRH-PNMVLL 523
IG G +G V K + H P +A+K +R + Q + +++V+ P +V
Sbjct: 12 IGRGAFGTVNK--MLHKPSGTIMAVKRIRSTV-DEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 524 LGAC-PEFGCLIYEYMANGSLEDRLFRR---GGSPVLPWQIRFRIAAEIATALLFLHQTK 579
GA E C I + + SL D+ ++ V+P +I +IA AL +L +
Sbjct: 69 YGALFREGDCWICMELMDISL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLA-RLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
++HRD+KP NILLDRN K+ D G++ +LV DS+ + T AG Y+ PE
Sbjct: 128 K--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV-----DSIAK---TRDAGCRPYMAPE 177
Query: 639 YQQTGMLG---VKSDVYSLGILLLQIITAKPP 667
V+SDV+SLGI L ++ T K P
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 51/234 (21%)
Query: 465 FSNSRKIGEGGYGPVYKSYL----DHTPVAIKVLRPDAAQ--GRSQFQ-QEVEVLCNIRH 517
+ IG G YG VYK+ D AIK + D Q G SQ +E+ +L ++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 518 PNMVLLLGACPEFGC----LIYEYMANGSLEDRLF------RRGGSPVLPWQIRFRIAAE 567
N+V L+ E L+++Y E L+ R+ +P + + +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNY----VSKISDVGLAR-----LVPPSVAD 618
I + +LH ++HRDLKP NIL+ V KI D+GLAR L P + D
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKPP 667
V T Y PE +LG + D++++G + +++T +P
Sbjct: 174 PVVV--------TIWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 471 IGEGGYGPV----YKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLL 524
+G+G +G V Y D+T VA+K L+ A+ F++E+E+L +++H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 525 GACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI--------AAEIATAL 572
G C G L+ EY+ GSL D L + R R+ A++I +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKH----------RERLDHRKLLLYASQICKGM 121
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG-- 630
+L + VHRDL NIL++ KI D GL +++P +Y G
Sbjct: 122 EYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQD-----KEYYKVREPGES 173
Query: 631 -TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-----AKPPMGLAHQV 674
F Y PE V SDV+S G++L ++ T PP +
Sbjct: 174 PIFWYA-PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 33/215 (15%)
Query: 469 RKIGEGGYGPVYKSYLDHTP-----VAIKVLRPDAAQGRSQ-----FQQEVEVLCNIRHP 518
+ +G+GGYG V++ A+KVL+ A R+Q + E +L ++HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLK-KATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 519 NMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
+V L+ A G LI EY++ G L L R G + F ++ EI+ AL LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG--IFMEDTACFYLS-EISLALEHLH 117
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC--- 633
Q + +++RDLKP NILLD K++D GL + +S+ + +T TFC
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTVTH---TFCGTI 164
Query: 634 -YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Y+ PE G D +SLG L+ ++T PP
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 470 KIGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
++G+G +G VYK+ T A KV+ + + + E+E+L HP +V LLGA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 528 PEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
G L + E+ G+++ + P QI+ I ++ AL +LH K ++H
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLHSMK---IIH 133
Query: 586 RDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML 645
RDLK GN+LL + K++D G+ S + T R S GT ++ PE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGV------SAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 646 -----GVKSDVYSLGILLLQIITAKPP 667
K+D++SLGI L+++ +PP
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLR-----PDAAQGRSQFQQEVEVLCNIR 516
N+ + +G+G +G VY Y T +A+K ++ P+ ++ + + E+++L N+
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 517 HPNMVLLLGAC---PEFGCLIY-EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
H +V G E I+ E+M GS++D+L G L + + +I +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGV 119
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
+LH +VHRD+K NIL D K+ D G ++ + ++ S T M S GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ-TICLSGTG--MKSVTGTP 173
Query: 633 CYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
++ PE G K+D++S+G +++++T KPP
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 460 EATENFSNSRKIGEGGYGPVYKSY--LDHTPVAIK-VLRP--DAAQGRSQFQQEVEVLCN 514
E T + + + +G G +G V + L VAIK +++P + ++ E+++L +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65
Query: 515 IRHPNMVLL--LGACP-EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
+RH N++ L + P E + E + G+ RL P+ I++ +I
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR--PLEKQFIQY-FLYQILRG 120
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
L ++H +VHRDLKP NIL++ N KI D GLAR+ P +MT T
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP---------QMTGYVST 168
Query: 632 FCYIDPEYQQTGM-LGVKSDVYSLGILLLQIITAKP 666
Y PE T V+ D++S G + +++ KP
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 73/220 (33%), Positives = 109/220 (49%), Gaps = 41/220 (18%)
Query: 469 RKIGEGGYGPVYKSYLDHTP----VAIKVLRPDAAQGRSQFQQEVEVLCNIRH-----PN 519
++G G YG V K + H P +A+K +R A SQ Q+ + + +I P
Sbjct: 7 EELGRGAYGVVDK--MRHVPTGTIMAVKRIR---ATVNSQEQKRLLMDLDISMRSVDCPY 61
Query: 520 MVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSP--VLPWQIRFRIAAEIATALL 573
V GA G C+ E M + SL D+ +++ +P I +IA I AL
Sbjct: 62 TVTFYGALFREGDVWICM--EVM-DTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA-RLVPPSVADSVTQYRMTSAAGTF 632
+LH ++HRD+KP N+L++RN K+ D G++ LV DSV + T AG
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV-----DSVAK---TIDAGCK 167
Query: 633 CY-----IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Y I+PE Q G VKSDV+SLGI ++++ T + P
Sbjct: 168 PYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 50/257 (19%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
R +G+G +G V + A+KVL+ D Q+ +V C + ++ L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV------ILQDDDVECTMTEKRILSLARN 54
Query: 527 CPEFGCLIYEYMANGSLEDRLF-----RRGGSPVLPWQIRFRI--------AAEIATALL 573
P L + DRLF GG + Q R AAEI +AL+
Sbjct: 55 HPFLTQLYCCFQT----PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALM 110
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
FLH + +++RDLK N+LLD K++D G+ + + + T TFC
Sbjct: 111 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKT-------TSTFC 157
Query: 634 ----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDP 689
YI PE Q + G D +++G+LL +++ P E E+ F+ L+
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF------EAENEDDLFEAILND 211
Query: 690 AV--PDWPVEEALILAK 704
V P W ++A+ + K
Sbjct: 212 EVVYPTWLSQDAVDILK 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGR-SQFQQEVEVLCNIRHPNM 520
NF K+GEG Y VYK T VA+K + DA +G S +E+ ++ ++H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 521 VLLLGACPEFG--CLIYEYMANG---SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
V L L++EYM ++ R P +++ IA F
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FC 116
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H+ + ++HRDLKP N+L+++ K++D GLAR A + ++ T Y
Sbjct: 117 HENR---VLHRDLKPQNLLINKRGELKLADFGLAR------AFGIPVNTFSNEVVTLWYR 167
Query: 636 DPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
P+ +LG ++ D++S+G ++ ++IT +P
Sbjct: 168 APDV----LLGSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 469 RKIGEGGYGPV----YKSYLDHT--PVAIKVLRPDAAQGRS-QFQQEVEVLCNIRHPNMV 521
R +GEG +G V Y D+T VA+K L+P++ ++E+E+L N+ H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 522 LLLGACPEFGC----LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
G C E G LI E++ +GSL++ L R L Q+++ A +I + +L
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY--AVQICKGMDYLGS 127
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
+ VHRDL N+L++ + KI D GL + + + + S F Y P
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP--VFWYA-P 181
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIIT 663
E + SDV+S G+ L +++T
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQG--RSQFQQEVEVLCNIRHPN 519
+++ KIGEG YG VYK T VA+K +R ++ + S +E+ +L ++HPN
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 520 MVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L + LI+E+++ L+ L + ++ +I +LF H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL--VPPSVADSVTQYRMTSAAGTFCYI 635
+ ++HRDLKP N+L+D V K++D GLAR +P V T T Y
Sbjct: 120 RR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV--------YTHEVVTLWYR 168
Query: 636 DPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
PE +LG D++S+G + ++ T KP
Sbjct: 169 APEV----LLGSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 465 FSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQ---QEVEVLCNIRHPN 519
FS+ R+IG G +G VY + + VAIK + Q ++Q +EV L +RHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 520 MVLLLGACPEF-GCLIYEYMANGSLEDRLFRRGGSPVL-----PWQIRFRIAAEIATALL 573
+ ++ GC + E+ A +E L S +L P Q IAA AL
Sbjct: 77 TI-------QYRGCYLREHTAWLVMEYCL--GSASDLLEVHKKPLQ-EVEIAAVTHGALQ 126
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
L ++HRD+K GNILL + K+ D G A ++ P+ GT
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----------NXFVGTPY 176
Query: 634 YIDPEY---QQTGMLGVKSDVYSLGILLLQIITAKPPM 668
++ PE G K DV+SLGI +++ KPP+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 463 ENFSNSRKIGEGGYGPV----YKSYLDHTPVAIKVLRPDAAQGRSQFQQ---EVEVLCNI 515
E+F+ R +G G +G V YK+ D PVAIK + Q E ++L I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNE-DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 516 RHPNMVLLLGACPE--FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
HP V L G+ + + L+ E++ G L R + P + AA+I
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFE 145
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
+L +V+RDLKP N+LLD++ K++D G A++V R + GT
Sbjct: 146 YLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV---------DTRTYTLCGTPE 193
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
YI PE G +D ++LGI + +I+ PP
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 73/257 (28%), Positives = 115/257 (44%), Gaps = 54/257 (21%)
Query: 471 IGEGGYGPVYK--SYLDHTPVAIKVLR-PDAAQGRSQFQ-QEVEVL---CNIRHPNMVLL 523
IGEG YG VYK VA+K +R P + +G +E+ +L + HPN+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 524 LGACPEFGC---------LIYEYMANGSLED--RLFRRGGSPVL-PWQIRFRIAAEIATA 571
L C G L++E++ +D + P L P I+ + ++
Sbjct: 67 LDVC--HGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIK-DLMRQLLRG 119
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
+ FLH + +VHRDLKP NIL+ + KI+D GLAR + + +TS T
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-----IYSF--EMALTSVVVT 169
Query: 632 FCYIDPE--YQQTGMLGVKSDVYSLGILLLQIITAKPPMGL------AHQVERSIENGTF 683
Y PE Q + V D++S+G + ++ +P L A Q+++ F
Sbjct: 170 LWYRAPEVLLQSSYATPV--DMWSVGCIFAELFRRRP---LFRGTSEADQLDK-----IF 219
Query: 684 DETLDPAVPDWPVEEAL 700
D P+ +WP +L
Sbjct: 220 DVIGLPSEEEWPRNVSL 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 70/224 (31%), Positives = 103/224 (45%), Gaps = 34/224 (15%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQ---QEVEVLC 513
E+ + F++ R+IG G +G VY + T VAIK + Q ++Q +EV+ L
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 514 NIRHPNMVLLLGACPEF-GCLIYEYMANGSLEDRLFRRGGSPVL-----PWQIRFRIAAE 567
I+HPN + E+ GC + E+ A +E L S +L P Q IAA
Sbjct: 81 RIKHPNSI-------EYKGCYLREHTAWLVMEYCL--GSASDLLEVHKKPLQ-EVEIAAI 130
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
AL L ++HRD+K GNILL K++D G A + P+ S
Sbjct: 131 THGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----------NS 180
Query: 628 AAGTFCYIDPEY---QQTGMLGVKSDVYSLGILLLQIITAKPPM 668
GT ++ PE G K DV+SLGI +++ KPP+
Sbjct: 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVL--RPDAAQGRSQFQQEVEVLCNIRHP 518
E + N +GEG YG V K T VAIK D + +E+ +L +RH
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 519 NMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V L+ L++E++ + L+D G L + +I + F H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS--AAGTFCY 634
++HRD+KP NIL+ ++ V K+ D G AR + + + T Y T A
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVATRWYRAPELLV 173
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIITAKP 666
D +Y G D++++G L+ +++T +P
Sbjct: 174 GDTKY------GRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEV 511
SI + + + ++ KIG+G G VY + T VAIK + + E+ V
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 512 LCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIA 569
+ ++PN+V L + + ++ EY+A GSL D + + + QI + E
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIA-AVCRECL 125
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
AL FLH + ++HRD+K NILL + K++D G + P Q + ++
Sbjct: 126 QALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMV 176
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
GT ++ PE G K D++SLGI+ ++++ +PP
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 470 KIGEGGYGPVYK--SYLDHTPVAIKVLRPDAA-QG-RSQFQQEVEVLCNIRHPNMVLLLG 525
KIGEG YG VYK L VA+K +R + +G S +E+ +L + HPN+V LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 526 ACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
L ++E++ + L+ + + + P I+ ++ + + H + +
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIK-SYLYQLLQGIAYCHSHR---V 120
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARL--VPPSVADSVTQYRMTSAAGTFCYIDPEYQQ 641
+HRDLKP N+L+DR K++D GLAR VP V Y T T Y PE
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVP------VRTY--THEVVTLWYRAPEI-- 170
Query: 642 TGMLGVKS-----DVYSLGILLLQIITAKP 666
+LG + D++S+G + +++ +P
Sbjct: 171 --LLGSRQYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 75/258 (29%), Positives = 114/258 (44%), Gaps = 56/258 (21%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
+G+G +G V + L T AIKVL+ D Q+ +V C + ++ L P
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDV------ILQDDDVDCTMTEKRILALAAKHP 56
Query: 529 EFGCLIYEYMANGSLEDRLF-----RRGGSPVLPWQI-----------RFRIAAEIATAL 572
L + +DRLF GG L +QI RF AAE+ AL
Sbjct: 57 FLTALHCCFQT----KDRLFFVMEYVNGGD--LMFQIQRSRKFDEPRSRF-YAAEVTLAL 109
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
+FLH+ +++RDLK NILLD K++D G+ + + + T+ TF
Sbjct: 110 MFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTT---TF 156
Query: 633 C----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETL- 687
C YI PE Q G D ++LG+L+ +++ +PP E E+ F+ L
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF------EADNEDDLFESILH 210
Query: 688 -DPAVPDWPVEEALILAK 704
D P W +EA+ + K
Sbjct: 211 DDVLYPVWLSKEAVSILK 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 74/261 (28%), Positives = 112/261 (42%), Gaps = 43/261 (16%)
Query: 471 IGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLG 525
IG G +G V+ + A+KVLR R+Q + E ++L + P +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 526 ACP--EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQI-RFRIAAEIATALLFLHQTKPEP 582
+ E L+ EYM G L + L R+ V P + RF IA E+ AL +H+
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIA-ELVLALDSVHKLG--- 121
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLA--------------RLVPPSVADSVT------Q 622
+HRD+KP NIL+D + K++D GL D+V +
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 623 YRMT---SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM--GLAHQVERS 677
R S GT YI PE + G++ D +SLG++L +++ PP +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241
Query: 678 IENGTFDETLD-PAVPDWPVE 697
I N + E+L P P E
Sbjct: 242 IIN--WKESLRFPPDPPVSPE 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 24/224 (10%)
Query: 471 IGEGGYGPVYKSYLD------HTPVAIKVLRPDAAQGRSQFQQEVE---VLCNIRHPNMV 521
+G G +G V+K PVAIK ++ + GR FQ+ + + ++ H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 522 LLLGACPEFGC-LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
LLG CP L+ + GSL D + + S L Q +IA + +L + +
Sbjct: 73 RLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR- 129
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ 640
+VHR+L NILL + + +I+D G+A L+ P +Y + ++ E
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYP----DDKKYFYSEHKTPIKWMALESI 183
Query: 641 QTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENG 681
G +SDV+S G+ + ++++ A+P G+ H+V +E G
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 8e-13
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEV 511
SI + + + ++ KIG+G G VY + T VAI+ + + E+ V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 512 LCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIA 569
+ ++PN+V L + + ++ EY+A GSL D + + + QI + E
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIA-AVCRECL 126
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
AL FLH + ++HRD+K NILL + K++D G + P Q + ++
Sbjct: 127 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMV 177
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
GT ++ PE G K D++SLGI+ +++I +PP
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLR-PDAAQGRSQ-FQQEVEVLCN 514
E E + +G+G YG VY + T V I + P+ Q +E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 515 IRHPNMVLLLGACPEFG-CLIY-EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
++H N+V LG+ E G I+ E + GSL L + G Q +I L
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVG----LARLVPPSVADSVTQYRMTS 627
+LH + +VHRD+K N+L++ + V KISD G LA + P ++ T
Sbjct: 122 KYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFT------ 170
Query: 628 AAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQIITAKPP 667
GT Y+ PE G G +D++SLG ++++ T KPP
Sbjct: 171 --GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 40/245 (16%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLDHTP-------VAIKVLRPDAAQG--RSQFQQ 507
EI +T F ++GE +G VYK +L T VAIK L+ D A+G R +F+
Sbjct: 1 EINLSTVRFM--EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKH 57
Query: 508 EVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRG-------------- 551
E + ++HPN+V LLG + +I+ Y ++ L + L R
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 552 GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611
S + P I +IA + FL +VH+DL N+L+ KISD+GL R
Sbjct: 118 KSTLEPADF-VHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 612 VPPSVADSVTQYR-MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPM 668
V + Y+ M ++ ++ PE G + SD++S G++L ++ + +P
Sbjct: 174 VY-----AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 669 GLAHQ 673
G ++Q
Sbjct: 229 GYSNQ 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 73/264 (27%), Positives = 109/264 (41%), Gaps = 61/264 (23%)
Query: 469 RKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNI----------R 516
+ +G+G +G V + L T A+KVL+ D Q+ +V C + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV------ILQDDDVECTMTEKRVLALAGK 54
Query: 517 HPNMVLLLGAC---PEFGCLIYEYMANGSL-----EDRLFRRGGSPVLPWQIRFRIAAEI 568
HP + L +C + + EY+ G L F + RF AAEI
Sbjct: 55 HPFLTQLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-------RARF-YAAEI 105
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
L FLH+ +++RDLK N+LLD KI+D G+ + + VT TS
Sbjct: 106 VLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVT----TS- 154
Query: 629 AGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFD 684
TFC YI PE G D ++LG+LL +++ + P E E+ F
Sbjct: 155 --TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF------EGDDEDELFQ 206
Query: 685 ETLD--PAVPDWPVEEAL-ILAKL 705
L+ P W +EA IL
Sbjct: 207 SILEDEVRYPRWLSKEAKSILKSF 230
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 464 NFSNSRKIGEGGYGPVY-----KSYLDHTPVAIKVLRPDAAQGRSQFQQ----EVEVLCN 514
NF R +G G YG V+ + A+KVL+ +++ + E +VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 515 IRH-PNMVLLLGACPEFGC-----LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEI 568
+R P +V L A F LI +Y+ G L L++R ++R IA EI
Sbjct: 61 VRRCPFLVTLHYA---FQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIA-EI 114
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
AL LHQ +++RD+K NILLD ++D GL++ + R S
Sbjct: 115 VLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-----EEERAYSF 166
Query: 629 AGTFCYIDPEYQQTGMLGVKS--DVYSLGILLLQIITAKPP 667
GT Y+ PE + G G D +SLG+L +++T P
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 77/275 (28%), Positives = 126/275 (45%), Gaps = 33/275 (12%)
Query: 458 IEEATENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLR-PDAAQGRSQFQQEVE 510
I + TE F + +G G +G VYK PVAIK LR + + + E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 511 VLCNIRHPNMVLLLGACPEFGC-LIYEYMANGSLEDRLF----RRGGSPVLPWQIRFRIA 565
V+ ++ +P++ LLG C LI + M G L D + G +L W +
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV----- 116
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM 625
+IA + +L + + LVHRDL N+L+ KI+D GLA+L+ AD +Y
Sbjct: 117 -QIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG---ADE-KEYHA 168
Query: 626 TSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGT 682
++ E + +SDV+S G+ + +++T +KP G+ A ++ +E G
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 227
Query: 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDR 717
E L P P ++ +I+ K + A+ R K R
Sbjct: 228 --ERL-PQPPICTIDVYMIMVKCWMIDADSRPKFR 259
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHTP----VAIKVLRPDAAQG-RSQFQQEVEVLC 513
E ++F ++G G G V+K + H P +A K++ + R+Q +E++VL
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK--VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 514 NIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
P +V GA G + E+M GSL D++ ++ G +P QI +++ +
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGR--IPEQILGKVSIAVIKG 115
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
L +L + ++HRD+KP NIL++ K+ D G++ + S+A+S GT
Sbjct: 116 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--------GT 165
Query: 632 FCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
Y+ PE Q V+SD++S+G+ L+++ + P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 70/282 (24%), Positives = 120/282 (42%), Gaps = 34/282 (12%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRP-DAAQGRSQFQQEVEVLCN 514
N +G G +G V+ + T V +K L+ +S+F++E+++
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 515 IRHPNMVLLLGACPEFG--CLIYEYMANGSLED--RLFRRGGSPVLPWQI----RFRIAA 566
+ H N+V LLG C E +I EY G L+ R + + P + + +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+IA + L + VHRDL N L+ K+S + L++ V S Y++
Sbjct: 125 QIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-----EYYKLR 176
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAK--PPMGLAH-QVERSIENGTF 683
+A ++ PE Q KSDV+S G+L+ ++ T P GL+ +V ++ G
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725
+ + P L KL +C + KDRP ++V
Sbjct: 237 ELPVPEGCPS-------RLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 17/218 (7%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKS--YLDHTPVAIKVLRPDAAQGRSQFQQEVEV 511
+I I + + ++ KIG+G G V+ + VAIK + + E+ V
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 512 LCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIA 569
+ +++PN+V L + + ++ EY+A GSL D + QI + E
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA---QIA-AVCRECL 125
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
AL FLH + ++HRD+K N+LL + K++D G + P Q + ++
Sbjct: 126 QALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE------QSKRSTMV 176
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
GT ++ PE G K D++SLGI+ ++++ +PP
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 74/254 (29%), Positives = 109/254 (42%), Gaps = 36/254 (14%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
IG GG+G VY T A+K L + R + +Q + N R ++ G CP
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD----KKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 529 EFGCLIYEY------------MANGSLEDRLFRRGGSPVLPWQ-IRFRIAAEIATALLFL 575
C+ Y + M G L L + G V +RF AAEI L +
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRF-YAAEIILGLEHM 113
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H +V+RDLKP NILLD + +ISD+GLA ++ + ++ GT Y+
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLAC--------DFSKKKPHASVGTHGYM 162
Query: 636 DPEYQQTGMLGVKS-DVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDW 694
PE Q G+ S D +SLG +L +++ P H+ + E T+ +PD
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 695 PVEEALILAKLALQ 708
E L + LQ
Sbjct: 222 FSPELRSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 32/222 (14%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIKV----LRPDAAQGRSQ---FQQEVEVLCNI 515
N+ + +G G +G VY Y T + V PD+ + + + E+++L N+
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 516 RHPNMVLLLGACPEFGCL----------IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIA 565
RH +V +GCL EYM GS++D+L G L + R
Sbjct: 62 RHDRIVQY------YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA---LTENVTRRYT 112
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM 625
+I + +LH +VHRD+K NIL D K+ D G ++ + ++ S T +
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ-TICMSGTGIK- 167
Query: 626 TSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
S GT ++ PE G K+DV+S+ +++++T KPP
Sbjct: 168 -SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 76/249 (30%), Positives = 115/249 (46%), Gaps = 34/249 (13%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDA-AQG-RSQFQQEVEVLCNIRHPN 519
NF KIGEG YG VYK+ T VA+K +R D +G S +E+ +L + HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 520 MVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPV--LPWQIRFRIAAEIATALLFL 575
+V LL L++E++ + L+ + SP+ +P + ++ L F
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H + ++HRDLKP N+L++ K++D GLAR A V T T Y
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR------AFGVPVRTYTHEVVTLWYR 167
Query: 636 DPEYQQTGMLGVK-----SDVYSLGILLLQIITAK---PPMGLAHQVERSIEN-GTFDET 686
PE +LG K D++SLG + +++T + P Q+ R GT DE
Sbjct: 168 APEI----LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223
Query: 687 LDPAVPDWP 695
+ P V P
Sbjct: 224 VWPGVTSLP 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 73/260 (28%), Positives = 118/260 (45%), Gaps = 37/260 (14%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQ--QEVEVLCNIRHPN 519
F +IGEG YG VY++ + VA+K +R D + +E+ +L N+RHPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 520 MVLLL----GACPEFGCLIYEYMAN--GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
+V L G + L+ EY SL D + +P Q++ + ++ L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM----PTPFSESQVKC-LMLQLLRGLQ 122
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
+LH+ ++HRDLK N+LL KI+D GLAR MT T
Sbjct: 123 YLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP------MTPKVVTLW 173
Query: 634 YIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKPPM---GLAHQVERSIEN-GTFD 684
Y PE +LG + D++++G +L +++ KP + Q++ I+ GT +
Sbjct: 174 YRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229
Query: 685 ETLDPAVPDWPVEEALILAK 704
E++ P D P+ L K
Sbjct: 230 ESIWPGFSDLPLVGKFTLPK 249
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 36/213 (16%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRH-PNMVL 522
+ I +G +G VY K AIKVL+ ++Q + E ++ P +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 523 LLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
L + ++ L+ EY+ G + GG LP + AE+ + LHQ
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDLHQ--- 115
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLAR--LVPPSVADSVTQYRMTSAAGTFCYIDPE 638
++HRD+KP N+L+D+ K++D GL+R L GT Y+ PE
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF------------VGTPDYLAPE 163
Query: 639 YQQTGMLGV----KSDVYSLGILLLQIITAKPP 667
+LGV SD +SLG ++ + + PP
Sbjct: 164 T----ILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 68/224 (30%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQ---QEVEVLC 513
++ E F +IG G +G VY + HT VA+K + Q ++Q +EV+ L
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 514 NIRHPNMVLLLGACPEF-GCLIYEYMANGSLEDRLFRRGGSPVL-----PWQIRFRIAAE 567
++HPN + E+ GC + E+ A +E L S +L P Q IAA
Sbjct: 77 QLKHPNTI-------EYKGCYLKEHTAWLVMEYCL--GSASDLLEVHKKPLQ-EVEIAAI 126
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
AL L ++HRD+K GNILL K++D G A P+ S
Sbjct: 127 THGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----------NS 176
Query: 628 AAGTFCYIDPEY---QQTGMLGVKSDVYSLGILLLQIITAKPPM 668
GT ++ PE G K DV+SLGI +++ KPP+
Sbjct: 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 470 KIGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQGR-SQFQQEVEVLCNIRHPNMVLLLGA 526
++G+G YG VYK T V A+K +R + + + +Q E+++L P +V GA
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 527 CPEFGCLIY--EYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
G + EYM GSL D+L+ G + +P + RI + L FL + +
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY---- 639
+HRD+KP N+L++ N K+ D G++ + S+A + G Y+ PE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--------KTNIGCQSYMAPERIKSG 176
Query: 640 --QQTGMLGVKSDVYSLGILLLQIITAKPP 667
Q V+SDV+SLG+ +L++ + P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 67/234 (28%), Positives = 112/234 (47%), Gaps = 39/234 (16%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYL---------DHTPVAIKVLRPDAAQGR-SQFQQE 508
E + + + + +GEG +G V + + VA+K+L+ DA + S E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 509 VEVLCNI-RHPNMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSP----------- 554
+E++ I +H N++ LLGAC + G L I EY + G+L R + R P
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL--REYLRARRPPGMEYSYDIAR 128
Query: 555 VLPWQIRFR----IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
V Q+ F+ ++A + +L K +HRDL N+L+ N V KI+D GLAR
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 611 LVPPSVADSVTQYRMTSAAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
V +++ Y+ T+ ++ PE + +SDV+S G+L+ +I T
Sbjct: 186 DV-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 72/263 (27%), Positives = 111/263 (42%), Gaps = 66/263 (25%)
Query: 458 IEEATENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVL-RP--DAAQGRSQFQQEVEVL 512
+ E + + N +G G YG V ++ T VAIK L RP A + ++ E+ +L
Sbjct: 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLL 68
Query: 513 CNIRHPNMVLLLGA-CP-----EF----------GCLIYEYMANGSLEDRLFRRGGSPVL 556
++ H N++ LL P +F G + + L D
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD---------- 118
Query: 557 PWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616
I+F + +I L ++H ++HRDLKP NI ++ + KI D GLAR
Sbjct: 119 --HIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH----- 167
Query: 617 ADSVTQYRMTSAAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQIITAKP--P 667
T MT T Y PE Y QT D++S+G ++ +++T K P
Sbjct: 168 ----TDDEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGKTLFP 217
Query: 668 MGLAH--QVERSIE-NGTFDETL 687
G H Q++R + GT DE L
Sbjct: 218 -GSDHIDQLKRIMNLVGTPDEEL 239
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQ---QEVEVLCNIRHPNMVLLLG 525
+G G +G V + T AIK L+ Q Q QE +L + HP +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 526 ACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
+ + + + E++ G L L R+ G P + AE+ A +LH +
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHL-RKAGR--FPNDVAKFYHAELVLAFEYLHSKD---I 139
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG 643
++RDLKP N+LLD K++D G A+ VP R + GT Y+ PE Q+
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---------RTFTLCGTPEYLAPEVIQSK 190
Query: 644 MLGVKSDVYSLGILLLQIITAKPP 667
G D +++G+LL + I PP
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 35/228 (15%)
Query: 463 ENFSNSRKIGEGGYGPVY--------KSYLDHT-PVAIKVLRPDAA-QGRSQFQQEVEVL 512
+ + +GEG +G V KS D T VA+K+L+ +A + + E+E++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 513 CNI-RHPNMVLLLGACPEFGCL--IYEYMANGSLEDRL-FRRGGSPVLPW--------QI 560
I +H N++ LLG C + G L I EY A G+L + L RR P + Q+
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 561 RFR----IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616
F+ A ++A + +L + +HRDL N+L+ + V KI+D GLAR V
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGV---- 184
Query: 617 ADSVTQYRMTSAAGT-FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
+ Y+ TS ++ PE + +SDV+S GIL+ +I T
Sbjct: 185 -HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 469 RKIGEGGYGP--VYKSYLDHTPVAIKVLR-PDAAQGRSQFQQEVEVLCNIRHPNMVLLLG 525
R +GEG +G + + A+K +R P ++ ++E +L ++HPN+V
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 526 ACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
+ G L + EY G L ++ + G + P + ++ + +H+ + +
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGK-LFPEDTILQWFVQMCLGVQHIHEKR---V 121
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG 643
+HRD+K NI L +N K+ D G ARL+ A + T GT Y+ PE +
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY------VGTPYYVPPEIWENM 175
Query: 644 MLGVKSDVYSLGILLLQIITAKPP 667
KSD++SLG +L ++ T K P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDHTP--VAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPN 519
F R +G+GG+G V + T A K L R +G S E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 520 MVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L A + CL+ M G L+ ++ G +P + AAEI L LH+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHR 120
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
E V+RDLKP NILLD +ISD+GLA +P +S+ GT Y+ P
Sbjct: 121 ---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESI-----RGRVGTVGYMAP 170
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPPM-GLAHQVER 676
E + D + LG L+ ++I + P G +V+R
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 9e-12
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 465 FSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRP---DAAQGRSQFQQEVEVLCNIRHPN 519
+ + IG G YG V + VAIK + D + + E+++L ++RH N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHEN 60
Query: 520 MVLLL-----GACPEFG--CLIYEYMANGSLEDRLFR--RGGSPVLPWQIRFRIAAEIAT 570
++ LL + +F ++ E M E L + + P+ I++ +I
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQY-FLYQILR 114
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
L +LH ++HRDLKP NIL++ N KI D GLAR V P D + +T
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP---DEDEKGFLTEYVV 168
Query: 631 TFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
T Y PE +L D++S+G + +++T KP
Sbjct: 169 TRWYRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 55/230 (23%)
Query: 470 KIGEGGYGPVYKSYLDHTP--VAIK-VLRPDAAQGRSQFQ----QEVEVLCNIRHPNMVL 522
KIG+G +G V+K+ T VA+K VL + +G F +E+++L ++H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVN 75
Query: 523 LLGAC-----PEFGC-----LIYEYMAN---GSLEDRLFRRGGSPVLPWQIRF------R 563
L+ C P L++E+ + G L ++ ++F +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK------------NVKFTLSEIKK 123
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623
+ + L ++H+ K ++HRD+K NIL+ ++ + K++D GLAR S++ +
Sbjct: 124 VMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR--AFSLSKNSKPN 178
Query: 624 RMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKPPM 668
R T+ T Y PE +LG + D++ G ++ ++ T P M
Sbjct: 179 RYTNRVVTLWYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 502 RSQFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQ 559
R+Q +E++VL P +V GA G + E+M GSL D++ ++ G +P
Sbjct: 43 RNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGR--IPEN 99
Query: 560 IRFRIAAEIATALLFL---HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616
I +I+ + L +L H+ ++HRD+KP NIL++ K+ D G++ + S+
Sbjct: 100 ILGKISIAVLRGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154
Query: 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER 676
A+S GT Y+ PE Q V+SD++SLG+ L+++ + P+ E
Sbjct: 155 ANSFV--------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
Query: 677 SIENGTFDETLDPAVPDWPV 696
G + PV
Sbjct: 207 EAMFGRPVSEGEAKESHRPV 226
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLL 523
+ +G+G G V+ L T A+KVL R++ ++ E E+L + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 524 LG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQ-IRFRIAAEIATALLFLHQTKP 580
+ CL+ +Y G L L R+ G L + RF AAE+ AL +LH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGK-CLSEEVARF-YAAEVLLALEYLHL--- 121
Query: 581 EPLVHRDLKPGNILLDRNY--------VSKISDVG----------------LARLVPPSV 616
+V+RDLKP NILL + +SK SDV + + +
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
++ + +R S GT YI PE G D ++LGILL +++ P
Sbjct: 182 SEEPS-FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 34/261 (13%)
Query: 471 IGEGGYGPVYKSY------LDHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLL 523
+G G +G VYK PVAIK+L + +F E ++ ++ HP++V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 524 LGAC--PEFGCLIYEYMANGSLEDRLFRR----GGSPVLPWQIRFRIAAEIATALLFLHQ 577
LG C P L+ + M +G L D + G +L W + +IA +++L +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV------QIAKGMMYLEE 127
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
+ LVHRDL N+L+ KI+D GLARL + +Y ++
Sbjct: 128 RR---LVHRDLAARNVLVKSPNHVKITDFGLARL----LEGDEKEYNADGGKMPIKWMAL 180
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVPDW 694
E +SDV+S G+ + +++T KP G+ ++ +E G E L P P
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG---ERL-PQPPIC 236
Query: 695 PVEEALILAKLALQCAELRRK 715
++ +++ K + A+ R K
Sbjct: 237 TIDVYMVMVKCWMIDADSRPK 257
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 37/223 (16%)
Query: 469 RKIGEGGYGPVYKSY---LDH------TPVAIKVLRPDAAQGR-SQFQQEVEVLCNI-RH 517
+ +GEG +G V + LD T VA+K+L+ DA + S E+E++ I +H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 518 PNMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPW----------QIRFR-- 563
N++ LLGAC + G L I EY + G+L + L R P + + Q+ F+
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYCYNPTQVPEEQLSFKDL 142
Query: 564 --IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621
A ++A + +L K +HRDL N+L+ + V KI+D GLAR + +
Sbjct: 143 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHID 194
Query: 622 QYRMTSAAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
Y+ T+ ++ PE + +SDV+S G+LL +I T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 470 KIGEGGYGPVYKSYLDHTP--VAIK--VLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLG 525
KIGEG YG V+K T VAIK V D + +E+ +L ++HPN+V L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 526 ACPEFG-----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
F L++EY + L + G P I+ +I + A+ F H+
Sbjct: 68 V---FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH--LIK-KIIWQTLQAVNFCHKHN- 120
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+HRD+KP NIL+ + K+ D G AR++ D T Y T
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTGP-GDDYTDYVAT 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 68/256 (26%), Positives = 116/256 (45%), Gaps = 31/256 (12%)
Query: 425 NVEFKALREAKERKAALNSLTVDLRYRKY--SIEEIEEATENFSNSRKIGEGGYGPV--Y 480
+++F ALR+ K LN RY K I +++ E++ + IG G +G V
Sbjct: 9 DLDFPALRKNKNIDNFLN------RYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLV 62
Query: 481 KSYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535
+ A+K+L RS F +E +++ P +V L A + + ++
Sbjct: 63 RHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122
Query: 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595
EYM G L + + + +P + AE+ AL +H L+HRD+KP N+LL
Sbjct: 123 EYMPGGDLVNLM----SNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLL 175
Query: 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT----GMLGVKSDV 651
D++ K++D G + D R +A GT YI PE ++ G G + D
Sbjct: 176 DKHGHLKLADFGTCMKM-----DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 652 YSLGILLLQIITAKPP 667
+S+G+ L +++ P
Sbjct: 231 WSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 456 EEIEEATENFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPD--AAQGRSQFQQEVEV 511
+E + + SR +G G G V K D P A+KV+ + + +++ Q EV
Sbjct: 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCC 84
Query: 512 LCNI-----------------RHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSP 554
L N R+P VL++ L+ +Y G L + R +
Sbjct: 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIA-------LVLDYANAGDLRQEIKSRAKTN 137
Query: 555 VLPWQIRFRIAAEIATALLFL------HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608
R E LLF+ H + ++HRD+K NILL N + K+ D G
Sbjct: 138 --------RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189
Query: 609 ARLVPPSVADSVTQYRMTSAAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITA 664
+++ +V+D V + TFC Y+ PE + K+D++SLG+LL +++T
Sbjct: 190 SKMYAATVSDDVGR--------TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241
Query: 665 KPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
K P + E + + T DP P E I+ AL ++ +R RP K++
Sbjct: 242 KRPFDGENMEE--VMHKTLAGRYDPLPPSISPEMQEIVT--ALLSSDPKR--RPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 470 KIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVLLL 524
++G+GGYG V+ K VA+K ++ E ++L + +V LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 525 GAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPW-QIRFRIAAEIATALLFLHQTKPE 581
A E+ L EY+ G L G VL RF +A E+ A+ LH+
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMA-EMFEAVDALHELG-- 121
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ 641
+HRDLKP N L+D + K++D GL+ VT S G+ Y+ PE +
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGLS-------KGIVT--YANSVVGSPDYMAPEVLR 171
Query: 642 TGMLGVKSDVYSLGILLLQIITAKPP 667
D +SLG +L + + PP
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 67/238 (28%), Positives = 103/238 (43%), Gaps = 34/238 (14%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
IG GG+G VY T A+K L + R + +Q + N R ++ G CP
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD----KKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 529 EFGCLIYEY------------MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
C+ Y + M G L L + G ++RF A EI L +H
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRF-YATEIILGLEHMH 114
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
+V+RDLKP NILLD + +ISD+GLA ++ + ++ GT Y+
Sbjct: 115 N---RFVVYRDLKPANILLDEHGHVRISDLGLAC--------DFSKKKPHASVGTHGYMA 163
Query: 637 PEYQQTGM-LGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD 693
PE Q G +D +SLG +L +++ P H+ + E T++ +PD
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTVNVELPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDHTP--VAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPN 519
F R +G+GG+G V + T A K L R +G S E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 520 MVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L A + CL+ M G L+ ++ G + + F AAEI L LHQ
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQ 120
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
E +V+RDLKP NILLD + +ISD+GLA VP + R+ GT Y+ P
Sbjct: 121 ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRV----GTVGYMAP 170
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
E + D ++LG LL ++I + P
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 469 RKIGEGGYGPVYKSYLD------HTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMV 521
+ +G G +G VYK PVAIKVLR + + + + E V+ + P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 522 LLLGACPEFGC-LIYEYMANGSLEDRLF----RRGGSPVLPWQIRFRIAAEIATALLFLH 576
LLG C L+ + M G L D + R G +L W + +IA + +L
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV------QIAKGMSYLE 126
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ + LVHRDL N+L+ KI+D GLARL+ D T+Y ++
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD---IDE-TEYHADGGKVPIKWMA 179
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVPD 693
E +SDV+S G+ + +++T AKP G+ A ++ +E G E L P P
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG---ERL-PQPPI 235
Query: 694 WPVEEALILAKLALQCAELRRKDRPDLGKVV 724
++ +I+ K C + + RP ++V
Sbjct: 236 CTIDVYMIMVK----CWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 29/266 (10%)
Query: 469 RKIGEGGYGPVYKSYLD-----HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVL 522
R +G G +G + + L PVAI LR + R F E L H N+V
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 523 LLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
L G + + EYM+NG+L D R+ ++ Q+ + +A+ + +L +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQL-MGMLPGLASGMKYLSEMG- 127
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ 640
VH+ L +L++ + V KIS G RL ++++ Y S + PE
Sbjct: 128 --YVHKGLAAHKVLVNSDLVCKIS--GFRRL-QEDKSEAI--YTTMSGKSPVLWAAPEAI 180
Query: 641 QTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQ-VERSIENGTFDETLDPAVPDWPVE 697
Q SDV+S GI++ ++++ +P ++ Q V +++E+G L P
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF---RLPA-----PRN 232
Query: 698 EALILAKLALQCAELRRKDRPDLGKV 723
+L +L L C + R +RP ++
Sbjct: 233 CPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 65/243 (26%), Positives = 102/243 (41%), Gaps = 38/243 (15%)
Query: 455 IEEIEEATENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVL 512
+E + + T+ + IG+G YG VYK + D + A+K+L P S +E+E
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-----ISDVDEEIEAE 68
Query: 513 CNI-----RHPNMVLLLGACPEFG-------CLIYEYMANGSLEDR---LFRRGGSPVLP 557
NI HPN+V G + L+ E GS+ + L G
Sbjct: 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128
Query: 558 WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617
I+ + ALL L ++HRD+K NILL K+ D G+ S
Sbjct: 129 -----MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV------SAQ 177
Query: 618 DSVTQYRMTSAAGTFCYIDPEY-----QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672
+ T+ R ++ GT ++ PE Q + DV+SLGI +++ PP+ H
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
Query: 673 QVE 675
V+
Sbjct: 238 PVK 240
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 67/247 (27%), Positives = 115/247 (46%), Gaps = 31/247 (12%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDAA-QGRSQFQQEVE 510
E + E + R++G+G +G VY+ T VA+K + A+ + R +F E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 511 VLCNIRHPNMVLLLGACP--EFGCLIYEYMANGSLED--RLFR-----RGGSPVLPWQIR 561
V+ ++V LLG + ++ E MA+G L+ R R G P Q
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621
++AAEIA + +L+ K VHRDL N ++ ++ KI D G+ R + T
Sbjct: 122 IQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE------T 172
Query: 622 QYRMTSAAGTF--CYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAH-QVER 676
Y G ++ PE + G+ SD++S G++L +I + +P GL++ QV +
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
Query: 677 SIENGTF 683
+ +G +
Sbjct: 233 FVMDGGY 239
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 471 IGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQQ---EVEVLC-NIRHPNMVLLL 524
IG+G +G V K D A+KVL+ A + + + E VL N++HP +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 525 GA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI-AAEIATALLFLHQTKPE 581
+ + + +Y+ G L L R P + R R AAEIA+AL +LH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSLN-- 116
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC----YIDP 637
+++RDLKP NILLD ++D GL + + + + TS TFC Y+ P
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTS---TFCGTPEYLAP 165
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
E + D + LG +L +++ PP
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHTP----VAIKVLRPDAAQG-RSQFQQEVEVLC 513
E ++F ++G G G V K + H P +A K++ + R+Q +E++VL
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 514 NIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
P +V GA G + E+M GSL D++ + +P +I +++ +
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKR--IPEEILGKVSIAVLRG 115
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
L +L + ++HRD+KP NIL++ K+ D G++ + S+A+S GT
Sbjct: 116 LAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--------GT 165
Query: 632 FCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
Y+ PE Q V+SD++S+G+ L+++ + P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 471 IGEGGYGPV--YKSYLDHTPVAIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLLLG 525
+G+G +G V + A+K+L+ + + + E VL N RHP + L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 526 A--CPEFGCLIYEYMANGSL-----EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
+ + C + EY+ G L +R+F + RF AEI +AL +LH
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSED-------RTRF-YGAEIVSALDYLHSG 114
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
K +V+RDLK N++LD++ KI+D GL + + D+ T M + GT Y+ PE
Sbjct: 115 K---IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAAT---MKTFCGTPEYLAPE 165
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
+ G D + LG+++ +++ + P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDHTP--VAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPN 519
F + R +G+GG+G V + T A K L R +G + E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 520 MVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L A + CL+ M G L+ ++ G +P + AAEI L LH+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHR 120
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
E +V+RDLKP NILLD +ISD+GLA +P + GT Y+ P
Sbjct: 121 ---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-------ETIRGRVGTVGYMAP 170
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
E + D + LG L+ ++I K P
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 28/199 (14%)
Query: 487 TPVAIKVLRPDAA-QGRSQFQQEVEVLCNI-RHPNMVLLLGACPEFGCL--IYEYMANGS 542
VA+K+L+ DA + S E+E++ I +H N++ LLGAC + G L + EY + G+
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 543 LEDRLFRRGGSPVLPW----------QIRFR----IAAEIATALLFLHQTKPEPLVHRDL 588
L + L R P + + Q+ F+ A ++A + +L K +HRDL
Sbjct: 105 LREYL-RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL 160
Query: 589 KPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG-TFCYIDPEYQQTGMLGV 647
N+L+ + V KI+D GLAR V ++ Y+ T+ ++ PE +
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDV-----HNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215
Query: 648 KSDVYSLGILLLQIITAKP 666
+SDV+S G+LL +I T
Sbjct: 216 QSDVWSFGVLLWEIFTLGG 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 68/245 (27%), Positives = 99/245 (40%), Gaps = 28/245 (11%)
Query: 470 KIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEV-----LCNIRHPNMVL 522
+IG G YG VYK+ H+ VA+K +R + EV L HPN+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 523 LLGACPEFGC-------LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
L+ C L++E++ + L L + P LP + + + L FL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H +VHRDLKP NIL+ K++D GLAR+ +A +T T Y
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-------LTPVVVTLWYR 174
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWP 695
PE D++S+G + ++ KP E FD P DWP
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPL--FCGNSEADQLGKIFDLIGLPPEDDWP 232
Query: 696 VEEAL 700
+ L
Sbjct: 233 RDVTL 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP----VAIKVLRPDAAQGRSQFQ-QEVEVLCNIRH 517
+ N IGEG YG V + H P VAIK + P Q Q +E+++L +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSAT--HKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 518 PNMVLLLGA-CPEFGC------LIYEYMANGSLEDRLFRRGGSPVLPWQ-IRFRIAAEIA 569
N++ +L P ++ E M E L++ + L I++ + +I
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYFLY-QIL 116
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
L ++H ++HRDLKP N+LL+ N KI D GLAR+ P + +T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP---EHDHTGFLTEYV 170
Query: 630 GTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
T Y PE ML K D++S+G +L ++++ +P
Sbjct: 171 ATRWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 60/224 (26%), Positives = 90/224 (40%), Gaps = 47/224 (20%)
Query: 469 RKIGEGGYGPVYK----SYLDHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLL 523
+IG G +G V + V +K LR A + F QEV+ + HPN++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 524 LGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAEIATALLFLHQTK 579
LG C E L+ E+ G L++ L G Q R+A E+A+ LL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLA-------------------RLVPPSVADSV 620
+H DL N L + KI D GLA R + P + +
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA 664
Q + QT KS+++SLG+ + ++ TA
Sbjct: 178 GQDLLPK------------DQTK----KSNIWSLGVTMWELFTA 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQ----QEVEVLCNIR 516
+ + +I EG YG VY++ T VA+K L+ + + + F +E+ +L ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKME--KEKEGFPITSLREINILLKLQ 62
Query: 517 HPNMV----LLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
HPN+V +++G+ + ++ EY+ + L+ L P L +++ + ++ + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVKC-LMLQLLSGV 119
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
LH ++HRDLK N+LL+ + KI D GLAR S + T T
Sbjct: 120 AHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-----SPLK-PYTQLVVTL 170
Query: 633 CYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
Y PE +LG K D++S+G + +++T KP
Sbjct: 171 WYRAPEL----LLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 5e-10
Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 56/241 (23%)
Query: 469 RKIGEGGYGPVYKSYLD---HTPVAIKVLRPDAAQGRSQFQQ---EVEVLCNIR-HPNMV 521
+K+G+G YG V+K+ +D VA+K + DA + + Q+ E+ L + HPN+V
Sbjct: 13 QKLGKGAYGIVWKA-IDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQELGDHPNIV 70
Query: 522 LLLGACPEFG----CLIYEYMAN--------GSLEDRLFRRGGSPVLPWQIRFRIAAEIA 569
LL L++EYM LED R+ I ++
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV------------HKRY-IMYQLL 117
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
AL ++H ++HRDLKP NILL+ + K++D GLAR + + ++ +T
Sbjct: 118 KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENPVLTDYV 173
Query: 630 GTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP------PMGLAHQVERSI 678
T Y PE +LG D++S+G +L +++ KP + +Q+E+ I
Sbjct: 174 ATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL---NQLEKII 226
Query: 679 E 679
E
Sbjct: 227 E 227
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDHTP--VAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPN 519
F + R +G+GG+G V + T A K L R +G + E +L + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSR 60
Query: 520 MVLLLGACPEFG---CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
V+ L E CL+ M G L+ ++ G +P Q AAE+ L L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ E +V+RDLKP NILLD +ISD+GLA +P + GT Y+
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-------ETVRGRVGTVGYMA 169
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
PE D + LG L+ ++I + P
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 54/222 (24%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
+G+G +G V + T AIK+L+ D Q+ +V C + VL L P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDV------IIQDDDVECTMVEKR-VLALPGKP 60
Query: 529 EFGCLIYEYMANGSLEDRL-----FRRGGSPVLPWQI----RFR------IAAEIATALL 573
F ++ DRL + GG L + I +F+ AAEIA L
Sbjct: 61 PFLTQLHSCFQT---MDRLYFVMEYVNGGD--LMYHIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
FLH + +++RDLK N++LD KI+D G+ + ++ T TFC
Sbjct: 116 FLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKT-------TRTFC 162
Query: 634 ----YIDPE---YQQTGMLGVKS-DVYSLGILLLQIITAKPP 667
YI PE YQ G KS D ++ G+LL +++ +PP
Sbjct: 163 GTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 76/277 (27%), Positives = 120/277 (43%), Gaps = 32/277 (11%)
Query: 470 KIGEGGYGPVYKSY-LDHTP--VAIKVLRPDAAQGRSQFQ--QEVEVLCNIR---HPNMV 521
+IGEG YG V+K+ L + VA+K +R + +EV VL ++ HPN+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 522 LLLGACPEFGC-------LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
L C L++E++ + L L + P +P + + ++ L F
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
LH + +VHRDLKP NIL+ + K++D GLAR+ Q +TS T Y
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS-------FQMALTSVVVTLWY 175
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDW 694
PE D++S+G + ++ KP + V++ D P DW
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIGLPGEEDW 233
Query: 695 PVEEALILAKLALQCAELRRKDRPD---LGKVVVPKL 728
P + AL + A+ K D LGK ++ K
Sbjct: 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 270
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 73/270 (27%), Positives = 105/270 (38%), Gaps = 60/270 (22%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVE-VLC---------NIRHP 518
+G G +G V + T AIK L+ R EVE ++C + RHP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR----DEVESLMCEKRIFETANSERHP 62
Query: 519 NMVLLLGAC---PEFGCLIYEYMANGSL-----EDRLFRRGGSPVLPWQIRFRIAAEIAT 570
+V L AC + C + EY A G L D + F AA +
Sbjct: 63 FLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP--------RAVF-YAACVVL 112
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
L +LH+ K +V+RDLK N+LLD KI+D GL +
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCK----------EGMGFGDRTS 159
Query: 631 TFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKPPM--GLAHQVERSIENGTF 683
TFC PE+ +L S D + LG+L+ +++ + P +V SI N
Sbjct: 160 TFCGT-PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--- 215
Query: 684 DETLDPAVPDWPVEEALILAKLALQCAELR 713
DE P E I+ +L + E R
Sbjct: 216 DEVRYPRF--LSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 469 RKIGEGGYGPVYKSYLDHT----PVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMV 521
+ +GEG +G V + L+ VA+K ++ A RS+ F E + HPN++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKI-AICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 522 LLLGACPEFG--------CLIYEYMANGSLEDRLF--RRGGSPV-LPWQIRFRIAAEIAT 570
L+G C + +I +M +G L L R G P LP Q+ + +IA+
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
+ +L +HRDL N +L+ N ++D GL++ + D Q R+ A
Sbjct: 124 GMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKI--YNGDYYRQGRI--AKM 176
Query: 631 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
+I E + KSDV+S G+ + +I T
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 471 IGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQ----EVEVLCNIRHPNMVLLLGA 526
+GEG YG V K T + + + ++ + ++ E+++L ++ N+V L A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 527 CPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
G L++EY+ LE L + V P ++R I ++ A+ + H+ +V
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY-QLIKAIHWCHKND---IV 122
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM 644
HRD+KP N+L+ N V K+ D G AR + + T+Y T Y PE
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY-----VATRWYRSPELLLGAP 177
Query: 645 LGVKSDVYSLGILLLQIITAKP 666
G D++S+G +L ++ +P
Sbjct: 178 YGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 27/188 (14%)
Query: 490 AIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSL- 543
A+K+LR + + + E VL N RHP + L A + C + EY G L
Sbjct: 24 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 83
Query: 544 ----EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599
+R+F + RF AEI +AL +LH +V+RD+K N++LD++
Sbjct: 84 FHLSRERVFTEE-------RARF-YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDG 132
Query: 600 VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLL 659
KI+D GL + ++D T M + GT Y+ PE + G D + LG+++
Sbjct: 133 HIKITDFGLCK---EGISDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 660 QIITAKPP 667
+++ + P
Sbjct: 187 EMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 9e-10
Identities = 70/249 (28%), Positives = 120/249 (48%), Gaps = 33/249 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQGRSQFQ--QEVEVLCNIRHP 518
+++ K+GEG Y VYK S ++ VA+KV+R +G + F +E +L ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHA 63
Query: 519 NMVLL--LGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+VLL + E L++EY+ + GG + P ++ + ++ L ++H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG--LHPENVKLFLF-QLLRGLSYIH 120
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
Q ++HRDLKP N+L+ K++D GLAR A SV + ++ T Y
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR------AKSVPSHTYSNEVVTLWYRP 171
Query: 637 PEYQQTGMLGVKS-----DVYSLGILLLQII---TAKPPM-GLAHQVERS-IENGTFDET 686
P+ +LG D++ +G + +++I A P M + Q+ER + GT +E
Sbjct: 172 PDV----LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227
Query: 687 LDPAVPDWP 695
P V P
Sbjct: 228 TWPGVHSLP 236
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 471 IGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLC-NIRHPNMVLLL 524
IG+G +G V K LD A+KVL+ R + E VL N++HP L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP---FLV 59
Query: 525 GACPEFGC-----LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI-AAEIATALLFLHQT 578
G F + +++ G L L R P + R R AAEIA+AL +LH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSI 115
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
+V+RDLKP NILLD ++D GL + + +D+ T + GT Y+ PE
Sbjct: 116 N---IVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTF-----CGTPEYLAPE 166
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+ D + LG +L +++ PP
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 471 IGEGGYGPV--YKSYLDHTPVAIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLLLG 525
+G+G +G V K A+K+L+ + + + E VL N RHP + L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 526 ACPEFG--CLIYEYMANGSL-----EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
+ C + EY G L +R+F + RF AEI +AL +LH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSED-------RARF-YGAEIVSALDYLHSE 114
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
K +V+RDLK N++LD++ KI+D GL + + D T M + GT Y+ PE
Sbjct: 115 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGAT---MKTFCGTPEYLAPE 166
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+ G D + LG+++ +++ + P
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 470 KIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA- 526
KIGEG G V + H+ VA+K++ Q R EV ++ + +H N+V + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 527 -CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIAT-------ALLFLHQT 578
E ++ E++ G+L D + Q R +IAT AL +LH
Sbjct: 88 LVGEELWVLMEFLQGGALTD----------IVSQTRLN-EEQIATVCESVLQALCYLHS- 135
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
+ ++HRD+K +ILL + K+SD G + V + S GT ++ PE
Sbjct: 136 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------KRKSLVGTPYWMAPE 187
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
G + D++SLGI++++++ +PP
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 463 ENFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQQ---EVEVLCNIRH 517
E+F + I G YG VY + A+K + R+Q QQ E ++L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 518 PNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
P +V + + C++ EY+ G L G PV ++ F AE AL +L
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYF---AETVLALEYL 117
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR---------LVPPSVADSVTQYRMT 626
H +VHRDLKP N+L+ K++D GL++ L + ++
Sbjct: 118 HNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
GT YI PE G D +++GI+L + + P
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRH 517
F+ R +G+G +G V ++ L VA+K+L+ D ++ +F +E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 518 PNMVLLLGACPE--------FGCLIYEYMANGSLEDRLF--RRGGSPV-LPWQIRFRIAA 566
PN++ L+G +I +M +G L L R G P LP Q R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+IA+ + +L +HRDL N +L+ N ++D GL++ + S YR
Sbjct: 121 DIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIY-----SGDYYRQG 172
Query: 627 SAAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
A+ ++ E + SDV++ G+ + +I+T
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 46/236 (19%)
Query: 461 ATENFSNSRKIGEGGYGPVYKSY--LDHTPVAIK-VLRPDAAQGRSQF----QQEVEVLC 513
++ K+GEG +G VYK+ VA+K +L + G F +E+++L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 514 NIRHPNMVLLL--------GACPEFGC--LIYEYMA---NGSLEDRLFRRGGSPVLPWQI 560
++HPN+V L+ + + G ++ YM +G LE+ + + QI
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTESQI 117
Query: 561 RFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV---PPSV- 616
+ ++ + +LH+ ++HRD+K NIL+D + KI+D GLAR PP+
Sbjct: 118 KC-YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 617 -ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
+ T+ T Y PE +LG + D++ +G + ++ T +P
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 70/257 (27%), Positives = 115/257 (44%), Gaps = 39/257 (15%)
Query: 428 FKALREAKERKAALNSLTVDLRYRKY--SIEEIEEATENFSNSRKIGEGGYGPV----YK 481
ALR+ K L+ RY K I ++ E+F + IG G +G V +K
Sbjct: 12 IPALRKNKNIDNFLS------RYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK 65
Query: 482 SYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYE 536
S A+K+L RS F +E +++ + +V L A ++ ++ E
Sbjct: 66 S--SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123
Query: 537 YMANGSLEDRLFRRGGSPVLP--WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNIL 594
YM G L + + + +P W RF A E+ AL +H +HRD+KP N+L
Sbjct: 124 YMPGGDLVNLM----SNYDIPEKWA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNML 174
Query: 595 LDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT----GMLGVKSD 650
LD++ K++D G + D+ R +A GT YI PE ++ G G + D
Sbjct: 175 LDKSGHLKLADFGTCMKM-----DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 651 VYSLGILLLQIITAKPP 667
+S+G+ L +++ P
Sbjct: 230 WWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 471 IGEGGYGPVY--KSYLDHTPVAIKVLRPDA---AQGRSQFQQEVEVLC-NIRHPNMVLLL 524
IG+G +G V K D + A+KVL+ + ++ E VL N++HP +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 525 GA--CPEFGCLIYEYMANGSL-----EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+ E + +Y+ G L +R F + RF AAE+A+A+ +LH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-------RARF-YAAEVASAIGYLHS 114
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC---- 633
+++RDLKP NILLD ++D GL + + V TS TFC
Sbjct: 115 LN---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGVEPEETTS---TFCGTPE 161
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Y+ PE + D + LG +L +++ PP
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 43/217 (19%)
Query: 471 IGEGGYGPVYKSYLDHTPVAIKVLRPDAAQ---------------GRSQFQQEVEVLCNI 515
+G+G +G V+ + K+ PDA Q R + + E ++L +
Sbjct: 4 LGQGSFGKVF--------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV 55
Query: 516 RHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQ--IRFRIAAEIATA 571
HP +V L A G LI +++ G L F R V+ + ++F +A E+A A
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLA-ELALA 110
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT-SAAG 630
L LH +++RDLKP NILLD K++D GL++ +S+ + S G
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-------ESIDHEKKAYSFCG 160
Query: 631 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
T Y+ PE +D +S G+L+ +++T P
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 461 ATENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQGRSQFQ--QEVEVLCNIR 516
A ++ N K+GEG Y VYK S ++ VA+KV+ +G F +E +L ++
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLK 61
Query: 517 HPNMVLL--LGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
H N+VLL + E ++EYM + + GG + P+ +R ++ L +
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRL-FMFQLLRGLAY 118
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
+H ++HRDLKP N+L+ K++D GLAR A S+ +S T Y
Sbjct: 119 IHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSEVVTLWY 169
Query: 635 IDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
P+ +LG D++ G + ++++ +P
Sbjct: 170 RPPDV----LLGATDYSSALDIWGAGCIFIEMLQGQP 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 69/256 (26%), Positives = 114/256 (44%), Gaps = 31/256 (12%)
Query: 425 NVEFKALREAKERKAALNSLTVDLRYRKY--SIEEIEEATENFSNSRKIGEGGYGPV--Y 480
+++F ALR+ K LN RY+ I ++ E++ + IG G +G V
Sbjct: 9 DLDFPALRKNKNIDNFLN------RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV 62
Query: 481 KSYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535
+ A+K+L RS F +E +++ P +V L A + + ++
Sbjct: 63 RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122
Query: 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595
EYM G L + L P W RF AE+ AL +H +HRD+KP N+LL
Sbjct: 123 EYMPGGDLVN-LMSNYDVPE-KWA-RF-YTAEVVLALDAIHSMG---FIHRDVKPDNMLL 175
Query: 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT----GMLGVKSDV 651
D++ K++D G + + R +A GT YI PE ++ G G + D
Sbjct: 176 DKSGHLKLADFGTCMKM-----NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 652 YSLGILLLQIITAKPP 667
+S+G+ L +++ P
Sbjct: 231 WSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPNMVLLLG 525
+G+GG+G V + +T A K L R G E E+L + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 526 A--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
A CL+ M G L+ ++ G + ++ +A+I +L LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIH-YSAQITCGILHLHSMD---I 116
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG 643
V+RD+KP N+LLD ++SD+GLA + ++TQ AGT Y+ PE +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKD--GKTITQ-----RAGTNGYMAPEILKEE 169
Query: 644 MLGVKSDVYSLGILLLQIITAKPP 667
D +++G + +++ + P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 14/157 (8%)
Query: 565 AAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYR 624
AAEI L FLH + +V+RDLK NILLD + KI+D G+ + + + +
Sbjct: 102 AAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK------ENMLGDAK 152
Query: 625 MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFD 684
+ GT YI PE D +S G+LL +++ + P H E ++ D
Sbjct: 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH-GHDEEELFQSIRMD 211
Query: 685 ETLDPAVPDWPVEEAL-ILAKLALQCAELRRKDRPDL 720
+P P W EA IL KL ++ E R + D+
Sbjct: 212 ---NPCYPRWLTREAKDILVKLFVREPERRLGVKGDI 245
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 32/215 (14%)
Query: 465 FSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMV 521
F + + E G +Y A+KV++ A + S F++E ++L P +
Sbjct: 14 FGEVQVVREKATGDIY---------AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 522 LLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
L A + L+ EY G L L R +F +A E+ A+ +HQ
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQMG 122
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVG-LARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
VHRD+KP N+L+DR K++D G ARL + GT YI PE
Sbjct: 123 ---YVHRDIKPENVLIDRTGHIKLADFGSAARL------TANKMVNSKLPVGTPDYIAPE 173
Query: 639 YQQT------GMLGVKSDVYSLGILLLQIITAKPP 667
T G GV+ D +SLG++ ++I + P
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 49/227 (21%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA-QG-RSQFQQEVEVLCNIRHP 518
+ + KIGEG YG VYK+ T +A+K +R + +G S +E+ +L ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 519 NMVLLLGACPEFGC--LIYEYM-----------ANGSLEDRLFRRGGSPVLPWQIRFRIA 565
N+V L L++EY+ + + RL + +QI IA
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIK-----TYLYQILRGIA 116
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS-KISDVGLARLVPPSVADSVTQYR 624
+ H + ++HRDLKP N+L+DR + K++D GLAR A +
Sbjct: 117 --------YCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR------AFGIPVRT 159
Query: 625 MTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
T T Y PE +LG + D++S+G + +++ KP
Sbjct: 160 FTHEVVTLWYRAPEI----LLGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLLLG 525
+G+GG+G V + T A K L + R ++ E +L + H ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 526 ACPEFG---CLIYEYMANGSLEDRLFR-RGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
+ CL+ M G L ++ +P P A+I + L LHQ +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ 641
+++RDLKP N+LLD + +ISD+GLA V Q + AGT ++ PE Q
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLA------VELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 642 TGMLGVKSDVYSLGILLLQIITAKPP 667
D ++LG+ L ++I A+ P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 69/269 (25%), Positives = 113/269 (42%), Gaps = 28/269 (10%)
Query: 470 KIGEGGYGPVYKSYLD----HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLL 523
++G G +G V K VA+K+L+ D + + +E V+ + +P +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 524 LGACP-EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
+G C E L+ E G L F + V I + +++ + +L +T
Sbjct: 62 IGICEAESWMLVMELAELGPLNK--FLQKNKHVTEKNIT-ELVHQVSMGMKYLEETN--- 115
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT 642
VHRDL N+LL + +KISD GL++ + AD T + PE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALG---ADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 643 GMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVPDWPVEEA 699
KSDV+S G+L+ + + KP G+ ++V + IE+G E P E
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME----CPQRCPPE-- 226
Query: 700 LILAKLALQCAELRRKDRPDLGKVVVPKL 728
+ L C +RP VV +L
Sbjct: 227 --MYDLMKLCWTYGVDERPGFA-VVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQGRS-QFQQEVEVLCNIRHPN 519
E + K+GEG Y V+K S L VA+K +R + +G +EV +L N++H N
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L CL ++EY+ + L+ L G + F ++ L + H+
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF--QLLRGLSYCHK 121
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
K ++HRDLKP N+L++ K++D GLAR A SV ++ T Y P
Sbjct: 122 RK---ILHRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNEVVTLWYRPP 172
Query: 638 EYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
+ +LG D++ +G +L ++ T +P
Sbjct: 173 DV----LLGSTEYSTPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 473 EGGYGPVYK-SYLDHTP-----VAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLG 525
EG +G ++ +D P V +K ++ A++ + QE +L + H N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 526 AC---PEFGCLIYEYMANGSLED-----RLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
C E ++Y YM G+L+ RL L Q +A +IA + +LH+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV--TQYRMTSAAGTFCYI 635
++H+D+ N ++D KI+D L+R + P + + R ++
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------WM 186
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIIT 663
E SDV+S G+LL +++T
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 23/262 (8%)
Query: 470 KIGEGGYG----PVYKSYLDHTPVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNMVLLL 524
++G G +G VYK VAIKVL+ + + R + +E E++ + +P +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 525 GACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
G C ++ MA+G ++ F G + + +++ + +L V
Sbjct: 62 GVCEAEALMLVMEMASGGPLNK-FLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FV 117
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM 644
HRDL N+LL + +KISD GL++ + DS + R ++ + PE
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKAL--GADDSYYKAR-SAGKWPLKWYAPECINFRK 174
Query: 645 LGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVPDWPVEEALI 701
+SDV+S GI + + + KP + +V IE G + LD + P E
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG---KRLD-CPAECPPE---- 226
Query: 702 LAKLALQCAELRRKDRPDLGKV 723
+ L C + +DRP+ KV
Sbjct: 227 MYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGAC 527
+G G YG VYK T AIKV+ + + +QE+ +L H N+ GA
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 528 PEFG--------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
+ L+ E+ GS+ D + G+ + I + I EI L LHQ K
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQHK 131
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
++HRD+K N+LL N K+ D G++ + +V R + GT ++ PE
Sbjct: 132 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEV 182
Query: 640 -----QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672
KSD++SLGI +++ PP+ H
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 62/227 (27%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 471 IGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-----RHPNMVLL 523
IG+G YG V+K + + + A+K+L P +E+E NI HPN+V
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-----IHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 524 LGACPEFGC-------LIYEYMANGSLEDR---LFRRG---GSPVLPWQIRFRIAAEIAT 570
G + L+ E GS+ D +RG P++ + I E
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALM 135
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
L LH K +HRD+K NILL K+ D G+ S + T+ R ++ G
Sbjct: 136 GLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGV------SAQLTSTRLRRNTSVG 186
Query: 631 TFCYIDPEY-----QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672
T ++ PE Q + DV+SLGI +++ PP+ H
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 50/224 (22%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQ----QEVEVLCNIRHPNMVLL- 523
IGEG YG VYK+ T VA+K +R D + F +E+++L + H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLD--NEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 524 ---------LGACPEFGC--LIYEYMAN---GSLEDRL--FRRGGSPVLPWQIRFRIAAE 567
L + G L++EYM + G LE L F I+ +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-------HIK-SFMKQ 124
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
+ L + H+ +HRD+K NILL+ K++D GLARL ++ Y T+
Sbjct: 125 LLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLY---NSEESRPY--TN 176
Query: 628 AAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
T Y PE +LG + DV+S G +L ++ T KP
Sbjct: 177 KVITLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM 520
E + KIGEG G V + HT VA+K + Q R EV ++ + H N+
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 521 VLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
V + + + ++ E++ G+L D + + + QI + + AL +LH
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIA-TVCLSVLRALSYLHN- 136
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
+ ++HRD+K +ILL + K+SD G V V + S GT ++ PE
Sbjct: 137 --QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP------KRKSLVGTPYWMAPE 188
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
G + D++SLGI+++++I +PP
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 70/235 (29%), Positives = 104/235 (44%), Gaps = 42/235 (17%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQ---FQQEVEVLCNIRH 517
++F + IG G +G V + HT A+K+L R++ F++E VL N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 518 PNMVLLLGACPE--FGCLIYEYMANGSL-------EDRLFRRGGSPVLPWQI-RFRIAAE 567
+ L A + + L+ +Y G L EDRL P + RF IA E
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL---------PEDMARFYIA-E 110
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG--LARLVPPSVADSVTQYRM 625
+ A+ +HQ VHRD+KP N+LLD N +++D G L +V SV
Sbjct: 111 MVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV----- 162
Query: 626 TSAAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE 675
A GT YI PE Q G G + D +SLG+ + +++ + P VE
Sbjct: 163 --AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 50/220 (22%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
+G+G +G V + T AIK+L+ D Q+ +V C + ++ L G P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALSGKPP 61
Query: 529 EFGCL--IYEYMANGSLEDRL-----FRRGGSPVLPWQI----RFR------IAAEIATA 571
L ++ M DRL + GG L +QI RF+ AAEIA
Sbjct: 62 FLTQLHSCFQTM------DRLYFVMEYVNGGD--LMYQIQQVGRFKEPHAVFYAAEIAIG 113
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
L FLH + +++RDLK N++LD KI+D G+ + ++ D VT T
Sbjct: 114 LFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVT-------TKT 160
Query: 632 FC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
FC YI PE G D ++ G+LL +++ + P
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVA---IKVLR--------PDAAQGRSQFQQEVEVLCNIRH 517
+++G+G +G VY D VA +KVL+ P+ Q QE ++L + H
Sbjct: 6 QRLGKGSFGTVY-LVKDKKAVAEERLKVLKEIPVGELNPNET---VQANQEAQLLSKLDH 61
Query: 518 PNMVLLLGACPEFG--CLIYEYMANGSLEDRL--FRRGG-----SPVLPWQIRFRIAAEI 568
P +V + E C+I EY L+ +L + G + V W I+ +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH- 120
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
++HQ + ++HRDLK NI L N + KI D G++RL+ S D T +
Sbjct: 121 -----YMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS-CDLATTF----- 165
Query: 629 AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQI 661
GT Y+ PE + KSD++SLG +L ++
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 26/148 (17%)
Query: 565 AAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYR 624
AAEI L FLH+ +++RDLK N+LLD++ KI+D G+ +
Sbjct: 102 AAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK----------ENMN 148
Query: 625 MTSAAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN 680
A TFC YI PE + D +S G+LL +++ + P H + E+
Sbjct: 149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF---HGED---ED 202
Query: 681 GTFDETLD--PAVPDWPVEEAL-ILAKL 705
FD L+ P P W +EA L+KL
Sbjct: 203 ELFDSILNDRPHFPRWISKEAKDCLSKL 230
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQ---QEVEVLCNIRHP 518
+F+ +G+G +G V + T AIK+L+ D + E VL P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 519 NMVLLLGACPEFGCLIY---EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
+ L +C + +Y EY+ G L + ++ G P + + AAEI+ L FL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFY--AAEISVGLFFL 117
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC-- 633
H+ +++RDLK N++LD KI+D G+ + + D VT TFC
Sbjct: 118 HR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVT-------TRTFCGT 164
Query: 634 --YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
YI PE G D ++ G+LL +++ +PP
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 471 IGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLC-NIRHPNMVLLL 524
IG+G +G V + + A+KVL+ A + + E VL N++HP +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 525 GACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
+ L + +Y+ G L L R L + RF AAEIA+AL +LH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARF-YAAEIASALGYLHSLN--- 116
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC----YIDPE 638
+V+RDLKP NILLD ++D GL + +++ TS TFC Y+ PE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNGTTS---TFCGTPEYLAPE 166
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
D + LG +L +++ PP
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 33/150 (22%), Positives = 64/150 (42%), Gaps = 16/150 (10%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
+ VA+D + S+ AL WA++ RG L LLHV + + + + E
Sbjct: 5 ILVAVDGSEESERALEWALELAKRRGAELILLHV------IDPEPSGAASEALEEEEEEE 58
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
+ +++ + +A E+V+ D A+A+++ + +V+G+
Sbjct: 59 LEEEEAEAEALA-------AAAEAGGVVVEVVVRGGDPAEAILEVAEEEDADLIVMGSRG 111
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162
R+G +R + V + AP C V V+
Sbjct: 112 RSGL-RRLLLGSVAEKVLRHAP--CPVLVV 138
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 27/188 (14%)
Query: 490 AIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSL- 543
A+K+L+ + + + E VL N RHP + L + C + EY G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 544 ----EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599
+R+F + RF AEI +AL +LH +V+RDLK N++LD++
Sbjct: 84 FHLSRERVFSED-------RARF-YGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDG 132
Query: 600 VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLL 659
KI+D GL + ++D T M + GT Y+ PE + G D + LG+++
Sbjct: 133 HIKITDFGLCK---EGISDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 660 QIITAKPP 667
+++ + P
Sbjct: 187 EMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGN 592
L+ EY+ G D +F LP + AAEI AL FLH+ +++RDLK N
Sbjct: 73 LVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDN 126
Query: 593 ILLDRNYVSKISDVGLAR--LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSD 650
+LLD + K++D G+ + L P D+ + + GT YI PE + G D
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGP---GDTTSTF-----CGTPNYIAPEILRGEEYGFSVD 178
Query: 651 VYSLGILLLQIITAKPPMGL 670
++LG+L+ +++ + P +
Sbjct: 179 WWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQGRS-QFQQEVEVLCNIRHPN 519
E + K+GEG Y VYK S L VA+K +R + +G +EV +L +++H N
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 520 MVLL--LGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L + + L++EY+ + L+ L G S + F ++ L + H+
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLF--QLLRGLNYCHR 122
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
K ++HRDLKP N+L++ K++D GLAR A S+ ++ T Y P
Sbjct: 123 RK---VLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNEVVTLWYRPP 173
Query: 638 EYQQTGMLG-----VKSDVYSLGILLLQIITAKP 666
+ +LG + D++ +G + ++ T +P
Sbjct: 174 DI----LLGSTDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 48/149 (32%), Positives = 70/149 (46%), Gaps = 33/149 (22%)
Query: 533 LIYEYMANGSL-------EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
L+ +Y G L EDRL P RF +A E+ A+ +HQ VH
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRL------P--EDMARFYLA-EMVLAIDSVHQLG---YVH 125
Query: 586 RDLKPGNILLDRNYVSKISDVG--LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ-- 641
RD+KP N+LLD+N +++D G L L +V +V A GT YI PE Q
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-------AVGTPDYISPEILQAM 178
Query: 642 ---TGMLGVKSDVYSLGILLLQIITAKPP 667
G G + D +SLG+ + +++ + P
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQ---FQQEVEVLCNIRH 517
E+F + IG G +G V L + A+K+L R++ F++E +VL N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 518 PNMVLLLGACPEFG--CLIYEYMANGSL-------EDRLFRRGGSPVLPWQIRFRIAAEI 568
+ L A + L+ +Y G L EDRL P + AE+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL---------PEDMARFYLAEM 111
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG--LARLVPPSVADSVTQYRMT 626
A+ +HQ VHRD+KP NIL+D N +++D G L + +V SV
Sbjct: 112 VIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV------ 162
Query: 627 SAAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE 675
A GT YI PE Q G G + D +SLG+ + +++ + P VE
Sbjct: 163 -AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 470 KIGEGGYGPVYKSYLDHTP--VAIKVLR-PDAAQG-RSQFQQEVEVLCNIRHPNMVLL-- 523
KIGEG YG V+K+ T VA+K +R D +G S +E+ +L ++H N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 524 -LGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
L + + L++EY + L+ G F ++ L F H
Sbjct: 67 VLHSDKKL-TLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMF--QLLKGLAFCHS---HN 119
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLAR 610
++HRDLKP N+L+++N K++D GLAR
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 43/232 (18%)
Query: 452 KYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRP--DAAQGRSQFQQ 507
+Y I+E+ IG+G YG V + HT VAIK + + ++ +
Sbjct: 1 RYKIQEV------------IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR 48
Query: 508 EVEVLCNIRHPNMV----LLLGACP-EFGCL--IYEYMANGSLEDRLFR--RGGSPVLPW 558
E+++L +RHP++V ++L EF + ++E M E L + + + P
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPE 103
Query: 559 QIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618
+F + ++ AL ++H + HRDLKP NIL + + KI D GLAR + D
Sbjct: 104 HHQFFLY-QLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR---VAFND 156
Query: 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS----DVYSLGILLLQIITAKP 666
+ T T T Y PE G K D++S+G + +++T KP
Sbjct: 157 TPTAIFWTDYVATRWYRAPEL--CGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 13/154 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQ--QEVEVLCNIRHP 518
E + K+GEG Y VYK T VA+K +R + +G + F +E +L +++H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHA 63
Query: 519 NMVLL--LGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V L + + L++EY+ + L+ + GG + +R ++ L + H
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGG-LSMHNVRL-FLFQLLRGLAYCH 120
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
Q + ++HRDLKP N+L+ K++D GLAR
Sbjct: 121 QRR---VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 470 KIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA- 526
KIGEG G V + + + VA+K + Q R EV ++ + +H N+V + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 527 -CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
+ ++ E++ G+L D + + + QI + + AL LH + ++H
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIA-AVCLAVLKALSVLHA---QGVIH 139
Query: 586 RDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML 645
RD+K +ILL + K+SD G V V R S GT ++ PE
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKSLVGTPYWMAPELISRLPY 193
Query: 646 GVKSDVYSLGILLLQIITAKPP 667
G + D++SLGI++++++ +PP
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 46/144 (31%), Positives = 68/144 (47%), Gaps = 18/144 (12%)
Query: 565 AAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYR 624
AAEI L FLH + +++RDLK N++LDR+ KI+D G+ + + R
Sbjct: 102 AAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK------ENVFGDNR 152
Query: 625 MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGT 682
++ GT YI PE Q D +S G+LL +++ + P + E SI T
Sbjct: 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT 212
Query: 683 FDETLDPAVPDWPVEEAL-ILAKL 705
P P W +E+ IL KL
Sbjct: 213 ------PHYPRWITKESKDILEKL 230
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 20/166 (12%)
Query: 524 LGACPEFGC--------------LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIA 569
L AC FG LI EY + G L ++ +R LP+Q + +
Sbjct: 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEH-LPFQ-EYEVGLLFY 176
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
+L L + ++HRDLK NI L + K+ D G ++ +DSV+ +S
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK----QYSDSVSLDVASSFC 232
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE 675
GT Y+ PE + K+D++SLG++L +++T P Q E
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE 278
|
Length = 478 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 469 RKIGEGGYGPVY----KSYLDHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLL 523
++IG G +G V S V +K LR A+ Q + +F +E + +++H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 524 LGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAEIATALLFLHQTK 579
LG C E L+ E+ G L+ L + ++ R+A EIA LL LH+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611
+H DL N LL + KI D GL+
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 469 RKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQF---QQEVEVLCNIRHPNMVLL 523
R IG G Y V L T A+KV++ + Q E V + ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 524 LGACPEFGCLIY---EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
L +C + ++ EY+ G D +F LP + +AEI+ AL +LH+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHE--- 114
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLAR--LVPPSVADSVTQYRMTSAAGTFCYIDPE 638
+++RDLK N+LLD K++D G+ + L P D+ + + GT YI PE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GDTTSTF-----CGTPNYIAPE 166
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIENGTFDETLDPAV 691
+ G D ++LG+L+ +++ + P +G + +++ E+ F L+ +
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 40/168 (23%)
Query: 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGN 592
LI EY+ G + L ++ + RF IA E A+ +H+ +HRD+KP N
Sbjct: 78 LIMEYLPGGDMMTLLMKK--DTFTEEETRFYIA-ETILAIDSIHKLG---YIHRDIKPDN 131
Query: 593 ILLDRNYVSKISDVGL------------ARLVP---PSVADSVTQYRMT----------- 626
+LLD K+SD GL R++ PS M+
Sbjct: 132 LLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRN 191
Query: 627 ------SAAGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
S GT YI PE + QTG + D +SLG+++ +++ PP
Sbjct: 192 RRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 469 RKIGEGGYGPV----YKSYLDHTPVAIK----VLRPDAAQGRSQFQQEVEVLCNIR-HPN 519
+++G+G YG V + VAIK V R+ +E+++L + R H N
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKN 63
Query: 520 MVLLLGACPEF-----GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
+ L F +YE + L + R G P+ + I +I L +
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQSFIY-QILCGLKY 120
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
+H ++HRDLKPGN+L++ + KI D GLAR + MT T Y
Sbjct: 121 IHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSE-NPGENAGF-MTEYVATRWY 175
Query: 635 IDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
PE ML +S DV+S+G +L +++ KP
Sbjct: 176 RAPEI----MLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 31/229 (13%)
Query: 453 YSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGR---SQFQQEV 509
I+ IE + S I E +YK ++ V I+ + + + E+
Sbjct: 10 NDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEI 69
Query: 510 EVLCNIRHPNMVLLLGACPEF------GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR 563
+ L I N++ + G + LI EY G L + L + L ++ +
Sbjct: 70 KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLD 126
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL--VPPS--VADS 619
+A + L L++ +P +++L + L+ NY KI GL ++ PP V
Sbjct: 127 MAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM 184
Query: 620 VTQ-YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
V Y+M + I EY +K D+YSLG++L +I T K P
Sbjct: 185 VYFSYKMLND------IFSEYT------IKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 32/224 (14%)
Query: 464 NFSNSRKIGEGGYGPVY--KSYLDHTP---VAIKVLRPDAAQGRSQFQQ----EVEVLCN 514
NF + +G G YG V+ + H A+KVL+ A +++ + E VL +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 515 IRH-PNMVLLLGACPEFGC-----LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEI 568
+R P +V L A F LI +Y++ G + L++R ++RF + EI
Sbjct: 61 VRQSPFLVTLHYA---FQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRF-YSGEI 114
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
AL LH+ +V+RD+K NILLD ++D GL++ S + R S
Sbjct: 115 ILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL-----SEEKERTYSF 166
Query: 629 AGTFCYIDPEY--QQTGMLGVKSDVYSLGILLLQIITAKPPMGL 670
GT Y+ PE + G G D +SLGIL+ +++T P L
Sbjct: 167 CGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLLLG 525
IG+G +G V + T A+K +R RS+ E VL + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 526 A--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
+ PE L+ ++ G L L R G + + RF A E+ AL LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL--SRARFYTA-ELLCALENLHKFN---V 114
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC----YIDPEY 639
++RDLKP NILLD + D GL +L ++ D TFC Y+ PE
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDK-------TNTFCGTPEYLAPEL 164
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKPP 667
D ++LG+LL +++T PP
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 60/251 (23%), Positives = 100/251 (39%), Gaps = 48/251 (19%)
Query: 469 RKIGEGGYGPVYKSYLDHTP-----VAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNM 520
R IG+GG G VY L + P VA+K +R D ++ + +F +E ++ ++ HP +
Sbjct: 8 RLIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 521 VLLLGACPEFGCLIYE--YMANGSLEDRLFRRGGSPVLPWQIR--------FRIAAEIAT 570
V + C + + Y Y+ +L+ L L ++ I +I
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL--------------VPPSV 616
+ ++H + ++HRDLKP NILL I D G A
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP--------M 668
S+T GT Y+ PE +D+Y+LG++L Q++T P +
Sbjct: 182 YSSMT--IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 669 GLAHQVERSIE 679
+ IE
Sbjct: 240 SYRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 66/248 (26%)
Query: 450 YRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDH---TPVAIKVL-RP---DAAQGR 502
YR+ + I E + + + +++G G YG V + LD VAIK L RP + R
Sbjct: 2 YRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 503 SQFQQEVEVLCNIRHPNMVLLLGA----------------CPEFGCLIYEYMANGSL-ED 545
+ +E+ +L +++H N++ LL P G + + M + L ED
Sbjct: 61 AY--RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED 118
Query: 546 RLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISD 605
R I+F + ++ L ++H ++HRDLKPGN+ ++ + KI D
Sbjct: 119 R-------------IQF-LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161
Query: 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILL 658
GLAR DS MT T Y PE Y QT D++S+G ++
Sbjct: 162 FGLARQ-----TDS----EMTGYVVTRWYRAPEVILNWMHYTQT------VDIWSVGCIM 206
Query: 659 LQIITAKP 666
+++T KP
Sbjct: 207 AEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQGRS-QFQQEVEVLCNIRHPN 519
E + K+GEG Y V+K S L VA+K +R + +G +EV +L +++H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 520 MVLL--LGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L + + L++EY+ + L+ + G ++ +I L + H+
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHR 122
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
K ++HRDLKP N+L++ K++D GLAR A SV ++ T Y P
Sbjct: 123 RK---VLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNEVVTLWYRPP 173
Query: 638 EYQQTGMLG-----VKSDVYSLGILLLQIITAKP 666
+ +LG + D++ +G + ++ + +P
Sbjct: 174 DV----LLGSSEYSTQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 469 RKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRS-----QFQQEV-EVLCNIRHPNM 520
R IG G Y V L T A+KV++ + Q ++ V E N HP +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFL 58
Query: 521 VLLLGAC---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQ-IRFRIAAEIATALLFLH 576
V L +C + E+++ G L +F LP + RF +AEI+ AL FLH
Sbjct: 59 VGL-HSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARF-YSAEISLALNFLH 113
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC--- 633
+ +++RDLK N+LLD K++D G+ + + + TS TFC
Sbjct: 114 E---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTS---TFCGTP 160
Query: 634 -YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN 680
YI PE + G D ++LG+L+ +++ + P + + +N
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 31/175 (17%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLL 523
R IG G +G V+ D VA+K + P+ Q ++ E+++LC +H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 524 LGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE--------IATALL 573
L P Y+ ++ L + SP ++++ I L
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-------PLSSDHVKVFLYQILRGLK 117
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS-----VADSVTQY 623
+LH ++HRD+KPGN+L++ N V KI D GLAR+ P + VTQY
Sbjct: 118 YLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 464 NFSNSRKIGEGGYGPVY--KSYLDHTP---VAIKVLRP----DAAQGRSQFQQEVEVLCN 514
NF + +G G YG V+ + H A+KVL+ A+ + E +VL +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 515 IRHPNMVLLLGACPEFGC---LIYEYMANGSLEDRLFRRGGSPVLPWQIRFR------IA 565
IR ++ L + LI +Y+ G L L +R RF+ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR---------ERFKEQEVQIYS 111
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM 625
EI AL LH+ +++RD+K NILLD N ++D GL++ D V R
Sbjct: 112 GEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK---EFHEDEVE--RA 163
Query: 626 TSAAGTFCYIDPEYQQTGMLGVKS--DVYSLGILLLQIITAKPP 667
S GT Y+ P+ + G G D +S+G+L+ +++T P
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 35/150 (23%), Positives = 59/150 (39%), Gaps = 16/150 (10%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM----VLLL 524
+ + G VY +K+ + ++EV +L + + VL
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLAS 61
Query: 525 GACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
G + L+ E++ +L++ + + + IA ++A L LHQ L
Sbjct: 62 GESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPP 614
H DL PGNIL+D + I D A PP
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVL--LLGA 526
IG+G +G VY+ T A+KVL + + + EV I N+++ LL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 527 CP-----EFGC-------LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
P +F L+ +YM+ G L L + G + +F IA E+ AL
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS--EDRAKFYIA-ELVLALEH 111
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC- 633
LH+ +V+RDLKP NILLD + D GL++ ++ D+ T TFC
Sbjct: 112 LHKYD---IVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKT-------TNTFCG 158
Query: 634 ---YIDPE--YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTF 683
Y+ PE + G D +SLG+L+ ++ P A ++ N F
Sbjct: 159 TTEYLAPEVLLDEKGY-TKHVDFWSLGVLVFEMCCGWSPF-YAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 47/218 (21%)
Query: 470 KIGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR---HPNMVLLL 524
KIGEG + V K S AIK ++ + Q E+ R HPN++ L+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 525 GAC--PEFGCL----------IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
+ G L +YE + R+ P+ +++ ++ +L
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKG--------RK--RPLPEKRVK-SYMYQLLKSL 113
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV---PPSVADSVTQYRMTSAA 629
+H+ + HRD+KP NIL+ + + K++D G R + PP T+Y
Sbjct: 114 DHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPP-----YTEY-----I 159
Query: 630 GTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKP 666
T Y PE T G G K D++++G + +I++ P
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 471 IGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGAC 527
+G G YG VYK T AIKV+ + + + E+ +L H N+ GA
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 528 PEFG--------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
+ L+ E+ GS+ D + G+ + I + I EI L LH K
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLHAHK 141
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
++HRD+K N+LL N K+ D G++ + +V R + GT ++ PE
Sbjct: 142 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEV 192
Query: 640 -----QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672
+SD++SLGI +++ PP+ H
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 48/226 (21%)
Query: 470 KIGEGGYGPVYKSYL----DHTPVAIKVLRPDAAQGRSQFQ-QEVEVLCNIRHPNMVLL- 523
K+G G YG VYK+ D A+K + G S +E+ +L ++HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIE---GTGISMSACREIALLRELKHPNVISLQ 64
Query: 524 ---LGACPEFGCLIYEYMANGSLEDRLFRRGGS----PV-LPWQIRFRIAAEIATALLFL 575
L L+++Y + F R PV LP + + +I + +L
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 576 HQTKPEPLVHRDLKPGNILL-----DRNYVSKISDVGLARLV-----PPSVADSVTQYRM 625
H ++HRDLKP NIL+ +R V KI+D+G ARL P + D V
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVV--- 177
Query: 626 TSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
TF Y PE +LG + D++++G + +++T++P
Sbjct: 178 -----TFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 450 YRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVL-RP-DAAQGRSQF 505
YR+ + I E E + N +G G YG V ++ T VA+K L RP + +
Sbjct: 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 63
Query: 506 QQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQ------ 559
+E+ +L +++H N++ LL L E + L L + ++ Q
Sbjct: 64 YRELRLLKHMKHENVIGLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDH 121
Query: 560 IRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619
++F I +I L ++H ++HRDLKP N+ ++ + KI D GLAR
Sbjct: 122 VQFLIY-QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH-------- 169
Query: 620 VTQYRMTSAAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQIITAK 665
T MT T Y PE M D++S+G ++ +++T +
Sbjct: 170 -TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 61/254 (24%), Positives = 102/254 (40%), Gaps = 64/254 (25%)
Query: 465 FSNSRKIGEGGYGPVY-KSYLD-HTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPN 519
F + IG G +G V +D + A+K LR R+Q + E ++L +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQI-RFRIAAEIATALLFLH 576
+V L + + L + +Y+ G + L R G + + RF IA E+ A+ +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIA-ELTCAIESVH 118
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA---------------------RLVPPS 615
+ +HRD+KP NIL+DR+ K++D GL + P
Sbjct: 119 KMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 616 VADSVTQYRMT----------------SAAGTFCYIDPE------YQQTGMLGVKSDVYS 653
+ + R+ S GT YI PE Y Q D +S
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL------CDWWS 229
Query: 654 LGILLLQIITAKPP 667
+G++L +++ +PP
Sbjct: 230 VGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 25/174 (14%)
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV---PPSVADSVTQY 623
++A + FL K +HRDL NILL N V KI D GLAR + P V
Sbjct: 181 QVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 230
Query: 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQVE--RSIE 679
R A ++ PE + +SDV+S G+LL +I + A P G+ E R ++
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290
Query: 680 NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733
GT P++ E + + L C +DRP ++V ++L+
Sbjct: 291 EGT-----RMRAPEYATPE---IYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 51/171 (29%), Positives = 75/171 (43%), Gaps = 19/171 (11%)
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
++A + FL K +HRDL NILL N V KI D GLAR + R
Sbjct: 187 QVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR----DIYKDPDYVRKG 239
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQVE--RSIENGT 682
A ++ PE + ++SDV+S G+LL +I + A P G+ E R ++ GT
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733
PD+ E + + L C RP ++V N+L+A
Sbjct: 300 -----RMRAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 46/225 (20%)
Query: 470 KIGEGGYGPVYKSYL----DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLL-- 523
K+G G YG VYK+ D A+K + + +E+ +L ++HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC--REIALLRELKHPNVIALQK 65
Query: 524 --LGACPEFGCLIYEYMANGSLEDRLFRRGGS----PV-LPWQIRFRIAAEIATALLFLH 576
L L+++Y + F R P+ LP + + +I + +LH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 577 QTKPEPLVHRDLKPGNILL-----DRNYVSKISDVGLARLV-----PPSVADSVTQYRMT 626
++HRDLKP NIL+ +R V KI+D+G ARL P + D V
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVV---- 177
Query: 627 SAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
TF Y PE +LG + D++++G + +++T++P
Sbjct: 178 ----TFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 60/231 (25%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 450 YRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVL-RPDAAQ--GRSQ 504
YR+ + + E E +++ +++G G YG V + T VAIK L RP ++ +
Sbjct: 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA 61
Query: 505 FQQEVEVLCNIRHPNMVLLLG---ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIR 561
++ E+ +L +++H N++ LL + Y+ ++ L + G P+ +++
Sbjct: 62 YR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621
+ + ++ L ++H ++HRDLKPGN+ ++ + KI D GLAR AD+
Sbjct: 121 YLVY-QMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADA-- 169
Query: 622 QYRMTSAAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQIITAK 665
MT T Y PE Y QT D++S+G ++ +++T K
Sbjct: 170 --EMTGYVVTRWYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 25/189 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP---VAIKVLRPDA----AQGRSQFQQEVEVLCNI 515
+ IG G YG V S +D VAIK + P A + + E+++L +
Sbjct: 5 SRYKPIENIGSGAYGVVC-SAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLR-ELKILRHF 61
Query: 516 RHPNMV----LLLGACPEFGCLIYEYMANGSLEDRLFR--RGGSPVLPWQIRFRIAAEIA 569
+H N++ +L +F Y+ +E L P+ IR+ + ++
Sbjct: 62 KHDNIIAIRDILRPPGADF---KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY-QLL 117
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
L ++H ++HRDLKP N+L++ + +I D G+AR + S + +Y MT
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH--KYFMTEYV 172
Query: 630 GTFCYIDPE 638
T Y PE
Sbjct: 173 ATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 71/288 (24%), Positives = 110/288 (38%), Gaps = 84/288 (29%)
Query: 463 ENFSNSRKIGEGGYGPVY--------KSYLDHTPVAIKVLRPDAAQGRSQF---QQEVEV 511
E+F + IG+G +G V K Y A+K L + Q + E +V
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIY------AMKTLLKSEMFKKDQLAHVKAERDV 54
Query: 512 LCNIRHPNMVLLLGACPE--FGCLIYEYMANGSLEDRLFRRGGSPVLPWQI------RFR 563
L P +V L + + + LI E++ G L L + + RF
Sbjct: 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--------YDTFSEDVTRFY 106
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA-------------R 610
+A E A+ +H+ +HRD+KP NIL+DR K+SD GL+ +
Sbjct: 107 MA-ECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162
Query: 611 LVPPSVADSVTQYRMT----------------------------SAAGTFCYIDPE-YQQ 641
L+ + R + S GT YI PE + Q
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222
Query: 642 TGMLGVKSDVYSLGILLLQIITAKPPMGL--AHQVERSIENGTFDETL 687
G G + D +SLG ++ + + PP +H+ R I N + ETL
Sbjct: 223 QGY-GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIIN--WRETL 267
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|224755 COG1842, PspA, Phage shock protein A (IM30), suppresses sigma54-dependent transcription [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 37/109 (33%), Positives = 52/109 (47%), Gaps = 17/109 (15%)
Query: 329 SQSVEEVEVEMRRLRLELRQTMDMYSAACKE--------------ALAAKQKARE-LHRW 373
Q++ ++E E+ + R L Q + ++ A A Q E L R
Sbjct: 30 EQAIRDMESELAKARQALAQAIARQKQLERKLEEAQARAEKLEEKAELALQAGNEDLARE 89
Query: 374 KLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQK 422
LEEKQ LED A EA L AE++ K K+ + A E Q+IAEL A+K
Sbjct: 90 ALEEKQSLEDLAKALEAELQQAEEQVEKLKKQLAALE--QKIAELRAKK 136
|
Length = 225 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 33/208 (15%)
Query: 469 RKIGE----GGYGPVYKSYLDHTPVAIKVLRPDAAQGR--SQFQQEVEVLCNIRHPNMVL 522
IG+ + K +T VA+K + D+ QQE+ ++HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 523 LLGACPEFGCL--IYEYMANGSLEDRL---FRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+ + L + MA GS ED L F G + I F I ++ AL ++H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA---IAF-ILKDVLNALDYIHS 119
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP-------PSVADSVTQYRMTSAAG 630
+ +HR +K +ILL + +S GL V V + S+
Sbjct: 120 ---KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPK----SSVK 170
Query: 631 TFCYIDPEYQQTGMLG--VKSDVYSLGI 656
++ PE Q + G KSD+YS+GI
Sbjct: 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 23/73 (31%), Positives = 28/73 (38%), Gaps = 13/73 (17%)
Query: 528 PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV--H 585
PE G LI E++ L F +IA + LH + LV H
Sbjct: 63 PETGVLITEFIEGSELLTEDFSDPE-------NLEKIAKLLKK----LHSSPLPDLVPCH 111
Query: 586 RDLKPGNILLDRN 598
DL PGN LLD
Sbjct: 112 NDLLPGNFLLDDG 124
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 31/91 (34%), Positives = 41/91 (45%), Gaps = 19/91 (20%)
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE---- 638
++HRDLKP N+LL+ N KI D GLAR S MT T Y PE
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLAR------TTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 639 ---YQQTGMLGVKSDVYSLGILLLQIITAKP 666
Y DV+S+G + +++ KP
Sbjct: 183 CSEY------TTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
++A + FL K +HRDL NILL N V KI D GLAR + R
Sbjct: 182 QVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR----DIYKDPDYVRKG 234
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQVE--RSIENGT 682
SA ++ PE + +SDV+S G+LL +I + A P G+ E + +++GT
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294
Query: 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+ A P+ + ++ L C + K+RP +V
Sbjct: 295 RMRAPENATPE--------IYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 12/149 (8%)
Query: 474 GGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFG 531
G YG ++K T V +KVL F + ++ + H ++VL G C +
Sbjct: 20 GDYGELHK-----TEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES 74
Query: 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPG 591
++ EY+ GSL+ L + + W++ +A ++A AL FL L H ++
Sbjct: 75 IMVQEYVKFGSLDTYLKKNKNLINISWKL--EVAKQLAWALHFLEDKG---LTHGNVCAK 129
Query: 592 NILLDRNYVSKISDVGLARLVPPSVADSV 620
N+LL R K + +L P ++ +V
Sbjct: 130 NVLLIREEDRKTGNPPFIKLSDPGISITV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLR--------PDAA-------QGRSQF 505
+ + KIGEG YG VYK+ +T VA+K R P A Q S+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 506 QQEVEVLC--NIRHPNMVLLLGACPEFGCLIYEYMANG--SLEDRLFRRGGSPVLPWQIR 561
V +L ++ N L L++EY+ + D R G P LP +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSL-------YLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTI 112
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVPPSVADSV 620
++ + H+ ++HRDLKP N+L+D+ + KI+D+GL R A S+
Sbjct: 113 KSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSI 163
Query: 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
T T Y PE +LG D++S+G + ++ +P
Sbjct: 164 PVKSYTHEIVTLWYRAPEV----LLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 45/157 (28%), Positives = 60/157 (38%), Gaps = 30/157 (19%)
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
R AAE+ AL LH+ E +V RDL P NILLD +++ V S D
Sbjct: 89 RWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAV 144
Query: 623 YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKP-----PMGLAHQVERS 677
M A PE D +SLG +L +++T K P G+ +
Sbjct: 145 ENMYCA--------PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN 196
Query: 678 IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRR 714
I P+W EEA L + LQ R
Sbjct: 197 I-------------PEWVSEEARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206039 pfam13868, Trichoplein, Tumour suppressor, Mitostatin | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 26/130 (20%), Positives = 50/130 (38%), Gaps = 9/130 (6%)
Query: 332 VEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAA 391
+E ++ E E R+ E + + +E + E+++ E+ ++ E
Sbjct: 105 IERIQEEDEAEAQEKREKQKKLREEIDEFNEERIERKEEEK----EREREEELKILEYQR 160
Query: 392 LALAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVEFKALREAKERKAALNSLTVDLRYR 451
+E + +R E + +A L AQ + +A E +E L + R
Sbjct: 161 EKAEREEEREAERRERKEEKEREVARLRAQ-----QEEAEDEREELDELRADLYQEEYER 215
Query: 452 KYSIEEIEEA 461
K +E EEA
Sbjct: 216 KERQKEKEEA 225
|
Trichoplein or mitostatin, was first defined as a meiosis-specific nuclear structural protein. It has since been linked with mitochondrial movement. It is associated with the mitochondrial outer membrane, and over-expression leads to reduction in mitochondrial motility whereas lack of it enhances mitochondrial movement. The activity appears to be mediated through binding the mitochondria to the actin intermediate filaments (IFs). Length = 349 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 62/251 (24%), Positives = 106/251 (42%), Gaps = 43/251 (17%)
Query: 450 YRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVL-RP--DAAQGRSQ 504
YR+ + + E E + N +G G YG V +Y VA+K L RP R
Sbjct: 2 YRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT 61
Query: 505 FQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQ----- 559
++ E+ +L +++H N++ LL + E L L + ++ Q
Sbjct: 62 YR-ELRLLKHMKHENVIGLLDVFTPATSI--ENFNEVYLVTNLMGADLNNIVKCQKLSDE 118
Query: 560 -IRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618
++F I ++ L ++H ++HRDLKP N+ ++ + +I D GLAR
Sbjct: 119 HVQFLIY-QLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ------- 167
Query: 619 SVTQYRMTSAAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQIITAK---PPM 668
MT T Y PE Y QT D++S+G ++ +++ K P
Sbjct: 168 --ADDEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLKGKALFPGN 219
Query: 669 GLAHQVERSIE 679
Q++R +E
Sbjct: 220 DYIDQLKRIME 230
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 29/192 (15%)
Query: 482 SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYEYMA 539
SY V +KVL P F + ++ + H ++VLL G C ++ E++
Sbjct: 28 SYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVE 87
Query: 540 NGSLEDRLFRRGGSPVL--PWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR 597
G L+ LF S VL PW +F++A ++A+AL +L LVH ++ NILL R
Sbjct: 88 FGPLD--LFMHRKSDVLTTPW--KFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAR 140
Query: 598 NYVS-------KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-YQQTGMLGVKS 649
+ K+SD G+ +T +I PE + + L + +
Sbjct: 141 EGIDGECGPFIKLSDPGI----------PITVLSRQECVERIPWIAPECVEDSKNLSIAA 190
Query: 650 DVYSLGILLLQI 661
D +S G L +I
Sbjct: 191 DKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 17/151 (11%)
Query: 469 RKIGEGGYGPVYKS--YLDH--TPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLL 523
++IG G +G V S Y D V +K L+ +A+ + +++F Q+ + ++HPN++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 524 LGACPEF--GCLIYEYMANGSLEDRL----FRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
LG C E L++EY G L+ L + R S +L Q R+A EIA + +H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHK 117
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608
+H DL N L + K+ D G+
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 29/90 (32%), Positives = 40/90 (44%), Gaps = 4/90 (4%)
Query: 355 AACKEALAAKQKARELHRWKLEEKQK-LEDARMAEEAALALAEKERAKCKRAIEAAEAAQ 413
A K+A A ++A E + E K K +A+ EA KE AK + EA A
Sbjct: 102 KAAKQAEQAAKQAEEKQKQAEEAKAKQAAEAKAKAEAEAEKKAKEEAKKQAEEEAKAKAA 161
Query: 414 RIAELEAQKCK---NVEFKALREAKERKAA 440
A+ +A + K E KA EAK + A
Sbjct: 162 AEAKKKAAEAKKKAEAEAKAKAEAKAKAKA 191
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 37/141 (26%), Positives = 63/141 (44%), Gaps = 14/141 (9%)
Query: 482 SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG-CLIYEYMAN 540
V +KVL D + F + ++ + H ++V L G C ++ EY+
Sbjct: 26 GPGQEVSVVLKVLGSDHRDSLA-FFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKF 84
Query: 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV 600
G L+ L R + L W + +A ++A+AL +L K LVH ++ NIL+ R +
Sbjct: 85 GPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGL 139
Query: 601 S-------KISDVGLARLVPP 614
+ K+SD G+ V
Sbjct: 140 NEGYVPFIKLSDPGIPITVLS 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 39/202 (19%)
Query: 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGN 592
LI E++ G + L ++ + +F IA E A+ +HQ +HRD+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKK--DTLSEEATQFYIA-ETVLAIDAIHQLG---FIHRDIKPDN 131
Query: 593 ILLDRNYVSKISDVGLARLV---------------PPS-----------VADSVTQYRMT 626
+LLD K+SD GL + PPS A++ + R
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 627 ---SAAGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQIITAKPPM--GLAHQVERSIEN 680
S GT YI PE + QTG + D +SLG+++ +++ PP + R + N
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN 250
Query: 681 GTFDETLDPAVPDWPVEEALIL 702
P VP + LIL
Sbjct: 251 WKETLVFPPEVPISEKAKDLIL 272
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 39/202 (19%)
Query: 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGN 592
LI E++ G + L ++ + + +F IA E A+ +HQ +HRD+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKK--DTLTEEETQFYIA-ETVLAIDSIHQLG---FIHRDIKPDN 131
Query: 593 ILLDRNYVSKISDVGLA------------RLVPPSVADSVTQYRMT-------------- 626
+LLD K+SD GL R + S+ T M
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 627 ---SAAGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQIITAKPPM--GLAHQVERSIEN 680
S GT YI PE + QTG + D +SLG+++ +++ PP + + + N
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN 250
Query: 681 GTFDETLDPAVPDWPVEEALIL 702
P VP + LIL
Sbjct: 251 WKETLIFPPEVPISEKAKDLIL 272
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|225606 COG3064, TolA, Membrane protein involved in colicin uptake [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 39/133 (29%), Positives = 50/133 (37%), Gaps = 17/133 (12%)
Query: 318 QESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEE 377
E R + Q + EE E + + A K A K+KA E
Sbjct: 106 LEKERLKAQEQQKQAEEAE------KQAQLEQKQQEEQARKAAAEQKKKAEAAKAKAAAE 159
Query: 378 ----------KQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVE 427
K+K E+A A E A A AE AK K EA AA++ K K E
Sbjct: 160 AAKLKAAAEAKKKAEEAAKAAEEAKAKAEAAAAKKKAEAEAKAAAEKAKAEAEAKAK-AE 218
Query: 428 FKALREAKERKAA 440
KA A+E+ AA
Sbjct: 219 KKAEAAAEEKAAA 231
|
Length = 387 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 36/114 (31%), Positives = 50/114 (43%), Gaps = 13/114 (11%)
Query: 553 SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612
SP L + + ++A + FL VHRDL N+L+ + KI D GLAR
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLAR-- 287
Query: 613 PPSVADSVTQYRMTSAAGTFC---YIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
D + S TF ++ PE + SDV+S GILL +I T
Sbjct: 288 -----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 40/165 (24%), Positives = 66/165 (40%), Gaps = 31/165 (18%)
Query: 508 EVEVLCNIRHPNMVLLLG-------AC---PEFGCLIYEYMANGSLEDRLFRRGGSPVLP 557
E +L N+ HP+++ + C P + +Y Y+ S R LP
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS------RP-----LP 155
Query: 558 WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617
I +I L +LH + ++HRD+K NI ++ I D+G A+
Sbjct: 156 IDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF------ 206
Query: 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQII 662
V AGT PE K+D++S GI+L +++
Sbjct: 207 -PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 67/264 (25%), Positives = 114/264 (43%), Gaps = 37/264 (14%)
Query: 453 YSIEEIEEAT----ENFSNSRKIGEGGYGPV---YKSYLDHTPVAIKVLRP--DAAQGRS 503
YS+E + ++T + + N + IG G G V Y + LD K+ RP + +
Sbjct: 4 YSVE-VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 504 QFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF- 562
+++ V + C + H N++ LL L E + L L V+ ++
Sbjct: 63 AYRELVLMKC-VNHKNIISLLNVFTPQKSL--EEFQDVYLVMELMDANLCQVIQMELDHE 119
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
R++ + L + ++HRDLKP NI++ + KI D GLAR + T
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTS 172
Query: 623 YRMTSAAGTFCYIDPEYQQTGMLGV----KSDVYSLGILLLQIITAK---PPMGLAHQVE 675
+ MT T Y PE +LG+ D++S+G ++ +++ K P Q
Sbjct: 173 FMMTPYVVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
Query: 676 RSIEN-GT----FDETLDPAVPDW 694
+ IE GT F + L P V ++
Sbjct: 229 KVIEQLGTPCPEFMKKLQPTVRNY 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 39/161 (24%), Positives = 65/161 (40%), Gaps = 20/161 (12%)
Query: 508 EVEVLCNIRHPNMVLLLGACP--EFGCLI---YEYMANGSLEDRLFRRGGSPVLPWQIRF 562
E +L I HP+++ L G +F CLI Y+ L + R +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK--RN-----IAICDIL 185
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
I + A+ +LH+ + ++HRD+K NI +++ DV L +
Sbjct: 186 AIERSVLRAIQYLHENR---IIHRDIKAENI-----FINHPGDVCLGDFGAACFPVDINA 237
Query: 623 YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
+ AGT PE G D++S GI+L ++ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 72/303 (23%), Positives = 118/303 (38%), Gaps = 59/303 (19%)
Query: 465 FSNSRKIGEGGYGPV-YKSYLD-HTPVAIKVLRPDAAQGRSQF---QQEVEVLCNIRHPN 519
F + +G G +G V +D H A+K LR R+Q + E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 520 MVLLLGACPEFGCLIY--EYMANGSLEDRLFRRGGSPVLPWQI-RFRIAAEIATALLFLH 576
+V L + + L + +Y+ G + L R V P + RF IA E+ A+ +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIA-ELTLAIESVH 118
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA---------------------RLVPPS 615
+ +HRD+KP NIL+D + K++D GL + P
Sbjct: 119 KMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 616 VADSVTQYR-----MT---------------SAAGTFCYIDPEYQQTGMLGVKSDVYSLG 655
+ D V+ R T S GT YI PE D +S+G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 656 ILLLQIITAKPPMGLAHQVERSIENGTFDETLD-PAVPDWPVEEALILAKLALQCAELRR 714
++L +++ +PP E ++ ++ TL P E ++ KL C+ R
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLC--CSAEER 293
Query: 715 KDR 717
R
Sbjct: 294 LGR 296
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGR---SQFQQEVEVLCNIRH 517
E F + I G +G VY + A+KV++ + Q Q E + L +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 518 PNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
P +V L + L+ EY+ G ++ L G ++ + +E+A AL +L
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYL 120
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611
H+ ++HRDLKP N+L+ K++D GL+++
Sbjct: 121 HR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 17/100 (17%)
Query: 358 KEALAAKQKARELHRWKLEE-KQKLEDARMAEEAALALAEKER----AKCKRAIEA---- 408
E ++ A + + +LE+ + A+ AE+AA EK++ AK K+A EA
Sbjct: 77 AEEAEKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQAEEKQKQAEEAKAKQAAEAKAKA 136
Query: 409 --------AEAAQRIAELEAQKCKNVEFKALREAKERKAA 440
E A++ AE EA+ E K ++KA
Sbjct: 137 EAEAEKKAKEEAKKQAEEEAKAKAAAEAKKKAAEAKKKAE 176
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 30/83 (36%), Positives = 40/83 (48%), Gaps = 10/83 (12%)
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC---YIDPEYQ 640
VHRDL N+LL + + KI D GLAR D + S TF ++ PE
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLAR-------DIMHDSNYVSKGSTFLPVKWMAPESI 311
Query: 641 QTGMLGVKSDVYSLGILLLQIIT 663
+ SDV+S GILL +I +
Sbjct: 312 FDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 4e-04
Identities = 31/83 (37%), Positives = 45/83 (54%), Gaps = 2/83 (2%)
Query: 358 KEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAE 417
K+A AK+KA E + K+K E+A+ A EAA A AE + + A E AEAA++ E
Sbjct: 1315 KKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAEAAEEKAEAAEKKKE 1374
Query: 418 LEAQKCKNVEFKA--LREAKERK 438
+K + KA ++A E K
Sbjct: 1375 EAKKKADAAKKKAEEKKKADEAK 1397
|
Length = 2084 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 31/92 (33%), Positives = 43/92 (46%), Gaps = 6/92 (6%)
Query: 355 AACKEALAAKQKARELHRWKLEE--KQKLEDARMAEEAALALAEKERAKCKRAIEA---A 409
A K+A AK KA K +E K++ E+ A+ AA A + AK K EA A
Sbjct: 124 AKAKQAAEAKAKAEAEAEKKAKEEAKKQAEEEAKAKAAAEAKKKAAEAKKKAEAEAKAKA 183
Query: 410 EAAQRIAELEAQ-KCKNVEFKALREAKERKAA 440
EA + EA+ K + + KA EA + A
Sbjct: 184 EAKAKAKAEEAKAKAEAAKAKAAAEAAAKAEA 215
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 29/90 (32%), Positives = 39/90 (43%), Gaps = 8/90 (8%)
Query: 355 AACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQR 414
A K A AK+KA E + E + +A+ +A A A+ E AK K A EAA A+
Sbjct: 156 AKAKAAAEAKKKAAEAKKKAEAEAKAKAEAKAKAKAEEAKAKAEAAKAKAAAEAAAKAEA 215
Query: 415 IAELEAQKCKNVEFKALREAKERKAALNSL 444
A A A E K +A L +
Sbjct: 216 EAAAAA--------AAEAERKADEAELGDI 237
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 31/112 (27%), Positives = 53/112 (47%), Gaps = 20/112 (17%)
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLD-RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
L ++H ++HRDLKP N+ ++ + V KI D GLAR+V P + ++
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK---GYLSEGLV 180
Query: 631 TFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE 675
T Y P Y + D+++ G + +++T KP AH++E
Sbjct: 181 TKWYRSPRLLLSPNNYTKA------IDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 40/237 (16%)
Query: 449 RYRKYSIEEIEEAT----ENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVL-RP--DAA 499
R + EI ++T + + N + IG G G V +Y + VAIK L RP +
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 500 QGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGSLED----RLFRRGGSPV 555
+ +++ V + C + H N++ LL + SLE+ +
Sbjct: 66 HAKRAYRELVLMKC-VNHKNIIGLLNV----------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 556 LPWQIRFRIAAEIATALLF-----LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
L I+ + E + LL+ + ++HRDLKP NI++ + KI D GLAR
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS--DVYSLGILLLQIITAK 665
+ T + MT T Y PE GM G K D++S+G ++ ++I
Sbjct: 175 -------TAGTSFMMTPYVVTRYYRAPEV-ILGM-GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 6/76 (7%)
Query: 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGN 592
+ +Y+ G + L R G + P + AE+ A+ +H+ +HRD+KP N
Sbjct: 78 FVMDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDN 131
Query: 593 ILLDRNYVSKISDVGL 608
IL+DR+ K++D GL
Sbjct: 132 ILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 9/102 (8%)
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
R ++++A + FL + +HRD+ N+LL V+KI D GLAR + + DS
Sbjct: 216 RFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI---MNDS--N 267
Query: 623 YRMTSAAG-TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
Y + A ++ PE + V+SDV+S GILL +I +
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 15/84 (17%)
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT 642
++HRDLKP NI++ + KI D GLAR + T + MT T Y PE
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TACTNFMMTPYVVTRYYRAPEV--- 193
Query: 643 GMLGVK----SDVYSLGILLLQII 662
+LG+ D++S+G ++ +++
Sbjct: 194 -ILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.002
Identities = 35/139 (25%), Positives = 55/139 (39%), Gaps = 45/139 (32%)
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN----YVSKISDVGLARLV-PPSVAD 618
I ++ AL LH+ ++H D+K N+L DR Y + D GL +++ PS D
Sbjct: 114 IIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIY---LCDYGLCKIIGTPSCYD 167
Query: 619 SVTQYRMTSAAGTFCYIDPE------YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672
GT Y PE Y + D +++G+L +++T K H
Sbjct: 168 -----------GTLDYFSPEKIKGHNYDVS------FDWWAVGVLTYELLTGK------H 204
Query: 673 QVERSIENGTFDETLDPAV 691
+ DE LD
Sbjct: 205 PFKED-----EDEELDLES 218
|
Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 15/84 (17%)
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT 642
++HRDLKP NI++ + KI D GLAR + T + MT T Y PE
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTPYVVTRYYRAPEV--- 188
Query: 643 GMLGV----KSDVYSLGILLLQII 662
+LG+ D++S+G ++ ++I
Sbjct: 189 -ILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|234750 PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 333 EEVEVEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAAL 392
E++ + L EL + ++ + +EA A ++A +L E+K+KL++ E+ L
Sbjct: 516 EKLNELIASL-EELERELEQKA---EEAEALLKEAEKLKEELEEKKEKLQEE---EDKLL 568
Query: 393 ALAEKERAKCKRAIEAA--EAAQRIAEL-EAQKCKNVEFKALREAKERKAALN 442
AEKE + AI+ A EA + I EL + QK KA E E + LN
Sbjct: 569 EEAEKEAQQ---AIKEAKKEADEIIKELRQLQKGGYASVKA-HELIEARKRLN 617
|
Length = 782 |
| >gnl|CDD|217843 pfam04012, PspA_IM30, PspA/IM30 family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 25/108 (23%), Positives = 44/108 (40%), Gaps = 17/108 (15%)
Query: 330 QSVEEVEVEMRRLRLELRQTM-------DMYSAACKEALAAKQKAR--------ELHRWK 374
Q++ +++ E+ + R L Q + ++A + KAR EL R
Sbjct: 30 QAIRDMQSELGKARQALAQVIARQKQLERKLEEQKEQAKKLENKARAALTKGNEELAREA 89
Query: 375 LEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQK 422
L E LE A E L + ++ + A E +I +L+A+K
Sbjct: 90 LAEIATLEKQAEALETQLTQQRSAVEQLRKQLAALE--TKIQQLKAKK 135
|
This family includes PspA a protein that suppresses sigma54-dependent transcription. The PspA protein, a negative regulator of the Escherichia coli phage shock psp operon, is produced when virulence factors are exported through secretins in many Gram-negative pathogenic bacteria and its homologue in plants, VIPP1, plays a critical role in thylakoid biogenesis, essential for photosynthesis. Activation of transcription by the enhancer-dependent bacterial sigma(54) containing RNA polymerase occurs through ATP hydrolysis-driven protein conformational changes enabled by activator proteins that belong to the large AAA(+) mechanochemical protein family. It has been shown that PspA directly and specifically acts upon and binds to the AAA(+) domain of the PspF transcription activator. Length = 220 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 33/134 (24%), Positives = 55/134 (41%), Gaps = 27/134 (20%)
Query: 318 QESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEE 377
Q+ + Q + E+ + E EL+Q + A +++ ++L + +L
Sbjct: 70 QQKSAKRAEEQRKKKEQQQAE------ELQQ----------KQAAEQERLKQLEKERLAA 113
Query: 378 ----KQKLEDARM-------AEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKNV 426
KQ E A+ AEEAA A +AK + + A AA + A EA+K
Sbjct: 114 QEQKKQAEEAAKQAALKQKQAEEAAAKAAAAAKAKAEAEAKRAAAAAKKAAAEAKKKAEA 173
Query: 427 EFKALREAKERKAA 440
E A+ +K A
Sbjct: 174 EAAKKAAAEAKKKA 187
|
Length = 387 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 36/120 (30%), Positives = 50/120 (41%), Gaps = 9/120 (7%)
Query: 328 QSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQKAR-ELHRWKLEEKQKLEDARM 386
+Q ++ E + ++ + AA K A AAK KA E R K+ +A+
Sbjct: 112 AAQEQKKQAEEAAKQAALKQKQAEE--AAAKAAAAAKAKAEAEAKRAAAAAKKAAAEAKK 169
Query: 387 AEEAALALAEKERAKCKRAIE----AAEAAQRIAELEAQK--CKNVEFKALREAKERKAA 440
EA A AK K E AA A++ AE EA+K + KA EAK A
Sbjct: 170 KAEAEAAKKAAAEAKKKAEAEAAAKAAAEAKKKAEAEAKKKAAAEAKKKAAAEAKAAAAK 229
|
Length = 387 |
| >gnl|CDD|225606 COG3064, TolA, Membrane protein involved in colicin uptake [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 30/90 (33%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 355 AACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQR 414
A K A AK KA K K + E AE+A K +A+ K A E A
Sbjct: 175 EAAKAAEEAKAKAEAAAAKK---KAEAEAKAAAEKAKAEAEAKAKAEKKAEAAAEEKAAA 231
Query: 415 IAELEAQKCKNVEFKALREAKERKAALNSL 444
+ A K K + A +A ERKAA +L
Sbjct: 232 EKKKAAAKAKADKAAAAAKAAERKAAAAAL 261
|
Length = 387 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 26/86 (30%), Positives = 39/86 (45%)
Query: 355 AACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQR 414
A K A +KA + K E + + A A++ A A A+K+ A + AAEA
Sbjct: 167 AKKKAEAEAAKKAAAEAKKKAEAEAAAKAAAEAKKKAEAEAKKKAAAEAKKKAAAEAKAA 226
Query: 415 IAELEAQKCKNVEFKALREAKERKAA 440
A+ A+ E A +A E+ AA
Sbjct: 227 AAKAAAEAKAAAEKAAAAKAAEKAAA 252
|
Length = 387 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 50/190 (26%), Positives = 71/190 (37%), Gaps = 61/190 (32%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIK---VLRPDAAQGRSQFQQEVEVLCNIRHPN 519
++F +K+GEG +G VYK+ L + + VL+ G VE+ N R
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNER--- 182
Query: 520 MVLLLGACPEFGC--------------------LIYEYMANGSL-------------EDR 546
+ ACP C L++ Y +L E
Sbjct: 183 ---VRRACPN-SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY 238
Query: 547 LFRRGGSPVLPW------QIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV 600
L + LP +I I +I AL LH T +VHRD+KP NI+
Sbjct: 239 LLGKVQD--LPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSG 293
Query: 601 S-KISDVGLA 609
S KI D+G A
Sbjct: 294 SFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.004
Identities = 34/148 (22%), Positives = 59/148 (39%), Gaps = 11/148 (7%)
Query: 326 SSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDAR 385
S Q E +E E+ L E+ + + +E +++ EL EE ++LE +
Sbjct: 817 ESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELK----EELEELEAEK 872
Query: 386 MAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVEFKALREAKERKAALNSLT 445
E L E+E+ + + + E+ E + K K +E +A L L
Sbjct: 873 EELEDELKELEEEKEELEEELRELES-------ELAELKEEIEKLRERLEELEAKLERLE 925
Query: 446 VDLRYRKYSIEEIEEATENFSNSRKIGE 473
V+L + +EE E T R+I
Sbjct: 926 VELPELEEELEEEYEDTLETELEREIER 953
|
Length = 1163 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 768 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.77 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.76 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.59 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.06 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.89 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.52 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.19 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.02 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.95 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.71 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.48 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.47 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.37 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.28 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.07 | |
| PLN02236 | 344 | choline kinase | 96.98 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.68 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.61 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=420.33 Aligned_cols=270 Identities=45% Similarity=0.784 Sum_probs=233.9
Q ss_pred ccccCCHHHHHHHhcCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc
Q 035604 449 RYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527 (768)
Q Consensus 449 ~~~~~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 527 (768)
..+.|+..++..+|++|.....||+||||.||+|...+ +.||||++.....+...+|.+|+++|.+++|||+|+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 35679999999999999999999999999999999955 89999988765543134599999999999999999999999
Q ss_pred cCC---ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEe
Q 035604 528 PEF---GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 604 (768)
Q Consensus 528 ~~~---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~ 604 (768)
.+. .+||||||++|+|.+.|...... .++|..|++|+.++|+||.|||...+++||||||||+|||||.++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 532 69999999999999999876554 68999999999999999999999888899999999999999999999999
Q ss_pred ecccccccCC-CCCCccccccccCC-CCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCC---------hHH
Q 035604 605 DVGLARLVPP-SVADSVTQYRMTSA-AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGL---------AHQ 673 (768)
Q Consensus 605 DFGla~~~~~-~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~---------~~~ 673 (768)
|||||+..+. ... .... .||..|+|||+...+.++.|+|||||||+|+||+||+.|.+. ..+
T Consensus 220 DFGLa~~~~~~~~~-------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTS-------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CccCcccCCccccc-------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999976543 111 1112 799999999999999999999999999999999999988752 234
Q ss_pred HHHHHHcCCccccCCCCCC--CCCH-HHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 674 VERSIENGTFDETLDPAVP--DWPV-EEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 674 ~~~~i~~~~~~~~ld~~~~--~~~~-~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
....+.++.+.+++|+.+. .++. .+...+..++..|++.+|.+||+|.+|+..
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 4567788899999999975 4453 567779999999999999999999998643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=393.00 Aligned_cols=246 Identities=25% Similarity=0.324 Sum_probs=202.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHH---HHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~---~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|++++.||+|+||.||+++. +|..+|+|+|++.....+.+ ++.|..||...++|+||+||.+|.+ +.|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 46899999999999999999986 66789999999887655544 5789999999999999999999955 56999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||++||++..+|.+.+ .|++...+.++.+++.||..||+.| ||||||||+|+|||..|++||+|||||..+..
T Consensus 220 MEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999877 5999999999999999999999999 99999999999999999999999999975532
Q ss_pred CCCC-------------------ccc----c------------------ccccCCCCCCCCCCcccccCCCCCccccHHH
Q 035604 615 SVAD-------------------SVT----Q------------------YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYS 653 (768)
Q Consensus 615 ~~~~-------------------~~~----~------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwS 653 (768)
.... ... . ....+.+|||.|||||++.+.+|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 1000 000 0 0013689999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCC--ChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC
Q 035604 654 LGILLLQIITAKPPMG--LAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD 719 (768)
Q Consensus 654 lGvil~elltg~~Pf~--~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs 719 (768)
||||+||||+|.+||. ......+.|...+..-...... ..+.+..+||.+||. ||.+|--
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~-----~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV-----DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC-----cccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999995 4455556666543222111111 123568999999999 9999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=391.14 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=210.9
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh-------hHHHHHHHHHHHhhcCCCceeeeeccc--cC
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ-------GRSQFQQEVEVLCNIRHPNMVLLLGAC--PE 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~g~~--~~ 529 (768)
..+.|.+.+.||.|+||.|-+|.. +++.||||++++.... ....+.+|++||++|+|||||+++++| ++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 356788999999999999999987 6779999999765221 223467999999999999999999999 45
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CcEEEeec
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN---YVSKISDV 606 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~vKL~DF 606 (768)
+.|+||||++||+|.+++..++. +.+..-.-++.|++.||.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 56999999999999999988763 778888899999999999999999 9999999999999665 78999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCC---CccccHHHHHHHHHHHHhCCCCCCCh--H-HHHHHHHc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML---GVKSDVYSLGILLLQIITAKPPMGLA--H-QVERSIEN 680 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---s~ksDvwSlGvil~elltg~~Pf~~~--~-~~~~~i~~ 680 (768)
|+|+.... ...+.+.|||+.|.|||++.++.+ ..++||||+|||||-+|+|.+||... . .....|..
T Consensus 324 GlAK~~g~-------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 324 GLAKVSGE-------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred chhhcccc-------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 99997642 234678899999999999987763 44789999999999999999999533 2 36677888
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
|.|... +......+.+..+||.+||..||++||++.+++. +|++
T Consensus 397 G~y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 397 GRYAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred Cccccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 876432 1222345667999999999999999999999997 8887
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=387.14 Aligned_cols=244 Identities=28% Similarity=0.433 Sum_probs=206.7
Q ss_pred CCccceecccCceeEEEEEEC--CccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC---CceeEEEec
Q 035604 465 FSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---FGCLIYEYM 538 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~lV~E~~ 538 (768)
.+.++.||+|..|+||++.+. ++.+|+|++... ....++++.+|+++++.++||+||.+||+|.. ..+|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344667999999999999995 678999999544 34456789999999999999999999999833 258999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
++|+|++++...+ .+++...-+|+.+|++||.|||. .+ ||||||||+||||+..|.+||||||.++.+..+.
T Consensus 161 DgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~- 233 (364)
T KOG0581|consen 161 DGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI- 233 (364)
T ss_pred CCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhhh-
Confidence 9999999987764 49999999999999999999996 77 9999999999999999999999999998775442
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh-------HHHHHHHHcCCccccCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA-------HQVERSIENGTFDETLDPA 690 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~-------~~~~~~i~~~~~~~~ld~~ 690 (768)
..+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||... -.....| ++..
T Consensus 234 -------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I--------v~~p 298 (364)
T KOG0581|consen 234 -------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI--------VDEP 298 (364)
T ss_pred -------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH--------hcCC
Confidence 35789999999999999999999999999999999999999999543 1122233 3333
Q ss_pred CCCCCHH-HHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 691 VPDWPVE-EALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 691 ~~~~~~~-~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.|..|.. ++.++..++..||++||.+||++.+++. +++..
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 3444554 6778999999999999999999999987 66644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=372.43 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=213.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeec-cccCC---ceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLG-ACPEF---GCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g-~~~~~---~~lV 534 (768)
.+|.++++||+|.||.||++.. ++..||.|.++.. +...++++..|+.+|++|+|||||++|+ .|.+. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4588899999999999999876 7889999999855 3455677899999999999999999998 44332 4899
Q ss_pred EEeccCCChHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 535 YEYMANGSLEDRLFR-RGGSPVLPWQIRFRIAAEIATALLFLHQTKP-EPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
||||.+|+|..++.. +.....+++.++|+++.|++.||..+|..-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998875 3345679999999999999999999999433 24999999999999999999999999999988
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPA 690 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~ 690 (768)
.... ....+.+|||.||+||.+.+.+|+.||||||+||++|||+.-++||... ..+..+|..|.+.
T Consensus 179 ~s~~------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~------ 246 (375)
T KOG0591|consen 179 SSKT------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP------ 246 (375)
T ss_pred cchh------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC------
Confidence 5432 2346789999999999999999999999999999999999999999644 4566788887542
Q ss_pred CCCCC-HHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHH
Q 035604 691 VPDWP-VEEALILAKLALQCAELRRKDRPDLGKVVVPKLN 729 (768)
Q Consensus 691 ~~~~~-~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~ 729 (768)
..| .-++..|..||..|+..||+.||+...++....+
T Consensus 247 --~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 --PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 233 4567789999999999999999997656554444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=396.88 Aligned_cols=256 Identities=35% Similarity=0.574 Sum_probs=210.4
Q ss_pred CCccceecccCceeEEEEEECCcc-EEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccCC---ceeEEEec
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDHTP-VAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF---GCLIYEYM 538 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~~~-vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~lV~E~~ 538 (768)
+.+.+.||.|+||+||+|.+.++. ||||++..... .....|.+|+.+|.+++|||||+++|+|.+. .+||||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344556999999999999999998 99999976432 2256899999999999999999999999664 58999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeecccccccCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVPPSVA 617 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFGla~~~~~~~~ 617 (768)
++|+|..++... ....+++..+++|+.+|++||.|||+.++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999874 22359999999999999999999999985 99999999999999998 99999999998764321
Q ss_pred CccccccccCCCCCCCCCCccccc--CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQ--TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPD 693 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~ 693 (768)
..++...||+.|||||++. ...|+.|+||||||++||||+||+.||....... ..+..+. ..+.+
T Consensus 199 -----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~----~Rp~~-- 267 (362)
T KOG0192|consen 199 -----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG----LRPPI-- 267 (362)
T ss_pred -----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC----CCCCC--
Confidence 2345579999999999999 5689999999999999999999999997666422 2222221 12222
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAE 736 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~ 736 (768)
|..+...+..|+..||..+|..||++.+++..+.........
T Consensus 268 -p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 268 -PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 223456699999999999999999999998766655554443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=401.28 Aligned_cols=242 Identities=26% Similarity=0.409 Sum_probs=210.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.+|...+.||+|||+.||.++. .|..||+|++.+.. ...++.+.+|++|.+.|+|||||+++++|++ +.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999987 67899999997642 3345678899999999999999999999966 459999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|+|.+++|..++.++. .+++.+++.++.||+.||.|||+.+ |||||||..||||+.+.++||+|||||..+...
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999887554 5999999999999999999999999 999999999999999999999999999988543
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
. .+..+.||||.|+|||++....++..+||||+|||||.||+|+|||... .+....|+...+.
T Consensus 172 ~------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--------- 236 (592)
T KOG0575|consen 172 G------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--------- 236 (592)
T ss_pred c------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc---------
Confidence 2 3456789999999999999999999999999999999999999999744 4566677765542
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.|...+.+..+||.++|+.+|.+||++.+|+.
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12233456889999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=379.72 Aligned_cols=244 Identities=33% Similarity=0.522 Sum_probs=204.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~ 535 (768)
.++|.+.+.||.|+||+||+|++ ++..||||.+.+. .....+.+..|+.||+.++|||||.|++++ .++.||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46799999999999999999998 5678999999766 445566788999999999999999999998 44569999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC------CcEEEeecccc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN------YVSKISDVGLA 609 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~------~~vKL~DFGla 609 (768)
|||.||+|.++|.+++ .+++.+.+.++.||+.||++||+++ ||||||||+||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999876 3999999999999999999999999 9999999999999764 46799999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCC--ChHHHHHHHHcCCccccC
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMG--LAHQVERSIENGTFDETL 687 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~--~~~~~~~~i~~~~~~~~l 687 (768)
+.+.... ...+.+|++.|||||+++...|+.|+|+||+|+|+|++++|++||. ...++...++.++..-
T Consensus 163 R~L~~~~-------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~-- 233 (429)
T KOG0595|consen 163 RFLQPGS-------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV-- 233 (429)
T ss_pred hhCCchh-------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc--
Confidence 9886432 2356799999999999999999999999999999999999999996 3344445566554221
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
+ ..+...+..+.+|+...+..+|.+|-+..+-.
T Consensus 234 -~---~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 234 -P---VLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred -C---chhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 1 22222333466888888888888888877655
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=377.51 Aligned_cols=237 Identities=28% Similarity=0.361 Sum_probs=200.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|+++++||+|+||+||.++. +++.+|+|++++... ........|..||..++||.||.++..|.+ ..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999998876 567899999987643 234567899999999999999999999965 45999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
+||+.||.|...|.+.+. |++..++.++.+|+.||.|||+.| ||||||||+|||||.+|+++|+|||||+..-.
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999987764 999999999999999999999999 99999999999999999999999999985422
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~ 692 (768)
.. ....+++||+.|||||++.+.+|+..+|+||||+++|||++|.+||... ..+.+.|..+... ..+
T Consensus 178 ~~------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~-----~~p 246 (357)
T KOG0598|consen 178 DG------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-----LPP 246 (357)
T ss_pred CC------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC-----CCC
Confidence 21 1234579999999999999999999999999999999999999999644 4555667666521 111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCC
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRP 718 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RP 718 (768)
. -.+....+|+.+.|..+|++|-
T Consensus 247 ~---~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 G---YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred c---cCCHHHHHHHHHHhccCHHHhc
Confidence 1 1234588999999999999995
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=378.34 Aligned_cols=247 Identities=30% Similarity=0.405 Sum_probs=206.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh---hHHHHHHHHHHHhhc-CCCceeeeeccccCC--ceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ---GRSQFQQEVEVLCNI-RHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~--~~lV 534 (768)
.+|.+++.||+|+|++||+|+. .++.||||++.+.... ..+-+..|-++|.+| .||.||+||..|.+. .|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 5788899999999999999987 5678999999765322 223467899999999 899999999999664 4999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
+||+++|+|.++|.+.+. |++...+.++.||+.||+|||++| ||||||||+|||||.++++||+|||.|+.+++
T Consensus 153 Le~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999998864 999999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCC-----cc--ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccc
Q 035604 615 SVAD-----SV--TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDE 685 (768)
Q Consensus 615 ~~~~-----~~--~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~ 685 (768)
.... .. ...+..+++||..|.+||++.....++.+|+|+||||||+|+.|.+||...++. .+.|..-.+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y-- 304 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY-- 304 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc--
Confidence 4322 11 111236799999999999999999999999999999999999999999755543 334433222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
.+|...+....+|+.+.|..||.+|++..++-
T Consensus 305 -------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 305 -------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred -------cCCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 33334445689999999999999999998875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=346.01 Aligned_cols=231 Identities=28% Similarity=0.384 Sum_probs=200.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhh---HHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~ 535 (768)
++|+..+.||.|+||+|.+++. .+..+|+|++.+..... .+...+|..+|+.+.||++++|++.|.+. .|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 5688999999999999999887 45689999998764433 34567899999999999999999998664 48999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||++||.|..+|.+.+. |++...+.++.||+.||+|||+++ |++|||||+|||||.+|++||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999988664 999999999999999999999999 999999999999999999999999999987432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
..+.|||+.|+|||+++..+|+.++|+|||||++|||+.|++||.... .+..+|..+.+ .
T Consensus 198 ---------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v---------~ 259 (355)
T KOG0616|consen 198 ---------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV---------K 259 (355)
T ss_pred ---------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc---------c
Confidence 356799999999999999999999999999999999999999996444 45566776653 2
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCC
Q 035604 694 WPVEEALILAKLALQCAELRRKDR 717 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~R 717 (768)
.|.-.+..+.+|+...|+.|-.+|
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhh
Confidence 233344569999999999999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=345.68 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=199.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
+.|+.+.++|+|+||.||++++ +|+.||||.+... +....+...+|+.+|++|+|||+|.|+.+|.. ..+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688889999999999999998 5678999999654 33445567899999999999999999999954 4499999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
||+..-|.+ |.+..+ .++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+...
T Consensus 82 ~~dhTvL~e-Le~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHH-HHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 998765554 554443 3889999999999999999999999 999999999999999999999999999988532
Q ss_pred CCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHH--H--------------
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSI--E-------------- 679 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i--~-------------- 679 (768)
....+..+.|.||.|||.+.+ ..|+..+||||+||++.||++|.+.|-+..++.+.. .
T Consensus 155 -----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 155 -----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred -----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 122466789999999998887 679999999999999999999999996554443311 1
Q ss_pred --cCCccccCCCCCCC------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 680 --NGTFDETLDPAVPD------WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 680 --~~~~~~~ld~~~~~------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..|.-+.-|.... -....+..+.+|+..||+.||.+|++-++++.
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111122111 01123346899999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=367.08 Aligned_cols=242 Identities=29% Similarity=0.446 Sum_probs=202.8
Q ss_pred CCccceecccCceeEEEEEECCc-cEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCC
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDHT-PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANG 541 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~~-~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 541 (768)
+...+.||+|-||.||.|.++++ .||+|.++... ...+.|.+|++||++|+|+|||+|+|+|.. ..|||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 45567899999999999999876 99999998764 334678999999999999999999999965 359999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|.++|.... ...+...+.+.++.|||.|++||++++ +|||||-..||||+.++.+||+|||||+.+..+...
T Consensus 287 sLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~--- 359 (468)
T KOG0197|consen 287 SLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT--- 359 (468)
T ss_pred cHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee---
Confidence 9999998732 345888999999999999999999999 999999999999999999999999999965433211
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCCHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
......-...|.|||.+..+.++.|||||||||+||||+| |+.||... .++...++.|... ..|..+
T Consensus 360 --~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl--------p~P~~C 429 (468)
T KOG0197|consen 360 --ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL--------PRPEGC 429 (468)
T ss_pred --ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC--------CCCCCC
Confidence 1122334567999999999999999999999999999999 89998643 4566677777532 223344
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
+..+.+|+..||+.+|++|||+..+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 55699999999999999999999554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=357.10 Aligned_cols=250 Identities=29% Similarity=0.479 Sum_probs=204.3
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecc--ccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA--CPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~--~~~--~~~lV~E 536 (768)
.+|...+.||+|+||.||++.+. +..+|||..........+.+.+|+.+|.+++|||||+++|. ..+ ..+|+||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 46788899999999999999985 58999999875543336678999999999999999999996 334 4789999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCcEEEeecccccccCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARLVPPS 615 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~vKL~DFGla~~~~~~ 615 (768)
|+++|+|.+++.+.+. .|++..+.++..||+.||.|||++| ||||||||+||||+. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999988765 4999999999999999999999999 999999999999999 799999999999876531
Q ss_pred CCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCC-hHHHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGL-AHQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~-~~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
...........||+.|||||++..+ ..+.++|||||||++.||+||++||.. .......+..+.-. ..|.
T Consensus 172 ---~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----~~P~ 243 (313)
T KOG0198|consen 172 ---GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----SLPE 243 (313)
T ss_pred ---cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----CCCC
Confidence 1112224567899999999998853 344699999999999999999999975 23333223322211 2234
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+|...+....+++.+|+..+|..|||+.+++.
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 44556667999999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.69 Aligned_cols=253 Identities=29% Similarity=0.376 Sum_probs=201.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC----Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~l 533 (768)
.+.|+.+++||+|.||.||++++ +++.||+|.++.+.. ....-..+|+.||++|+||||++|.+...+ ..||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35577788899999999999998 667899999987652 223345799999999999999999998743 3499
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|+|||++ +|.-++...+ -.|++.++..|+.|++.||.|||..| |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999975 6777765533 24999999999999999999999999 9999999999999999999999999999886
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HH--cCCccccCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IE--NGTFDETLD 688 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~--~~~~~~~ld 688 (768)
.... ..+++.+.|+||.+||++.|. .|+..+|+||.||||.||++|++.|....++.+. |- -|.-.+...
T Consensus 270 ~~~~-----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 270 PSGS-----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred CCCC-----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 5432 236788999999999988876 5999999999999999999999999877766542 11 122111111
Q ss_pred C--CCC---------CCC-------HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 689 P--AVP---------DWP-------VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 689 ~--~~~---------~~~-------~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+ .++ .+. ...+....+|+..+|.+||.+|.|+.+++.
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 011 000 122345788999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=363.85 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=208.9
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC----ch-hhHHHHHHHHHHHhhcC-CCceeeeeccc--cCC
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD----AA-QGRSQFQQEVEVLCNIR-HPNMVLLLGAC--PEF 530 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~----~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~--~~~ 530 (768)
..++|.+.+.||+|+||+|+.|.+ .+..||+|++... .. .....+.+|+.+++.++ ||||++++.++ ...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 357899999999999999999987 5689999987653 11 23446778999999999 99999999998 445
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeecccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLA 609 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DFGla 609 (768)
.++||||+.||+|.+++...+ .+.+....+++.|++.|+.|||+.| |+||||||+|||++.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 699999999999999998854 4888999999999999999999999 9999999999999999 99999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCC-C-CccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccc
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM-L-GVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDE 685 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~-s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~ 685 (768)
..... ........+||+.|+|||++.+.. | +.++||||+||+||-|++|+.||+... .+...|..+.+
T Consensus 169 ~~~~~------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-- 240 (370)
T KOG0583|consen 169 AISPG------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-- 240 (370)
T ss_pred cccCC------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--
Confidence 87631 123356789999999999999877 7 589999999999999999999997643 23344555543
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.++.|-. +..+..|+.+||..+|.+|+++.+++. +|+..
T Consensus 241 ----~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 ----KIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ----cCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 2233321 566999999999999999999999986 66643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=358.82 Aligned_cols=241 Identities=29% Similarity=0.424 Sum_probs=206.9
Q ss_pred cCCCccceecccCceeEEEEEECC--ccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E 536 (768)
++|.+.+.||+|+||.||+|+-++ +.||+|.+.+.. ......+.+|++|++.++|||||.++++|+.. .++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999998754 579999997653 34456689999999999999999999999664 499999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+.| +|..+|...+. ++++.++.++.+++.||.|||+.+ |+|||+||.|||++.+|++|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9966 99999987764 999999999999999999999999 999999999999999999999999999987442
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
....++..||+.|||||...+..|+..+|+||||||+||+++|+|||-.. ......|.. ....|
T Consensus 154 -----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~---------d~v~~ 219 (808)
T KOG0597|consen 154 -----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK---------DPVKP 219 (808)
T ss_pred -----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---------CCCCC
Confidence 22356789999999999999999999999999999999999999999422 222233332 22356
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
|...+..+..++...|.+||..|-+-.+++-
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 6677788999999999999999999998875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=362.50 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=211.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~ 538 (768)
..|...++||+|+-|.||.+.. ++..||||.+.......++-+.+|+.+|+.++|+|||.++..| .+..++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778899999999998876 5668999999877766677789999999999999999999887 45679999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
+||+|.|.+.... +++.++..|+.+++.||.|||..| |||||||.+|||++.+|.+||+|||+|..+....
T Consensus 353 ~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-- 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-- 423 (550)
T ss_pred CCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc--
Confidence 9999999886653 899999999999999999999999 9999999999999999999999999998875443
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCCCH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~~~ 696 (768)
.+....+||++|||||+.....|++++||||||++++||+-|.+||-....+.. .|.... .|.+ ..+.
T Consensus 424 ----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-----~P~l-k~~~ 493 (550)
T KOG0578|consen 424 ----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-----TPKL-KNPE 493 (550)
T ss_pred ----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-----CCCc-CCcc
Confidence 245677999999999999999999999999999999999999999965544433 232221 1222 2344
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
..+..|.+++.+||+.|+++||++.++|. +.++.
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 56678999999999999999999999986 66633
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=365.29 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=212.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
+-|++++.||.|+-|.|..|.+ +|+.+|||++.+.. ......+.+|+-||+.+.||||++||++|.+ +.|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5688999999999999999988 78899999997652 2223458899999999999999999999955 559999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|.|.+++.+++. +++.+..++++||+.|+.|+|..+ |+||||||+|+|||..+.+||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999999874 899999999999999999999999 999999999999999999999999999865332
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~ 692 (768)
. -..+.||++.|.+||++.|..| +.++||||.|||||.||||+.||+.. ..+..++..|.|.
T Consensus 166 k-------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~-------- 230 (786)
T KOG0588|consen 166 K-------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE-------- 230 (786)
T ss_pred c-------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--------
Confidence 2 2456799999999999999987 78999999999999999999999733 3455567777762
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILR 732 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~ 732 (768)
.|...+.+.++|+.+|+.+||..|.|+.+|+. +|+..-.
T Consensus 231 -MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 231 -MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred -CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 23344456899999999999999999999997 7775443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=355.12 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=201.0
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcC-CCceeeeeccccCC---cee
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIR-HPNMVLLLGACPEF---GCL 533 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~---~~l 533 (768)
..++|...++||.|+||.||+|.. .+..||||.++..-. .....=.+|+..|++|+ |||||+|..++.+. .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 357899999999999999999987 567899999975422 22222368999999999 99999999998543 489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|||||+ .+|..++..+ ...|++..++.|+.||+.||.|+|.+| ++||||||+|||+..+..+||+||||||.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999994 6888877766 347999999999999999999999999 9999999999999999999999999999774
Q ss_pred CCCCCccccccccCCCCCCCCCCcccc-cCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc----CC------
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQ-QTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN----GT------ 682 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~----~~------ 682 (768)
. ....+.++.|.||.|||++ +.+.|+.+.|||++|||++||.+-++.|-+..++.+..+- |+
T Consensus 162 S-------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 162 S-------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred c-------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 3 2345678999999999965 5667999999999999999999999999766555442211 11
Q ss_pred -------------ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 -------------FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 -------------~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.......+...-...+.+..+|+.+||..||.+|||+.+.+.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 1111111111111224567999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=344.42 Aligned_cols=258 Identities=24% Similarity=0.311 Sum_probs=209.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E 536 (768)
.+.|++...||.|.-++||+|+. .+..||||+++.+.- ...+.+.+|+..|+.++||||+.++..| ....++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46799999999999999999987 667999999986533 3357899999999999999999999888 455699999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
||.+|++.+++...-.. .+++..+..|..++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+..+.
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998775433 3899999999999999999999999 9999999999999999999999999887765544
Q ss_pred CCccccccccCCCCCCCCCCccccc--CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcC--CccccCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQ--TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENG--TFDETLDPAVP 692 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~--~~~~~ld~~~~ 692 (768)
.. ...++..++||++|||||++. ..+|+.|+||||||+..+||.+|..||.....+.-.+.+- .....+....+
T Consensus 181 ~R--~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 181 DR--QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred ce--eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 22 222337889999999999844 3479999999999999999999999998776665433321 11111100000
Q ss_pred -CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 -DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 -~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.....+..+.+++..||..||.+|||+.+++.
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 112335567999999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=356.71 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=200.4
Q ss_pred hcCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC---
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--- 529 (768)
.++|.+.+.||+|+||.||+|.+ .+..||||+++... ......+.+|+.+|..+ +|||||+++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999974 23579999997543 23345688999999999 89999999998853
Q ss_pred CceeEEEeccCCChHHHHhhcCC---------------------------------------------------------
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGG--------------------------------------------------------- 552 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 552 (768)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 35899999999999999875321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCC
Q 035604 553 --SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630 (768)
Q Consensus 553 --~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~g 630 (768)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ........+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~~ 238 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGSARL 238 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc----hhcccCCCC
Confidence 124788889999999999999999999 99999999999999999999999999986532211 111223456
Q ss_pred CCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH---HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHH
Q 035604 631 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH---QVERSIENGTFDETLDPAVPDWPVEEALILAKLA 706 (768)
Q Consensus 631 t~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~---~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li 706 (768)
++.|+|||++.+..++.++|||||||++|||++ |..||.... .....+..+.... .+...+..+.+|+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li 310 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--------APENATPEIYRIM 310 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--------CCCCCCHHHHHHH
Confidence 788999999999999999999999999999997 999996432 2333344332211 1122335689999
Q ss_pred HHhhhcCccCCCChhhhhhHHHHH
Q 035604 707 LQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 707 ~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
.+||..+|.+||++.+++..+.+.
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999998544433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=359.96 Aligned_cols=267 Identities=27% Similarity=0.455 Sum_probs=211.2
Q ss_pred HHHHHHhcCCCccceecccCceeEEEEEECCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC-Cce
Q 035604 456 EEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGC 532 (768)
Q Consensus 456 ~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 532 (768)
++++...+.+.+...||+|.||+||+|.+-| .||||+++... ....+.|++|+.++++-+|-||+-++|+|.. ...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 4444555667888999999999999999854 69999998663 3456779999999999999999999999944 448
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
||..+|+|.+|..+|.-... .|.....+.|+.||+.|+.|||.++ |||||||..||||.+++.|||+||||+..-
T Consensus 464 IiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 99999999999999876543 4888899999999999999999999 999999999999999999999999999643
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccC---CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDP 689 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~ 689 (768)
..- ..........|...|||||+++. .+|++.+|||||||++|||+||..||.........+..|+ -.+.+
T Consensus 539 ~~w----~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr--G~l~p 612 (678)
T KOG0193|consen 539 TRW----SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR--GYLMP 612 (678)
T ss_pred eee----ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc--cccCc
Confidence 211 01112345578899999998764 3589999999999999999999999973332222222222 11223
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
........++.++.+|+..||..++++||.+.+++..++.+++.+
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 333334456677999999999999999999999987676666543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=320.01 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=199.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh-h-HHHHHHHHHHHhhcCCCceeeeeccccCCc--eeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ-G-RSQFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~-~-~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~lV~E 536 (768)
.+|...++||+|.||.||+|++ +++.||||.++..... + .....+|+..|+.++||||+.|+++|+... .||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678888999999999999998 6679999999765322 1 234679999999999999999999996644 78999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
||+ .+|...+.... ..++...+..++.++++||+|||.+. |+||||||.|+||+.+|.+||+|||||+.+....
T Consensus 82 fm~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 68888876544 46999999999999999999999999 9999999999999999999999999999886432
Q ss_pred CCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH----cCCccccCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE----NGTFDETLDPAV 691 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~----~~~~~~~ld~~~ 691 (768)
. ..+..+.|.+|.|||.+.|. .|+..+||||.|||+.||+-|.|-|.+..++.+.-. -|.-.+...|.+
T Consensus 156 ~------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 156 R------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred c------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 2 22344889999999987765 699999999999999999999999976665554211 122111111111
Q ss_pred CC-----------------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PD-----------------WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~-----------------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. .-...+....+|+.+++.+||.+|+++.+++.
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 11 11123445799999999999999999999984
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.69 Aligned_cols=244 Identities=26% Similarity=0.430 Sum_probs=211.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh---hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ---GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
..+|++.+.||+|.||.|-++.. .|+.||||.++++... ..-.+.+|++||..|+||||+.+|.+|.. ...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788889999999999999876 6789999999877543 34457899999999999999999999955 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||..+|.|.|++...+. |++.+.+.++.||+.|+.|+|.++ ++|||||.+|||+|.|+++||+||||+-++..
T Consensus 132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999988774 999999999999999999999999 99999999999999999999999999987743
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
. ....++||++-|.+||+..|.+| ++.+|-|||||+||.|..|..||++.+ .+.+.|..|.|.+.-.|.
T Consensus 206 ~-------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PS- 277 (668)
T KOG0611|consen 206 K-------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPS- 277 (668)
T ss_pred c-------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCc-
Confidence 2 23578899999999999999887 789999999999999999999997654 345678888776543332
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
...-||++||-++|+.|.|+++|...|.
T Consensus 278 ---------dA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 278 ---------DASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ---------hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 2566999999999999999999987554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.36 Aligned_cols=237 Identities=25% Similarity=0.308 Sum_probs=196.9
Q ss_pred hcCCCccceecccCceeEEEEEECC--ccEEEEEEcCCchh---hHHHHHHHHHHHhhcC-CCceeeeecccc--CCcee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDAAQ---GRSQFQQEVEVLCNIR-HPNMVLLLGACP--EFGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~-HpnIv~l~g~~~--~~~~l 533 (768)
.++|.++++||+|.||+|+++.+.+ ..+|||++++.... ..+....|..|+...+ ||.++.|+.+|. +..|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 4689999999999999999999854 58999999987543 3445677888877775 999999999994 45699
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+.||++..+... ..|++..++.|+++|+.||.|||+++ |||||||.+|||||.+|++||+|||||+-.-
T Consensus 447 vmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999994433222 24999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~ 691 (768)
....+..+++||+.|||||++.+..|+..+|+|||||+|||||+|..||... +++...|.... +
T Consensus 520 ------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~------~-- 585 (694)
T KOG0694|consen 520 ------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE------V-- 585 (694)
T ss_pred ------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------C--
Confidence 1223457889999999999999999999999999999999999999999644 44445555432 2
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCCh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
-+|.-.+.+...|+.++|.++|.+|--+
T Consensus 586 -~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 -RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2344445668999999999999999887
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.48 Aligned_cols=236 Identities=21% Similarity=0.312 Sum_probs=194.3
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhh---HHHHHHHHHHHhhcCCCceeeeeccccC------CceeEEEec
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVLLLGACPE------FGCLIYEYM 538 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~lV~E~~ 538 (768)
...||+|++|.||+|.++++.||||.++...... .+.|.+|+.+|.+++|||||+++|+|.+ ..++||||+
T Consensus 25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3679999999999999999999999997653322 4567899999999999999999998854 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
++|+|.+++.... .+++...+.++.+++.||.|||.. + ++||||||+|||++.++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999987643 488999999999999999999985 6 8899999999999999999999999998653211
Q ss_pred CccccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... .+...+..+.... .
T Consensus 178 --------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----~--- 242 (283)
T PHA02988 178 --------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL----K--- 242 (283)
T ss_pred --------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC----C---
Confidence 23468899999999876 679999999999999999999999997443 2333332222111 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..++..+.+|+.+||+.+|.+||++.+++.
T Consensus 243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 12223456999999999999999999999974
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.82 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=200.6
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--------------hhHHHHHHHHHHHhhcCCCceeeee
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--------------QGRSQFQQEVEVLCNIRHPNMVLLL 524 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--------------~~~~~~~~E~~il~~l~HpnIv~l~ 524 (768)
..++|.+.+.||+|.||.|-+++. +++.||||++.+... ...+...+|+.||++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 357899999999999999999987 678999999965321 1235688999999999999999999
Q ss_pred cccc----CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc
Q 035604 525 GACP----EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV 600 (768)
Q Consensus 525 g~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 600 (768)
.+.. +..|||+|||..|.+.. .....+.+++.+.++|+.+++.||+|||.+| ||||||||+|+||+.+|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 9874 35699999999887754 2223334899999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCC----CCccccHHHHHHHHHHHHhCCCCCCChHH--H
Q 035604 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM----LGVKSDVYSLGILLLQIITAKPPMGLAHQ--V 674 (768)
Q Consensus 601 vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDvwSlGvil~elltg~~Pf~~~~~--~ 674 (768)
+||+|||.+.....+. +..........+||+.|+|||...++. -+.+.||||+||+||.|+.|+.||..... .
T Consensus 249 VKIsDFGVs~~~~~~~-~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGS-DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred EEeeccceeeecccCC-ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999998764432 122222344589999999999877643 47789999999999999999999964443 3
Q ss_pred HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 675 ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 675 ~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+|.+..+. .+..+ ++...+.+||.++|++||..|.++.+|.+
T Consensus 328 ~~KIvn~pL~------fP~~p-e~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 328 FDKIVNDPLE------FPENP-EINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHHhcCccc------CCCcc-cccHHHHHHHHHHhhcChhheeehhhhee
Confidence 4455554321 11222 34566999999999999999999998864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=354.38 Aligned_cols=237 Identities=27% Similarity=0.427 Sum_probs=198.0
Q ss_pred ccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCChH
Q 035604 467 NSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSLE 544 (768)
Q Consensus 467 ~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~ 544 (768)
.++-||.|+.|.||+|++.+..||||.++. .-.-++.-|++|+||||+.+.|+|.. .+|||||||..|.|.
T Consensus 128 ELeWlGSGaQGAVF~Grl~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhhccCcccceeeeeccCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 356699999999999999999999998752 12346777999999999999999954 559999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcccccc
Q 035604 545 DRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYR 624 (768)
Q Consensus 545 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 624 (768)
..|.... .++......|..+||.|+.|||.++ |||||||.-||||..+..|||+|||-++....- ..
T Consensus 201 ~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-------ST 267 (904)
T KOG4721|consen 201 EVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-------ST 267 (904)
T ss_pred HHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh-------hh
Confidence 9997654 4888888999999999999999999 999999999999999999999999999865321 23
Q ss_pred ccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHH
Q 035604 625 MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAK 704 (768)
Q Consensus 625 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~ 704 (768)
+.+++||..|||||+++..+.+.|+|||||||+|||||||..||...+.....+--| ...|.-.+ |..++..|.-
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG--sNsL~Lpv---PstcP~Gfkl 342 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG--SNSLHLPV---PSTCPDGFKL 342 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc--CCcccccC---cccCchHHHH
Confidence 567899999999999999999999999999999999999999997665543333222 22232222 3344556888
Q ss_pred HHHHhhhcCccCCCChhhhhhHHH
Q 035604 705 LALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 705 Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
|+.+||+-.|+.||++.++++.|-
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHh
Confidence 999999999999999999986543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=343.66 Aligned_cols=243 Identities=26% Similarity=0.370 Sum_probs=200.5
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++... ++.||+|++.... ......+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999984 6789999996532 2234568899999999999999999998854 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++...+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999987654 4889999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 693 (768)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.. .
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------~ 216 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---------E 216 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---------C
Confidence 1235789999999999999999999999999999999999999965432 2333433321 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh-HHHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPD-----LGKVVV-PKLN 729 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~-~~l~ 729 (768)
++...+..+.+|+.+||+.||.+||+ +.+++. +|..
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 22233456899999999999999995 787775 4553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=317.83 Aligned_cols=243 Identities=28% Similarity=0.379 Sum_probs=205.5
Q ss_pred hcCCCccceecccCceeEEEEEECC--ccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV 534 (768)
.++|++++.||+|-||.||.|+.+. ..||+|++.+.. .....++.+|++|-+.|+||||+++|++|-+. .||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3579999999999999999999854 579999997653 23456789999999999999999999999554 4999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
+||..+|+|...|..... ..+++.....++.|++.||.|+|..+ ||||||||+|+|++..+.+||+|||-+-.-+
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999985433 24889999999999999999999999 9999999999999999999999999986543
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~ 692 (768)
..+....+||..|.+||+..+..++..+|+|++|++.||+++|.+||... ....+.|.+-.+ ..
T Consensus 176 -------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~---~~---- 241 (281)
T KOG0580|consen 176 -------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL---KF---- 241 (281)
T ss_pred -------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc---cC----
Confidence 22346679999999999999999999999999999999999999999533 344445554322 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
|...+....++|.+|+.++|.+|..+.+|+.
T Consensus 242 --p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 --PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 2233456899999999999999999999986
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=338.79 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=196.8
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.|...+.||+|+||.||++.+ +++.||+|.+..... .....+.+|+.++..++||||++++++|.+ ..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999987 578999999865432 223457889999999999999999988744 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++|+|..++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988765432 24899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 694 (768)
......||..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+.... . .....+
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~----~~~~~~ 224 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-K----EDQEEY 224 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-h----cccccC
Confidence 123457899999999999999999999999999999999999999643221 11111100 0 001122
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh-HHH
Q 035604 695 PVEEALILAKLALQCAELRRKDRPD-----LGKVVV-PKL 728 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~-~~l 728 (768)
+...+..+.+|+.+||..+|.+||+ +.+++. ++.
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~ 264 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence 2334456899999999999999997 677765 444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=365.68 Aligned_cols=255 Identities=32% Similarity=0.523 Sum_probs=211.3
Q ss_pred cCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
.+....+.||+|.||+||+|...+ +.||||.++..... .+.+|++|+++|..|+|||||+|+|+|.+ ..|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 344566789999999999988632 47999999877554 78899999999999999999999999944 559
Q ss_pred eEEEeccCCChHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 533 LIYEYMANGSLEDRLFRRGG-----------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
+|+|||..|||.++|..... .+.|+..+.+.|+.|||.|+.||-+++ +|||||-..|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999975421 223888999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccCCCCCCcccccccc-CCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCC--hHHHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMT-SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGL--AHQVERS 677 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~--~~~~~~~ 677 (768)
||+||||++-+..... |+.. ...-..+||+||.+..+.++++||||||||+|||+++ |+.||.. ..++...
T Consensus 643 KIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred Eecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 9999999986643321 2222 3445789999999999999999999999999999998 9999853 3456677
Q ss_pred HHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhhc
Q 035604 678 IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737 (768)
Q Consensus 678 i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~~ 737 (768)
|..|.+ ...|..++.++..|+..||+.+|.+||++.+|- .+|..+...
T Consensus 718 i~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~----~~L~~~~~~ 765 (774)
T KOG1026|consen 718 IRAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH----SRLQAWAQA 765 (774)
T ss_pred HHcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH----HHHHHHHhc
Confidence 777764 244566667899999999999999999999987 445444433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=326.83 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=198.2
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhh--HHHHHHHHHHHhhcCCCceeeeecc----ccCCceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQG--RSQFQQEVEVLCNIRHPNMVLLLGA----CPEFGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~----~~~~~~lV 534 (768)
+.|+.++.|++|+||.||+|.+ ++..||+|.++.+.... .-.-.+|+.+|.+++|||||.+-.+ -.+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4588889999999999999998 45689999998654221 1124799999999999999988554 45667999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||||+. +|..++..-. ..|...++..++.|++.||.|||... |+||||||+|+|++..|.+||+|||||+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999964 7888776644 35889999999999999999999999 99999999999999999999999999998854
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH---HH-HcCCccccCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER---SI-ENGTFDETLDP 689 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~---~i-~~~~~~~~ld~ 689 (768)
. ...++..+.|.+|.|||++.+. .|++.+|+||+|||+.||+++++.|.+..++.+ .+ ..|.-.+.+.|
T Consensus 230 p------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 230 P------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred C------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 3 2346778999999999987765 599999999999999999999999965544332 11 12332222222
Q ss_pred CCCCCC--------------------HH-HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 690 AVPDWP--------------------VE-EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 690 ~~~~~~--------------------~~-~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.....| .. .+..-.+|+..+|.+||.+|-|+.+.+.
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 221111 00 2245778999999999999999999885
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=343.54 Aligned_cols=245 Identities=26% Similarity=0.360 Sum_probs=205.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~ 537 (768)
..|...+.||+|.||.||+|.+ .++.||+|++..+. ....+++++|+.+|.+++++||.++||.+ .....++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3567778899999999999998 45689999997653 34567889999999999999999999987 4455899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
|.||++.+.|.... .+.+..+.-++.+++.||.|||..+ .+|||||+.|||+..+|.+||+|||.+..+...
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~-- 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT-- 164 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech--
Confidence 99999999887654 3577888889999999999999999 999999999999999999999999999876432
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHH
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
..+...++||+.|||||++....|+.|+||||||++.|||++|.+||...+.+.-. .-+-....|.....
T Consensus 165 ----~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------flIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 165 ----VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------FLIPKSAPPRLDGD 234 (467)
T ss_pred ----hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------EeccCCCCCccccc
Confidence 23346789999999999999889999999999999999999999999877763221 11111122233335
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..|.+++..||+++|+.||++.+++.
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 6677999999999999999999999873
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.44 Aligned_cols=239 Identities=26% Similarity=0.401 Sum_probs=198.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.+ +++.||+|++.... ......+.+|+.+|+.++||||+++++++.+ ..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5789999999999999999988 46789999997542 2234568899999999999999999998844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987654 4889999999999999999999999 999999999999999999999999999865322
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 693 (768)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.+ ..+.
T Consensus 172 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------~~p~ 236 (329)
T PTZ00263 172 ---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL------KFPN 236 (329)
T ss_pred ---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc------CCCC
Confidence 1235789999999999999999999999999999999999999965433 3334444432 1122
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPD-----LGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~ 725 (768)
+ .+..+.+|+.+||+.||.+||+ +.+++.
T Consensus 237 ~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 237 W---FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred C---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2 2345899999999999999997 577764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.85 Aligned_cols=250 Identities=27% Similarity=0.367 Sum_probs=202.7
Q ss_pred cCCCccceecccCceeEEEEEECC--ccEEEEEEcCCchhhH---HHHHHHHHHHhhcCCCceeeeecccc--CCceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDAAQGR---SQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~---~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 535 (768)
+.|++++.||.|.-|+||++.+.+ ..+|+|++.+.....+ ...+-|.+||+.++||.+..||..|. ++.||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778899999999999999966 5899999987654433 34567999999999999999999984 4669999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||+||+|..+++++.. ..|++..++.++.+|+.||+|||-+| ||+|||||+||||.++|++-|+||.|+......
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999988776554 46999999999999999999999999 999999999999999999999999998654210
Q ss_pred C-------------------------------C-C------------------ccccccccCCCCCCCCCCcccccCCCC
Q 035604 616 V-------------------------------A-D------------------SVTQYRMTSAAGTFCYIDPEYQQTGML 645 (768)
Q Consensus 616 ~-------------------------------~-~------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 645 (768)
. . . .....+..+++||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0 011133457899999999999999999
Q ss_pred CccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC----
Q 035604 646 GVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD---- 719 (768)
Q Consensus 646 s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs---- 719 (768)
+.++|||+|||++||||.|..||.+... ....|... +...++.+ ..+..+.+||.+.|.+||.+|--
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~------~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ------PLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC------CCcCCCCC-cchhHHHHHHHHHhccChhhhhccccc
Confidence 9999999999999999999999954432 22233222 12333433 45567999999999999999988
Q ss_pred hhhh
Q 035604 720 LGKV 723 (768)
Q Consensus 720 ~~ev 723 (768)
+.+|
T Consensus 386 A~eI 389 (459)
T KOG0610|consen 386 AAEI 389 (459)
T ss_pred hHHh
Confidence 5555
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.81 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=209.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccCC---ceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF---GCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~lV 534 (768)
.++|..++.+|+|+||.++..++ +++.|++|.++... ...+....+|+.++++++|||||.+++.|.+. .|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 36799999999999999986665 66789999987543 33445678999999999999999999999543 4899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|+||+||+|.+.+.+.. ...|+++.++.|+.|++.|+.|||+.+ |+|||||+.|||++.++.|||+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998765 346999999999999999999999888 99999999999999999999999999998865
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~ 692 (768)
... ...+.+||+.|++||++.+.+|+.|+|||||||++|||++-+++|...+. ....|..+. ..
T Consensus 159 ~~~------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--------~~ 224 (426)
T KOG0589|consen 159 EDS------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--------YS 224 (426)
T ss_pred chh------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--------CC
Confidence 421 23567999999999999999999999999999999999999999964443 333444433 22
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..|..++.+|..|+..|+..+|..||++.+++.
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence 345566677999999999999999999999987
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.82 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=193.9
Q ss_pred cCCCccceecccCceeEEEEEEC------------------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD------------------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLL 523 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~------------------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l 523 (768)
++|.+.+.||+|+||.||++.+. +..||+|++.... ......|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 57888999999999999999752 2369999997653 3345678999999999999999999
Q ss_pred eccccC--CceeEEEeccCCChHHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 035604 524 LGACPE--FGCLIYEYMANGSLEDRLFRRG----------------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585 (768)
Q Consensus 524 ~g~~~~--~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH 585 (768)
+++|.+ ..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999843 4599999999999999886532 1134788899999999999999999999 999
Q ss_pred CCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh--
Q 035604 586 RDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-- 663 (768)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-- 663 (768)
|||||+|||++.++.+||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999999999999999986533211 111223456788999999988899999999999999999986
Q ss_pred CCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 664 AKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 664 g~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
+..||...... ...+.. .+...........+..++..+.+|+.+||..+|.+||++.+|.
T Consensus 238 ~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 238 KEQPYGELTDEQVIENAGE-FFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCCcCCHHHHHHHHHH-HhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 66788643221 111110 0000000000011112334699999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=340.48 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=201.5
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|++.+.||+|+||.||++.+. +..||+|++.... ......+.+|+++|+.++||||+++++++.. ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999984 5689999987542 2345678999999999999999999998843 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999987654 3889999999999999999999853 3999999999999999999999999999765322
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCcc-------c--
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFD-------E-- 685 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~-------~-- 685 (768)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+...... .
T Consensus 158 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 158 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred -------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 12345789999999999999999999999999999999999999964322 11111110000 0
Q ss_pred -----------------------------cCCCCCCCCC-HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 686 -----------------------------TLDPAVPDWP-VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 686 -----------------------------~ld~~~~~~~-~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
+.....+..+ ...+..+.+|+.+||..||++||++.+++. +|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 0000001111 123456999999999999999999999987 56543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.30 Aligned_cols=236 Identities=25% Similarity=0.315 Sum_probs=192.2
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 541 (768)
+.||+|+||.||++.. +++.||||++.... ......+.+|+.+++.++||||++++++|.. ..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 56789999997542 2233457789999999999999999988844 458999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----- 149 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----- 149 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-----
Confidence 9999887654 4899999999999999999999999 9999999999999999999999999987532111
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEA 699 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~ 699 (768)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+.. ..+...+
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---------~~p~~~~ 219 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------RFPRTLS 219 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------CCCCCCC
Confidence 112345799999999999999999999999999999999999999964432 2223322221 1222334
Q ss_pred HHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 700 LILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 700 ~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
..+.+|+.+||..||++|| ++.+++.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 5689999999999999999 7888774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=345.14 Aligned_cols=247 Identities=23% Similarity=0.288 Sum_probs=199.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.++..++||||+++++++.+ ..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3689999999999999999998 46789999997542 2234567899999999999999999998844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999987654 4889999999999999999999999 99999999999999999999999999976532
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 693 (768)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... ...+..... ....+....
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~ 224 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TLQRPVYDD 224 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-cccCCCCCc
Confidence 123457999999999999999999999999999999999999999654332 222322110 011111111
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.....+..+.+|+.+||..+|.+||++.+++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 01123456899999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=331.21 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=205.7
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEc--CCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-------
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLR--PDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 529 (768)
....|...+.||.|+||.|+.+.+ ++..||||.+. .......+...+|+.+|+.++|+||+.+++.+..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345677789999999999999987 56789999986 3444555677899999999999999999998733
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..|+|+|+| ..+|...+.... .|+......++.||++||.|+|+.+ |+||||||+|+|++.+..+||||||||
T Consensus 100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 239999999 678888876654 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCccccc-CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH------------
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER------------ 676 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~------------ 676 (768)
+..... .....++..+.|.+|.|||++. ...|+...||||+||||.||++|++-|-+.+.+.+
T Consensus 173 R~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 173 RYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred eecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 987543 2234467889999999999654 56799999999999999999999999954443322
Q ss_pred -----HHHcCC---ccccCCCCCCCCC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHH
Q 035604 677 -----SIENGT---FDETLDPAVPDWP-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRA 733 (768)
Q Consensus 677 -----~i~~~~---~~~~ld~~~~~~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~ 733 (768)
.+.... +...+ +..+..+ ........+|+.+||..||.+|+|+++.+. +.+..+..
T Consensus 249 ~e~l~~i~s~~ar~yi~sl-p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSL-PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHHHHhccHHHHHHHHhC-CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 111000 11111 1111111 133456889999999999999999999987 77766544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=339.90 Aligned_cols=236 Identities=26% Similarity=0.322 Sum_probs=191.2
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 541 (768)
+.||+|+||.||++.. ++..||+|+++... ......+.+|+.+++.++||||++++++|.. ..||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999987 56789999997542 2234457789999999999999999998844 458999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 149 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----- 149 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-----
Confidence 9998887654 4899999999999999999999999 9999999999999999999999999987532211
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEA 699 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~ 699 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.. ..+...+
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~---------~~p~~~~ 219 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------RFPRTLS 219 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------CCCCCCC
Confidence 112345799999999999999999999999999999999999999964432 2222222221 1222334
Q ss_pred HHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 700 LILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 700 ~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
..+.+|+.+||..+|.+|| ++.+++.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 5689999999999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.88 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=197.9
Q ss_pred hcCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 530 (768)
.++|.+.+.||+|+||.||+|.+ .+..||||+++... ......+.+|+.+|..+ +|||||+++++|.+ .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34789999999999999999864 23479999997543 33455788999999999 89999999999854 4
Q ss_pred ceeEEEeccCCChHHHHhhcCC----------------------------------------------------------
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG---------------------------------------------------------- 552 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 552 (768)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 5899999999999999865321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 553 --------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 553 --------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence 124788899999999999999999999 99999999999999999999999999986643211
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH---HHHHHHHcCCccccCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH---QVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~---~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
........++..|+|||++.+..++.++|||||||++|||++ |..||.... .....+..+... ..+.
T Consensus 270 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~- 340 (375)
T cd05104 270 ---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-----LSPE- 340 (375)
T ss_pred ---ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-----CCCC-
Confidence 011123345678999999999999999999999999999998 899996432 233334433211 1111
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
..+..+.+|+.+||..+|.+||++.+|+..+
T Consensus 341 --~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 341 --CAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 1234699999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=340.86 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=195.9
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-------Cce
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------FGC 532 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~~ 532 (768)
+|.+.+.||+|+||.||+|.+ ++..||||++... .......+.+|+.+++.++||||+++++++.. ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 488899999999999999987 5678999998643 22334568899999999999999999988722 248
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999999 478988886544 4899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--------------
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER-------------- 676 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~-------------- 676 (768)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||........
T Consensus 154 ~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTP---TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccC---ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 32211 1111244679999999998876 6789999999999999999999999954322110
Q ss_pred ---HHHcCCccc---cCCCCC----CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 677 ---SIENGTFDE---TLDPAV----PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 677 ---~i~~~~~~~---~ld~~~----~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.+....... .+.... .......+..+.+++.+||..+|.+||++.+++. +|.+.+
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 010000000 000000 0000112345789999999999999999999997 666543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=355.54 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=202.6
Q ss_pred CCCccceecccCceeEEEEEEC---CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD---HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
.|.+.+.||+|+||.||++... +..||+|.+..........+.+|+.+|+.++|||||+++++|. +..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999863 4578999876555555556788999999999999999999984 4459999999
Q ss_pred cCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 539 ANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 539 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 22335889999999999999999999999 99999999999999999999999999987643221
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+.+. ..+
T Consensus 225 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--------~~~ 292 (478)
T PTZ00267 225 ----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--------PFP 292 (478)
T ss_pred ----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCC
Confidence 1122456799999999999999999999999999999999999999965432 22333333321 112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
...+..+.+|+.+||..+|.+||++.+++. +++.
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 223356999999999999999999999985 4443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=358.21 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=206.7
Q ss_pred cCCCccceecccCceeEEEEEE-CC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeecccc-----C----C
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-DH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACP-----E----F 530 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~-----~----~ 530 (768)
.++.+.+.|.+|||+.||.+.+ .+ +.||+|++-..+......+.+|+++|+.|. |||||.+++.+. . .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4677889999999999999998 33 799999997777788888999999999997 999999999431 1 1
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.+|+||||.||.|-|++..+.... |++.++++|+.++++|+.+||.+. +||||||||-+||||+.+|..||||||.+.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 268999999999999998765544 999999999999999999999997 689999999999999999999999999996
Q ss_pred ccCCCCCCcc---ccccccCCCCCCCCCCcccc---cCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCcc
Q 035604 611 LVPPSVADSV---TQYRMTSAAGTFCYIDPEYQ---QTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFD 684 (768)
Q Consensus 611 ~~~~~~~~~~---~~~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~ 684 (768)
.......... .-.......-|+.|+|||++ .+...+.|+|||+|||+||-|+....||+....+ +|.+++|.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--aIlng~Y~ 272 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--AILNGNYS 272 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--eEEecccc
Confidence 4432221000 00011234568999999964 5678999999999999999999999999755332 34455542
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
+|.. ..++..|.+||..||+.+|.+||++.+|+..+..+
T Consensus 273 ------~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 273 ------FPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ------CCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 1221 34567799999999999999999999998544433
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=332.89 Aligned_cols=252 Identities=25% Similarity=0.321 Sum_probs=194.7
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
++|.+.+.||+|+||.||++.+. +..||+|++.... ......+.+|+.+++.++||||++++++|.. ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999984 5689999987542 2334567899999999999999999998844 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|++++.+..+.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99987766544322 24889999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHc--CC----------
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IEN--GT---------- 682 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~--~~---------- 682 (768)
. .......||+.|+|||++.+..++.++|||||||++|+|++|++||......... +.. +.
T Consensus 155 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 N-----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred c-----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 1 1123457899999999999888999999999999999999999999644322111 100 00
Q ss_pred ----ccccCCCCC-------CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 ----FDETLDPAV-------PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ----~~~~ld~~~-------~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.....+.. ..+....+..+.+|+.+||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0011123456999999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=345.80 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=197.1
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.+ +++.||||++.... ......+.+|+.+|..++||||++++++|.+ ..||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999988 56789999997542 2233457889999999999999999998854 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987654 4899999999999999999999999 999999999999999999999999999765321
Q ss_pred CCCcc--------------------------------ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh
Q 035604 616 VADSV--------------------------------TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663 (768)
Q Consensus 616 ~~~~~--------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt 663 (768)
..... ........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10000 0001123579999999999999999999999999999999999
Q ss_pred CCCCCCChHHHH--HHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC---hhhhhh
Q 035604 664 AKPPMGLAHQVE--RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD---LGKVVV 725 (768)
Q Consensus 664 g~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs---~~evl~ 725 (768)
|.+||....... ..+......-.+ +... ..+..+.+|+.+|+. +|.+|++ +.+++.
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~----~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQF-PDEV----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccCC-CCCC----CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999996544322 222222111111 1111 123458889999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=342.55 Aligned_cols=240 Identities=27% Similarity=0.380 Sum_probs=197.9
Q ss_pred hcCCCccceecccCceeEEEEEECC---ccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH---TPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~---~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
.++|.+.+.||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+++.++|||||++++++.+ ..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998633 479999986432 2234567899999999999999999999854 3589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999987654 4899999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~ 691 (768)
.. .....||+.|+|||++.+..++.++|||||||++|||++|.+||...... ...+..+...
T Consensus 183 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~------- 246 (340)
T PTZ00426 183 TR---------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY------- 246 (340)
T ss_pred CC---------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-------
Confidence 21 13457999999999999988999999999999999999999999755432 3344443211
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
+|...+..+.+++.+||+.+|.+|+ ++.+++.
T Consensus 247 --~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 247 --FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1122234588999999999999995 7888764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=332.72 Aligned_cols=249 Identities=25% Similarity=0.418 Sum_probs=198.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCc----cEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHT----PVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 534 (768)
.+|++.+.||+|+||.||+|.+ .+. .||+|+++... ......+.+|+.+++.++||||++++|+|.. ..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 4689999999999999999986 333 38999987543 3445678899999999999999999999844 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
++|+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999876542 4889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
... ........++..|++||++.+..++.++|||||||++|||++ |..||.... .....+..+... +.
T Consensus 162 ~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----~~- 232 (316)
T cd05108 162 DEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----PQ- 232 (316)
T ss_pred CCc----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCC----CC-
Confidence 211 111122345678999999999999999999999999999998 999996433 223333332211 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
+..++..+.+++.+||..+|.+||++.+++..+.
T Consensus 233 ---~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 233 ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1122345899999999999999999999986443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=312.81 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=207.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++.|++.+.||+|.|+.||++.+ .|+.+|+|+++.. ...+.+.+.+|+.|.+.|+|||||+|...+.+ +.|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46788888899999999999887 5678999988543 33356778999999999999999999998744 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCcEEEeeccccccc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLV 612 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~vKL~DFGla~~~ 612 (768)
|+|.|++|..-+..+. .+++..+-.++.||+.+|.|+|.++ |||||+||+|+|+ +..-.+||+|||+|.-+
T Consensus 90 e~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999988776653 5889999999999999999999999 9999999999999 34557899999999877
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCC--hHHHHHHHHcCCccccCCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGL--AHQVERSIENGTFDETLDPA 690 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~--~~~~~~~i~~~~~~~~ld~~ 690 (768)
... .....++|||.|||||++...+|+..+|||+.|||||-||.|++||.. .+.+...|..|.+. -.
T Consensus 164 ~~g-------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd----~~ 232 (355)
T KOG0033|consen 164 NDG-------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD----YP 232 (355)
T ss_pred CCc-------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC----CC
Confidence 522 223567999999999999999999999999999999999999999954 56667778877653 22
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+.|+ ..+.+..+|+.+||..||.+|.|+.|.+. +|+
T Consensus 233 ~~~w~-~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 233 SPEWD-TVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred CcccC-cCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 22343 23456889999999999999999999985 443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.13 Aligned_cols=234 Identities=25% Similarity=0.289 Sum_probs=189.6
Q ss_pred ecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCCh
Q 035604 471 IGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSL 543 (768)
Q Consensus 471 LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 543 (768)
||+|+||.||++.+ ++..||+|++.... ......+.+|+.+++.++||||++++++|.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999998 45689999997532 2334567889999999999999999988844 45999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 623 (768)
.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------~ 148 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------D 148 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC------C
Confidence 99987654 3899999999999999999999999 9999999999999999999999999997542211 1
Q ss_pred cccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHHHHH
Q 035604 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEALI 701 (768)
Q Consensus 624 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~ 701 (768)
......||+.|+|||++.+..++.++|||||||++|+|++|++||..... ....+..+.+ .++...+..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~~~ 219 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL---------RFPDGFDRD 219 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---------CCCCcCCHH
Confidence 12345799999999999999999999999999999999999999964322 2222322211 122233456
Q ss_pred HHHHHHHhhhcCccCCCC---hhhhhh
Q 035604 702 LAKLALQCAELRRKDRPD---LGKVVV 725 (768)
Q Consensus 702 l~~Li~~cl~~~P~~RPs---~~evl~ 725 (768)
+.+++.+||..+|.+||+ +.+++.
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 899999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.98 Aligned_cols=236 Identities=25% Similarity=0.312 Sum_probs=191.4
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 541 (768)
+.||+|+||.||++.. ++..||+|++.... ......+.+|+.+|+.++||||+++++++.. ..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 56789999997542 2334567889999999999999999988744 458999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------ 148 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------ 148 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc------
Confidence 9998886644 4899999999999999999999999 999999999999999999999999998753221
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVEEA 699 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~~ 699 (768)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+.. ..+...+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~---------~~p~~~~ 219 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI---------KFPRTLS 219 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc---------cCCCCCC
Confidence 11123457999999999999999999999999999999999999999644322 222222111 1222334
Q ss_pred HHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 700 LILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 700 ~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
..+.+|+.+||..+|.+|| ++.+++.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 5689999999999999997 7888774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.91 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=194.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|.+.+.||+|+||.||+|.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999998 567899999975432 223457789999999999999999998843 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+. ++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 678777765432 4888999999999999999999999 9999999999999999999999999997542211
Q ss_pred CCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc-----CCccc-----
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN-----GTFDE----- 685 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~-----~~~~~----- 685 (768)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+.. +....
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 11234578999999998765 45899999999999999999999999754332221110 00000
Q ss_pred -----cCCCC-C----C-CCCH-----HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 686 -----TLDPA-V----P-DWPV-----EEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 686 -----~ld~~-~----~-~~~~-----~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
...+. . + .+.. ..+..+.+|+.+||+.||.+|||+.+++. ++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 00000 0 0 0000 01245789999999999999999999985 454
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=330.97 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=209.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 535 (768)
.+-|++.+.||+|.|+.|-++++ .|..||||++.+... .....+.+|+..|+.++|||||+||.+.. ...|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45688889999999999998765 899999999976543 34567889999999999999999999974 4569999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-cCCCcEEEeecccccccCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL-DRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl-~~~~~vKL~DFGla~~~~~ 614 (768)
|+-++|+|.++|.++... +.+....+++.||+.||.|+|+.+ +|||||||+||.+ ..-|.+||.|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999987653 999999999999999999999999 9999999999887 5678999999999976644
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCC-ccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLG-VKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~ 691 (768)
+ .+.+..||++.|.|||++.|..|+ +++||||||||||.|.+|++||...++-+ ..|.+-+|
T Consensus 172 G-------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-------- 236 (864)
T KOG4717|consen 172 G-------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-------- 236 (864)
T ss_pred c-------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--------
Confidence 3 345778999999999999999885 57899999999999999999997554432 23333322
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
..|...+.+..+||..||..||++|.++++++. .|++
T Consensus 237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq 274 (864)
T KOG4717|consen 237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ 274 (864)
T ss_pred -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence 345566778999999999999999999999986 6664
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=340.57 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=193.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|++.+.||+|+||.||++.. .++.||||++..... .....+.+|+.++..++||||+++++.+.+ ..||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999987 467899999975422 233467889999999999999999999855 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.+.+ .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCc-----------------------------cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCC
Q 035604 616 VADS-----------------------------VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKP 666 (768)
Q Consensus 616 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~ 666 (768)
.... .........+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 00001134589999999999999999999999999999999999999
Q ss_pred CCCChHH--HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhh--cCccCCCChhhhhh
Q 035604 667 PMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAE--LRRKDRPDLGKVVV 725 (768)
Q Consensus 667 Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~--~~P~~RPs~~evl~ 725 (768)
||..... ....+......-.+.+.. . .+..+.+++.+++. .++..||++.+++.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~-~----~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIFPPEV-P----ISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccCCCcC-C----CCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 9965433 223333321111111111 1 12346677776443 34446799999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.14 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=200.4
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.+. +..||||+++.... .....+..|+.++..++||||+++++++.+ ..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999985 78999999975421 334568899999999999999999998854 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999998763 4899999999999999999999998 999999999999999999999999999876433
Q ss_pred CCC-----------------------ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH
Q 035604 616 VAD-----------------------SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672 (768)
Q Consensus 616 ~~~-----------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~ 672 (768)
... ...........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 200 000112234679999999999999999999999999999999999999996554
Q ss_pred HHH--HHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC-hhhhhh
Q 035604 673 QVE--RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD-LGKVVV 725 (768)
Q Consensus 673 ~~~--~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs-~~evl~ 725 (768)
... ..+.... .....+.... .+..+.+|+..|+. +|.+||+ +.+++.
T Consensus 235 ~~~~~~~i~~~~-~~~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 235 LQETYNKIINWK-ESLRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHHHHHHhccC-CcccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 322 2222210 0111111111 34568999999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.36 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=194.9
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.|.+++.||+|+||.||++.+ ++..||||++.... ......+.+|+.+++.++|||||+++++|.+ ..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999988 55689999997542 2234568899999999999999999999854 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++|+|.+++.... .+++..+..++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987654 4889999999999999999999999 9999999999999999999999999986442110
Q ss_pred CCc-----------------------------------------cccccccCCCCCCCCCCcccccCCCCCccccHHHHH
Q 035604 617 ADS-----------------------------------------VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLG 655 (768)
Q Consensus 617 ~~~-----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlG 655 (768)
... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 000 000011345799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCCCHHHHHHHHHHHHH--hhhcCccCCCChhhhhh-HHH
Q 035604 656 ILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDWPVEEALILAKLALQ--CAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 656 vil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~--cl~~~P~~RPs~~evl~-~~l 728 (768)
|++|||++|++||........ .+...... ...+.+ ...+..+.+|+.+ |+..+|..||++.+++. ++.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~-~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f 308 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENT----LHIPPQ-VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccc----cCCCCC-CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCccc
Confidence 999999999999965443222 22211100 111111 1123457788877 55666777999999986 443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=340.11 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=196.4
Q ss_pred hcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 530 (768)
.++|.+.+.||+|+||.||++... +..||+|+++... ......+.+|+.+++.+ +|||||+++++|.. .
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357899999999999999998752 2469999997543 33455688999999999 89999999999854 4
Q ss_pred ceeEEEeccCCChHHHHhhcCC----------------------------------------------------------
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG---------------------------------------------------------- 552 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 552 (768)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 5899999999999999864321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccc
Q 035604 553 ---------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623 (768)
Q Consensus 553 ---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 623 (768)
...+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----~~ 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----YV 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----ee
Confidence 124788889999999999999999999 99999999999999999999999999976533211 01
Q ss_pred cccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH---HHHHHHcCCccccCCCCCCCCCHHHH
Q 035604 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ---VERSIENGTFDETLDPAVPDWPVEEA 699 (768)
Q Consensus 624 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~---~~~~i~~~~~~~~ld~~~~~~~~~~~ 699 (768)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....+..+ + .+..+.+ .+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-~----~~~~~~~---~~ 341 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-Y----QMSRPDF---AP 341 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-c----CccCCCC---CC
Confidence 1122345678999999998899999999999999999997 9999964332 22222222 1 1111221 23
Q ss_pred HHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 700 LILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 700 ~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
..+.+++.+||+.+|.+||++.+|+..+
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 5699999999999999999999998533
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.06 Aligned_cols=245 Identities=26% Similarity=0.410 Sum_probs=196.1
Q ss_pred cCCCccceecccCceeEEEEEEC-----CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-----HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
++|.+.+.||+|+||.||+|.+. +..||+|.++... ......+.+|+.++..++||||+++++++.. ..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999763 3579999997653 2334568899999999999999999998744 45999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999876432 4899999999999999999999999 99999999999999999999999998764321
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
.. ........++..|+|||.+.+..++.++|||||||++||+++ |..||.... .....+..+... +
T Consensus 160 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----~-- 228 (266)
T cd05064 160 EA-----IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL----P-- 228 (266)
T ss_pred cc-----hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC----C--
Confidence 11 011123345678999999999999999999999999999775 999996432 223334433211 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..++..+.+++..||+.+|.+||++.+++.
T Consensus 229 --~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 --APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 12233456999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.11 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=192.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E~ 537 (768)
++|.+.+.||.|+||.||+|.. ++..||+|+++.... .....+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5799999999999999999987 467899999875432 2344678999999999999999999987543 5899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
++ |+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LD-SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CC-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 97 589888865442 4788999999999999999999999 9999999999999999999999999997643211
Q ss_pred CccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--C-----------
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--G----------- 681 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~----------- 681 (768)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||........ .+.. +
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 11234578999999998765 5689999999999999999999999964332111 1100 0
Q ss_pred ---CccccCCCCCC-----CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 682 ---TFDETLDPAVP-----DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 682 ---~~~~~ld~~~~-----~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+...+.+... +.....+..+.+|+.+||..||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111111100 000112346889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.61 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=191.5
Q ss_pred cCCCccceecccCceeEEEEEE---CCccEEEEEEcCCch--hhHHHHHHHHHHHhhc---CCCceeeeecccc------
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL---DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNI---RHPNMVLLLGACP------ 528 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~---~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~------ 528 (768)
.+|.+.+.||+|+||.||++.+ .++.||+|+++.... .....+.+|+.+++.+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999987 346799999865422 1223456777777765 6999999999873
Q ss_pred -CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 529 -EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 529 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
...++||||+. ++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 23589999995 689888865432 24899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCC---
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGT--- 682 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~--- 682 (768)
+++.+... .......||+.|+|||.+.+..++.++|||||||++|||++|++||....... ..+.+..
T Consensus 156 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 156 LARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred ceEeccCC-------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99865332 11234578999999999988899999999999999999999999996543322 1121110
Q ss_pred ----cc-------ccCCCCCC----CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 ----FD-------ETLDPAVP----DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ----~~-------~~ld~~~~----~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+. ..+.+... .+....+..+.+|+.+||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00000000 001123345889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=342.64 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=195.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.. +++.||||++.... ......+.+|+++++.++|||||+++++|.+ ..||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688999999999999999987 56789999986532 2234567889999999999999999999854 459999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987644 4889999999999999999999999 999999999999999999999999999643211
Q ss_pred CCCc----------cc-------------------------------cccccCCCCCCCCCCcccccCCCCCccccHHHH
Q 035604 616 VADS----------VT-------------------------------QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSL 654 (768)
Q Consensus 616 ~~~~----------~~-------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSl 654 (768)
.... .. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0000 00 000013579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCC---CChhhhhh-HHH
Q 035604 655 GILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDR---PDLGKVVV-PKL 728 (768)
Q Consensus 655 Gvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~R---Ps~~evl~-~~l 728 (768)
||++|||++|++||...... ...+.... ..+ ..++. ...+..+.+|+.+|+. +|.+| |++.+++. +|+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~--~~p~~-~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~ 308 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWR--ETL--YFPDD-IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF 308 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccC--Ccc--CCCCC-CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence 99999999999999644332 22222211 101 11111 1123468899999997 67665 59999886 443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=333.09 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=199.4
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|++.+.||+|+||.||++.+. +..+|+|++.... ......+.+|+++++.++||||++++++|.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999984 5689999887542 2344678999999999999999999999844 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|+++|+|.+++.... .+++.....++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999987644 488999999999999999999975 5 999999999999999999999999999765322
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHH---cCCcccc----
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIE---NGTFDET---- 686 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~---~~~~~~~---- 686 (768)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+. .+.....
T Consensus 158 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 M--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229 (333)
T ss_pred c--------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence 1 12347899999999999888999999999999999999999999643321 11110 0000000
Q ss_pred -----------------------------CCCCCCCCC-HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 687 -----------------------------LDPAVPDWP-VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 687 -----------------------------ld~~~~~~~-~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.....+..+ ...+.++.+|+.+||+.||.+||++.+++. +++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 000000000 012356899999999999999999999986 55543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=324.76 Aligned_cols=249 Identities=29% Similarity=0.470 Sum_probs=200.5
Q ss_pred cCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
++|++.+.||+|+||.||+|...+ ..||+|.+.... ......|.+|+.++..++||||+++++++.. ..|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998743 359999987543 3345568999999999999999999999854 458
Q ss_pred eEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 035604 533 LIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 599 (768)
++|||+++|+|.+++..... ...+++..++.++.|++.||.|||..+ |+||||||+|||++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999976422 134888999999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHH
Q 035604 600 VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVER 676 (768)
Q Consensus 600 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~ 676 (768)
.+||+|||+++.+..... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||... ..+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADY----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEECCCcceeecccccc----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999986532211 111233456889999999988899999999999999999998 99999543 23334
Q ss_pred HHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 677 ~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
.+..+... ..+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 238 ~i~~~~~~--------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLL--------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcC--------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44444322 1233344679999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=333.37 Aligned_cols=236 Identities=29% Similarity=0.384 Sum_probs=190.6
Q ss_pred ceecccCceeEEEEEE-----CCccEEEEEEcCCc----hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 469 RKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA----AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+.||+|+||.||++.. .++.||+|++.... ......+.+|+.+|+.++||||+++++.|.. ..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 45689999997532 1223457789999999999999999998844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999887654 4788889999999999999999999 9999999999999999999999999987532211
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.......||+.|+|||++.+..++.++|||||||++|||++|++||...... ...+..+.. ..+
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~---------~~~ 220 (323)
T cd05584 155 -----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---------NLP 220 (323)
T ss_pred -----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------CCC
Confidence 1123457999999999999988999999999999999999999999654432 223333321 112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
...+..+.+|+.+||+.+|.+|| ++.+++.
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 22335689999999999999999 7777764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=336.41 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=211.7
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh---hHHHHHHHHHHHhhcC-CCceeeeeccccCC--ce
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ---GRSQFQQEVEVLCNIR-HPNMVLLLGACPEF--GC 532 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~--~~ 532 (768)
....|.+.+.||+|.||.||++.. +++.+|+|++.+.... ....+.+|+.||+.+. |||||.++++|.+. .+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 356799999999999999999998 4678999999766443 3457899999999998 99999999999654 49
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC----CCcEEEeeccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR----NYVSKISDVGL 608 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~----~~~vKL~DFGl 608 (768)
+|||++.||.|.+.+... . +++.....++.||+.++.|||+.| |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999887 2 999999999999999999999999 999999999999943 35899999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCcccc
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDET 686 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ 686 (768)
+..+.. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.... .....+..+.+ +.
T Consensus 186 a~~~~~-------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-~f 257 (382)
T KOG0032|consen 186 AKFIKP-------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-DF 257 (382)
T ss_pred ceEccC-------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-CC
Confidence 987743 234567899999999999999999999999999999999999999996554 44456667765 12
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+.|+ ..+..+.+++..|+..||..|+++.+++. +|+
T Consensus 258 ---~~~~w~-~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 258 ---TSEPWD-DISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred ---CCCCcc-ccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 222333 33567999999999999999999999987 553
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.49 Aligned_cols=244 Identities=26% Similarity=0.426 Sum_probs=189.3
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
+|...+.||+|+||.||++.+ +++.||||++.... ......+.+|+++++.++||||++++++|.+ ..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 455677899999999999987 46799999996543 2345678899999999999999999999854 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.... .+.+..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 222 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-- 222 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--
Confidence 999986422 3567788899999999999999999 9999999999999999999999999998763321
Q ss_pred ccccccccCCCCCCCCCCcccccC-----CCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||.... .....+...... ..
T Consensus 223 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-----~~ 293 (353)
T PLN00034 223 ----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-----QP 293 (353)
T ss_pred ----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-----CC
Confidence 11234579999999998743 335679999999999999999999996322 111111110000 01
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+..+...+..+.+|+.+||..+|.+||++.+++. +|+
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~ 331 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 1122234456999999999999999999999986 444
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=353.63 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=204.1
Q ss_pred HHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC----
Q 035604 458 IEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---- 529 (768)
Q Consensus 458 i~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 529 (768)
+....++|.+.+.||+|+||.||++.. +++.||||++.... ......+.+|+.++..++|+||++++..+..
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344567999999999999999999987 67899999986542 3345567899999999999999998876521
Q ss_pred ------CceeEEEeccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEE
Q 035604 530 ------FGCLIYEYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSK 602 (768)
Q Consensus 530 ------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vK 602 (768)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 1378999999999999886532 2346899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHc
Q 035604 603 ISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIEN 680 (768)
Q Consensus 603 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~ 680 (768)
|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+..
T Consensus 184 L~DFGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 184 LGDFGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred EEecccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 9999999876432211 112346799999999999999999999999999999999999999964432 2233333
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.+. + .+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 260 ~~~~----~----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 260 GRYD----P----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCC----C----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 3321 1 12223456999999999999999999999875
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.77 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=195.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.. .++.||||++..... .....+.+|+.+|+.++||||+++++.|.+ ..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999987 467899999965422 223457899999999999999999998854 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997654 4889999999999999999999999 999999999999999999999999998643210
Q ss_pred CCCc-------------------------------------cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHH
Q 035604 616 VADS-------------------------------------VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658 (768)
Q Consensus 616 ~~~~-------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil 658 (768)
.... .........+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0000 000011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCC---Chhhhhh-HHH
Q 035604 659 LQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP---DLGKVVV-PKL 728 (768)
Q Consensus 659 ~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RP---s~~evl~-~~l 728 (768)
|||++|+.||........ .+...... ...+.. ...+..+.+++.+|+ .+|.+|+ ++.+++. +|+
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~----~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~ 304 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETT-LHIPSQ----AKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF 304 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCcc-ccCCCC----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence 999999999975543322 22221111 111111 122345778888876 5999999 8898885 444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=341.89 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=192.8
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
+|.+.+.||+|+||.||++.. .++.||+|++.... ......+.+|+.+++.++|||||++++.|.+ ..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999987 55689999997542 2234567899999999999999999999854 4599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
||++|+|.+++.+.+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987654 4889999999999999999999999 9999999999999999999999999986432100
Q ss_pred CCc-----------------------------------------cccccccCCCCCCCCCCcccccCCCCCccccHHHHH
Q 035604 617 ADS-----------------------------------------VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLG 655 (768)
Q Consensus 617 ~~~-----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlG 655 (768)
... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 000 000011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC---hhhhhh
Q 035604 656 ILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD---LGKVVV 725 (768)
Q Consensus 656 vil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs---~~evl~ 725 (768)
|++|||++|++||........ .+..... ....+... ..+..+.+++.+|+ .+|.+|++ +.+++.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~----~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQT-SLHIPPQA----KLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCC-CcCCCCcc----cCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999999975543322 2222111 11111111 12345777887776 49999997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=334.14 Aligned_cols=234 Identities=25% Similarity=0.318 Sum_probs=186.9
Q ss_pred CCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHH---hhcCCCceeeeeccccC--CceeE
Q 035604 465 FSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVL---CNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il---~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
|.+.+.||+|+||.||++.+ +++.||||++++.. ......+.+|+.++ +.++||||+++++++.+ ..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67788999999999999987 46789999997542 12234566666654 56789999999998844 45999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|...+... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999998877542 4899999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~ 692 (768)
. ........|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+..
T Consensus 154 ~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--------- 218 (324)
T cd05589 154 F------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--------- 218 (324)
T ss_pred C------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 1 1122456799999999999999999999999999999999999999965432 2333333321
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCCh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
..+...+..+.+++.+||..+|.+||+.
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 1122234568899999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=341.37 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=192.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
.+|.+.+.||+|+||.||++.+ .+..||+|... ...+.+|+++|+.++|||||+++++|. ...|+|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5699999999999999999988 45689999753 234678999999999999999999874 4458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
+++|..++.... .+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 166 -~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~--- 235 (391)
T PHA03212 166 -KTDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--- 235 (391)
T ss_pred -CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc---
Confidence 478888876644 3889999999999999999999999 999999999999999999999999999754221
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH----------HHHHHHHc-CCccc--
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH----------QVERSIEN-GTFDE-- 685 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~----------~~~~~i~~-~~~~~-- 685 (768)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .+...+.. |....
T Consensus 236 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 236 --NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred --cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 1112345689999999999999999999999999999999999998863211 11111110 10000
Q ss_pred -------------------cCC-CCCCCCC--HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 686 -------------------TLD-PAVPDWP--VEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 686 -------------------~ld-~~~~~~~--~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
... ...+.|. ...+..+.+|+.+||+.||.+|||+.+++. +|.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 000 0011111 123456999999999999999999999985 444
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=323.87 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=197.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc----C---Ccee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP----E---FGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~---~~~l 533 (768)
-.|...+++|.|+||.||+|.. .+..||||..-.+... -.+|+++|+.+.|||||+|..+|. . +..|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3577789999999999999998 4468999988654432 247999999999999999987762 2 2378
Q ss_pred EEEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeecccccc
Q 035604 534 IYEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARL 611 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DFGla~~ 611 (768)
|||||+. +|...+... .....++...+.-+.+||++||.|||..+ |+||||||.|||+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999964 787777642 12234778888889999999999999998 9999999999999976 8999999999998
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHH------------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSI------------ 678 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i------------ 678 (768)
+..+. ...+...|..|.|||.+.|. .|+.+.||||.|||+.||+-|++-|.+.....+..
T Consensus 176 L~~~e-------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGE-------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred eccCC-------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 75432 23556789999999977665 69999999999999999999999996443322211
Q ss_pred --H--cCCccccCCCCCCC------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHHH
Q 035604 679 --E--NGTFDETLDPAVPD------WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRAL 734 (768)
Q Consensus 679 --~--~~~~~~~ld~~~~~------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~~ 734 (768)
. +..+.+...|.+.. +....+.++.+|+.++|..+|.+|.++.+++. +.-+.|+.-
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1 12222222233321 22345567999999999999999999999986 666666543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.52 Aligned_cols=246 Identities=26% Similarity=0.357 Sum_probs=197.0
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 536 (768)
+|++.++||+|+||.||++.. +++.||+|++..... .....+.+|+.+++.++||||+++++.+. +..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999987 467899999975432 22345778999999999999999999874 35699999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865432 34899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 694 (768)
......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..+... +.......
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~ 224 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-----VKEDQEEY 224 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-----hhhccccc
Confidence 1134578999999999998899999999999999999999999996443211 111111 11111122
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
+...+..+.+|+.+||..||.+|| ++.+++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 333456689999999999999999 7778765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=336.21 Aligned_cols=236 Identities=25% Similarity=0.311 Sum_probs=190.1
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 541 (768)
+.||+|+||.||++.. ++..||+|++.... ......+.+|+.++..++||||+++++++.. ..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 56789999997542 2233456789999999999999999988744 459999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
+|..++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---- 150 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---- 150 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----
Confidence 9998886654 48999999999999999999997 67 9999999999999999999999999987532211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.+ ..+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~---------~~p~~~ 219 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------RFPRTL 219 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC---------CCCCCC
Confidence 112345799999999999999999999999999999999999999964432 2222222211 112223
Q ss_pred HHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 699 ALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
+..+.+|+.+||+.+|.+|+ ++.+++.
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 45689999999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.18 Aligned_cols=244 Identities=25% Similarity=0.424 Sum_probs=196.6
Q ss_pred cCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEecc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMA 539 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 539 (768)
++|.+.+.||+|+||.||++.+.. ..+|+|.+.... ....++.+|+.+|+.++||||++++++|.+ ..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458888999999999999998844 589999886443 234578899999999999999999998854 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-- 155 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce--
Confidence 9999998875432 4889999999999999999999999 99999999999999999999999999986532211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......++..|+|||++.+..++.++||||||+++|+|++ |++||..... ....+..+.. ... +.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~--~~~------~~ 224 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR--LYR------PK 224 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--CCC------CC
Confidence 11122345678999999988889999999999999999999 9999965432 3334444321 111 11
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+|+.+||..+|.+||++.+++.
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22346899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=318.32 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=199.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh--hHHHHHHHHHHHhhcCCCc-eeeeeccccC-------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ--GRSQFQQEVEVLCNIRHPN-MVLLLGACPE------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~------- 529 (768)
...|...++||+|+||+||+|+. +|..||+|.++..... ......+|+.+|+.++|+| ||.|++++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577778899999999999987 6778999999765432 2345679999999999999 9999999833
Q ss_pred -CceeEEEeccCCChHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGGS-PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..++|+||+ ..+|..++...... ..++...+..++.||+.||.|||+++ |+||||||+||||+..|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 347999999 56899988775432 34777899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH----cCC
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE----NGT 682 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~----~~~ 682 (768)
+|+.+.- .....++.++|.+|.|||++.+. .|+...||||+|||++||+++++.|....+..+... -|.
T Consensus 166 lAra~~i------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 166 LARAFSI------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred hHHHhcC------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 9996532 12235677899999999998887 799999999999999999999999966555433211 121
Q ss_pred ccccCCC----------CCCCCC------HHHH---HHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 FDETLDP----------AVPDWP------VEEA---LILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ~~~~ld~----------~~~~~~------~~~~---~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
-.+...| ..+.|. ...+ ....+++.+||+.+|.+|.++..++.
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 1111111 112222 1111 36889999999999999999998874
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.55 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=198.3
Q ss_pred hcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcC-CCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~ 530 (768)
.++|.+.++||+|+||.||+|.+.+ ..||||++.... ....+.+.+|+++|+.+. |||||+++++|.+ .
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678899999999999999998632 259999997543 233457899999999996 9999999999954 4
Q ss_pred ceeEEEeccCCChHHHHhhcCC----------------------------------------------------------
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG---------------------------------------------------------- 552 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 552 (768)
.|||||||++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 5999999999999998865321
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 035604 553 -----------------------------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR 597 (768)
Q Consensus 553 -----------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~ 597 (768)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788889999999999999999999 999999999999999
Q ss_pred CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH---H
Q 035604 598 NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH---Q 673 (768)
Q Consensus 598 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~---~ 673 (768)
++.+||+|||+++.+..... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||.... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred CCEEEEEeCCcceecccccc----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 99999999999986532211 111223456788999999998899999999999999999997 999995432 2
Q ss_pred HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 674 VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 674 ~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
....+..+... ..+...+..+.+++.+||..+|++||++.+|+..+.
T Consensus 349 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 349 FYNKIKSGYRM--------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHHhcCCCC--------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 22333333111 112233456899999999999999999999874333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=332.15 Aligned_cols=236 Identities=24% Similarity=0.306 Sum_probs=190.2
Q ss_pred CCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCC-ceeeeecccc--CCceeEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHP-NMVLLLGACP--EFGCLIY 535 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~Hp-nIv~l~g~~~--~~~~lV~ 535 (768)
+|.+.+.||+|+||.||+|... ++.||||++.+.. ......+..|..++..+.|+ +|+.+++++. +..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999884 4589999997542 23345677899999999765 5778887774 4569999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999887654 3889999999999999999999999 999999999999999999999999998743211
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 693 (768)
. .......||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ....+..+.. .
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---------~ 219 (324)
T cd05587 155 G------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---------S 219 (324)
T ss_pred C------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------C
Confidence 1 112345799999999999999999999999999999999999999964432 2333333221 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCCh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
++...+..+.+++.+||..+|.+||+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 122234568999999999999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=333.81 Aligned_cols=242 Identities=29% Similarity=0.358 Sum_probs=192.2
Q ss_pred CCCccceecccCceeEEEEEE-----CCccEEEEEEcCCc----hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--Cc
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA----AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FG 531 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~ 531 (768)
+|.+.+.||+|+||.||++.. .+..||+|++.+.. ......+..|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999998875 45789999996532 12234578899999999 49999999988744 45
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 89999999999999987654 3899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChH------HHHHHHHcCCcc
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAH------QVERSIENGTFD 684 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~------~~~~~i~~~~~~ 684 (768)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .+...+...
T Consensus 155 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--- 226 (332)
T cd05614 155 FLSEEK-----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--- 226 (332)
T ss_pred ccccCC-----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC---
Confidence 532211 112345799999999998765 47899999999999999999999995321 122222211
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
++. .+...+..+.+++.+||..+|++|| ++.+++.
T Consensus 227 ---~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 ---DPP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111 1222345689999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.90 Aligned_cols=235 Identities=26% Similarity=0.316 Sum_probs=186.0
Q ss_pred ceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhh-cCCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCN-IRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.+. +..||||+++... ......+..|..++.. .+||||+++++++.. ..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999884 4579999997542 1223345567777765 489999999998743 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---- 150 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---- 150 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----
Confidence 99999887654 4899999999999999999999999 9999999999999999999999999997542211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+.... +. .+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------~~---~~~~~ 219 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR------PH---FPRWI 219 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------CC---CCCCC
Confidence 122345799999999999999999999999999999999999999965433 222332221 11 12223
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
+..+.+|+.+||..+|.+||++.+.+
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 45688999999999999999976433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=304.43 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=205.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc-------cCCce
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC-------PEFGC 532 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~-------~~~~~ 532 (768)
.++|.+.+.||+|||+.||.+.. ++..||+|.+.-...++.+...+|++..++++|||++++++++ ....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46899999999999999998875 6778999999877777788899999999999999999999886 22359
Q ss_pred eEEEeccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 533 LIYEYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
|++.|...|+|.+.+.... .+..+++.+++.|+.+|++||.+||...+ |+.||||||.|||+...+.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999987632 33479999999999999999999999874 899999999999999999999999999987
Q ss_pred cCCCCCCccc---cccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChHH----HHHHHHcC
Q 035604 612 VPPSVADSVT---QYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ----VERSIENG 681 (768)
Q Consensus 612 ~~~~~~~~~~---~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~----~~~~i~~~ 681 (768)
.+-....... -........|..|.|||.+. +...+.++|||||||+||.|+.|..||+.... +.-++.++
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA 258 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence 6533221111 11123456789999999765 45679999999999999999999999964332 11122222
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
.+. .|+-+. ++..+.+|+.+|++.||.+||+..+++..
T Consensus 259 q~s------~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 259 QIS------IPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccc------cCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 221 111111 55679999999999999999999998853
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.87 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=199.1
Q ss_pred hcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC---
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--- 529 (768)
.++|++.+.||+|+||.||+|... ++.||+|+++... ......+.+|+.++.++ +||||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999998752 2579999987543 23345678899999999 89999999998743
Q ss_pred CceeEEEeccCCChHHHHhhcCC---------------------------------------------------------
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGG--------------------------------------------------------- 552 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 552 (768)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 34889999999999999864321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCC
Q 035604 553 -SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631 (768)
Q Consensus 553 -~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt 631 (768)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ........++
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----~~~~~~~~~~ 238 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGDARLP 238 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc----hhhccCCCCC
Confidence 125889999999999999999999998 99999999999999999999999999987633211 1112334567
Q ss_pred CCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh---HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHH
Q 035604 632 FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA---HQVERSIENGTFDETLDPAVPDWPVEEALILAKLAL 707 (768)
Q Consensus 632 ~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~---~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~ 707 (768)
..|+|||++.+..++.++|||||||++|||++ |..||... ......+..+.... .+...+..+.+|+.
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~ 310 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR--------APEYATPEIYSIML 310 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC--------CCccCCHHHHHHHH
Confidence 78999999999999999999999999999998 99999542 22333333332111 11123356899999
Q ss_pred HhhhcCccCCCChhhhhhHHHHH
Q 035604 708 QCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 708 ~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
+||+.+|.+||++.+++..+...
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999998544443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=346.54 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=193.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC----------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---------- 529 (768)
..+|.+.+.||+|+||.||+|.+ .+..||||++.... ....+|+.+|+.++|||||++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 35799999999999999999987 56789999886432 234579999999999999999876521
Q ss_pred CceeEEEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeecc
Q 035604 530 FGCLIYEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVG 607 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFG 607 (768)
..++||||+++ +|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 23689999974 676666432 22345899999999999999999999999 99999999999998664 79999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHHH-cC-
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIE-NG- 681 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i~-~~- 681 (768)
+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||....... ..+. .+
T Consensus 217 la~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 217 SAKNLLAGQ-------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred cchhccCCC-------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 998664321 1234578999999998765 468999999999999999999999996543221 1111 01
Q ss_pred -----------CccccCCCCCC------CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHH
Q 035604 682 -----------TFDETLDPAVP------DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRA 733 (768)
Q Consensus 682 -----------~~~~~ld~~~~------~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~ 733 (768)
.+....-+.+. .+|...+..+.+|+.+||..+|.+||++.+++. +|...++.
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 01111001110 012223456899999999999999999999987 77766544
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.90 Aligned_cols=236 Identities=25% Similarity=0.332 Sum_probs=188.8
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.+ ++..||+|+++... ......+..|..++..+ +||||++++++|.+ ..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999987 46689999997542 22344578899999988 79999999998844 45999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|.+++.+.+ .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----- 149 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----- 149 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-----
Confidence 99998886654 4899999999999999999999999 999999999999999999999999998742111
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH-----------HHHHHHHcCCccccCCC
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH-----------QVERSIENGTFDETLDP 689 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~-----------~~~~~i~~~~~~~~ld~ 689 (768)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+.+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 222 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------ 222 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------
Confidence 111234579999999999999999999999999999999999999995211 11222222211
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCC------hhhhhh
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPD------LGKVVV 725 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs------~~evl~ 725 (768)
..|...+..+.+++.+||..+|.+||+ +.+++.
T Consensus 223 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 ---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112223456899999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.13 Aligned_cols=241 Identities=24% Similarity=0.379 Sum_probs=193.8
Q ss_pred eecccCceeEEEEEE----CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeecccc-CCceeEEEeccCCC
Q 035604 470 KIGEGGYGPVYKSYL----DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACP-EFGCLIYEYMANGS 542 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~----~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E~~~~gs 542 (768)
.||+|+||.||+|.+ ++..+|+|+++... ....+.+.+|+.+++.+.||||+++++++. +..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999975 35689999986543 234567889999999999999999999884 34589999999999
Q ss_pred hHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcccc
Q 035604 543 LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622 (768)
Q Consensus 543 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 622 (768)
|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||.|||++.++.+||+|||+++.+...... .
T Consensus 82 L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---~ 152 (257)
T cd05116 82 LNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---Y 152 (257)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe---e
Confidence 999986543 4899999999999999999999999 999999999999999999999999999876433211 0
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCCHHHH
Q 035604 623 YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWPVEEA 699 (768)
Q Consensus 623 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~~~~~ 699 (768)
.......++..|+|||.+....++.++|||||||++|||++ |.+||... ......+..+... ..+...+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~--------~~~~~~~ 224 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM--------ECPQRCP 224 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC--------CCCCCCC
Confidence 11122345678999999988889999999999999999998 99999643 3344445544321 1222334
Q ss_pred HHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 700 LILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 700 ~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
..+.+|+.+||..+|.+||++.+|+..+
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 5699999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=331.17 Aligned_cols=231 Identities=24% Similarity=0.309 Sum_probs=186.9
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.+ +++.||||++.+.. ......+..|..++..+ +||||+++++++.. ..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 46789999997542 22334567888888876 69999999998844 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---- 150 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---- 150 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----
Confidence 99999887654 3899999999999999999999999 9999999999999999999999999987532211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.. ..+. ..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~------~~~~---~~ 219 (320)
T cd05590 151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV------VYPT---WL 219 (320)
T ss_pred --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC------CCCC---CC
Confidence 112345799999999999999999999999999999999999999965433 2333433321 1111 22
Q ss_pred HHHHHHHHHHhhhcCccCCCCh
Q 035604 699 ALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
+..+.+|+.+||+.+|.+||++
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCC
Confidence 3468999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.10 Aligned_cols=236 Identities=24% Similarity=0.296 Sum_probs=190.6
Q ss_pred CCCccceecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~ 535 (768)
+|.+.+.||+|+||.||++.+. +..||||++.+... .....+..|..++..+ +||+|+++++++.+ ..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999884 46899999975422 2233466788888777 58899999988744 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999887654 3889999999999999999999999 999999999999999999999999999754221
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 693 (768)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+.. .
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---------~ 219 (323)
T cd05616 155 G------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------A 219 (323)
T ss_pred C------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------C
Confidence 1 112345799999999999999999999999999999999999999965432 2333333321 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCCh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
+|...+..+.+|+.+||+.+|.+|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 222334568999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.45 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=190.9
Q ss_pred ecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCCh
Q 035604 471 IGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSL 543 (768)
Q Consensus 471 LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 543 (768)
||+|+||+||++.+ +++.||+|.+..... .....+..|+.+++.++||||+++++++.. ..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999987 567899999875432 223457789999999999999999988744 45899999999999
Q ss_pred HHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcccc
Q 035604 544 EDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622 (768)
Q Consensus 544 ~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 622 (768)
.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 9887542 22345899999999999999999999999 99999999999999999999999999976543211
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHHHHH
Q 035604 623 YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVEEAL 700 (768)
Q Consensus 623 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~~~ 700 (768)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+....+.. ....+...+.
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 226 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-----SVTYPDKFSP 226 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-----CCCCcccCCH
Confidence 123457899999999999999999999999999999999999999643211 11111111111 1122334456
Q ss_pred HHHHHHHHhhhcCccCCC-----Chhhhhh-HHH
Q 035604 701 ILAKLALQCAELRRKDRP-----DLGKVVV-PKL 728 (768)
Q Consensus 701 ~l~~Li~~cl~~~P~~RP-----s~~evl~-~~l 728 (768)
.+.+++.+||+.+|.+|| ++.+++. +|.
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 699999999999999999 5555554 444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.09 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=194.8
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-------
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 529 (768)
..++|.+.+.||+|+||.||++.+ .+..||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999987 5678999998643 22334567899999999999999999998732
Q ss_pred -CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
..|+||||+++ +|...+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 24899999965 56555532 2788899999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH---HH-------
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER---SI------- 678 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~---~i------- 678 (768)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.... .+
T Consensus 170 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTN-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccccccC-------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9754221 112345789999999999999999999999999999999999999964432111 00
Q ss_pred ---------------Hc-CCccc-cCCCCCCCC--------CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 679 ---------------EN-GTFDE-TLDPAVPDW--------PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 679 ---------------~~-~~~~~-~ld~~~~~~--------~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
.. ..+.. .+....++| ....+..+.+|+.+||..||++||++.+++. +|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 00 00000 000000111 1112356899999999999999999999987 5654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=318.27 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=197.1
Q ss_pred cCCCccceecccCceeEEEEEE--CCc----cEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccCC-ceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHT----PVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF-GCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~lV 534 (768)
++|++.+.||+|+||.||+|.+ ++. .|++|.+.... ......+..|+.+++.++||||+++++++... .+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 4678889999999999999987 344 47788875432 23345678888899999999999999998543 4789
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
+||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999976443 4899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
... ........++..|++||++.+..++.++|||||||++|||++ |..||.... .....+.++.... .+
T Consensus 162 ~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~-- 233 (279)
T cd05111 162 DDK----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA--QP-- 233 (279)
T ss_pred CCc----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC--CC--
Confidence 211 111233457778999999998899999999999999999998 999996543 2334444443211 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
. .+...+..++.+||..+|.+||++.+++..+.
T Consensus 234 -~---~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 234 -Q---ICTIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred -C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 12245788999999999999999999875433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=332.50 Aligned_cols=231 Identities=26% Similarity=0.337 Sum_probs=184.9
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.+ +++.||+|++.+.. ......+..|+.++..+ +||||+++++++.. ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 45689999997542 23344577888888776 79999999998844 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---- 150 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---- 150 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----
Confidence 99998886654 4899999999999999999999999 9999999999999999999999999997532111
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh-----------HHHHHHHHcCCccccCCC
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA-----------HQVERSIENGTFDETLDP 689 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~-----------~~~~~~i~~~~~~~~ld~ 689 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ......+..+..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 222 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 222 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------
Confidence 1123457899999999999999999999999999999999999999421 111222222211
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCCh
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
..|...+..+.+|+.+||..+|.+||+.
T Consensus 223 ---~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 ---RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1222334568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=333.83 Aligned_cols=250 Identities=26% Similarity=0.306 Sum_probs=197.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.. +++.||+|+++.... .....+.+|+.+++.++||||+++++++.+ ..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688999999999999999987 567899999975432 234567899999999999999999988844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.+... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999876532 4899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCccccc------CCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQ------TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETL 687 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~l 687 (768)
.. .......||+.|+|||++. +..++.++|||||||++|+|++|+.||...... ...+..... ...
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~ 229 (330)
T cd05601 156 KM-----VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR-FLK 229 (330)
T ss_pred Cc-----eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-ccC
Confidence 11 1123357899999999876 456889999999999999999999999644322 222222210 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+..+. .+..+.+|+..||. +|.+||++.+++. ++.
T Consensus 230 ~~~~~~----~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 230 FPEDPK----VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred CCCCCC----CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 111112 23458899999998 9999999999885 443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.23 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=200.0
Q ss_pred cCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCcee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~l 533 (768)
++|.+.+.||+|+||.||++.. ++..+|+|.+..........+.+|++++++++||||++++++|. ...++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688899999999999999874 23458999987665555667999999999999999999999884 45589
Q ss_pred EEEeccCCChHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 534 IYEYMANGSLEDRLFRRG----------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999987543 1224899999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHc
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIEN 680 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~ 680 (768)
+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|+|++ |.+||.... .....+..
T Consensus 162 ~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 162 GDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred ccCCccccccCCce----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999986532211 111223456788999999998899999999999999999998 999996443 23344544
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..... +...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQR--------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCCC--------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 432211 1122345999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=320.07 Aligned_cols=260 Identities=25% Similarity=0.431 Sum_probs=208.3
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhh-----HHHHHHHHHHHhhcCCCceeeeeccc---c
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQG-----RSQFQQEVEVLCNIRHPNMVLLLGAC---P 528 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~-----~~~~~~E~~il~~l~HpnIv~l~g~~---~ 528 (768)
..++|-.+.+||+|||+.||++.+ ..+.||+|+-..+. ... .+...+|..|-+.|.||.||++|++| .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 346788899999999999999987 55689999864332 111 12245899999999999999999998 4
Q ss_pred CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCcEEEee
Q 035604 529 EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD---RNYVSKISD 605 (768)
Q Consensus 529 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~vKL~D 605 (768)
+..|-|+|||+|.+|+-+|..+. .+++.+.+.|+.||+.||.||.... +||||-||||.||||- ..|.+||+|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 56699999999999999997765 5999999999999999999999886 6899999999999994 458899999
Q ss_pred cccccccCCCCCCcccc-ccccCCCCCCCCCCcccccCC----CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc
Q 035604 606 VGLARLVPPSVADSVTQ-YRMTSAAGTFCYIDPEYQQTG----MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN 680 (768)
Q Consensus 606 FGla~~~~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~ 680 (768)
|||+++++.+..+.... .....+.||.||++||.+.-+ ..+.|+||||+|||||++|.|+.||+........+..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 99999997765543322 234567999999999965433 4789999999999999999999999877666666665
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.++.......+|.-| ..+.+...+|++||++.-++|.+..++..
T Consensus 697 NTIlkAtEVqFP~KP-vVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 NTILKATEVQFPPKP-VVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hchhcceeccCCCCC-ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 555444333333322 23456889999999999999999988764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.93 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=197.5
Q ss_pred HhcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--C
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--F 530 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~ 530 (768)
..++|++.+.||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999987643 469999986532 2344568899999999999999999999854 4
Q ss_pred ceeEEEeccCCChHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG-------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 5899999999999999865322 224678889999999999999999998 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHc
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIEN 680 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~ 680 (768)
+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..
T Consensus 161 ~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCcce----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999976533211 011122355778999999998899999999999999999999 7899964432 2222333
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.+.. .+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 237 GGLLD--------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred CCcCC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 32211 11223346999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.38 Aligned_cols=246 Identities=28% Similarity=0.434 Sum_probs=203.2
Q ss_pred eecccCceeEEEEEECCc--cEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccCCc--eeEEEeccCCChHH
Q 035604 470 KIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLED 545 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~~~~--~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~lV~E~~~~gsL~~ 545 (768)
+||+|.||+||-|++..+ .+|||-+........+-+..|+.+-+.|+|.|||+++|.|.+.+ -|.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999998665 57999987666555667899999999999999999999997766 46899999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCcEEEeecccccccCCCCCCcccccc
Q 035604 546 RLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-RNYVSKISDVGLARLVPPSVADSVTQYR 624 (768)
Q Consensus 546 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~ 624 (768)
+|..+.+.-.-.+.+.-.+..||+.||.|||.+. |||||||-+||||+ -.|.+||+|||-++.+..- . .-
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-----n-P~ 732 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-----N-PC 732 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-----C-cc
Confidence 9987665322378888899999999999999999 99999999999995 5799999999999876321 1 11
Q ss_pred ccCCCCCCCCCCcccccCC--CCCccccHHHHHHHHHHHHhCCCCCC-ChHHHHHHHHcCCccccCCCCCCCCCHHHHHH
Q 035604 625 MTSAAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQIITAKPPMG-LAHQVERSIENGTFDETLDPAVPDWPVEEALI 701 (768)
Q Consensus 625 ~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltg~~Pf~-~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~ 701 (768)
..++.||..|||||++..+ +|+.++|||||||.+.||.||+|||. +........+-|-|. .-|..|.+.+.+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----vHP~iPeelsae 807 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----VHPPIPEELSAE 807 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----cCCCCcHHHHHH
Confidence 2467899999999988765 59999999999999999999999994 333333444445432 224667788888
Q ss_pred HHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 702 LAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 702 l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
...+|++|+.++|.+||++.+++. +.+.
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~DpFlq 836 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQDPFLQ 836 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhccCcccc
Confidence 999999999999999999999986 5553
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.60 Aligned_cols=236 Identities=26% Similarity=0.339 Sum_probs=189.4
Q ss_pred ceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||+|.+. ++.||||++.... ......+..|..++..+ +||||+++++++.+ ..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999884 5689999997542 22334567888998866 79999999999854 45999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 150 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---- 150 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC----
Confidence 99999887654 3889999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.. ..+.+ .
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~------~~p~~---~ 219 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV------LYPVW---L 219 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------CCCCC---C
Confidence 112345789999999999999999999999999999999999999965433 2233333221 11111 2
Q ss_pred HHHHHHHHHHhhhcCccCCC-------Chhhhhh
Q 035604 699 ALILAKLALQCAELRRKDRP-------DLGKVVV 725 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RP-------s~~evl~ 725 (768)
+..+.+|+..||..+|.+|| ++.+++.
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 34689999999999999999 6776664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.19 Aligned_cols=255 Identities=24% Similarity=0.290 Sum_probs=196.8
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC------
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------ 529 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 529 (768)
...++|.+.+.||+|+||.||++.+ .+..||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3567899999999999999999987 4678999998753 22334567889999999999999999998732
Q ss_pred --CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 --FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..|+||||+++ +|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 24899999965 56665543 3788999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH---HHH-----
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER---SIE----- 679 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~---~i~----- 679 (768)
+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||........ .+.
T Consensus 165 ~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 165 LARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred ccccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998653221 12345789999999999999999999999999999999999999964332111 000
Q ss_pred -----------------c-CCccc---------cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 680 -----------------N-GTFDE---------TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 680 -----------------~-~~~~~---------~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
. ..+.. .+.+.....+...+..+.+|+.+||..||.+|||+.+++. +|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0 00000 0000001111223456899999999999999999999997 66653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.10 Aligned_cols=248 Identities=28% Similarity=0.437 Sum_probs=200.1
Q ss_pred cCCCccceecccCceeEEEEEEC---C--cc-EEEEEEcCC---chhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD---H--TP-VAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFG 531 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~---~--~~-vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~ 531 (768)
++-.+.++||+|+||.||+|.+. + .. ||||..+.. .......|.+|.++|+.++|||||++||++ .+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34455689999999999999872 1 13 899998853 355677899999999999999999999987 5567
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
+||||+|.||+|.++|.+... .++..+++.++.+.+.||.|||+++ +|||||-..|+|++.++.+||+||||++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999998765 4899999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLD 688 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld 688 (768)
-..- ........-...|+|||.+..+.|+.++|||||||++||+++ |..||... ..+...|....+.-...
T Consensus 312 ~~~~------~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 312 GSQY------VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred Ccce------eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 4210 001112245678999999999999999999999999999998 88899644 34555663333222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
. ..+..+..++.+||..+|.+||+|.++...+.
T Consensus 386 ~-------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 386 S-------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred C-------CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 2 22345888999999999999999999875333
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.75 Aligned_cols=248 Identities=28% Similarity=0.429 Sum_probs=198.6
Q ss_pred cCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
++|.+.+.||+|+||.||+|... +..||||.++..... ....+.+|+++|+.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45788889999999999999762 357999999765433 45679999999999999999999999844 459
Q ss_pred eEEEeccCCChHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 533 LIYEYMANGSLEDRLFRRGG-----------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
+||||+++++|.+++...+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999975431 234788999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSI 678 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i 678 (768)
||+|||++..+..... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .....+
T Consensus 162 kl~d~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred EECCcccceecccCcc----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999975532211 011123356788999999999999999999999999999998 999985432 223334
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..... +...+..+.+++.+||..+|.+||++.+|+.
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQR--------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 43332211 1123356999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.31 Aligned_cols=243 Identities=35% Similarity=0.552 Sum_probs=190.4
Q ss_pred ccceecccCceeEEEEEEC------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 467 NSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 467 ~~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+.+.||.|.||.||+|.+. +..|+||.++... ....+.|.+|++++++++||||++++|+|.. ..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999987 4689999996543 3346789999999999999999999999963 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++|+|.++|..... ..+++..++.|+.||+.||.|||+.+ |+|+||++.|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999988622 34899999999999999999999999 99999999999999999999999999987622211
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||... ..+...+.++.....
T Consensus 159 ----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------- 226 (259)
T PF07714_consen 159 ----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI-------- 226 (259)
T ss_dssp ----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS--------
T ss_pred ----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee--------
Confidence 112233456778999999999889999999999999999999 78999643 233345544433211
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..++..+.+|+..||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1122345889999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.63 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=195.1
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-------Cce
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------FGC 532 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~~ 532 (768)
+|++.+.||+|+||.||++.+ +++.||||.+... .......+.+|+.+|+.++||||+++++++.. ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999986 5789999998643 22344568899999999999999999998743 348
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
+||||+. ++|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999995 67887775543 4899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CC-----
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GT----- 682 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~----- 682 (768)
..... .......+++.|+|||++.+. .++.++|||||||++|||++|++||........ .+.+ |.
T Consensus 154 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDES-----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCcc-----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 33211 122345689999999988774 479999999999999999999999964432211 1100 00
Q ss_pred ------------ccccCC-CC---CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 683 ------------FDETLD-PA---VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 683 ------------~~~~ld-~~---~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
...... +. ........+..+.+|+.+||+.||.+||++.+++. +|+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 000000 00 00111122456889999999999999999999986 55543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=316.06 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=194.2
Q ss_pred CCccceecccCceeEEEEEECCc----cEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--------C
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDHT----PVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--------F 530 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~~----~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~ 530 (768)
|.+.+.||+|+||.||+|.+... .||+|.++.. .......+.+|+.+++.++||||+++++.|.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678899999999999987432 5899988654 23445678899999999999999999987622 2
Q ss_pred ceeEEEeccCCChHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 531 GCLIYEYMANGSLEDRLFRR---GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
.+++|||+.+|+|.+++... .....+++...+.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 37999999999999887532 12235899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCcc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFD 684 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~ 684 (768)
+++.+..... ........+++.|++||++.+..++.++|||||||++|||++ |+.||.... .....+..+...
T Consensus 158 ~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd05075 158 LSKKIYNGDY----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233 (272)
T ss_pred cccccCcccc----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9987643211 001123346778999999999999999999999999999999 899996432 233344444321
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
. ..+ ..+..+.+++.+||+.+|.+||++.+++..+
T Consensus 234 ~----~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 234 K----QPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred C----CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 111 2234589999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=315.24 Aligned_cols=245 Identities=28% Similarity=0.451 Sum_probs=197.1
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.++|++.++||+|+||.||+|.. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+ ..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35789999999999999999987 456799999875433 35678999999999999999999988744 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 84 AKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 99999999876432 34889999999999999999999998 99999999999999999999999999987643211
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.......++..|+|||++.+..++.++|||||||++|+|++ |+.||... ......+..+... +....
T Consensus 159 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~-- 228 (261)
T cd05072 159 ----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----PRMEN-- 228 (261)
T ss_pred ----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----CCCCC--
Confidence 11123345678999999988889999999999999999998 99999533 2233333333211 11112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
.+..+.+++.+||..+|++||++.+++
T Consensus 229 --~~~~~~~li~~~l~~~p~~Rp~~~~i~ 255 (261)
T cd05072 229 --CPDELYDIMKTCWKEKAEERPTFDYLQ 255 (261)
T ss_pred --CCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 234589999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=321.64 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=200.7
Q ss_pred cCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
.+|.+.+.||+|+||.||++... +..+++|.+..........+.+|++++++++||||+++++++.. ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778889999999999998752 24589999876666666779999999999999999999999854 4589
Q ss_pred EEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc
Q 035604 534 IYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV 600 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 600 (768)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975431 234889999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHH
Q 035604 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERS 677 (768)
Q Consensus 601 vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~ 677 (768)
+||+|||++........ ........++..|+|||++.+..++.++|||||||++|||+| |+.||.... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred EEECCCCcccccCCCce----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999976532211 111234456788999999999999999999999999999999 999985332 23333
Q ss_pred HHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 678 IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 678 i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
+..+.... .+..++..+.+++.+||..+|.+||++.+|+..+
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 238 ITQGRVLE--------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred HhCCCCCC--------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 44433221 1122335699999999999999999999997433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.62 Aligned_cols=247 Identities=24% Similarity=0.314 Sum_probs=195.8
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+ ..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 46799999999999999999987 46789999996432 1233457789999999999999999998854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999988653 3788899999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCC----CCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTG----MLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLD 688 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld 688 (768)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|++||...... ...+..+.. ....
T Consensus 195 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~~~ 268 (370)
T cd05596 195 NG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-SLTF 268 (370)
T ss_pred CC-----cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-cCCC
Confidence 21 1112345799999999987653 4789999999999999999999999654332 233332211 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccC--CCChhhhhh
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKD--RPDLGKVVV 725 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~--RPs~~evl~ 725 (768)
+... ..+..+.+|+.+||..+|.+ ||++.+++.
T Consensus 269 ~~~~----~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 269 PDDI----EISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCcC----CCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1111 23456899999999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.43 Aligned_cols=248 Identities=29% Similarity=0.462 Sum_probs=198.8
Q ss_pred cCCCccceecccCceeEEEEEEC-----CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-----HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
++|.+.+.||+|+||.||+|.+. ...||||.+.... ......|.+|+.+++.++||||+++++.+.. ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 57889999999999999999873 2479999987543 3345578899999999999999999998744 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999876443 4899999999999999999999998 99999999999999999999999999987742
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .....+..+... +
T Consensus 159 ~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~-- 228 (266)
T cd05033 159 SEA----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL----P-- 228 (266)
T ss_pred ccc----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----C--
Confidence 111 111123345678999999998899999999999999999998 999995332 223333332211 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
.+..++..+.+|+.+||+.+|.+||++.+++..+
T Consensus 229 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 229 --PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1122345689999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.29 Aligned_cols=232 Identities=27% Similarity=0.334 Sum_probs=184.5
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHH-HHhhcCCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVE-VLCNIRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.+ +++.||||++..... .....+..|.. +++.++||||+++++.+.+ ..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999998 567899999975422 12234445544 5678999999999988744 45999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---- 150 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----
Confidence 99999887654 4889999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+... +. ...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~-------~~~ 219 (323)
T cd05575 151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LK-------PNI 219 (323)
T ss_pred --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--CC-------CCC
Confidence 11234579999999999999999999999999999999999999996443 222333332211 11 122
Q ss_pred HHHHHHHHHHhhhcCccCCCChh
Q 035604 699 ALILAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~ 721 (768)
+..+.+++.+||+.+|.+||++.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCC
Confidence 35689999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.71 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=192.9
Q ss_pred CCccceecccCceeEEEEEE------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC----Ccee
Q 035604 465 FSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCL 533 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~l 533 (768)
|.+.+.||+|+||+||++.+ ++..||+|++.... ......+.+|+++|+.++||||++++++|.. ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999987653 45679999997543 2345678899999999999999999998743 3589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999998654 3899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH-HHHHHc-------CCccc
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV-ERSIEN-------GTFDE 685 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~-~~~i~~-------~~~~~ 685 (768)
..... ........++..|++||.+.+..++.++|||||||++|+|++|..||...... ...+.. ..+.+
T Consensus 159 ~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEY---YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred Ccchh---hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 32110 00012234567799999998888999999999999999999999998543221 111100 00000
Q ss_pred cCCC-CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 TLDP-AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 ~ld~-~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.++. .....+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 001112233456999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=313.67 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=199.0
Q ss_pred CCCccceecccCceeEEEEEE-CCccEEEEEEcCCc------hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDA------AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
+|...+.||.|+||.||+|.. ++..+|+|.+.... ......+.+|+++++.++||||++++++|.+ ..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999987 66789999986432 1223468899999999999999999999854 44899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997654 3789999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
...............|+..|+|||++.+..++.++|||||||++|+|++|..||.................. .+ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~---~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-MP---RL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-CC---CC
Confidence 111111111123456899999999999888999999999999999999999999754443332221111111 11 11
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+++.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2233456899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.47 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=198.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-----hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-----AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
++|.+.+.||+|+||.||++.. .+..||+|.+.... ......+.+|++++++++||||+++++++.+ ..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999986 56799999986432 1223468899999999999999999999844 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999887654 4889999999999999999999999 9999999999999999999999999997653
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.... .........++..|+|||++.+..++.++|||||||++|+|++|+.||............... ... ..
T Consensus 156 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~---~~ 227 (263)
T cd06625 156 TICS---SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTN---PQ 227 (263)
T ss_pred cccc---ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc--CCC---CC
Confidence 2211 011113456788999999999989999999999999999999999999654333222111110 011 12
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+...+..+.+++.+||..+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 23334456899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.03 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=196.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||+|.. ++..||+|++..........+.+|+.+++.++||||+++++.+. ...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999987 56789999997654444556889999999999999999999874 345899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999886543 4889999999999999999999998 99999999999999999999999999986632211
Q ss_pred CccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHcCCccccCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IENGTFDETLDPAVP 692 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~~~~~~~ld~~~~ 692 (768)
......|+..|+|||.+. ...++.++|||||||++|+|++|+.||......... +....+. .+..
T Consensus 162 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~- 231 (267)
T cd06646 162 ------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ---PPKL- 231 (267)
T ss_pred ------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC---CCCC-
Confidence 123356889999999874 345788999999999999999999999543322211 1111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+...+..+.+++.+||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 111223456999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.75 Aligned_cols=236 Identities=25% Similarity=0.305 Sum_probs=190.2
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.+ ++..||||++.+.. ......+..|..++..+ +||||+++++++.. ..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999988 45689999997542 22344567888999887 69999999998744 45999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 150 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---- 150 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC----
Confidence 99998887654 4899999999999999999999999 9999999999999999999999999987432111
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.. ..+...
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~---------~~~~~~ 219 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV---------RYPRWL 219 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------CCCCcC
Confidence 112345789999999999999999999999999999999999999964432 2233333221 112223
Q ss_pred HHHHHHHHHHhhhcCccCCCCh-----hhhhh
Q 035604 699 ALILAKLALQCAELRRKDRPDL-----GKVVV 725 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~-----~evl~ 725 (768)
+..+.+|+.+||..+|.+||++ .+++.
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 4568999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.66 Aligned_cols=240 Identities=23% Similarity=0.337 Sum_probs=187.7
Q ss_pred ecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCCh
Q 035604 471 IGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSL 543 (768)
Q Consensus 471 LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 543 (768)
||+|+||.||++.. .+..||+|.+..... .....+..|+++++.++||||+++++.+.. ..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999987 477899999864321 123345679999999999999999988844 45899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 623 (768)
.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~------- 149 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK------- 149 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-------
Confidence 988865433 24889999999999999999999999 9999999999999999999999999997653321
Q ss_pred cccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHHHHH
Q 035604 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEALI 701 (768)
Q Consensus 624 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~ 701 (768)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ....+........+... ....+..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 225 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE----HQNFTEE 225 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc----cccCCHH
Confidence 12335789999999999988899999999999999999999999964321 11111111111111111 1123456
Q ss_pred HHHHHHHhhhcCccCCCChhhhhh
Q 035604 702 LAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 702 l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.+|+.+||+.+|.+||++.+++.
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchh
Confidence 899999999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=332.81 Aligned_cols=253 Identities=24% Similarity=0.298 Sum_probs=196.0
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-------
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 529 (768)
..++|.+.+.||+|+||.||++.+ .++.||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999987 4678999999753 22334567899999999999999999987632
Q ss_pred -CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
..|+||||+++ +|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 24899999964 67666643 2788899999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH---HHHc-C---
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER---SIEN-G--- 681 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~---~i~~-~--- 681 (768)
++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||........ .+.. +
T Consensus 173 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 173 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred ccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98653221 12345789999999999999999999999999999999999999964432211 1100 0
Q ss_pred -------------------Cc---------cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 682 -------------------TF---------DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 682 -------------------~~---------~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
.+ ...+.+............+.+|+.+||..||.+|||+.+++. +|++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00 000000011111123346889999999999999999999987 5664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=316.34 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=195.8
Q ss_pred CCccceecccCceeEEEEEECC-----ccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
|.+.+.||+|+||.||+|.... ..||+|.++... ......+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998632 569999987542 2334578999999999999999999987632
Q ss_pred CceeEEEeccCCChHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeec
Q 035604 530 FGCLIYEYMANGSLEDRLFRRG---GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DF 606 (768)
..+++|||+++|+|..++.... ....+++...+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 2489999999999999885432 2235899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTF 683 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~ 683 (768)
|+++.+...... .......++..|++||.+.+..++.++|||||||++|||++ |.+||..... ....+..+..
T Consensus 158 g~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred cceeeccccccc----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999876432211 11122345678999999988899999999999999999999 9999954332 2233333321
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
. ..+..++..+.+++.+||..+|.+||++.+++..+.
T Consensus 234 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 234 L--------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred C--------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 112233456999999999999999999999985433
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.18 Aligned_cols=235 Identities=26% Similarity=0.329 Sum_probs=186.9
Q ss_pred ceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhh-cCCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCN-IRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||+|.+. +..||||+++... ......+..|..++.. ++||||+++++++.+ ..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999984 5689999997542 1223446678888876 589999999998844 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---- 150 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----
Confidence 99999887643 4889999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+. +..+.+ .
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~------~~~~~~---~ 219 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN------PCYPRW---L 219 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CCCCcc---C
Confidence 112345789999999999999999999999999999999999999964432 222332221 112222 3
Q ss_pred HHHHHHHHHHhhhcCccCCCChh-hhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLG-KVV 724 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~-evl 724 (768)
+..+.+|+.+||..+|.+||++. ++.
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 34588999999999999999997 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.43 Aligned_cols=233 Identities=26% Similarity=0.318 Sum_probs=189.1
Q ss_pred ceecccCceeEEEEEE-----CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEecc
Q 035604 469 RKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMA 539 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 539 (768)
+.||+|+||.||++.. .++.||+|++..... .....+.+|+++|++++||||+++++++.+ ..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998764 467899999975432 233456789999999999999999998844 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|.+++.+.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--- 152 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--- 152 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC---
Confidence 999999886644 4899999999999999999999999 9999999999999999999999999987643221
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+.+ ..+..
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---------~~p~~ 220 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---------GMPQF 220 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---------CCCCC
Confidence 1123457899999999999888999999999999999999999999654332 222322221 11222
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGK 722 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~e 722 (768)
.+..+.+|+.+||+.+|.+||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3456899999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.47 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=196.8
Q ss_pred cCCCccceecccCceeEEEEEE------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCcee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~l 533 (768)
+.|++.+.||+|+||.||+|.+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++. ...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999985 34579999997533 334467889999999999999999999874 35599
Q ss_pred EEEeccCCChHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 035604 534 IYEYMANGSLEDRLFRRGG--------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 599 (768)
||||+++++|.+++..... ...+++...+.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999864321 234788999999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHH
Q 035604 600 VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVER 676 (768)
Q Consensus 600 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~ 676 (768)
.+||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|||++ |.+||.... .+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADY----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEeccccccccccCCcc----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999986533211 111233455778999999988889999999999999999998 999995432 2333
Q ss_pred HHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 677 ~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+... ..+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 238 MVRKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred HHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 33333211 112223356899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.43 Aligned_cols=246 Identities=29% Similarity=0.450 Sum_probs=197.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
..|.+.+.||+|+||.||+|.+ .++.||+|++.... .....+.+|+++++.++||||++++++|.. ..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3577888999999999999987 46789999987543 335678899999999999999999998843 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 85 TYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 99999999865432 34899999999999999999999998 99999999999999999999999999986643211
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.... .....+..+. .+ ..+
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-----~~---~~~ 227 (263)
T cd05052 160 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-----RM---ERP 227 (263)
T ss_pred ----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----CC---CCC
Confidence 11112234567999999998999999999999999999998 999996432 2223333321 11 112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
...+..+.+++.+||..+|.+||++.+++..
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 2234569999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.34 Aligned_cols=235 Identities=27% Similarity=0.310 Sum_probs=184.4
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHH-HHHhhcCCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEV-EVLCNIRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~-~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.+ ++..||+|++..... .....+..|. .+++.++||||+++++++.. ..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999988 456799999975421 1222344444 45678999999999988744 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---- 150 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---- 150 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC----
Confidence 99999887644 3788888899999999999999999 9999999999999999999999999997532211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||...... ...+..... .+.+ ..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~-------~~ 219 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKP-------NI 219 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCC-------CC
Confidence 1123457999999999999999999999999999999999999999644322 223322211 1111 22
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
+..+.+++.+||+.+|.+||++.+.+
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 34589999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.54 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=197.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCc----cEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHT----PVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 534 (768)
++|.+.+.||+|+||.||+|.+ ++. .||+|+++... ......+.+|+.+++.+.||||+++++.|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 5688899999999999999986 333 48999987543 3345678899999999999999999998844 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|+|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999887643 24899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
... ........++..|++||...+..++.++|||||||++|||++ |.+||.... .....+..+.....
T Consensus 162 ~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----- 232 (279)
T cd05109 162 DET----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ----- 232 (279)
T ss_pred ccc----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC-----
Confidence 211 111122345678999999988899999999999999999998 999996432 33334444321111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
+...+..+.+++.+||..+|.+||++.+++..
T Consensus 233 ---~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 233 ---PPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred ---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11234568999999999999999999998843
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.21 Aligned_cols=235 Identities=25% Similarity=0.334 Sum_probs=187.4
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhh-cCCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCN-IRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.+ ++..||+|+++.... .....+..|..++.. ++||||+++++++.+ ..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999998 456899999975421 223456678888875 489999999998854 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 149 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----- 149 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-----
Confidence 99999887654 3889999999999999999999999 999999999999999999999999998743211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+ .+..+.+ .
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~---~ 219 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------TPHYPRW---I 219 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCC---C
Confidence 1122446799999999999999999999999999999999999999964432 22233222 1222222 3
Q ss_pred HHHHHHHHHHhhhcCccCCCChh-hhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLG-KVV 724 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~-evl 724 (768)
+..+.+|+.+||..+|.+||++. ++.
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 34589999999999999999985 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=314.33 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=198.3
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh---------hHHHHHHHHHHHhhcCCCceeeeecccc--CC
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ---------GRSQFQQEVEVLCNIRHPNMVLLLGACP--EF 530 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~---------~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~ 530 (768)
+|.+...||.|+||.||+|.+ .++.||+|.+...... ....+.+|+.++++++||||+++++++. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477788999999999999987 5678999988643221 1245789999999999999999999874 45
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 589999999999999997654 4889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCC
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPA 690 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~ 690 (768)
.+.................|+..|+|||.+.+..++.++|||||||++|+|++|+.||.............. ...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~- 230 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---NASP- 230 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---cCCC-
Confidence 775322111111112335688999999999988899999999999999999999999976544332221111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 231 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 --EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 122233456899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=320.35 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=201.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
.+|.+.+.||+|+||.||++.. .+..||+|.+..........+.+|+.+++.++||||+++++.|. ...|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788999999999999999986 56789999997665555667889999999999999999999874 3559999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-- 170 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--
Confidence 999999988543 3789999999999999999999999 9999999999999999999999999987653221
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||............... ..+.. ..+...
T Consensus 171 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~-~~~~~~ 242 (296)
T cd06654 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPEL-QNPEKL 242 (296)
T ss_pred ----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC---CCCCC-CCcccc
Confidence 1123347889999999998888999999999999999999999999655432221111100 00111 112234
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
+..+.+++.+||..+|.+||++.+++. +++.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~ 274 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhhChhhh
Confidence 456899999999999999999999986 4443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=313.98 Aligned_cols=246 Identities=28% Similarity=0.479 Sum_probs=197.5
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.++|.+.+.||+|+||.||+|.+ .++.||+|.++.... ...++.+|+.++++++||||+++++++.. ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688999999999999999987 445799999976542 34578899999999999999999998844 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999987644 235899999999999999999999999 999999999999999999999999999876422110
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.......+..|+|||++.+..++.++||||||+++|+|++ |+.||..... ....+..+. .. + .+
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~---~----~~ 226 (261)
T cd05068 160 -----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RM---P----CP 226 (261)
T ss_pred -----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC---C----CC
Confidence 0111223457999999998899999999999999999999 9999964432 222333221 11 1 11
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 223356999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=319.57 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=190.2
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh--hHHHHHHHHHHHhhc---CCCceeeeeccccC-------
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ--GRSQFQQEVEVLCNI---RHPNMVLLLGACPE------- 529 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~g~~~~------- 529 (768)
+|.+.+.||+|+||.||++.+ +++.||+|.++..... ....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488889999999999999988 4678999998754221 223456777777765 79999999998742
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 2489999996 588888765432 34899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--C----
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--G---- 681 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~---- 681 (768)
+.+.... ......||..|+|||++.+..++.++|||||||++|+|++|++||....... ..+.. +
T Consensus 156 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 156 RIYSCQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccccCcc-------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 8664321 1234578999999999998899999999999999999999999995432211 11110 0
Q ss_pred -Cccc-------cCCCCC----CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 682 -TFDE-------TLDPAV----PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 682 -~~~~-------~ld~~~----~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+.. ...+.. .......+..+.+|+.+||+.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 000000 0111123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=333.92 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=194.1
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|++.+.||+|+||.||++.. .+..||||+++... ......+.+|+.++..++||||+++++.+.+ ..||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999987 46789999997532 2234567889999999999999999998854 459999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999987654 4899999999999999999999999 999999999999999999999999999755321
Q ss_pred CCCc-----------------------------cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCC
Q 035604 616 VADS-----------------------------VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKP 666 (768)
Q Consensus 616 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~ 666 (768)
.... .........+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 1000 00001124579999999999999999999999999999999999999
Q ss_pred CCCChHHH--HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC---hhhhhh
Q 035604 667 PMGLAHQV--ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD---LGKVVV 725 (768)
Q Consensus 667 Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs---~~evl~ 725 (768)
||...... ...+......-.+.+.. ..+..+.+|+.+|+. +|.+|++ +.+++.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~-----~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPPEV-----PISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCCCC-----CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99644332 22333211111111111 123457888888774 9999995 566664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=320.12 Aligned_cols=254 Identities=30% Similarity=0.459 Sum_probs=198.4
Q ss_pred cCCCccceecccCceeEEEEEECC--c--cEEEEEEcCC-chhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH--T--PVAIKVLRPD-AAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~--~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 534 (768)
++|.+.+.||+|+||.||+|.... . .+++|.++.. .......+.+|+.++.++ +||||+++++++.+ ..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998733 2 4788888743 333456788999999999 79999999998854 35899
Q ss_pred EEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 535 YEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965321 124889999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSI 678 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i 678 (768)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.... .....+
T Consensus 159 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred EECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999986432110 1111233567999999988889999999999999999997 999995433 222333
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
..+.. . ..+...+..+.+|+.+||..+|.+||++.+++..+.+.+...
T Consensus 232 ~~~~~-----~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQGYR-----M---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcCCC-----C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 22211 1 112223356899999999999999999999987766666543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=313.25 Aligned_cols=244 Identities=28% Similarity=0.395 Sum_probs=200.3
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|.+.+.||+|+||.||++.. +++.|++|.+... .......+.+|+++++.++||||+++++++.+ ..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477888999999999999987 5678999998643 23445678899999999999999999999854 45999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++.... ...+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999987642 235899999999999999999999998 99999999999999999999999999987643211
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~ 695 (768)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+.+. ..+
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~ 222 (256)
T cd08529 157 ------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP--------PVS 222 (256)
T ss_pred ------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------CCc
Confidence 112346888999999999999999999999999999999999999655432 2223332221 122
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+++.+||+.+|++||++.+++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 234456999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.64 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=194.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ ++..||+|++.+.. ......+.+|+.+++.++||||+++++++.+ ..|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46799999999999999999988 45689999986432 2233457899999999999999999998854 45999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 122 ~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999988643 3789999999999999999999999 99999999999999999999999999987632
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCC----CCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTG----MLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLD 688 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld 688 (768)
.. ........||+.|+|||++.+. .++.++|||||||++|+|++|++||...... ...+......
T Consensus 195 ~~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~---- 265 (370)
T cd05621 195 TG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS---- 265 (370)
T ss_pred CC-----ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc----
Confidence 21 1122356799999999988754 3789999999999999999999999644322 2223222110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCcc--CCCChhhhhh-HHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRK--DRPDLGKVVV-PKL 728 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~--~RPs~~evl~-~~l 728 (768)
...+. ....+..+.+++..|+..++. .||++.+++. +|.
T Consensus 266 ~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 266 LNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred cCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 11111 112345688899999975554 3899999886 443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.51 Aligned_cols=248 Identities=24% Similarity=0.384 Sum_probs=197.7
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
+.|++.+.||.|+||.||+|.+ .+..|++|++..........+.+|+.+++.++||||+++++.|. ...|+||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5688999999999999999987 45789999998766666677899999999999999999999873 3459999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|..++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 99999887765432 4899999999999999999999998 9999999999999999999999999987542211
Q ss_pred ccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.......++..|+|||++. ...++.++|||||||++|+|++|.+||.............. ...+.. .
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~-~ 236 (292)
T cd06644 165 ----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTL-S 236 (292)
T ss_pred ----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCccC-C
Confidence 1123456888999999874 34578899999999999999999999965443322211111 011111 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+...+..+.+++.+||..+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 12223345889999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.12 Aligned_cols=233 Identities=27% Similarity=0.347 Sum_probs=184.9
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHH-HHhhcCCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVE-VLCNIRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.. +++.||+|++.... ......+..|.. +++.++||||+++++.+.. ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999987 56789999997542 122334555555 4677999999999988743 45999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 150 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---- 150 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----
Confidence 99998887644 4899999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||.... .....+..+.. .+.+ ..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~-------~~ 219 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRP-------GA 219 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCC-------CC
Confidence 11234579999999999999999999999999999999999999996443 22233333221 1111 22
Q ss_pred HHHHHHHHHHhhhcCccCCCChhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLGK 722 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~e 722 (768)
+..+.+++.+|+..+|.+||++.+
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCC
Confidence 345889999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=312.17 Aligned_cols=244 Identities=22% Similarity=0.383 Sum_probs=196.6
Q ss_pred cCCCccceecccCceeEEEEEECCc-cEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEecc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHT-PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMA 539 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~-~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 539 (768)
++|.+.+.||+|+||.||++.+.+. .||+|.+..... ....+.+|+.+++.++||||++++++|.+ ..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999987554 699999875432 34578999999999999999999999844 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|.+++..... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.+.....
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence 9999998876433 4899999999999999999999999 99999999999999999999999999986533211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......++..|++||.+.+..++.++|||||||++|+|++ |+.||..... ....+..+... . .+.
T Consensus 156 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----~---~~~ 224 (256)
T cd05113 156 ---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-----Y---RPH 224 (256)
T ss_pred ---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----C---CCC
Confidence 11122345678999999988889999999999999999998 9999964432 23333333211 1 111
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22356999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.04 Aligned_cols=246 Identities=31% Similarity=0.506 Sum_probs=200.9
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
..+|.+.+.||.|+||.||+|.+ .+..+|+|++..........+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688899999999999999987 457899999987766556779999999999999999999998744 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 85 EKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred ccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 99999999976433 34899999999999999999999999 99999999999999999999999999986633211
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
......++..|++||.+.+..++.++||||||+++|+|++ |+.||.... .....+..+. . . ..+
T Consensus 160 -----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~----~---~~~ 226 (261)
T cd05148 160 -----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-R----M---PCP 226 (261)
T ss_pred -----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-c----C---CCC
Confidence 1123446778999999988889999999999999999998 899996433 2223333221 1 1 112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..++..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 233456899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=312.50 Aligned_cols=244 Identities=30% Similarity=0.486 Sum_probs=196.8
Q ss_pred cCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEeccC
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMAN 540 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~ 540 (768)
++|++.+.||+|+||.||++.. .+..||+|.+..... ....+.+|+.++++++||||+++++++.+ ..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 5688899999999999999987 446799999976443 34578999999999999999999988743 45999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
++|.+++..... ..+++..++.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05070 85 GSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc---
Confidence 999998875432 34899999999999999999999999 99999999999999999999999999987643211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
.......++..|+|||++.+..++.++||||||+++|+|++ |.+||..... ....+..+. .. ..+..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~---~~~~~ 227 (260)
T cd05070 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-----RM---PCPQD 227 (260)
T ss_pred --ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----CC---CCCCc
Confidence 01122345678999999988889999999999999999999 9999964332 223333221 11 12223
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
.+..+.+|+.+||..+|.+||++.+++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 345699999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.20 Aligned_cols=244 Identities=25% Similarity=0.357 Sum_probs=195.5
Q ss_pred CCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccC
Q 035604 465 FSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
|++.+.||.|+||.||++.+. +..+++|.+..........+.+|+++++.++||||+++++.|.. ..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677788999999999999984 45789999876655556678899999999999999999998743 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99988876533 24899999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHcCCccccCCCCCCC
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IENGTFDETLDPAVPD 693 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~~~~~~~ld~~~~~ 693 (768)
.......++..|+|||++. +..++.++|||||||++|+|++|++||......... +.........
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 229 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA------ 229 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC------
Confidence 1123457899999999874 445788999999999999999999999755433322 2222111111
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123346899999999999999999999885
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=353.00 Aligned_cols=254 Identities=32% Similarity=0.477 Sum_probs=204.2
Q ss_pred CCCccceecccCceeEEEEEEC---Cc----cEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccCC--cee
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD---HT----PVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCL 533 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~---~~----~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~l 533 (768)
+-...+.||+|.||.||.|... +. .||||.++.. +.+...+|.+|..+|+.++|||||+++|+|.+. .+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 4556778999999999999873 22 3999999765 456677899999999999999999999999553 489
Q ss_pred EEEeccCCChHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 534 IYEYMANGSLEDRLFRRG----GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
++|||++|+|..+|.... ....++....+.++.+||+|+.||++++ +|||||-..|+||+....+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998752 1345888999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccC-CCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHHHH--H-HHHcCCcc
Q 035604 610 RLVPPSVADSVTQYRMTS-AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQVE--R-SIENGTFD 684 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~-~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~~--~-~i~~~~~~ 684 (768)
+-+.... -++... ..-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+ . ....|+
T Consensus 850 rDiy~~~-----yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR-- 922 (1025)
T KOG1095|consen 850 RDIYDKD-----YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR-- 922 (1025)
T ss_pred Hhhhhch-----heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc--
Confidence 9332211 112122 234568999999999999999999999999999999 899997554433 2 333442
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
++ .|..++..+.+|+.+||+.+|++||++..++..+-..+..+
T Consensus 923 --L~-----~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 923 --LD-----PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred --cC-----CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 22 12333445889999999999999999999987555555443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=314.82 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=196.6
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
++|.+.+.||+|+||.||++.. +++.||+|+++.........+.+|+.+++.++||||+++++.+. +..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 5688888999999999999987 56789999997665555556889999999999999999999874 4558999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++...+ .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999887654 4899999999999999999999999 9999999999999999999999999987653221
Q ss_pred ccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPD 693 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~ 693 (768)
.......|+..|+|||++. ...++.++|||||||++|+|++|.+||........ ......+..........
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence 1123457899999999874 45688999999999999999999999854332221 11112111111111112
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+ +..+.+++.+||..+|++||++.+++.
T Consensus 237 ~----~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 237 W----SNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred C----CHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 2 345889999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=318.78 Aligned_cols=246 Identities=27% Similarity=0.350 Sum_probs=194.0
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.|...+.||+|+||+||++.+ +++.||+|.+..... .....+.+|+++|+.++|+||+.+++.+.. ..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367788999999999999988 467899999865432 223457789999999999999999888743 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999988865432 35899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 694 (768)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ..+.. ...... ..+
T Consensus 157 -------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~-~~~~~~----~~~ 224 (285)
T cd05632 157 -------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR-RVLETE----EVY 224 (285)
T ss_pred -------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hhhccc----ccc
Confidence 1134578999999999998899999999999999999999999996543221 11111 111110 111
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPD-----LGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~ 725 (768)
+...+..+.+|+..||..+|.+||+ +.+++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2223345899999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=311.02 Aligned_cols=240 Identities=29% Similarity=0.426 Sum_probs=190.3
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCCh
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSL 543 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 543 (768)
+.||+|+||.||++.+ +++.||+|.+.... ......+.+|+++++.++||||++++++|.. ..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999987 67789999886442 3345678999999999999999999999844 45899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 623 (768)
.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... .
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~----~ 151 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA----S 151 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc----c
Confidence 99986543 24889999999999999999999999 999999999999999999999999999765322110 0
Q ss_pred cccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCHHHHH
Q 035604 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPVEEAL 700 (768)
Q Consensus 624 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~~~~ 700 (768)
......++..|+|||.+.++.++.++|||||||++|+|++ |.+||.... .....+..+.. . ..+...+.
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~ 223 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-----L---PCPELCPD 223 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----C---CCcccCCH
Confidence 0111223457999999998899999999999999999998 999995332 22233332211 1 11223345
Q ss_pred HHHHHHHHhhhcCccCCCChhhhhh
Q 035604 701 ILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 701 ~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+.+|+.+||..+|.+||++.+++.
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=317.39 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=197.5
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccC-------
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE------- 529 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~------- 529 (768)
.+++.|.+.+.||+|+||.||+|.. .++.||+|++.... .....+.+|+.++.++ +||||+++++.|..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3567899999999999999999987 55689999986543 2345688999999998 69999999998742
Q ss_pred -CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
..++||||+.+|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 35899999999999998876432 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCc
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTF 683 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~ 683 (768)
+..+.... .......|+..|+|||++. +..++.++|||||||++|+|++|+.||..............
T Consensus 158 ~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~- 230 (272)
T cd06637 158 SAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR- 230 (272)
T ss_pred ceeccccc------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-
Confidence 98653321 1123457899999999876 34588899999999999999999999964443332221111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....... ....+..+.+|+.+||..+|.+||++.+++.
T Consensus 231 --~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 --NPAPRLK--SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --CCCCCCC--CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0011110 1122345899999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=319.48 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=204.2
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.+|.+.+.||.|+||.||++.. .+..||+|.+..........+.+|+.+++.++||||+++++.|.. ..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4689999999999999999986 667899999876554555678899999999999999999998843 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|..++... .+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.....
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 999999988643 3899999999999999999999999 99999999999999999999999999876533211
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHcCCccccCCCCCCCCCH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~~~~~~~ld~~~~~~~~ 696 (768)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||......... +....... ...+.
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~------~~~~~ 239 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE------LQNPE 239 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc------cCCcc
Confidence 123346889999999999888999999999999999999999999765443322 11111111 11122
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILR 732 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~ 732 (768)
..+..+.+++.+||..+|.+||++.+++. +|++..+
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 23456889999999999999999999997 6665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.87 Aligned_cols=252 Identities=27% Similarity=0.371 Sum_probs=196.9
Q ss_pred CCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCcee
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCL 533 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~l 533 (768)
+|.+.+.||+|+||.||+|.... ..+++|.+.... ......+.+|+.+++.++||||+++++.|. ...++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788899999999999998632 458999887543 233467889999999999999999999874 34589
Q ss_pred EEEeccCCChHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 035604 534 IYEYMANGSLEDRLFRRG---------------------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGN 592 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~N 592 (768)
||||+.+|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 1134789999999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh
Q 035604 593 ILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA 671 (768)
Q Consensus 593 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~ 671 (768)
||++.++.+||+|||+++.+..... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDS----YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccc----hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999976532211 011123355678999999988889999999999999999998 99999644
Q ss_pred H--HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 672 H--QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 672 ~--~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
. .+...+..+. ... .+...+..+.+++..||+.+|.+||++.+++..+.+.
T Consensus 234 ~~~~~~~~~~~~~-----~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 234 APERLFNLLKTGY-----RME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred CHHHHHHHHhCCC-----CCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 3 2223333221 111 1222335699999999999999999999998544433
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=355.26 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=198.4
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeecccc----CCc
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACP----EFG 531 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~ 531 (768)
...++|.+.+.||+|+||.||++.+ .+..||+|++.... ......|..|+.+|+.|+|||||+++++|. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3457899999999999999999998 44579999987542 234567889999999999999999999873 235
Q ss_pred eeEEEeccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeCCCCCCCeEEcC---------
Q 035604 532 CLIYEYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKP----EPLVHRDLKPGNILLDR--------- 597 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~----~~iiHrDLKp~NILl~~--------- 597 (768)
||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.++ .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999987532 22358999999999999999999998542 34999999999999954
Q ss_pred --------CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCC
Q 035604 598 --------NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPP 667 (768)
Q Consensus 598 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~P 667 (768)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||+|+||+.|
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 3458999999998653221 1234579999999998854 4588999999999999999999999
Q ss_pred CCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 668 MGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 668 f~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
|.........+...... ....+.. .+..+.+||..||..+|.+||++.+++. +++
T Consensus 243 F~~~~~~~qli~~lk~~--p~lpi~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 243 FHKANNFSQLISELKRG--PDLPIKG----KSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred CCcCCcHHHHHHHHhcC--CCCCcCC----CCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 97544333322211100 0111111 2356999999999999999999999985 443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=345.73 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=191.6
Q ss_pred HHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCC------CceeeeeccccC-
Q 035604 459 EEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH------PNMVLLLGACPE- 529 (768)
Q Consensus 459 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~g~~~~- 529 (768)
...+++|.+.++||+|+||.||++.+ .+..||||+++.... ....+..|+.++..++| ++|++++++|..
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 34568899999999999999999987 456899999964322 23345667777777654 458888887743
Q ss_pred --CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCC-------
Q 035604 530 --FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNY------- 599 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~------- 599 (768)
..|+||+++ +++|.+++.+.+ .+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 458999988 788988887654 48999999999999999999997 58 99999999999998765
Q ss_pred ---------cEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 035604 600 ---------VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGL 670 (768)
Q Consensus 600 ---------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~ 670 (768)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998853211 12456899999999999999999999999999999999999999964
Q ss_pred hHHHHH--HHHc--CCccc-------------------cCCCCCC------------CCCHHHHHHHHHHHHHhhhcCcc
Q 035604 671 AHQVER--SIEN--GTFDE-------------------TLDPAVP------------DWPVEEALILAKLALQCAELRRK 715 (768)
Q Consensus 671 ~~~~~~--~i~~--~~~~~-------------------~ld~~~~------------~~~~~~~~~l~~Li~~cl~~~P~ 715 (768)
...... .+.. |.+.. .+.+... .........+.+||.+||..||.
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 432211 1110 11000 0000000 00001234588999999999999
Q ss_pred CCCChhhhhh-HHHHH
Q 035604 716 DRPDLGKVVV-PKLNI 730 (768)
Q Consensus 716 ~RPs~~evl~-~~l~~ 730 (768)
+||++.+++. +|+..
T Consensus 428 ~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 428 KRLNARQMTTHPYVLK 443 (467)
T ss_pred hCCCHHHHhcCccccc
Confidence 9999999996 66644
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.82 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=198.6
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC---chhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 535 (768)
++|.+.+.||+|+||.||+|.. +++.||||.+... .......+.+|+.+++.++||||+++++++. ...++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999987 6789999987642 2333456889999999999999999999874 3458999
Q ss_pred EeccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 536 EYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886422 2235889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH----HHHHHHHcCCccccCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH----QVERSIENGTFDETLDPA 690 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~----~~~~~i~~~~~~~~ld~~ 690 (768)
.. .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .....+....+ +.
T Consensus 159 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~ 227 (267)
T cd08228 159 KT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-----PP 227 (267)
T ss_pred hh------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC-----CC
Confidence 21 11223468889999999988889999999999999999999999995332 22223322221 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. .+...+..+.+++.+||..+|.+||++.+|+.
T Consensus 228 ~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 L--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred C--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 1 11234456999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=317.22 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=195.3
Q ss_pred cCCCccceecccCceeEEEEEE------CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc----CCce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP----EFGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~ 532 (768)
.+|++.+.||+|+||.||++.. .+..||+|.+..........+.+|+++++.++||||+++++++. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788899999999999999874 35689999998766666678899999999999999999998763 2458
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
+||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999875432 4899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH-HHHHHcCCcc-------
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV-ERSIENGTFD------- 684 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~-~~~i~~~~~~------- 684 (768)
....... .......++..|+|||++.+..++.++|||||||++|||++|..|+...... ...+......
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYY---KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCcce---eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 4322110 0011223455699999999889999999999999999999988776432211 1111110000
Q ss_pred -ccCC-CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 685 -ETLD-PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 685 -~~ld-~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.+. ......+...+..+.+|+.+||..+|.+|||+.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000 0000111223346999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=350.83 Aligned_cols=261 Identities=23% Similarity=0.284 Sum_probs=198.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.++||+|+||.||+|.+ .++.||||++.... ......+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999987 46789999997542 2234568899999999999999999999854 448999
Q ss_pred EeccCCChHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 536 EYMANGSLEDRLFRRGG--------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
||++||+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 123566778899999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCc------------cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH
Q 035604 608 LARLVPPSVADS------------VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE 675 (768)
Q Consensus 608 la~~~~~~~~~~------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~ 675 (768)
+++......... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998762211000 00011123579999999999999999999999999999999999999996533211
Q ss_pred HHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 676 RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 676 ~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
.... .... .+.........+..+.+++.+|+..+|++||+..+.+...+..
T Consensus 239 i~~~-~~i~---~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISYR-DVIL---SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhh-hhcc---ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 1111 1100000112335689999999999999998877666544333
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.57 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=201.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||.|+||.||++.+ ++..||+|++..........+.+|+++++.++||||+++++.+.. ..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35688899999999999999987 467899999976665566778999999999999999999998844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 999999998876432 4899999999999999999999999 9999999999999999999999999987553221
Q ss_pred CccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPA 690 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~ 690 (768)
.......+++.|++||.+. +..++.++|||||||++|+|++|++||........ .+..+.. +.
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~ 227 (280)
T cd06611 158 -----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-----PT 227 (280)
T ss_pred -----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-----CC
Confidence 1123456889999999874 34578899999999999999999999975543332 2222211 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
. ..+...+..+.+++..||..+|.+||++.+++. +|+
T Consensus 228 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 228 L-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred c-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 1 112223346899999999999999999999986 444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=326.24 Aligned_cols=237 Identities=24% Similarity=0.314 Sum_probs=189.8
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcC-CCceeeeeccccC--CceeEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~ 535 (768)
+|...+.||+|+||.||++.. ++..||+|++..... .....+..|..++..+. ||+|+++++++.+ ..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999987 467899999975422 22345678889998886 5677788887743 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999887654 3899999999999999999999999 999999999999999999999999998754221
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 693 (768)
. .......||+.|+|||++.+..++.++|||||||++|+|++|++||..... ....+..+.. .
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---------~ 219 (323)
T cd05615 155 G------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---------S 219 (323)
T ss_pred C------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------C
Confidence 1 112345689999999999999999999999999999999999999965432 2233333221 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~ 721 (768)
++...+..+.+++.+||..+|.+|++..
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 2223345689999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=327.03 Aligned_cols=232 Identities=25% Similarity=0.321 Sum_probs=183.8
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHH-HHhhcCCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVE-VLCNIRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.+ ++..||+|++.+... .....+..|.. +++.++||||+++++.+.+ ..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 567899999975422 22234455554 6788999999999988744 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|...+.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---- 150 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----
Confidence 99988886543 4888899999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.......||+.|+|||++.+..++.++|||||||++|||++|++||...+. ....+..+.. ..+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---------~~~~~~ 219 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL---------QLPGGK 219 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC---------CCCCCC
Confidence 112345789999999999998999999999999999999999999965432 2223322211 122233
Q ss_pred HHHHHHHHHHhhhcCccCCCChh
Q 035604 699 ALILAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~ 721 (768)
+..+.+++.+||+.+|.+||+..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCC
Confidence 45689999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.56 Aligned_cols=232 Identities=26% Similarity=0.330 Sum_probs=185.9
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++.. .++.||+|++..... .....+.+|+.++.++ +||||+.+++++.+ ..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 456899999976432 2344578899999888 69999999998743 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 150 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---- 150 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC----
Confidence 99998887654 4899999999999999999999999 9999999999999999999999999987432111
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh---------HHHHHHHHcCCccccCCCCC
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA---------HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~---------~~~~~~i~~~~~~~~ld~~~ 691 (768)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ......+....+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 220 (327)
T cd05617 151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-------- 220 (327)
T ss_pred --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--------
Confidence 1123467999999999999999999999999999999999999999521 112222222111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~ 721 (768)
..|...+..+.+++.+||..+|.+||+..
T Consensus 221 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 -RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 12222335588999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=326.15 Aligned_cols=254 Identities=29% Similarity=0.435 Sum_probs=198.0
Q ss_pred cCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC---C
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE---F 530 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~ 530 (768)
++|++.+.||+|+||.||+|.+ .++.||||+++... ......+.+|+.+|.++ +||||++++++|.. .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999974 34689999997543 23345688999999999 68999999998743 3
Q ss_pred ceeEEEeccCCChHHHHhhcCC----------------------------------------------------------
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG---------------------------------------------------------- 552 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 552 (768)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 4899999999999999865321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcccccccc
Q 035604 553 ------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626 (768)
Q Consensus 553 ------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~ 626 (768)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc----hhhcC
Confidence 123678888999999999999999999 99999999999999999999999999986532211 11112
Q ss_pred CCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH---HHHHHHHcCCccccCCCCCCCCCHHHHHHH
Q 035604 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH---QVERSIENGTFDETLDPAVPDWPVEEALIL 702 (768)
Q Consensus 627 ~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~---~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l 702 (768)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||.... .....+..+... ..+.+ .+..+
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~ 311 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----RAPDY---TTPEM 311 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-----CCCCC---CCHHH
Confidence 3345678999999988899999999999999999997 999995432 223333333211 11222 22458
Q ss_pred HHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 703 AKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 703 ~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
.+++..||+.+|.+||++.+++..+...+
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999986555443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.90 Aligned_cols=240 Identities=25% Similarity=0.397 Sum_probs=190.9
Q ss_pred eecccCceeEEEEEEC----CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEeccCCCh
Q 035604 470 KIGEGGYGPVYKSYLD----HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMANGSL 543 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~gsL 543 (768)
.||+|+||.||+|.+. +..||+|++.... ......+.+|+.++++++||||++++++|.. ..++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999763 3469999987653 2334568999999999999999999999854 45899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 623 (768)
.+++.... ..+++..+++++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+..... ...
T Consensus 82 ~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~ 153 (257)
T cd05115 82 NKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYK 153 (257)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc---cee
Confidence 99886533 25899999999999999999999999 99999999999999999999999999986533211 001
Q ss_pred cccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCHHHHH
Q 035604 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPVEEAL 700 (768)
Q Consensus 624 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~~~~ 700 (768)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||.... .+...+..+... ..+..++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 225 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL--------DCPAECPP 225 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC--------CCCCCCCH
Confidence 1122334678999999988889999999999999999996 999996443 233344443211 12223345
Q ss_pred HHHHHHHHhhhcCccCCCChhhhhh
Q 035604 701 ILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 701 ~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+.+++.+||..+|++||++.+|..
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.93 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=196.5
Q ss_pred cCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
.+|.+.+.||+|+||.||+|.+. +..||||+++.... .....+.+|+.++..++||||+++++++.+ ..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677888999999999999863 35799999975432 234568899999999999999999998844 458
Q ss_pred eEEEeccCCChHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 035604 533 LIYEYMANGSLEDRLFRRG-------------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 599 (768)
+++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1234788889999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHH
Q 035604 600 VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVER 676 (768)
Q Consensus 600 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~ 676 (768)
.+||+|||+++.+..... ........+++.|+|||.+.++.++.++|||||||++|||++ |..||.... ....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADY----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred ceEecccccccccccchh----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999886533211 111233456788999999988889999999999999999998 888985432 3333
Q ss_pred HHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 677 ~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+... ..+..++..+.+|+..||+.+|.+||++.+|+.
T Consensus 238 ~i~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 238 MIRNRQVL--------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHcCCcC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 44443321 122233455899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.26 Aligned_cols=240 Identities=30% Similarity=0.440 Sum_probs=196.7
Q ss_pred cCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc---CCceeEEEecc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP---EFGCLIYEYMA 539 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~---~~~~lV~E~~~ 539 (768)
.+|.+.+.||+|+||.||++...+..||+|.++... ....+.+|+.+++.++||||+++++++. ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 468888999999999999999999999999987543 2456889999999999999999998752 34589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 84 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999876443 34889999999999999999999999 9999999999999999999999999987543211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||.... .....+..+... ..+.
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--------DAPD 222 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------CCCC
Confidence 22344568999999998899999999999999999997 999996432 333334333211 1112
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.++..+.+++.+||..+|++||++.+++.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 23456899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.93 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=197.9
Q ss_pred hcCCCccceecccCceeEEEEEECC------------------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH------------------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVL 522 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~------------------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~ 522 (768)
..+|++.+.||+|+||.||++.+.. ..||+|++.... ......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999987633 348999997653 334567899999999999999999
Q ss_pred eeccccC--CceeEEEeccCCChHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 035604 523 LLGACPE--FGCLIYEYMANGSLEDRLFRRGG--------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGN 592 (768)
Q Consensus 523 l~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~N 592 (768)
++++|.. ..+++|||+++++|..++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9998854 55999999999999999876431 125899999999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh--CCCCCCC
Q 035604 593 ILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL 670 (768)
Q Consensus 593 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--g~~Pf~~ 670 (768)
||++.++.+||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcc----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999976533211 111234456788999999988889999999999999999998 7888864
Q ss_pred hHH--HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 671 AHQ--VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 671 ~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
... ....+... +...........+..++..+.+|+.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LTDQQVIENAGHF-FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cChHHHHHHHHhc-cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 322 22222111 0000000011112223356999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=323.76 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=194.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
++|.+.+.||+|+||.||+|.. .+..||+|.++.... .....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5789999999999999999987 456899999875432 22345778999999999999999999984 455899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
++ ++|..++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LD-KDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 96 478887765432 4788999999999999999999999 9999999999999999999999999997543221
Q ss_pred CccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--CC-----cc---
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--GT-----FD--- 684 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~~-----~~--- 684 (768)
.......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||....... ..+.. +. +.
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 11233467899999998765 468999999999999999999999995432211 11100 00 00
Q ss_pred ---ccCCCCCCC--------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 685 ---ETLDPAVPD--------WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 685 ---~~ld~~~~~--------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
...+...+. .....+..+.+|+.+||..||.+|||+.+++. +|...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 000000000 01123456889999999999999999999986 55533
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.73 Aligned_cols=248 Identities=28% Similarity=0.422 Sum_probs=201.6
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
++|.+.+.||.|+||.||++.. .++.+++|++..........+.+|+++++.++||||+++++.+. ...|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5789999999999999999987 45789999997665556678899999999999999999999874 3458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 83 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 99999998876522 4889999999999999999999999 9999999999999999999999999997653321
Q ss_pred ccccccccCCCCCCCCCCcccccCC---CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHcCCccccCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTG---MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IENGTFDETLDPAVPD 693 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~~~~~~~ld~~~~~ 693 (768)
.......++..|++||++.+. .++.++|||||||++|+|++|++||......... +....+ .+....
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 227 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF----PPPKLK 227 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----CCcccc
Confidence 112345688899999998776 7899999999999999999999999654433222 222211 111111
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+...+..+.+++.+||..+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23344567999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=319.61 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=193.9
Q ss_pred cCCCccceecccCceeEEEEEECC----------------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH----------------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLG 525 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~----------------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g 525 (768)
++|++.+.||+|+||.||++...+ ..||+|.++... ......|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987632 248999997653 334567899999999999999999999
Q ss_pred ccc--CCceeEEEeccCCChHHHHhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 035604 526 ACP--EFGCLIYEYMANGSLEDRLFRRG---------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNIL 594 (768)
Q Consensus 526 ~~~--~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NIL 594 (768)
++. ...++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 884 34599999999999999886532 1124788999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh--CCCCCCChH
Q 035604 595 LDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAH 672 (768)
Q Consensus 595 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--g~~Pf~~~~ 672 (768)
++.++.+||+|||++..+..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcc----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999976532211 111223355778999999988899999999999999999998 678886432
Q ss_pred H--HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 673 Q--VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 673 ~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. ....+.. .+...........+...+..+.+|+.+||..+|.+||++.+|+.
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGE-FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHH-hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2 1111110 00000000000111123356999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=298.68 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=211.0
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--------hhhHHHHHHHHHHHhhc-CCCceeeeeccccC
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--------AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--------~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~ 529 (768)
.-..|...+.||.|..+.|.++.+ .+..+|+|++.... ..-++.-.+|+.||+++ .||+|+.+.++|..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345677788899999999999877 56689999885321 11234456899999997 59999999999955
Q ss_pred --CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 --FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..++|+|.|+.|.|.|+|...- .+++...++|+.|+..|+.|||..+ ||||||||+|||+|.|.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 4488999999999999998764 4999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCccccc------CCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHH
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ------TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIE 679 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~ 679 (768)
+++.+.++ .+....|||+.|+|||.+. ..+|+..+|+|++|+|||.||.|.+||-...+ +.+.|.
T Consensus 169 Fa~~l~~G-------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im 241 (411)
T KOG0599|consen 169 FACQLEPG-------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM 241 (411)
T ss_pred eeeccCCc-------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence 99987654 3456779999999999764 34689999999999999999999999954433 346777
Q ss_pred cCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHHHhhc
Q 035604 680 NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRALAEE 737 (768)
Q Consensus 680 ~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~~~~~ 737 (768)
.|++.- -. ++|. +.+....+||.+||+.||.+|.|+.+++. ++...+......
T Consensus 242 eGkyqF-~s---peWa-dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 242 EGKYQF-RS---PEWA-DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred hccccc-CC---cchh-hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence 887532 22 2332 34456899999999999999999999987 777665444333
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.69 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=197.7
Q ss_pred cCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
.+|...++||+|+||.||++.. .+..+|+|.+..........+.+|+++++.++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4577788999999999999864 245799999876665666789999999999999999999998854 4589
Q ss_pred EEEeccCCChHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 534 IYEYMANGSLEDRLFRRGG------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
+|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999876432 124789999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSI 678 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i 678 (768)
||+|||++..+..... ........+++.|+|||.+.+..++.++|||||||++|||++ |.+||..... ....+
T Consensus 162 kL~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred EECCCCceeEcCCCce----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999976532211 011123345788999999998999999999999999999998 9999954332 22233
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+... . .+..++..+.+|+.+||..+|.+||++.+|+.
T Consensus 238 ~~~~~~-----~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGREL-----E---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccC-----C---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 333211 1 11123345899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=328.32 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=194.7
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC------
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------ 529 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 529 (768)
...++|.+.+.||.|+||.||++.+ .+..||||++.... ......+.+|+.+|+.++||||++++++|..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3467899999999999999999987 45689999987542 2234457789999999999999999988732
Q ss_pred --CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 --FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..|++|+++ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 237899988 78898876532 3899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CC
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GT 682 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~ 682 (768)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+.. +.
T Consensus 164 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 164 LARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred cceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99865321 234578999999998876 5689999999999999999999999964332111 1100 00
Q ss_pred c-cccC-----------CCCCCCCCH--------HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 683 F-DETL-----------DPAVPDWPV--------EEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 683 ~-~~~l-----------d~~~~~~~~--------~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
. .+.+ ...++..+. .....+.+|+.+||..||.+||++.+++. +|...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0 0000 000011110 11234789999999999999999999987 55543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.16 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=197.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
++|.+.+.||+|+||.||++.+ .+..+|+|.+.... .....++.+|++++++++||||++++++|. +..|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4688999999999999999987 45678999987542 233456889999999999999999999884 345999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+ |+||||||.|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999987653 48899999999999999999997 46 9999999999999999999999999987553221
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCC------
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLD------ 688 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld------ 688 (768)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... ..+.. .......
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 225 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR-PVSEGEAKESHRP 225 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC-ccccccccCCccc
Confidence 134578899999999988889999999999999999999999995332211 11110 0000000
Q ss_pred -----------------------CCCCCCC-HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 689 -----------------------PAVPDWP-VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 689 -----------------------~~~~~~~-~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
...+..+ ...+..+.+|+.+||..+|++||++.+++. +|..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0000001 113456999999999999999999999986 5553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.82 Aligned_cols=245 Identities=32% Similarity=0.456 Sum_probs=197.0
Q ss_pred cCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc-CCceeEEEeccC
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP-EFGCLIYEYMAN 540 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E~~~~ 540 (768)
++|.+.++||+|+||.||+|.+.+ ..||+|++..... ....+.+|+++++.++||||+++++.+. ...++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 569999999999999999998744 4799999975432 3457899999999999999999998774 445899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~--- 157 (262)
T cd05071 85 GSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--- 157 (262)
T ss_pred CcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc---
Confidence 999999976432 34789999999999999999999999 99999999999999999999999999986643211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
.......++..|++||+..+..++.++|||||||++|+|++ |.+||.... .....+..+.. . ..+..
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~-------~~~~~ 227 (262)
T cd05071 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M-------PCPPE 227 (262)
T ss_pred --ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-C-------CCccc
Confidence 01123346778999999988889999999999999999999 899996432 22223322210 0 11223
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+.+|+.+||+.+|.+||++.+++.
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4456899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.62 Aligned_cols=243 Identities=28% Similarity=0.437 Sum_probs=194.3
Q ss_pred CCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccC
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+|.+.+.||+|+||.||++.+.+ ..+|+|++..... ....+.+|+++++.++||||+++++++.. ..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 47788899999999999998744 4799999865432 23468889999999999999999998744 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--- 155 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--- 155 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc---
Confidence 999999876443 5899999999999999999999999 99999999999999999999999999976532111
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
.......++..|+|||++.+..++.++|||||||++|+|++ |++||..... ....+..+. .. ..+..
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~---~~~~~ 225 (256)
T cd05059 156 --TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-----RL---YRPKL 225 (256)
T ss_pred --cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-----cC---CCCCC
Confidence 00112234467999999998899999999999999999999 8999964432 222333221 11 11222
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+.+|+.+||..+|++||++.+++.
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3456999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=316.10 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=200.3
Q ss_pred hcCCCccceecccCceeEEEEEEC------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc---CCc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP---EFG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~---~~~ 531 (768)
.++|.+.+.||+|+||.||+|.+. +..|++|.+.... ......+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 467899999999999999999974 3679999987542 334566889999999999999999999873 345
Q ss_pred eeEEEeccCCChHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeec
Q 035604 532 CLIYEYMANGSLEDRLFRRGGS-----PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DF 606 (768)
+++++|+++|+|.+++...... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998764322 45899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTF 683 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~ 683 (768)
|+++.+..... ........++..|+|||++.+..++.++|||||||++||+++ |++||..... ....+..+..
T Consensus 162 g~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 237 (280)
T cd05043 162 ALSRDLFPMDY----HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237 (280)
T ss_pred CCcccccCCce----EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence 99986533211 011122346778999999988889999999999999999999 9999964432 2233333211
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
. ..+..++..+.+++.+||..+|++||++.+++..+.
T Consensus 238 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 238 L--------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred C--------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 0 111223356899999999999999999999985433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.05 Aligned_cols=249 Identities=29% Similarity=0.397 Sum_probs=198.3
Q ss_pred hcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|.+.+.||+|+||.||++...+ ..||+|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678899999999999999988743 569999987553 2344568899999999999999999998743 45
Q ss_pred eeEEEeccCCChHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEe
Q 035604 532 CLIYEYMANGSLEDRLFRRGG-------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 604 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~ 604 (768)
++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999875332 224788999999999999999999999 9999999999999999999999
Q ss_pred ecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcC
Q 035604 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENG 681 (768)
Q Consensus 605 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~ 681 (768)
|||+++.+...... .......++..|+|||.+.+..++.++|||||||++|||++ |.+||.... .....+..+
T Consensus 162 dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred CcccchhhccCccc----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 99999865432110 11123456788999999988889999999999999999998 999995332 233333332
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
... ..+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 GHL--------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCC--------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 211 111222456999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=331.62 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=195.2
Q ss_pred HHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--
Q 035604 457 EIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-- 529 (768)
Q Consensus 457 ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-- 529 (768)
++....++|.+.+.||+|+||.||++.+ .+..||+|++.... ......+.+|+.+++.++||||+++++.+.+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3344467899999999999999999988 45689999986432 2233457889999999999999999998854
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..|+||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 458999999999999988653 2788999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCC----CCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCc
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG----MLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTF 683 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~ 683 (768)
+.+.... ........||+.|+|||++.+. .++.++|||||||++|||++|++||...... ...+.....
T Consensus 190 ~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (371)
T cd05622 190 MKMNKEG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264 (371)
T ss_pred eEcCcCC-----cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 8764321 1112356799999999988654 3789999999999999999999999754432 223332211
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccC--CCChhhhhh
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKD--RPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~--RPs~~evl~ 725 (768)
.+ ..+. ....+..+.+|+..||...+.+ ||++.+++.
T Consensus 265 --~~--~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 265 --SL--TFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred --cc--cCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 00 1111 1123456889999999844433 788888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.38 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=197.4
Q ss_pred cCCCccceecccCceeEEEEEECC-----ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~ 535 (768)
++|.+.+.||+|+||.||+|.+.. ..||||...... ....+.+.+|+.+++.+.||||++++++|.+ ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 458888999999999999998632 368999987654 4456678999999999999999999998844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++..... .+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999976432 4899999999999999999999999 999999999999999999999999999866432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQV--ERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~ 692 (768)
. ........++..|+|||.+....++.++|||||||++|||++ |..||...... ...+..+....
T Consensus 161 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~------- 228 (270)
T cd05056 161 S-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP------- 228 (270)
T ss_pred c-----ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC-------
Confidence 1 111123345568999999988889999999999999999996 99999654332 22333332111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+...+..+.+++.+|+..+|.+||++.+++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 229 -MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12233456999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.20 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=195.6
Q ss_pred hcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
+++|.+.+.||+|+||.||+|.+.+ ..||+|.+.... ......|.+|+.+++.++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678999999999999999998843 568999886543 3334568899999999999999999998743 45
Q ss_pred eeEEEeccCCChHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC---cEEEe
Q 035604 532 CLIYEYMANGSLEDRLFRRGG----SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY---VSKIS 604 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~vKL~ 604 (768)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 899999999999999876432 124899999999999999999999999 99999999999998654 68999
Q ss_pred ecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcC
Q 035604 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENG 681 (768)
Q Consensus 605 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~ 681 (768)
|||+++.+..... .........+..|+|||++.+..++.++|||||||++|||++ |..||.... .....+..+
T Consensus 162 dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 162 DFGMARDIYRASY----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred cCccccccCCccc----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999987632211 011122234567999999998899999999999999999997 999996432 222223222
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. ...+...+..+.+++.+||+.+|++||++.+|+.
T Consensus 238 ~~--------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 238 GR--------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred Cc--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11 1122233456899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=323.38 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=172.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHH---HHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~---~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.-|..++.||-|+||.|.++.. +...||+|.|++.+...+.+ ++.|..||....+++||+||..|.+ ..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3477788999999999998875 45589999998765544443 5789999999999999999999955 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
+|++||++..+|.+.+ .|++...+.++.++..|+++.|..| +|||||||+|||||.+|++||+|||||+-+...
T Consensus 709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999876 5999999999999999999999999 999999999999999999999999999866321
Q ss_pred CCCccc------------------------------------cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHH
Q 035604 616 VADSVT------------------------------------QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLL 659 (768)
Q Consensus 616 ~~~~~~------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ 659 (768)
-..... .....+.+||+.|+|||++....|+..||+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 100000 01113578999999999999999999999999999999
Q ss_pred HHHhCCCCCCCh
Q 035604 660 QIITAKPPMGLA 671 (768)
Q Consensus 660 elltg~~Pf~~~ 671 (768)
||+.|++||-..
T Consensus 863 em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 863 EMLVGQPPFLAD 874 (1034)
T ss_pred HHhhCCCCccCC
Confidence 999999999543
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=318.47 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=196.7
Q ss_pred HhcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--C
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--F 530 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~ 530 (768)
..++|.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3578999999999999999998753 2379999986543 2334457889999999999999999998744 4
Q ss_pred ceeEEEeccCCChHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG-------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
.|+||||+++|+|.+++..... .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 5999999999999999975321 234567888999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHc
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIEN 680 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~ 680 (768)
+|||+++.+..... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.... .....+..
T Consensus 161 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred CcCCcccccccccc----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999986533211 111122345678999999998899999999999999999998 789996433 22233333
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+... ..+..++..+.+++.+||+.+|++||++.+++.
T Consensus 237 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 237 GGYL--------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCC--------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3221 112223456999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.96 Aligned_cols=253 Identities=30% Similarity=0.465 Sum_probs=197.3
Q ss_pred cCCCccceecccCceeEEEEEEC--Cc--cEEEEEEcCC-chhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HT--PVAIKVLRPD-AAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 534 (768)
++|.+.+.||+|+||.||+|.+. +. .+|+|.+... .......+.+|++++.++ +||||+++++++.+ ..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999873 33 4577777643 233456788999999999 89999999999844 45999
Q ss_pred EEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 535 YEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999875431 235889999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSI 678 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i 678 (768)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||..... ....+
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred EeCccccCcccchhh-------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999986431110 1112234667999999988889999999999999999998 9999954322 22222
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
..+. . ...+...+..+.+|+.+||..+|++||++.+++..+.+.+..
T Consensus 237 ~~~~-----~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 237 PQGY-----R---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred hcCC-----c---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2211 0 011122344689999999999999999999998766655544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.31 Aligned_cols=246 Identities=32% Similarity=0.464 Sum_probs=198.7
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc-CCceeEEEecc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP-EFGCLIYEYMA 539 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E~~~ 539 (768)
.++|.+.++||+|+||.||++.. +++.||+|.+..... ....+.+|+.++++++||||+++++++. ...+++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 35788999999999999999987 557899999975543 3457899999999999999999998874 34599999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05067 84 NGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc--
Confidence 9999998876443 35899999999999999999999999 99999999999999999999999999986642211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......++..|+|||++.+..++.++||||||+++|+|++ |++||..... ....+..+... .. +.
T Consensus 158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----~~---~~ 226 (260)
T cd05067 158 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-----PR---PD 226 (260)
T ss_pred ---ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----CC---CC
Confidence 11123345678999999998899999999999999999999 9999964332 22333332111 11 11
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+++.+||..+|++||++.+++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22346999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=331.64 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=201.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-C-----Cceeeeeccc--cCCc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-H-----PNMVLLLGAC--PEFG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~l~g~~--~~~~ 531 (768)
..+|.+.+.||+|+||.|.+|++ +++.||||+++.... -..+-..|+.||..|+ | -|+|+++++| ....
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 34789999999999999999998 456899999986543 3446678999999997 3 3899999997 4566
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC--CcEEEeecccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN--YVSKISDVGLA 609 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~--~~vKL~DFGla 609 (768)
|||+|++ ..+|.++|..+.- ..|+...++.++.||+.||.+||..+ |||+||||+||||... ..+||+|||.+
T Consensus 264 ciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999 6799999977544 34999999999999999999999999 9999999999999543 37899999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HH---------
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SI--------- 678 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i--------- 678 (768)
....... ...+.+..|.|||++.|.+|+.+.||||||||++||++|.+.|.+..+..+ .|
T Consensus 339 c~~~q~v---------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 339 CFESQRV---------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred cccCCcc---------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 8764322 256789999999999999999999999999999999999998854433221 00
Q ss_pred ---HcC----Cc---------------------------------cccCCC-CCCC----CCHHHHHHHHHHHHHhhhcC
Q 035604 679 ---ENG----TF---------------------------------DETLDP-AVPD----WPVEEALILAKLALQCAELR 713 (768)
Q Consensus 679 ---~~~----~~---------------------------------~~~ld~-~~~~----~~~~~~~~l~~Li~~cl~~~ 713 (768)
+.+ .+ .+...| .... .+......+.+++.+||+.|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 000 00 000011 1111 12244567999999999999
Q ss_pred ccCCCChhhhhh-HHHHHHHHH
Q 035604 714 RKDRPDLGKVVV-PKLNILRAL 734 (768)
Q Consensus 714 P~~RPs~~evl~-~~l~~l~~~ 734 (768)
|.+|+|..+.+. +++......
T Consensus 490 P~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred chhcCCHHHHhcCccccccccc
Confidence 999999999987 777654433
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.93 Aligned_cols=253 Identities=28% Similarity=0.387 Sum_probs=199.8
Q ss_pred hcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 530 (768)
.++|.+.+.||+|+||.||++...+ ..+|+|.+.... ......+.+|++++.++ +||||++++++|.. .
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 4578889999999999999998632 469999987542 23345688999999999 79999999999854 3
Q ss_pred ceeEEEeccCCChHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 035604 531 GCLIYEYMANGSLEDRLFRR-------------GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR 597 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~ 597 (768)
.+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 58999999999999998653 12345889999999999999999999998 999999999999999
Q ss_pred CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HH
Q 035604 598 NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QV 674 (768)
Q Consensus 598 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~ 674 (768)
++.+||+|||+++.+..... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDY----YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred CCeEEeCccccccccccccc----eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 99999999999987643211 011122345678999999988899999999999999999997 999996432 33
Q ss_pred HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHH
Q 035604 675 ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLN 729 (768)
Q Consensus 675 ~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~ 729 (768)
...+..+... ..+...+..+.+|+.+||..+|.+||++.+++..+.+
T Consensus 244 ~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 244 FKLLKEGYRM--------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HHHHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 3333333211 1222334569999999999999999999999865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.88 Aligned_cols=241 Identities=27% Similarity=0.441 Sum_probs=192.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
++|++.++||+|+||.||++.+ .+..||+|++... .......+.+|++++++++||||+++++.|. +..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999987 5678999998654 2334456889999999999999999999874 345899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999986542 3788889999999999999999999 9999999999999999999999999997653221
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH---------HHHHHHcCCccccCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ---------VERSIENGTFDETLD 688 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~---------~~~~i~~~~~~~~ld 688 (768)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ....+.... .
T Consensus 150 -------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~ 217 (279)
T cd06619 150 -------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----P 217 (279)
T ss_pred -------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----C
Confidence 2345789999999999998999999999999999999999999953211 111111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+..+ ....+..+.+++.+||..+|.+||++.+++. +|+
T Consensus 218 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 218 PVLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred CCCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 1111 1112345899999999999999999999985 444
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=349.28 Aligned_cols=247 Identities=26% Similarity=0.307 Sum_probs=198.0
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh---hHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ---GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
..++|.++++||+|+||.|..++. .++.||+|++++..+. ...-|..|..||..-+.++||.|+.+|.+ +.|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 357899999999999999999988 4568999999874332 34568899999999999999999999965 4599
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|||||+||+|..++.+.+ .+++..++.|+.+|+.||.-||+.| +|||||||+|||||..|++||+|||.|-.+.
T Consensus 153 VMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999998876 4999999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCCccccccccCCCCCCCCCCccccc----C-CCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCcccc
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQ----T-GMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDET 686 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ 686 (768)
.+. ..+....+|||.|++||++. + +.|+..+|+||+||++||||.|..||.-.. .....|.+..-. +
T Consensus 227 ~dG-----~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~-l 300 (1317)
T KOG0612|consen 227 ADG-----TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES-L 300 (1317)
T ss_pred CCC-----cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh-c
Confidence 332 23456789999999999876 2 569999999999999999999999995333 333444433100 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC---hhhhh
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPD---LGKVV 724 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs---~~evl 724 (768)
--|.. .+.+.+..+||...+. +|..|-. ++++-
T Consensus 301 ~FP~~----~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 301 SFPDE----TDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred CCCcc----cccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 01111 1244568888887775 5666666 66553
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=320.21 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=203.8
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
..+|.+.+.||.|+||.||++.. .+..||+|.+..........+.+|+.+++.++||||+++++.|.. ..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36789999999999999999986 578999999976555555678899999999999999999998844 45999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999988643 3789999999999999999999999 99999999999999999999999999976533211
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHH
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
......+++.|++||.+.+..++.++|||||||++|+|++|+.||............... ..+. ...+..
T Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~---~~~~-~~~~~~ 240 (297)
T cd06656 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---GTPE-LQNPER 240 (297)
T ss_pred ------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC---CCCC-CCCccc
Confidence 113346888999999999888999999999999999999999999654432221111100 0011 112233
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.+..+.+++.+||..+|.+||++.+++. +|+...
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 4456899999999999999999999986 555433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.47 Aligned_cols=252 Identities=26% Similarity=0.303 Sum_probs=192.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.. .++.||+|++.+.. ......+.+|+.++..++||||+.++++|.+ ..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999987 46789999997532 1233457889999999999999999998854 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.+... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999876432 4889999999999999999999999 999999999999999999999999999765332
Q ss_pred CCCccccccccCCCCCCCCCCcccccC-----CCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLD 688 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld 688 (768)
.. .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||..... ....+........+.
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 156 GT-----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred CC-----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 11 11123468999999998863 4578899999999999999999999965432 222232221111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhc--CccCCCChhhhhh-HHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAEL--RRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~--~P~~RPs~~evl~-~~l 728 (768)
+..+. .+..+.+++.+|+.. ++..||++.+++. +|.
T Consensus 231 ~~~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 231 PDVTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred CccCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 21112 334578888887755 3344889999886 443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.04 Aligned_cols=240 Identities=28% Similarity=0.439 Sum_probs=192.1
Q ss_pred ceecccCceeEEEEEECC-----ccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYLDH-----TPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~g 541 (768)
+.||+|+||.||+|.+.. ..||+|.+..... .....+.+|+.+++.+.|||||++++++.. ..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 469999999999997622 5799999976544 345678899999999999999999998743 458999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|.+++.... .+++..++.++.|++.||.|||..+ ++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc---
Confidence 9999997654 4899999999999999999999999 999999999999999999999999999866432210
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
........++..|+|||.+.+..++.++|||||||++|+|++ |.+||..... +...+..+... ..+...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL--------PRPEEC 223 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC--------CCCCCC
Confidence 001112234568999999998899999999999999999998 9999964432 33334333211 112223
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..+.+|+.+||..+|.+||++.+++.
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 356899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.78 Aligned_cols=233 Identities=26% Similarity=0.424 Sum_probs=183.4
Q ss_pred ceecccCceeEEEEEECC--------------ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 469 RKIGEGGYGPVYKSYLDH--------------TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~--------------~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
+.||+|+||.||+|.... ..|++|++..........+..|+.++..++||||++++++|.. ..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998521 2589999876555555578899999999999999999998844 458
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc-------EEEee
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV-------SKISD 605 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-------vKL~D 605 (768)
+||||+++|+|..++..... .+++..++.++.||+.||.|||+.+ |+||||||.|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888765432 4899999999999999999999999 999999999999987654 89999
Q ss_pred cccccccCCCCCCccccccccCCCCCCCCCCccccc-CCCCCccccHHHHHHHHHHHH-hCCCCCCChHHHHH-HHHcCC
Q 035604 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQII-TAKPPMGLAHQVER-SIENGT 682 (768)
Q Consensus 606 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~ell-tg~~Pf~~~~~~~~-~i~~~~ 682 (768)
||++..+... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||........ .+..+.
T Consensus 156 ~g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (262)
T cd05077 156 PGIPITVLSR----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ 225 (262)
T ss_pred CCCCccccCc----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC
Confidence 9998754221 2346788899999876 567899999999999999998 58999864332211 111221
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+. . ... ....+.+|+.+||+.+|.+||++.+++.
T Consensus 226 ~~-~----~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 226 CM-L----VTP----SCKELADLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred cc-C----CCC----ChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 1 111 1245899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.48 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=192.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.. .+..||+|++.... ......+.+|..++..++||||+.+++++.+ ..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999987 45689999986532 1223457889999999999999999998844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||++||+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976432 4889999999999999999999999 999999999999999999999999999866432
Q ss_pred CCCccccccccCCCCCCCCCCcccccC-----CCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLD 688 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld 688 (768)
.. .......||+.|+|||++.+ +.++.++|||||||++|+|++|+.||...... ...+......-.+.
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 156 GT-----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred Cc-----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 11 11123579999999998875 56789999999999999999999999644332 22232221111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccC--CCChhhhhh
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKD--RPDLGKVVV 725 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~--RPs~~evl~ 725 (768)
.... ..+..+.+|+.+|+..++++ |+++.+++.
T Consensus 231 ~~~~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 231 SHIT----DVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred Cccc----cCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 1122 22356888999998865544 567887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.13 Aligned_cols=254 Identities=28% Similarity=0.385 Sum_probs=199.2
Q ss_pred hcCCCccceecccCceeEEEEEECC---------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH---------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 529 (768)
.++|.+.+.||+|+||.||++.+.+ ..+|+|.+.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3679999999999999999987522 369999997643 33455688899999999 79999999998844
Q ss_pred -CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 45899999999999999976432 124889999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH-- 672 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~-- 672 (768)
+.++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchh----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999765321110 01112234568999999998889999999999999999998 899996433
Q ss_pred HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 673 QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 673 ~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
.+...+..+... ..+...+..+.+|+.+||..+|.+||++.+|+..+...
T Consensus 250 ~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 250 ELFKLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHHHHHHcCCCC--------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 223333333211 11223345689999999999999999999998544443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.95 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=193.3
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|.+.+.||.|+||.||+|.. ++..||||.+..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999987 467899999865422 223567899999999999999999999843 45999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+. ++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 688888765444346899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH---c-CCcc--------
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE---N-GTFD-------- 684 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~---~-~~~~-------- 684 (768)
.......+++.|+|||++.+. .++.++|||||||++|+|+||++||........... . +...
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 112334678899999987654 578999999999999999999999965433221111 0 0000
Q ss_pred ----------ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 685 ----------ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 685 ----------~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..............+.++.+++.+||..||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000001123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.74 Aligned_cols=242 Identities=36% Similarity=0.517 Sum_probs=197.5
Q ss_pred ceecccCceeEEEEEEC-----CccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYLD-----HTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||+|+||.||++... +..|++|++...... ....+.+|+.++..++||||+++++++.+ ..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999885 668999999866433 36678999999999999999999998854 45899999999
Q ss_pred CChHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 541 GSLEDRLFRRGG------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 541 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999977521 245899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~ 691 (768)
... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ....+..+..
T Consensus 158 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------- 225 (262)
T cd00192 158 DDY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-------- 225 (262)
T ss_pred ccc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 321 111234567889999999988899999999999999999999 6999965432 2333333221
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+...+..+.+++.+||..+|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 259 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1122233456999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=321.08 Aligned_cols=263 Identities=19% Similarity=0.180 Sum_probs=194.9
Q ss_pred ccceeccc--CceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 467 NSRKIGEG--GYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 467 ~~~~LG~G--~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
+.++||+| +||+||++.. ++..||+|.+.... ......+.+|+.+++.++|||||+++++|. +..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 7889999887 56789999997542 233446778999999999999999999883 4559999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC-
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA- 617 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~- 617 (768)
++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999865432 24899999999999999999999999 99999999999999999999999987654321110
Q ss_pred CccccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCC---
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPA--- 690 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~--- 690 (768)
............++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ....+.....++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0000011123456788999999876 4589999999999999999999999964322111 11111111111000
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHH
Q 035604 691 ----------------------------------VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRA 733 (768)
Q Consensus 691 ----------------------------------~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~ 733 (768)
........+..+.+|+.+||+.||.+|||+.+++. ++...++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~ 315 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence 00011123457999999999999999999999987 67766543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=318.62 Aligned_cols=250 Identities=28% Similarity=0.371 Sum_probs=195.7
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 536 (768)
.|+..+.||+|+||.||++.+ .++.||+|.+..... .....+.+|+.+++.++|+||+.+++.+. +..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999988 466899999865422 22345778999999999999999998874 34589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998865432 24889999999999999999999999 9999999999999999999999999997653221
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 694 (768)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+.. .... ... ..
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-~~~~-~~~---~~ 224 (285)
T cd05630 157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-LVKE-VQE---EY 224 (285)
T ss_pred -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-hhhh-hhh---hc
Confidence 112347899999999999999999999999999999999999999643211 011100 0000 000 11
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh-HHHH
Q 035604 695 PVEEALILAKLALQCAELRRKDRPD-----LGKVVV-PKLN 729 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~-~~l~ 729 (768)
+...+..+.+|+.+||+.+|.+||+ +.+++. +|..
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 2223456899999999999999999 777775 4543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.28 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=200.7
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
++|++.+.||.|+||.||++... +..|++|.+..... ..++.+|+++++.++||||+++++.+.+ ..|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57889999999999999999984 57899999975533 5689999999999999999999998844 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
.+++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999986543 25899999999999999999999999 99999999999999999999999999987643211
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
......++..|++||++.+..++.++|||||||++|+|++|++||............... ..+.. ..+...
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~-~~~~~~ 225 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPPTL-SDPEKW 225 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCCCC-Cchhhc
Confidence 112345788999999999989999999999999999999999999755443332221110 00111 112234
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..+.+++.+||+.+|.+||++.+++.
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 456999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.13 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=198.0
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
++|++.+.||+|+||.||++.+. +..||+|.+... .......+.+|++++++++||||+++++.+. ...++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888899999999999999984 678999988654 2233467889999999999999999999874 345899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
+++++|..++........+++..+..++.+++.||.|||. .+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999998888664323358999999999999999999997 47 9999999999999999999999999997653221
Q ss_pred CCccccccccCCCCCCCCCCcccccCC------CCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTG------MLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLD 688 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld 688 (768)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||..... ....+.. ...
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-----~~~ 224 (286)
T cd06622 158 --------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-----IVD 224 (286)
T ss_pred --------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH-----Hhh
Confidence 1234678899999987544 358899999999999999999999954322 1111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
...+..+...+..+.+|+.+||..+|.+||++.+++. +|+..
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 225 GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 1112233345567999999999999999999999986 45433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.76 Aligned_cols=247 Identities=27% Similarity=0.442 Sum_probs=197.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC---chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||.|+||.||++.. ++..||||.+... .......+.+|+.+++.++||||++++++|.+ ..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999986 6779999988643 22334578899999999999999999998743 458999
Q ss_pred EeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 536 EYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 536 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 22345899999999999999999999999 99999999999999999999999999876533
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH----HHHHHHcCCccccCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ----VERSIENGTFDETLDPA 690 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~----~~~~i~~~~~~~~ld~~ 690 (768)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||..... ....+.... .+.
T Consensus 159 ~~~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~ 227 (267)
T cd08229 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-----YPP 227 (267)
T ss_pred CCc------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC-----CCC
Confidence 211 11234688999999999888899999999999999999999999953321 111122111 111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+ +...+..+.+++.+||..+|.+|||+.+|+.
T Consensus 228 ~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 228 LP--SDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CC--cccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 11 1234456999999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.16 Aligned_cols=253 Identities=28% Similarity=0.399 Sum_probs=198.5
Q ss_pred HhcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCch-hhHHHHHHHHHHHhhcC-CCceeeeeccccC--
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDAA-QGRSQFQQEVEVLCNIR-HPNMVLLLGACPE-- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-- 529 (768)
..++|.+.+.||+|+||.||+|.+.+ ..||+|+++.... .....+.+|+.+|.++. |||||+++++|..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 34678889999999999999998632 4799999975432 23446889999999997 9999999999854
Q ss_pred CceeEEEeccCCChHHHHhhcCC---------------------------------------------------------
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGG--------------------------------------------------------- 552 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 552 (768)
..++||||+.+|+|.+++.+...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 45899999999999999975321
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 035604 553 --------------------------------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNIL 594 (768)
Q Consensus 553 --------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NIL 594 (768)
...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 134677888999999999999999998 999999999999
Q ss_pred EcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH
Q 035604 595 LDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ 673 (768)
Q Consensus 595 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~ 673 (768)
++.++.+||+|||+++.+...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNY----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EeCCCEEEEEecCcceeccccccc----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999865322110 11123456788999999998889999999999999999998 8999954322
Q ss_pred ---HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 674 ---VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 674 ---~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
....+..+.. +. .+...+..+.+|+.+||..+|.+||++.+++..+.
T Consensus 348 ~~~~~~~~~~~~~-----~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 348 NEQFYNAIKRGYR-----MA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred hHHHHHHHHcCCC-----CC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 2222333211 11 11223456999999999999999999999985443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=308.07 Aligned_cols=246 Identities=27% Similarity=0.449 Sum_probs=199.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC---chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||+|.. +++.||+|.++.. .......+.+|++++++++|+||+++++.+.+ ..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5789999999999999999998 4788999988643 22335678899999999999999999998844 458999
Q ss_pred EeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 536 EYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 536 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||+++|+|..++... .....+++..++.++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988653 22345899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH----HHHHHHHcCCccccCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH----QVERSIENGTFDETLDPA 690 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~----~~~~~i~~~~~~~~ld~~ 690 (768)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.... .....+..+.+..
T Consensus 159 ~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 227 (267)
T cd08224 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP----- 227 (267)
T ss_pred CCc------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC-----
Confidence 211 1123468889999999988889999999999999999999999995432 1222222222211
Q ss_pred CCCCCH-HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPV-EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~-~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+. ..+..+.+++.+||..+|.+||++.+++.
T Consensus 228 ---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 ---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111 33456899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=306.37 Aligned_cols=242 Identities=30% Similarity=0.463 Sum_probs=199.5
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEecc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYMA 539 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 539 (768)
.++|.+.+.||.|+||.||++...+..||+|.+..... ....+.+|+.+++.++||||+++++.+. ...++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 35788899999999999999999999999999976654 4567899999999999999999999874 44589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999876543 24899999999999999999999999 9999999999999999999999999998663221
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .....+..+... ..+.
T Consensus 157 ------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (256)
T cd05039 157 ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM--------EAPE 222 (256)
T ss_pred ------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--------CCcc
Confidence 12344667999999988889999999999999999997 999996442 222333332111 1112
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 23456899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.73 Aligned_cols=243 Identities=26% Similarity=0.392 Sum_probs=194.5
Q ss_pred ceecccCceeEEEEEECC---c--cEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYLDH---T--PVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~---~--~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~g 541 (768)
+.||+|+||.||++.+.. + .||||.+..... .....+.+|+.++++++||||+++++.+.+ ..++||||+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 368999999999998732 2 589999987655 556789999999999999999999988754 448999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 153 (257)
T cd05040 81 SLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--- 153 (257)
T ss_pred cHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---
Confidence 99999977543 35899999999999999999999999 999999999999999999999999999876432210
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
........++..|++||++.+..++.++|||||||++|+|++ |+.||..... ....+.... .. ...+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~-----~~~~~~~ 226 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG--ER-----LERPEAC 226 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--Cc-----CCCCccC
Confidence 001123457788999999998899999999999999999998 9999953322 222222111 00 0112223
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 456999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.05 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=206.6
Q ss_pred cCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~ 538 (768)
....+.++||+|-||.|..+...+ ..||||.++..... .+..|.+|+.+|.+|+|||||.|+|+| .+..|+|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345677899999999999999876 89999999987544 458899999999999999999999999 56779999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|..++..+... .+......+|+.||+.|+.||.+.+ +|||||.+.|+|+|.++++||+|||+++-+.....-
T Consensus 618 EnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999886432 2445556679999999999999999 999999999999999999999999999965433221
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh--CCCCCCChHHHHHHHHcCCccc-cCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQVERSIENGTFDE-TLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--g~~Pf~~~~~~~~~i~~~~~~~-~ld~~~~~~~ 695 (768)
. .....+-...|||||.+.-+.+++++|||+||+++||+++ ...||+......-.-..+.+.. .-...+...|
T Consensus 694 ~----vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 694 R----VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred e----eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 1 1234566789999999999999999999999999999875 7889964433221111122111 1112223345
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVVPKLN 729 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~ 729 (768)
..++..+.+++..||..+-++||+++++.+.+.+
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 5566778899999999999999999999876654
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.08 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=194.1
Q ss_pred cCCCccceecccCceeEEEEEEC------------------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD------------------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLL 523 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~------------------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l 523 (768)
++|++.+.||+|+||.||++.+. ...||+|++.... ......+.+|+.+|+.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999987542 2358999997543 3345678999999999999999999
Q ss_pred ecccc--CCceeEEEeccCCChHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 035604 524 LGACP--EFGCLIYEYMANGSLEDRLFRRGG--------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNI 593 (768)
Q Consensus 524 ~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NI 593 (768)
++++. +..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99874 455999999999999999876431 124778889999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh--CCCCCCCh
Q 035604 594 LLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA 671 (768)
Q Consensus 594 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--g~~Pf~~~ 671 (768)
|++.++.+||+|||+++.+..... ........++..|++||...++.++.++|||||||++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999986533211 011122345678999998888889999999999999999998 77898533
Q ss_pred HHHHH--HH----HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 672 HQVER--SI----ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 672 ~~~~~--~i----~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
..... .. .... .....+. +..++..+.+|+.+||..+|.+||++.+|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 293 (296)
T cd05095 238 SDEQVIENTGEFFRDQG-RQVYLPK----PALCPDSLYKLMLSCWRRNAKERPSFQEIHAT 293 (296)
T ss_pred ChHHHHHHHHHHHhhcc-ccccCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22111 11 0100 0011111 11233569999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.66 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=199.6
Q ss_pred HHHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeecccc----
Q 035604 456 EEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACP---- 528 (768)
Q Consensus 456 ~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~---- 528 (768)
+.+..+.++|.+.+.||+|+||.||++.. .++.+|+|++..... ....+.+|+.++..+ +||||++++++|.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 44555678999999999999999999987 567899999865332 235678899999999 6999999999862
Q ss_pred ---CCceeEEEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEe
Q 035604 529 ---EFGCLIYEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 604 (768)
Q Consensus 529 ---~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~ 604 (768)
...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 2359999999999999987642 22335889999999999999999999998 9999999999999999999999
Q ss_pred ecccccccCCCCCCccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH
Q 035604 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE 679 (768)
Q Consensus 605 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~ 679 (768)
|||+++.+.... .......|++.|+|||++. +..++.++|||||||++|+|++|+.||...........
T Consensus 167 dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 167 DFGVSAQLTSTR------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred cCCceeecccCC------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 999998653221 1123446899999999875 34578999999999999999999999975544333222
Q ss_pred cCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 680 NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 680 ~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..... .+.. ..+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 241 ~~~~~---~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 241 IPRNP---PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred ccccC---CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11111 0111 011112345899999999999999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.93 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=198.5
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.|...+.||.|+||.||+|.+ .+..||+|.+.... ......+.+|+.+++.++||||+++++.|.. ..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 366677899999999999987 45689999987543 3345578899999999999999999998844 459999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 999999887542 4889999999999999999999998 9999999999999999999999999997654321
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCCCH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+..+ ..+..+.
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 223 (277)
T cd06642 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------SPPTLEG 223 (277)
T ss_pred ----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------CCCCCCc
Confidence 112234688899999999988999999999999999999999999964432221 11111 1112233
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
..+..+.+++.+||..+|.+||++.+++. +++..
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 44567999999999999999999999996 55443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=338.17 Aligned_cols=254 Identities=29% Similarity=0.464 Sum_probs=212.8
Q ss_pred CCCccceecccCceeEEEEEEC--C---ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD--H---TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~--~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
...+.++||.|.||.||+|+++ + ..||||.|+... ...+.+|+.|..||.++.||||++|.|+... ...||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456789999999999999983 3 379999998763 4557789999999999999999999999844 448899
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||+||+|+.+|..+.+. |++.+..-++.+|+.|+.||-+.+ +|||||-..|||+|.|..+|++||||++.+.++
T Consensus 710 EyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999987754 999999999999999999999999 999999999999999999999999999987544
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCC-CC-hHHHHHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPM-GL-AHQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf-~~-~~~~~~~i~~~~~~~~ld~~~~ 692 (768)
.. ..+......-..+|.|||.+....++.+|||||||++|||.++ |..|| +. ..++...|+.|.. |
T Consensus 785 ~~---~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR---L----- 853 (996)
T KOG0196|consen 785 PE---AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR---L----- 853 (996)
T ss_pred CC---ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC---C-----
Confidence 31 1222223344678999999999999999999999999999886 88887 43 3456677777642 1
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
.-|++++..|.+|++.||++|..+||.+.+++..+-+++++
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 12556667799999999999999999999999877766655
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=309.39 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=197.6
Q ss_pred HHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 459 EEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 459 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
+.+++++.....||+|+||.||+|.+ ++..||+|.+..........+.+|+.+++.++||||+++++++.. ..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34566777778999999999999987 456799999877666666789999999999999999999998844 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCcEEEeecccccccC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARLVP 613 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~vKL~DFGla~~~~ 613 (768)
|||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999876432211278888899999999999999998 999999999999976 6799999999997653
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCC--CCccccHHHHHHHHHHHHhCCCCCCChHHHHHH-HHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQIITAKPPMGLAHQVERS-IENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~-i~~~~~~~~ld~~ 690 (768)
.... ......|+..|+|||++.+.. ++.++||||||+++|+|++|++||......... ...+. ...
T Consensus 161 ~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~ 229 (268)
T cd06624 161 GINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM-----FKI 229 (268)
T ss_pred cCCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh-----hcc
Confidence 2111 112346789999999886643 789999999999999999999999643221111 11110 011
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+......+.+++.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 12223334456899999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.78 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=197.3
Q ss_pred hcCCCccceecccCceeEEEEEEC--Cc---cEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HT---PVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~---~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
.++|...+.||+|+||.||+|... +. .+|+|.+.... ......+.+|+.+++.++||||+++++++.+ ..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999873 22 69999987552 3345678899999999999999999999854 4489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999886543 24899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~ 690 (768)
...... ........+..|++||++.+..++.++|||||||++|||++ |+.||.... .....+..+. ..+.
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~----~~~~ 231 (268)
T cd05063 159 DDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF----RLPA 231 (268)
T ss_pred cccccc---eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC----CCCC
Confidence 321110 11112233567999999988889999999999999999997 999995332 3333343321 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
+...+..+.+++.+||..+|.+||++.+|+..+
T Consensus 232 ----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 232 ----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred ----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 122335689999999999999999999998533
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.77 Aligned_cols=244 Identities=23% Similarity=0.380 Sum_probs=198.2
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
+|.+.+.||.|+||.||++.. ++..||+|.++.. .....+.+.+|+.+++.++||||+++++.+.+ ..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478889999999999999987 5678999998643 23345678899999999999999999998844 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... ..+++...+.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 99999998865332 34789999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ...+..+.+.. .+.
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (255)
T cd08219 155 ----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP--------LPS 222 (255)
T ss_pred ----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC--------CCc
Confidence 1123356889999999999888999999999999999999999999754432 22333333221 112
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+|+.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 23345889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.61 Aligned_cols=193 Identities=25% Similarity=0.404 Sum_probs=156.6
Q ss_pred cceecccCceeEEEEEEC----CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC----CceeEEEecc
Q 035604 468 SRKIGEGGYGPVYKSYLD----HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCLIYEYMA 539 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~E~~~ 539 (768)
.++||+|+||.||+|... +..||+|.+..... ...+.+|+.+|+.++||||+++++++.. ..|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999863 35799999875432 2356789999999999999999998732 3489999985
Q ss_pred CCChHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----cCCCcEEEeecccc
Q 035604 540 NGSLEDRLFRRG------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL----DRNYVSKISDVGLA 609 (768)
Q Consensus 540 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~vKL~DFGla 609 (768)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57887765321 1224889999999999999999999999 9999999999999 45689999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCC
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMG 669 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~ 669 (768)
+.+..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 160 ~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCc---cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 87643221 1112245678999999998876 458999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.93 Aligned_cols=250 Identities=30% Similarity=0.468 Sum_probs=198.2
Q ss_pred hcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|++.+.||+|+||.||++.+. ++.||+|++.... ......+.+|+.+++.++||||++++++|.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 4689999987543 3345678899999999999999999998854 45
Q ss_pred eeEEEeccCCChHHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 035604 532 CLIYEYMANGSLEDRLFRRG-------------------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGN 592 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~N 592 (768)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999987432 1134788899999999999999999998 9999999999
Q ss_pred eEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh
Q 035604 593 ILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA 671 (768)
Q Consensus 593 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~ 671 (768)
||++.++.+||+|||++..+..... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCcc----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999876532211 001112234667999999988899999999999999999997 88888432
Q ss_pred --HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 672 --HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 672 --~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
......+..+... ..+...+..+.+|+.+||..+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~ 285 (288)
T cd05050 237 AHEEVIYYVRDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285 (288)
T ss_pred CHHHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 2333344444321 1122334569999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.51 Aligned_cols=245 Identities=25% Similarity=0.437 Sum_probs=204.2
Q ss_pred CCCccceecccCceeEEEEEECCc--cEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEEecc
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMA 539 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~~~--~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~~ 539 (768)
.|.++..||.|+||.||++....+ ..|.|++........++|.-|++||..+.||+||+|++.| ....+|++|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 466777899999999999998655 4688998777777788999999999999999999999875 556689999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
||-.+..+...+. .|++.++..+++|++.||.|||+.+ |||||||..|||++.+|.++|+|||.+....
T Consensus 113 GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred CchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch------
Confidence 9999888877654 5999999999999999999999999 9999999999999999999999999986432
Q ss_pred cccccccCCCCCCCCCCcccc-----cCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH--cCCccccCCCCCC
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQ-----QTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE--NGTFDETLDPAVP 692 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~-----~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~--~~~~~~~ld~~~~ 692 (768)
.+..+..++.||++|||||+. ...+|++++||||||+.|.||.-+.||-.....+.-.++ +..-..++.| .
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP--S 259 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP--S 259 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc--c
Confidence 233455789999999999964 467899999999999999999999999876666554443 3222222222 2
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.|. ..+.+++..||..||+.||++.+++.
T Consensus 260 ~Ws----~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 HWS----RSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhh----hHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 343 45889999999999999999999873
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.46 Aligned_cols=245 Identities=30% Similarity=0.439 Sum_probs=196.3
Q ss_pred cCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEeccC
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMAN 540 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~ 540 (768)
++|.+...||+|+||.||++.+.+ ..+|+|.+..... ....+.+|+.+++.++||||+++++++.. ..++||||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 468888999999999999998754 4799998865432 34568899999999999999999998744 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.....
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 85 GSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc---
Confidence 999999876432 34889999999999999999999999 99999999999999999999999999986633211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
.......++..|++||...+..++.++|||||||++|+|++ |+.||...... ...+..+. . + ..+..
T Consensus 158 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~----~---~~~~~ 227 (260)
T cd05069 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R----M---PCPQG 227 (260)
T ss_pred --cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C----C---CCCcc
Confidence 11122345678999999988889999999999999999999 99999644322 22222221 1 1 11223
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+.+++.+||..+|.+||++.+|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 3456999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.88 Aligned_cols=246 Identities=27% Similarity=0.360 Sum_probs=188.9
Q ss_pred ceecccCceeEEEEEEC-----CccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeecccc---CCceeEEEecc
Q 035604 469 RKIGEGGYGPVYKSYLD-----HTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP---EFGCLIYEYMA 539 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~---~~~~lV~E~~~ 539 (768)
+.||+|+||.||+|.+. ...||+|.+... .......+.+|+.+++.++||||++++++|. ...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 35899999999999862 246999998543 3344567889999999999999999999763 23589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999876432 3677888899999999999999998 9999999999999999999999999997653221100
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
........++..|+|||.+.+..++.++|||||||++|||++ |.+||..... ....+..+.. + ..+.
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~-----~---~~~~ 225 (262)
T cd05058 156 --VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-----L---LQPE 225 (262)
T ss_pred --ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-----C---CCCC
Confidence 011123456778999999988899999999999999999999 5667753322 2222322211 1 1111
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhhHHHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVVPKLN 729 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~ 729 (768)
..+..+.+++..||..+|.+||++.+++..+.+
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 223468999999999999999999999854443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.78 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=195.1
Q ss_pred cCCCccceecccCceeEEEEEE------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC----Cc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FG 531 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 531 (768)
..|.+.+.||+|+||.||++.+ .+..||+|.++... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999874 35679999987553 3344678999999999999999999998844 35
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+++++|.+++.+... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999865432 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH-----------------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV----------------- 674 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~----------------- 674 (768)
+...... ........++..|+|||++.+..++.++|||||||++|+|+++..|+......
T Consensus 159 ~~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 159 IETDKEY---YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccCccc---eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 6432211 01112345677899999998888999999999999999999987765321111
Q ss_pred HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 675 ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 675 ~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
...+..+.. ...+..++..+.+|+.+||+.+|.+||++.+++..
T Consensus 236 ~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 VRVLEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 011111111 01112234569999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.09 Aligned_cols=231 Identities=25% Similarity=0.408 Sum_probs=180.8
Q ss_pred eecccCceeEEEEEEC--------------------------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeee
Q 035604 470 KIGEGGYGPVYKSYLD--------------------------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLL 523 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~~--------------------------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l 523 (768)
+||+|+||.||+|.+. ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999998741 12589999876554445568889999999999999999
Q ss_pred eccccC--CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC--
Q 035604 524 LGACPE--FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-- 599 (768)
Q Consensus 524 ~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-- 599 (768)
+++|.+ ..++||||+++|+|..++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999844 45899999999999988865432 4889999999999999999999998 99999999999997643
Q ss_pred -----cEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHH-hCCCCCCChH
Q 035604 600 -----VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQII-TAKPPMGLAH 672 (768)
Q Consensus 600 -----~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~ell-tg~~Pf~~~~ 672 (768)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4799999988643211 22357788999998765 56899999999999999985 7999996432
Q ss_pred HH--HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 673 QV--ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 673 ~~--~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. ...+.... ..+ ......+.+|+.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~-------~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 227 PSEKERFYEKKH-------RLP---EPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred hHHHHHHHHhcc-------CCC---CCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 21 11111110 011 111235899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.59 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=195.3
Q ss_pred cCCCccceecccCceeEEEEEEC--C---ccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--H---TPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~---~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
..|.+.+.||+|+||.||+|.+. + ..||||++... .......|..|+.+++.++||||+++++++.+ ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35788899999999999999873 2 25999998754 33445679999999999999999999998844 34899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998876433 4899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
..... ..........+..|++||++.+..++.++|||||||++||+++ |..||.... .....+..+. . .+
T Consensus 159 ~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~---~~-- 231 (269)
T cd05065 159 DTSDP-TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-R---LP-- 231 (269)
T ss_pred Ccccc-ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-c---CC--
Confidence 22110 0000111122457999999999999999999999999999886 999995433 2223332221 0 01
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
.+.+.+..+.+++.+||..+|.+||++.+++..
T Consensus 232 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 232 --PPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred --CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112233558999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.97 Aligned_cols=252 Identities=27% Similarity=0.382 Sum_probs=198.5
Q ss_pred hcCCCccceecccCceeEEEEEEC---------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 529 (768)
.++|.+.+.||+|+||.||++... +..||+|.+.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888999999999999998741 2369999987542 34456788999999999 89999999998844
Q ss_pred -CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 45899999999999999976421 234788899999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--H
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--H 672 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~ 672 (768)
+.++.+||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||... .
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred cCCCcEEECCCccceecccccc----cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9999999999999986643211 111123345678999999988889999999999999999998 88898533 2
Q ss_pred HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 673 QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 673 ~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
.+...+..+... ..+..++..+.+|+.+||..+|.+||++.+++..+.
T Consensus 247 ~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 247 ELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred HHHHHHHcCCcC--------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 333334333211 111233456999999999999999999999985443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.73 Aligned_cols=238 Identities=29% Similarity=0.432 Sum_probs=193.9
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E 536 (768)
.|..++.||.|+||.||.+++ +...||||.+..... ....++.+|+..|.+++|||+|.+-|+| ....+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 366678899999999999887 556899999976543 4466789999999999999999999998 445699999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|| -|+-.|+|.-... ++-+..+.-|+.+.+.||.|||+.+ .||||||..|||+..+|.|||+|||.|.++.+.
T Consensus 107 YC-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HH-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 99 5677777754332 4888999999999999999999999 999999999999999999999999999876432
Q ss_pred CCccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCC--
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAV-- 691 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~-- 691 (768)
.+++|||+|||||++. .+.|+-++||||||++..||...+||+...+-+.....-.. .-.|.+
T Consensus 180 ---------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ---NesPtLqs 247 (948)
T KOG0577|consen 180 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NESPTLQS 247 (948)
T ss_pred ---------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh---cCCCCCCC
Confidence 5789999999999765 46799999999999999999999999755544433222111 111222
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
++|. ..+..++..||++-|.+|||.++++
T Consensus 248 ~eWS----~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 248 NEWS----DYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred chhH----HHHHHHHHHHHhhCcccCCcHHHHh
Confidence 2343 4599999999999999999998865
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.09 Aligned_cols=247 Identities=30% Similarity=0.449 Sum_probs=194.9
Q ss_pred CCccceecccCceeEEEEEECC--ccEEEEEEcCCchhhHH--HHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDAAQGRS--QFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~--~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
|++.+.||+|+||+||++...+ ..||+|++......... ...+|+.+++.++||||+++++++. ...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778899999999999999954 46999999876543322 3456999999999999999999984 4458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
.+++|.+++.... .+++..++.++.||+.||.+||+.+ |+|+||||+||+++.++.++|+|||++..+..
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---- 150 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE---- 150 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS----
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc----
Confidence 9999999998443 4899999999999999999999999 99999999999999999999999999976411
Q ss_pred ccccccccCCCCCCCCCCccccc-CCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.........++..|+|||++. +..++.++||||||+++|+|++|..||... ......+........ ...... .
T Consensus 151 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~ 226 (260)
T PF00069_consen 151 --NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL-PSSSQQ-S 226 (260)
T ss_dssp --TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH-HHHTTS-H
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc-cccccc-c
Confidence 112234567899999999988 888999999999999999999999999755 111111111110000 000000 0
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
......+.+++.+||+.+|.+||++.+++.
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001256999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.03 Aligned_cols=248 Identities=29% Similarity=0.466 Sum_probs=196.8
Q ss_pred cCCCccceecccCceeEEEEEEC-----CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-----HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV 534 (768)
.+|.+.+.||+|+||.||+|.+. +..+|+|.+.... ......+.+|+.+++.++||||+++++++. +..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999862 2369999987543 233567899999999999999999999874 345899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999976542 4899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
.... ........++..|++||++.+..++.++|+|||||++|++++ |..||.... .....+..+.. .+
T Consensus 159 ~~~~---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----~~-- 229 (267)
T cd05066 159 DPEA---AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----LP-- 229 (267)
T ss_pred ccce---eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc----CC--
Confidence 2111 011122334568999999998889999999999999999886 999995432 23333433311 01
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
.+...+..+.+++.+|++.+|.+||++.+++..
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 230 --APMDCPAALHQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred --CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHH
Confidence 112233568999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=315.13 Aligned_cols=254 Identities=27% Similarity=0.386 Sum_probs=198.6
Q ss_pred cCCCccceecccCceeEEEEEEC---------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE-- 529 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 529 (768)
++|.+.+.||+|+||.||++... ...||+|+++... ......+.+|+.+++.+ +||||++++++|.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999998752 2368999987542 33455688999999999 69999999998854
Q ss_pred CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD 596 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~ 596 (768)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 45899999999999999976421 235889999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--H
Q 035604 597 RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--Q 673 (768)
Q Consensus 597 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~ 673 (768)
.++.+||+|||+++.+...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYY----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred CCCcEEEccccccccccccccc----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999866322110 01112234567999999988899999999999999999999 899996432 3
Q ss_pred HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 674 VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 674 ~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
....+..+... ..+..++..+.+|+.+||..+|.+||++.+++..+....
T Consensus 245 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 LFKLLREGHRM--------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHcCCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 33344333211 112223346889999999999999999999985444333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.26 Aligned_cols=257 Identities=23% Similarity=0.315 Sum_probs=195.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
++|.+.+.||.|+||.||++.+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.. ..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5789999999999999999987 45789999986543 2223457789999999999999999999844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+. ++|..++..... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 96 688888865432 4889999999999999999999999 9999999999999999999999999997543211
Q ss_pred CccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc-------CCcccc-
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN-------GTFDET- 686 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~-------~~~~~~- 686 (768)
.......+++.|+|||++.+. .++.++|||||||++|+|++|++||........ .+.. ..+...
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 112234678899999987654 578999999999999999999999964332111 0000 000000
Q ss_pred -----CCCCCCC--------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 687 -----LDPAVPD--------WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 687 -----ld~~~~~--------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.....+. .....+..+.+|+.+||..+|.+||++.+++. +|...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0000011 11123446889999999999999999999986 665444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=333.47 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=192.5
Q ss_pred hcCCCccceecccCceeEEEEEEC----CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD----HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
..+|.+.+.||+|+||.||++... +..||+|.+... ..+.+|+.+|+.++|||||++++++.. ..|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999998753 357999988643 235689999999999999999988843 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|++. ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9994 68888884433 4899999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH------HHHHHHHcCC-------
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH------QVERSIENGT------- 682 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~------~~~~~i~~~~------- 682 (768)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .+...+..-.
T Consensus 239 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 239 PD----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cc----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 21 112234679999999999999999999999999999999999999994321 1111111000
Q ss_pred -------------ccccCCCCC--CCC--CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 683 -------------FDETLDPAV--PDW--PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 683 -------------~~~~ld~~~--~~~--~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+.....+.. +.. .......+.++|.+||..+|.+||++.+++. ++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 000000000 000 0112346889999999999999999999986 444
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.64 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=205.4
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEecc
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYMA 539 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 539 (768)
-|+++.+||+|+||.||++.+ .|..+|||.+..+. ..+.+.+|+.||++++.|++|++||.|. ...+||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 477889999999999999987 56789999986543 3567889999999999999999999873 34599999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
.|++.+.+..+.. +|+++++..++...++||+|||... -||||||..|||++.+|+.||+|||.|..+...
T Consensus 112 AGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT---- 182 (502)
T KOG0574|consen 112 AGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT---- 182 (502)
T ss_pred CCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh----
Confidence 9999998876543 6999999999999999999999998 899999999999999999999999999876443
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEA 699 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~ 699 (768)
..+.....||+.|||||++..-.|+.++||||||+...||..|++||...+.++....- ..-.|.--.-|..-+
T Consensus 183 --MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 183 --MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PTKPPPTFKKPEEWS 256 (502)
T ss_pred --HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cCCCCCCCCChHhhh
Confidence 23346679999999999999999999999999999999999999999888876542211 111111112355556
Q ss_pred HHHHHHHHHhhhcCccCCCChhhhh
Q 035604 700 LILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 700 ~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
.++.+++..||-++|++|-++.+++
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLC 281 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHh
Confidence 7799999999999999999998876
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=318.68 Aligned_cols=254 Identities=28% Similarity=0.387 Sum_probs=198.6
Q ss_pred cCCCccceecccCceeEEEEEEC---------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE-- 529 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 529 (768)
.+|.+.+.||+|+||.||++... ...||+|+++... ......+.+|+.+++++ +||||++++++|..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999998752 1268999887542 33456789999999999 79999999999854
Q ss_pred CceeEEEeccCCChHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRG-------------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD 596 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~ 596 (768)
..+++|||+++|+|.+++.... ....+++..+..++.|++.||.|||..+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 4589999999999999987642 1234788999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--H
Q 035604 597 RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--Q 673 (768)
Q Consensus 597 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~ 673 (768)
.++.+||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CCCcEEECCcccceecccccc----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999986533211 011122344567999999999999999999999999999998 899995432 3
Q ss_pred HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 674 VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 674 ~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
....+..+... ..+...+..+.+|+.+||..+|.+||++.+++..+.+.+
T Consensus 245 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 LFKLLKEGHRM--------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHcCCCC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 33333333211 111223346899999999999999999999986554444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=304.40 Aligned_cols=240 Identities=26% Similarity=0.417 Sum_probs=190.9
Q ss_pred ceecccCceeEEEEEE-CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCChH
Q 035604 469 RKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSLE 544 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~ 544 (768)
++||+|+||.||+|.. +++.||+|+++.... .....+.+|+++++.++||||++++++|.. ..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999987 456899999876532 334468899999999999999999999844 458999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcccccc
Q 035604 545 DRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYR 624 (768)
Q Consensus 545 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 624 (768)
+++..... .+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... .
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~ 150 (250)
T cd05085 81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----S 150 (250)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-----c
Confidence 98865432 4789999999999999999999999 999999999999999999999999999754332111 1
Q ss_pred ccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHHHHH
Q 035604 625 MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEALI 701 (768)
Q Consensus 625 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~ 701 (768)
.....++..|+|||++.+..++.++||||||+++|++++ |..||..... ....+..+... . .+...+..
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~ 222 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-----S---CPQKCPDD 222 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC-----C---CCCCCCHH
Confidence 112244567999999998889999999999999999998 9999964432 22333332211 1 11123356
Q ss_pred HHHHHHHhhhcCccCCCChhhhhhH
Q 035604 702 LAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 702 l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
+.+|+.+||..+|.+||++.+++..
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=308.15 Aligned_cols=246 Identities=24% Similarity=0.299 Sum_probs=185.4
Q ss_pred ceecccCceeEEEEEECC----ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYLDH----TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 541 (768)
+.||+|+||.||+|...+ ..+|+|.++... ......+.+|+.+++.++||||+++++.|.+ ..++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 359999999999998632 368999987553 2334578899999999999999999998854 458999999999
Q ss_pred ChHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 542 SLEDRLFRRG--GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 542 sL~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 9999987533 2234667788899999999999999999 99999999999999999999999999975432211
Q ss_pred cccccccCCCCCCCCCCcccccCC-------CCCccccHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHcCCccccCCC
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTG-------MLGVKSDVYSLGILLLQIIT-AKPPMGLAHQVE--RSIENGTFDETLDP 689 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~~--~~i~~~~~~~~ld~ 689 (768)
........++..|+|||++.+. .++.++|||||||++|||++ |..||....... .....+.......+
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 156 --YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred --eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 1111234578889999987542 35789999999999999996 999996443222 11112211222222
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. ....+..+.+|+..|+ .+|.+||++.+|+.
T Consensus 234 ~~---~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RL---KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cc---CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 22 1123345888999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.50 Aligned_cols=249 Identities=26% Similarity=0.290 Sum_probs=191.7
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.+. +..||+|++.+.. ......+..|+.++..++||||+++++.+.+ ..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999884 4679999986432 1223347889999999999999999998844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.+... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976432 4899999999999999999999999 999999999999999999999999999754321
Q ss_pred CCCccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLD 688 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld 688 (768)
. ........||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...+.......
T Consensus 156 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--- 227 (332)
T cd05623 156 G-----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--- 227 (332)
T ss_pred C-----cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc---
Confidence 1 11123357999999999876 346889999999999999999999999654332 22332221111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCc--cCCCChhhhhh
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRR--KDRPDLGKVVV 725 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P--~~RPs~~evl~ 725 (768)
..+......+..+.+|+.+|+..++ ..||++.+++.
T Consensus 228 -~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 228 -QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred -cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 1111112234568889999886544 44788998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=313.63 Aligned_cols=246 Identities=25% Similarity=0.457 Sum_probs=195.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCc----cEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHT----PVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~----~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 534 (768)
++|+..+.||+|+||.||++.+ .+. .||+|.+..... .....+.+|+.+++.++||||+++++.|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 5678889999999999999986 333 479998875532 334468899999999999999999998843 45799
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
+||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999876432 4889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~ 691 (768)
... ........++..|++||++.+..++.++|||||||++|||++ |..||... ......+..+... +..
T Consensus 162 ~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----~~~ 233 (303)
T cd05110 162 DEK----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL----PQP 233 (303)
T ss_pred ccc----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC----CCC
Confidence 211 111223455778999999998899999999999999999997 99999543 3333444433211 111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+. ++..+.+++..||..+|.+||++.+++.
T Consensus 234 ~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 234 PI----CTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred CC----CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 2345899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=303.73 Aligned_cols=244 Identities=26% Similarity=0.417 Sum_probs=198.8
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC---CceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---FGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~lV~E 536 (768)
+|++.+.||.|+||.||++.. ++..||+|.+.... ......+.+|++++++++|||++++++.+.. ..|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488899999999999999887 45689999986432 2344568899999999999999999988642 2489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++++|.+++..... ..+++.+++.++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999998876432 34899999999999999999999999 9999999999999999999999999998663321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~ 694 (768)
. ......+++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.+. ..
T Consensus 157 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~ 222 (257)
T cd08223 157 D------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--------PM 222 (257)
T ss_pred C------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------CC
Confidence 1 12345688999999999999999999999999999999999999964432 22233333221 12
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+++.+||..+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 2334456999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.59 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=197.4
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-----hhhHHHHHHHHHHHhhcCCCceeeeeccccC----Cc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-----AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FG 531 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 531 (768)
.+|.+.+.||+|+||.||++.+ ++..||||.+.... ......+.+|+.++++++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999987 46789999885321 2234568889999999999999999998754 34
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+++++|.+++.... .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 78999999999999887654 3788999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~ 691 (768)
+..... .........|+..|+|||.+.+..++.++|||||||++|+|++|+.||............ . ..+..
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~----~~~~~ 227 (265)
T cd06652 156 LQTICL---SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-A----TQPTN 227 (265)
T ss_pred cccccc---cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH-h----cCCCC
Confidence 532111 111123346889999999998888999999999999999999999999754333322111 1 11112
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..+......+.+++.+|+. +|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 23344555678899999994 9999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.29 Aligned_cols=240 Identities=29% Similarity=0.430 Sum_probs=196.4
Q ss_pred cCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc-CCceeEEEeccCC
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP-EFGCLIYEYMANG 541 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E~~~~g 541 (768)
++|.+.+.||+|+||.||++...+..||+|.++... ....+.+|+.+++.++||||+++++++. +..++||||+.++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 458889999999999999999999999999987543 2356889999999999999999999874 3458999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99999876543 34889999999999999999999998 9999999999999999999999999987543211
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.....+..|+|||++.+..++.++|||||||++|+|++ |++||.... .....+..+.... .+...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~ 222 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME--------PPEGC 222 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC--------CCCcC
Confidence 12234567999999988899999999999999999997 999995433 2333333332111 11223
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 456889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=310.11 Aligned_cols=243 Identities=26% Similarity=0.382 Sum_probs=199.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
++|.+.+.||.|+||.||++.+ +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+ ..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3688889999999999999987 56789999987543 3334568899999999999999999998743 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999988654 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~~ 695 (768)
.......++..|++||++.+..++.++|||||||++|+|++|++||........ .+..+ ..+..+...
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~ 222 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-----NPPSLEGNK 222 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-----CCCCCcccc
Confidence 112345788899999999988899999999999999999999999965443221 12222 112221111
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+.+++.+||..+|++||++.+++.
T Consensus 223 --~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 223 --FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 3456899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.76 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=197.2
Q ss_pred hcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 530 (768)
.++|.+.+.||+|+||.||++... +..||+|+++... ......+.+|+.+++++ +||||++++++|.. .
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457999999999999999998751 2369999987543 23345688999999999 79999999998844 4
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.++||||+.+|+|.+++..... ..+++.++..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 5899999999999999875432 24899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH---HHHHHHcCCcccc
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ---VERSIENGTFDET 686 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~---~~~~i~~~~~~~~ 686 (768)
.+..... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ....+..+..
T Consensus 190 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~--- 262 (302)
T cd05055 190 DIMNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--- 262 (302)
T ss_pred cccCCCc----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc---
Confidence 6543211 011123356788999999998899999999999999999998 9999964332 2223332211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
... +...+..+.+|+.+||..+|++||++.+++..
T Consensus 263 --~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 263 --MAQ---PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred --CCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 111 11123469999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.38 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=199.4
Q ss_pred HHHHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeecccc---
Q 035604 455 IEEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACP--- 528 (768)
Q Consensus 455 ~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--- 528 (768)
..++....+.|++.+.||.|+||.||+|.+ .+..||+|++..... ....+..|+.+++++ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 344445678899999999999999999998 557899999865432 345688999999998 6999999999873
Q ss_pred -----CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 529 -----EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 529 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
...|++|||+.+|+|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 234899999999999998865432 24788889999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHH
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSI 678 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i 678 (768)
+|||++....... .......|++.|+|||.+. +..++.++|||||||++|+|++|..||..........
T Consensus 163 ~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 163 VDFGVSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred eeCcchhhhhccc------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 9999987653211 1123457899999999875 3468889999999999999999999996544332221
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.... ...+.. .....+..+.+|+.+||..+|.+||++.+++.
T Consensus 237 ~~~~---~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LIPR---NPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hHhh---CCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1111 111111 01123456999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=306.65 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=195.2
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-----hhhHHHHHHHHHHHhhcCCCceeeeeccccC----Cc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-----AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FG 531 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 531 (768)
.+|...+.||+|+||.||++.. .+..||+|.+.... ......+.+|+.+++.++||||+++++.+.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788999999999999999987 56789999986432 1234568899999999999999999998743 34
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
+++|||+++++|.+++.... .+++...+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 78999999999999987644 3889999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~ 691 (768)
+...... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||.............. ....+
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-- 228 (266)
T cd06651 156 LQTICMS---GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTNP-- 228 (266)
T ss_pred ccccccc---CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc--CCCCC--
Confidence 5321110 0111234588899999999988899999999999999999999999975543322211111 11122
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+......+..++ .||..+|.+||++.+|+.
T Consensus 229 -~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 -QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 23333445577777 788899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=308.47 Aligned_cols=244 Identities=27% Similarity=0.368 Sum_probs=183.3
Q ss_pred eecccCceeEEEEEE-C---CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCC
Q 035604 470 KIGEGGYGPVYKSYL-D---HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGS 542 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~-~---~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gs 542 (768)
.||+|+||.||+|.. . ...+|+|.+.... ......+.+|+.+++.++||||+++++.|.+ ..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 599999999999975 2 2368888876443 2334568899999999999999999998854 4599999999999
Q ss_pred hHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 543 LEDRLFRRGG--SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 543 L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|.+++..... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999976432 223567888899999999999999999 99999999999999999999999999865422110
Q ss_pred ccccccCCCCCCCCCCccccc-------CCCCCccccHHHHHHHHHHHHh-CCCCCCChHHH---HHHHHcCCccccCCC
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQ-------TGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQV---ERSIENGTFDETLDP 689 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~---~~~i~~~~~~~~ld~ 689 (768)
........++..|+|||++. ...++.++|||||||++|||++ |..||...... ...+..+. .....+
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 233 (269)
T cd05042 156 -YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD-IKLPKP 233 (269)
T ss_pred -eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-ccCCCC
Confidence 00112335677899999864 3356889999999999999999 88898644322 12222221 112122
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.++...+..+.+++..|| .+|++||++.+|+.
T Consensus 234 ---~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 ---QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 223334455778888898 59999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=311.94 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=202.3
Q ss_pred CCHHHHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccC
Q 035604 453 YSIEEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE 529 (768)
Q Consensus 453 ~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~ 529 (768)
+...++..++++|.+.+.||+|+||.||++.. +++.+|+|++..... ....+.+|+.++.++ +||||++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44566667789999999999999999999987 567899999865432 235678899999998 79999999998732
Q ss_pred -------CceeEEEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 530 -------FGCLIYEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 530 -------~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 358999999999999988642 12235899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCC-----CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-----MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER 676 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~ 676 (768)
||+|||++..+..... ......|+..|+|||.+... .++.++|||||||++|+|++|++||........
T Consensus 168 kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred EEeecccchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 9999999986532211 11234688999999987543 368899999999999999999999975544332
Q ss_pred H--HHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 677 S--IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 677 ~--i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. +..+......+ +......+.+|+.+||..+|.+||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 LFKIPRNPPPTLLH------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHhcCCCCCCCc------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2 22221111111 1223346999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=328.26 Aligned_cols=237 Identities=24% Similarity=0.404 Sum_probs=194.4
Q ss_pred cceecccCceeEEEEEECCc--cEEEEEEcC----CchhhHHHHHHHHHHHhhcCCCceeeeeccccCC----ceeEEEe
Q 035604 468 SRKIGEGGYGPVYKSYLDHT--PVAIKVLRP----DAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF----GCLIYEY 537 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~--~vAvK~l~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----~~lV~E~ 537 (768)
...||+|+|-+||+|.+..+ .||--.++. ......+.|..|+++|+.|+|||||++|.+|.+. ..+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 34699999999999998544 444322221 1234457799999999999999999999998442 3678999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DFGla~~~~~~~ 616 (768)
|..|+|..|+.+.+. +..+.+..|+.||++||.|||++. +||||||||.+||+|+.+ |.|||+|+|||+++..+.
T Consensus 125 ~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999988764 788899999999999999999987 599999999999999765 899999999999875443
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCC---ChHHHHHHHHcCCccccCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMG---LAHQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~---~~~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
+ .+..|||.|||||+.. ..|+..+||||||++|+||.|+..||. ...++.+++-.|.....+..
T Consensus 201 a--------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k---- 267 (632)
T KOG0584|consen 201 A--------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK---- 267 (632)
T ss_pred c--------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc----
Confidence 2 4579999999999877 789999999999999999999999995 45566667766654333221
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+++.+||.+|+.. ..+||++.++|.
T Consensus 268 ---V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 ---VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1124699999999999 999999999986
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.78 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=199.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~ 535 (768)
+.|...++||+||||.||-++. +|+.||.|.+.+.. ..+.....+|-.||.+++.|.||.|-.+| .+..||||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5588889999999999997665 78899999986542 23344567999999999999999998887 55669999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
..|.||+|.-.|...++ +.|++...+.++.+|+.||++||+.+ ||+|||||+|||+|+.|++.|+|+|||.-++..
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999988877654 57999999999999999999999999 999999999999999999999999999877543
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
. .....+||..|||||++.++.|+...|+|||||++|||+.|+.||..... +++...+...+....-.++
T Consensus 341 ~-------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke---Kvk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 341 K-------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE---KVKREEVDRRTLEDPEEYS 410 (591)
T ss_pred C-------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh---hhhHHHHHHHHhcchhhcc
Confidence 2 23455999999999999999999999999999999999999999953221 1111111111111122456
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~ 721 (768)
...+.+...|+...|..||.+|--..
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCC
Confidence 66777899999999999999997654
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=314.88 Aligned_cols=242 Identities=23% Similarity=0.345 Sum_probs=194.8
Q ss_pred CCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEeccC
Q 035604 465 FSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYMAN 540 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~ 540 (768)
|.....||+|+||.||++.. .++.||+|++..........+.+|+.++..++||||+++++.|. +..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33445799999999999987 57899999997654445567889999999999999999999874 456999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
++|..++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--- 172 (297)
T cd06659 103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--- 172 (297)
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc---
Confidence 9999877542 3889999999999999999999999 99999999999999999999999999976533211
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||........ .+..... ..... ....
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~----~~~~ 243 (297)
T cd06659 173 ---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP--PKLKN----AHKI 243 (297)
T ss_pred ---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--CCccc----cCCC
Confidence 12345789999999999988899999999999999999999999965443322 2221111 00111 1122
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..+.+++.+||+.+|.+||++.+++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 345889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.65 Aligned_cols=243 Identities=30% Similarity=0.476 Sum_probs=189.6
Q ss_pred eecccCceeEEEEEECC--c--cEEEEEEcCC-chhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEEeccCC
Q 035604 470 KIGEGGYGPVYKSYLDH--T--PVAIKVLRPD-AAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYEYMANG 541 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~~~--~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~g 541 (768)
.||+|+||.||+|.+.+ . .+++|.++.. .......+.+|++++.++ +||||++++++|.. ..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999998743 2 4688888743 234456788999999999 79999999999854 458999999999
Q ss_pred ChHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 542 SLEDRLFRRG-------------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 542 sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999987542 1234789999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccc
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDE 685 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~ 685 (768)
+...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.... .....+..+...
T Consensus 159 ~~~~~~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~- 230 (270)
T cd05047 159 SRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL- 230 (270)
T ss_pred ccccchh-------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC-
Confidence 8632211 01112234667999999988889999999999999999997 999995432 222333222111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
..+...+..+.+|+.+||..+|.+||++.+++..+.+.
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 231 -------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11112334689999999999999999999998655443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.89 Aligned_cols=248 Identities=28% Similarity=0.422 Sum_probs=196.0
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
++|++.+.||+|+||.||++... ++.||+|++.... ......+.+|+++++.++||||+++++.+.. ..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999874 7789999986543 3345678999999999999999999999844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
+++++|.+++...+ .+++.....++.+++.||.|||+ .+ ++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999886643 48999999999999999999997 46 9999999999999999999999999987542211
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH------HHHHHcCCccccCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV------ERSIENGTFDETLDPA 690 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~------~~~i~~~~~~~~ld~~ 690 (768)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...... ...+.. .+.......
T Consensus 159 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 229 (284)
T cd06620 159 --------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQEP 229 (284)
T ss_pred --------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH-HHHHHhhcc
Confidence 12347899999999998889999999999999999999999999643221 000000 000011111
Q ss_pred CCCCCH-HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPV-EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~-~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+. ..+..+.+|+.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111111 24456999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=314.50 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=195.9
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEecc
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYMA 539 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 539 (768)
.|.....||+|+||.||++.. ++..||||.+..........+.+|+.+++.++||||+++++.+. +..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 445556799999999999987 56789999987655555667899999999999999999998873 45599999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 99999987542 3889999999999999999999999 99999999999999999999999999976533211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCCCHH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~~~~ 697 (768)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+.. .+.+.... ...
T Consensus 174 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~-~~~ 243 (292)
T cd06658 174 ----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-----NLPPRVKD-SHK 243 (292)
T ss_pred ----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----cCCCcccc-ccc
Confidence 11234688999999999888899999999999999999999999965433221 1211 11111111 112
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+..++.+||..+|.+||++.+++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 3446889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.81 Aligned_cols=234 Identities=24% Similarity=0.395 Sum_probs=184.7
Q ss_pred ceecccCceeEEEEEEC---------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 469 RKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
+.||.|+||.||+|... ...||+|.+........+.+..|+.+++.+.||||+++++++. ...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 35999999999999763 2348889886655455567889999999999999999999884 456999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc--------EEEeecccc
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV--------SKISDVGLA 609 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--------vKL~DFGla 609 (768)
+++|+|..++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999876543 4889999999999999999999999 999999999999977664 699999988
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhC-CCCCCChHHHHHH-HHcCCcccc
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITA-KPPMGLAHQVERS-IENGTFDET 686 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg-~~Pf~~~~~~~~~-i~~~~~~~~ 686 (768)
..+... ....+++.|+|||++.+ ..++.++|||||||++|+|++| .+||......... +....
T Consensus 156 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~---- 221 (258)
T cd05078 156 ITVLPK----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR---- 221 (258)
T ss_pred cccCCc----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcc----
Confidence 654221 23467889999998876 4589999999999999999998 4676544332221 11111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
. ..+......+.+|+.+||+.+|++||++.+++..
T Consensus 222 --~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 --H---QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred --c---cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 1111122458999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.64 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=199.5
Q ss_pred cCCCccceecccCceeEEEEEEC--Cc----cEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HT----PVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 534 (768)
.+|.+.+.||+|+||.||+|.+. +. .||+|.+.... ......+.+|+.+++.++||||++++++|.. ..++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 56888899999999999999863 22 58999887654 3345678899999999999999999998854 55899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999876543 3899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
... ........++..|++||.+....++.++|||||||++|||++ |+.||.... .+...+..+... +
T Consensus 162 ~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----~-- 231 (279)
T cd05057 162 DEK----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL----P-- 231 (279)
T ss_pred ccc----ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC----C--
Confidence 211 111122334678999999988889999999999999999998 999996543 334444433211 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
.+..++..+.+++.+||..+|.+||++.+++..+.+.
T Consensus 232 --~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 232 --QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred --CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111234588999999999999999999987544443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=304.89 Aligned_cols=231 Identities=28% Similarity=0.470 Sum_probs=185.0
Q ss_pred ceecccCceeEEEEEECCc------------cEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc-CCceeEE
Q 035604 469 RKIGEGGYGPVYKSYLDHT------------PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP-EFGCLIY 535 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~~------------~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~ 535 (768)
+.||+|+||.||+|.+..+ .|++|++...... ...+.+|+.+++.++||||++++++|. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 3699999999999998543 3788887655433 567889999999999999999999874 4458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-------cEEEeeccc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-------VSKISDVGL 608 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-------~vKL~DFGl 608 (768)
||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999876543 4899999999999999999999998 99999999999999887 799999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCC--CCCccccHHHHHHHHHHHHh-CCCCCCChHHHH--HHHHcCCc
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQIIT-AKPPMGLAHQVE--RSIENGTF 683 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~~--~~i~~~~~ 683 (768)
+..+.. .....++..|+|||++.+. .++.++|||||||++|+|++ |..||....... ..+.....
T Consensus 155 a~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 224 (259)
T cd05037 155 PITVLS----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224 (259)
T ss_pred cccccc----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC
Confidence 986532 1223567789999998876 78999999999999999999 688885442211 11111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. + .+. ...+.+++.+||..+|.+||++.+++.
T Consensus 225 ---~-~-~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 225 ---L-P-MPD-----CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ---C-C-CCC-----chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 0 111 146899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=300.10 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=202.9
Q ss_pred hcCCCcc-ceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhh-cCCCceeeeeccccCCc------
Q 035604 462 TENFSNS-RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCN-IRHPNMVLLLGACPEFG------ 531 (768)
Q Consensus 462 ~~~y~~~-~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~~------ 531 (768)
+++|.+. ++||-|-.|.|..+.+ ++..+|+|+|... ...++|+++--. -.|||||.++++|....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556543 5799999999999887 5568999998632 345688887444 46999999999985432
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCcEEEeeccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYVSKISDVGL 608 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~vKL~DFGl 608 (768)
.+|||.|+||.|...+..++. ..|++.++..|+.||+.|+.|||+.+ |.||||||+|+|... |..+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 579999999999999987664 46999999999999999999999999 999999999999954 56789999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCC------ChHHHHHHHHcCC
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMG------LAHQVERSIENGT 682 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~------~~~~~~~~i~~~~ 682 (768)
|+.-.. ...+.+.+-|+.|.|||++....|+..+|+||+|||+|-||+|++||. .+..+...|..|.
T Consensus 211 AK~t~~-------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 211 AKETQE-------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred ccccCC-------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 986432 344567889999999999999999999999999999999999999995 3345667788876
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 683 ~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
|. +-+ ++|. ..+....++|+.+|..+|.+|-|+.+++. +|.+.
T Consensus 284 y~-FP~---pEWs-~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 284 YE-FPE---PEWS-CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred cc-CCC---hhHh-HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 53 111 2343 44567899999999999999999999986 56544
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.94 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=198.4
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh---hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ---GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.. .+..||+|.+...... ....+..|+++++.++||||+++++.+.+ ..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688899999999999999988 4578999999765322 44568899999999999999999998844 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999886543 235899999999999999999999999 999999999999999999999999998765332
Q ss_pred CCCcc-----------------------ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH
Q 035604 616 VADSV-----------------------TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH 672 (768)
Q Consensus 616 ~~~~~-----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~ 672 (768)
..... .........||..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11000 0011123478899999999998889999999999999999999999996554
Q ss_pred HHHHH--HHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC----hhhhhh
Q 035604 673 QVERS--IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD----LGKVVV 725 (768)
Q Consensus 673 ~~~~~--i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs----~~evl~ 725 (768)
..... +..... ..+. ....+..+.+++.+||..+|.+||+ +.+++.
T Consensus 237 ~~~~~~~~~~~~~------~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDETFSNILKKEV------TFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHHHHHHhcCCc------cCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 33221 111111 1111 1113466999999999999999999 777664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.80 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=197.0
Q ss_pred cCCCccceecccCceeEEEEEE-CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcC-CCceeeeeccc--cCCceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIR-HPNMVLLLGAC--PEFGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~--~~~~~lV~E 536 (768)
..|+++++||.||-+.||++.. +.+.||+|.+... +.+...-|.+|+.+|.+|+ |.+||.||++- +.+.|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4588899999999999999988 4567888876533 4455677999999999996 99999999885 556699999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|- ..+|..+|.++... ++.-.+..+..|++.|+.++|+.| |||.||||.|+|+- .|.+||+|||+|..+..+.
T Consensus 441 ~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 87 57899999876643 332367789999999999999999 99999999999995 5789999999999886543
Q ss_pred CCccccccccCCCCCCCCCCcccccCC-----------CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccc
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTG-----------MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDE 685 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~ 685 (768)
. .-...+.+||+.||+||.+... ..+.++||||||||||+|+.|++||+........+. .
T Consensus 514 T----sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~-----a 584 (677)
T KOG0596|consen 514 T----SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLH-----A 584 (677)
T ss_pred c----ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHH-----h
Confidence 2 2234567999999999976432 257899999999999999999999976654444332 2
Q ss_pred cCCC----CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 686 TLDP----AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 686 ~ld~----~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
+.+| ..++.+... ++.+++..||..||++||+..++|. +.+..
T Consensus 585 I~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3333 223333322 2999999999999999999999985 44433
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.84 Aligned_cols=237 Identities=26% Similarity=0.318 Sum_probs=195.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHH---HHHHHHHHhhcCCCceeeeecccc--CCceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLGACP--EFGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~---~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV 534 (768)
.++|+.+++||+|.||+|.+++. .++.||||++++.....++. -.-|-.+|+..+||.+..|-..|. +..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46799999999999999998876 56789999998875443333 456889999999999998887774 455999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||..||.|.-.|.+.. .|++...+.+-.+|+.||.|||+.+ ||+||||.+|+|+|.+|++||+|||||+--.
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999988887644 5899999999999999999999999 9999999999999999999999999997421
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~ 692 (768)
.....+..+|||+.|+|||++....|+..+|+|.+||++|||++|+.||...+. +...|..+.+
T Consensus 320 -----~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--------- 385 (516)
T KOG0690|consen 320 -----KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--------- 385 (516)
T ss_pred -----cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc---------
Confidence 223346789999999999999999999999999999999999999999964432 2222222211
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCC
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPD 719 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs 719 (768)
..|...+.+...|+...|.+||.+|--
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 233344456888999999999999964
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=308.15 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=198.4
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccC--------
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE-------- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-------- 529 (768)
.+++|.+.+.||.|+||.||+|.. .+..+++|++..... ....+.+|+.+++++ .||||++++++|..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 468899999999999999999998 456899999876543 345789999999999 69999999998833
Q ss_pred CceeEEEeccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 2489999999999999886532 1235899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccC-----CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcC
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENG 681 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~ 681 (768)
+....... .......|+..|+|||++.. ..++.++|||||||+||+|++|++||........ .+..+
T Consensus 160 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 160 SAQLDSTL------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ceecccch------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 97653321 11234568999999998753 3468899999999999999999999964433222 12222
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. +.. ..+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 234 ~~-----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PP-----PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CC-----CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 111 112224456999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=315.38 Aligned_cols=193 Identities=25% Similarity=0.408 Sum_probs=156.0
Q ss_pred cceecccCceeEEEEEEC----CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc----CCceeEEEecc
Q 035604 468 SRKIGEGGYGPVYKSYLD----HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP----EFGCLIYEYMA 539 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~lV~E~~~ 539 (768)
..+||+|+||.||+|... +..||+|.+..... ...+.+|+.+|+.++||||++++++|. ...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999863 35799999875432 235778999999999999999999873 23489999986
Q ss_pred CCChHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----cCCCcEEEeecccc
Q 035604 540 NGSLEDRLFRR------GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL----DRNYVSKISDVGLA 609 (768)
Q Consensus 540 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~vKL~DFGla 609 (768)
++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5777766432 11234889999999999999999999999 9999999999999 56789999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCC
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMG 669 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~ 669 (768)
+.+..... .........||+.|+|||++.+ ..++.++|||||||++|||+||++||.
T Consensus 160 ~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 160 RLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCcc---cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 87643321 1112234578999999998876 458999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.82 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=208.7
Q ss_pred cCCCccceecccCceeEEEEEECC----c--cEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccCC-ceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH----T--PVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF-GCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~----~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~lV 534 (768)
+.....+.||+|-||.||+|.+.. . .||||..+.+ .....+.|..|.-+|++++|||||+|+|+|.+. .+||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wiv 468 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIV 468 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEE
Confidence 344556789999999999999732 2 5999999875 455678899999999999999999999999664 5999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||+++-|.|..+|..+.. .|+......++.||+.||.|||+.. +|||||-..|||+...-.+||+||||++.+..
T Consensus 469 mEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999988665 4888999999999999999999999 99999999999999999999999999998855
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
+. -++.+...-..-|||||.+.-..++.++|||-|||++||++. |..||.+.. ++...+++|. .
T Consensus 544 ~~-----yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe--------R 610 (974)
T KOG4257|consen 544 DA-----YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE--------R 610 (974)
T ss_pred cc-----hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC--------C
Confidence 43 233334455678999999999999999999999999999986 999996543 2333344443 2
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
...|..|++.|..|+.+||.++|.+||.+.++...+.+.+.
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 24455566779999999999999999999998765555443
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.12 Aligned_cols=244 Identities=25% Similarity=0.359 Sum_probs=198.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
..|...+.||.|+||.||+|.+ .+..||+|++.... ......+.+|+.+++.++||||+++++.+.+ ..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3577788899999999999987 46789999987543 3445678899999999999999999999854 45999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++|+|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999988643 3889999999999999999999998 99999999999999999999999999976643211
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHH
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
......++..|+|||++.+..++.++|+|||||++|||++|.+||............ . ....+..+..
T Consensus 157 ------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~---~~~~~~~~~~ 224 (277)
T cd06640 157 ------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---P---KNNPPTLTGE 224 (277)
T ss_pred ------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh---h---cCCCCCCchh
Confidence 122346788999999998888999999999999999999999999654332211100 0 0111233445
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+.+++.+||..+|.+||++.+++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 6677999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.99 Aligned_cols=246 Identities=31% Similarity=0.485 Sum_probs=197.4
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEecc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMA 539 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~ 539 (768)
.++|.+.++||+|+||.||++.+ .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.+ ..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 46789999999999999999986 45679999887543 234678899999999999999999988754 3489999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 157 (260)
T cd05073 84 KGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-- 157 (260)
T ss_pred CCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc--
Confidence 9999999976432 34788999999999999999999998 99999999999999999999999999976543211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......++..|++||++.+..++.++|+|||||++|++++ |++||.... .....+..+... +. +.
T Consensus 158 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----~~----~~ 226 (260)
T cd05073 158 ---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----PR----PE 226 (260)
T ss_pred ---ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC----CC----cc
Confidence 01122345677999999998889999999999999999999 999996433 233334333211 11 11
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 23346999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.99 Aligned_cols=244 Identities=28% Similarity=0.429 Sum_probs=197.6
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-----hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-----AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
+|...+.||+|+||.||+|.. ++..|++|.+.... ......+.+|+.+++.++||||+++++++.. ..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477788999999999999988 47799999986432 2244578899999999999999999998854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999987653 4889999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCC-CCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.. ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||............+... ..+.
T Consensus 155 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~ 222 (258)
T cd06632 155 FS-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-----ELPP 222 (258)
T ss_pred cc-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-----cCCC
Confidence 21 123456889999999887766 8999999999999999999999996554333322222111 0111
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+......+.+++.+||..+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 22233456899999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.96 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=200.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
++|++.+.||.|+||.||++.. ++..+|+|++.... ......+.+|+++++.++||||+++++.+. +..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999987 55689999997543 234567899999999999999999998874 345899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++........+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976543345899999999999999999999999 99999999999999999999999999987644322
Q ss_pred CccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCC-
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWP- 695 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~- 695 (768)
.. ........|+..|++||++... .++.++|+|||||++|+|++|+.||.............. ...+......
T Consensus 158 ~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (267)
T cd06610 158 RT--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---NDPPSLETGAD 232 (267)
T ss_pred cc--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CCCCCcCCccc
Confidence 10 0112344688999999988777 789999999999999999999999965443221111100 0111111111
Q ss_pred -HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 -VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 -~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+++.+||..+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 234466899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=329.07 Aligned_cols=248 Identities=20% Similarity=0.261 Sum_probs=191.7
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
...|.+.+.||+|+||.||++.+. +..||||.... ..+.+|+++|++++|||||++++++. ...|+||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999984 46799996432 23568999999999999999999874 345899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+ .++|.+++..... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~-~~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 Y-RSDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred c-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9 5788888765432 5899999999999999999999999 99999999999999999999999999987643211
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCC-CC---------hHHHHHHHHcCCccc-c
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM-GL---------AHQVERSIENGTFDE-T 686 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf-~~---------~~~~~~~i~~~~~~~-~ 686 (768)
. .......||+.|+|||++.+..++.++|||||||+||||++|..|+ .. ...+.+.+....+.. .
T Consensus 316 ~----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 316 T----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred c----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1 1123457999999999999999999999999999999999987654 21 122333333322110 0
Q ss_pred CCC----------------------CCCCCCH--HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 687 LDP----------------------AVPDWPV--EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 687 ld~----------------------~~~~~~~--~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.+ ..+.|.. .....+.+|+.+||..||.+||++.+++.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 0111211 12335889999999999999999999985
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.79 Aligned_cols=235 Identities=25% Similarity=0.273 Sum_probs=183.1
Q ss_pred ecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhc---CCCceeeeeccccC--CceeEEEeccC
Q 035604 471 IGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNI---RHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 471 LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
||+|+||.||++.+ .+..||||++..... .....+..|..++..+ +||||+.+++.+.+ ..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 467899999864322 1223345677777665 69999999998744 45999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 150 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN---- 150 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----
Confidence 99998887654 4899999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCCCCHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... .....+..+... .+. ..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------~~~--~~ 220 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR------FPK--NV 220 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC------CCC--cc
Confidence 112345799999999988754 48999999999999999999999996443 233344433321 111 01
Q ss_pred HHHHHHHHHHHhhhcCccCCCC----hhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPD----LGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs----~~evl~ 725 (768)
.+..+.+++.+||..+|.+||+ +.+++.
T Consensus 221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 2345889999999999999994 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.82 Aligned_cols=244 Identities=22% Similarity=0.364 Sum_probs=199.0
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E~ 537 (768)
+|+..+.||.|+||.||.+.. ++..+++|.+... .......+.+|+.++++++||||+++++++.+. .+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999998887665 6678999987643 234455788999999999999999999998543 4889999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999987653 235899999999999999999999999 99999999999999999999999999986643221
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~ 695 (768)
......+++.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+.+... +
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--------~ 222 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV--------V 222 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--------c
Confidence 123456899999999998888999999999999999999999999654332 223333332211 1
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+++.+||..+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 223456899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=308.70 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=193.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
++|++.+.||+|+||.||++.+ +++.||+|++.... ......+.+|+.+++.++||||++++++|.. ..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688899999999999999988 46789999986432 2234567899999999999999999998844 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|++++.|..++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988877665433 3899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHc--CC---------
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IEN--GT--------- 682 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~--~~--------- 682 (768)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|++||......... +.. +.
T Consensus 155 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 155 D------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred c------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1 1123467889999998776 45789999999999999999999999644332211 110 00
Q ss_pred ----c-cccCCCCCC-CCC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 ----F-DETLDPAVP-DWP-----VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ----~-~~~ld~~~~-~~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+ .....+... ..+ ...+..+.+|+.+||..+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 000000000 000 122456899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.14 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=198.0
Q ss_pred cCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
++|.+...||.|+||.||++... ...|++|.+...... ....+.+|+.++++++||||++++++|.+ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999863 346999998654333 45678999999999999999999999854 569
Q ss_pred eEEEeccCCChHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeec
Q 035604 533 LIYEYMANGSLEDRLFRRGGS------PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DF 606 (768)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998765422 15899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTF 683 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~ 683 (768)
|++....... ........++..|++||.+.+..++.++||||||+++|+|++ |..||.... .....+..+..
T Consensus 162 ~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSE-----YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred ccccccCccc-----ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 9987542211 112233456778999999888889999999999999999998 889995432 22233333332
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..... ...+..+.+++.+||..+|.+||++.+++.
T Consensus 237 ~~~~~-------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 237 ELPVP-------EGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred CCCCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 21111 122346999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.01 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=203.1
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
++|.+.+.||.|+||.||++... +..|++|++..... .....+.+|+.++..++||||+++++.+.. ..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999884 67899999976643 445678999999999999999999998854 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
+++++|.+++.... .+++..++.++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999997653 48999999999999999999999 88 9999999999999999999999999998764322
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .....+..-. ....+..
T Consensus 155 ~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 223 (264)
T cd06623 155 DQ------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-----DGPPPSL 223 (264)
T ss_pred Cc------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-----cCCCCCC
Confidence 11 123467889999999999999999999999999999999999996553 2222111110 1111122
Q ss_pred CHH-HHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 695 PVE-EALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 695 ~~~-~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
+.. .+..+.+++.+||..+|.+||++.+++. ++++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~ 260 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence 222 4456999999999999999999999986 4554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.25 Aligned_cols=244 Identities=28% Similarity=0.502 Sum_probs=195.6
Q ss_pred cCCCccceecccCceeEEEEEEC-CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEecc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMA 539 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 539 (768)
.+|.+.+.||.|+||.||++.+. +..+|+|.+..... ....+.+|+++++.++||||+++++++.. ..++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999874 67899999875432 34568899999999999999999998844 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++..... .+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 155 (256)
T cd05112 83 HGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-- 155 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc--
Confidence 9999998865432 4789999999999999999999999 99999999999999999999999999976532211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... .....+..+. ....+..
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~----- 225 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--RLYKPRL----- 225 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--CCCCCCC-----
Confidence 01122345678999999998899999999999999999998 999996443 2233333321 1111211
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+.+|+.+||..+|.+||++.+++.
T Consensus 226 -~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 226 -ASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred -CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2356999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.84 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=198.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccC----CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~ 535 (768)
++|...+.||.|+||.||++.+ .++.||+|.+..... .....+.+|+++++.++||||++++++|.+ ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688889999999999999998 567899999875432 345678999999999999999999998733 348999
Q ss_pred EeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 536 EYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 536 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|.||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 22345889999999999999999999999 99999999999999999999999999875532
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH-------HHHHHHHcCCccccC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH-------QVERSIENGTFDETL 687 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~-------~~~~~i~~~~~~~~l 687 (768)
.. .....++..|++||.+.+..++.++|||||||++|+|++|..||.... .....+...... .+
T Consensus 158 ~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 228 (287)
T cd06621 158 SL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP-EL 228 (287)
T ss_pred cc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch-hh
Confidence 21 123457889999999998899999999999999999999999996441 122222221111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.... ......+..+.+++.+||..+|.+||++.+++. +|.
T Consensus 229 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 229 KDEP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred ccCC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 1111 100123456899999999999999999999986 444
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.80 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=202.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
.++|.+.+.||.|+||.||++.. ++..||+|.+..........+.+|+.+++.++||||+++++.|. +..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 46899999999999999999986 56789999987554445567889999999999999999999884 456999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999988653 3789999999999999999999999 99999999999999999999999999876533211
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHH
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
......+++.|++||.+.+..++.++|||||||++|++++|+.||............+... .+.. ..+..
T Consensus 171 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~---~~~~-~~~~~ 240 (293)
T cd06647 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---TPEL-QNPEK 240 (293)
T ss_pred ------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC---CCCC-CCccc
Confidence 1233468889999999988889999999999999999999999997554332211111000 0111 11222
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.+..+.+++.+||..+|.+||++.+++. ++...
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 3456899999999999999999999986 45543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.33 Aligned_cols=249 Identities=24% Similarity=0.432 Sum_probs=196.8
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc------hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA------AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
+|+..+.||+|+||.||++.. ++..||+|++.... ......+.+|+.++++++||||+++++.+.+ ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999986 56789999986432 1134568899999999999999999999854 4489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeeccccccc
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLV 612 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFGla~~~ 612 (768)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999887644 4889999999999999999999999 99999999999998776 5899999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH---HHHHHHcCCccccCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ---VERSIENGTFDETLDP 689 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~---~~~~i~~~~~~~~ld~ 689 (768)
....... ........++..|+|||++.+..++.++|||||||++|+|++|..||..... ......... ..
T Consensus 155 ~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~--- 227 (268)
T cd06630 155 AAKGTGA--GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS--AT--- 227 (268)
T ss_pred ccccccC--CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc--cC---
Confidence 4331110 0111234688999999999888899999999999999999999999953321 111111110 00
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+...+..+.+++.+||..+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 112334445567999999999999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.48 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=195.6
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch----------hhHHHHHHHHHHHhhcCCCceeeeeccccC--
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA----------QGRSQFQQEVEVLCNIRHPNMVLLLGACPE-- 529 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-- 529 (768)
+|...+.||.|+||.||+|.. ++..||+|.++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999976 567899998853211 112357889999999999999999998844
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 4589999999999999987653 4889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCC--CCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc--CCccc
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN--GTFDE 685 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~--~~~~~ 685 (768)
....... .........|+..|+|||.+.... ++.++|+||||+++|+|++|..||............ .....
T Consensus 156 ~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (272)
T cd06629 156 KKSDDIY----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP 231 (272)
T ss_pred ccccccc----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC
Confidence 7653211 111123456889999999887654 899999999999999999999999755443332221 11111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+.. ......+..+.+++.+||..+|.+||++.+|+.
T Consensus 232 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 122234567999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=323.35 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=185.9
Q ss_pred cCCCccceecccCceeEEEEEECC--ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.+|.+.+.||+|+||.||+|...+ ..||+|+.... ....|+.++++++||||++++++|.. ..|+||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 469999999999999999999844 58999985432 23569999999999999999998844 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
.++|.+++..... .+++..++.|+.||+.||.|||..+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 140 -~~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 140 -SSDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred -CCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 5688888765432 5899999999999999999999999 999999999999999999999999999753211
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCC-CCChH------------HHHHHHHc-CCcc
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP-MGLAH------------QVERSIEN-GTFD 684 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~P-f~~~~------------~~~~~i~~-~~~~ 684 (768)
.......||+.|+|||++.+..++.++|||||||++|||+++..| |.... .+...+.. +...
T Consensus 211 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 211 ----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 112345789999999999999999999999999999999985444 43211 11111111 1000
Q ss_pred ccCCC-------------------CCCCCC----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 685 ETLDP-------------------AVPDWP----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 685 ~~ld~-------------------~~~~~~----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+.. ....++ ...+..+.+||.+||+.||.+|||+.+++. +|.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 00000 000000 012234667999999999999999999986 443
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.10 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=196.5
Q ss_pred cCCCccceecccCceeEEEEEEC------CccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC----Cc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE----FG 531 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 531 (768)
..|.+.+.||+|+||.||++.++ +..||||++...... ....|.+|+++++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777889999999999999863 468999999765443 45679999999999999999999998754 45
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 899999999999999976543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH-----------------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV----------------- 674 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~----------------- 674 (768)
....... ........++..|++||.+.+..++.++|||||||++|+|++|..||......
T Consensus 159 ~~~~~~~---~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 159 LPEDKDY---YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccCCcc---eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 6432111 00111234566799999998889999999999999999999999998532211
Q ss_pred HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 675 ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 675 ~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+. .. ..+..++..+.+|+.+||..+|.+||++.+|+.
T Consensus 236 ~~~~~~~~-------~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 236 LELLKEGE-------RL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHcCC-------cC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111111 00 111223356999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=300.87 Aligned_cols=246 Identities=33% Similarity=0.490 Sum_probs=197.5
Q ss_pred hcCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.++|.+.+.||.|+||.||++.+.+ ..||||.+..... ....+.+|+.+++.++||||+++++++.. ..++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4678999999999999999998744 5799999975543 34578999999999999999999998854 459999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 84 ~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (261)
T cd05034 84 SKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-- 157 (261)
T ss_pred CCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh--
Confidence 99999999876432 34899999999999999999999999 9999999999999999999999999998664311
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
........++..|+|||.+.+..++.++|||||||++|+|++ |+.||.... .....+..+. .... +
T Consensus 158 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~-------~ 226 (261)
T cd05034 158 ---YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RMPR-------P 226 (261)
T ss_pred ---hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC-------C
Confidence 011122334678999999998889999999999999999998 999995433 2223332221 1111 1
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+++.+|+..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 122346899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=299.47 Aligned_cols=244 Identities=33% Similarity=0.508 Sum_probs=197.2
Q ss_pred CCccceecccCceeEEEEEECC------ccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDH------TPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
|.+.+.||.|+||.||++.+.. ..||+|++...... ....+..|+.++..++||||+++++.+.+ ..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999854 67999999766543 56688999999999999999999998854 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++++|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999998764421 2899999999999999999999999 999999999999999999999999999876433
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~ 692 (768)
.. .......+++.|++||.+.+..++.++|||||||++|+|++ |.+||... ......+..+.....
T Consensus 157 ~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 225 (258)
T smart00219 157 DY-----YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK------ 225 (258)
T ss_pred cc-----cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC------
Confidence 11 11112336789999999988889999999999999999998 89999643 233334443332111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+++.+||..+|.+||++.+++.
T Consensus 226 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 226 --PENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --CCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 1123456999999999999999999999873
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.03 Aligned_cols=240 Identities=30% Similarity=0.430 Sum_probs=191.3
Q ss_pred ceecccCceeEEEEEEC-CccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCChH
Q 035604 469 RKIGEGGYGPVYKSYLD-HTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSLE 544 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~ 544 (768)
++||.|+||.||++.+. ++.||+|.+...... ....+.+|+++++.++||||+++++++.+ ..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999875 789999998765433 45678999999999999999999998844 458999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcccccc
Q 035604 545 DRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYR 624 (768)
Q Consensus 545 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 624 (768)
+++..... .+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++......... ..
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~----~~ 151 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT----VS 151 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce----ec
Confidence 99876433 4789999999999999999999999 999999999999999999999999999765321110 00
Q ss_pred ccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCHHHHHH
Q 035604 625 MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPVEEALI 701 (768)
Q Consensus 625 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~~~~~ 701 (768)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||.... .....+..+. . .. .+...+..
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~----~~---~~~~~~~~ 223 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-R----MP---APQLCPEE 223 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-C----CC---CCccCCHH
Confidence 112234567999999988899999999999999999999 899995433 2223333221 0 01 12223456
Q ss_pred HHHHHHHhhhcCccCCCChhhhhh
Q 035604 702 LAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 702 l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.+|+.+||..+|.+||++.+++.
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.88 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=191.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHH-HhhcCCCceeeeecccc--CCceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEV-LCNIRHPNMVLLLGACP--EFGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~--~~~~lV~E 536 (768)
++|.+.+.||+|+||.||++.+ +++.||+|++.... ......+..|+.+ ++.++||||+++++++. ...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688899999999999999988 46799999987543 2233455566665 66678999999999884 34589999
Q ss_pred eccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 537 YMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 537 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|++ |+|.+++... .....+++..++.++.||+.||.|||+. + ++||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6788777542 2234689999999999999999999987 7 99999999999999999999999999986532
Q ss_pred CCCCccccccccCCCCCCCCCCcccccC----CCCCccccHHHHHHHHHHHHhCCCCCCChHH-HH--HHHHcCCccccC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQT----GMLGVKSDVYSLGILLLQIITAKPPMGLAHQ-VE--RSIENGTFDETL 687 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDvwSlGvil~elltg~~Pf~~~~~-~~--~~i~~~~~~~~l 687 (768)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... .. ..+..+.
T Consensus 157 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 224 (283)
T cd06617 157 SV-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP----- 224 (283)
T ss_pred cc-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-----
Confidence 11 1123468889999998765 4568899999999999999999999963221 11 1111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.+..+. ...+..+.+++.+||..+|.+||++.+++. +|...
T Consensus 225 ~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 225 SPQLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CCCCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 111111 113356899999999999999999999985 44433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=299.95 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=198.1
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
+|.+.+.||+|+||.||++.. ++..|++|.+..... .....+.+|+++++.++||||+++++.+. +..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999987 567899999976544 25667899999999999999999999874 345899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++.... .+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999887643 4788999999999999999999999 99999999999999999999999999987643321
Q ss_pred CccccccccCCCCCCCCCCcccccCCC---CCccccHHHHHHHHHHHHhCCCCCCChH-HHHHHHHcCCccccCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGM---LGVKSDVYSLGILLLQIITAKPPMGLAH-QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltg~~Pf~~~~-~~~~~i~~~~~~~~ld~~~~~ 693 (768)
... .......++..|++||++.+.. ++.++||||||+++|+|++|+.||.... .......... ...+..+.
T Consensus 155 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 229 (264)
T cd06626 155 TMG--EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPIPD 229 (264)
T ss_pred ccc--ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCCCc
Confidence 110 0012356788999999988766 8999999999999999999999996432 2111111111 11222222
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+. ..+..+.+++.+||..+|.+||++.+++.
T Consensus 230 ~~-~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 SL-QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cc-ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 21 22456889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.06 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=199.3
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC----CceeEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCLIY 535 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~ 535 (768)
+|.+.+.||.|+||.||++.+ ++..||+|++.... ......+.+|+++++.++||||+++++.+.. ..+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999987 55789999986542 3345568899999999999999999987632 248999
Q ss_pred EeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 536 EYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLH-----QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 536 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
||+++++|.+++... .....+++..++.++.||+.||.||| +.+ |+|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 22345899999999999999999999 666 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccC
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETL 687 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~l 687 (768)
........ ......++..|++||.+.+..++.++|+||||+++|+|++|+.||.... .....+..+.+
T Consensus 158 ~~~~~~~~------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 227 (265)
T cd08217 158 KILGHDSS------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF---- 227 (265)
T ss_pred ccccCCcc------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC----
Confidence 87643221 1123468999999999998889999999999999999999999996543 22333333322
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..+...+..+.+++.+|+..+|.+||++.+|+.
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1233344567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.43 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=199.2
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
++|+..+.||.|+||.||++.+. +..||+|.+.... ......+.+|+++++.++||||+++++.+.. ..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999984 6789999987653 3445678899999999999999999998744 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999887653 358899999999999999999999 88 9999999999999999999999999987553211
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH----HHHHHHHcCCccccCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH----QVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~----~~~~~i~~~~~~~~ld~~~~ 692 (768)
.....++..|++||++.+..++.++|||||||++|+|++|+.||.... .....+... +....+
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-----VNEPPP 222 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-----hcCCCC
Confidence 112578889999999999899999999999999999999999996431 111111110 011111
Q ss_pred CCCHH-HHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 693 DWPVE-EALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 693 ~~~~~-~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
..+.. .+..+.++|.+||..+|.+||++.+++. +|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence 11222 4556999999999999999999999986 5543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.97 Aligned_cols=241 Identities=29% Similarity=0.456 Sum_probs=189.8
Q ss_pred eecccCceeEEEEEECC--------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 470 KIGEGGYGPVYKSYLDH--------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~~~--------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.||+|+||.||+|.... ..+|||.+.... ......+.+|+.+++.++||||++++++|.. ..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998642 469999886543 2345678899999999999999999998844 458999999
Q ss_pred cCCChHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-----cEEEeecccc
Q 035604 539 ANGSLEDRLFRRG----GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-----VSKISDVGLA 609 (768)
Q Consensus 539 ~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-----~vKL~DFGla 609 (768)
++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997532 2234788999999999999999999998 99999999999998877 8999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCcccc
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDET 686 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ 686 (768)
+.+..... ........++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ....+..+..
T Consensus 159 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--- 231 (269)
T cd05044 159 RDIYKSDY----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR--- 231 (269)
T ss_pred cccccccc----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc---
Confidence 76532211 011123345678999999999999999999999999999998 9999964332 2222222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+...+..+.+++.+||..+|.+||++.+++.
T Consensus 232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 -----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1112234456899999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.82 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=208.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~ 535 (768)
...|.+.+.||+|.|++|..+.+ .++.||||.+.+... ..+..+.+|+++|+.++|||||++|.+. ....|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 57899999999999999999987 678999999987632 3345588999999999999999999987 45569999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+.+|.+.++|.+.+. +.+.....++.|+.+|++|||+++ |||||||.+||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999998875 666888899999999999999999 999999999999999999999999999887533
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~ 692 (768)
....+++|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++.. ........|++
T Consensus 209 -------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~--------- 272 (596)
T KOG0586|consen 209 -------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY--------- 272 (596)
T ss_pred -------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee---------
Confidence 23467899999999999998876 789999999999999999999997432 22222222322
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRAL 734 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~~ 734 (768)
..|.-.+.+..+|++++|.++|.+|+++.++.. .|.+.+...
T Consensus 273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 112222234788999999999999999999987 666665443
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=306.87 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=193.8
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~ 535 (768)
++|.+.+.||+|+||.||++.+. ++.||+|.+..... .....+.+|+++++.++||||+++++.+... .++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999884 56899999876532 2345678999999999999999999988544 48999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||++|++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999986654 4899999999999999999999998 999999999999999999999999998742211
Q ss_pred CCC---------ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCcc
Q 035604 616 VAD---------SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFD 684 (768)
Q Consensus 616 ~~~---------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~ 684 (768)
... ...........++..|+|||.+.+..++.++|+|||||++|+|++|..||.... .+...+..+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 100 001111123467889999999988889999999999999999999999996432 222233222211
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhh
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKV 723 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~ev 723 (768)
.+.. ....+..+.+|+.+||..+|.+||+..++
T Consensus 235 ---~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 267 (305)
T cd05609 235 ---WPEG---DEALPADAQDLISRLLRQNPLERLGTGGA 267 (305)
T ss_pred ---CCCc---cccCCHHHHHHHHHHhccChhhccCccCH
Confidence 1111 11233458999999999999999996433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=299.41 Aligned_cols=244 Identities=26% Similarity=0.421 Sum_probs=197.9
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|++.+.||+|+||.||++.. ++..||+|.+... .......+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488899999999999999887 5678999998643 22334578899999999999999999998854 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+.+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999998865432 24789999999999999999999999 9999999999999999999999999998653321
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||..... ....+..+.+. ..+
T Consensus 156 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (256)
T cd08218 156 -----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP--------PVS 222 (256)
T ss_pred -----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC--------CCc
Confidence 112234678899999999988899999999999999999999999964332 22222233221 112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+++.+||+.+|.+||++.+|+.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 233456999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=302.69 Aligned_cols=244 Identities=26% Similarity=0.379 Sum_probs=197.3
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
-|...+.||.|+||.||+|.+ ++..||||++.... ......+.+|+.++.+++||||+++++.+. ...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 377888999999999999986 56789999986443 233457889999999999999999999884 4459999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 999999888542 3889999999999999999999998 9999999999999999999999999987653321
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCCCCCCH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......++..|++||++.+..++.++|+|||||++|+|++|..||....... ..+..+. .+..+.
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (277)
T cd06641 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--------PPTLEG 223 (277)
T ss_pred ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--------CCCCCc
Confidence 11233467889999999988889999999999999999999999996543322 1222211 111222
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+..+.+++.+||..+|.+||++.+++. +++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 256 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 33456899999999999999999999986 344
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.12 Aligned_cols=239 Identities=27% Similarity=0.386 Sum_probs=196.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.+ .+..||+|++.... ......+.+|++++++++||||+++++.+.+ ..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688899999999999999987 46789999986542 2334568899999999999999999998744 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987764 4899999999999999999999999 999999999999999999999999999865332
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 693 (768)
.....+++.|++||.+.+..++.++||||||+++|+|++|+.||..... ....+..+.. ..
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~-- 217 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV------RF-- 217 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc------cC--
Confidence 1234688999999999888899999999999999999999999965442 2222332221 11
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
+...+..+.+++.+||..+|.+|| ++.+++.
T Consensus 218 -~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 -PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 112245689999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.71 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=203.1
Q ss_pred HhcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYE 536 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 536 (768)
.+++|...+.||.|+||.||++.+. +..|++|++..... ....+.+|+++++.++||||+++++.+. ...++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4677888899999999999999985 77899999976544 4567889999999999999999999873 45589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999998754 25899999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~~~~~~~ld~~~~~~ 694 (768)
. ......++..|++||++.+..++.++|||||||++|+|++|+.||......... +......... .
T Consensus 171 ~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~ 238 (286)
T cd06614 171 S------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK------N 238 (286)
T ss_pred h------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc------c
Confidence 1 112345788999999998888999999999999999999999999755443322 2221111111 1
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+...+..+.+++.+||+.+|.+||++.+++. +++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence 1113356999999999999999999999985 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=303.45 Aligned_cols=244 Identities=25% Similarity=0.415 Sum_probs=195.6
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcC---CCceeeeeccccC--CceeEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIR---HPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~--~~~lV~ 535 (768)
.|+..+.||.|+||.||+|.+ ++..||+|++.... ......+.+|+.+++.++ |||+++++++|.+ ..|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999997 56789999987542 334557889999999997 9999999998844 358999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++++|.+++... .+++...+.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999987543 4899999999999999999999999 999999999999999999999999999876433
Q ss_pred CCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
. .......|+..|+|||.+.++ .++.++|||||||++|+|++|..||............. ....+.++..
T Consensus 155 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~ 225 (277)
T cd06917 155 S------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP---KSKPPRLEDN 225 (277)
T ss_pred c------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---cCCCCCCCcc
Confidence 2 112344688999999987654 57899999999999999999999997554432221111 1111111110
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 226 --~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 --GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 13456999999999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=298.57 Aligned_cols=243 Identities=28% Similarity=0.433 Sum_probs=195.7
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
+|...+.||+|+||.||++.. .+..+|+|.+.... ......+.+|+++++.++||||+++++.+. ...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588889999999999999887 56789999986542 234567889999999999999999998874 345899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DFGla~~~~~~~ 616 (768)
+++++|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999976432 34899999999999999999999999 9999999999999754 567999999998764321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~ 694 (768)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .+..+.... .
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 221 (256)
T cd08220 157 K-------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP--------I 221 (256)
T ss_pred c-------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC--------C
Confidence 1 1234678899999999988899999999999999999999999965433222 222222111 1
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+++.+||..+|.+||++.+++.
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1123446899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.01 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=195.2
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|.+.+.||.|+||.||+|.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.. ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999987 56789999987543 2334578899999999999999999998744 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886544 35899999999999999999999999 99999999999999999999999999987643211
Q ss_pred CccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH---HHHc-CC----------
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER---SIEN-GT---------- 682 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~---~i~~-~~---------- 682 (768)
.......|+..|+|||++.+. .++.++|||||||++|+|++|.+||........ .+.. +.
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 112345789999999987654 468999999999999999999988864432211 1110 00
Q ss_pred ----ccccCCCCC-----CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 ----FDETLDPAV-----PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ----~~~~ld~~~-----~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.....+.. .+...+.+..+.+++.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 0011123467999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=309.01 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=193.5
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
++|.+.+.||+|+||.||++.+. ++.||+|++..... .....+.+|+++++.++||||++++++|.. ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999984 67899999864322 234568899999999999999999999854 4599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++++|..+..... .+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999988887665432 3899999999999999999999999 9999999999999999999999999998653321
Q ss_pred CCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH----cCCcc-------
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE----NGTFD------- 684 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~----~~~~~------- 684 (768)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|++||........... .+.+.
T Consensus 155 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 155 E------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1 1233467899999998765 4578899999999999999999999964432211000 00000
Q ss_pred -------ccCCCCCCC------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 685 -------ETLDPAVPD------WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 685 -------~~ld~~~~~------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+.... .....+..+.+|+.+||..+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000011100 01123456999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.70 Aligned_cols=254 Identities=27% Similarity=0.346 Sum_probs=192.0
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcC-CCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|...+.||+|+||.||++.+ .++.||+|.+.... ......+.+|+.++.++. ||||+++++++.. ..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455667899999999999988 46789999987543 234556889999999996 9999999998743 45899999
Q ss_pred ccCCChHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 538 MANGSLEDRLFR--RGGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 538 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
+. +++.++... ......+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 455543321 11123589999999999999999999975 7 99999999999999999999999999976532
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCC---CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTG---MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~ 691 (768)
.. ......|++.|+|||++.+. .++.++|||||||++|+|++|++||.........+..... ...+..
T Consensus 161 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~ 231 (288)
T cd06616 161 SI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPIL 231 (288)
T ss_pred CC-------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC--CCCCcC
Confidence 21 11234678899999988776 6899999999999999999999999654332222221110 011111
Q ss_pred -CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 692 -PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 692 -~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
...+...+..+.+|+.+||..+|.+||++.+|+. +++..
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 1111234567999999999999999999999987 55543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.25 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=195.9
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
++|++.+.||+|+||.||++.+. +..||+|+++... ......+.+|+++++.++||||++++++|.. ..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999884 5689999986532 2334678999999999999999999999844 4599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|++++.+..++.... .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998877765554332 3899999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc----CC---------
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN----GT--------- 682 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~----~~--------- 682 (768)
. .......++..|+|||++.+. .++.++||||||+++|+|++|++||............ +.
T Consensus 155 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 155 A-----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred c-----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 1 122345678899999999888 8899999999999999999999999644332211110 00
Q ss_pred -----cc--ccCCCCCC-----CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 -----FD--ETLDPAVP-----DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 -----~~--~~ld~~~~-----~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+. .......+ .++...+..+.+|+.+||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 012223567999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.69 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=191.7
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|+..+.||.|+||.||++.+ ++..||||.+.... ......+.+|++++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 588899999999999999987 56789999986542 2233568899999999999999999999844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+. ++|..++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 688888765432 34899999999999999999999999 99999999999999999999999999976533211
Q ss_pred CccccccccCCCCCCCCCCcccccCCC-CCccccHHHHHHHHHHHHhCCCCCCChHHHHH---HHHcCC-----------
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQIITAKPPMGLAHQVER---SIENGT----------- 682 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~---~i~~~~----------- 682 (768)
......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||........ .+....
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 112345688999999876644 68899999999999999999999954432221 111100
Q ss_pred --------ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 --------FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 --------~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...............+..+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000011122345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=301.35 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=193.3
Q ss_pred CCccceecccCceeEEEEEEC-----CccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccCC-------
Q 035604 465 FSNSRKIGEGGYGPVYKSYLD-----HTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF------- 530 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------- 530 (768)
|.+.+.||+|+||.||+|.+. +..||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567788999999999999852 467999998754 233456788999999999999999999976321
Q ss_pred -ceeEEEeccCCChHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeec
Q 035604 531 -GCLIYEYMANGSLEDRLFRRG---GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606 (768)
Q Consensus 531 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DF 606 (768)
.+++++|+.+|+|.+++.... ....+++...+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 268899999999998875321 2224788999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTF 683 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~ 683 (768)
|+++.+..... ........+++.|++||.+....++.++|||||||++|+|++ |++||..... ....+..+..
T Consensus 158 g~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 158 GLSKKIYSGDY----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred cccccccCCcc----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99986533211 111123345678999999988889999999999999999999 8999964433 2233333221
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
. ..+...+..+.+++.+||..+|.+||++.+++..+
T Consensus 234 ~--------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 234 L--------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 11112334699999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.24 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=189.2
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|.+.+.||.|+||.||++.+ .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+ ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999998 567899999865422 223457789999999999999999999844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+. ++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 96 578777765332 4899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH---HHc--CC--------c
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS---IEN--GT--------F 683 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~---i~~--~~--------~ 683 (768)
.......+++.|+|||++.+. .++.++|||||||++|+|+||..||......... +.. +. +
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 112334678899999988764 4799999999999999999999886322211111 100 00 0
Q ss_pred cccCC-CCCCCC---------CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 DETLD-PAVPDW---------PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld-~~~~~~---------~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+ ...+.+ ....+..+.+|+.+||..+|.+|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 000000 1123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=302.84 Aligned_cols=243 Identities=24% Similarity=0.351 Sum_probs=196.5
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEEecc
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMA 539 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~~ 539 (768)
.|...+.||+|++|.||++.. .+..+++|++..........+.+|+.+++.++||||+++++++ .+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567899999999999986 5678999998755555556788999999999999999999987 445699999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 99999988762 3889999999999999999999999 99999999999999999999999999875532211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCCCCCCHH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ..+..+. .+.. ..+..
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-----~~~~-~~~~~ 240 (285)
T cd06648 171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-----PPKL-KNLHK 240 (285)
T ss_pred ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-----CCCC-ccccc
Confidence 1123468899999999988889999999999999999999999996543322 2222221 1111 11112
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+.+++.+||..+|.+||++.+++.
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 3456999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.07 Aligned_cols=246 Identities=26% Similarity=0.422 Sum_probs=200.1
Q ss_pred CCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEecc
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYMA 539 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 539 (768)
.|...+.||.|+||.||++... +..+++|++..........+.+|+++++.++||||+++++.+. ...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778889999999999999984 6789999998765555678999999999999999999999874 34589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++.... ..+++..+..++.|++.||.|||..+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999887653 24899999999999999999999988 99999999999999999999999999987643321
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEA 699 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~ 699 (768)
.....++..|++||++.+..++.++||||||+++|+|++|+.||............... ..+.. ..+...+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~ 224 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN---GPPGL-RNPEKWS 224 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---CCCCc-CcccccC
Confidence 23456888999999998888999999999999999999999999755332222111110 00111 1111123
Q ss_pred HHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 700 LILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 700 ~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+.+++.+||..+|.+||++.+++.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 56999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=303.58 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=191.7
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++++|.+.+.||+|+||.||+|.. ++..||+|++...... ....+.+|+.+++.++|+||+++++++.+ ..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999986 5779999998654322 23357789999999999999999998854 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+. ++|..++..... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 677776654332 4788888899999999999999999 999999999999999999999999999754221
Q ss_pred CCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc-----C--------
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN-----G-------- 681 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~-----~-------- 681 (768)
. .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........+.. +
T Consensus 157 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 S------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred C------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 1 112234578999999988754 5788999999999999999999999654432221111 0
Q ss_pred ------CccccCCCCC-CC-----C-CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 682 ------TFDETLDPAV-PD-----W-PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 682 ------~~~~~ld~~~-~~-----~-~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+.....+.. +. | .......+.+++.+|+..+|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 00 0 0012356889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=303.85 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=194.2
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
+|++.+.||.|+||.||+|.+ ++..||||+++..... ....+.+|+.+++.++||||+++++.|.+ ..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588899999999999999998 4678999999765322 24567789999999999999999999854 459999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
+ ++|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 488888876554446899999999999999999999999 99999999999999999999999999976532211
Q ss_pred ccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcC------------Cc
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENG------------TF 683 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~------------~~ 683 (768)
......++..|++||.+.+. .++.++|||||||++|+|++|++||........ .+... ..
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 11234578899999987654 578999999999999999999999964432211 11000 00
Q ss_pred cccCCCCCCC--------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 DETLDPAVPD--------WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld~~~~~--------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+....+. .....+..+.+++.+|++.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000011110 11123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=299.39 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=183.0
Q ss_pred eecccCceeEEEEEE-CC---ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCC
Q 035604 470 KIGEGGYGPVYKSYL-DH---TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGS 542 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~-~~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gs 542 (768)
.||+|+||.||++.. ++ ..+++|.+.... ......+.+|+.+++.++||||+++++.|.+ ..|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999875 22 246677776543 3345678999999999999999999999854 4599999999999
Q ss_pred hHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 543 LEDRLFRRGG-SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 543 L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 9999876422 234677788899999999999999999 99999999999999999999999999864321110
Q ss_pred cccccCCCCCCCCCCcccccC-------CCCCccccHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHcCCccccCCCCC
Q 035604 622 QYRMTSAAGTFCYIDPEYQQT-------GMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQV--ERSIENGTFDETLDPAV 691 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~--~~~i~~~~~~~~ld~~~ 691 (768)
........++..|+|||++.. ..++.++|||||||++|||++ |.+||...... ...+..+......++..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 011134567889999998743 235789999999999999997 57788543322 22222222223333333
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
. ......+.+++..|| .+|++||++.+|+
T Consensus 235 ~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~ 263 (268)
T cd05086 235 E---LPYSERWYEVLQFCW-LSPEKRATAEEVH 263 (268)
T ss_pred C---CCCcHHHHHHHHHHh-hCcccCCCHHHHH
Confidence 2 223345888999999 6899999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.75 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=190.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|.+.+.||.|+||.||+|.. +++.||||.+...... ....+.+|+++++.++||||+++++++.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36789999999999999999987 5678999998654322 23456789999999999999999998854 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+. ++|.+++..... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 997 589888876443 4889999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH---c--CC--------
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE---N--GT-------- 682 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~---~--~~-------- 682 (768)
.......++..|+|||++.+ ..++.++|||||||++|+|++|++||.........+. + +.
T Consensus 158 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 158 ------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred ------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 11122356889999998765 4588999999999999999999999964431111110 0 00
Q ss_pred ------ccccCCCCCCCC-------CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 ------FDETLDPAVPDW-------PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ------~~~~ld~~~~~~-------~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.....+..... .......+.+++.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000 0011145789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=306.56 Aligned_cols=264 Identities=20% Similarity=0.207 Sum_probs=198.7
Q ss_pred CCccceecccCceeEEEEEECCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccC
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
|.+.+.+|.|+++.||++..+++.||||+++.. .......+.+|+++++.++||||+++++++.+ ..+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 344555677788888888888999999999754 33445678999999999999999999998843 45899999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC-c
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD-S 619 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~-~ 619 (768)
|+|.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+..+...... .
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999998764332 4889999999999999999999999 999999999999999999999999998765322110 0
Q ss_pred cccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc--CCccccCC-------
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN--GTFDETLD------- 688 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~--~~~~~~ld------- 688 (768)
..........++..|+|||++.. ..++.++|||||||++|||++|+.||.........+.. +.....++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 01111233467788999998876 35889999999999999999999999754433322211 11111000
Q ss_pred -------------CCC-----CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHH
Q 035604 689 -------------PAV-----PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILR 732 (768)
Q Consensus 689 -------------~~~-----~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~ 732 (768)
+.. .......+..+.+|+.+||..+|.+||++.+++. ++++.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000 0112234457899999999999999999999997 6665553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=313.30 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=196.4
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-------
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 529 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++... .......+.+|+.++++++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999987 5678999998643 22334567789999999999999999998732
Q ss_pred -CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
..|+||||+. ++|.+.+... ++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 2489999995 5787776532 788899999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HH-H------
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SI-E------ 679 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i-~------ 679 (768)
++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... .+ .
T Consensus 165 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCC-------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98653321 12344678999999999999999999999999999999999999964322110 00 0
Q ss_pred ----------------cCC------ccccCC----CCC-CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 680 ----------------NGT------FDETLD----PAV-PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 680 ----------------~~~------~~~~ld----~~~-~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
... +..... +.. ...+...+..+.+++.+||..||.+||++.+++. +|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000 000000 000 0001123456889999999999999999999987 66653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.86 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=193.0
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh-----hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ-----GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
+|.+.+.||.|+||.||+|.. .++.||||.+...... ....+..|+++++.++||||+++++++.+ ..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477888999999999999987 4679999999755322 23456789999999999999999999855 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+ +|+|..++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999886644 25899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcC--C-------
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENG--T------- 682 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~--~------- 682 (768)
.. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||........ .+... .
T Consensus 155 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PN------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CC------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 21 11223456788999998754 4578999999999999999999888854433211 11000 0
Q ss_pred ----ccccCC------CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 ----FDETLD------PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ----~~~~ld------~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...... ..........+..+.+++.+||..+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000 0000011223456899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.23 Aligned_cols=240 Identities=29% Similarity=0.413 Sum_probs=192.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
..|...+.||+|+||.||++.. .+..||+|++.... ......+.+|+++++.++||||++++++|.+ ..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999987 56789999986432 2334568899999999999999999999843 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+. |+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 577776654332 4899999999999999999999999 999999999999999999999999999765322
Q ss_pred CCCccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHcCCccccCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IENGTFDETLDPA 690 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~~~~~~~ld~~ 690 (768)
....++..|+|||++. ...++.++||||||+++|+|++|++||......... +..... +.
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~ 233 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-----PT 233 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----CC
Confidence 2346788999999874 456889999999999999999999999655433321 111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. +...+..+.+++.+||..+|.+||++.+++.
T Consensus 234 ~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 234 LS--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CC--chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11 1223456999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.37 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=191.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcC-CCceeeeeccccC--C-----
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--F----- 530 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~----- 530 (768)
++|++.+.||+|+||.||++.+ +++.||||.+..... .....+.+|+.+++.+. ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999987 567899999865422 22346788999999995 6999999988732 2
Q ss_pred ceeEEEeccCCChHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCcEEEeecc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG--SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVG 607 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~vKL~DFG 607 (768)
.|+||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 4899999975 78888765332 245899999999999999999999999 999999999999998 8999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH--c--CC
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE--N--GT 682 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~--~--~~ 682 (768)
++..+.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||........... . +.
T Consensus 157 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPV------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCc------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 997653221 11223457889999998765 4579999999999999999999999965433322111 0 00
Q ss_pred cccc-----------------CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 FDET-----------------LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ~~~~-----------------ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
-... ............+..+.++|.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000000001123456899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.93 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=209.0
Q ss_pred cCCCccceecccCceeEEEEEECCc--cEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~--~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
.+.....+||.|-||.||.|.|+.. .||||.|+.+.+. .+.|..|..+|+.++|||+|+|+|+|. ...|||.|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 3445567899999999999999653 7999999877654 568999999999999999999999994 4569999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
.+|+|.++|.+.+.. .++.-..+.++.||..|+.||..++ +|||||-..|.|+.++..+|++||||++++..+...
T Consensus 346 ~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999999876543 4777888899999999999999999 999999999999999999999999999998654321
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
. .....-..-|.|||-+....++.|+|||+|||+||||.| |..||-+. .++...+++|... +-|
T Consensus 422 A-----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM--------~~P 488 (1157)
T KOG4278|consen 422 A-----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM--------DGP 488 (1157)
T ss_pred c-----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc--------cCC
Confidence 1 112233567999999999999999999999999999998 88899544 4566777777532 234
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
..|+..+.+|++.||+.+|.+||++.++-..+..++
T Consensus 489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 455567999999999999999999999876555444
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=302.79 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=191.6
Q ss_pred CCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 465 FSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
|++.+.||.|++|.||+|.+ +++.||+|++..... .....+.+|+++++.++||||+++++++.+ ..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 66788999999999999987 578999999875432 223467889999999999999999999854 448999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+....
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 81 -DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred -CcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 4689988866442 24899999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH---HHc-CC-----------
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS---IEN-GT----------- 682 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~---i~~-~~----------- 682 (768)
.......++..|+|||++.+. .++.++|||||||++|+|++|++||......... ... +.
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 112233568899999987654 5789999999999999999999999644332211 110 00
Q ss_pred -------ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 -------FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 -------~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...............+..+.+++.+||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000001111111223356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.08 Aligned_cols=245 Identities=24% Similarity=0.414 Sum_probs=193.5
Q ss_pred CCCccceecccCceeEEEEEECC---ccEEEEEEcCCc----------hhhHHHHHHHHHHHhh-cCCCceeeeeccccC
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLDH---TPVAIKVLRPDA----------AQGRSQFQQEVEVLCN-IRHPNMVLLLGACPE 529 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~~---~~vAvK~l~~~~----------~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~ 529 (768)
+|.+.+.||+|+||.||++.+.+ ..+|+|.+.... ......+.+|+.++.+ ++||||+++++.|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999844 679999885321 2233456788888875 799999999998844
Q ss_pred --CceeEEEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEee
Q 035604 530 --FGCLIYEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISD 605 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~D 605 (768)
..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ |+|+||+|.|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 448999999999999987542 223358999999999999999999996 56 99999999999999999999999
Q ss_pred cccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCc
Q 035604 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTF 683 (768)
Q Consensus 606 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~ 683 (768)
||++....... ......|+..|++||++.+..++.++||||||+++|+|++|++||....... ..+..+.+
T Consensus 158 fg~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 230 (269)
T cd08528 158 FGLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230 (269)
T ss_pred ccceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC
Confidence 99998654321 2234578899999999998889999999999999999999999996543322 22333322
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
... .. ...+..+.+++.+||..+|++||++.+|..
T Consensus 231 ~~~----~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 231 EPL----PE---GMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred CcC----Cc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 111 11 122356999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.52 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=198.7
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccCCc--------e
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG--------C 532 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--------~ 532 (768)
.|...+.||+||||.||+|++ .|..||||.+++.. ....+...+|+++|++|+|||||+++++-.+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 345567799999999999997 67789999998653 345566789999999999999999998764322 7
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc--CCC--cEEEeeccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD--RNY--VSKISDVGL 608 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~--~~~--~vKL~DFGl 608 (768)
+|||||.||+|...|.+-.+...|++.+.+.+...++.||.|||.+| |+||||||.||++- .+| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 89999999999999998777777999999999999999999999999 99999999999993 323 349999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCC---ChH----HHHHHHH-
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMG---LAH----QVERSIE- 679 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~---~~~----~~~~~i~- 679 (768)
|+-++.+. .+.+.+||..|.+||+... +.|+.-+|.|||||++|+++||..||. ... -....+.
T Consensus 171 Arel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 171 ARELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred cccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 99775432 4678999999999998884 889999999999999999999999993 111 1111111
Q ss_pred -------------cCCc--cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCC--ChhhhhhHHHHHHH
Q 035604 680 -------------NGTF--DETLDPAVPDWPVEEALILAKLALQCAELRRKDRP--DLGKVVVPKLNILR 732 (768)
Q Consensus 680 -------------~~~~--~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RP--s~~evl~~~l~~l~ 732 (768)
+|.+ ...+.... .........+.+.+..+|..+|++|- ...+.....-.+|+
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~-~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPN-HLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcc-cccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1111 11111211 12233445588888999999999999 55544444444443
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.63 Aligned_cols=261 Identities=20% Similarity=0.290 Sum_probs=198.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC------Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~ 531 (768)
.++|.+.+.||.|+||.||++.. ++..||+|++.... ......+.+|+.+|+.++||||++++++|.. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46899999999999999999987 56789999987542 2334567789999999999999999987732 34
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+. |+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 68888876543 3899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--H-HH--------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--S-IE-------- 679 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~-i~-------- 679 (768)
+...... .........|+..|++||++.+ ..++.++|||||||++|+|++|++||........ . ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 5432211 1111234578999999998765 4589999999999999999999999954322111 0 00
Q ss_pred ------cCCcccc---CCCCC-CCC---CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 680 ------NGTFDET---LDPAV-PDW---PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 680 ------~~~~~~~---ld~~~-~~~---~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
...+... ..... ..| ....+..+.+++.+||+.+|.+||++.+++. +|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0000000 00000 001 1223466999999999999999999999987 777544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.27 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=196.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC-----chhhHHHHHHHHHHHhhcCCCceeeeeccccC----Cc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD-----AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FG 531 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 531 (768)
.+|.+.+.||+|+||.||++.+ ++..||+|.+... .......+.+|++++++++||||+++++.+.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999987 5678999987532 12334578899999999999999999998743 24
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+++++|.+++.... .+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 78999999999999887644 3789999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~ 691 (768)
...... .........++..|+|||++.+..++.++|||||||++|+|++|++||.............. ....
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--- 227 (264)
T cd06653 156 IQTICM---SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTK--- 227 (264)
T ss_pred cccccc---cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCC---
Confidence 532111 11112335688999999999888899999999999999999999999975544333222111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..|...+..+.+++.+||. +|..||+..+++.
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 12233445669999999999 5799999997764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=334.23 Aligned_cols=253 Identities=29% Similarity=0.406 Sum_probs=195.3
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-------
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------- 529 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 529 (768)
....+|+.+.+||+||||.||++++ +|+.||||.+.... ......+.+|+.+|++|+|||||++|.+|-+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3457789999999999999999987 89999999997553 2334568899999999999999998865410
Q ss_pred --------------------------------------------------------------------------------
Q 035604 530 -------------------------------------------------------------------------------- 529 (768)
Q Consensus 530 -------------------------------------------------------------------------------- 529 (768)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 035604 530 ----------------------------------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575 (768)
Q Consensus 530 ----------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L 575 (768)
..||=||||+...|.+++.++.... .....|+++.+|+.||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0145689998888888776654211 3667889999999999999
Q ss_pred HhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC------------CCCCCccccccccCCCCCCCCCCcccccCC
Q 035604 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP------------PSVADSVTQYRMTSAAGTFCYIDPEYQQTG 643 (768)
Q Consensus 576 H~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~------------~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 643 (768)
|++| ||||||||.||+||.++.|||+|||+|+... ............++.+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 000111112245788999999999988765
Q ss_pred C---CCccccHHHHHHHHHHHHhCCCCCCChHHH---HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCC
Q 035604 644 M---LGVKSDVYSLGILLLQIITAKPPMGLAHQV---ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDR 717 (768)
Q Consensus 644 ~---~s~ksDvwSlGvil~elltg~~Pf~~~~~~---~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~R 717 (768)
. |+.|+|||||||||+||+. ||+..-+- ...++++.+... .+........-.++|.++++.||.+|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-----cccccccchHHHHHHHHHhcCCCccC
Confidence 5 9999999999999999986 57655433 334445554433 22233333446789999999999999
Q ss_pred CChhhhhh
Q 035604 718 PDLGKVVV 725 (768)
Q Consensus 718 Ps~~evl~ 725 (768)
||+.+++.
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999984
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.67 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=201.5
Q ss_pred CCCccceecccCceeEEEEEEC--CccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccCC----ceeEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF----GCLIY 535 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----~~lV~ 535 (768)
+|.+.+.||+|++|.||+|... ++.|++|++..... .....+.+|+.++++++||||+++++.+.+. .++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999985 77899999876542 4456789999999999999999999988544 58999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987654 5899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
... .......++..|++||.+.+..++.++||||||+++|+|++|..||.........+..-.. ....+..+
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 226 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS----SGEPPEIP 226 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc----cCCCcCCC
Confidence 210 0123456888999999998888999999999999999999999999655422221111110 01112223
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+++.+|+..+|.+||++.+++.
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 333567999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.12 Aligned_cols=253 Identities=17% Similarity=0.218 Sum_probs=179.9
Q ss_pred hcCCCccceecccCceeEEEEEECC-----ccEEEEEEcCCchhhH-----------HHHHHHHHHHhhcCCCceeeeec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPDAAQGR-----------SQFQQEVEVLCNIRHPNMVLLLG 525 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~~~~~-----------~~~~~E~~il~~l~HpnIv~l~g 525 (768)
.++|.+.+.||+|+||.||+|.+.+ ..+|+|+......... .....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999998743 3567776433221110 01123334456678999999998
Q ss_pred cccC------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 035604 526 ACPE------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599 (768)
Q Consensus 526 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 599 (768)
++.. ..+++++++ ..++.+.+.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 7532 226777776 346666554432 2678888999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccCCCCCCc-cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH---HH
Q 035604 600 VSKISDVGLARLVPPSVADS-VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ---VE 675 (768)
Q Consensus 600 ~vKL~DFGla~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~---~~ 675 (768)
.+||+|||+++.+....... ..........||+.|+|||++.+..++.++|||||||++|||++|++||..... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999998764321110 011112335799999999999999999999999999999999999999964421 11
Q ss_pred HHHHcCCccccCCC--CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 676 RSIENGTFDETLDP--AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 676 ~~i~~~~~~~~ld~--~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.....+.+..+..+ ..+.. +..+.+++..|+..+|++||++.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKNA----NKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhhccCCC----CHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11111100111111 11222 355999999999999999999998873
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=296.71 Aligned_cols=244 Identities=28% Similarity=0.457 Sum_probs=195.8
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E~ 537 (768)
+|.+.+.||.|+||.||++.. ++..||+|.+.... ......+.+|+.+++.++||||+++++.+.+. .++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 578889999999999999988 56789999986542 23345688999999999999999999988543 4899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFGla~~~~~~~ 616 (768)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||.||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999998876443 24799999999999999999999999 99999999999998876 46999999998664321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~ 694 (768)
. ......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ .+..+. +.+..+
T Consensus 157 ~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~-- 224 (257)
T cd08225 157 E------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY----FAPISP-- 224 (257)
T ss_pred c------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc----CCCCCC--
Confidence 1 11234688999999999888899999999999999999999999964432221 122221 111111
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+++.+||..+|++||++.+++.
T Consensus 225 --~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 --NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 22345999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=298.28 Aligned_cols=242 Identities=24% Similarity=0.276 Sum_probs=195.8
Q ss_pred CCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
+|.+.+.||.|+||.||++... ++.||+|++.... ......+.+|++++++++||||+++++.+.+ ..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999884 6789999997543 2345678899999999999999999988844 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999987652 4889999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~ 694 (768)
......|+..|++||++.+..++.++|+||||+++|+|++|..||..... .......... .....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~ 221 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------ADVLY 221 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------ccccC
Confidence 11334688899999999888899999999999999999999999964432 1111111110 11112
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCCh--hhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDL--GKVV 724 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~--~evl 724 (768)
+...+..+.+++.+||..+|.+||+. .+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22233568999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.99 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=190.8
Q ss_pred CccceecccCceeEEEEEECC--ccEEEEEEcCC-chhhHHHHHHHHHHHhhcC-CCceeeeeccccC--CceeEEEecc
Q 035604 466 SNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPD-AAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLIYEYMA 539 (768)
Q Consensus 466 ~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~E~~~ 539 (768)
.++..||.|+.|.|+++++.. ...|||.+... +....+.+...+.++...+ .|.||+.+|+|.. ..++.||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 345569999999999999854 78999999755 4455667888888877665 9999999999843 447889988
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
...++.+|.+-. .++++...-++...++.||.||..++ +|||||+||+|||+|..|++||||||++..+..+.+
T Consensus 174 s~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 174 STCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 344555555433 24999999999999999999999876 599999999999999999999999999987754433
Q ss_pred cccccccCCCCCCCCCCcccccCC---CCCccccHHHHHHHHHHHHhCCCCCCChH---HHHHHHHcCCccccCCCCCCC
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTG---MLGVKSDVYSLGILLLQIITAKPPMGLAH---QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltg~~Pf~~~~---~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.+...|.+.|||||.+... .|+.++||||||+.|+||.||+.||.+.+ ++...+.+. ..|.++.
T Consensus 248 -----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-----ePP~L~~ 317 (391)
T KOG0983|consen 248 -----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-----EPPLLPG 317 (391)
T ss_pred -----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-----CCCCCCc
Confidence 3456899999999987644 58999999999999999999999996543 233333332 1233322
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+..+++++..||.+|+.+||.+.+++.
T Consensus 318 -~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 -HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2236677999999999999999999998874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=307.24 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=190.5
Q ss_pred CCCccceecccCceeEEEEEE----CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC----ce
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL----DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF----GC 532 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~----~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----~~ 532 (768)
.|.+.+.||+|+||.||+|.. .+..||+|.+.... ......+.+|+.+++.++||||++++++|.+. .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478889999999999999998 45789999997632 23335678899999999999999999998544 59
Q ss_pred eEEEeccCCChHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC----CCcEEEeec
Q 035604 533 LIYEYMANGSLEDRLFRRG--GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR----NYVSKISDV 606 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~----~~~vKL~DF 606 (768)
+||||+++ +|.+.+.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 6666664322 1235889999999999999999999999 999999999999999 999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH----------
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---------- 675 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---------- 675 (768)
|++..+...... ........+++.|+|||.+.+ ..++.++|||||||++|+|++|++||.......
T Consensus 157 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 157 GLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred ccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999876432211 112234567899999997766 458999999999999999999999995332110
Q ss_pred --HHHHc---------------CCccc----cCCCCCCC-----CC---HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 676 --RSIEN---------------GTFDE----TLDPAVPD-----WP---VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 676 --~~i~~---------------~~~~~----~ld~~~~~-----~~---~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+.. ..+.. ......+. +. ...+..+.+++.+||..+|++||++.+++.
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000 00000010 00 023356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=312.41 Aligned_cols=258 Identities=23% Similarity=0.285 Sum_probs=194.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-------Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~ 531 (768)
+++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57899999999999999999987 56789999986432 2334567889999999999999999987632 24
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+. ++|...+... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999995 5777766432 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HH----------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SI---------- 678 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i---------- 678 (768)
....... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...+.... .+
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccc---cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 5432111 111234578999999997654 5689999999999999999999999964322110 00
Q ss_pred -----HcCCccccC--CCCCCCC-----CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 679 -----ENGTFDETL--DPAVPDW-----PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 679 -----~~~~~~~~l--d~~~~~~-----~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
........+ .+..+.. ....+..+.+++.+||+.+|.+||++.+++. ++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 000000000 0000000 0122456889999999999999999999986 56543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.19 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=192.2
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
++|.+.+.||+|+||.||+|.. +++.||+|.+..... .....+.+|+++++.++||||+++++++.+ ..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5788999999999999999987 467899999865422 233567899999999999999999999844 4599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCcEEEeecccccccCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARLVPPS 615 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~vKL~DFGla~~~~~~ 615 (768)
|++ ++|.+.+..... ..+++.....++.||+.||.|||+.+ |+||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 578777755432 23678888899999999999999999 999999999999985 567999999999765322
Q ss_pred CCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHH---Hc-CC-ccccCC-
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSI---EN-GT-FDETLD- 688 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i---~~-~~-~~~~ld- 688 (768)
. .......+++.|++||++.+ ..++.++|||||||++|+|+||++||.......... .. +. ......
T Consensus 157 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 V------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred c------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 1 11233467889999998765 457899999999999999999999996443221111 10 00 000000
Q ss_pred --------CCCCCC--------CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 689 --------PAVPDW--------PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 689 --------~~~~~~--------~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
...+.+ ....+..+.+++.+|++.+|.+||++.+++. +|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 000000 1122345889999999999999999999986 55443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.67 Aligned_cols=243 Identities=24% Similarity=0.348 Sum_probs=194.3
Q ss_pred ccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEEeccCCC
Q 035604 467 NSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGS 542 (768)
Q Consensus 467 ~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~~~gs 542 (768)
...+||+|+||.||++.. ++..||||.+..........+.+|+.+++.++||||+++++.+ .+..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 346799999999999987 5678999998655545566789999999999999999999987 445699999999999
Q ss_pred hHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcccc
Q 035604 543 LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622 (768)
Q Consensus 543 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 622 (768)
|.+++... .+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..+.....
T Consensus 104 L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~----- 171 (292)
T cd06657 104 LTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP----- 171 (292)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-----
Confidence 99877432 3789999999999999999999999 99999999999999999999999999876532211
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCCCCCCHHHHH
Q 035604 623 YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDWPVEEAL 700 (768)
Q Consensus 623 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~~~~~~~~ 700 (768)
......|++.|++||++.+..++.++|+|||||++|+|++|.+||....... ..+..+. .+.... ....+.
T Consensus 172 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~ 244 (292)
T cd06657 172 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-----PPKLKN-LHKVSP 244 (292)
T ss_pred -cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-----CcccCC-cccCCH
Confidence 1133568899999999988889999999999999999999999996543322 2222211 111111 112234
Q ss_pred HHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 701 ILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 701 ~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+.+++.+||..+|.+||++.+++. +++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~~ 273 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKHPFL 273 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcChHH
Confidence 5889999999999999999999986 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=311.42 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=197.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-------C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~ 530 (768)
.++|.+.+.||+|+||.||++.. +++.||||.+... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999987 5678999998653 22334467789999999999999999998742 2
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 489999995 78888876543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HH---------
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SI--------- 678 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i--------- 678 (768)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|++||........ .+
T Consensus 157 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 157 TTSEKG------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccCCCc------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 663321 11234567889999998764 4689999999999999999999999964321110 00
Q ss_pred ------HcCCcc-------ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 679 ------ENGTFD-------ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 679 ------~~~~~~-------~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
..+... ....+.........+..+.+++.+||+.+|.+||++.+++. +|+..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000 00001001111234456899999999999999999999997 676554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.48 Aligned_cols=239 Identities=26% Similarity=0.375 Sum_probs=188.4
Q ss_pred ecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEeccCCCh
Q 035604 471 IGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYMANGSL 543 (768)
Q Consensus 471 LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~gsL 543 (768)
||+|+||+||++.. +++.||+|++.... ......+.+|+++|+.++||||+++++.+. +..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999876 56789999986532 223445678999999999999999998874 345999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 623 (768)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-------
Confidence 999876543 34899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHHHHH
Q 035604 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEALI 701 (768)
Q Consensus 624 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~ 701 (768)
......++..|++||++.+..++.++|||||||++|+|++|+.||..... ....+....... ....+...+..
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 224 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM-----AVEYPDKFSPE 224 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc-----cccCCccCCHH
Confidence 11234678899999999888899999999999999999999999964432 111222221111 11122233456
Q ss_pred HHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 702 LAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 702 l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
+.+++.+||..+|.+|| ++.+++.
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 89999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=304.26 Aligned_cols=261 Identities=19% Similarity=0.241 Sum_probs=194.0
Q ss_pred eeccc--CceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCC
Q 035604 470 KIGEG--GYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANG 541 (768)
Q Consensus 470 ~LG~G--~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 541 (768)
.||.| +||+||++.+ .++.||+|++.... ....+.+.+|+.+++.++||||++++++|.. ..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999987 67899999987542 2334678899999999999999999999844 458999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||.+............
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99998876543 24889999999999999999999999 999999999999999999999999866443221110000
Q ss_pred cc-cccCCCCCCCCCCcccccCC--CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH--cCCcc------------
Q 035604 622 QY-RMTSAAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE--NGTFD------------ 684 (768)
Q Consensus 622 ~~-~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~--~~~~~------------ 684 (768)
.. ......++..|++||++.+. .++.++|||||||++|+|++|++||.........+. .+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 00 01122356679999998764 478999999999999999999999964432222111 11000
Q ss_pred -------------------------ccCCCCC-CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHHH
Q 035604 685 -------------------------ETLDPAV-PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRAL 734 (768)
Q Consensus 685 -------------------------~~ld~~~-~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~~ 734 (768)
......+ ...+..++..+.+|+.+||..+|.+|||+.+++. +|+..++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 0000000 1112345667999999999999999999999996 777766553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.36 Aligned_cols=235 Identities=26% Similarity=0.375 Sum_probs=190.9
Q ss_pred ecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCCh
Q 035604 471 IGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSL 543 (768)
Q Consensus 471 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 543 (768)
||.|+||.||++.+. ++.||+|++..... .....+.+|+.+++.++||||+++++.+.+ ..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999985 77999999975432 334578999999999999999999998743 45899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 623 (768)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 99987654 3889999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--H--HHHHHHcCCccccCCCCCCCCCHHHH
Q 035604 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--Q--VERSIENGTFDETLDPAVPDWPVEEA 699 (768)
Q Consensus 624 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~--~~~~i~~~~~~~~ld~~~~~~~~~~~ 699 (768)
......++..|++||.+.+..++.++|+||||+++|+|++|..||.... . ....+..+.. .. ..+...+
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~ 220 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG----KL---EFPNYID 220 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC----CC---CCCcccC
Confidence 1233468889999999988889999999999999999999999996554 2 1222221111 11 1222224
Q ss_pred HHHHHHHHHhhhcCccCCCC-----hhhhhh
Q 035604 700 LILAKLALQCAELRRKDRPD-----LGKVVV 725 (768)
Q Consensus 700 ~~l~~Li~~cl~~~P~~RPs-----~~evl~ 725 (768)
..+.+++.+||..+|.+||+ +.+++.
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 56999999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.78 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=203.3
Q ss_pred CCccceecccCceeEEEEEECC---c--cEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEe
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDH---T--PVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEY 537 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~---~--~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~ 537 (768)
....++||+|.||.|++|.|+. + .||||+++.+... ...+|.+|+.+|.+|+|||+++|||+.-+ ...+|||+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL 191 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL 191 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence 4556789999999999999843 3 6999999877543 67789999999999999999999999864 55899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
++.|+|.++|.+ .....|.......++.||+.|+.||..++ +|||||-..||||-..-.|||+||||.+.+.....
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999988 33445778888899999999999999999 99999999999999999999999999998865432
Q ss_pred Ccccccccc-CCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 618 DSVTQYRMT-SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 618 ~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.|.+. .....+.|+|||.+....++.++|||+|||++|||+| |..||-+.. ++...|+++.. ..
T Consensus 268 ----~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er--------Lp 335 (1039)
T KOG0199|consen 268 ----MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER--------LP 335 (1039)
T ss_pred ----ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc--------CC
Confidence 22322 2345678999999999999999999999999999998 889995443 33444544331 12
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.|..|+..+.+++..||..+|.+||++..+..
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 34556677999999999999999999998863
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.99 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=192.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh--hHHHHHHHHHHHhhcCCCceeeeecccc----CCceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ--GRSQFQQEVEVLCNIRHPNMVLLLGACP----EFGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~lV 534 (768)
++|.+.+.||.|+||.||+|.+ +++.+|+|.++..... ....+.+|+.++++++||||+++++++. ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5688899999999999999998 4678999999754321 2235678999999999999999999873 456999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+. ++|.+++..... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 589888876443 5899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc-----------
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN----------- 680 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~----------- 680 (768)
.. .......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||........ .+..
T Consensus 159 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 159 PL------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred Cc------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 21 112334678899999987654 468999999999999999999999964332211 1100
Q ss_pred ----------CCccccCCCCC-CCCCHH-HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 681 ----------GTFDETLDPAV-PDWPVE-EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 681 ----------~~~~~~ld~~~-~~~~~~-~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+........ ..++.. .+..+.+|+.+||..+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000 011111 2456899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=291.00 Aligned_cols=244 Identities=27% Similarity=0.422 Sum_probs=199.3
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|.+.+.||+|+||.||++.. .+..|++|.+..... .....+.+|++++++++|||++++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478889999999999999987 456899999976643 445678999999999999999999988744 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999987653 4899999999999999999999999 99999999999999999999999999987643321
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHH
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
. .....++..|++||...+..++.++||||||+++|+|++|..||.............. ...+ ..+..
T Consensus 155 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~---~~~~~ 222 (254)
T cd06627 155 D------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---DDHP---PLPEG 222 (254)
T ss_pred c------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---cCCC---CCCCC
Confidence 1 2334678899999998888899999999999999999999999965544333222111 0011 11222
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+.+++.+||..+|++||++.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 3456899999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.53 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=196.5
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC------
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------ 529 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 529 (768)
...++|.+.+.||+|+||.||++.. ++..||||++... .......+.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3467899999999999999999987 5678999998643 22334567899999999999999999998743
Q ss_pred --CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 --FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..++||+|+ +++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 238999999 78898877532 4899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH--c--CC
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE--N--GT 682 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~--~--~~ 682 (768)
++...... .....+++.|++||.+.+ ..++.++|+|||||++|+|++|++||........... . +.
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 164 LARQTDSE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred cccccccC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99765321 123467889999998776 4588999999999999999999999965433211110 0 00
Q ss_pred c--------------------cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 683 F--------------------DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 683 ~--------------------~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
. ...............+..+.+++.+|+..+|.+||++.+++. ++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 000000000111123345889999999999999999999986 666554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.30 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=197.2
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhc-CCCceeeeeccccC----Cc
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE----FG 531 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~----~~ 531 (768)
..++|.+.+.||+|+||.||+|.+ .++.+|+|.+... .......+.+|+.+++++ +||||++++++|.. ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 357889999999999999999987 4678999988542 223344577899999999 99999999998743 34
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+. ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999996 5888877653 4889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH---HHHc-CCc---
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER---SIEN-GTF--- 683 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~---~i~~-~~~--- 683 (768)
+....... .........|+..|++||.+.+ ..++.++|||||||++|+|++|++||........ .+.. +..
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 64332110 1112234568999999997654 5678999999999999999999999964322111 0000 000
Q ss_pred ----------cccC-------CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 684 ----------DETL-------DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 684 ----------~~~l-------d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
...+ ...........+..+.+++.+||+.+|.+||++.+++. +++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000 00001111113456999999999999999999999996 566554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.89 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=191.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
.++|.+.+.||+|+||.||++.. ++..||||.+..... .....+.+|+.++++++||||++++++|..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46799999999999999999987 567899999864321 222345689999999999999999998732
Q ss_pred --CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 --FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..++||||+. ++|.+.+.... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 2389999995 57887776543 24899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CC
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GT 682 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~ 682 (768)
++..+....... ........++..|+|||++.+. .++.++||||||+++|+|++|.+||........ .+.. +.
T Consensus 165 ~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CcccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 998764332111 1112345678899999987664 478999999999999999999999964432211 1110 11
Q ss_pred ccccCCCCC-----------CC----------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 FDETLDPAV-----------PD----------WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ~~~~ld~~~-----------~~----------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.....+.. +. ++......+.+|+.+||..+|.+||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 111000000 00 01112345789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=295.99 Aligned_cols=243 Identities=21% Similarity=0.288 Sum_probs=187.3
Q ss_pred HHHHHHhcCCCcccee--cccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccc--c
Q 035604 456 EEIEEATENFSNSRKI--GEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGAC--P 528 (768)
Q Consensus 456 ~ei~~~~~~y~~~~~L--G~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~--~ 528 (768)
.++....++|.+.+.+ |.|+||.||++.. .+..+|+|++....... .|+.+...+ +||||+++++.| .
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444456677777776 9999999999987 55689999986542211 122222222 799999999987 4
Q ss_pred CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeecc
Q 035604 529 EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVG 607 (768)
Q Consensus 529 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFG 607 (768)
+..|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 45699999999999999987654 4899999999999999999999999 99999999999999988 99999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHHHcCCcc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIENGTFD 684 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i~~~~~~ 684 (768)
++...... ....++..|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.... .
T Consensus 156 ~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~ 224 (267)
T PHA03390 156 LCKIIGTP----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q 224 (267)
T ss_pred cceecCCC----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c
Confidence 99765322 23468899999999999899999999999999999999999996332111 1111111 1
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC-hhhhhh
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD-LGKVVV 725 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs-~~evl~ 725 (768)
... ..+...+..+.+++.+||+.+|.+||+ +.+++.
T Consensus 225 ----~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 ----KKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----ccC-CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111 112234566999999999999999996 588774
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=298.22 Aligned_cols=237 Identities=24% Similarity=0.338 Sum_probs=195.4
Q ss_pred cCCCccceecccCceeEEEEEECCc--cEEEEEEcCCchhhHHH---HHHHHHHHhhc-CCCceeeeecccc--CCceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQ---FQQEVEVLCNI-RHPNMVLLLGACP--EFGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~--~vAvK~l~~~~~~~~~~---~~~E~~il~~l-~HpnIv~l~g~~~--~~~~lV 534 (768)
.+|.++.+||+|+||.|.++.-.|+ .+|||+++++.....++ -..|-.+|... +-|.++.|..+|. +..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4688899999999999999988665 79999999874332222 24566777665 4678888888874 566999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+.||+|.-.+...+. +-+..+..++.+|+-||-|||++| ||+||||.+|||+|.+|++||+|||+++--
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-- 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-- 500 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc--
Confidence 999999999998887764 778888899999999999999999 999999999999999999999999999732
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~ 692 (768)
. .......+++||+.|+|||++...+|+..+|+|||||+||||+.|++||+..+ .+.+.|.+.+.
T Consensus 501 -i---~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--------- 567 (683)
T KOG0696|consen 501 -I---FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--------- 567 (683)
T ss_pred -c---cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---------
Confidence 1 12223467899999999999999999999999999999999999999997654 44456655432
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCCh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
.+|...+.+...++...|.+.|.+|--.
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 4566667788999999999999998543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.87 Aligned_cols=247 Identities=22% Similarity=0.313 Sum_probs=187.0
Q ss_pred CCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcC-CCceeeeeccccC----CceeEEE
Q 035604 465 FSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIR-HPNMVLLLGACPE----FGCLIYE 536 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~----~~~lV~E 536 (768)
|.+.+.||+|+||.||++.. +++.||+|+++.... .......+|+.++.++. ||||+++++++.+ ..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 66788999999999999987 567899999875421 22223457888999885 9999999998853 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+. |+|.+.+.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++. +.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 57877776543 25899999999999999999999999 999999999999999 999999999998663321
Q ss_pred CCccccccccCCCCCCCCCCccccc-CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCc--------
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTF-------- 683 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~-------- 683 (768)
......++..|+|||.+. +..++.++|||||||++|||++|.+||...+.... .+.. +..
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 154 -------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred -------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 112346788999999654 45678999999999999999999999964432211 1100 000
Q ss_pred --cccCCCCCC--------CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 --DETLDPAVP--------DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 --~~~ld~~~~--------~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
........+ ......+..+.+|+.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 011234567999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=310.33 Aligned_cols=237 Identities=22% Similarity=0.330 Sum_probs=203.2
Q ss_pred cCCCccceecccCceeEEEEEECCc--cEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~--~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.++..+..||-||||.|=++...+. .+|+|++++... ...+.+..|.+||..++.|.||+||..|.+ +.|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 3455667899999999998887655 489999987532 334557789999999999999999999955 558899
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|-|-||.|+..|..++. |...+...++..++.|+.|||+++ ||+|||||+|.++|.+|-+||.|||+|+.+..+
T Consensus 500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999988774 899999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~ 693 (768)
.+..+++||+.|.|||++.+...+.++|.||||+++||||+|.+||...+.+. +.|.+|. ....
T Consensus 574 -------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-------d~i~ 639 (732)
T KOG0614|consen 574 -------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-------DKIE 639 (732)
T ss_pred -------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------hhhh
Confidence 34567899999999999999999999999999999999999999998776654 4565553 1225
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCC
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPD 719 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs 719 (768)
||........+|+++.|..+|.+|--
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhc
Confidence 56666677899999999999999987
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.11 Aligned_cols=237 Identities=28% Similarity=0.346 Sum_probs=180.2
Q ss_pred eecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHh---hcCCCceeeeecccc--CCceeEEEecc
Q 035604 470 KIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLC---NIRHPNMVLLLGACP--EFGCLIYEYMA 539 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~---~l~HpnIv~l~g~~~--~~~~lV~E~~~ 539 (768)
.||+|+||.||++.. +++.||+|.+..... .....+.+|..++. ..+||||+.+++.+. +..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 467899999865422 11223344444433 347999999998874 35589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999887654 4899999999999999999999999 9999999999999999999999999987543211
Q ss_pred cccccccCCCCCCCCCCccccc-CCCCCccccHHHHHHHHHHHHhCCCCCCChHH-HHHHHHcCCccccCCCCCCCCCHH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ-VERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~-~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
.....|+..|+|||.+. +..++.++|||||||++|+|++|..||..... ....+..... .... ..+..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~---~~~~~ 221 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNV---ELPDS 221 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCc---CCccc
Confidence 12346899999999876 45689999999999999999999999953221 1111111111 1111 12233
Q ss_pred HHHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
.+..+.+++.+||..+|.+|| ++.+++.
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 445699999999999999999 5777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=299.13 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=192.0
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcC-CCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~ 535 (768)
.++|.+.+.||.|+||.||++.+. ++.||||.++... ......+..|+.++.++. ||||++++++|.+ ..|++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 367889999999999999999985 7899999997543 233445667777776665 9999999999844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||+. ++|.+++..... .+++..+..++.||+.||.|||+ .+ |+||||+|+||+++.++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9984 577776655332 58999999999999999999997 47 99999999999999999999999999976532
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCC----CCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHHHcCCccccC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGM----LGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIENGTFDETL 687 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i~~~~~~~~l 687 (768)
... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ..+..+..
T Consensus 168 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 236 (296)
T cd06618 168 SKA-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP---- 236 (296)
T ss_pred CCc-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC----
Confidence 211 12335788999999887554 7899999999999999999999996532211 12222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
+..+ ....++..+.+|+.+||..+|.+||++.+++. +|...
T Consensus 237 -~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 237 -PSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred -CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 1111 11123456999999999999999999999986 44443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.93 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=194.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
.++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+++.++||||++++++|..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999986 56789999986532 2223457899999999999999999998743
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..++|+||+. ++|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 2389999995 46665542 13889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHHHcC----
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIENG---- 681 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i~~~---- 681 (768)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+...
T Consensus 165 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 165 RHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred cCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 754321 123467889999998876 468999999999999999999999996443211 111100
Q ss_pred ----------CccccC--CCCCC-----CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHHHh
Q 035604 682 ----------TFDETL--DPAVP-----DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRALA 735 (768)
Q Consensus 682 ----------~~~~~l--d~~~~-----~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~~~ 735 (768)
...... .+..+ ......+..+.+|+.+||+.+|.+||++.+++. ++.+.++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 000000 00000 000112345889999999999999999999986 7776665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.75 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=199.1
Q ss_pred ccCCHHHHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeecc
Q 035604 451 RKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGA 526 (768)
Q Consensus 451 ~~~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~ 526 (768)
+.....++..++++|.+.+.||+|+||.||++.. ++..||+|++.... ......+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3444566677889999999999999999999986 56789999987532 2234567889999999999999999988
Q ss_pred ccC--------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 035604 527 CPE--------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN 598 (768)
Q Consensus 527 ~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 598 (768)
+.. ..|++++++ +++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 732 247788877 78998877543 3899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--
Q 035604 599 YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE-- 675 (768)
Q Consensus 599 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~-- 675 (768)
+.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|++||.......
T Consensus 157 ~~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 157 CELKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred CCEEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999998754221 233467899999998766 568899999999999999999999995332211
Q ss_pred HHHHc--CCc--------------------cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 676 RSIEN--GTF--------------------DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 676 ~~i~~--~~~--------------------~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
..+.. +.. .........+.....+..+.+++.+||..+|.+||++.+++. ++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 11100 000 000000000001112345889999999999999999999986 5443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.13 Aligned_cols=258 Identities=22% Similarity=0.263 Sum_probs=191.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh--hHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ--GRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
.++|.+.++||.|+||.||++.+ +++.||||++...... ....+.+|+++++.++||||+++++.+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999997 4678999998643221 22356789999999999999999987622
Q ss_pred --CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 --FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..++||+|+. ++|...+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 2389999996 46776665432 35999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCcc-----ccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHH
Q 035604 608 LARLVPPSVADSV-----TQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIE 679 (768)
Q Consensus 608 la~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~ 679 (768)
+++.......... .....+...+++.|+|||.+.+ ..++.++|||||||++|+|++|++||........ .+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9986643221111 1112234567889999998765 4589999999999999999999999964433221 110
Q ss_pred c--CCc-----------cc----cCCCCCCCC----CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 680 N--GTF-----------DE----TLDPAVPDW----PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 680 ~--~~~-----------~~----~ld~~~~~~----~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. +.. .. ......+.. .......+.+++.+||..+|.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 000 00 000000000 0112245889999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.23 Aligned_cols=239 Identities=28% Similarity=0.390 Sum_probs=189.7
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.|...+.||+|+||.||++.. ++..||+|++.... ......+.+|+.+++.++|||+++++++|.+ ..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999999999987 56789999986432 2234568899999999999999999998844 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+. |+|.+.+.... ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 996 57777765433 24899999999999999999999999 999999999999999999999999998754321
Q ss_pred CCccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAV 691 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~ 691 (768)
....|++.|+|||++. ++.++.++|||||||++|+|++|+.||...... ...+..+..... .
T Consensus 179 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~- 245 (317)
T cd06635 179 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---Q- 245 (317)
T ss_pred ---------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC---C-
Confidence 2346888999999873 456889999999999999999999998644322 122222211111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+..+.+|+.+||..+|.+||++.+++.
T Consensus 246 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 246 ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred ---CccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 1123345899999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=323.85 Aligned_cols=258 Identities=19% Similarity=0.242 Sum_probs=182.1
Q ss_pred HhcCCCccceecccCceeEEEEEECC---ccEEEE------------------EEcCCchhhHHHHHHHHHHHhhcCCCc
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDH---TPVAIK------------------VLRPDAAQGRSQFQQEVEVLCNIRHPN 519 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~---~~vAvK------------------~l~~~~~~~~~~~~~E~~il~~l~Hpn 519 (768)
..++|.+.+.||+|+||.||++.... ..+++| .+. ........+.+|+.+|+.++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999886522 112222 111 11123446789999999999999
Q ss_pred eeeeecccc--CCceeEEEeccCCChHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 520 MVLLLGACP--EFGCLIYEYMANGSLEDRLFRRGG--SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 520 Iv~l~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
||++++++. +..|+|++++ +++|..++..... .........+.|+.||+.||.|||+.+ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999884 4458999998 4677777654321 112345667789999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCC-CCCCh---
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKP-PMGLA--- 671 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~-Pf~~~--- 671 (768)
+.++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||+||||++|.. ||...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER-----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCCEEEEeCCCceecCccc-----ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 999999999999998764321 111234679999999999999999999999999999999999875 44311
Q ss_pred --HHHHHHHHcCC-ccc-cCCC--------------CCC-CCCH-----HHHHHHHHHHHHhhhcCccCCCChhhhhh-H
Q 035604 672 --HQVERSIENGT-FDE-TLDP--------------AVP-DWPV-----EEALILAKLALQCAELRRKDRPDLGKVVV-P 726 (768)
Q Consensus 672 --~~~~~~i~~~~-~~~-~ld~--------------~~~-~~~~-----~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~ 726 (768)
..+...+.... ... ..+. ..+ ..+. .....+.+++.+||..||.+||++.+++. +
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 11111111100 000 0000 000 0000 11234778899999999999999999986 4
Q ss_pred HH
Q 035604 727 KL 728 (768)
Q Consensus 727 ~l 728 (768)
|.
T Consensus 456 ~f 457 (501)
T PHA03210 456 LF 457 (501)
T ss_pred hh
Confidence 43
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=338.70 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=201.3
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLI 534 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV 534 (768)
.+-+|.....||.|.||.||.+.. +|...|+|.++-. .......+.+|+.+|..++|||+|++||+- .+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345677788899999999999987 5667899987643 233445678999999999999999999975 5567999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||||++|+|.+.+.... ..++.....+..|++.||.|||+.| ||||||||.||||+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999887654 3677777789999999999999999 99999999999999999999999999998866
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCC---CCCccccHHHHHHHHHHHHhCCCCCCChH-HHHH--HHHcCCccccCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTG---MLGVKSDVYSLGILLLQIITAKPPMGLAH-QVER--SIENGTFDETLD 688 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltg~~Pf~~~~-~~~~--~i~~~~~~~~ld 688 (768)
+..+. ..-.....||+.|||||++.+. +..-+.|||||||+++||+||+.||...+ .... .+..|.
T Consensus 1387 ~~~~~--~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh------ 1458 (1509)
T KOG4645|consen 1387 NAQTM--PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH------ 1458 (1509)
T ss_pred chhcC--CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC------
Confidence 53221 2234577999999999988754 45779999999999999999999995333 2222 223332
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
.|..|...+.+-.+++..||+.||+.|.++.+++
T Consensus 1459 --~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1459 --KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred --CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 3455666777899999999999999998887665
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.68 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=191.5
Q ss_pred CCccceecccCceeEEEEEEC--CccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC----CceeEEE
Q 035604 465 FSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCLIYE 536 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~E 536 (768)
|.+.+.||.|+||.||++... ++.+|+|++.... ......+.+|+.+++.++|||++++++++.. ..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999884 5789999997653 2234567899999999999999999999854 4599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|++ ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 996 48888876543 25899999999999999999999999 9999999999999999999999999998664332
Q ss_pred CCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CC-----cc--
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GT-----FD-- 684 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~-----~~-- 684 (768)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .+.. +. +.
T Consensus 155 ~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 S-----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred c-----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 1 11233456888999997664 4578999999999999999999999964432211 1111 00 00
Q ss_pred -c-----cCCCCC------CCCCHH-HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 685 -E-----TLDPAV------PDWPVE-EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 685 -~-----~ld~~~------~~~~~~-~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. ...+.. .+.... ++..+.+++.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000000 000001 2567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.25 Aligned_cols=252 Identities=26% Similarity=0.303 Sum_probs=192.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC----Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~l 533 (768)
.++|.+.+.||+|+||.||+|.+ ++..||+|++..... .....+.+|+.++++++||||+++++++.. ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999988 467899999864422 112345689999999999999999998732 3589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 57888876543 35899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCccccC-
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTFDETL- 687 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~~~~l- 687 (768)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||........ .+.. +.-....
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 160 LPA------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred Ccc------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 321 11223356788999998765 5689999999999999999999999964433221 1111 0000000
Q ss_pred --------------C-CCCCCCC---HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 688 --------------D-PAVPDWP---VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 688 --------------d-~~~~~~~---~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. .....+. ...+..+.+++.+||..||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000 012456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=289.01 Aligned_cols=243 Identities=29% Similarity=0.479 Sum_probs=198.7
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|++.+.||+|+||.||++.. ++..+|+|.+.... ......+.+|+.+++.++||||+++++.+.+ ..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999977 56689999987542 2334567889999999999999999988744 45899999
Q ss_pred ccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
+++++|..++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|.||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886622 1245899999999999999999999999 9999999999999999999999999998764431
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 694 (768)
.....++..|++||.+.+..++.++|+||||+++|+|++|+.||...... ...+..+.+. ..
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~ 221 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--------PI 221 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--------CC
Confidence 12246788999999999988999999999999999999999999655432 2233333222 22
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+++.+||..+|.+||++.+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2344566999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=297.32 Aligned_cols=255 Identities=25% Similarity=0.288 Sum_probs=193.5
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC------
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE------ 529 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 529 (768)
...++|++.+.||+|+||.||+|.+ +++.||+|+++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999998 467899999975422 223457789999999999999999998743
Q ss_pred ------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 530 ------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 530 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
..++|+||+++ ++...+.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 35899999975 6767665442 24899999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHc
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IEN 680 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~ 680 (768)
+|||++..+..... .......++..|++||.+.+ ..++.++|||||||++|+|++|++||......... +..
T Consensus 158 ~dfg~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 158 ADFGLARLYNSEES-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcccccccccCCcc-----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999987643221 11122356788999997764 45789999999999999999999999754432221 111
Q ss_pred ---CCcc----cc--------CCCCC------CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 681 ---GTFD----ET--------LDPAV------PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 681 ---~~~~----~~--------ld~~~------~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+... .. .++.. .......+..+.+++.+||..+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 00 00000 0001112456899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=294.41 Aligned_cols=247 Identities=29% Similarity=0.419 Sum_probs=198.7
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcC-CCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV 534 (768)
++|.+.+.||.|+||.||++.. ++..||+|++.... ......+.+|++++++++ ||||+++++.+.+ ..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688899999999999999988 57799999987532 233456789999999998 9999999998854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997654 4999999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCcc--------------ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HH
Q 035604 615 SVADSV--------------TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SI 678 (768)
Q Consensus 615 ~~~~~~--------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i 678 (768)
...... .........++..|++||...+..++.++||||||+++|++++|+.||........ .+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 221100 01223345678999999998888899999999999999999999999975543221 22
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCCh----hhhh
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDL----GKVV 724 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~----~evl 724 (768)
.... . .++...+..+.+++.+||..+|.+||++ .+++
T Consensus 235 ~~~~------~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 235 LKLE------Y---SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HhcC------C---CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1111 0 1222224568999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.36 Aligned_cols=260 Identities=25% Similarity=0.301 Sum_probs=200.7
Q ss_pred CCCccceecccCceeEEEEEEC--CccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC-------Cce
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------FGC 532 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~~ 532 (768)
+|.+.+.||.|+||.||++... +..||||.+.... ......+.+|+.+++.++||||+++++++.. ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888899999999999999973 6789999987543 3345678899999999999999999998844 348
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
+||+|+. ++|..++.... .+++..++.++.||+.||.|||+.+ |+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999996 57888776543 5899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCcc---
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTFD--- 684 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~~--- 684 (768)
...... ........++..|+|||++.+. .++.++|||||||++|+|++|++||........ .+.. +...
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 443210 1112345678999999998887 799999999999999999999999964433211 1110 0000
Q ss_pred ----------ccCC---CC----CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHH
Q 035604 685 ----------ETLD---PA----VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRA 733 (768)
Q Consensus 685 ----------~~ld---~~----~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~ 733 (768)
..+. .. ........+..+.+++.+||+.+|.+||++.+++. +|++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000 00 00001113456899999999999999999999987 67766544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=295.03 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=193.8
Q ss_pred CCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 465 FSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
|.+.+.||.|++|.||++.. ++..+++|.+..... .....+.+|+.+++.++||||+++++++.. ..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778899999999999987 567899999875432 234578899999999999999999998744 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++ +|..++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 64 8888776643 24899999999999999999999999 9999999999999999999999999998764332
Q ss_pred ccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH---HHc-CC--------ccc
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS---IEN-GT--------FDE 685 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~---i~~-~~--------~~~ 685 (768)
.......++..|++||.+.+. .++.++||||||+++|+|++|+.||......... ... +. +..
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 112334678899999988776 7899999999999999999999999654432211 100 00 000
Q ss_pred -----------cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 -----------TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 -----------~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.............+..+.+++.+||..+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000001111234567999999999999999999999885
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=287.71 Aligned_cols=245 Identities=26% Similarity=0.460 Sum_probs=199.4
Q ss_pred CCCccceecccCceeEEEEEEC--CccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
+|.+.+.||.|+||.||++.+. +..|++|++..... .....+.+|+++++.++|||++++++.+.. ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999985 67899999975532 455678899999999999999999988743 45899999
Q ss_pred ccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887642 1245899999999999999999999998 9999999999999999999999999998664321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~ 694 (768)
.......|++.|++||.+.+..++.++|+||||+++|+|++|+.||..... ....+..... .+ .
T Consensus 158 ------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~----~ 223 (258)
T cd08215 158 ------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PP----I 223 (258)
T ss_pred ------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC----CC----C
Confidence 112334688899999999888899999999999999999999999965432 2222222221 11 1
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+++.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123345899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=304.54 Aligned_cols=259 Identities=22% Similarity=0.264 Sum_probs=193.2
Q ss_pred CCCccceecccCceeEEEEEEC----CccEEEEEEcCC--chhhHHHHHHHHHHHhhc-CCCceeeeecccc------CC
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD----HTPVAIKVLRPD--AAQGRSQFQQEVEVLCNI-RHPNMVLLLGACP------EF 530 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~------~~ 530 (768)
+|.+.+.||+|+||.||++... +..||+|++... .......+.+|+.+++++ .||||+++++.+. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999984 558999998643 222345678899999999 5999999998642 23
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.+++++|+. ++|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 478888885 68988886543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHHH-------
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIE------- 679 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i~------- 679 (768)
.+...... .........|+..|+|||++.+ ..++.++|||||||++|+|++|++||....... ..+.
T Consensus 154 ~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred eccccccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 66432211 1112234578999999997765 468999999999999999999999996433211 0000
Q ss_pred -------cCC-------ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 680 -------NGT-------FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 680 -------~~~-------~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
... +...-...........+..+.+++.+||+.+|.+||++.+++. +|+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000 0000000000111112456999999999999999999999987 776554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.72 Aligned_cols=257 Identities=22% Similarity=0.325 Sum_probs=193.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC----------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---------- 529 (768)
..+|.+.+.||.|+||.||+|.. +++.||+|.+..........+.+|+++++.++||||+++++++..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999987 467899999876555556678899999999999999999987633
Q ss_pred ------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCcEE
Q 035604 530 ------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-RNYVSK 602 (768)
Q Consensus 530 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~vK 602 (768)
..|+||||+. ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 2489999996 5888777532 3889999999999999999999999 99999999999997 456789
Q ss_pred EeecccccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHH--H
Q 035604 603 ISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSI--E 679 (768)
Q Consensus 603 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i--~ 679 (768)
|+|||+++.+...... ........++..|+|||++.. ..++.++|||||||++|+|++|+.||.......... .
T Consensus 156 l~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSH---KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred ECCcccceecCCcccc---ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999765322110 001122357889999997654 568899999999999999999999996443322111 0
Q ss_pred cC-Cc-------------cccC--CCCCCCCC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 680 NG-TF-------------DETL--DPAVPDWP-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 680 ~~-~~-------------~~~l--d~~~~~~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
.. .. .... .......+ ...+..+.+|+.+||..+|.+||++.+++. +|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 00 00 0000 00000111 123356889999999999999999999986 5654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=290.52 Aligned_cols=240 Identities=27% Similarity=0.340 Sum_probs=190.9
Q ss_pred ecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCCh
Q 035604 471 IGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSL 543 (768)
Q Consensus 471 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 543 (768)
||.|+||.||++.+. +..|++|++..... .....+.+|++++++++||||+++++.+.. ..|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999984 77899999976543 345568899999999999999999988744 44899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc--cc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS--VT 621 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~--~~ 621 (768)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99987654 4899999999999999999999999 9999999999999999999999999987653221100 00
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHHH-
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVEE- 698 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~- 698 (768)
........++..|++||...+..++.++||||||+++|+|++|..||...... ...+..+.+ .++...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~ 225 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI---------EWPEDVE 225 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---------CCCcccc
Confidence 01123456788999999998888999999999999999999999999644332 222332221 111121
Q ss_pred -HHHHHHHHHHhhhcCccCCCCh---hhhhh
Q 035604 699 -ALILAKLALQCAELRRKDRPDL---GKVVV 725 (768)
Q Consensus 699 -~~~l~~Li~~cl~~~P~~RPs~---~evl~ 725 (768)
+..+.+++.+||+.+|.+||++ .+++.
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 4568999999999999999999 55543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=297.44 Aligned_cols=246 Identities=26% Similarity=0.342 Sum_probs=190.9
Q ss_pred CCCccceecccCceeEEEEEE-----CCccEEEEEEcCCch----hhHHHHHHHHHHHhhc-CCCceeeeeccccCC--c
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDAA----QGRSQFQQEVEVLCNI-RHPNMVLLLGACPEF--G 531 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~--~ 531 (768)
+|++.+.||.|+||.||++.. ++..||+|++..... .....+.+|+.++..+ +||||+.+++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999876 567899999975322 2345678899999999 599999999887543 4
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 89999999999999987654 4889999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCC--CCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETL 687 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~l 687 (768)
+..... .......|+..|++||.+.+. .++.++||||||+++|+|++|..||...... ...+....
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~----- 224 (290)
T cd05613 155 FHEDEV-----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI----- 224 (290)
T ss_pred cccccc-----cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh-----
Confidence 533211 112345688999999988653 4788999999999999999999999632110 11111100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
....+.++...+..+.+++.+||..+|.+|| +..+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0011122333445689999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.49 Aligned_cols=232 Identities=23% Similarity=0.268 Sum_probs=181.4
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCchh---hHHHHHHHHHHH-hhcCCCceeeeeccccC--CceeEEEeccC
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ---GRSQFQQEVEVL-CNIRHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~E~~il-~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+.||.|+||.||+|.. .++.||+|++...... ....+..|..++ ...+||||+++++++.. ..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999987 5679999999754322 122344555544 45589999999999854 45999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|.||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999887644 4889999999999999999999999 99999999999999999999999999875422
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
.....++..|++||.+.+..++.++||||||+++|+|++|.+||...... ...+..+... ... .....+
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~ 220 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPE---EVKEFC 220 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCC---cccccC
Confidence 12346788999999998888999999999999999999999999644322 2222222211 011 111123
Q ss_pred HHHHHHHHHHhhhcCccCCCChh
Q 035604 699 ALILAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~ 721 (768)
+..+.+++.+||..+|++||++.
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCC
Confidence 45699999999999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.48 Aligned_cols=255 Identities=26% Similarity=0.322 Sum_probs=194.4
Q ss_pred HHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeecccc---CCc
Q 035604 459 EEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACP---EFG 531 (768)
Q Consensus 459 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~---~~~ 531 (768)
..++++|.+.+.||.|+||.||++.. ++..||+|++.... ......+.+|+++++.++||||++++++|. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678999999999999999999986 56789999886432 223456789999999999999999999873 345
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
+++|||+ +++|..++... .+++.....++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 67888777532 3788888899999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHH---------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIE--------- 679 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~--------- 679 (768)
.... .....++..|++||.+.+ ..++.++|||||||++|+|++|++||........ .+.
T Consensus 158 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd07856 158 QDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228 (328)
T ss_pred cCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 4221 123467889999998765 5689999999999999999999999954332110 000
Q ss_pred ------cCCccccCC--CCCCCCC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 680 ------NGTFDETLD--PAVPDWP-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 680 ------~~~~~~~ld--~~~~~~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.+...+.+. +.....+ ...+..+.+++.+||+.+|.+||++.+++. +++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 000000000 0000001 123456999999999999999999999986 55533
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=289.07 Aligned_cols=245 Identities=28% Similarity=0.347 Sum_probs=189.1
Q ss_pred cceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhh-cCCCceeeeecccc-CC-ceeEEEeccCC
Q 035604 468 SRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCN-IRHPNMVLLLGACP-EF-GCLIYEYMANG 541 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~-l~HpnIv~l~g~~~-~~-~~lV~E~~~~g 541 (768)
+..||.|+||+|++-.+ .|+..|||.++.... ....++..|.++..+ -+.||||++||++. +. .++.||+|+ .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 45699999999998877 567899999986644 456678888887555 47999999999873 33 378899994 5
Q ss_pred ChHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 542 SLEDRLFR--RGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 542 sL~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+.+... .-....+++...-.|....+.||.||...- .|||||+||+|||||..|.+||||||++..+-.+.+
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA-- 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA-- 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence 66654432 111234899999999999999999998653 299999999999999999999999999987754443
Q ss_pred cccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH---HHcCCccccCCCCCCCC
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS---IENGTFDETLDPAVPDW 694 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~---i~~~~~~~~ld~~~~~~ 694 (768)
.+.-+|...|||||.+.. ..|+.+|||||||++|||+.||..|+..-..+... +..|....++.+ .-
T Consensus 224 -----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~---~~ 295 (361)
T KOG1006|consen 224 -----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD---KE 295 (361)
T ss_pred -----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc---cc
Confidence 244589999999997754 35999999999999999999999999755554443 334432222111 12
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+..+..+|.-||.+|..+||.+.++..
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2346778999999999999999999998864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=282.75 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=204.1
Q ss_pred ceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccccC--CceeEEEeccCCCh
Q 035604 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLIYEYMANGSL 543 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~E~~~~gsL 543 (768)
+.||+|+|+.|-.+.. ++..||||++.+.....+..+.+|++++..++ |+||+.|+.+|++ ..|||||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 5699999999987765 78899999998887778889999999999985 9999999999955 45999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC---cEEEeecccccccCCCC-CCc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY---VSKISDVGLARLVPPSV-ADS 619 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~vKL~DFGla~~~~~~~-~~~ 619 (768)
...|.++. .|++.+..++..+|+.||.|||.+| |.||||||+|||..... .+|||||.|...+.... ...
T Consensus 164 LshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99998765 3999999999999999999999999 99999999999995543 56999999986543211 112
Q ss_pred cccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCCh-----------------HHHHHH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLA-----------------HQVERS 677 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~-----------------~~~~~~ 677 (768)
.......+.+|+..|||||+.. ...|+.++|.||||||||-||.|++||.+. ..+...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 2233456789999999999532 335899999999999999999999999422 123445
Q ss_pred HHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHH
Q 035604 678 IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILR 732 (768)
Q Consensus 678 i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~ 732 (768)
|.+|.|. +-+. +|. ..+.+..+|+...+..++.+|-++.+++. +|.++..
T Consensus 318 IQEGkYe-FPdk---dWa-hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 318 IQEGKYE-FPDK---DWA-HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HhccCCc-CChh---hhH-HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 6666642 1111 332 34556888999999999999999999998 7877663
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=293.71 Aligned_cols=240 Identities=28% Similarity=0.334 Sum_probs=182.6
Q ss_pred eecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHH---HHhhcCCCceeeeeccccC--CceeEEEecc
Q 035604 470 KIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVE---VLCNIRHPNMVLLLGACPE--FGCLIYEYMA 539 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~---il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 539 (768)
.||+|+||.||++.+ .++.||+|++..... .....+..|.. +++...||||+.+++.+.+ ..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999887 467899999865422 11222334443 3444679999999988743 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
||+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998886543 4899999999999999999999999 9999999999999999999999999987553211
Q ss_pred cccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHH-HHHHcCCccccCCCCCCCCCHH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVE-RSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~-~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
.....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||....... ..+.... ....+ .++..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~---~~~~~ 221 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAV---ELPDS 221 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCC---CCCCc
Confidence 1234789999999988754 68999999999999999999999996442110 0111110 01111 22223
Q ss_pred HHHHHHHHHHHhhhcCccCCC-----Chhhhhh-HHH
Q 035604 698 EALILAKLALQCAELRRKDRP-----DLGKVVV-PKL 728 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RP-----s~~evl~-~~l 728 (768)
.+..+.+++.+||..+|.+|| ++.+++. +|.
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 356799999999999999999 8888874 444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=290.17 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=189.9
Q ss_pred CCccceecccCceeEEEEEEC--CccEEEEEEcCCch--hhHHHHHHHHHHHhhc---CCCceeeeecccc--CC-----
Q 035604 465 FSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA--QGRSQFQQEVEVLCNI---RHPNMVLLLGACP--EF----- 530 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~--~~----- 530 (768)
|++.+.||.|+||.||++.+. ++.||+|+++.... .....+.+|+.+++++ +||||++++++|. +.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 667889999999999999984 67899999974322 1233466788877766 5999999999983 23
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 589999996 578888866433 24899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHHHcCC-----
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIENGT----- 682 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i~~~~----- 682 (768)
.+.... ......++..|+|||++.+..++.++|||||||++|+|++|.+||....... ..+..-.
T Consensus 156 ~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 156 IYSFEM-------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eccCCc-------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 763321 1123357889999999998899999999999999999999999996443221 1111000
Q ss_pred ------------ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 ------------FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ------------~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...............+..+.+++.+||..+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000001111233456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.14 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=190.6
Q ss_pred cCCC-ccceecccCceeEEEEEE--CCccEEEEEEcCCchhh--------------HHHHHHHHHHHhhcCCCceeeeec
Q 035604 463 ENFS-NSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQG--------------RSQFQQEVEVLCNIRHPNMVLLLG 525 (768)
Q Consensus 463 ~~y~-~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~--------------~~~~~~E~~il~~l~HpnIv~l~g 525 (768)
++|. +.+.||.|+||.||++.+ .++.||||++....... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 457799999999999986 56789999986542211 124678999999999999999999
Q ss_pred ccc--CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 526 ACP--EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 526 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
++. +..|+||||+. |+|.+++.... .+++.....++.|++.||.|||+.+ |+|+||+|+|||++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 874 45589999996 68988886543 4899999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCc--------cccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHH
Q 035604 604 SDVGLARLVPPSVADS--------VTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQV 674 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~ 674 (768)
+|||++..+....... ..........++..|+|||++.+. .++.++|||||||++|+|++|++||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998764211100 001112334578899999988764 4789999999999999999999999654432
Q ss_pred HHH--HHc--CC-----cccc--------CCCCCC----CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 675 ERS--IEN--GT-----FDET--------LDPAVP----DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 675 ~~~--i~~--~~-----~~~~--------ld~~~~----~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
... +.. +. +... .....+ ......+..+.+++.+||..+|.+||++.+++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 211 100 00 0000 000000 001122456889999999999999999999985
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.57 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=192.2
Q ss_pred CCCccceecccCceeEEEEEECC--ccEEEEEEcCCc-----hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDA-----AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
+|.+.+.||+|+||.||++.+.. ..+++|+++... ......+..|+.+++.++||||+++++.+.+ ..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998743 356667665321 1223456789999999999999999998843 45899
Q ss_pred EEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 535 YEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++..+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988652 22345899999999999999999999999 999999999999975 569999999997663
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~ 691 (768)
.... ......|++.|++||.+.+..++.++|+||||+++|+|++|..||........ .+..+ ..
T Consensus 157 ~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--------~~ 222 (260)
T cd08222 157 GSCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--------PT 222 (260)
T ss_pred CCcc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--------CC
Confidence 3211 12234678899999998888899999999999999999999999964433222 12111 12
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..+...+..+.+++.+||..+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 2233445567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.18 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=190.0
Q ss_pred CCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcC-CCceeeeeccccC--CceeEEEec
Q 035604 465 FSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
|.+.+.||.|+||.||+|.. .+..|+||.+..... .......+|+..+++++ ||||+++++.+.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 66788999999999999998 456899999865422 22334567999999999 9999999998844 448999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
+|+|.+++..... ..+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 8899888876542 35899999999999999999999999 9999999999999999999999999998653321
Q ss_pred ccccccccCCCCCCCCCCccccc-CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH---HH---------------
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQ-TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS---IE--------------- 679 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~---i~--------------- 679 (768)
......++..|+|||++. +..++.++|+||||+++|+|++|++||......... ..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 112346788999999775 445799999999999999999999999544322111 00
Q ss_pred -cCCccccCCCCC----CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 680 -NGTFDETLDPAV----PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 680 -~~~~~~~ld~~~----~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+...+.... .......+..+.+++.+||..+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000 0001112356999999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=339.65 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=192.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
...|...+.||+|+||.||+|.. ++..||||.+...... ...|++++++++|||||+++|+|.+ ..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577788999999999999986 5779999998643321 2356889999999999999999844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++|+|.+++.. ++|..+.+|+.||+.||.|||.....+|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 999999999852 8899999999999999999996544459999999999999999888875 666543311
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--------HHHHHHHcCCccccCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--------QVERSIENGTFDETLDP 689 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--------~~~~~i~~~~~~~~ld~ 689 (768)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.||+... ..............+++
T Consensus 835 -------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 835 -------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred -------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 122367899999999999999999999999999999999999984221 11111112222333444
Q ss_pred CCC---CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 690 AVP---DWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 690 ~~~---~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
.+. ..+..+...+.+++.+||+.+|.+||++.+|+..+.
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 332 234456667899999999999999999999985433
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=293.92 Aligned_cols=239 Identities=28% Similarity=0.392 Sum_probs=189.1
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCC---chhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYE 536 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 536 (768)
.|...+.||+|+||.||+|.. ++..||+|.+... .......+.+|+++++.++|||++++++++. ...++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 466778899999999999987 5668999998643 2233456788999999999999999999874 34589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 67877765433 24889999999999999999999998 999999999999999999999999998765321
Q ss_pred CCccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAV 691 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~ 691 (768)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||....... ..+..+......
T Consensus 169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 235 (308)
T cd06634 169 ---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---- 235 (308)
T ss_pred ---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC----
Confidence 2346788999999874 3567889999999999999999999986443222 222222211111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 236 ---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred ---cccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 1133456899999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.80 Aligned_cols=245 Identities=27% Similarity=0.417 Sum_probs=202.7
Q ss_pred cceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEEeccCC
Q 035604 468 SRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANG 541 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~~~g 541 (768)
.+.||.|-||+||-|.+ .|+.||||++.+. ......++++|+.||+.+.||.||.|.-.| ++..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 37899999999998876 6789999999654 234457899999999999999999998777 45669999999 55
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CcEEEeecccccccCCCCCC
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN---YVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~vKL~DFGla~~~~~~~~~ 618 (768)
++.+++..... ..|++.....++.||+.||.|||.++ |+|+||||+|||+... -.+||||||+|++++...
T Consensus 648 DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 DMLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 66555544322 24999999999999999999999999 9999999999999543 478999999999986532
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
...+.+||+.|+|||+++.+.|+..-|+||+|||+|--|.|..||+-..++...|.+..|.-.-. .|. +.
T Consensus 722 -----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~----PW~-ei 791 (888)
T KOG4236|consen 722 -----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPN----PWS-EI 791 (888)
T ss_pred -----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCC----chh-hc
Confidence 23567999999999999999999999999999999999999999998888888888876543222 232 34
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
+....+||...|+..-++|-+...-+. +||+
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq 823 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ 823 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence 456889999999999999999988764 4543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=291.63 Aligned_cols=238 Identities=27% Similarity=0.393 Sum_probs=188.1
Q ss_pred CCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 465 FSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
|...+.||+|+||.||+|.. .+..|++|++..... .....+.+|+++++.++|||++++++++.+ ..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999987 567899999864322 233467889999999999999999998844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+. |+|.+++..... .+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 677777765432 4899999999999999999999999 99999999999999999999999999864311
Q ss_pred CccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVP 692 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~ 692 (768)
.....|+..|+|||++. +..++.++|||||||++|+|++|.+||........ .+......... ..
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 243 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ---SN 243 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---cc
Confidence 12346888999999874 45688999999999999999999999965433222 12111111111 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+ +..+.+|+.+||+.+|.+||++.+++.
T Consensus 244 ~~----~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 244 EW----TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred cc----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22 245899999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=292.76 Aligned_cols=246 Identities=29% Similarity=0.485 Sum_probs=192.7
Q ss_pred CCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhh--cCCCceeeeeccccC------CceeEE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCN--IRHPNMVLLLGACPE------FGCLIY 535 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~------~~~lV~ 535 (768)
...+.++||+|.||.||+|.++++.||||++.. +..+.|.+|.+|... ++|+||++++++-.. .+.||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 445567899999999999999999999999974 445678888888765 689999999987522 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC------CCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP------EPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~------~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
+|.+.|+|.++|..+ .++|....+|+.-+++||.|||.-.+ ++|+|||||+.||||..+++..|+|||||
T Consensus 288 ~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999875 49999999999999999999997644 57999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCC-CC-----ccccHHHHHHHHHHHHhCC------------CCCC--
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM-LG-----VKSDVYSLGILLLQIITAK------------PPMG-- 669 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-----~ksDvwSlGvil~elltg~------------~Pf~-- 669 (768)
..+...... ......+||.+|||||++.+.. +. .+.||||+|.+||||+++- .||+
T Consensus 364 l~~~p~~~~----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 364 LRLEPGKPQ----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred EEecCCCCC----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 988755432 2234579999999999887642 22 3689999999999999853 2342
Q ss_pred -----ChHHHHHHHHcCCccccCCCCCCC-CCH-HHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 670 -----LAHQVERSIENGTFDETLDPAVPD-WPV-EEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 670 -----~~~~~~~~i~~~~~~~~ld~~~~~-~~~-~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
..+++...+...+ ..|.+++ |-. .....|.+.+..||..||+-|-|+.=|-
T Consensus 440 vG~hPt~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred hcCCCCHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 1223333333222 2233332 211 2344599999999999999999998665
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=289.20 Aligned_cols=249 Identities=28% Similarity=0.407 Sum_probs=192.8
Q ss_pred CCccceecccCceeEEEEEEC--CccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 465 FSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
|+..+.||+|+||.||+|... ++.||+|++.... ......+..|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999984 6789999997653 2234567889999999999999999998854 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
. ++|.+++.... ..+++..++.++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 58999887653 24899999999999999999999999 99999999999999999999999999986643211
Q ss_pred ccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH--c--CC--------ccc
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE--N--GT--------FDE 685 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~--~--~~--------~~~ 685 (768)
......++..|+|||.+.+. .++.++|||||||++|||++|++||........... . +. +..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 12234567889999988776 789999999999999999999999965433221100 0 00 000
Q ss_pred c--CCCCCCCCC--------HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 T--LDPAVPDWP--------VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 ~--ld~~~~~~~--------~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. .+...+.+. ...+..+.+++..||..+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 000111110 112456999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.45 Aligned_cols=245 Identities=28% Similarity=0.347 Sum_probs=189.7
Q ss_pred CCCccceecccCceeEEEEEE-----CCccEEEEEEcCCc----hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--Cc
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA----AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FG 531 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~ 531 (768)
+|.+.+.||+|+||.||++.. +++.||||+++... ......+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999875 45689999987532 12345678999999999 59999999988744 45
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||.||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 89999999999999887543 4889999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCC--CCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETL 687 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~l 687 (768)
+..... .......|+..|++||.+.+.. .+.++||||||+++|+|++|..||..... ....+.......
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 227 (288)
T cd05583 155 FLAEEE-----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-- 227 (288)
T ss_pred cccccc-----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence 533211 1112346889999999887655 78899999999999999999999953211 011111110000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
.+ ..+...+..+.+++.+||+.+|++||++.++.
T Consensus 228 ~~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~ 261 (288)
T cd05583 228 KP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGAD 261 (288)
T ss_pred CC---CCCcccCHHHHHHHHHHhcCCHhhccCcchHH
Confidence 11 12222345689999999999999999987664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=281.69 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=190.3
Q ss_pred hcCCCccceecccCceeEEEEEEC------CccEEEEEEcCCchh-h-HHHHHHHHHHHhhcCCCceeeeeccccC---C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDAAQ-G-RSQFQQEVEVLCNIRHPNMVLLLGACPE---F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~~~-~-~~~~~~E~~il~~l~HpnIv~l~g~~~~---~ 530 (768)
...|+....||+|.||.||++.-. ...+|||.++..... + -...-+|+.+++.++||||+.|..+|-. .
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457999999999999999999542 236899998754211 1 1235689999999999999999988744 4
Q ss_pred ceeEEEeccCCChHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC----CcEEEe
Q 035604 531 GCLIYEYMANGSLEDRLFRR--GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN----YVSKIS 604 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~----~~vKL~ 604 (768)
.++++||.+. +|...|... .....++...+..|++||+.|+.|||++. |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 4899999975 677777532 22346899999999999999999999999 9999999999999877 999999
Q ss_pred ecccccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChH-----------
Q 035604 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAH----------- 672 (768)
Q Consensus 605 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~----------- 672 (768)
|||+++++..... ..+.....+.|.+|.|||.+.|. .|+.+.|||++|||+.||||-.+.|....
T Consensus 179 DlGlaR~~~~plk---pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 179 DLGLARLFNNPLK---PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred cccHHHHhhcccc---ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 9999998854332 12233456889999999987765 59999999999999999999998884221
Q ss_pred -HHHHHHH-cCCccccCCCCCCCCCH--------------------------HHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 673 -QVERSIE-NGTFDETLDPAVPDWPV--------------------------EEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 673 -~~~~~i~-~~~~~~~ld~~~~~~~~--------------------------~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
++.+.++ -|.-.+-..|.+...|. .-+..-.+|+.++|.+||.+|.|+++.+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 1111111 12111111111111110 0112367899999999999999999887
Q ss_pred h
Q 035604 725 V 725 (768)
Q Consensus 725 ~ 725 (768)
.
T Consensus 336 e 336 (438)
T KOG0666|consen 336 E 336 (438)
T ss_pred c
Confidence 4
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=320.82 Aligned_cols=144 Identities=28% Similarity=0.445 Sum_probs=127.0
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV 534 (768)
.++|.+.++||+|+||.||+|.+. ++.||||+++... ......+..|+.+++.++||||+++++.+. ...|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999985 7799999997542 223456889999999999999999998874 456999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
|||+.+++|.+++...+ .+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999987644 4889999999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.47 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=195.0
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--C---
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--F--- 530 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~--- 530 (768)
...++|.+...||.|+||.||+|.+ ++..||||++... .......+.+|+.+++.++||||+++++++.. .
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3467899999999999999999998 4678999998643 22234567789999999999999999887632 2
Q ss_pred ---ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 531 ---GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 531 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
.++|+||+ +++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 58999998 67998887642 4899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CC
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GT 682 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~ 682 (768)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .+.. +.
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 99765321 234467889999998765 4678999999999999999999999954332211 1111 00
Q ss_pred ccc----------------cC----CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 683 FDE----------------TL----DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 683 ~~~----------------~l----d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
..+ .+ .+.........+..+.+++.+||..+|.+||++.+++. +|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 000 00 00000001112456999999999999999999999986 55543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=279.97 Aligned_cols=230 Identities=30% Similarity=0.364 Sum_probs=188.2
Q ss_pred ecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCCh
Q 035604 471 IGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSL 543 (768)
Q Consensus 471 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 543 (768)
||.|+||.||++... ++.||+|++..... .....+..|+.+++.++||||+++++.+.. ..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999884 67899999876532 234578899999999999999999988854 44999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 623 (768)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------~ 148 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------S 148 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC------C
Confidence 99987654 3899999999999999999999998 9999999999999999999999999997653321 1
Q ss_pred cccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCHHHHHH
Q 035604 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEALI 701 (768)
Q Consensus 624 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~ 701 (768)
......++..|++||...+...+.++|+||||+++|+|++|..||..... ....+..+. . ..+...+..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------~---~~~~~~~~~ 219 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP------L---RFPEFLSPE 219 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC------C---CCCCCCCHH
Confidence 12345678899999999888899999999999999999999999965542 222222211 1 122222456
Q ss_pred HHHHHHHhhhcCccCCCChh
Q 035604 702 LAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 702 l~~Li~~cl~~~P~~RPs~~ 721 (768)
+.+++.+||..+|++||++.
T Consensus 220 l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcc
Confidence 89999999999999999994
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=302.67 Aligned_cols=236 Identities=25% Similarity=0.326 Sum_probs=194.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccCCc--eeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPEFG--CLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~--~lV~E 536 (768)
++.|.+...+|.|+|+.|-++.+ +++..++|++.... .+..+|+.++... +||||+++.+.|.+.. ++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56788888899999999999987 56689999997652 2344677666665 6999999999996644 99999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-cCCCcEEEeecccccccCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL-DRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl-~~~~~vKL~DFGla~~~~~~ 615 (768)
++.|+-+.+.+..... +. ..+..|+.+|+.|+.|||.+| +|||||||+|||+ +..++++|+|||.++.+...
T Consensus 397 ~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999999888876542 33 777789999999999999999 9999999999999 68999999999999877543
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh---HHHHHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA---HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~---~~~~~~i~~~~~~~~ld~~~~ 692 (768)
....+-|..|.|||++....|+.+|||||||++||+||+|+.||... .++...+..+.+.
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s-------- 532 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS-------- 532 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--------
Confidence 23457789999999999999999999999999999999999999532 2333444444332
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
...+....+|+.+||+.+|.+||++.++.. +|+
T Consensus 533 ---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 334566899999999999999999999986 554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=306.69 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=208.0
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccc-------cCC
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGAC-------PEF 530 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~-------~~~ 530 (768)
-++.|++.+.||.|.||.||++.. +++.+|+|++..+... .+.++.|.+||+.+ .|||++.+||+| .+.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 467799999999999999998765 7789999999876543 34678899999987 699999999987 345
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.+||||||.+|+..|++.... ...+.|..+..|+.+++.||.+||... +||||||-.|||++.++.|||+|||++.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 599999999999999887654 456999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccC-----CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccc
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDE 685 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~ 685 (768)
.++. +..+..+++||++|||||++.- ..|+..+|+||||++..||--|.+|+-..+.+...+.--+-
T Consensus 172 Qlds------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-- 243 (953)
T KOG0587|consen 172 QLDS------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-- 243 (953)
T ss_pred eeec------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC--
Confidence 7643 3345567899999999998653 34888999999999999999999999888887765543221
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
-.|.+ .-|..-+..+.++|..||.+|...||++.+++.
T Consensus 244 -PPPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 244 -PPPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -CCccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 123344566999999999999999999999873
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-33 Score=275.05 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=196.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-h-hhHHHHHHHHHHHhhcCCCceeeeeccccC---------
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-A-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--------- 529 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------- 529 (768)
+.|....+||+|.||.||+++. .++.||+|+..... . .......+|+.+|..|+|+|++.++..|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4577778899999999998876 45678888654321 1 112345799999999999999999998832
Q ss_pred -CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
..|+||.+|+. +|..+|.... ..++..++.+++.++..||.|+|... |+|||+|+.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 13899999964 6777664432 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HH--HcCCc
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SI--ENGTF 683 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i--~~~~~ 683 (768)
++.+.... .....+.+..+.|++|.+||.+.|. .|+++.|||.-|||+.||+||.+-|.......+ .| .-|.+
T Consensus 171 ar~fs~~~--n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSK--NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccceeccc--ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 98774432 2333446778889999999977664 699999999999999999999999965544332 11 23444
Q ss_pred cccCCCCCCCCCHH------------------------HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 DETLDPAVPDWPVE------------------------EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld~~~~~~~~~------------------------~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+.|.+.+.|.- ......+|+.+++..||.+||++.+++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 44444444332211 1125778999999999999999999984
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=284.29 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=192.6
Q ss_pred HhcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcC--CC----ceeeeeccccCC--
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR--HP----NMVLLLGACPEF-- 530 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~--Hp----nIv~l~g~~~~~-- 530 (768)
.+++|.+..++|+|.||.|..+.+. +..||||+++.-.. -++...-|+++|.++. -| .+|.+.++|.-.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3788999999999999999999874 45899999975432 3455678999999994 22 367777777543
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc--------------
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-------------- 596 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-------------- 596 (768)
.|||+|.+ |-++.++|..++. .+++...++.|++|++.++.|||+.+ ++|-||||+|||+.
T Consensus 166 iCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 49999999 6799999976554 46899999999999999999999999 99999999999992
Q ss_pred ------CCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 035604 597 ------RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGL 670 (768)
Q Consensus 597 ------~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~ 670 (768)
.+..+||+|||.|+..... ....+.|..|.|||++.+-+++.++||||+||||+||.||...|..
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~---------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH---------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC---------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 1346899999999864322 2456889999999999999999999999999999999999999964
Q ss_pred hHHHHH-----------------------HHHcCCccc-----------cCCCCCC-----CCCHHHHHHHHHHHHHhhh
Q 035604 671 AHQVER-----------------------SIENGTFDE-----------TLDPAVP-----DWPVEEALILAKLALQCAE 711 (768)
Q Consensus 671 ~~~~~~-----------------------~i~~~~~~~-----------~ld~~~~-----~~~~~~~~~l~~Li~~cl~ 711 (768)
.+..+. ....|.+.. .+++..+ .....+...|.+|+.+||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 432110 011111110 0000000 0112455679999999999
Q ss_pred cCccCCCChhhhhh
Q 035604 712 LRRKDRPDLGKVVV 725 (768)
Q Consensus 712 ~~P~~RPs~~evl~ 725 (768)
.||.+|+|+.|++.
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=275.44 Aligned_cols=219 Identities=24% Similarity=0.204 Sum_probs=174.8
Q ss_pred cCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCChHHHHhh
Q 035604 474 GGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSLEDRLFR 549 (768)
Q Consensus 474 G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~~l~~ 549 (768)
|.||.||++.+ +++.||+|.+.... .+.+|...+....||||+++++++.+ ..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999988 56789999997543 23345555666679999999998744 45999999999999999876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCC
Q 035604 550 RGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629 (768)
Q Consensus 550 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 629 (768)
.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+... .....
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---------~~~~~ 143 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---------CDGEA 143 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc---------cccCC
Confidence 54 3899999999999999999999999 999999999999999999999999988655322 12335
Q ss_pred CCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHh
Q 035604 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQC 709 (768)
Q Consensus 630 gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~c 709 (768)
++..|+|||.+.+..++.++|||||||++|||++|+.||...... +.. .... ..+...+..+.+++.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~~~-----~~~~---~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---INT-----HTTL---NIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---ccc-----cccc---CCcccCCHHHHHHHHHH
Confidence 677899999998888999999999999999999999988533211 000 0011 12222345689999999
Q ss_pred hhcCccCCCChhhh
Q 035604 710 AELRRKDRPDLGKV 723 (768)
Q Consensus 710 l~~~P~~RPs~~ev 723 (768)
++.||.+||++.+.
T Consensus 213 l~~dp~~R~~~~~~ 226 (237)
T cd05576 213 LQFNPTERLGAGVA 226 (237)
T ss_pred ccCCHHHhcCCCcc
Confidence 99999999998544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=274.40 Aligned_cols=236 Identities=25% Similarity=0.330 Sum_probs=187.5
Q ss_pred cCCCccceecccCceeEEEEEECC--ccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 534 (768)
++|.++.+||+|+|++|..+++.. +.||+|++++.- ....+-.+.|-.+..+. +||.+|-|..+|.. ..++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 578999999999999999998854 579999987642 22334456666666654 79999999998854 34899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
.||++||+|.-.+.+.. .++++..+.+..+|+.||.|||+.| ||+||||.+|+|||..|++||+|||+|+---.
T Consensus 330 ieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999987776654 3999999999999999999999999 99999999999999999999999999974321
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH----------HHHHHHHcCCcc
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH----------QVERSIENGTFD 684 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~----------~~~~~i~~~~~~ 684 (768)
. .....+++||+.|+|||++++..|+..+|+|+||++++||+.|+.||+... .+.+.|....
T Consensus 404 ~------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-- 475 (593)
T KOG0695|consen 404 P------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-- 475 (593)
T ss_pred C------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--
Confidence 1 122357899999999999999999999999999999999999999996322 1122222111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD 719 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs 719 (768)
...|...+.....++...|++||.+|--
T Consensus 476 -------iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 -------IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -------ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1223333445677899999999999854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=278.54 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=196.3
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhh--cCCCceeeeecccc------CCcee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCN--IRHPNMVLLLGACP------EFGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~------~~~~l 533 (768)
..+..+.+.||+|.||.||+|.+.|..||||++.... ...+.+|.+|.+. |+|+||+.++++-. ...+|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 3566778899999999999999999999999997543 3357789998886 59999999998752 23489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-----TKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-----~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
|.+|.++|+|.|+|.+. .++-...++++.-++.||.+||. +|.+.|.|||||+.|||+..+|.+-|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999874 48999999999999999999994 3556799999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCC-----CC-ccccHHHHHHHHHHHHhC----------CCCCCChH
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM-----LG-VKSDVYSLGILLLQIITA----------KPPMGLAH 672 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~s-~ksDvwSlGvil~elltg----------~~Pf~~~~ 672 (768)
|-...... +.-.......+||-+|||||++...- -+ ..+||||||.|+||+..+ ++||....
T Consensus 363 Av~h~~~t--~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 363 AVRHDSDT--DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eEEecccC--CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 97664432 12223346679999999999886542 12 357999999999999863 57774221
Q ss_pred ---HHHHHHHcCCccccCCCCCCC-CCH-HHHHHHHHHHHHhhhcCccCCCChhhh
Q 035604 673 ---QVERSIENGTFDETLDPAVPD-WPV-EEALILAKLALQCAELRRKDRPDLGKV 723 (768)
Q Consensus 673 ---~~~~~i~~~~~~~~ld~~~~~-~~~-~~~~~l~~Li~~cl~~~P~~RPs~~ev 723 (768)
.-.....+-...+.+.|.+++ |.. .....+.+|+..||..+|.-|-++--+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 111122222334445566654 432 445669999999999999999998644
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=249.75 Aligned_cols=249 Identities=26% Similarity=0.349 Sum_probs=188.8
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEEe
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEY 537 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~ 537 (768)
+|...++||+|.||+||+++. .+..||+|..+.+.. .......+|+-+|+.++|.|||++++.. .....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 566778899999999999987 456899999876532 2345678999999999999999999986 4455899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
|. .+|..++...++ .+..+..+.++.|+++||.|+|+.+ ++||||||.|+||+.||.+||+|||+++.+.-..
T Consensus 83 cd-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hh-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 94 578887766543 4889999999999999999999999 9999999999999999999999999999774322
Q ss_pred CccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHh-CCCCCCChH---HHHHHH-HcCCccccCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIIT-AKPPMGLAH---QVERSI-ENGTFDETLDPAV 691 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~ellt-g~~Pf~~~~---~~~~~i-~~~~~~~~ld~~~ 691 (768)
.-....+.|.+|.+|.++.+. -|++..|+||-|||+.||.. |++.|.+.+ +..+.. .-|...+...|.+
T Consensus 156 -----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 156 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred -----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 112345779999999987765 48999999999999999997 556564332 222211 1233222222222
Q ss_pred C---------------CCCH---HHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 692 P---------------DWPV---EEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 692 ~---------------~~~~---~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
+ .|.. .....-.+|+.+.+.-+|.+|.+++..+
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 1 1111 1122356788888889999999998776
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=296.75 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=208.1
Q ss_pred CccceecccCceeEEEEEE--CC----ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEe
Q 035604 466 SNSRKIGEGGYGPVYKSYL--DH----TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEY 537 (768)
Q Consensus 466 ~~~~~LG~G~fG~Vy~~~~--~~----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~ 537 (768)
...++||.|+||+||+|.+ .+ -+||||++.... ......+..|+-+|.+++|||+++|+|+|.. ...||++|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 4467899999999999988 33 379999997653 3445679999999999999999999999954 45789999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
|++|+|.+++..+.. .+-.+..+.|..||++|+.|||.+. ++||||-..||||....++||.|||+++++....
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~- 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE- 852 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc-
Confidence 999999999987543 4778889999999999999999999 9999999999999999999999999999886543
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCC--hHHHHHHHHcCCccccCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGL--AHQVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~--~~~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
..+......-.+-|||=|.+....|+.++|||||||.+|||+| |..|+.. ..++...+++|.. + ..
T Consensus 853 ---~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---L-----sq 921 (1177)
T KOG1025|consen 853 ---KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---L-----SQ 921 (1177)
T ss_pred ---ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---C-----CC
Confidence 2333344455677999999999999999999999999999998 8888853 3566677777753 1 23
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
|..++..+.-++.+||-.|+..||++.++....-+.+++
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 445566789999999999999999999988666655544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=303.64 Aligned_cols=255 Identities=32% Similarity=0.441 Sum_probs=204.8
Q ss_pred hcCCCccceecccCceeEEEEEEC---------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 529 (768)
.++..+.+.||+|.||.|++|... ...||||.++... ......+..|+++|+.+ +|||||.++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344566679999999999998752 3469999998653 34567799999999998 59999999999965
Q ss_pred -CceeEEEeccCCChHHHHhhcC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRG-------G----S--PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
..++|+||+..|+|..+|.... . . ..++....+.++.||+.|++||++.+ +|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 4589999999999999998765 0 0 13888999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCC--CCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCC--
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA--GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGL-- 670 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~-- 670 (768)
..+..+||+|||+|+...... .+...... -...|||||.+....|+.++||||||++||||+| |..||..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~-----~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKD-----YYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred cCCCEEEEccccceeccCCCC-----ceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999998653322 12212222 2455999999999999999999999999999998 8899964
Q ss_pred -hHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 671 -AHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 671 -~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
...+...+..|...+ -|..+..++.+|+..||+.+|.+||++.+++..+...|.
T Consensus 527 ~~~~l~~~l~~G~r~~--------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLEFLKEGNRME--------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHHHHhcCCCCC--------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 445555667765322 233334568899999999999999999999876666543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=298.79 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=200.2
Q ss_pred CCccceecccCcee-EEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEEeccC
Q 035604 465 FSNSRKIGEGGYGP-VYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 465 y~~~~~LG~G~fG~-Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
|...+.+|.|+.|+ ||+|.+.++.||||++-... ..-..+|+..|+.- .|||||++|+.-.+ ..||..|+| .
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 45556799999984 78999999999999986432 33467999999987 59999999987644 458999999 6
Q ss_pred CChHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---C--CcEEEeecccccccCC
Q 035604 541 GSLEDRLFRRGG-SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---N--YVSKISDVGLARLVPP 614 (768)
Q Consensus 541 gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~--~~vKL~DFGla~~~~~ 614 (768)
.+|.+++..... .........+.+..|++.||.+||+.+ ||||||||.||||+. + ..++|+|||+|+.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 899999977411 111111344678999999999999999 999999999999965 2 5789999999999866
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhC-CCCCCChHHHHHHHHcCCccccCCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA-KPPMGLAHQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg-~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
+.. ...+.....||-+|+|||++....-+.++|||||||++|+.++| ..||+....-+..|..+.+.-..-....+
T Consensus 664 ~~s---S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKS---SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPD 740 (903)
T ss_pred Ccc---hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCch
Confidence 532 22235677899999999999999888899999999999999986 99999888877788887755443333333
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhh-----hHHHHHHHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVV-----VPKLNILRA 733 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl-----~~~l~~l~~ 733 (768)
+ +..+||.+|+.++|..||++.+|+ +.+.++|.-
T Consensus 741 ~------eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~F 779 (903)
T KOG1027|consen 741 C------EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSF 779 (903)
T ss_pred H------HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHH
Confidence 2 588999999999999999999998 344455533
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=261.13 Aligned_cols=232 Identities=31% Similarity=0.409 Sum_probs=189.0
Q ss_pred CceeEEEEEEC--CccEEEEEEcCCchhh-HHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEeccCCChHHHHhh
Q 035604 475 GYGPVYKSYLD--HTPVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYMANGSLEDRLFR 549 (768)
Q Consensus 475 ~fG~Vy~~~~~--~~~vAvK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~gsL~~~l~~ 549 (768)
+||.||++... +..+|+|++....... ...+.+|++++++++|+||+++++.+. ...+++|||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999984 5789999997665443 678999999999999999999999985 455899999999999998876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCC
Q 035604 550 RGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629 (768)
Q Consensus 550 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 629 (768)
... +++..++.++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||++....... ......
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~ 147 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV 147 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence 442 889999999999999999999998 9999999999999999999999999998764431 223456
Q ss_pred CCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH---HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHH
Q 035604 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ---VERSIENGTFDETLDPAVPDWPVEEALILAKLA 706 (768)
Q Consensus 630 gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~---~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li 706 (768)
++..|++||.+.+..++.++||||||+++|+|++|..||..... ....+..+...... . ....+..+.+++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~-~~~~~~~~~~~i 221 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-----P-EWKISPEAKDLI 221 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-----c-cccCCHHHHHHH
Confidence 88899999999888899999999999999999999999965222 22222222211100 0 000334699999
Q ss_pred HHhhhcCccCCCChhhhhh
Q 035604 707 LQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 707 ~~cl~~~P~~RPs~~evl~ 725 (768)
.+|+..+|.+||++.+++.
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=248.75 Aligned_cols=197 Identities=29% Similarity=0.434 Sum_probs=159.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC-chhhHHHHHHHHHHHhh-cCCCceeeeeccccCC--ceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD-AAQGRSQFQQEVEVLCN-IRHPNMVLLLGACPEF--GCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~--~~lV~E 536 (768)
+....+..||+|+||.|-+-++ .|+..|+|.+... ..+...+..+|+++..+ ...|.+|.+||..... .+|.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4455566799999998765554 8899999999755 34455678889998665 4799999999987443 489999
Q ss_pred eccCCChHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 537 YMANGSLEDRLFR-RGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 537 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
.| ..+|+.+..+ ......+++..+-+|+..++.||.|||++- .+||||+||+|||||.+|++||||||++..+..+
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99 4677765543 122346899999999999999999999874 3999999999999999999999999999988666
Q ss_pred CCCccccccccCCCCCCCCCCcccccC----CCCCccccHHHHHHHHHHHHhCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQT----GMLGVKSDVYSLGILLLQIITAKPPMG 669 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDvwSlGvil~elltg~~Pf~ 669 (768)
.+. +-..|.-.|||||.+.. ..|+.++||||||+.+.||.+++.||.
T Consensus 203 iAk-------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 203 IAK-------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hHH-------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 543 22478889999997653 369999999999999999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=279.41 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=199.2
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC------CCceeeeecccc--C
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR------HPNMVLLLGACP--E 529 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~g~~~--~ 529 (768)
..-.+|.+....|+|-|++|.+|.+ .+..||||+++.+..... .=+.|++||++|+ --|+++|+..|. .
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K-tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK-TGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh-hhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 3567899999999999999999987 566999999987643322 2358999999995 347899998874 4
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeeccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGL 608 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DFGl 608 (768)
..|||+|.+ ..+|.+.|.+.+....|....++.++.|++.||..|..++ |+|.||||+|||++++ ..+||||||.
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 569999998 6799999999888778999999999999999999999999 9999999999999876 4669999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHH-----------
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVE----------- 675 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~----------- 675 (768)
|..+.... .+.+..+..|.|||++.|..|+...|+||+||+||||.||+..|.+.. ++.
T Consensus 584 A~~~~ene--------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 584 ASFASENE--------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred cccccccc--------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 98764322 245567788999999999999999999999999999999999994321 111
Q ss_pred -HHHHcCCccc---------------------------cCCC------------CCCCCCHHHHHHHHHHHHHhhhcCcc
Q 035604 676 -RSIENGTFDE---------------------------TLDP------------AVPDWPVEEALILAKLALQCAELRRK 715 (768)
Q Consensus 676 -~~i~~~~~~~---------------------------~ld~------------~~~~~~~~~~~~l~~Li~~cl~~~P~ 715 (768)
..+.+|.|.+ .+.| .+++-.......|.+|+.+||.+||.
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 1122222111 0111 11222223445699999999999999
Q ss_pred CCCChhhhhh
Q 035604 716 DRPDLGKVVV 725 (768)
Q Consensus 716 ~RPs~~evl~ 725 (768)
+|.+..+.|.
T Consensus 736 KRit~nqAL~ 745 (752)
T KOG0670|consen 736 KRITVNQALK 745 (752)
T ss_pred hcCCHHHHhc
Confidence 9999998874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=295.68 Aligned_cols=256 Identities=22% Similarity=0.250 Sum_probs=168.7
Q ss_pred HhcCCCccceecccCceeEEEEEEC------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecc--------
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA-------- 526 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~-------- 526 (768)
..++|.+.+.||+|+||.||+|.+. +..||||.+...... +.+..+ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3578999999999999999999983 568999998643221 111111 1122222223222221
Q ss_pred ccCCceeEEEeccCCChHHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 035604 527 CPEFGCLIYEYMANGSLEDRLFRRGGS-----------------PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLK 589 (768)
Q Consensus 527 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLK 589 (768)
.....+|||||+.+++|.+++...... .......+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 133458999999999999988654210 01123445679999999999999998 9999999
Q ss_pred CCCeEEcC-CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCC----------------------CCC
Q 035604 590 PGNILLDR-NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG----------------------MLG 646 (768)
Q Consensus 590 p~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s 646 (768)
|+|||++. ++.+||+|||+++.+.... .+......+++.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999985 6899999999998653321 1223456789999999954322 234
Q ss_pred ccccHHHHHHHHHHHHhCCCCCCChHH-HHHHHHcCCcc-----ccCCCCCC-CC------CHHHHHHHHHHHHHhhhcC
Q 035604 647 VKSDVYSLGILLLQIITAKPPMGLAHQ-VERSIENGTFD-----ETLDPAVP-DW------PVEEALILAKLALQCAELR 713 (768)
Q Consensus 647 ~ksDvwSlGvil~elltg~~Pf~~~~~-~~~~i~~~~~~-----~~ld~~~~-~~------~~~~~~~l~~Li~~cl~~~ 713 (768)
.++||||||||||||+++..|++.... ....+...... ..+.+... +. .........+|+.+||+.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 567999999999999998877653321 11222221110 01111100 00 0011223558999999999
Q ss_pred ccCCCChhhhhh-HHH
Q 035604 714 RKDRPDLGKVVV-PKL 728 (768)
Q Consensus 714 P~~RPs~~evl~-~~l 728 (768)
|++||++.+++. ++.
T Consensus 438 P~kR~ta~e~L~Hpff 453 (566)
T PLN03225 438 GRQRISAKAALAHPYF 453 (566)
T ss_pred cccCCCHHHHhCCcCc
Confidence 999999999986 554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=283.52 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=178.1
Q ss_pred hcCCCccceecccCceeEEEEEE------------------CCccEEEEEEcCCchhhHHHH--------------HHHH
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL------------------DHTPVAIKVLRPDAAQGRSQF--------------QQEV 509 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~------------------~~~~vAvK~l~~~~~~~~~~~--------------~~E~ 509 (768)
.++|.+.++||+|+||.||+|.+ .++.||||.+.........+| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999964 235799999875433323333 3466
Q ss_pred HHHhhcCCCce-----eeeecccc----------CCceeEEEeccCCChHHHHhhcCC---------------------C
Q 035604 510 EVLCNIRHPNM-----VLLLGACP----------EFGCLIYEYMANGSLEDRLFRRGG---------------------S 553 (768)
Q Consensus 510 ~il~~l~HpnI-----v~l~g~~~----------~~~~lV~E~~~~gsL~~~l~~~~~---------------------~ 553 (768)
.++.+++|.++ ++++++|. ...+|||||+++++|.+++..... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777766654 56677663 234899999999999998864211 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCC
Q 035604 554 PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633 (768)
Q Consensus 554 ~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~ 633 (768)
..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..... .......+|+.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~g~~tp~ 375 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-----FNPLYGMLDPR 375 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-----cCccccCCCcc
Confidence 12467788899999999999999999 99999999999999999999999999976533211 11122345789
Q ss_pred CCCcccccCCC--------------------C--CccccHHHHHHHHHHHHhCCC-CCCChHHHHHHHHcCC-----c--
Q 035604 634 YIDPEYQQTGM--------------------L--GVKSDVYSLGILLLQIITAKP-PMGLAHQVERSIENGT-----F-- 683 (768)
Q Consensus 634 Y~aPE~~~~~~--------------------~--s~ksDvwSlGvil~elltg~~-Pf~~~~~~~~~i~~~~-----~-- 683 (768)
|++||.+.... | ..+.||||+|||+|+|++|.. ||.........+.... +
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 99999765322 1 234799999999999999986 7753322221111100 0
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCc---cCCCChhhhhh
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRR---KDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P---~~RPs~~evl~ 725 (768)
........+.+ ...+....+|+.+||..+| .+|+++.+++.
T Consensus 456 ~~~~~~~~~~~-d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 YKGQKYDFSLL-DRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hcccCCCcccc-cccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00001111111 1234568899999999866 78999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=246.96 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=194.0
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccccCC----cee
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPEF----GCL 533 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~----~~l 533 (768)
.+++|++.+++|+|.|+.||.|.. ++..++||++++-. .+.+.+|+.||..|. ||||++|++...+. ..|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999985 67789999998643 456889999999997 99999999998554 379
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeeccccccc
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLV 612 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DFGla~~~ 612 (768)
++||+.+.+...+.. .|+...++.++.+++.||.|+|+.| |+|||+||.|++||.. -.++|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999888766542 3788889999999999999999999 9999999999999864 57899999999988
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCCh----H------------HHH
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLA----H------------QVE 675 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~----~------------~~~ 675 (768)
.+...- ...+.+..|.-||.+-. ..|+..-|+|||||+|..|+..+.||-.. + ++.
T Consensus 184 Hp~~eY-------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 184 HPGKEY-------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred CCCcee-------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 665432 22366778999997665 46899999999999999999999999311 1 111
Q ss_pred HHHHcCCccccCCCCCCC---------CC--------HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 676 RSIENGTFDETLDPAVPD---------WP--------VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 676 ~~i~~~~~~~~ld~~~~~---------~~--------~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
..+.+- .-.++|...+ |. .-.+++..+|+.+.|..|-.+|||+.|.+. ++-..+
T Consensus 257 ~Yl~KY--~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 257 AYLNKY--QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHH--ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 111111 1112322211 11 012356889999999999999999999875 444333
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=257.27 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=189.5
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-------Cce
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------FGC 532 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~~ 532 (768)
+.+..+.||-|+||.||..++ +++.||+|.+..- .....+.+.+|+.+|+-++|.|++..++.... ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345567899999999999887 7889999988532 22344568899999999999999998876522 237
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
++.|+| ..+|...+..-. .++...+.-+..||++||.|||+.+ |+||||||.|+|++.|..+|||||||++..
T Consensus 134 V~TELm-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 888988 578888876543 4888888889999999999999999 999999999999999999999999999975
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HH-----------
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SI----------- 678 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i----------- 678 (768)
.... ...++..+.|..|.|||++.|. .|+...||||+|||+.||+.++..|.-...+.+ .|
T Consensus 207 e~d~-----~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 207 DQRD-----RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred chhh-----hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 4332 2345666789999999999876 599999999999999999999999953332221 11
Q ss_pred ----HcCCccccCCC--CCCCC--------CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 679 ----ENGTFDETLDP--AVPDW--------PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 679 ----~~~~~~~~ld~--~~~~~--------~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
-+|....++.. ..++. +....-+...+..+++..+|+.|.+..+.+.
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 11111111111 11111 1122234667888899999999999988764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=261.18 Aligned_cols=128 Identities=26% Similarity=0.414 Sum_probs=108.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-----C---CceeeeeccccCC--
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-----H---PNMVLLLGACPEF-- 530 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----H---pnIv~l~g~~~~~-- 530 (768)
.+|.+.++||+|-|++||++.+ ..+.||+|+.+... .-.+....|+.+|++++ | .+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999998 45689999997543 33455678999999984 3 3699999999443
Q ss_pred ----ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 531 ----GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 531 ----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
.|+|+|++ |.+|..+|.+... +.++...+.+|+.||+.||.|||... +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 39999999 8889888877544 34999999999999999999999875 49999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=252.08 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=193.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
..+|..++.+|.|.- .|..+.+ .+.+||+|.+... .........+|..++..++|+||++++.+|..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888899999998 6666654 6789999987432 12233456789999999999999999999832
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..|+||||| ..+|...+.- .+.-.....|+.|++.|+.|||+.+ |+||||||+||+++.+..+||+|||++
T Consensus 95 e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 238999999 5678877762 2667888899999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc---------
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN--------- 680 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~--------- 680 (768)
+.-.. ...++..+.|..|.|||++.+..|...+||||+|||+.||++|+..|.+.+.+.+..+-
T Consensus 166 r~e~~-------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDT-------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCc-------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 85322 24567889999999999999999999999999999999999999998544332211100
Q ss_pred --------------------------CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 681 --------------------------GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 681 --------------------------~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
..+.+.+-+...+.+.-....+.+++.+||..+|++|-+..++|. +..+
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 001111111111122223445889999999999999999999986 5554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=277.01 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=207.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc--cCCceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~ 537 (768)
.++|+....+|.|.||.||++++ .+...|+|+++........-+++|+-+++..+|||||.++|.+ .+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46799999999999999999988 5678999999988777777788999999999999999999998 4566999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
|.+|+|.+..+-.+ .+++.++...+++.+.||.|||+.+ -+|||||-.|||++..|.+|+.|||.+..+...
T Consensus 94 cgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred cCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence 99999999765444 5999999999999999999999999 899999999999999999999999998766433
Q ss_pred CccccccccCCCCCCCCCCccc---ccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH--cCCccccCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEY---QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE--NGTFDETLDPAVP 692 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~---~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~--~~~~~~~ld~~~~ 692 (768)
-.+..++.||+.|||||+ -+.+.|...||||++|+...|+-.-++|....+..+.... +..+...-...-.
T Consensus 166 ----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 166 ----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT 241 (829)
T ss_pred ----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc
Confidence 334578899999999995 4567899999999999999999999999876666655332 2223322222223
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
.|. ..|.++++.|+..+|++||+++.+|
T Consensus 242 kws----~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 242 KWS----EFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cch----HHHHHHHHHHhcCCCccCCChhhhe
Confidence 444 4599999999999999999999876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=249.72 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=197.8
Q ss_pred cCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC---Cc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---FG 531 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~ 531 (768)
.++...-++-+|.||.||+|.+.. +.|-+|.++... ......+..|.-++..+.|||+..+.+++.+ ..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 345555668999999999997622 356777776543 2334567889999999999999999999844 34
Q ss_pred eeEEEeccCCChHHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeec
Q 035604 532 CLIYEYMANGSLEDRLF-----RRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DF 606 (768)
+++|.++.-|+|..+|. .....+.++..+...++.|++.|+.|||..+ |||.||-..|.+||+...+||+|=
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccc
Confidence 78899999999999997 3333445777888899999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTF 683 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~ 683 (768)
.|++-+-+...... ..+......||+||.+....|+..+||||||++||||+| |+.|+... .++...+++|..
T Consensus 441 aLSRDLFP~DYhcL----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCL----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR 516 (563)
T ss_pred hhccccCccccccc----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence 99986644332211 123345678999999999999999999999999999998 99999644 455567777753
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. .-|.+++.+|..++..||...|++||++++++.
T Consensus 517 l--------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 L--------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred e--------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 2 224455667999999999999999999999973
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=264.72 Aligned_cols=193 Identities=25% Similarity=0.354 Sum_probs=165.9
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhh--------HHHHHHHHHHHhhcC---CCceeeeeccccC
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQG--------RSQFQQEVEVLCNIR---HPNMVLLLGACPE 529 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~--------~~~~~~E~~il~~l~---HpnIv~l~g~~~~ 529 (768)
..|..++.||.|+||.|+.+.++ ...|+||.+.+..... ...+-.|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999984 4579999987653211 122457999999998 9999999999955
Q ss_pred --CceeEEEec-cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeec
Q 035604 530 --FGCLIYEYM-ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606 (768)
Q Consensus 530 --~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DF 606 (768)
++||+||-. +|-+|.+++..+. .+++.+..-|+.||+.|+.+||+++ |||||||-+|+.++.+|.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 558889875 5668999987765 4999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCC
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMG 669 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~ 669 (768)
|.+.+...+ .+..++||..|.|||++.|..| +..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksg--------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG--------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC--------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876432 3456799999999999999876 888999999999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=232.74 Aligned_cols=206 Identities=33% Similarity=0.536 Sum_probs=178.7
Q ss_pred ecccCceeEEEEEEC--CccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCChHH
Q 035604 471 IGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSLED 545 (768)
Q Consensus 471 LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~ 545 (768)
||.|++|.||++... +..+++|++...... ....+.+|+.+++.+.|++|+++++++.. ..+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999996 789999999865432 34678999999999999999999999865 5699999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCcEEEeecccccccCCCCCCcccccc
Q 035604 546 RLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARLVPPSVADSVTQYR 624 (768)
Q Consensus 546 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~ 624 (768)
++.... ..+++..++.++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||++........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence 987653 24889999999999999999999999 999999999999999 89999999999986643211 1
Q ss_pred ccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHH
Q 035604 625 MTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILA 703 (768)
Q Consensus 625 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~ 703 (768)
.....+...|++||.+... .++.+.|+|+||+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2345678889999998877 888999999999999999 3589
Q ss_pred HHHHHhhhcCccCCCChhhhhh
Q 035604 704 KLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 704 ~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+++..|+..+|.+||++.+++.
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhh
Confidence 9999999999999999998873
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=231.24 Aligned_cols=196 Identities=35% Similarity=0.561 Sum_probs=168.2
Q ss_pred CCccceecccCceeEEEEEEC--CccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEecc
Q 035604 465 FSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYMA 539 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 539 (768)
|.+.+.||.|++|.||++... +..+|+|.+...... ....+.+|++.+..++|+|++++++.+. ...++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567788999999999999984 578999999866544 5678899999999999999999999875 45689999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++...... +++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++..+.....
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-- 153 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-- 153 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--
Confidence 99999988765421 789999999999999999999998 99999999999999999999999999987644320
Q ss_pred cccccccCCCCCCCCCCcccc-cCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQ-QTGMLGVKSDVYSLGILLLQIITAKPPMGL 670 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltg~~Pf~~ 670 (768)
.......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 154 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 012344678889999988 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=230.70 Aligned_cols=239 Identities=23% Similarity=0.322 Sum_probs=178.7
Q ss_pred hcCCCccceecccCceeEEEEEECC--ccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeecc-c--cCCceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGA-C--PEFGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~-~--~~~~~lV~ 535 (768)
.+.|.+.+.||+|.||.+.++.+.+ +.+++|.+.... ....+|.+|..---.| .|.||+.-|.. | .+++++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4578899999999999999999854 689999886443 3356788988765555 48999988865 4 34557899
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-c-CCCcEEEeecccccccC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL-D-RNYVSKISDVGLARLVP 613 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl-~-~~~~vKL~DFGla~~~~ 613 (768)
||++.|+|..-+...+ +-+....+++.|+++||.|+|+.+ +||||||.+|||| + ....+||||||+.+..+
T Consensus 102 E~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999998776644 777888899999999999999999 9999999999999 3 34589999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCC---C--CCccccHHHHHHHHHHHHhCCCCCCChH------HHHHHHHcCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTG---M--LGVKSDVYSLGILLLQIITAKPPMGLAH------QVERSIENGT 682 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~--~s~ksDvwSlGvil~elltg~~Pf~~~~------~~~~~i~~~~ 682 (768)
..+. ....+..|.+||..... . ..+.+|||.||+|+|.++||.+||.... .-...+..+.
T Consensus 175 ~tV~---------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 175 TTVK---------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred ceeh---------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 4321 12345679999965433 2 4678999999999999999999996221 1112233332
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhh
Q 035604 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGK 722 (768)
Q Consensus 683 ~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~e 722 (768)
.+.+|.--.-.+..+.++..+-+..+|++|=...+
T Consensus 246 -----~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 246 -----NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred -----CccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 22333322233456888999999999999944333
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=212.96 Aligned_cols=146 Identities=52% Similarity=0.975 Sum_probs=121.0
Q ss_pred EEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHHHH
Q 035604 12 AVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPFRC 91 (768)
Q Consensus 12 ~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 91 (768)
+||||+|+|+.|.+|++||+++|...+++|++|||.++........+. ......+.+...+.++++++++.+
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~~~ 72 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGK--------LEVASAYKQEEDKEAKELLLPYRC 72 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccc--------hHHHHHHHHHHHHHHHHHHHHHHH
Confidence 499999999999999999999999999999999999764322211110 012233445566778889999999
Q ss_pred HhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 92 FCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 92 ~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
.|...|+.+...++.+|+|+++|+++|+++++|+||||+||++++.+.++||||+.+|++++|++||||||++|
T Consensus 73 ~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 73 FCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred HHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeCc
Confidence 99888998777666667999999999999999999999999988887777778999999999999999999987
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=275.83 Aligned_cols=201 Identities=17% Similarity=0.193 Sum_probs=140.6
Q ss_pred hcCC-Cceeeeecccc---------CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 035604 514 NIRH-PNMVLLLGACP---------EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583 (768)
Q Consensus 514 ~l~H-pnIv~l~g~~~---------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 583 (768)
.++| +||+.++++|. +..+++|||+ +++|.++|.... ..+++..++.++.||+.||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 57777887761 1235667887 679999996532 34899999999999999999999999 9
Q ss_pred eeCCCCCCCeEEcCCCc-------------------EEEeecccccccCCCCCC---cc-------ccccccCCCCCCCC
Q 035604 584 VHRDLKPGNILLDRNYV-------------------SKISDVGLARLVPPSVAD---SV-------TQYRMTSAAGTFCY 634 (768)
Q Consensus 584 iHrDLKp~NILl~~~~~-------------------vKL~DFGla~~~~~~~~~---~~-------~~~~~~~~~gt~~Y 634 (768)
|||||||+||||+..+. +||+|||+++........ .. .........||++|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 455555555432110000 00 00011224689999
Q ss_pred CCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCc
Q 035604 635 IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRR 714 (768)
Q Consensus 635 ~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P 714 (768)
+|||++.+..|+.++|||||||+||||++|.+||.........+.... +.+.. .........++.+||..+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRV----LPPQI----LLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhh----cChhh----hhcCHHHHHHHHHhCCCCh
Confidence 999999999999999999999999999999999864333322222221 11111 1112346688899999999
Q ss_pred cCCCChhhhhh-HHH
Q 035604 715 KDRPDLGKVVV-PKL 728 (768)
Q Consensus 715 ~~RPs~~evl~-~~l 728 (768)
.+||++.+++. +++
T Consensus 254 ~~Rps~~eil~h~~~ 268 (793)
T PLN00181 254 SCRPSMSELLQSEFI 268 (793)
T ss_pred hhCcChHHHhhchhh
Confidence 99999999985 443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-26 Score=238.25 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=190.2
Q ss_pred HhcCCCccceecccCceeEEEEEEC-----CccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccc--cCCce
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD-----HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGAC--PEFGC 532 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~--~~~~~ 532 (768)
..+.|...++||+|.|+.||++.+. ...||+|.+..... ...+.+|+++|..+. +-||+++.+++ .+..+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3467889999999999999998763 35799999865443 345889999999995 88999999987 55669
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCcEEEeecccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARL 611 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~vKL~DFGla~~ 611 (768)
+|+||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||+|||.+. -+.-.|+|||||..
T Consensus 112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999888764 667888899999999999999999 999999999999975 46678999999983
Q ss_pred cCCCC-------------CC-------------------------ccccccccCCCCCCCCCCcccccCC-CCCccccHH
Q 035604 612 VPPSV-------------AD-------------------------SVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVY 652 (768)
Q Consensus 612 ~~~~~-------------~~-------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvw 652 (768)
..... .. ...........||++|.|||++... ..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21100 00 0001112356899999999987665 478999999
Q ss_pred HHHHHHHHHHhCCCCCCChH----------------HHHH-HHHcCC--ccc---------------cC-----CC----
Q 035604 653 SLGILLLQIITAKPPMGLAH----------------QVER-SIENGT--FDE---------------TL-----DP---- 689 (768)
Q Consensus 653 SlGvil~elltg~~Pf~~~~----------------~~~~-~i~~~~--~~~---------------~l-----d~---- 689 (768)
|.|+|++-+++++.||.... .+.. +...|. +.+ .+ .+
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999993111 1111 111122 111 00 00
Q ss_pred --CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 690 --AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 690 --~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..-.|....+..+.+|+.+|++.||.+|.++++.|.
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011222333447899999999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=210.35 Aligned_cols=162 Identities=25% Similarity=0.253 Sum_probs=124.4
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|.+++...+. .+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 689998876432 4999999999999999999999876 999999999999999 9999865331
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH---HHHcCCccccCCCCCCCCCHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER---SIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~---~i~~~~~~~~ld~~~~~~~~~ 697 (768)
...||+.|+|||++.+..++.++|||||||++|||+||+.||........ .+..+.. . ..+.....+..
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~ 134 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-A-DDPRDRSNLES 134 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-c-CCccccccHHH
Confidence 12688999999999999999999999999999999999999964433221 1111111 1 11111111222
Q ss_pred HHH--HHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 698 EAL--ILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 698 ~~~--~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
... .+.+++.+||..+|.+||++.+++....
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 222 5999999999999999999999986433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=228.34 Aligned_cols=259 Identities=24% Similarity=0.307 Sum_probs=192.0
Q ss_pred CCCccceecccCceeEEEEEECCc---cEEEEEEcCCchhhHHHHHHHHHHHhhcCC----Cceeeeeccc---cCCcee
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLDHT---PVAIKVLRPDAAQGRSQFQQEVEVLCNIRH----PNMVLLLGAC---PEFGCL 533 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~~~---~vAvK~l~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~g~~---~~~~~l 533 (768)
+|.+.++||+|+||.||.+..... .+|+|+...........+..|+.++..+.. +++..+++.. ..+.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999998543 699999876543333367889999998873 4777777655 345699
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-----CcEEEeeccc
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-----YVSKISDVGL 608 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-----~~vKL~DFGl 608 (768)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.| +|||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 899999775554 456999999999999999999999999 9999999999999765 4689999999
Q ss_pred ccccC--CCCCCcccccc--ccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCC
Q 035604 609 ARLVP--PSVADSVTQYR--MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGT 682 (768)
Q Consensus 609 a~~~~--~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~ 682 (768)
++.+. ..........+ ...+.||..|+++..+.+...+.+.|+||++.++.+++.|..||...... ...+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98332 21111111111 23567999999999999999999999999999999999999999543321 12222111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 683 ~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
....... ....+ +..+.++...+-..+..++|+...+...+....
T Consensus 254 ~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 254 RKLLTDR-FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred hhhcccc-ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 1111111 11112 234777877888899999999998875433333
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=214.06 Aligned_cols=270 Identities=20% Similarity=0.261 Sum_probs=205.0
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceee--eeccccCCceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVL--LLGACPEFGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~--l~g~~~~~~~lV~E~ 537 (768)
-+|.++++||+|.||.++.|.. ++.+||||.-...+ ..-++..|....+.|. .++|-. ++|-|.-+..||||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4799999999999999999986 88999999864332 1235777888887774 566644 445566677899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-----CcEEEeeccccccc
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-----YVSKISDVGLARLV 612 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-----~~vKL~DFGla~~~ 612 (768)
+ |-+|+|++.-.+. .|+..++..++.|++.-++|+|.+. +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 9 8899998866554 4999999999999999999999999 9999999999999643 46899999999988
Q ss_pred CCCCCCcccccc-ccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH-----HHHHcCCcccc
Q 035604 613 PPSVADSVTQYR-MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE-----RSIENGTFDET 686 (768)
Q Consensus 613 ~~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~-----~~i~~~~~~~~ 686 (768)
.+.....-..++ ..+..||..||+--...|...+.+.|+-|||-+++..|-|..||.+..-.. .+|-+.+....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 654443333343 457789999999999999999999999999999999999999996443222 22222211111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhhcCcchhcc
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINL 744 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~~~~~~~~~ 744 (768)
+. +.+...+.++..-+.-.-.++-++-|+..-+..-..+.|..+.....-..++
T Consensus 260 i~----~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW 313 (449)
T KOG1165|consen 260 IE----VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDW 313 (449)
T ss_pred HH----HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 11 2233345568888888889999999999877655666666655444433443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=227.45 Aligned_cols=170 Identities=18% Similarity=0.157 Sum_probs=130.6
Q ss_pred HHHhcCCCccceecccCceeEEEEEE---CCccEEEEEEcCC-----chhhHHHHHHHHHHHhhcCCCceee-eeccccC
Q 035604 459 EEATENFSNSRKIGEGGYGPVYKSYL---DHTPVAIKVLRPD-----AAQGRSQFQQEVEVLCNIRHPNMVL-LLGACPE 529 (768)
Q Consensus 459 ~~~~~~y~~~~~LG~G~fG~Vy~~~~---~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~-l~g~~~~ 529 (768)
....++|.+.+.||+|+||+||+|.+ +++.||||++... .......|.+|+++|+.++|+||+. +++. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--~ 91 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--G 91 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--C
Confidence 34567899999999999999999987 3567899987533 1223456899999999999999985 5443 3
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCeEEcCCCcEEEeeccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDL-KPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDL-Kp~NILl~~~~~vKL~DFGl 608 (768)
..||||||++|++|.. + .. .. ...++.+++.||.|||+.| |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~-~-~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-A-RP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHH-h-Cc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 5699999999999963 2 11 11 1467889999999999999 999999 99999999999999999999
Q ss_pred ccccCCCCCCcc--ccccccCCCCCCCCCCcccccCC
Q 035604 609 ARLVPPSVADSV--TQYRMTSAAGTFCYIDPEYQQTG 643 (768)
Q Consensus 609 a~~~~~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~ 643 (768)
|+.+........ .....+...+++.|++||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 998754322111 00112467889999999987643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=200.78 Aligned_cols=261 Identities=20% Similarity=0.281 Sum_probs=197.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCC-Cceeeee--ccccCCceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH-PNMVLLL--GACPEFGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~--g~~~~~~~lV~E 536 (768)
.+.|.++++||.|+||.+|.|.. .|..||||+-...... .++..|..+...|++ ..|..+. +.-.++..+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 57899999999999999999887 7789999998765433 357788888888874 3333333 333556789999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CcEEEeecccccccC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN---YVSKISDVGLARLVP 613 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~vKL~DFGla~~~~ 613 (768)
++ |-+|.+++.-... .|+..+++-++-|++.-|+|+|..+ +|||||||+|+|+.-+ ..+.|+||||++.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 99 8899998865433 3899999999999999999999999 9999999999999654 457999999998875
Q ss_pred CCCCCccccc-cccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH-----HHHHcCCccccC
Q 035604 614 PSVADSVTQY-RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE-----RSIENGTFDETL 687 (768)
Q Consensus 614 ~~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~-----~~i~~~~~~~~l 687 (768)
+.....-..+ ......||..|.+--.+.+...+...|+-|+|.+|..+.-|..||....... ..|.+.++.-.+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 4322222222 2456789999999888888888999999999999999999999997543322 234444444444
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
...+..+|. ++.-.+..|-...-++-|+..-+-...+-+++.+
T Consensus 246 e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 246 EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 445555554 4777899999999999999875543344344443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-22 Score=209.46 Aligned_cols=258 Identities=32% Similarity=0.448 Sum_probs=197.1
Q ss_pred CCccceecccCceeEEEEEECCccEEEEEEcCCchh---hHHHHHHHHHHHhhcCCC-ceeeeeccccCCc--eeEEEec
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQ---GRSQFQQEVEVLCNIRHP-NMVLLLGACPEFG--CLIYEYM 538 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~Hp-nIv~l~g~~~~~~--~lV~E~~ 538 (768)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++.+.... +++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 667788999999999999987 88999999765332 356789999999999988 7999998885443 8999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeecccccccCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVPPSVA 617 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFGla~~~~~~~~ 617 (768)
.++++.+++........++......++.|++.+|.|+|..+ ++||||||+||+++..+ .++++|||+++.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966654321124888999999999999999999999 99999999999999988 799999999986543321
Q ss_pred CccccccccCCCCCCCCCCcccccC---CCCCccccHHHHHHHHHHHHhCCCCCCChH------HHHHHHHcCCccccCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQIITAKPPMGLAH------QVERSIENGTFDETLD 688 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltg~~Pf~~~~------~~~~~i~~~~~~~~ld 688 (768)
............||..|++||.+.+ ..++...|+||+|++++++++|..||.... .....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 1100012456789999999999887 578999999999999999999999986543 2333333322110111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
.............+.+++..|+..+|..|.+....+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111111223468899999999999999999987754
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=183.84 Aligned_cols=139 Identities=15% Similarity=0.143 Sum_probs=106.5
Q ss_pred CcEEEEEecCCc--CcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHH
Q 035604 10 EEAVAVAIDKDK--GSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFV 87 (768)
Q Consensus 10 ~~~IlVavDgS~--~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 87 (768)
+++||||||||+ .|.+|++||+.+|.. +++|+||||+++...... .. + . .....+.+...+.+++.|+
T Consensus 2 ~~~ILv~vD~S~~~~s~~al~~A~~la~~-~~~l~llhv~~~~~~~~~--~~-~-----~-~~~~~~~~~~~~~~~~~l~ 71 (142)
T PRK15456 2 YKTIIMPVDVFEMELSDKAVRHAEFLAQD-DGVIHLLHVLPGSASLSL--HR-F-----A-ADVRRFEEHLQHEAEERLQ 71 (142)
T ss_pred CccEEEeccCCchhHHHHHHHHHHHHHhc-CCeEEEEEEecCcccccc--cc-c-----c-cchhhHHHHHHHHHHHHHH
Confidence 578999999994 899999999999876 569999999976432111 00 0 0 1112334555666777778
Q ss_pred HHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 88 PFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 88 ~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
++.+.+...++++ ...+..|+|++.|+++|+++++||||||+||+ ++.+. +.|||+.+|+++++ ||||||+
T Consensus 72 ~~~~~~~~~~~~v-~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g~-~~~~~-llGS~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 72 TMVSHFTIDPSRI-KQHVRFGSVRDEVNELAEELGADVVVIGSRNP-SISTH-LLGSNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred HHHHHhCCCCcce-EEEEcCCChHHHHHHHHhhcCCCEEEEcCCCC-Cccce-ecCccHHHHHHcCC--CCEEEeC
Confidence 7777665556663 45677899999999999999999999999998 56554 45699999999999 9999984
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=196.65 Aligned_cols=169 Identities=19% Similarity=0.201 Sum_probs=132.0
Q ss_pred HhcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHH---------HHHHHHHHHhhcCCCceeeeecccc---
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRS---------QFQQEVEVLCNIRHPNMVLLLGACP--- 528 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~---------~~~~E~~il~~l~HpnIv~l~g~~~--- 528 (768)
..++|...++||.|+||.||....++..+|||++++....... .+.+|+..+.++.||+|..+..++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4678999999999999999997777789999999765332222 1678999999999999988876642
Q ss_pred -------CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 529 -------EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 529 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
...+|||||++|.+|.++.. ++. ....+++.+|..||..| ++||||||+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 23589999999999987631 333 24569999999999999 99999999999999888 9
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQII 662 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ell 662 (768)
+|+|||.......... ...+.....|+.+.|+|+||+.+..+.
T Consensus 174 ~liDfg~~~~~~e~~a------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhh------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9999998865422111 011444556778999999999987654
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=178.77 Aligned_cols=141 Identities=11% Similarity=0.172 Sum_probs=104.2
Q ss_pred CcEEEEEecCCcC--cHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHH
Q 035604 10 EEAVAVAIDKDKG--SQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFV 87 (768)
Q Consensus 10 ~~~IlVavDgS~~--S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 87 (768)
+++||||+|||+. +.+|++||+++|...+++|+||||+++...... .+... ..... ..+...+.+++.++
T Consensus 2 ~~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~-~~~~~-----~~~~~--~~~~~~~~~~~~l~ 73 (144)
T PRK15005 2 NRTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYAS-LGLAY-----SAELP--AMDDLKAEAKSQLE 73 (144)
T ss_pred CccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCccccc-ccccc-----cccch--HHHHHHHHHHHHHH
Confidence 4789999999998 579999999999999999999999976432111 01000 00000 01223444556666
Q ss_pred HHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 88 PFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 88 ~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
.+.+.+...++.+ ...+..|+|++.|+++|+++++||||||+|+ +++.+.++ ||++.+|++++| ||||||+
T Consensus 74 ~~~~~~~~~~~~~-~~~v~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~~~~~~ll-GS~a~~vl~~a~--cpVlvVr 144 (144)
T PRK15005 74 EIIKKFKLPTDRV-HVHVEEGSPKDRILELAKKIPADMIIIASHR-PDITTYLL-GSNAAAVVRHAE--CSVLVVR 144 (144)
T ss_pred HHHHHhCCCCCce-EEEEeCCCHHHHHHHHHHHcCCCEEEEeCCC-CCchheee-cchHHHHHHhCC--CCEEEeC
Confidence 6666665566663 4556789999999999999999999999995 47775555 599999999999 9999984
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=189.10 Aligned_cols=138 Identities=17% Similarity=0.174 Sum_probs=107.3
Q ss_pred cceecccCceeEEEEEE-CCccEEEEEEcCCchh--h------------------------HHHHHHHHHHHhhcCCCce
Q 035604 468 SRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQ--G------------------------RSQFQQEVEVLCNIRHPNM 520 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~--~------------------------~~~~~~E~~il~~l~HpnI 520 (768)
...||+|+||.||+|.. +|+.||||+++..... . .....+|+.+|..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 45799999999999987 6889999999754211 0 1122459999999987776
Q ss_pred eeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCCeEEcCCC
Q 035604 521 VLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL-HQTKPEPLVHRDLKPGNILLDRNY 599 (768)
Q Consensus 521 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiHrDLKp~NILl~~~~ 599 (768)
...........+|||||++|+++...+.... .++......++.|++.+|.|| |+.| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 4333222334589999999887765443322 488999999999999999999 6888 99999999999998 57
Q ss_pred cEEEeeccccccc
Q 035604 600 VSKISDVGLARLV 612 (768)
Q Consensus 600 ~vKL~DFGla~~~ 612 (768)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=179.38 Aligned_cols=137 Identities=13% Similarity=0.189 Sum_probs=103.7
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
+++||||||||+.|.+|+++|+.+|+..+++|++|||.++...... +..+ .......+...+.+++.++++
T Consensus 3 ~k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~--~~~~-------~~~~~~~~~~~~~~~~~l~~~ 73 (142)
T PRK09982 3 YKHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELYP--GIYF-------PATEDILQLLKNKSDNKLYKL 73 (142)
T ss_pred ceEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhch--hhhc-------cchHHHHHHHHHHHHHHHHHH
Confidence 5899999999999999999999999999999999999876432110 0000 001122344555666777777
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGK 164 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k 164 (768)
.+.+...+ ....+..|+|++.|+++|++.++||||||+| ++++. +++ | |+++|+++++ ||||||+.
T Consensus 74 ~~~~~~~~---~~~~v~~G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~-~~~-~-va~~V~~~s~--~pVLvv~~ 139 (142)
T PRK09982 74 TKNIQWPK---TKLRIERGEMPETLLEIMQKEQCDLLVCGHH-HSFIN-RLM-P-AYRGMINKMS--ADLLIVPF 139 (142)
T ss_pred HHhcCCCc---ceEEEEecCHHHHHHHHHHHcCCCEEEEeCC-hhHHH-HHH-H-HHHHHHhcCC--CCEEEecC
Confidence 76554322 3456677999999999999999999999986 75665 455 4 9999999999 99999975
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=185.46 Aligned_cols=188 Identities=15% Similarity=0.106 Sum_probs=140.7
Q ss_pred CccceecccCceeEEEEEECCccEEEEEEcCCchhh----HHHHHHHHHHHhhcC-CCceeeeeccccCCceeEEEeccC
Q 035604 466 SNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQG----RSQFQQEVEVLCNIR-HPNMVLLLGACPEFGCLIYEYMAN 540 (768)
Q Consensus 466 ~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~----~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~lV~E~~~~ 540 (768)
.+...|++|+||+||.+...+..++.+.+....... ...+.+|+++|++|. |++|.+++++ ...+++|+|+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 456789999999999887788889988886554321 225789999999995 5788888875 346999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCeEEcCCCcEEEeecccccccCCCCC--
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDL-KPGNILLDRNYVSKISDVGLARLVPPSVA-- 617 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDL-Kp~NILl~~~~~vKL~DFGla~~~~~~~~-- 617 (768)
.+|...+.. . ...++.|++.+|.++|..| |+|||| ||+|||++.++.++|+|||++........
T Consensus 83 ~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 888653311 1 1357789999999999999 999999 79999999999999999999986543221
Q ss_pred -----CccccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCCC
Q 035604 618 -----DSVTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPPM 668 (768)
Q Consensus 618 -----~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~Pf 668 (768)
.+...........++.|++|+...- ..--...++++.|+.+|.++|+..|+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0000000112346888999984322 22225679999999999999999886
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-21 Score=190.21 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=185.0
Q ss_pred CccceecccCceeEEEEEECCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCC
Q 035604 466 SNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANG 541 (768)
Q Consensus 466 ~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 541 (768)
.+..+|.+...|..|+|++.+..+++|+++... ...-.+|..|.-.|+.+.||||+.++|+|.. ...++..||+.|
T Consensus 193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 344568889999999999999999999986542 2223468999999999999999999999944 457888999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC-CCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR-DLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHr-DLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
+|...|....+ -..+..+..+++.+|++|+.|||+..+ +|-| -|.+..++||++.+.+|+= +-+++
T Consensus 273 slynvlhe~t~-vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarism-ad~kf--------- 339 (448)
T KOG0195|consen 273 SLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISM-ADTKF--------- 339 (448)
T ss_pred HHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheec-cccee---------
Confidence 99999976543 346677888999999999999999873 4443 5788899999998877641 11111
Q ss_pred ccccccCCCCCCCCCCcccccCCCC---CccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGML---GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~---s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
........-.+.||+||.++..+- -..+|+|||.+++|||.|...||.....++...+- .+.......|..
T Consensus 340 -sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-----aleglrv~ippg 413 (448)
T KOG0195|consen 340 -SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-----ALEGLRVHIPPG 413 (448)
T ss_pred -eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----hhccccccCCCC
Confidence 111123355788999998887653 34789999999999999999999755554432211 111222244556
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
.+..+.+|+.-|+..||.+||.+..| .++|+++
T Consensus 414 is~hm~klm~icmnedpgkrpkfdmi-vpilekm 446 (448)
T KOG0195|consen 414 ISRHMNKLMNICMNEDPGKRPKFDMI-VPILEKM 446 (448)
T ss_pred ccHHHHHHHHHHhcCCCCcCCCccee-hhhHHHh
Confidence 67789999999999999999999865 4666543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-21 Score=222.07 Aligned_cols=257 Identities=20% Similarity=0.257 Sum_probs=183.1
Q ss_pred CccceecccCceeEEEEEE--CCccEEEEEEc----CC-ch-hhHHHHHHHHHHHhhcCCCceeeeeccccCCc--eeEE
Q 035604 466 SNSRKIGEGGYGPVYKSYL--DHTPVAIKVLR----PD-AA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIY 535 (768)
Q Consensus 466 ~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~----~~-~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~lV~ 535 (768)
....++|.|++|.|+.... ....++.|..+ +. .. +....+..|+-+-..+.|||++..+..+.+.. +-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999997776554 33334444332 11 11 11112566777788899999987766653322 3349
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||++ +|..++.... .++...+..++.|++.|+.|||..| |.||||||+|+++..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999988763 3888888999999999999999999 999999999999999999999999999876443
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCc-cccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCC-
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGV-KSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD- 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~- 693 (768)
.... .......+|+-.|+|||++.+..|++ ..||||.|++++.|++|+.||..............+........+.
T Consensus 474 ~e~~--~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 474 WEKN--IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cchh--hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 3221 12345678999999999999988865 6799999999999999999995443322210000101111111111
Q ss_pred -CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 694 -WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 694 -~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.-...+.....++.++|+++|.+|-++.+|+. +|...+
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 11234456888999999999999999999996 565443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-21 Score=221.28 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=180.0
Q ss_pred CCCccceecccCceeEEEEEECCccEEEEEEcCCc-hhhHHHHHHHHHH--HhhcCCCceeeeeccc--cCCceeEEEec
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDA-AQGRSQFQQEVEV--LCNIRHPNMVLLLGAC--PEFGCLIYEYM 538 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~i--l~~l~HpnIv~l~g~~--~~~~~lV~E~~ 538 (768)
+|...+.||.+.|=+|.++.++...|+||++-+.. ......|.++++- ...++|||++.+.-+- ....|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 67788899999999999999987789999985443 3444444443333 4556899999886553 33458888888
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc--CCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV--PPSV 616 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~--~~~~ 616 (768)
..+|.|+|..+ +.+..-+...|+.|++.||..+|..| |+|||||.+||||+.-.-+.|+||..-+.. +.+.
T Consensus 104 -khnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 -KHNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred -hhhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 45788888654 46888888889999999999999999 999999999999999889999999876533 2221
Q ss_pred CCccccccccCCCCCCCCCCcccccCC----------C-CCccccHHHHHHHHHHHHh-CCCCCCChHHHHHHHHcCCcc
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTG----------M-LGVKSDVYSLGILLLQIIT-AKPPMGLAHQVERSIENGTFD 684 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------~-~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~~~~i~~~~~~ 684 (768)
. ....+.+.+...-.+|+|||.+... . ++++.||||+||+++||++ |++||.+..-....-......
T Consensus 177 P-adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 177 P-ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred c-ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 1 1122223333445689999965431 1 6789999999999999998 799997655433211111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
+.+...+.+ ..+.+|+..|++.||..|-++++.+..
T Consensus 256 e~~Le~Ied------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIED------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcC------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111222 248999999999999999999998743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.7e-20 Score=182.92 Aligned_cols=139 Identities=19% Similarity=0.170 Sum_probs=109.9
Q ss_pred cceecccCceeEEEEEE-CCccEEEEEEcCCchh---------------------h-----HHHHHHHHHHHhhcCCCce
Q 035604 468 SRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQ---------------------G-----RSQFQQEVEVLCNIRHPNM 520 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~---------------------~-----~~~~~~E~~il~~l~HpnI 520 (768)
...||+|+||.||+|.+ +|+.||||+++..... . ...+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 5889999999865210 0 1124578999999999987
Q ss_pred eeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCC
Q 035604 521 VLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNY 599 (768)
Q Consensus 521 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~ 599 (768)
.....+.....+|||||++|+++........ .++......++.|++.+|.+||+ .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 5443333334689999998886544322222 37788889999999999999999 88 99999999999998 89
Q ss_pred cEEEeecccccccC
Q 035604 600 VSKISDVGLARLVP 613 (768)
Q Consensus 600 ~vKL~DFGla~~~~ 613 (768)
.++|+|||++..+.
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-21 Score=210.76 Aligned_cols=222 Identities=27% Similarity=0.301 Sum_probs=178.2
Q ss_pred ecccCceeEEEE-----EECCccEEEEEEcCCchhh--HHHHHHHHHHHhhcC-CCceeeeeccccC--CceeEEEeccC
Q 035604 471 IGEGGYGPVYKS-----YLDHTPVAIKVLRPDAAQG--RSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLIYEYMAN 540 (768)
Q Consensus 471 LG~G~fG~Vy~~-----~~~~~~vAvK~l~~~~~~~--~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~E~~~~ 540 (768)
+|+|+||.|+.+ .+.+..+|+|++++..... +.....|..++..++ ||.+|++..++.. ..+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999953 3466789999997653222 123456888899887 9999999988744 45999999999
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 620 (768)
|+|...+.... .+.+.....+..+++.++.++|+.+ |+|||+|++||+++.+|++|+.|||+++..-..
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~----- 150 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE----- 150 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh-----
Confidence 99988776554 3777888889999999999999999 999999999999999999999999999865221
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHH
Q 035604 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEAL 700 (768)
Q Consensus 621 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~ 700 (768)
...+||..|||||++. ......|+||||++++||+||-.||.. ++...|-+. ....|...+.
T Consensus 151 -----~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~Il~~---------~~~~p~~l~~ 212 (612)
T KOG0603|consen 151 -----KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKRILKA---------ELEMPRELSA 212 (612)
T ss_pred -----hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHHHHHhhh---------ccCCchhhhH
Confidence 1128999999999988 667899999999999999999999987 222323221 1244556667
Q ss_pred HHHHHHHHhhhcCccCCCChh
Q 035604 701 ILAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 701 ~l~~Li~~cl~~~P~~RPs~~ 721 (768)
....++..++..+|..|--..
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccC
Confidence 788899999999999987663
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-20 Score=175.11 Aligned_cols=137 Identities=13% Similarity=0.221 Sum_probs=99.1
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
+++||||+|+|+.|..||++|+.+|...+++|+||||..+.... . .+ +. ......+.+...+...+.++.+
T Consensus 3 ~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~-~-~~--~~-----~~~~~~~~~~~~~~~~~~l~~~ 73 (144)
T PRK15118 3 YKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSDL-Y-TG--LI-----DVNLGDMQKRISEETHHALTEL 73 (144)
T ss_pred ceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhhh-h-hh--hh-----hcchHHHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999999889999999995332111 0 00 00 0001112222333333444433
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGK 164 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k 164 (768)
+...|+.+...++..|+|+++|+++|+++++||||||+||+ +.++ +| |||++|+++|+ ||||||+.
T Consensus 74 ---~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~~--~~~~-lg-Sva~~v~~~a~--~pVLvv~~ 139 (144)
T PRK15118 74 ---STNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQD--FWSK-LM-SSARQLINTVH--VDMLIVPL 139 (144)
T ss_pred ---HHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCccc--HHHH-HH-HHHHHHHhhCC--CCEEEecC
Confidence 34567775556667899999999999999999999999974 3334 45 99999999999 99999974
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=182.18 Aligned_cols=230 Identities=22% Similarity=0.302 Sum_probs=146.5
Q ss_pred CCCccceecccCceeEEEEEEC--CccEEEEEEcCC---chhhHHHHHHHHHHHhhcCC---C-------ce------ee
Q 035604 464 NFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPD---AAQGRSQFQQEVEVLCNIRH---P-------NM------VL 522 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~H---p-------nI------v~ 522 (768)
.+.....||.|+|+.||.+++. +..+|+|+.... .....+++++|.-....+.+ | .+ ++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455678999999999999994 578999997533 22345566666655544322 1 11 12
Q ss_pred eecc---c---c-------CCceeEEEeccCCChHHHHh---hcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 035604 523 LLGA---C---P-------EFGCLIYEYMANGSLEDRLF---RRGGS-PVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585 (768)
Q Consensus 523 l~g~---~---~-------~~~~lV~E~~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH 585 (768)
+-+- + . -..+++|.-+ .++|.+++. ..... ..+....++.+..|+++.+++||..| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1110 0 0 0225677777 678887754 22221 12334556677899999999999999 999
Q ss_pred CCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC--------CCCCccccHHHHHHH
Q 035604 586 RDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT--------GMLGVKSDVYSLGIL 657 (768)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDvwSlGvi 657 (768)
+||+|+|+|++.+|.++|+||+.....+.. . .....+..|.+||.... -.++.+.|.|+||++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-------~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR-------Y--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE-------E--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce-------e--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999999999999999999987654221 1 11344577999996533 247899999999999
Q ss_pred HHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCC
Q 035604 658 LLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDR 717 (768)
Q Consensus 658 l~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~R 717 (768)
+|.|++|..||+....... .+ .....+. +.+..+..||..+|+.+|.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~-------~~---~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEAD-------PE---WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGST-------SG---GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCcccc-------cc---ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999986543211 00 0222333 556679999999999999998
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-18 Score=203.32 Aligned_cols=245 Identities=21% Similarity=0.251 Sum_probs=177.8
Q ss_pred HHHhcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC---CCceeeeecc--ccCCce
Q 035604 459 EEATENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR---HPNMVLLLGA--CPEFGC 532 (768)
Q Consensus 459 ~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~--~~~~~~ 532 (768)
+.-...|.+.+.||+|+||.||+|.. +++.||+|+-++..... |.--.+++.+|+ -+-|..+..+ |.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 33456799999999999999999987 67899999998765442 333344555555 1223333332 366779
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-------CCCcEEEee
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-------RNYVSKISD 605 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-------~~~~vKL~D 605 (768)
||+||.+.|+|.+++. ....++|.....++.|++..+..||..+ |||+||||+|+||. .+-.++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999987 3346999999999999999999999999 99999999999993 245689999
Q ss_pred cccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccc
Q 035604 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDE 685 (768)
Q Consensus 606 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~ 685 (768)
||.+--+..- ....++....+|-.+-.+|+..|..+++..|.|.|+.+++-||.|+.- + ..+|. ..
T Consensus 845 fG~siDm~lf----p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q--~~~g~-~~ 910 (974)
T KOG1166|consen 845 FGRSIDMKLF----PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------E--VKNGS-SW 910 (974)
T ss_pred cccceeeeEc----CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------H--hcCCc-ce
Confidence 9988433110 112345667889999999999999999999999999999999998742 1 33343 23
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
.++..++.+... ..+.+++..+|+.+-..=|.+.++...+.
T Consensus 911 ~~~~~~~Ry~~~--~~W~~~F~~lLN~~~~~~p~l~~lr~~~~ 951 (974)
T KOG1166|consen 911 MVKTNFPRYWKR--DMWNKFFDLLLNPDCDTLPNLQELRTELE 951 (974)
T ss_pred eccccchhhhhH--HHHHHHHHHHhCcCcccchhHHHHHHHHH
Confidence 333334332222 12666777777755555566655544333
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=175.92 Aligned_cols=134 Identities=17% Similarity=0.233 Sum_probs=104.7
Q ss_pred CccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhc-----CCCceeeeeccccCCc---e---eE
Q 035604 466 SNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-----RHPNMVLLLGACPEFG---C---LI 534 (768)
Q Consensus 466 ~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~g~~~~~~---~---lV 534 (768)
...++||+|+||.||....++. .+||++..........+.+|+.+++.+ .||||+++||++.+.. + +|
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEECCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 3456899999999996322333 479988765444566799999999999 5799999999996642 3 68
Q ss_pred EEe--ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeCCCCCCCeEEcC----CCcEEEeecc
Q 035604 535 YEY--MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL-LFLHQTKPEPLVHRDLKPGNILLDR----NYVSKISDVG 607 (768)
Q Consensus 535 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~~iiHrDLKp~NILl~~----~~~vKL~DFG 607 (768)
+|| +.+|+|.+++.... +++. ..++.+++.++ .|||+.+ |+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 55799999996532 5555 35678888888 8999999 999999999999974 3489999954
Q ss_pred cc
Q 035604 608 LA 609 (768)
Q Consensus 608 la 609 (768)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.3e-19 Score=204.15 Aligned_cols=212 Identities=25% Similarity=0.345 Sum_probs=147.1
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccCCceeEEEecc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMA 539 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~lV~E~~~ 539 (768)
..+|..+++|-.|+||.||...++ .+++|+|+ ++.... +++ |+....+|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee------------------
Confidence 467999999999999999999875 66899954 322211 111 33333444444
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC---
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV--- 616 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~--- 616 (768)
|+-.+.+..-+ .++.. ++.+++|||+.+ |+|||+||+|.||+.=|++|++|||+.+..-...
T Consensus 136 -gDc~tllk~~g---~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -GDCATLLKNIG---PLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -chhhhhcccCC---CCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33344333222 23322 278999999999 9999999999999999999999999997542211
Q ss_pred ------CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHH-HHHcCC-cccc
Q 035604 617 ------ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVER-SIENGT-FDET 686 (768)
Q Consensus 617 ------~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~-~i~~~~-~~~~ 686 (768)
.....+......+||+.|+|||++....|+..+|||++|+|+||.+.|..||... ..+.. .|.+.. +.+-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 1111122234579999999999999999999999999999999999999999655 22222 222211 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhh
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGK 722 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~e 722 (768)
|. ....+.+++|.+.|..+|..|--...
T Consensus 281 -de-------a~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 281 -DE-------ALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred -Cc-------CCCHHHHHHHHHHHHhChHhhcccch
Confidence 11 12245899999999999999975544
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=160.70 Aligned_cols=132 Identities=16% Similarity=0.234 Sum_probs=108.3
Q ss_pred EEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHHHH
Q 035604 12 AVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPFRC 91 (768)
Q Consensus 12 ~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 91 (768)
+||||+|+|+.+..|+++|..+|...+++|+++||++++..... .. .....+..++.++.+.+
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~-------------~~----~~~~~~~~~~~~~~~~~ 63 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSP-------------SQ----LEVNVQRARKLLRQAER 63 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCc-------------ch----hHHHHHHHHHHHHHHHH
Confidence 59999999999999999999999989999999999976432111 00 01223456677888888
Q ss_pred HhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 92 FCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 92 ~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
.+...|+++...+...|+|.++|+++++++++|+||||++|++++.+.++ ||++.+|+++++ |||+||+
T Consensus 64 ~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~l-Gs~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 64 IAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLF-GGVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred HhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceec-CchHHHHHhcCC--CCEEEeC
Confidence 88888998666666678999999999999999999999999977765555 599999999999 9999984
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=162.32 Aligned_cols=137 Identities=9% Similarity=0.149 Sum_probs=105.3
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
+++||||+|+|+.+..||++|+.+|...+++|+++||++++..... + .......+.+...+..++.++.+
T Consensus 3 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~-----~-----~~~~~~~~~~~~~~~~~~~l~~~ 72 (142)
T PRK10116 3 YSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMYNQ-----F-----AAPMLEDLRSVMQEETQSFLDKL 72 (142)
T ss_pred CceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccchh-----h-----hHHHHHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999999999989999999999865422111 0 11122233344444455555554
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGK 164 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k 164 (768)
. ...|+......+..|++.+.|+++|++.++||||||+||++++.+ + + ||+++|+++++ ||||||+-
T Consensus 73 ~---~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~-~-~-s~a~~v~~~~~--~pVLvv~~ 139 (142)
T PRK10116 73 I---QDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSR-A-S-CSAKRVIASSE--VDVLLVPL 139 (142)
T ss_pred H---HhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHH-H-H-HHHHHHHhcCC--CCEEEEeC
Confidence 3 345776555677889999999999999999999999999977664 4 2 89999999999 99999963
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.4e-18 Score=156.97 Aligned_cols=122 Identities=12% Similarity=0.211 Sum_probs=98.7
Q ss_pred EEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHHHH
Q 035604 12 AVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPFRC 91 (768)
Q Consensus 12 ~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 91 (768)
+||||+|+|+.+..|++||+.+|...+++|++|||.++.... ..+..++.++.+.+
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~~------------------------~~~~~~~~l~~~~~ 56 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLNR------------------------LSEAERRRLAEALR 56 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCcccc------------------------CCHHHHHHHHHHHH
Confidence 599999999999999999999999999999999998653110 11123445566666
Q ss_pred HhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccC-CCceeEEEE
Q 035604 92 FCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGA-PDYCNVYVI 162 (768)
Q Consensus 92 ~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~A-p~~C~VlvV 162 (768)
.+...++.+ ..+..|+|+++|+++++++++|+||||+||++++.+. +.||++.+|++++ + |||||+
T Consensus 57 ~~~~~~~~~--~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~-~~Gs~~~~v~~~a~~--~~v~v~ 123 (124)
T cd01987 57 LAEELGAEV--VTLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWREL-FRGSLVDRLLRRAGN--IDVHIV 123 (124)
T ss_pred HHHHcCCEE--EEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHH-hcccHHHHHHHhCCC--CeEEEe
Confidence 666667652 3456789999999999999999999999999666655 4559999999999 6 999997
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.4e-18 Score=175.58 Aligned_cols=193 Identities=22% Similarity=0.268 Sum_probs=139.3
Q ss_pred CCCceeeeeccccCC-----------------------------ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHH
Q 035604 516 RHPNMVLLLGACPEF-----------------------------GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAA 566 (768)
Q Consensus 516 ~HpnIv~l~g~~~~~-----------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 566 (768)
+|||||+++++|.+. .|+||... ..+|..++..+. .+....+-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence 599999999887221 17888877 458999987765 66777888999
Q ss_pred HHHHHHHHHHhCCCCCeeeCCCCCCCeEE--cCCC--cEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC
Q 035604 567 EIATALLFLHQTKPEPLVHRDLKPGNILL--DRNY--VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT 642 (768)
Q Consensus 567 qi~~aL~~LH~~~~~~iiHrDLKp~NILl--~~~~--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 642 (768)
|+++|+.|||++| |.|||||++|||| |.++ .+.|+|||+|-.-....-.-..........|.-..||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 4443 5699999988543221111111112234567888999998765
Q ss_pred CCC------CccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccC
Q 035604 643 GML------GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKD 716 (768)
Q Consensus 643 ~~~------s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~ 716 (768)
.+- -.|.|.|+.|.+.||+++...||....+.. +...++.+...|.+ |..++..+.+|+...|+.||.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~r~Yqe~qLPal---p~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDTRTYQESQLPAL---PSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--echhhhhhhhCCCC---cccCChHHHHHHHHHhcCCccc
Confidence 431 248899999999999999999996532221 11122333333333 3344556999999999999999
Q ss_pred CCChh
Q 035604 717 RPDLG 721 (768)
Q Consensus 717 RPs~~ 721 (768)
||+..
T Consensus 501 Rvsp~ 505 (598)
T KOG4158|consen 501 RVSPN 505 (598)
T ss_pred cCCcc
Confidence 99975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.2e-19 Score=190.45 Aligned_cols=179 Identities=25% Similarity=0.352 Sum_probs=137.3
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
+.||.|++|.-.+|.++|.++......++.....++.|++.|+.| ++ .+|||+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 458999999999999999876666668889999999999999999 66 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHHHHHHHHcCCccccCC
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQVERSIENGTFDETLD 688 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~~~~i~~~~~~~~ld 688 (768)
.-.............++..+||.+||+||.+.+..|+.++||||||+||+||++ -.-+|..... ..-+.+|.+.....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t-~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT-LTDIRDGIIPPEFL 482 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh-hhhhhcCCCChHHh
Confidence 876543322222334677899999999999999999999999999999999998 3333322211 12234444331111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhh
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKV 723 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~ev 723 (768)
.++|. =..|+.+++.+.|.+||+..++
T Consensus 483 ---~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 483 ---QDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ---hcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 12232 3469999999999999955443
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.6e-18 Score=157.93 Aligned_cols=139 Identities=23% Similarity=0.353 Sum_probs=100.3
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.+..|++||+.+|...+++|++|||.+....... . .....................
T Consensus 2 ~~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~-----------~-~~~~~~~~~~~~~~~~~~~~~ 69 (140)
T PF00582_consen 2 YKRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSF-----------S-AAEDEESEEEAEEEEQARQAE 69 (140)
T ss_dssp TSEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHH-----------H-HHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeecccccccc-----------c-cccccccccccchhhhhhhHH
Confidence 5899999999999999999999999999999999999977432111 0 000000000000001011111
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
...+...+.......+..|+++++|++++++.++|+||||+++++++.+.+ .||++.+|++++| |||+||+
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~-~gs~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 70 AEEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLL-FGSVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp HHHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSS-SHHHHHHHHHHTS--SEEEEEE
T ss_pred HHHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCC-cCCHHHHHHHcCC--CCEEEeC
Confidence 133334455546677888999999999999999999999999997777655 4599999999999 9999985
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=185.49 Aligned_cols=203 Identities=25% Similarity=0.419 Sum_probs=153.9
Q ss_pred HhhcCCCceeeeeccccC--CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-eeCCC
Q 035604 512 LCNIRHPNMVLLLGACPE--FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL-VHRDL 588 (768)
Q Consensus 512 l~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i-iHrDL 588 (768)
|+.+.|.|+.+++|.+.+ ..++|.+||..|+|.|.+.... ..+++.-...++.+|+.||.|||... | .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 467899999999999844 3478999999999999998743 34888889999999999999999876 4 99999
Q ss_pred CCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCC-------CCccccHHHHHHHHHHH
Q 035604 589 KPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM-------LGVKSDVYSLGILLLQI 661 (768)
Q Consensus 589 Kp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~s~ksDvwSlGvil~el 661 (768)
++.|.++|....+||+|||+..+...... ........-..-|.|||.+.+.. .+.+.||||||+|++|+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAE----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccc----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 99999999999999999999987643100 01112223456799999887642 46789999999999999
Q ss_pred HhCCCCCCChH------HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 662 ITAKPPMGLAH------QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 662 ltg~~Pf~~~~------~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
++...||.... .+...++++ -...+.|.+.... +....+..++..||..+|.+||++.+|-.
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~~-~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKKG-GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HhccCccccccccCChHHHHHHHHhc-CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 99999996422 233334441 1233344443211 33336999999999999999999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=164.67 Aligned_cols=132 Identities=22% Similarity=0.301 Sum_probs=110.0
Q ss_pred ceecccCceeEEEEEECCccEEEEEEcCCch--------hhHHHHHHHHHHHhhcCCCceeeeecc--ccCCceeEEEec
Q 035604 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAA--------QGRSQFQQEVEVLCNIRHPNMVLLLGA--CPEFGCLIYEYM 538 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~--~~~~~~lV~E~~ 538 (768)
+.||+|++|.||+|.+.+..|++|+...... .....+.+|+.++..+.|++|.....+ .....++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5699999999999999999999998764321 112457789999999999887654443 456679999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
+|++|.+++.... + .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999886432 2 77889999999999999999 99999999999999 78999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-17 Score=169.46 Aligned_cols=141 Identities=19% Similarity=0.182 Sum_probs=109.7
Q ss_pred CCCccceecccCceeEEEEE-E--CCccEEEEEEcCCchh------------------------hHHHHHHHHHHHhhcC
Q 035604 464 NFSNSRKIGEGGYGPVYKSY-L--DHTPVAIKVLRPDAAQ------------------------GRSQFQQEVEVLCNIR 516 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~-~--~~~~vAvK~l~~~~~~------------------------~~~~~~~E~~il~~l~ 516 (768)
.|.+.+.||+|+||.||+|. . +++.||||+++..... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 3 6789999998754210 1123568999999997
Q ss_pred CCc--eeeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 035604 517 HPN--MVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNIL 594 (768)
Q Consensus 517 Hpn--Iv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NIL 594 (768)
+.+ +..+++. ...+|||||++|++|...+.... .+.......++.||+.+|.+||..+ .|+||||||+||+
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 533 3344443 24589999999988866543322 3556667889999999999999886 4999999999999
Q ss_pred EcCCCcEEEeeccccccc
Q 035604 595 LDRNYVSKISDVGLARLV 612 (768)
Q Consensus 595 l~~~~~vKL~DFGla~~~ 612 (768)
++ ++.++|+|||++...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998754
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-17 Score=175.41 Aligned_cols=145 Identities=17% Similarity=0.084 Sum_probs=110.6
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
+++||||+|+|+.|..|+++|+.+|+..+++|++|||++..... .+ +. ..........+...+..++.|+.+
T Consensus 3 ~~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~-~~-~~------~~~~~~~~~~~~~~~~~~~~l~~~ 74 (305)
T PRK11175 3 YQNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSYE-MT-TL------LSPDEREAMRQGVISQRTAWIREQ 74 (305)
T ss_pred cceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchhh-hh-cc------cchhHHHHHHHHHHHHHHHHHHHH
Confidence 58999999999999999999999999999999999998653211 10 00 011222122233334456667777
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
...+...|+.+...++..|+|.++|+++|+++++||||||+||++++.+.++ ||++.+|+++++ ||||||+.+
T Consensus 75 ~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~-gs~~~~l~~~~~--~pvlvv~~~ 147 (305)
T PRK11175 75 AKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIF-TPTDWHLLRKCP--CPVLMVKDQ 147 (305)
T ss_pred HHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhcc-ChhHHHHHhcCC--CCEEEeccc
Confidence 7766777888655455579999999999999999999999999977665555 599999999999 999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.9e-17 Score=163.93 Aligned_cols=128 Identities=22% Similarity=0.317 Sum_probs=105.9
Q ss_pred eecccCceeEEEEEECCccEEEEEEcCCch--------hhHHHHHHHHHHHhhcCCCce--eeeeccccCCceeEEEecc
Q 035604 470 KIGEGGYGPVYKSYLDHTPVAIKVLRPDAA--------QGRSQFQQEVEVLCNIRHPNM--VLLLGACPEFGCLIYEYMA 539 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnI--v~l~g~~~~~~~lV~E~~~ 539 (768)
.||+|+||.||+|.+++..|++|+...... .....+.+|++++..+.|+++ ..++....+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 389999999999999999999999754321 113457789999999988764 4455555666799999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
|++|.+++.... . .++.+++.+|.+||+.+ ++|||++|.||+++ ++.++|+|||++..
T Consensus 81 g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998775421 1 78999999999999999 99999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=159.47 Aligned_cols=135 Identities=22% Similarity=0.173 Sum_probs=107.2
Q ss_pred CCCccceecccCceeEEEEEE-CCccEEEEEEcCCch----------------------hhHHHHHHHHHHHhhcCCCc-
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA----------------------QGRSQFQQEVEVLCNIRHPN- 519 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~----------------------~~~~~~~~E~~il~~l~Hpn- 519 (768)
.|.+.+.||.|+||.||++.. +++.||||++..... .....+..|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 477889999999999999988 688999999764321 01123567899999998774
Q ss_pred -eeeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 035604 520 -MVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN 598 (768)
Q Consensus 520 -Iv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 598 (768)
+...++. ...++||||++|++|...... .....++.+++.++.++|+.+ |+||||||+||+++.+
T Consensus 96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 4445443 345899999999998764321 234578899999999999998 9999999999999999
Q ss_pred CcEEEeeccccccc
Q 035604 599 YVSKISDVGLARLV 612 (768)
Q Consensus 599 ~~vKL~DFGla~~~ 612 (768)
+.++|+|||++..+
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.5e-17 Score=187.11 Aligned_cols=138 Identities=21% Similarity=0.261 Sum_probs=111.8
Q ss_pred HHhcCCCccceecccCceeEEEEEECCccEEEEEEcCCc--------hhhHHHHHHHHHHHhhcCCCceeeeeccc--cC
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDA--------AQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PE 529 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~ 529 (768)
.....|...+.||+|+||.||+|.+.+..+++|+..... ......+.+|++++..++|++|+..+.++ ..
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556778999999999999999977777766543211 11234578999999999999987755444 44
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..++||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 6799999999999998774 24578999999999999999 9999999999999 6789999999999
Q ss_pred ccc
Q 035604 610 RLV 612 (768)
Q Consensus 610 ~~~ 612 (768)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.9e-16 Score=166.93 Aligned_cols=141 Identities=15% Similarity=0.179 Sum_probs=101.8
Q ss_pred CcEEEEEecCCcCc-------HHHHHHHHHhhcCC-CCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHH
Q 035604 10 EEAVAVAIDKDKGS-------QYALRWAVDHLLSR-GQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQ 81 (768)
Q Consensus 10 ~~~IlVavDgS~~S-------~~Al~~A~~~a~~~-~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (768)
.++||||+|+|+.+ ..|+++|+.+|... +++|+||||++....... .. ++ . .....+.+..++.
T Consensus 152 ~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~-~~--~~--~---~~~~~~~~~~~~~ 223 (305)
T PRK11175 152 GGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIA-IE--LP--E---FDPSVYNDAIRGQ 223 (305)
T ss_pred CCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhcc-cc--cc--c---cchhhHHHHHHHH
Confidence 68999999999764 68999999999887 999999999865422110 00 00 0 0011122223333
Q ss_pred HHHhHHHHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEE
Q 035604 82 AKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYV 161 (768)
Q Consensus 82 ~~~~l~~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~Vlv 161 (768)
..+.++.+.+ ..++......+..|+|.++|+++|+++++||||||+||++++.+.|+| |++.+|+++++ |||||
T Consensus 224 ~~~~l~~~~~---~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llG-S~a~~v~~~~~--~pVLv 297 (305)
T PRK11175 224 HLLAMKALRQ---KFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLG-NTAEHVIDHLN--CDLLA 297 (305)
T ss_pred HHHHHHHHHH---HhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeec-chHHHHHhcCC--CCEEE
Confidence 3344444433 346664455677899999999999999999999999999888765555 99999999999 99999
Q ss_pred EeC
Q 035604 162 IGK 164 (768)
Q Consensus 162 V~k 164 (768)
|+.
T Consensus 298 v~~ 300 (305)
T PRK11175 298 IKP 300 (305)
T ss_pred EcC
Confidence 953
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.8e-15 Score=148.49 Aligned_cols=135 Identities=23% Similarity=0.256 Sum_probs=96.3
Q ss_pred cceecccCceeEEEEEEC-CccEEEEEEcCCchh--hHHH----------------------HHHHHHHHhhcCCCc--e
Q 035604 468 SRKIGEGGYGPVYKSYLD-HTPVAIKVLRPDAAQ--GRSQ----------------------FQQEVEVLCNIRHPN--M 520 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~--~~~~----------------------~~~E~~il~~l~Hpn--I 520 (768)
.+.||+|+||.||++.+. +..||||+++..... .... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999885 889999998754211 1111 134566666654432 3
Q ss_pred eeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCC
Q 035604 521 VLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNY 599 (768)
Q Consensus 521 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~ 599 (768)
.+.++. ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+||||||+||+++ ++
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 334433 245899999998544321111110 11 5567899999999999999 88 99999999999999 99
Q ss_pred cEEEeeccccccc
Q 035604 600 VSKISDVGLARLV 612 (768)
Q Consensus 600 ~vKL~DFGla~~~ 612 (768)
.++|+|||++...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.5e-15 Score=139.49 Aligned_cols=133 Identities=23% Similarity=0.276 Sum_probs=111.3
Q ss_pred ccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCC--CceeeeeccccC--CceeEEEeccCCC
Q 035604 467 NSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH--PNMVLLLGACPE--FGCLIYEYMANGS 542 (768)
Q Consensus 467 ~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~--~~~lV~E~~~~gs 542 (768)
+.+.||.|.++.||++...+..+++|....... ...+.+|+.++..+.| +++.++++.+.. ..+++|||+.++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 356799999999999999888999999876543 4578899999999976 488888877644 5699999998887
Q ss_pred hHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 543 LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 543 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
+..+ +......++.+++.+|.+||.....+++|+||+|.|||++..+.++++|||+++.
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7543 4556677899999999999986444599999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=139.24 Aligned_cols=146 Identities=19% Similarity=0.304 Sum_probs=113.6
Q ss_pred CcEEEEEec-CCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHH
Q 035604 10 EEAVAVAID-KDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVP 88 (768)
Q Consensus 10 ~~~IlVavD-gS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 88 (768)
.++|++++| +++.+..|+.+|...+...++.+.++||.+.............. ...............+.++.
T Consensus 5 ~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 78 (154)
T COG0589 5 YKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALAD------APIPLSEEELEEEAEELLAE 78 (154)
T ss_pred cceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEeccccccccccccccc------chhhhhHHHHHHHHHHHHHH
Confidence 689999999 99999999999999999999999999998765332211110000 00111223344566777888
Q ss_pred HHHHhhhcCceeEEEEEecCCH-HHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeC
Q 035604 89 FRCFCTRKEIKCKEIVLEDTDI-AKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGK 164 (768)
Q Consensus 89 ~~~~~~~~gv~~~~~~v~~G~~-a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k 164 (768)
+.+.+.+.|+......+..|+| .+.|++++.++++|+||||++|++++.+ ++.|||+.+|+++++ |||++|+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~-~llGsvs~~v~~~~~--~pVlvv~~ 152 (154)
T COG0589 79 AKALAEAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSR-LLLGSVAEKVLRHAP--CPVLVVRS 152 (154)
T ss_pred HHHHHHHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccc-eeeehhHHHHHhcCC--CCEEEEcc
Confidence 8888888888854566777988 7999999999999999999999988887 555699999999999 99999974
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=133.07 Aligned_cols=130 Identities=26% Similarity=0.433 Sum_probs=105.0
Q ss_pred EEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHHHH
Q 035604 12 AVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPFRC 91 (768)
Q Consensus 12 ~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 91 (768)
+||||+|+++.+..+++||..+|...+++|+++||.++...... ...+......++.|..+..
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~-----------------~~~~~~~~~~~~~l~~~~~ 63 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAA-----------------ELAELLEEEARALLEALRE 63 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch-----------------hHHHHHHHHHHHHHHHHHH
Confidence 59999999999999999999999999999999999865321110 1123344556778888888
Q ss_pred HhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEE
Q 035604 92 FCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162 (768)
Q Consensus 92 ~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV 162 (768)
.|...|+.+. ..+..|++.+.|++++++.++|+||||+++++.+.+.+ .|+++..++++++ |||++|
T Consensus 64 ~~~~~~~~~~-~~~~~~~~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~-~~~~~~~ll~~~~--~pvliv 130 (130)
T cd00293 64 ALAEAGVKVE-TVVLEGDPAEAILEAAEELGADLIVMGSRGRSGLRRLL-LGSVAERVLRHAP--CPVLVV 130 (130)
T ss_pred HHhcCCCceE-EEEecCCCHHHHHHHHHHcCCCEEEEcCCCCCccceee-eccHHHHHHhCCC--CCEEeC
Confidence 8777788854 44557888999999999999999999999996665544 4599999999988 999985
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.4e-14 Score=148.61 Aligned_cols=132 Identities=19% Similarity=0.188 Sum_probs=103.2
Q ss_pred ceec-ccCceeEEEEEECCccEEEEEEcCCc-------------hhhHHHHHHHHHHHhhcCCCce--eeeeccccC---
Q 035604 469 RKIG-EGGYGPVYKSYLDHTPVAIKVLRPDA-------------AQGRSQFQQEVEVLCNIRHPNM--VLLLGACPE--- 529 (768)
Q Consensus 469 ~~LG-~G~fG~Vy~~~~~~~~vAvK~l~~~~-------------~~~~~~~~~E~~il~~l~HpnI--v~l~g~~~~--- 529 (768)
..|| .||.|+||.....+..++||.+.... ......+.+|++++..|.|++| +..++++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4688 89999999998888999999885321 1223457889999999998875 555554311
Q ss_pred ---CceeEEEeccC-CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEee
Q 035604 530 ---FGCLIYEYMAN-GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISD 605 (768)
Q Consensus 530 ---~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~D 605 (768)
..++|||+++| .+|.+++... .++.. .+.+|+.+|.+||+.| |+||||||.|||++.++.++|+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 12599999997 6888877542 24543 3568999999999999 99999999999999999999999
Q ss_pred cccccc
Q 035604 606 VGLARL 611 (768)
Q Consensus 606 FGla~~ 611 (768)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.9e-15 Score=175.26 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=186.4
Q ss_pred cCCCccceecccCceeEEEEEE---CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcC-CCceeeeeccc--cCCceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL---DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIR-HPNMVLLLGAC--PEFGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~---~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~g~~--~~~~~lV 534 (768)
..|.+.+.||+|+|+.|-.... ....+|+|.+.... ......+..|..+-+.+. |+|++.+++.. .+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4678888899999999987665 22356667665432 223334556777777777 99999999987 4456889
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCCeEEcCCC-cEEEeeccccccc
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH-QTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLV 612 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFGla~~~ 612 (768)
++|..|+++.+.+.... ....+....-.++.|+..+|.|+| ..+ +.||||||+|.+++..+ .+|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999988773221 113555666778999999999999 777 99999999999999999 9999999999877
Q ss_pred CCCCCCccccccccCCCC-CCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCC-
Q 035604 613 PPSVADSVTQYRMTSAAG-TFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDP- 689 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~- 689 (768)
... ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..||....... +.+......
T Consensus 176 ~~~---~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~~~ 247 (601)
T KOG0590|consen 176 RNK---NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKSNK 247 (601)
T ss_pred ccc---CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeecccc
Confidence 551 112233445677 9999999988884 56889999999999999999999996444322 111111111
Q ss_pred ---CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 690 ---AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 690 ---~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
....| ........+++.+++..+|..|.+..++-. +|+..
T Consensus 248 ~~~~~~~~-~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 248 GRFTQLPW-NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccCcc-ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 11111 122345788999999999999999998875 55544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.9e-13 Score=150.57 Aligned_cols=141 Identities=22% Similarity=0.285 Sum_probs=100.7
Q ss_pred CCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhH----------------------------------------
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGR---------------------------------------- 502 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~---------------------------------------- 502 (768)
.|+ .+.||.|++|.||+|++ +|+.||||+.++......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 36899999999999998 789999999976521110
Q ss_pred HHHHHHHHHHhhcC-----CCcee--eeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHH
Q 035604 503 SQFQQEVEVLCNIR-----HPNMV--LLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIAT-ALLF 574 (768)
Q Consensus 503 ~~~~~E~~il~~l~-----HpnIv--~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-aL~~ 574 (768)
-+|.+|...+.+++ +++|. ++|..+....+|||||++|++|.++....... + .+..++..++. .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQ 272 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHH
Confidence 02445666555552 33332 33333344569999999999998876532211 2 23456666665 4678
Q ss_pred HHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 575 LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
+|..| ++|+|+||.||+++.++.++|+|||++..++
T Consensus 273 l~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 89988 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.6e-12 Score=127.30 Aligned_cols=130 Identities=22% Similarity=0.181 Sum_probs=100.3
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-eeeeccccCCceeEEEeccCCChHHH
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-VLLLGACPEFGCLIYEYMANGSLEDR 546 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~~~gsL~~~ 546 (768)
.+.|+.|.++.||++...+..|++|+...... ....+.+|+.++..+.+.++ .+++.......++||||++|.++...
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 35689999999999999899999999865432 12346789999998865544 35555555567999999999887543
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 547 LFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK--PEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 547 l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
. .. ...++.+++.+|..||..+ +..++|+|++|.||+++ ++.++|+|||.+.
T Consensus 82 ----~----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 82 ----D----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ----c----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 0 11 1245678999999999987 23469999999999999 6789999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=4e-12 Score=137.69 Aligned_cols=105 Identities=19% Similarity=0.278 Sum_probs=77.2
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCC--CCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSR--GQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFV 87 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~--~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 87 (768)
++|||||||||+.|++|+++|+++|+.. +++|++|||.+....... . .......+++++
T Consensus 5 ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~---------------~----~~~~~~~eelle 65 (357)
T PRK12652 5 ANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE---------------G----QDELAAAEELLE 65 (357)
T ss_pred cCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc---------------h----hHHHHHHHHHHH
Confidence 7999999999999999999999999874 699999999975321100 0 111122334444
Q ss_pred HHHHHhhh------cCceeEEEEEe-------cCCHHHHHHHHHHhcCCCEEEeecCCC
Q 035604 88 PFRCFCTR------KEIKCKEIVLE-------DTDIAKALIDYVSSHTIETLVLGAASR 133 (768)
Q Consensus 88 ~~~~~~~~------~gv~~~~~~v~-------~G~~a~~Iv~~a~~~~aDlIVmGs~g~ 133 (768)
.+.+.+.+ .|++++..++. .|+|+++|+++|+++++||||||-.=.
T Consensus 66 ~~~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~~~ 124 (357)
T PRK12652 66 RVEVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPEYN 124 (357)
T ss_pred HHHHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCCCC
Confidence 44444433 58886665554 289999999999999999999998644
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-12 Score=133.91 Aligned_cols=198 Identities=24% Similarity=0.297 Sum_probs=138.4
Q ss_pred HhhcCCCceeeeeccccCCc-------eeEEEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 035604 512 LCNIRHPNMVLLLGACPEFG-------CLIYEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583 (768)
Q Consensus 512 l~~l~HpnIv~l~g~~~~~~-------~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 583 (768)
|-.+-|-|||+++.+|.+.. .++.|||..|+|..+|.+- .....+......+|+.||+.||.|||+.. +||
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence 44557899999998885432 5789999999999999763 33445778888899999999999999987 689
Q ss_pred eeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh
Q 035604 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663 (768)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt 663 (768)
+|+++...-|++..+|.+||+-- ....+..+... ....-.....+-++|.+||+-.....+..+|||+||+..++|..
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~-~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNS-TREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccCCcchhheeecCCceEEeccc-Cccccchhhhh-hhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999998532 11111111110 01111123356788999998777778889999999999999988
Q ss_pred CCCCC-CChH--HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 664 AKPPM-GLAH--QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 664 g~~Pf-~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
+..-- .... .++..+.+-.+ ..-++. =..++.+|++-.|..||++.+++
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~-~len~l-----------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVII-GLENGL-----------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred heeccCCCcceeehhhhhhhhee-eccCcc-----------ccCcCcccccCCCCCCcchhhhh
Confidence 87642 2111 11111211110 000111 23478899999999999999876
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-11 Score=141.42 Aligned_cols=142 Identities=19% Similarity=0.232 Sum_probs=93.0
Q ss_pred hcCCCccceecccCceeEEEEEE-C-CccEEEEEEcCCchhh----------------------------------HH--
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-D-HTPVAIKVLRPDAAQG----------------------------------RS-- 503 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~-~~~vAvK~l~~~~~~~----------------------------------~~-- 503 (768)
...|+. +.||.|++|.||+|++ + |+.||||++++..... ..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 7899999999999998 4 7899999998652110 11
Q ss_pred ----HHHHHHHHHhhcC----CCceeeeeccc---cCCceeEEEeccCCChHHHH--hhcCC-CCCCCHHHHHHHHHHHH
Q 035604 504 ----QFQQEVEVLCNIR----HPNMVLLLGAC---PEFGCLIYEYMANGSLEDRL--FRRGG-SPVLPWQIRFRIAAEIA 569 (768)
Q Consensus 504 ----~~~~E~~il~~l~----HpnIv~l~g~~---~~~~~lV~E~~~~gsL~~~l--~~~~~-~~~l~~~~~~~i~~qi~ 569 (768)
+|.+|+..+.+++ +.+.|.+-.++ ....+|||||++|+.+.+.- ...+. ...+.......++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~--- 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT--- 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH---
Confidence 1334444444442 33333333333 34558999999999998743 22221 00122222222333
Q ss_pred HHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----cEEEeecccccccCC
Q 035604 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNY----VSKISDVGLARLVPP 614 (768)
Q Consensus 570 ~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~vKL~DFGla~~~~~ 614 (768)
.++..| ++|+|+||.||+++.+| .++++|||++..++.
T Consensus 275 ----Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 ----QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 344567 99999999999999888 999999999987754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.3e-12 Score=146.39 Aligned_cols=248 Identities=21% Similarity=0.248 Sum_probs=177.8
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhh---HHHHHHHHHHHhhcCCCceeeeecc--ccCCceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVLLLGA--CPEFGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g~--~~~~~~lV 534 (768)
.+.|.+.+.+-.|.++.++.+.-. +...++|+........ ......+-.++-..+||-++..... |....+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 466788889999999999966542 2334555543322211 1223344444444567888876655 56667999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
++|+.+++|...|..-+ ..+....+.++..+..+++|||... ++|||++|.|+|+..+|+.+++|||+...+..
T Consensus 883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999988876654 3666666778889999999999998 99999999999999999999999995543321
Q ss_pred C---CC-----C--------------cc---ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 035604 615 S---VA-----D--------------SV---TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMG 669 (768)
Q Consensus 615 ~---~~-----~--------------~~---~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~ 669 (768)
- .. . .. ...+.....||+.|.+||.+.+...+...|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 0 00 0022356789999999999999999999999999999999999999996
Q ss_pred ChHH--HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChh
Q 035604 670 LAHQ--VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 670 ~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~ 721 (768)
.... +.+.+-++. ...+..+...+....+++...+..+|.+|-.+.
T Consensus 1037 a~tpq~~f~ni~~~~------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRD------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CcchhhhhhccccCC------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 4433 222222222 222344555666789999999999999998876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-11 Score=138.45 Aligned_cols=247 Identities=22% Similarity=0.263 Sum_probs=173.8
Q ss_pred cCCCccceecc--cCceeEEEEEE----CCccEEEEEEcC--CchhhHHHHHHHHHHHhhcC-CCceeeeeccccCCc--
Q 035604 463 ENFSNSRKIGE--GGYGPVYKSYL----DHTPVAIKVLRP--DAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPEFG-- 531 (768)
Q Consensus 463 ~~y~~~~~LG~--G~fG~Vy~~~~----~~~~vAvK~l~~--~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~-- 531 (768)
..|-+.+.+|. |.+|.||.+.. .+..+|+|.-+. ........=.+|+...++++ |+|.|+.+..+....
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666778999 99999997765 456788887332 22222222345666666664 999999888875544
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeec
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIAT----ALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDV 606 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DF 606 (768)
++-+|++ +.+|..+...... .++....+.+..+... ||.++|..+ ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 6667887 5777776655433 4777778888888888 999999999 9999999999999988 88899999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh-HHHHHHHHcCCccc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA-HQVERSIENGTFDE 685 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~-~~~~~~i~~~~~~~ 685 (768)
|+...+............ ....|...|++||... +.++...|+|++|.++.+..++..++... ...+..+..+.+..
T Consensus 268 ~~v~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVS-KRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred ceeEEccCCccccceeee-ecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 999988654432222222 3346777899999665 45688999999999999999987665322 11112222221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
++...-+..+..++.++++.+|..|++...+.
T Consensus 346 -------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 346 -------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 12222234566799999999999999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.9e-11 Score=133.02 Aligned_cols=239 Identities=26% Similarity=0.263 Sum_probs=170.7
Q ss_pred HhcCCCccceecccCceeEEEEEE---CCccEEEEEEcCCchhhHHHH--HHHHHHHhhc-CCCceeeeeccc--cCCce
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL---DHTPVAIKVLRPDAAQGRSQF--QQEVEVLCNI-RHPNMVLLLGAC--PEFGC 532 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~---~~~~vAvK~l~~~~~~~~~~~--~~E~~il~~l-~HpnIv~l~g~~--~~~~~ 532 (768)
.+.+|..+..||.|.|+.|+.... ++..|++|.+.........++ ..|+-+...+ -|.+++.++..| .+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456789999999999999997654 467899998865543333332 3566666665 488888887666 33457
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeecccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARL 611 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DFGla~~ 611 (768)
+=-|||+++++...+.... .+.+..++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||+...
T Consensus 343 ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 8889999998887764332 3777888999999999999999999 9999999999999775 7889999999864
Q ss_pred cCCCCCCccccccccCCCCCCCCC--CcccccCCCCCccccHHHHHHHHHHHHhCCCCC-CChHHHHHHHHcCCccccCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYI--DPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM-GLAHQVERSIENGTFDETLD 688 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf-~~~~~~~~~i~~~~~~~~ld 688 (768)
+.-. .....+.-+|. +|.......+..+.|+||||.-+.+.+++.+-- ..... ..+..+
T Consensus 417 ~~~~---------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~--~~i~~~------- 478 (524)
T KOG0601|consen 417 LAFS---------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS--LTIRSG------- 478 (524)
T ss_pred ccee---------cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc--eeeecc-------
Confidence 3211 11222333344 555666677899999999999999999987532 21111 111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.++..+..- ..+..+...+...++..||.+.+...
T Consensus 479 -~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 479 -DTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred -cccCCCchH-HhhhhhhhhhcCCccccchhhhhhcc
Confidence 112222222 56888899999999999999887653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.6e-10 Score=111.97 Aligned_cols=135 Identities=17% Similarity=0.139 Sum_probs=95.9
Q ss_pred ceecccCceeEEEEEEC--------CccEEEEEEcCCch----------------------hhHHHHH----HHHHHHhh
Q 035604 469 RKIGEGGYGPVYKSYLD--------HTPVAIKVLRPDAA----------------------QGRSQFQ----QEVEVLCN 514 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~--------~~~vAvK~l~~~~~----------------------~~~~~~~----~E~~il~~ 514 (768)
..||.|-=+.||.|... +..+|||+.+.... ..+..+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999763 36899998753210 0122233 89999998
Q ss_pred cCC--CceeeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCC
Q 035604 515 IRH--PNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL-HQTKPEPLVHRDLKPG 591 (768)
Q Consensus 515 l~H--pnIv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiHrDLKp~ 591 (768)
+.. -++-..+++ ...+|||||+.++.+..-..+.. .++......+..+++.+|..| |..+ |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 853 334444443 56799999997654432222211 245556677889999999998 8888 999999999
Q ss_pred CeEEcCCCcEEEeeccccccc
Q 035604 592 NILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 592 NILl~~~~~vKL~DFGla~~~ 612 (768)
|||++ ++.+.|+|||.+-..
T Consensus 155 NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE-CCcEEEEECCCceeC
Confidence 99996 467999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.7e-10 Score=113.85 Aligned_cols=139 Identities=26% Similarity=0.341 Sum_probs=106.4
Q ss_pred ceecccCceeEEEEEECC-ccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCC--ceeeeeccccC-----CceeEEEecc
Q 035604 469 RKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHP--NMVLLLGACPE-----FGCLIYEYMA 539 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~Hp--nIv~l~g~~~~-----~~~lV~E~~~ 539 (768)
+.||.|.++.||++...+ ..+++|+...... .....+.+|++++..+.+. ++.+++.++.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998865 8999999865432 1345688999999998753 34566666644 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK---------------------------------------- 579 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------- 579 (768)
|.++.+.+.. ..++......++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765432 13667777788888888888888531
Q ss_pred -------------CCCeeeCCCCCCCeEEcC--CCcEEEeecccccc
Q 035604 580 -------------PEPLVHRDLKPGNILLDR--NYVSKISDVGLARL 611 (768)
Q Consensus 580 -------------~~~iiHrDLKp~NILl~~--~~~vKL~DFGla~~ 611 (768)
+..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235899999999999988 67789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=105.74 Aligned_cols=129 Identities=24% Similarity=0.363 Sum_probs=100.1
Q ss_pred ceecccCceeEEEEEECCccEEEEEEcCCc--------hhhHHHHHHHHHHHhhcCC--CceeeeeccccCCceeEEEec
Q 035604 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDA--------AQGRSQFQQEVEVLCNIRH--PNMVLLLGACPEFGCLIYEYM 538 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--------~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~lV~E~~ 538 (768)
.++++|+=+.+|.+.+.+..+++|.=.+.. ........+|..++.+++- -+.-.+|.+.++...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 358899999999998887778887643221 1123346789999998853 334456666777889999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
+|-.|.+.+... ...++..+-.-+.-||..| |||+||.++||++..++ +.++||||+..
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888654 2456778888888999999 99999999999997655 89999999863
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-09 Score=122.33 Aligned_cols=162 Identities=23% Similarity=0.240 Sum_probs=120.5
Q ss_pred CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccCCc--eeEEEeccCCChHHHHhhcCCCCCCCHHHHH
Q 035604 485 DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRF 562 (768)
Q Consensus 485 ~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 562 (768)
++.+|.|...+...........+-++-|+.++||||++++..+.... |||+|.+ .-|..++... ......
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l------~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL------GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh------HHHHHH
Confidence 56688888876554433456778899999999999999999986655 9999998 3566667653 355566
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC
Q 035604 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT 642 (768)
Q Consensus 563 ~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 642 (768)
-.+.||+.||.|||..+ .++|++|.-+-|+|+..|..||++|-++........ ......--..|..|+.+..
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChhhcCc
Confidence 67899999999998554 399999999999999999999999999865432111 0111122234666765433
Q ss_pred CCCCccccHHHHHHHHHHHHhC
Q 035604 643 GMLGVKSDVYSLGILLLQIITA 664 (768)
Q Consensus 643 ~~~s~ksDvwSlGvil~elltg 664 (768)
.. ...|.|-|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 457999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.8e-09 Score=102.49 Aligned_cols=141 Identities=20% Similarity=0.211 Sum_probs=104.8
Q ss_pred ccceecccCceeEEEEEECCccEEEEEEcCC--------chhhHHHHHHHHHHHhhcCCCcee--eeeccccCCceeEEE
Q 035604 467 NSRKIGEGGYGPVYKSYLDHTPVAIKVLRPD--------AAQGRSQFQQEVEVLCNIRHPNMV--LLLGACPEFGCLIYE 536 (768)
Q Consensus 467 ~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--------~~~~~~~~~~E~~il~~l~HpnIv--~l~g~~~~~~~lV~E 536 (768)
...+|-+|+=+.|+++.+.|..+.||.-... ....+....+|..+|.+++--.|. .++-+-....+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 5678899999999999999999888863211 223455678899999988643332 222222445699999
Q ss_pred eccC-CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC---cEEEeecccccc
Q 035604 537 YMAN-GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY---VSKISDVGLARL 611 (768)
Q Consensus 537 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~vKL~DFGla~~ 611 (768)
|++| .++.+++......... ......++..|-..|.-||..+ |||+||..+||+|..++ .+.|+||||+..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 4788888776554322 3333678999999999999999 99999999999996543 458999999853
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.1e-08 Score=125.33 Aligned_cols=126 Identities=13% Similarity=0.243 Sum_probs=99.5
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++|||+|++++.|.+++++|.++|.+.++++++|||..+...... . +. ...+...
T Consensus 250 ~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~~~~--------------------~---~~-~~~l~~~ 305 (895)
T PRK10490 250 RDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRLHRLP--------------------E---KK-RRAILSA 305 (895)
T ss_pred CCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCcCcCC--------------------H---HH-HHHHHHH
Confidence 5789999999999999999999999999999999999854211000 0 11 1222233
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
...|++.|.++ +.+.++|++++|++||++++++.||||.++++++ |+.||+++.+++.++ ..+|+||+..
T Consensus 306 ~~lA~~lGa~~--~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~---~~~~s~~~~l~r~~~-~idi~iv~~~ 375 (895)
T PRK10490 306 LRLAQELGAET--ATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRW---WRRESFADRLARLGP-DLDLVIVALD 375 (895)
T ss_pred HHHHHHcCCEE--EEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCC---ccCCCHHHHHHHhCC-CCCEEEEeCC
Confidence 34677788873 3567789999999999999999999999999765 556799999999998 5999999643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=9.3e-08 Score=104.78 Aligned_cols=209 Identities=19% Similarity=0.243 Sum_probs=143.8
Q ss_pred eeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC------CceeEEEeccC-CChHHHH
Q 035604 477 GPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------FGCLIYEYMAN-GSLEDRL 547 (768)
Q Consensus 477 G~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~lV~E~~~~-gsL~~~l 547 (768)
.+.|+++. +|..|++|+++-+..+.......-++.++++.|+|||.+..+|.. ..++||+|.++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57888886 788999999965443433334567889999999999999888742 23899999986 5677765
Q ss_pred hhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 548 FRRG------------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 548 ~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
+... .....++...|.++.|+..||.++|+.| +.-+=|.|.+||++.+-.++|+.+|+...+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 1234678999999999999999999999 999999999999999999999999887665332
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
. . +.+. --.+-|.-.||.+++-|.||..--...+..... . .....
T Consensus 447 ~------------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s-~-----------~~~I~ 491 (655)
T KOG3741|consen 447 P------------------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSS-H-----------LTRIT 491 (655)
T ss_pred C------------------C--cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHH-H-----------HHHhh
Confidence 1 0 1111 123679999999999999996431111110000 0 00111
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
..++.++.+++......++++ -++.+++
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 233345667777777777766 4555544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1e-07 Score=100.33 Aligned_cols=139 Identities=17% Similarity=0.055 Sum_probs=98.9
Q ss_pred ceecccCceeEEEEEECCccEEEEEEcCCchh-----------hHHHHHHHHHHHhhcC-----CCceeeeecc--c--c
Q 035604 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQ-----------GRSQFQQEVEVLCNIR-----HPNMVLLLGA--C--P 528 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~-----------~~~~~~~E~~il~~l~-----HpnIv~l~g~--~--~ 528 (768)
+.+-......|++..+.|+.|.||........ ....+.+|...+.+|. -|.+|-+... . .
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 34444445557788889999999977543211 0113678888888774 3444433211 1 1
Q ss_pred CCceeEEEeccCC-ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-------CCc
Q 035604 529 EFGCLIYEYMANG-SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-------NYV 600 (768)
Q Consensus 529 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-------~~~ 600 (768)
...+||||++++. +|.+++..... ...+...+..++.+++..+.-||..| |+|+||+++|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 2358999999876 78888754221 23556677789999999999999999 999999999999975 468
Q ss_pred EEEeecccccc
Q 035604 601 SKISDVGLARL 611 (768)
Q Consensus 601 vKL~DFGla~~ 611 (768)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.6e-08 Score=98.03 Aligned_cols=124 Identities=25% Similarity=0.255 Sum_probs=79.8
Q ss_pred eEEEEEE-CCccEEEEEEcCCch--------------------------hhHHHHHHHHHHHhhcCCC--ceeeeecccc
Q 035604 478 PVYKSYL-DHTPVAIKVLRPDAA--------------------------QGRSQFQQEVEVLCNIRHP--NMVLLLGACP 528 (768)
Q Consensus 478 ~Vy~~~~-~~~~vAvK~l~~~~~--------------------------~~~~~~~~E~~il~~l~Hp--nIv~l~g~~~ 528 (768)
.||.|.. ++..+|||+.+.... .......+|.+.|.++..- ++-+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3898887 678999999764210 0122357899999999755 34445433
Q ss_pred CCceeEEEecc--CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeCCCCCCCeEEcCCCcEEEee
Q 035604 529 EFGCLIYEYMA--NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF-LHQTKPEPLVHRDLKPGNILLDRNYVSKISD 605 (768)
Q Consensus 529 ~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~~iiHrDLKp~NILl~~~~~vKL~D 605 (768)
...+|||||++ |..+.. |.... ++......++.+++..+.. +|..| |||+||.+.|||++.+ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~-l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPR-LKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGC-HHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhh-HHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 35689999998 544543 32221 2234456677888886555 57888 9999999999999877 899999
Q ss_pred ccccccc
Q 035604 606 VGLARLV 612 (768)
Q Consensus 606 FGla~~~ 612 (768)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.3e-06 Score=93.73 Aligned_cols=245 Identities=19% Similarity=0.242 Sum_probs=159.7
Q ss_pred CccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceee--------eeccccCC-ceeEE
Q 035604 466 SNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVL--------LLGACPEF-GCLIY 535 (768)
Q Consensus 466 ~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~--------l~g~~~~~-~~lV~ 535 (768)
...+.||+|+-+.+|-.-.- ...+.|++.........+ -+..|... .||-+-. |+|--... ..++|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh-hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45678999999999943211 234567776543322222 22333333 4654322 22222112 35677
Q ss_pred EeccCCC-hHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 536 EYMANGS-LEDRLF---RRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 536 E~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
..+.+.. +.+++. ++...+...|.-.++.+..++.++..||..| .+-+|+.++|||+..++.+.|.|=..-.+
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7776542 222222 2334466889999999999999999999999 99999999999999999999988544332
Q ss_pred cCCCCCCccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhC-CCCCCChH-------HHHHHH
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITA-KPPMGLAH-------QVERSI 678 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg-~~Pf~~~~-------~~~~~i 678 (768)
.. ........+|...|.+||... +-.-+...|-|.||+++++||.| +.||.+.. ..+..|
T Consensus 167 ~~-------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 167 NA-------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cc-------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 21 112234568999999999655 33457789999999999999987 99996332 334456
Q ss_pred HcCCccccCC------CCCCCCCHH-HHHHHHHHHHHhhhc--CccCCCChhhhh
Q 035604 679 ENGTFDETLD------PAVPDWPVE-EALILAKLALQCAEL--RRKDRPDLGKVV 724 (768)
Q Consensus 679 ~~~~~~~~ld------~~~~~~~~~-~~~~l~~Li~~cl~~--~P~~RPs~~evl 724 (768)
..|.|...-+ +....||.. ....+..|..+|+.. ++.-||+.+.=+
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 6665544333 222245543 345688899999986 467899998443
|
|
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.3e-07 Score=106.76 Aligned_cols=131 Identities=18% Similarity=0.220 Sum_probs=104.8
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
..+|||+|++|+.|.+.+++|.++|.+.+++.++|||..+..... .+.....+...
T Consensus 248 ~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~~~av~v~~~~~~~~------------------------~~~~~~~l~~~ 303 (890)
T COG2205 248 RERILVCISGSPGSEKLIRRAARLASRLHAKWTAVYVETPELHRL------------------------SEKEARRLHEN 303 (890)
T ss_pred cceEEEEECCCCchHHHHHHHHHHHHHhCCCeEEEEEeccccccc------------------------cHHHHHHHHHH
Confidence 478999999999999999999999999999999999986532111 11233445566
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCCcee
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKIS 168 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~~~~ 168 (768)
...+.+.|.+ .+.+.+++++++|++||+.+++..||||.+.++.+. +++.||.+.++++.++ ..+|.+|..+...
T Consensus 304 ~~Lae~lGae--~~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~-~~~~~~l~~~L~~~~~-~idv~ii~~~~~~ 378 (890)
T COG2205 304 LRLAEELGAE--IVTLYGGDVAKAIARYAREHNATKIVIGRSRRSRWR-RLFKGSLADRLAREAP-GIDVHIVALDAPP 378 (890)
T ss_pred HHHHHHhCCe--EEEEeCCcHHHHHHHHHHHcCCeeEEeCCCcchHHH-HHhcccHHHHHHhcCC-CceEEEeeCCCCc
Confidence 6667777776 345677999999999999999999999999995555 4555699999999998 5899999875544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.4e-07 Score=102.01 Aligned_cols=138 Identities=21% Similarity=0.284 Sum_probs=92.3
Q ss_pred ceecccCceeEEEEEEC-CccEEEEEEcCCchhh----------------------------------------HHHHHH
Q 035604 469 RKIGEGGYGPVYKSYLD-HTPVAIKVLRPDAAQG----------------------------------------RSQFQQ 507 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~----------------------------------------~~~~~~ 507 (768)
..|+.++-|.||+|++. |+.||||+.+++-... .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999995 8999999998753211 001344
Q ss_pred HHHHHhhcC-----CCce--eeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 035604 508 EVEVLCNIR-----HPNM--VLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA-LLFLHQTK 579 (768)
Q Consensus 508 E~~il~~l~-----HpnI--v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~a-L~~LH~~~ 579 (768)
|..-+.+++ .|+| -++|.-+.....|+|||++|-.+.+....... .++... ++..++.+ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhcC
Confidence 555555542 3333 23333334556899999999988887533222 144333 33333332 22233355
Q ss_pred CCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 580 ~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
++|.|.+|.||+++.+|.+.+.|||+...++.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.9e-07 Score=91.82 Aligned_cols=105 Identities=27% Similarity=0.268 Sum_probs=79.5
Q ss_pred HHHHHHHHHHHhhcC-----CCceeeeeccc---cCCceeEEEeccCC-ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 035604 502 RSQFQQEVEVLCNIR-----HPNMVLLLGAC---PEFGCLIYEYMANG-SLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572 (768)
Q Consensus 502 ~~~~~~E~~il~~l~-----HpnIv~l~g~~---~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL 572 (768)
.....+|...+..|. -|..|-+...- ....+||+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 345678888877774 34444332110 12338999999875 78888876332 55667788999999999
Q ss_pred HHHHhCCCCCeeeCCCCCCCeEEcCCC---cEEEeeccccccc
Q 035604 573 LFLHQTKPEPLVHRDLKPGNILLDRNY---VSKISDVGLARLV 612 (768)
Q Consensus 573 ~~LH~~~~~~iiHrDLKp~NILl~~~~---~vKL~DFGla~~~ 612 (768)
.-||..| |+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999998877 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.2e-06 Score=84.89 Aligned_cols=137 Identities=17% Similarity=0.128 Sum_probs=102.5
Q ss_pred ecccCceeEEEEEECCccEEEEEEcCC------chhhHHHHHHHHHHHhhcCCCc--eeeee--ccccC----CceeEEE
Q 035604 471 IGEGGYGPVYKSYLDHTPVAIKVLRPD------AAQGRSQFQQEVEVLCNIRHPN--MVLLL--GACPE----FGCLIYE 536 (768)
Q Consensus 471 LG~G~fG~Vy~~~~~~~~vAvK~l~~~------~~~~~~~~~~E~~il~~l~Hpn--Iv~l~--g~~~~----~~~lV~E 536 (768)
-|+||.+-|++-.+.|..+-+|.-... ...+...|.+|+..|..|..-+ +.... +.-.. ..+||+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 578999999999988888889976411 1335667999999999985322 22332 11111 2379999
Q ss_pred eccC-CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc--EEEeecccccc
Q 035604 537 YMAN-GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV--SKISDVGLARL 611 (768)
Q Consensus 537 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--vKL~DFGla~~ 611 (768)
-+.| -+|.+++....- ...+...+..++.+|+..|.-||+.| +.|+|+-+.|||++.++. ++++||--++.
T Consensus 106 ~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7754 578887755322 24677778899999999999999999 999999999999986666 99999987764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.9e-06 Score=86.83 Aligned_cols=135 Identities=21% Similarity=0.201 Sum_probs=92.1
Q ss_pred HhcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHH---------HHHHHHHhhcCCC---ceeeeecc--
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQF---------QQEVEVLCNIRHP---NMVLLLGA-- 526 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~---------~~E~~il~~l~Hp---nIv~l~g~-- 526 (768)
..++|...+.+-......|.+-..++..+.+|..+.........| .+.+..+..++.. ....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 346788888888888888888888999999999876543322222 2333333333221 11121111
Q ss_pred -----ccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 527 -----CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 527 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
+....+|+|||++|-.|.+... +++ .+...+..+|..||..| ++|+|++|+|+++..++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 1233468999999988866432 222 24556778899999999 99999999999998655 8
Q ss_pred EEeeccccc
Q 035604 602 KISDVGLAR 610 (768)
Q Consensus 602 KL~DFGla~ 610 (768)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.2e-07 Score=107.53 Aligned_cols=153 Identities=20% Similarity=0.270 Sum_probs=103.8
Q ss_pred HHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCcccccc---ccCCCCCCCCCCcccccC
Q 035604 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYR---MTSAAGTFCYIDPEYQQT 642 (768)
Q Consensus 566 ~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~ 642 (768)
.+++.||.|+|..- .+||++|.|++|.++.++..||+.|+++........-....+. .........|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999864 4999999999999999999999999998765442221111111 112234578999999999
Q ss_pred CCCCccccHHHHHHHHHHHH-hCCCCCCChH-HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCCh
Q 035604 643 GMLGVKSDVYSLGILLLQII-TAKPPMGLAH-QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 643 ~~~s~ksDvwSlGvil~ell-tg~~Pf~~~~-~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
...+.++|+|||||++|.+. .|++-|.... .....+..+. .+.....++...+.++.+=+.+++..++.-||++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~----~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL----LNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc----cccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 88899999999999999999 5665553221 1111111111 0111111223344568888899999999999977
Q ss_pred hhhh
Q 035604 721 GKVV 724 (768)
Q Consensus 721 ~evl 724 (768)
..+.
T Consensus 260 ~~l~ 263 (700)
T KOG2137|consen 260 DLLL 263 (700)
T ss_pred hhhh
Confidence 7654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.4e-06 Score=87.66 Aligned_cols=134 Identities=21% Similarity=0.133 Sum_probs=92.0
Q ss_pred CCCccceecccCceeEEEEEE-CCccEEEEEEcCCch----------------------hhHHHHHHHHHHHhhcCCC--
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA----------------------QGRSQFQQEVEVLCNIRHP-- 518 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~----------------------~~~~~~~~E~~il~~l~Hp-- 518 (768)
-+.++.+||-|-=+.||.|.. .+.++|||.-+.... ..+...++|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356778999999999999998 588999997542110 1133357899999988643
Q ss_pred ceeeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 035604 519 NMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN 598 (768)
Q Consensus 519 nIv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 598 (768)
.+-+.+++ +..++||||++|-.|...-. .....-.++..|+.-+.-+-..| |||+|+.+-|||++.+
T Consensus 172 ~VP~P~~~--nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIAW--NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCcccc--ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 34443332 34489999998866644221 12222233444444444444677 9999999999999999
Q ss_pred CcEEEeeccccc
Q 035604 599 YVSKISDVGLAR 610 (768)
Q Consensus 599 ~~vKL~DFGla~ 610 (768)
|.+.++||--+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 999999997664
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.2e-06 Score=94.37 Aligned_cols=138 Identities=20% Similarity=0.211 Sum_probs=91.6
Q ss_pred ceecccCceeEEEEEE-CCccEEEEEEcCCchhh-------------------------------------HHHHHHHHH
Q 035604 469 RKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQG-------------------------------------RSQFQQEVE 510 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~-------------------------------------~~~~~~E~~ 510 (768)
+.||.-+.|.||++++ +|..||||+-++.-... .-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999998 67789999987642111 012444544
Q ss_pred HHhh----cCCCc------eeeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCC
Q 035604 511 VLCN----IRHPN------MVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL-FLHQTK 579 (768)
Q Consensus 511 il~~----l~Hpn------Iv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~ 579 (768)
-..+ +.|-+ |-++|-.+.....|+||||+|..+.|...-... .++...+. ..+.++.. -|-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~---~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDIL---NKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHH---HHHHHHHHHHHHhcC
Confidence 4333 34555 445555556667999999999877765432222 15555433 33333322 233345
Q ss_pred CCCeeeCCCCCCCeEEc----CCCcEEEeecccccccCC
Q 035604 580 PEPLVHRDLKPGNILLD----RNYVSKISDVGLARLVPP 614 (768)
Q Consensus 580 ~~~iiHrDLKp~NILl~----~~~~vKL~DFGla~~~~~ 614 (768)
++|+|-+|.||++. .++.+.+.|||+...+..
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999997 367899999999986643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.9e-06 Score=84.13 Aligned_cols=141 Identities=26% Similarity=0.296 Sum_probs=83.3
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCC--ceeeeeccc-----cCCceeEEEeccC
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHP--NMVLLLGAC-----PEFGCLIYEYMAN 540 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~g~~-----~~~~~lV~E~~~~ 540 (768)
++.|+.|..+.||+....+..+++|+.... .....+.+|..++..+... .+.+++..+ ....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 357899999999999998889999998654 3455678899988887532 234444422 1224789999999
Q ss_pred CChHH----------------HHhh---c-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh-
Q 035604 541 GSLED----------------RLFR---R-GGSPVLPWQIR---------FRI------------AAEIAT-ALLFLHQ- 577 (768)
Q Consensus 541 gsL~~----------------~l~~---~-~~~~~l~~~~~---------~~i------------~~qi~~-aL~~LH~- 577 (768)
..+.. .+.. . .....+..... ... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 1111 1 01111111110 000 112222 3333432
Q ss_pred ---CCCCCeeeCCCCCCCeEEc-CCCcEEEeeccccc
Q 035604 578 ---TKPEPLVHRDLKPGNILLD-RNYVSKISDVGLAR 610 (768)
Q Consensus 578 ---~~~~~iiHrDLKp~NILl~-~~~~vKL~DFGla~ 610 (768)
..+..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 66766899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.4e-05 Score=82.42 Aligned_cols=137 Identities=17% Similarity=0.235 Sum_probs=78.7
Q ss_pred ceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce--eeeeccc--cCCceeEEEeccCCC-h
Q 035604 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM--VLLLGAC--PEFGCLIYEYMANGS-L 543 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI--v~l~g~~--~~~~~lV~E~~~~gs-L 543 (768)
.+||.|..+.||+. .+..+++|...... ....+.+|.+++..+..-.+ .+.++++ .....+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56999999999984 35568889886533 23456889999988753222 3334443 333478999998863 1
Q ss_pred HHH--------------Hhh----cCCC--CCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeeeCCCCC
Q 035604 544 EDR--------------LFR----RGGS--PVLPWQIRF-RIAA----------EIAT-ALLFLHQT-KPEPLVHRDLKP 590 (768)
Q Consensus 544 ~~~--------------l~~----~~~~--~~l~~~~~~-~i~~----------qi~~-aL~~LH~~-~~~~iiHrDLKp 590 (768)
... +.. -... ......... .+.. .+.. ...+|... ....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 111 110 0000 001111100 0100 0111 12223222 123579999999
Q ss_pred CCeEEcCCCcEEEeeccccc
Q 035604 591 GNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 591 ~NILl~~~~~vKL~DFGla~ 610 (768)
.||+++.++ +.|+||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.7e-05 Score=80.89 Aligned_cols=153 Identities=20% Similarity=0.214 Sum_probs=96.7
Q ss_pred cccCCHHHHHHHhcCCCccceecc---cCceeEEEEEE-CCccEEEEEEcCCchhhHH-------------------H--
Q 035604 450 YRKYSIEEIEEATENFSNSRKIGE---GGYGPVYKSYL-DHTPVAIKVLRPDAAQGRS-------------------Q-- 504 (768)
Q Consensus 450 ~~~~~~~ei~~~~~~y~~~~~LG~---G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~-------------------~-- 504 (768)
+...+.+.+....++..+....|. |--+.||+|.. ++..+|+|+++........ +
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 344556666666777776666665 44558999886 5789999998754322111 1
Q ss_pred ---HHHHHHHHhhcCCC--ceeeeeccccCCceeEEEeccCCC-hHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 035604 505 ---FQQEVEVLCNIRHP--NMVLLLGACPEFGCLIYEYMANGS-LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ- 577 (768)
Q Consensus 505 ---~~~E~~il~~l~Hp--nIv~l~g~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~- 577 (768)
..+|..-|+++..- .+-+-+++ ..+.|||||+.... -.-.|.. ..+...+...+..+++..+.-|-.
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~--~~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAF--RNNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceee--cCCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHh
Confidence 23455555555321 12222222 23479999994331 1111111 113333566778888888887766
Q ss_pred CCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 578 ~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
.+ +||+||..=|||+. ++.+.|+|||-|...
T Consensus 186 a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 186 AG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 66 99999999999998 889999999988644
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.2e-05 Score=75.72 Aligned_cols=105 Identities=22% Similarity=0.236 Sum_probs=83.7
Q ss_pred HHHHHHHhhcCC-CceeeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 035604 506 QQEVEVLCNIRH-PNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584 (768)
Q Consensus 506 ~~E~~il~~l~H-pnIv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ii 584 (768)
..|.-+|+.+.+ +++.+++|+|.+ ++|.||...+++...-..-......+|..+.+|+.+++..+.+|+......+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 468888888876 699999999954 77999998776643200000111368999999999999999999987666699
Q ss_pred eCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 585 HRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
-.|++|+||-++.+|.+|++|...+...
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchh
Confidence 9999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.6e-05 Score=79.32 Aligned_cols=137 Identities=16% Similarity=0.113 Sum_probs=81.2
Q ss_pred ecccCc-eeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccccC--CceeEEEeccCCChHHH
Q 035604 471 IGEGGY-GPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLIYEYMANGSLEDR 546 (768)
Q Consensus 471 LG~G~f-G~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~~ 546 (768)
|-.|.+ ..||+....+..+.+|+..... ...+.+|+++++.+. +--+.++++++.. ..++||++++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 455555 7899988777788889876443 235678898888874 3234455555543 46899999998776643
Q ss_pred H----------------hhcCC----CCCCCHH--HHHHHHH--------------------HHHHHHHHHHhC----CC
Q 035604 547 L----------------FRRGG----SPVLPWQ--IRFRIAA--------------------EIATALLFLHQT----KP 580 (768)
Q Consensus 547 l----------------~~~~~----~~~l~~~--~~~~i~~--------------------qi~~aL~~LH~~----~~ 580 (768)
. .+-.. ...+... ....... .+...+..|-.. .+
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 1 01000 0011100 0000000 011112222111 12
Q ss_pred CCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 581 EPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 581 ~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 459999999999999998888999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.7e-05 Score=73.59 Aligned_cols=128 Identities=18% Similarity=0.174 Sum_probs=90.4
Q ss_pred ccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCcee-eeeccccCCceeEEEeccCCChHH
Q 035604 467 NSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV-LLLGACPEFGCLIYEYMANGSLED 545 (768)
Q Consensus 467 ~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~g~~~~~~~lV~E~~~~gsL~~ 545 (768)
..+.||+|.+|.||+|.+.+..+|+|+-+.++. +..+..|.++|..+.--++- ++|.+- ..++.|||+.|-.|.+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg--~~~i~me~i~G~~L~~ 101 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG--EDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec--hhhhhhhhhcCcchhh
Confidence 356799999999999999999999999876653 45688999999988765553 233222 3356699999888877
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC-CCCeEEcCCCcEEEeecccccc
Q 035604 546 RLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLK-PGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 546 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLK-p~NILl~~~~~vKL~DFGla~~ 611 (768)
.-... +.+. ...++..=.-|...| |-|+.|. |..++|-.++.+.|+||..|+.
T Consensus 102 ~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 54321 1222 334444434466667 9999987 5555555555999999998873
|
|
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.9e-05 Score=68.05 Aligned_cols=84 Identities=23% Similarity=0.163 Sum_probs=69.2
Q ss_pred EEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHHHHH
Q 035604 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPFRCF 92 (768)
Q Consensus 13 IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 92 (768)
|||+++|...|..++.||.+.+ ..+..++++|+.
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~~~~~~~~~~~--------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SGGPEVVALVVV--------------------------------------------- 34 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hcCCCEEEEEeH---------------------------------------------
Confidence 6899999999999999999987 557788888873
Q ss_pred hhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccC-CCcccccccCCCceeEEE
Q 035604 93 CTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTA-DIPSNVSKGAPDYCNVYV 161 (768)
Q Consensus 93 ~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~g-SVa~~V~~~Ap~~C~Vlv 161 (768)
.....+.+++++.++|+||+|+++..... ..++| +++..+++.++ |||+.
T Consensus 35 ----------------~~~~~~~~~a~~~~~~~Iv~G~~~~d~~~-~~~~~~~~~~~~~~~~~--~~vl~ 85 (86)
T cd01984 35 ----------------AFVRILKRLAAEEGADVIILGHNADDVAG-RRLGASANVLVVIKGAG--IPVLT 85 (86)
T ss_pred ----------------HHHHHHHHHHHHcCCCEEEEcCCchhhhh-hccCchhhhhhcccccC--CceeC
Confidence 34556778888899999999999995555 45556 89999999998 88874
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.5e-05 Score=77.86 Aligned_cols=71 Identities=11% Similarity=0.224 Sum_probs=44.2
Q ss_pred ceecccCce-eEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCC---ceeeeeccccC-----CceeEEEecc
Q 035604 469 RKIGEGGYG-PVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHP---NMVLLLGACPE-----FGCLIYEYMA 539 (768)
Q Consensus 469 ~~LG~G~fG-~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~g~~~~-----~~~lV~E~~~ 539 (768)
+.|+.||.. .||+. +..+++|+..... ....+.+|.++|..+... .+-.+++.... ..+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 467877776 58875 3457788765422 344688999998877521 22233333321 2378999999
Q ss_pred CCChH
Q 035604 540 NGSLE 544 (768)
Q Consensus 540 ~gsL~ 544 (768)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 86663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=2.1e-06 Score=96.47 Aligned_cols=183 Identities=19% Similarity=0.146 Sum_probs=128.7
Q ss_pred CCccceecccCceeEEEEEECCc-cEEEEEEcCCchhhHHHHHHHHHHHhhcCCCc-eeeeeccc--cCCceeEEEeccC
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDHT-PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN-MVLLLGAC--PEFGCLIYEYMAN 540 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~~-~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~--~~~~~lV~E~~~~ 540 (768)
|.....+++|++++++|.+...+ ....+++... ....-++++|.+++||| .+..++.+ +++..++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 44455689999999998876433 3334544322 34556899999999999 66666666 3455789999977
Q ss_pred C-ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 541 G-SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 541 g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+ +-..... .....+...+...+...-+++|++||+.. =+|+| |||..+ +..|..||+....+....
T Consensus 319 ~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 319 GRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred CccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence 6 1111110 00011333344556677788999999874 58999 777755 678999999987664432
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMG 669 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~ 669 (768)
......+++.+++||+.....+....|+|++|.--.++--|-+|-.
T Consensus 386 ----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3356789999999999999999999999999987777777777653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0001 Score=90.30 Aligned_cols=146 Identities=19% Similarity=0.278 Sum_probs=90.3
Q ss_pred cceecccCceeEEEEEECC----ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcC-CCce--eeeeccccC-----CceeE
Q 035604 468 SRKIGEGGYGPVYKSYLDH----TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIR-HPNM--VLLLGACPE-----FGCLI 534 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnI--v~l~g~~~~-----~~~lV 534 (768)
...|+.|.+..+|+....+ ..+++|+..... ......+.+|+.+|+.+. |++| .+++.+|.+ ..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4678999999999877644 367888764432 123356889999999995 6655 677777754 35899
Q ss_pred EEeccCCChHH--------------------HHhhcCC-----------CCCCCH--HHHHHHH---------------H
Q 035604 535 YEYMANGSLED--------------------RLFRRGG-----------SPVLPW--QIRFRIA---------------A 566 (768)
Q Consensus 535 ~E~~~~gsL~~--------------------~l~~~~~-----------~~~l~~--~~~~~i~---------------~ 566 (768)
|||++|..+.+ .|..-.. .....+ .++..|. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1111000 000011 1111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeeeCCCCCCCeEEcC-C-CcEEEeecccccccC
Q 035604 567 EIATALLFLHQTKP--------EPLVHRDLKPGNILLDR-N-YVSKISDVGLARLVP 613 (768)
Q Consensus 567 qi~~aL~~LH~~~~--------~~iiHrDLKp~NILl~~-~-~~vKL~DFGla~~~~ 613 (768)
.+...+.||..+-| ..+||+|+++.|||++. + ..+-|.||+++..-+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 23344667755433 24999999999999975 2 345899999987543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.80 E-value=7.8e-05 Score=78.28 Aligned_cols=138 Identities=12% Similarity=0.040 Sum_probs=79.6
Q ss_pred ecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-eeeeccccCCceeEEEeccCCChHH----
Q 035604 471 IGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-VLLLGACPEFGCLIYEYMANGSLED---- 545 (768)
Q Consensus 471 LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~~~gsL~~---- 545 (768)
+..|-...+|+...++..+++|+.......-.-...+|..+++.+..-.+ .++++.+ ..++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EHWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CCEEEEEeccCccccccccc
Confidence 55677789999888888899998654322211135688888888853322 2333333 3579999998865431
Q ss_pred ----------HHhhcCCC----CCCCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCCeeeCCCCCCCeEEc
Q 035604 546 ----------RLFRRGGS----PVLPWQI-RFRIAAEI---------ATALLFLHQT-----KPEPLVHRDLKPGNILLD 596 (768)
Q Consensus 546 ----------~l~~~~~~----~~l~~~~-~~~i~~qi---------~~aL~~LH~~-----~~~~iiHrDLKp~NILl~ 596 (768)
.+.+-... ..++... ...+..++ ...+..+-.. .+..++|+|+.|.||+++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 11111111 1112111 11111111 1112222111 123589999999999999
Q ss_pred CCCcEEEeecccccc
Q 035604 597 RNYVSKISDVGLARL 611 (768)
Q Consensus 597 ~~~~vKL~DFGla~~ 611 (768)
.++ +.|+||..+..
T Consensus 162 ~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 162 PQG-LKLIDWEYASD 175 (256)
T ss_pred CCC-CEEEeccccCc
Confidence 877 78999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00023 Score=73.55 Aligned_cols=72 Identities=15% Similarity=0.206 Sum_probs=47.5
Q ss_pred ceecccCceeEEEEEEC---CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCc-eeeeeccccCCceeEEEeccCCCh
Q 035604 469 RKIGEGGYGPVYKSYLD---HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN-MVLLLGACPEFGCLIYEYMANGSL 543 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~lV~E~~~~gsL 543 (768)
+.|..|-...+|+.... +..|++|+....... .-...+|+.+++.+...+ ..++++.+. ..++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcC
Confidence 45777778899998765 468999987643221 123357888888885333 344444443 3589999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00056 Score=73.56 Aligned_cols=74 Identities=19% Similarity=0.135 Sum_probs=53.1
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCC---Cceeeeecccc-----CCceeEEEecc
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH---PNMVLLLGACP-----EFGCLIYEYMA 539 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~g~~~-----~~~~lV~E~~~ 539 (768)
.+.||.|..+.||+....+..+.+|..+... ....+..|...|+.|.- ..+.++++.|. ...+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 3469999999999987755577888854311 23468899999988742 34666776653 33599999999
Q ss_pred CCCh
Q 035604 540 NGSL 543 (768)
Q Consensus 540 ~gsL 543 (768)
|+++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0003 Score=75.44 Aligned_cols=140 Identities=17% Similarity=0.176 Sum_probs=84.6
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCc--eeeeeccc--------cCCceeEEEe
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN--MVLLLGAC--------PEFGCLIYEY 537 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~--------~~~~~lV~E~ 537 (768)
.+.|..|....+|+...++..+++|+... .....+..|+.++..+.+-+ +.+++... ....++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 45677787789999887777899998864 22345677888887774322 34443321 2234789999
Q ss_pred ccCCChHH-----------HH---hhcCC---C-----CCCCHHHHH----------HHHHHHHHHHHHHHh----CCCC
Q 035604 538 MANGSLED-----------RL---FRRGG---S-----PVLPWQIRF----------RIAAEIATALLFLHQ----TKPE 581 (768)
Q Consensus 538 ~~~gsL~~-----------~l---~~~~~---~-----~~l~~~~~~----------~i~~qi~~aL~~LH~----~~~~ 581 (768)
++|..+.. .| ..... . ....|.... .....+..++.++.. .-+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98865421 11 11000 0 011121110 011123344555543 1234
Q ss_pred CeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 582 PLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 582 ~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 59999999999999998878999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.002 Score=69.98 Aligned_cols=154 Identities=18% Similarity=0.224 Sum_probs=82.1
Q ss_pred CHHHHHHHhcCCCc-----cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhc-----CCCceeee
Q 035604 454 SIEEIEEATENFSN-----SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-----RHPNMVLL 523 (768)
Q Consensus 454 ~~~ei~~~~~~y~~-----~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l 523 (768)
+.+++......|.+ .+.|+.|....+|+...++..+++|+..... ...+..|+.++..| ..|.++.-
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 34444444444543 3456677778999988766689999886212 23344455555554 33443321
Q ss_pred -----eccccCCceeEEEeccCCChH-----------HHHhh---cCCC--------CCCCH-HHHHH------------
Q 035604 524 -----LGACPEFGCLIYEYMANGSLE-----------DRLFR---RGGS--------PVLPW-QIRFR------------ 563 (768)
Q Consensus 524 -----~g~~~~~~~lV~E~~~~gsL~-----------~~l~~---~~~~--------~~l~~-~~~~~------------ 563 (768)
+.......+++++|++|..+. ..|.+ .... ..+.| .....
T Consensus 85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (319)
T PRK05231 85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA 164 (319)
T ss_pred CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence 111233348899999886431 11111 0000 00111 11111
Q ss_pred HHHH-HHHHHHHHHhC----CCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 564 IAAE-IATALLFLHQT----KPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 564 i~~q-i~~aL~~LH~~----~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.+.+ +...+..+... -+.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122333211 24569999999999999977666899999875
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0017 Score=65.32 Aligned_cols=126 Identities=25% Similarity=0.295 Sum_probs=83.9
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCc----------------hhhHHHHHHHHHHHhhcC------CCceeeeec
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDA----------------AQGRSQFQQEVEVLCNIR------HPNMVLLLG 525 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~E~~il~~l~------HpnIv~l~g 525 (768)
...||.|+.-.||..-. .....||+..+.. .....+..+|+.-...+. +.+|.++||
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 45799999999996543 3456788887655 112345566666555554 778899999
Q ss_pred cccCCc--eeEEEeccC------CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 035604 526 ACPEFG--CLIYEYMAN------GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR 597 (768)
Q Consensus 526 ~~~~~~--~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~ 597 (768)
+..... .+|+|.+.+ -+|.+++.... ++. .....+. .-..||-..+ |+.+||+|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEEe
Confidence 986644 688887633 26777774432 555 3333333 3445667777 999999999999943
Q ss_pred C---C-cEEEee
Q 035604 598 N---Y-VSKISD 605 (768)
Q Consensus 598 ~---~-~vKL~D 605 (768)
+ . .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 2 2 567777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0011 Score=73.71 Aligned_cols=74 Identities=18% Similarity=0.169 Sum_probs=54.1
Q ss_pred ceecccCceeEEEEEECC--ccEEEEEEcCCc-------hhhHHHHHHHHHHHhhcC---CCceeeeeccccCCceeEEE
Q 035604 469 RKIGEGGYGPVYKSYLDH--TPVAIKVLRPDA-------AQGRSQFQQEVEVLCNIR---HPNMVLLLGACPEFGCLIYE 536 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~-------~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~lV~E 536 (768)
+.||.|.+..||+....+ +.|+||.-.+.. ....+.+..|.+.|..+. ..++.+++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 569999999999998854 389999854221 123455677888888763 34567788777777899999
Q ss_pred eccCCC
Q 035604 537 YMANGS 542 (768)
Q Consensus 537 ~~~~gs 542 (768)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0009 Score=66.87 Aligned_cols=123 Identities=21% Similarity=0.337 Sum_probs=88.4
Q ss_pred cCCCccceecccCc-eeEEEEEECCccEEEEEEcC---Cch------------------hhHHHHHHHHHHHhhcC---C
Q 035604 463 ENFSNSRKIGEGGY-GPVYKSYLDHTPVAIKVLRP---DAA------------------QGRSQFQQEVEVLCNIR---H 517 (768)
Q Consensus 463 ~~y~~~~~LG~G~f-G~Vy~~~~~~~~vAvK~l~~---~~~------------------~~~~~~~~E~~il~~l~---H 517 (768)
.+++.++.||.|.- |.||++..+|..||+|+++. ... .....|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67889999999999 99999999999999999321 100 11234778888877764 4
Q ss_pred Cce--eeeeccc--c-C-----------------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 035604 518 PNM--VLLLGAC--P-E-----------------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575 (768)
Q Consensus 518 pnI--v~l~g~~--~-~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L 575 (768)
.++ |+.+|+. . + -..||.||++... .+.. .-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHHH
Confidence 455 8888875 1 0 0146778775543 0222 2355777888899
Q ss_pred HhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 576 H~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
|..| |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999987 2389999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0038 Score=67.41 Aligned_cols=141 Identities=18% Similarity=0.256 Sum_probs=80.6
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCc--eeeeeccc--------cCCceeEEEe
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN--MVLLLGAC--------PEFGCLIYEY 537 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~--------~~~~~lV~E~ 537 (768)
.+.++.|-...+|+...++..+++|+.+... ....+..|.+++..|.... +.+++... ....+++|+|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4567777778999887766678899876532 1234556677776663211 33333321 2234789999
Q ss_pred ccCCChH-----------HHH---hhcCCC--C-------CCCHHHHH------------HHHHHHHHHHHHHHh----C
Q 035604 538 MANGSLE-----------DRL---FRRGGS--P-------VLPWQIRF------------RIAAEIATALLFLHQ----T 578 (768)
Q Consensus 538 ~~~gsL~-----------~~l---~~~~~~--~-------~l~~~~~~------------~i~~qi~~aL~~LH~----~ 578 (768)
++|..+. ..+ ...... . .-.|.... .....+...+.++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9885431 111 110000 0 01111110 001123344555543 2
Q ss_pred CCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 579 ~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
-+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23569999999999999988877999999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00011 Score=89.84 Aligned_cols=174 Identities=13% Similarity=0.038 Sum_probs=123.6
Q ss_pred EEEEEEcCCchhhH-----HHHHHHHHHHhhcCCCceeeeeccccC----CceeEEEeccCCChHHHHhhcCC-CCCCCH
Q 035604 489 VAIKVLRPDAAQGR-----SQFQQEVEVLCNIRHPNMVLLLGACPE----FGCLIYEYMANGSLEDRLFRRGG-SPVLPW 558 (768)
Q Consensus 489 vAvK~l~~~~~~~~-----~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~ 558 (768)
+-+|+.+....+.. +....|++.++...|++++..+.-.++ ..+.+++|+.+|.+.+.|.+... .+.+..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45666554333322 223445556666789999887765533 34889999999999999987533 233333
Q ss_pred HHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCC
Q 035604 559 QIRFRIAAEIATALLFLHQTK--PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636 (768)
Q Consensus 559 ~~~~~i~~qi~~aL~~LH~~~--~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~a 636 (768)
.-+.....+.+....-+|... ...-+|++||+-|.+|..+..+|++++|+.++..+. ........+++.|+.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~------~sf~Gl~l~sp~~v~ 1408 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV------LSFFGLELCSPIYVL 1408 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch------HhhhhhhhCCHHHHH
Confidence 333333333366666666543 245799999999999999999999999999843221 112355678889999
Q ss_pred cccccCCCCCccccHHHHHHHHHHHHhCCCCC
Q 035604 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668 (768)
Q Consensus 637 PE~~~~~~~s~ksDvwSlGvil~elltg~~Pf 668 (768)
|++...-.++.++|+|..|+-+|++..|..||
T Consensus 1409 qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1409 QLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99888888898999999999999999999988
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0012 Score=71.15 Aligned_cols=139 Identities=25% Similarity=0.330 Sum_probs=80.9
Q ss_pred ceecccCceeEEEEEEC--------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-eeeeccccCCceeEEEecc
Q 035604 469 RKIGEGGYGPVYKSYLD--------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-VLLLGACPEFGCLIYEYMA 539 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~--------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~~ 539 (768)
+.|..|--..||+.... +..+++|+..... ....+..+|..++..+..-++ .++++.+. ..+|++|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--NGRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--CCchhheeC
Confidence 34555666688988764 3689999976543 222345688888888753323 34455543 356899998
Q ss_pred CCChHHH--------------Hhh---cCCCC------CCC--HHHHHH--------------------------HHHHH
Q 035604 540 NGSLEDR--------------LFR---RGGSP------VLP--WQIRFR--------------------------IAAEI 568 (768)
Q Consensus 540 ~gsL~~~--------------l~~---~~~~~------~l~--~~~~~~--------------------------i~~qi 568 (768)
|..+... |.+ ..... ..+ +..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8765321 111 00000 011 111101 11122
Q ss_pred HHHHHHHHh------CCCCCeeeCCCCCCCeEEcCC----CcEEEeeccccc
Q 035604 569 ATALLFLHQ------TKPEPLVHRDLKPGNILLDRN----YVSKISDVGLAR 610 (768)
Q Consensus 569 ~~aL~~LH~------~~~~~iiHrDLKp~NILl~~~----~~vKL~DFGla~ 610 (768)
...+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 233344432 133569999999999999874 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.002 Score=77.95 Aligned_cols=192 Identities=20% Similarity=0.157 Sum_probs=133.1
Q ss_pred HHHHHHHHhhcCCCceeeeeccccCCc------eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 035604 505 FQQEVEVLCNIRHPNMVLLLGACPEFG------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578 (768)
Q Consensus 505 ~~~E~~il~~l~HpnIv~l~g~~~~~~------~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 578 (768)
...|.+.+.++.|+|++.++.+--+.. .+.-+++..-++...+...+ ..+..+.+.+..++..||.|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345777788889999999987753322 23457787778877776654 478888899999999999999998
Q ss_pred CCCCeeeCCCCCC---CeEEcCCCcEEEe--ecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCc--cccH
Q 035604 579 KPEPLVHRDLKPG---NILLDRNYVSKIS--DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGV--KSDV 651 (768)
Q Consensus 579 ~~~~iiHrDLKp~---NILl~~~~~vKL~--DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~--ksDv 651 (768)
. ..|.=|.-+ +...+..+.+.++ ||+....++.... ......+..|.+||......+.. ..|+
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-------SFSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCccc-------chhhcCccccccccccccccchhhhhhHH
Confidence 6 555555444 4555667777777 9998876643221 22334455677888766665544 4799
Q ss_pred HHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 652 YSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 652 wSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
|.+|..+..+..|..+-....... ..++.... ..+.....+|+..++++|+...+++.
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~~~---------~~l~~~~~-------~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAVPV---------SLLDVLST-------SELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccchh---------hhhccccc-------hhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999999998876643222111 11111111 13677888999999999999999884
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0054 Score=68.06 Aligned_cols=73 Identities=14% Similarity=0.123 Sum_probs=53.0
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCch-------hhHHHHHHHHHHHhhcC---CCceeeeeccccCCceeEEEe
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAA-------QGRSQFQQEVEVLCNIR---HPNMVLLLGACPEFGCLIYEY 537 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~-------~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~lV~E~ 537 (768)
.+.||.|..-.||+....+..++||.-.+... .....-..|.+.|+.+. ..++.++|.+|.+..+++||+
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 45789999999999888777899998642111 12333445567776654 247788999999999999999
Q ss_pred ccC
Q 035604 538 MAN 540 (768)
Q Consensus 538 ~~~ 540 (768)
+++
T Consensus 117 L~~ 119 (418)
T PLN02756 117 LEP 119 (418)
T ss_pred cCC
Confidence 977
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0044 Score=68.06 Aligned_cols=140 Identities=18% Similarity=0.186 Sum_probs=79.3
Q ss_pred ceecccCceeEEEEEEC------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-eeeeccccCCceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYLD------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-VLLLGACPEFGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~~~g 541 (768)
..|-.|-.-.+|+.... +..|++|+......... +-.+|..+++.+..-++ .++++.+... .|++|+++.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~ 118 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHAR 118 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCC
Confidence 34545667789987642 25789998865432222 22578888888754333 3445655433 689999876
Q ss_pred ChHHH--------------HhhcCCC-----C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-CC
Q 035604 542 SLEDR--------------LFRRGGS-----P-VLPWQIRFRIAAEI-----------------ATALLFL----HQ-TK 579 (768)
Q Consensus 542 sL~~~--------------l~~~~~~-----~-~l~~~~~~~i~~qi-----------------~~aL~~L----H~-~~ 579 (768)
+|... +.+-... . ...+.....+..++ ...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65321 1111110 0 11123332332211 1112222 21 22
Q ss_pred CCCeeeCCCCCCCeEEcC-CCcEEEeecccccc
Q 035604 580 PEPLVHRDLKPGNILLDR-NYVSKISDVGLARL 611 (768)
Q Consensus 580 ~~~iiHrDLKp~NILl~~-~~~vKL~DFGla~~ 611 (768)
+..++|+|+++.|||++. ++.+.|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 335899999999999976 57899999998863
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0071 Score=65.95 Aligned_cols=79 Identities=15% Similarity=0.200 Sum_probs=52.1
Q ss_pred eecccCceeEEEEEECC--ccEEEEEEcC-------CchhhHHHHHHHHHHHhhcC--CC-ceeeeeccccCCceeEEEe
Q 035604 470 KIGEGGYGPVYKSYLDH--TPVAIKVLRP-------DAAQGRSQFQQEVEVLCNIR--HP-NMVLLLGACPEFGCLIYEY 537 (768)
Q Consensus 470 ~LG~G~fG~Vy~~~~~~--~~vAvK~l~~-------~~~~~~~~~~~E~~il~~l~--Hp-nIv~l~g~~~~~~~lV~E~ 537 (768)
.||.|....||++...+ +.|+||.-.+ +-........-|.+.|+... -| .+.++|.+-++...+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 47999999999998754 4799997432 11223344556777777653 34 4556776667777899999
Q ss_pred ccCC-ChHHHHh
Q 035604 538 MANG-SLEDRLF 548 (768)
Q Consensus 538 ~~~g-sL~~~l~ 548 (768)
++.. .|.+.|.
T Consensus 82 L~~~~ilR~~Li 93 (370)
T TIGR01767 82 LSHHKIARKGLI 93 (370)
T ss_pred CccchHHHHHHH
Confidence 9543 3444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.016 Score=62.35 Aligned_cols=141 Identities=21% Similarity=0.297 Sum_probs=81.2
Q ss_pred ccCce-eEEEEEECCccEEEEEEcC--CchhhHHHHHHHHHHHhhcCC--CceeeeeccccCCc----eeEEEeccCCCh
Q 035604 473 EGGYG-PVYKSYLDHTPVAIKVLRP--DAAQGRSQFQQEVEVLCNIRH--PNMVLLLGACPEFG----CLIYEYMANGSL 543 (768)
Q Consensus 473 ~G~fG-~Vy~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~----~lV~E~~~~gsL 543 (768)
.||++ .+|.....++.+++. ... ..........+|+.+|+.+.- .-+-..++.|.+.. +.||+|++|..+
T Consensus 34 ~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 34 SGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred cCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 44544 445555557788888 321 223334556788888888753 12345567776655 899999988322
Q ss_pred H------------------HHHhhcCC-----CC------CCCHHHHHHHHH--------------HHHHHHHHHHhCCC
Q 035604 544 E------------------DRLFRRGG-----SP------VLPWQIRFRIAA--------------EIATALLFLHQTKP 580 (768)
Q Consensus 544 ~------------------~~l~~~~~-----~~------~l~~~~~~~i~~--------------qi~~aL~~LH~~~~ 580 (768)
. +.|..-.. .+ .+...+..++.. ....-..||+...+
T Consensus 113 ~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p 192 (321)
T COG3173 113 WSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRP 192 (321)
T ss_pred cCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCC
Confidence 1 11111000 00 000011111111 12223455554433
Q ss_pred -----CCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 581 -----EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 581 -----~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
..++|+|+.+.||+|+.++.+=+.||+++.+-++
T Consensus 193 ~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 193 PWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 4699999999999999998899999999976443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.015 Score=61.80 Aligned_cols=30 Identities=40% Similarity=0.619 Sum_probs=25.3
Q ss_pred CeeeCCCCCCCeEEcCCCc-EEEeecccccc
Q 035604 582 PLVHRDLKPGNILLDRNYV-SKISDVGLARL 611 (768)
Q Consensus 582 ~iiHrDLKp~NILl~~~~~-vKL~DFGla~~ 611 (768)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987454 57999998863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 768 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-37 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-34 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 2wb8_A | 352 | Crystal Structure Of Haspin Kinase Length = 352 | 2e-04 | ||
| 3dlz_A | 357 | Crystal Structure Of Human Haspin In Complex With A | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 2vuw_A | 336 | Structure Of Human Haspin Kinase Domain Length = 33 | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2WB8|A Chain A, Crystal Structure Of Haspin Kinase Length = 352 | Back alignment and structure |
|
| >pdb|3DLZ|A Chain A, Crystal Structure Of Human Haspin In Complex With Amp Length = 357 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2VUW|A Chain A, Structure Of Human Haspin Kinase Domain Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 2e-96
Identities = 100/288 (34%), Positives = 149/288 (51%), Gaps = 21/288 (7%)
Query: 451 RKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEV 509
+ + ++EEAT NF + IG G +G VYK L D VA+K P+++QG +F+ E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 510 EVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGG-SPVLPWQIRFRIAA 566
E L RHP++V L+G C E LIY+YM NG+L+ L+ + + W+ R I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
A L +LH ++HRD+K NILLD N+V KI+D G+++ ++ T
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS----T 199
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM---------GLAHQVERS 677
GT YIDPEY G L KSDVYS G++L +++ A+ + LA S
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 678 IENGTFDETLDPA-VPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
NG ++ +DP E A++C L +DRP +G V+
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 1e-93
Identities = 105/299 (35%), Positives = 154/299 (51%), Gaps = 30/299 (10%)
Query: 447 DLRYRKYSIEEIEEATENFS------NSRKIGEGGYGPVYKSYLDHTPVAIKVLR----P 496
D R+ +S E++ T NF K+GEGG+G VYK Y+++T VA+K L
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDI 68
Query: 497 DAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSP 554
+ + QF QE++V+ +H N+V LLG + CL+Y YM NGSL DRL G+P
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 555 VLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614
L W +R +IA A + FLH+ +HRD+K NILLD + +KISD GLAR
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV 674
+T + GT Y+ PE G + KSD+YS G++LL+IIT P + H+
Sbjct: 186 FAQTVMT----SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 239
Query: 675 ERSI---------ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+ + E T ++ +D + D + +A QC ++ RPD+ KV
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 282 bits (725), Expect = 3e-89
Identities = 102/292 (34%), Positives = 154/292 (52%), Gaps = 24/292 (8%)
Query: 451 RKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGR-SQFQQE 508
+++S+ E++ A++NFSN +G GG+G VYK L D T VA+K L+ + QG QFQ E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 509 VEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLF-RRGGSPVLPWQIRFRIA 565
VE++ H N++ L G C L+Y YMANGS+ L R P L W R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS-VTQYR 624
A L +LH ++HRD+K NILLD + + + D GLA+L+ D+ VT
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK--DTHVT--- 192
Query: 625 MTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM-----------GLAHQ 673
T+ GT +I PEY TG K+DV+ G++LL++IT + L
Sbjct: 193 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 674 VERSIENGTFDETLDPAVP-DWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
V+ ++ + +D + ++ EE L ++AL C + +RP + +VV
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 9e-66
Identities = 67/320 (20%), Positives = 119/320 (37%), Gaps = 49/320 (15%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLC 513
E + + G +G V+K+ L + VA+K+ Q Q + EV L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS-WQNEYEVYSLP 73
Query: 514 NIRHPNMVLLLGACPEFG------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
++H N++ +GA LI + GSL D L V+ W IA
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAET 129
Query: 568 IATALLFLHQ--------TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619
+A L +LH+ KP + HRD+K N+LL N + I+D GLA
Sbjct: 130 MARGLAYLHEDIPGLKDGHKP-AISHRDIKSKNVLLKNNLTACIADFGLALKFEA----G 184
Query: 620 VTQYRMTSAAGTFCYIDPEYQQTGMLG-----VKSDVYSLGILLLQIITAKPPMGLAHQ- 673
+ GT Y+ PE + + ++ D+Y++G++L ++ +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 674 -----VERSIENGTFDE--------TLDPAVPD-WPVEEAL-ILAKLALQCAELRRKDRP 718
E ++ + ++ P + D W + +L + +C + + R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 719 DLGKVVVPKLNILRALAEET 738
G V + + T
Sbjct: 305 SAGCVGE----RITQMQRLT 320
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-63
Identities = 79/289 (27%), Positives = 124/289 (42%), Gaps = 30/289 (10%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLC 513
S+ I+ + +G G +G V K+ VAIK + ++ R F E+ L
Sbjct: 1 SLHMIDY--KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE--RKAFIVELRQLS 56
Query: 514 NIRHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
+ HPN+V L GAC CL+ EY GSL + L P + + +
Sbjct: 57 RVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
+LH +P+ L+HRDLKP N+LL V KI D G A + Q MT+ G+
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---------QTHMTNNKGSA 167
Query: 633 CYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP----MGLAHQVERSIENGTFDETLD 688
++ PE + K DV+S GI+L ++IT + P G A ++ ++ NG
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-----TR 222
Query: 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737
P + + + L +C RP + ++V I+ L
Sbjct: 223 PPLIKNLPKP---IESLMTRCWSKDPSQRPSMEEIV----KIMTHLMRY 264
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-62
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 36/287 (12%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
KIG G +G V+++ + VA+K+L A+ ++F +EV ++ +RHPN+VL +GA
Sbjct: 43 EKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 527 C---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
P ++ EY++ GSL L + G L + R +A ++A + +LH P P+
Sbjct: 103 VTQPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PI 160
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG 643
VHR+LK N+L+D+ Y K+ D GL+RL + T SAAGT ++ PE +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLK------ASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 644 MLGVKSDVYSLGILLLQIITAKPP------MGLAHQVERSIENGTFDETLDPAVPDW-PV 696
KSDVYS G++L ++ T + P + V + +P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF--------KCKRLEIPRNLNP 266
Query: 697 EEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAIN 743
+ +A + C RP ++ ++LR L + +P N
Sbjct: 267 Q----VAAIIEGCWTNEPWKRPSFATIM----DLLRPLIKSAVPPPN 305
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 7e-58
Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 31/272 (11%)
Query: 469 RKIGEGGYGPVYK-SYLDH-TPVAIKVLRPDAAQGRS-------QFQQEVEVLCNIRHPN 519
++IG+GG+G V+K + + VAIK L ++G + +FQ+EV ++ N+ HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 520 MVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
+V L G ++ E++ G L RL + + W ++ R+ +IA + ++
Sbjct: 85 IVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQNQN 142
Query: 580 PEPLVHRDLKPGNILLD-----RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
P P+VHRDL+ NI L +K++D GL++ + + ++ G F +
Sbjct: 143 P-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---------QSVHSVSGLLGNFQW 192
Query: 635 IDPE--YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVP 692
+ PE + K+D YS ++L I+T + P + N +E L P +P
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252
Query: 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+ L + C K RP +V
Sbjct: 253 EDCPPR---LRNVIELCWSGDPKKRPHFSYIV 281
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-57
Identities = 77/269 (28%), Positives = 116/269 (43%), Gaps = 39/269 (14%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRP----DAAQGRSQFQQEVEVLCNIRHPNMVLLL 524
IG GG+G VY+++ VA+K R D +Q +QE ++ ++HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 525 GAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
G C CL+ E+ G L L + +P I A +IA + +LH P
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 583 LVHRDLKPGNILLDR--------NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
++HRDLK NIL+ + N + KI+D GLAR + SAAG + +
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--------WHRTTKMSAAGAYAW 180
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIENGTFDETLDPAV 691
+ PE + M SDV+S G+LL +++T + P + N L +
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-----LALPI 235
Query: 692 PDW-PVEEALILAKLALQCAELRRKDRPD 719
P P AKL C RP
Sbjct: 236 PSTCPEP----FAKLMEDCWNPDPHSRPS 260
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-57
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 29/279 (10%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRS--QFQQEVEVLCNIRHPNMVLLLGA 526
++IG G +G VYK H VA+K+L A + F+ EV VL RH N++L +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 527 C--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
P+ ++ ++ SL L + IA + A + +LH + ++
Sbjct: 89 STAPQL-AIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE---YQQ 641
HRDLK NI L + KI D GLA + ++ +G+ ++ PE Q
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATE----KSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 642 TGMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIENGTFDETLDPAVPDWPVEE 698
+ +SDVY+ GI+L +++T + P + Q+ + G+ L + P
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR- 257
Query: 699 ALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737
+ +L +C + +R +RP +++ + LA E
Sbjct: 258 ---MKRLMAECLKKKRDERPSFPRIL----AEIEELARE 289
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-56
Identities = 59/284 (20%), Positives = 109/284 (38%), Gaps = 43/284 (15%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRS--QFQQEVEVLCNIRHPNMVLLLGA 526
K+ E G ++K + +KVL+ R F +E L HPN++ +LGA
Sbjct: 16 TKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 527 C----PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
C LI +M GSL + L G + V+ + A ++A + FLH +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-L 133
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE---Y 639
+ L ++++D + ++IS + ++ ++ PE
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS-----------FQSPGRMYAPAWVAPEALQK 182
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKPP------MGLAHQVERSIENGTFDETLDPAVPD 693
+ +D++S +LL +++T + P M + +V E L P +P
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL--------EGLRPTIPP 234
Query: 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737
++KL C RP +V IL + ++
Sbjct: 235 GISPH---VSKLMKICMNEDPAKRPKFDMIV----PILEKMQDK 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-55
Identities = 72/332 (21%), Positives = 111/332 (33%), Gaps = 52/332 (15%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEV-- 511
+ E +N IG G YG VYK LD PVA+KV R F E +
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSF---ANRQNFINEKNIYR 60
Query: 512 LCNIRHPNMVLLLGACPEFG-------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI 564
+ + H N+ + L+ EY NGSL L W R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRL 116
Query: 565 AAEIATALLFLHQTKPE------PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS--V 616
A + L +LH P + HRDL N+L+ + ISD GL+ + + V
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 617 ADSVTQYRMTSAAGTFCYIDPEY-------QQTGMLGVKSDVYSLGILLLQIITAK---- 665
S GT Y+ PE + + D+Y+LG++ +I
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 666 -----PPMGLAHQVERSIENGTFDETLD--------PAVPD-WPVEEALI--LAKLALQC 709
P +A Q E + TF++ P P+ W + L + C
Sbjct: 237 PGESVPEYQMAFQTEVG-NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 710 AELRRKDRPDLGKVVVPKLNILRALAEETMPA 741
+ + R ++ +
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-53
Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 34/284 (11%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRP--DAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
IG+G +G VY H VAI+++ D F++EV RH N+VL +GA
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 527 C--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
C P +I +L + R VL +IA EI + +LH + ++
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM 644
H+DLK N+ D V I+D GL + A + G C++ PE +
Sbjct: 153 HKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDK-LRIQNGWLCHLAPEIIRQLS 210
Query: 645 LGV---------KSDVYSLGILLLQIITAKPP-MGL-AHQVERSIENGTFDETLDPAVPD 693
SDV++LG + ++ + P A + + G + P +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-----MKPNLSQ 265
Query: 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737
+ + ++ + L C +++RP K++ ++L L +
Sbjct: 266 IGMGKE--ISDILLFCWAFEQEERPTFTKLM----DMLEKLPKR 303
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 65/285 (22%), Positives = 112/285 (39%), Gaps = 31/285 (10%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
+G+G +G K T + +K L + + F +EV+V+ + HPN++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 527 C--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
+ I EY+ G+L + PW R A +IA+ + +LH ++
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSMN---II 130
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVP--------PSVADSVTQYRMTSAAGTFCYID 636
HRDL N L+ N ++D GLARL+ + + + G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPPM--GLAHQVERSIENGTFDETLDPAVP-D 693
PE K DV+S GI+L +II L ++ + LD P +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---VRGFLDRYCPPN 247
Query: 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEET 738
P + ++C +L + RP K+ + L L
Sbjct: 248 CPPS----FFPITVRCCDLDPEKRPSFVKLE----HWLETLRMHL 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-49
Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 32/222 (14%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEV--LCNIRHPNMVLLLGA 526
+G+G YG V++ VA+K+ + + +E E+ +RH N++ + +
Sbjct: 14 ECVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 527 C-------PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH--- 576
+ LI Y GSL D L L RI IA+ L LH
Sbjct: 71 DMTSRHSSTQL-WLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 577 ---QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
Q KP + HRDLK NIL+ +N I+D+GLA + S + GT
Sbjct: 126 FGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS--TNQLDVGNNPRVGTKR 182
Query: 634 YIDPE------YQQTGMLGVKSDVYSLGILLLQIITAKPPMG 669
Y+ PE + D+++ G++L ++ G
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 32/222 (14%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEV--LCNIRHPNMVLLLGA 526
++IG+G YG V+ VA+KV + + +E E+ +RH N++ + A
Sbjct: 43 KQIGKGRYGEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 527 C-------PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH--- 576
+ LI +Y NGSL D L L + ++A + L LH
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 577 ---QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
Q KP + HRDLK NIL+ +N I+D+GLA + + GT
Sbjct: 155 FSTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD--TNEVDIPPNTRVGTKR 211
Query: 634 YIDPE------YQQTGMLGVKSDVYSLGILLLQIITAKPPMG 669
Y+ PE + + +D+YS G++L ++ G
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 470 KIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEV--LCNIRHPNMVLLLGAC 527
IG+G +G V++ VA+K+ + + +E E+ +RH N++ + A
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 528 PEFG------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH----- 576
+ L+ +Y +GSL D L R + + ++A A+ L LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 577 -QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
Q KP + HRDLK NIL+ +N I+D+GLA + GT Y+
Sbjct: 162 TQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA--TDTIDIAPNHRVGTKRYM 218
Query: 636 DPE-YQQTGMLGV-----KSDVYSLGILLLQIITAKPPMG 669
PE + + ++D+Y++G++ +I G
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 62/280 (22%), Positives = 106/280 (37%), Gaps = 34/280 (12%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLR-PDAAQGRSQFQQEVEVLCNIRHPN 519
+F + +G GG+G V++ + +D AIK +R P+ R + +EV+ L + HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 520 MVLLLGA--------------CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIA 565
+V A + + + +L+D + R + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT---- 621
+IA A+ FLH L+HRDLKP NI + V K+ D GL + +
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 622 --QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE 679
R T GT Y+ PE K D++SLG++L +++ + +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVR 241
Query: 680 NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD 719
N F P ++ + +RP+
Sbjct: 242 NLKF--------PPLFTQKYPCEYVMVQDMLSPSPMERPE 273
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 48/291 (16%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDAAQGRSQFQQEVE 510
+ EE + +++G+G +G V D VA+K L+ + F++E+E
Sbjct: 6 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 511 VLCNIRHPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAA 566
+L +++H N+V G C G LI EY+ GSL D L + +++ +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TS 121
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+I + +L + +HRDL NIL++ KI D GL +++P +++
Sbjct: 122 QICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEFFKVK 174
Query: 627 SAAGT-FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-----------------AKPPM 668
+ + PE V SDV+S G++L ++ T
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 669 GL-AHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
+ + ++N L P P E + + +C RP
Sbjct: 235 QMIVFHLIELLKNN---GRL-PRPDGCPDE----IYMIMTECWNNNVNQRP 277
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 71/327 (21%), Positives = 121/327 (37%), Gaps = 43/327 (13%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDAAQGRSQFQQEVE 510
EE + ++G+G +G V D VA+K L+ + FQ+E++
Sbjct: 19 IFEE--RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 511 VLCNIRHPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAA 566
+L + +V G G L+ EY+ +G L D L R + + ++
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY--SS 134
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+I + +L + VHRDL NIL++ KI+D GLA+L+P Y +
Sbjct: 135 QICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP----LDKDYYVVR 187
Query: 627 SAAGT-FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-----AKPPMGLAHQVERSIEN 680
+ + PE + +SDV+S G++L ++ T P + +
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 681 GTFDETLD--------PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732
L+ PA P P E + +L C +DRP + L
Sbjct: 248 PALSRLLELLEEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALG----PQLD 299
Query: 733 ALAEETMPAINLASGAGSSPSYSQVST 759
L + A A + +S
Sbjct: 300 MLWSGSRGCETHAFTAHPEGKHHSLSF 326
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 64/291 (21%), Positives = 114/291 (39%), Gaps = 48/291 (16%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDAAQGRSQFQQEVE 510
+ EE + +++G+G +G V D VA+K L+ + F++E+E
Sbjct: 37 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 511 VLCNIRHPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAA 566
+L +++H N+V G C G LI EY+ GSL D L + +++ +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TS 152
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+I + +L + +HRDL NIL++ KI D GL +++P Y++
Sbjct: 153 QICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEYYKVK 205
Query: 627 SAAGT-FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-----------------AKPPM 668
+ + PE V SDV+S G++L ++ T
Sbjct: 206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265
Query: 669 GL-AHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
+ + ++N L P P E + + +C RP
Sbjct: 266 QMIVFHLIELLKNN---GRL-PRPDGCPDE----IYMIMTECWNNNVNQRP 308
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 69/266 (25%), Positives = 103/266 (38%), Gaps = 29/266 (10%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPN 519
E+ +IG G +G V+ L D+T VA+K R +++F QE +L HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 520 MVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L+G C + ++ E + G L G + ++ + A + +L
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM--VGDAAAGMEYLES 231
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY--I 635
+HRDL N L+ V KISD G++R Y +
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD------GVYAASGGLRQVPVKWT 282
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVP 692
PE G +SDV+S GILL + + A P L Q +E G L P
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRL-PCPE 338
Query: 693 DWPVEEALILAKLALQCAELRRKDRP 718
P + +L QC RP
Sbjct: 339 LCPDA----VFRLMEQCWAYEPGQRP 360
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 64/232 (27%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 462 TENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN 519
+F +G+G +G V K+ LD AIK +R + S EV +L ++ H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 520 MVLLLGA------------CPEFGCLIY---EYMANGSLEDRLFRRGGSPVLPWQIRFRI 564
+V A + ++ EY NG+L D + + R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYW-RL 121
Query: 565 AAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY- 623
+I AL ++H ++HRDLKP NI +D + KI D GLA+ V S+
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 624 -------RMTSAAGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+TSA GT Y+ E TG K D+YSLGI+ P
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF--FEMIYPF 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 71/298 (23%), Positives = 123/298 (41%), Gaps = 62/298 (20%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDA-AQGRSQFQQEV 509
E+ R +GEG +G V D VA+K L+P++ + ++E+
Sbjct: 17 HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 74
Query: 510 EVLCNIRHPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIA 565
E+L N+ H N+V G C E G LI E++ +GSL++ L + L Q+++ A
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY--A 132
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM 625
+I + +L + VHRDL N+L++ + KI D GL + + Y +
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE----TDKEYYTV 185
Query: 626 TSA--------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-------------- 663
A PE + SDV+S G+ L +++T
Sbjct: 186 KDDRDSPVFWYA-------PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238
Query: 664 -AKPPMGL--AHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
P G ++ +++ G + L P P+ P E + +L +C E + +R
Sbjct: 239 MIGPTHGQMTVTRLVNTLKEG---KRL-PCPPNCPDE----VYQLMRKCWEFQPSNRT 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-36
Identities = 80/255 (31%), Positives = 121/255 (47%), Gaps = 23/255 (9%)
Query: 469 RKIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
K+G+G +G V+ ++ T VAIK L+P F QE +V+ +RH +V L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 528 PEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
E ++ EYM+ GSL D L G + Q+ +AA+IA+ + ++ + VHR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVERMN---YVHR 304
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLG 646
DL+ NIL+ N V K++D GLARL+ + A + PE G
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 647 VKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDWPVEEALILA 703
+KSDV+S GILL ++ T P G+ +V +E G + P P+ P L
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRM-PCPPECPES----LH 411
Query: 704 KLALQCAELRRKDRP 718
L QC ++RP
Sbjct: 412 DLMCQCWRKEPEERP 426
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 67/282 (23%), Positives = 115/282 (40%), Gaps = 46/282 (16%)
Query: 456 EEIEEATENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDA-AQGRSQFQQE 508
++E F + +G G +G VYK PVAIK LR + + E
Sbjct: 10 RILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 509 VEVLCNIRHPNMVLLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
V+ ++ +P++ LLG C LI + M G L D + + + + + +
Sbjct: 68 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQ 125
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
IA + +L + LVHRDL N+L+ KI+D GLA+L+ +
Sbjct: 126 IAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-----EKEYHAE 177
Query: 628 A--------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVER 676
A E + +SDV+S G+ + +++T +KP G+ A ++
Sbjct: 178 GGKVPIKWMA-------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230
Query: 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
+E G E L P P ++ + + +C + RP
Sbjct: 231 ILEKG---ERL-PQPPICTID----VYMIMRKCWMIDADSRP 264
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-36
Identities = 75/260 (28%), Positives = 118/260 (45%), Gaps = 31/260 (11%)
Query: 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
K+G G YG VY+ VA+K L+ D + +F +E V+ I+HPN+V LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 527 CPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
C +I E+M G+L D L V + +A +I++A+ +L + +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAMEYLEKKN---FI 340
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID---PEYQQ 641
HR+L N L+ N++ K++D GL+RL+ Y T+ AG I PE
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGD------TY--TAHAGAKFPIKWTAPESLA 392
Query: 642 TGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDWPVEE 698
+KSDV++ G+LL +I T P G+ QV +E + P +
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRM-ERPEGCPEK- 447
Query: 699 ALILAKLALQCAELRRKDRP 718
+ +L C + DRP
Sbjct: 448 ---VYELMRACWQWNPSDRP 464
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 72/259 (27%), Positives = 112/259 (43%), Gaps = 31/259 (11%)
Query: 469 RKIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
++IG G +G V+ +L+ VAIK +R A F +E EV+ + HP +V L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 528 PEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
E CL+ E+M +G L D L + G + ++ + +L + ++H
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYLEEAC---VIH 127
Query: 586 RDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID---PEYQQT 642
RDL N L+ N V K+SD G+ R V QY TS+ GT + PE
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDD------QY--TSSTGTKFPVKWASPEVFSF 179
Query: 643 GMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDWPVEEA 699
KSDV+S G+L+ ++ + P + +V I G L
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRL-YKPRLASTH-- 233
Query: 700 LILAKLALQCAELRRKDRP 718
+ ++ C R +DRP
Sbjct: 234 --VYQIMNHCWRERPEDRP 250
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 66/283 (23%), Positives = 117/283 (41%), Gaps = 36/283 (12%)
Query: 445 TVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRS 503
T L Y + EI+ ++ + +++G G +G V + VAIK+++ +
Sbjct: 11 TAGLGYGSW---EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-ED 64
Query: 504 QFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIR 561
+F +E +V+ N+ H +V L G C + +I EYMANG L + L +
Sbjct: 65 EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 124
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621
++ A+ +L + +HRDL N L++ V K+SD GL+R V
Sbjct: 125 M--CKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------D 173
Query: 622 QYRMTSAAGTFCYID---PEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVE 675
+Y TS+ G+ + PE KSD+++ G+L+ +I + P +
Sbjct: 174 EY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 231
Query: 676 RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
I G L + + + C + +RP
Sbjct: 232 EHIAQG---LRL-YRPHLASEK----VYTIMYSCWHEKADERP 266
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 60/265 (22%), Positives = 106/265 (40%), Gaps = 31/265 (11%)
Query: 463 ENFSNSRKIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
E + +++G G +G V + VA+K+++ + +F QE + + + HP +V
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLV 66
Query: 522 LLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
G C + ++ EY++NG L + L G + ++ + FL +
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFLESHQ 124
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID--- 636
+HRDL N L+DR+ K+SD G+ R V QY S+ GT +
Sbjct: 125 ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD------DQY--VSSVGTKFPVKWSA 173
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPD 693
PE KSDV++ GIL+ ++ + P +V + G L
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG---HRL-YRPHL 229
Query: 694 WPVEEALILAKLALQCAELRRKDRP 718
+ ++ C + RP
Sbjct: 230 ASDT----IYQIMYSCWHELPEKRP 250
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLD------HTPVAIKVLRPDA-AQGRSQFQQEV 509
+ R +GEG +G V D VA+K L+ DA Q RS ++QE+
Sbjct: 27 VFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84
Query: 510 EVLCNIRHPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIA 565
++L + H +++ G C + G L+ EY+ GSL D L S L + F A
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLF--A 140
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM 625
+I + +LH +HRDL N+LLD + + KI D GLA+ VP + YR+
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRV 193
Query: 626 TSA--------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT 663
A PE + SDV+S G+ L +++T
Sbjct: 194 REDGDSPVFWYA-------PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 73/257 (28%), Positives = 109/257 (42%), Gaps = 31/257 (12%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
+ IG+G +G V VA+K ++ DA F E V+ +RH N+V LLG
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 529 EFGCLIY---EYMANGSLEDRLFRRGGSPV-LPWQIRFRIAAEIATALLFLHQTKPEPLV 584
E +Y EYMA GSL D L RG S + ++F + ++ A+ +L V
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDVCEAMEYLEGNN---FV 311
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM 644
HRDL N+L+ + V+K+SD GL + + + T+ PE +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------PEALREKK 362
Query: 645 LGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDWPVEEALI 701
KSDV+S GILL +I + P + V +E G + A P
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKM-DAPDGCPPA---- 414
Query: 702 LAKLALQCAELRRKDRP 718
+ + C L RP
Sbjct: 415 VYDVMKNCWHLDAATRP 431
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 50/285 (17%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYK---------SYLDHTPVAIKVLRPDAAQGRSQFQQ 507
+I E+ + +G+G + ++K L T V +KVL F +
Sbjct: 4 KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 508 EVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIA 565
++ + H ++VL G C L+ E++ GSL+ L + + W++ +A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVA 119
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDR--------NYVSKISDVGLARLVPPSVA 617
++A A+ FL + L+H ++ NILL R K+SD G++ V +
Sbjct: 120 KQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV---LP 173
Query: 618 DSVTQYRMTSAAGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQ 673
+ Q R+ PE + L + +D +S G L +I + KP L +
Sbjct: 174 KDILQERIPWVP-------PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
Query: 674 VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
+ E+ L P LA L C + RP
Sbjct: 227 KLQFYEDR---HQLPA--PKAAE-----LANLINNCMDYEPDHRP 261
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 4e-35
Identities = 80/255 (31%), Positives = 121/255 (47%), Gaps = 23/255 (9%)
Query: 469 RKIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
K+G+G +G V+ ++ T VAIK L+P F QE +V+ +RH +V L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 528 PEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
E ++ EYM+ GSL D L G + Q+ +AA+IA+ + ++ + VHR
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVERMN---YVHR 387
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLG 646
DL+ NIL+ N V K++D GLARL+ + A + PE G
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 647 VKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDWPVEEALILA 703
+KSDV+S GILL ++ T P G+ +V +E G + P P+ P L
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRM-PCPPECPES----LH 494
Query: 704 KLALQCAELRRKDRP 718
L QC ++RP
Sbjct: 495 DLMCQCWRKEPEERP 509
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 69/277 (24%), Positives = 111/277 (40%), Gaps = 40/277 (14%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRSQFQQEVE 510
I E+ +R +GEG +G VY+ + VA+K + D + +F E
Sbjct: 8 GIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 511 VLCNIRHPNMVLLLGAC---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
++ N+ HP++V L+G P + +I E G L L R S + + + + +
Sbjct: 66 IMKNLDHPHIVKLIGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQ 121
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
I A+ +L VHRD+ NIL+ K+ D GL+R + D Y
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY----IEDE--DY--YK 170
Query: 628 AAGTFCYID---PEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENG 681
A+ T I PE SDV+ + + +I++ +P L V +E G
Sbjct: 171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
Query: 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
+ L P P L L +C + DRP
Sbjct: 231 ---DRL-PKPDLCPPV----LYTLMTRCWDYDPSDRP 259
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 33/296 (11%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRSQFQQEVE 510
I ++ + IG G +G VY L A+K L SQF E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 511 VLCNIRHPNMVLLLGACPEFG---CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
++ + HPN++ LLG C ++ YM +G L + + +P + I F +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQ 136
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
+A + +L K VHRDL N +LD + K++D GLAR + Y + +
Sbjct: 137 VAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM-----YDKEYYSVHN 188
Query: 628 AAGTFCYID---PEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENG 681
G + E QT KSDV+S G+LL +++T A P + + + G
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737
L P L ++ L+C + + RP ++V I E
Sbjct: 249 ---RRLLQP-EYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 73/256 (28%), Positives = 108/256 (42%), Gaps = 29/256 (11%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
+ IG+G +G V VA+K ++ DA F E V+ +RH N+V LLG
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 529 EFGCLIY---EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
E +Y EYMA GSL D L R G VL + + ++ A+ +L VH
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 586 RDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML 645
RDL N+L+ + V+K+SD GL + + + T+ PE +
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------PEALREKKF 191
Query: 646 GVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVPDWPVEEALIL 702
KSDV+S GILL +I + P + V +E G + A P +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKM-DAPDGCPPA----V 243
Query: 703 AKLALQCAELRRKDRP 718
++ C L RP
Sbjct: 244 YEVMKNCWHLDAAMRP 259
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 60/267 (22%), Positives = 104/267 (38%), Gaps = 46/267 (17%)
Query: 443 SLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQ 500
+ TVD R+ +F IG GG+G V+K +D IK ++
Sbjct: 2 AHTVDKRFGM-----------DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----Y 46
Query: 501 GRSQFQQEVEVLCNIRHPNMVLLLGACPEFG------------------CLIYEYMANGS 542
+ ++EV+ L + H N+V G F + E+ G+
Sbjct: 47 NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGT 106
Query: 543 LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSK 602
LE + +R G + + +I + ++H K L++RDLKP NI L K
Sbjct: 107 LEQWIEKRRGEKLDKVLAL-ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162
Query: 603 ISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQII 662
I D GL + + T + GT Y+ PE + G + D+Y+LG++L +++
Sbjct: 163 IGDFGLVTSLKNDG-------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
Query: 663 TAKPPMGLAHQVERSIENGTFDETLDP 689
+ + +G + D
Sbjct: 216 HVCDTAFETSKFFTDLRDGIISDIFDK 242
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-35
Identities = 79/257 (30%), Positives = 128/257 (49%), Gaps = 27/257 (10%)
Query: 469 RKIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
+K+G G +G V+ +Y HT VA+K ++P + F E V+ ++H +V L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 528 PEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHR 586
+ +I E+MA GSL D L GS ++ +A+IA + F+ Q +HR
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFIEQRN---YIHR 308
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY--IDPEYQQTGM 644
DL+ NIL+ + V KI+D GLAR++ + +Y F PE G
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDN------EYT-AREGAKFPIKWTAPEAINFGS 361
Query: 645 LGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDWPVEEALI 701
+KSDV+S GILL++I+T P G++ +V R++E G + P + P E
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YRM-PRPENCPEE---- 413
Query: 702 LAKLALQCAELRRKDRP 718
L + ++C + R ++RP
Sbjct: 414 LYNIMMRCWKNRPEERP 430
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 25/240 (10%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRSQFQQEVE 510
I + R IG+G +G VY + AIK L Q F +E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 511 VLCNIRHPNMVLLLGACPEFGCLIY---EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
++ + HPN++ L+G L + YM +G L + +P + I F +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQ 132
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
+A + +L + K VHRDL N +LD ++ K++D GLAR + Y +
Sbjct: 133 VARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI-----LDREYYSVQQ 184
Query: 628 AAGTFCYID---PEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENG 681
+ E QT KSDV+S G+LL +++T A P + + + G
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 78/281 (27%), Positives = 114/281 (40%), Gaps = 48/281 (17%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRSQFQQEVE 510
EI+ E R IGEG +G V++ VAIK + R +F QE
Sbjct: 11 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 511 VLCNIRHPNMVLLLGAC---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
+ HP++V L+G P + +I E G L L R S L I + A +
Sbjct: 69 TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILY--AYQ 124
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
++TAL +L + VHRD+ N+L+ N K+ D GL+R + + T Y+ +
Sbjct: 125 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASK 176
Query: 628 A-------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERS 677
A PE SDV+ G+ + +I+ KP G+ + V
Sbjct: 177 GKLPIKWMA-------PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229
Query: 678 IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
IENG E L P P+ P L L +C RP
Sbjct: 230 IENG---ERL-PMPPNCPPT----LYSLMTKCWAYDPSRRP 262
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 72/269 (26%), Positives = 105/269 (39%), Gaps = 43/269 (15%)
Query: 469 RKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVL 522
+ IG G G V L PVAIK L+ + R F E ++ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 523 LLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
L G ++ EYM NGSL+ L G + + + + +L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM--LRGVGAGMRYLSDLG- 171
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS--------AAGTF 632
VHRDL N+L+D N V K+SD GL+R+ + D T+ A
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGLSRV----LEDDPDAAYTTTGGKIPIRWTA--- 222
Query: 633 CYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDP 689
PE SDV+S G+++ +++ +P + V S+E G L P
Sbjct: 223 ----PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG---YRL-P 274
Query: 690 AVPDWPVEEALILAKLALQCAELRRKDRP 718
A P L +L L C R RP
Sbjct: 275 APMGCPHA----LHQLMLDCWHKDRAQRP 299
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 469 RKIGEGGYGPVYK-SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527
++G G +G V+ Y HT VA+K L+ + F E ++ ++H +V L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 528 ---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
P + +I EYM NGSL D L G + ++ +AA+IA + F+ + +
Sbjct: 78 TQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMAFIEERN---YI 131
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID---PEYQQ 641
HRDL+ NIL+ KI+D GLARL+ +Y T+ G I PE
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIED------NEY--TAREGAKFPIKWTAPEAIN 183
Query: 642 TGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENG 681
G +KSDV+S GILL +I+T P G+ +V +++E G
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 61/296 (20%), Positives = 120/296 (40%), Gaps = 42/296 (14%)
Query: 434 AKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT-PVAIK 492
+ ++ T +L ++ S++ +S ++IG GG V++ + AIK
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVK-----GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 58
Query: 493 VLRPDAAQGRS--QFQQEVEVLCNIRHPNM--VLLLGAC--PEFGCLIYEYMANGSLEDR 546
+ + A ++ ++ E+ L ++ + + L ++ ++ E N L
Sbjct: 59 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 117
Query: 547 LFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606
L ++ PW+ + + A+ +HQ +VH DLKP N L+ + K+ D
Sbjct: 118 LKKKKSID--PWERKS-YWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDF 170
Query: 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-----------YQQTGMLGVKSDVYSLG 655
G+A + T S GT Y+ PE + + KSDV+SLG
Sbjct: 171 GIANQMQ----PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226
Query: 656 ILLLQIITAKPP-MGLAHQVER--SIENGTFDETLDPAVPDWPVEEALILAKLALQ 708
+L + K P + +Q+ + +I + + PD P ++ + K L+
Sbjct: 227 CILYYMTYGKTPFQQIINQISKLHAIIDPNH----EIEFPDIPEKDLQDVLKCCLK 278
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 70/242 (28%), Positives = 108/242 (44%), Gaps = 31/242 (12%)
Query: 470 KIGEGGYGPVYKSYLDHT--PVAIKV--LRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLG 525
+IG G + VYK T VA R R +F++E E+L ++HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 526 ACPEFG------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
+ L+ E M +G+L+ L R V+ ++ +I L FLH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 580 PEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE 638
P P++HRDLK NI + KI D+GLA L S A +V GT ++ PE
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV--------IGTPEFMAPE 200
Query: 639 YQQTGMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIENGT----FDETLDPAV 691
+ DVY+ G+ +L++ T++ P A Q+ R + +G FD+ P V
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
Query: 692 PD 693
+
Sbjct: 260 KE 261
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 35/262 (13%)
Query: 469 RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
K+G G YG VY+ VA+K L+ D + +F +E V+ I+HPN+V LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 527 CPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
C +I E+M G+L D L R + + +A +I++A+ +L + +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG-----TFCYIDPEY 639
HRDL N L+ N++ K++D GL+RL+ Y + A T PE
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWT----APES 183
Query: 640 QQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDWPV 696
+KSDV++ G+LL +I T P G+ QV +E + P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRM-ERPEGCPE 239
Query: 697 EEALILAKLALQCAELRRKDRP 718
+ + +L C + DRP
Sbjct: 240 K----VYELMRACWQWNPSDRP 257
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 31/225 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPN 519
+ S +G+G V++ T AIKV + +E EVL + H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 520 MVLLLGACPEFG-----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
+V L A E LI E+ GSL L + LP + ++ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 575 LHQTKPEPLVHRDLKPGNILL----DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
L + +VHR++KPGNI+ D V K++D G AR + + S G
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVSLYG 177
Query: 631 TFCYIDPEYQQTGML--------GVKSDVYSLGILLLQIITAKPP 667
T Y+ P+ + +L G D++S+G+ T P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 65/274 (23%), Positives = 119/274 (43%), Gaps = 32/274 (11%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDA-AQGRSQFQQEV 509
+E + +G G +G V+K PV IKV+ + Q +
Sbjct: 9 IFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66
Query: 510 EVLCNIRHPNMVLLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEI 568
+ ++ H ++V LLG CP L+ +Y+ GSL D + + G+ + + +I
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW--GVQI 124
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
A + +L + +VHR+L N+LL +++D G+A L+PP + + S
Sbjct: 125 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-----DKQLLYSE 176
Query: 629 AGT-FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFD 684
A T ++ E G +SDV+S G+ + +++T A+P GL +V +E G
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG--- 233
Query: 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
E L ++ + + ++C + RP
Sbjct: 234 ERL-AQPQICTID----VYMVMVKCWMIDENIRP 262
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 77/306 (25%), Positives = 123/306 (40%), Gaps = 51/306 (16%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDAAQGRSQ---FQQE 508
I E ++ K+G+G +G V + VA+K L+PD F +E
Sbjct: 14 LIGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 509 VEVLCNIRHPNMVLLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
V + ++ H N++ L G ++ E GSL DRL + G +L R+ A +
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQ 129
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
+A + +L + +HRDL N+LL + KI D GL R +P + Y M
Sbjct: 130 VAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQE 182
Query: 628 A--------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVER 676
A PE +T SD + G+ L ++ T +P +GL Q+
Sbjct: 183 HRKVPFAWCA-------PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235
Query: 677 SIE-NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALA 735
I+ G E L P D P + + + +QC + +DRP + + L
Sbjct: 236 KIDKEG---ERL-PRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALR----DFLLEAQ 283
Query: 736 EETMPA 741
M A
Sbjct: 284 PTDMRA 289
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 32/275 (11%)
Query: 456 EEIEEATENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDA-AQGRSQFQQE 508
++E F + +G G +G VYK PVAIK LR + + E
Sbjct: 10 RILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 509 VEVLCNIRHPNMVLLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
V+ ++ +P++ LLG C LI + M G L D + + + + + +
Sbjct: 68 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQ 125
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
IA + +L + LVHRDL N+L+ KI+D GLA+L+ +
Sbjct: 126 IAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-----EKEYHAE 177
Query: 628 AAGT-FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTF 683
++ E + +SDV+S G+ + +++T +KP G+ A ++ +E G
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-- 235
Query: 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
E L P P ++ + + ++C + RP
Sbjct: 236 -ERL-PQPPICTID----VYMIMVKCWMIDADSRP 264
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 62/268 (23%), Positives = 108/268 (40%), Gaps = 43/268 (16%)
Query: 469 RKIGEGGYGPVYKSYL----DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVL 522
+++G G +G V K Y VA+K+L+ +A + + E V+ + +P +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 523 LLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
++G C L+ E G L L ++ I +++ + +L ++
Sbjct: 83 MIGICEAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL--VHQVSMGMKYLEESN-- 137
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA--------AGTFC 633
VHRDL N+LL + +KISD GL++ + Y+ + A
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYA---- 188
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPA 690
PE KSDV+S G+L+ + + KP G+ +V +E G E +
Sbjct: 189 ---PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERM-GC 241
Query: 691 VPDWPVEEALILAKLALQCAELRRKDRP 718
P E + L C ++RP
Sbjct: 242 PAGCPRE----MYDLMNLCWTYDVENRP 265
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 20/221 (9%)
Query: 463 ENFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM 520
+++ +K+GEGG+ V + D A+K + Q R + Q+E ++ HPN+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 521 VLLLGACPEFG------CLIYEYMANGSLEDRL--FRRGGSPVLPWQIRFRIAAEIATAL 572
+ L+ C L+ + G+L + + + G+ + QI + I L
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGL 147
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA--- 629
+H HRDLKP NILL + D+G V S + A
Sbjct: 148 EAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 630 GTFCYIDPE---YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
T Y PE Q ++ ++DV+SLG +L ++ + P
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 62/267 (23%), Positives = 106/267 (39%), Gaps = 41/267 (15%)
Query: 469 RKIGEGGYGPVYKSYL----DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLL 523
++G G +G V + VAIKVL+ + +E +++ + +P +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 524 LGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
+G C L+ E G L L + + +++ + +L +
Sbjct: 76 IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVSMGMKYLEEKN--- 130
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA--------AGTFCY 634
VHRDL N+LL + +KISD GL++ + + Y SA A
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTARSAGKWPLKWYA----- 181
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAV 691
PE +SDV+S G+ + + ++ KP + +V IE G + +
Sbjct: 182 --PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRM-ECP 235
Query: 692 PDWPVEEALILAKLALQCAELRRKDRP 718
P+ P E L L C + +DRP
Sbjct: 236 PECPPE----LYALMSDCWIYKWEDRP 258
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 73/301 (24%), Positives = 112/301 (37%), Gaps = 43/301 (14%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRSQFQQEVE 510
I ++ + IG G +G VY L A+K L SQF E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 511 VLCNIRHPNMVLLLGACPEFGCLIY---EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
++ + HPN++ LLG C YM +G L + + +P + I F +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQ 200
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
+A + FL K VHRDL N +LD + K++D GLAR + +
Sbjct: 201 VAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKT 254
Query: 628 A--------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVER 676
A E QT KSDV+S G+LL +++T A P + +
Sbjct: 255 GAKLPVKWMA-------LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307
Query: 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAE 736
+ G L P L ++ L+C + + RP ++V I
Sbjct: 308 YLLQG---RRLLQP-EYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
Query: 737 E 737
E
Sbjct: 360 E 360
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 78/281 (27%), Positives = 116/281 (41%), Gaps = 32/281 (11%)
Query: 450 YRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRS 503
Y S + E E R IGEG +G V++ VAIK + R
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436
Query: 504 QFQQEVEVLCNIRHPNMVLLLGAC---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQI 560
+F QE + HP++V L+G P + +I E G L L R S L I
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLI 494
Query: 561 RFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSV 620
+ A +++TAL +L + VHRD+ N+L+ N K+ D GL+R + +
Sbjct: 495 LY--AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDS 544
Query: 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERS 677
T Y+ + ++ PE SDV+ G+ + +I+ KP G+ + V
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
Query: 678 IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
IENG E L P P+ P L L +C RP
Sbjct: 605 IENG---ERL-PMPPNCPPT----LYSLMTKCWAYDPSRRP 637
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 72/264 (27%), Positives = 112/264 (42%), Gaps = 33/264 (12%)
Query: 469 RKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVL 522
+ +G G +G V L VAIK L+ + R F E ++ HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 523 LLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
L G + ++ EYM NGSL+ L + + + IA+ + +L
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--LRGIASGMKYLSDMG- 167
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID---P 637
VHRDL NIL++ N V K+SD GL R+ + D T G I P
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRV----LEDDPEAAYTTR--GGKIPIRWTSP 219
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIENGTFDETLDPAVPDW 694
E SDV+S GI+L ++++ +P ++ V ++++ G L P D
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG---YRL-PPPMDC 275
Query: 695 PVEEALILAKLALQCAELRRKDRP 718
P L +L L C + R +RP
Sbjct: 276 PAA----LYQLMLDCWQKDRNNRP 295
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 63/270 (23%), Positives = 109/270 (40%), Gaps = 45/270 (16%)
Query: 441 LNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLR 495
L+SL + K +E++ + F+ R +G+G +G V ++ L VA+K+L+
Sbjct: 2 LDSLGIS-DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK 60
Query: 496 PDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG--------CLIYEYMANGSLED 545
D +F +E + HP++ L+G +I +M +G L
Sbjct: 61 ADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA 120
Query: 546 --RLFRRGGSP-VLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSK 602
R G +P LP Q R +IA + +L +HRDL N +L +
Sbjct: 121 FLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177
Query: 603 ISDVGLARLVPPSVADSVTQYRMTSA--------AGTFCYIDPEYQQTGMLGVKSDVYSL 654
++D GL+R + S YR A A E + V SDV++
Sbjct: 178 VADFGLSRKI-----YSGDYYRQGCASKLPVKWLA-------LESLADNLYTVHSDVWAF 225
Query: 655 GILLLQIIT--AKPPMGLA-HQVERSIENG 681
G+ + +I+T P G+ ++ + G
Sbjct: 226 GVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHP 518
E + +KIGEG +G S D IK + ++ R + ++EV VL N++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 519 NMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V + E G L + +Y G L R+ + G QI +I AL +H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL-DWFVQICLALKHVH 142
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
K ++HRD+K NI L ++ ++ D G+AR++ + T + GT Y+
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL------NSTVELARACIGTPYYLS 193
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
PE + KSD+++LG +L ++ T K
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 58/261 (22%), Positives = 104/261 (39%), Gaps = 37/261 (14%)
Query: 469 RKIGEGGYGPVYKSYLDHT-PVAIKV--LRPDAAQGRSQFQQEVEVLCNIRHPNM--VLL 523
++IG GG V++ + AIK L Q ++ E+ L ++ + + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 524 LGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
++ ++ E N L L ++ PW+ + + A+ +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID--PWERK-SYWKNMLEAVHTIHQHG-- 128
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE--- 638
+VH DLKP N L+ + K+ D G+A + T S GT Y+ PE
Sbjct: 129 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQ----PDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 639 --------YQQTGMLGVKSDVYSLGILLLQIITAKPP-MGLAHQVER--SIENGTFDETL 687
+ + KSDV+SLG +L + K P + +Q+ + +I +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH---- 238
Query: 688 DPAVPDWPVEEALILAKLALQ 708
+ PD P ++ + K L+
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLK 259
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 77/269 (28%), Positives = 117/269 (43%), Gaps = 42/269 (15%)
Query: 469 RKIGEGGYGPVYKSYL------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMV 521
+ IG G +G VYK L PVAIK L+ + R F E ++ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 522 LLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
L G ++ +I EYM NG+L+ L + G + + IA + +L
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM--LRGIAAGMKYLANMN 167
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA-------AGTF 632
VHRDL NIL++ N V K+SD GL+R++ D Y + A
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE---DDPEATYTTSGGKIPIRWTA--- 218
Query: 633 CYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDP 689
PE SDV+S GI++ +++T +P L H+V ++I +G L P
Sbjct: 219 ----PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRL-P 270
Query: 690 AVPDWPVEEALILAKLALQCAELRRKDRP 718
D P + +L +QC + R RP
Sbjct: 271 TPMDCPSA----IYQLMMQCWQQERARRP 295
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 31/225 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPN 519
+ S +G+G V++ T AIKV + +E EVL + H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 520 MVLLLGACPEFG-----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
+V L A E LI E+ GSL L + LP + ++ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 575 LHQTKPEPLVHRDLKPGNILL----DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
L + +VHR++KPGNI+ D V K++D G AR + + S G
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVSLYG 177
Query: 631 TFCYIDPEYQQTGML--------GVKSDVYSLGILLLQIITAKPP 667
T Y+ P+ + +L G D++S+G+ T P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 55/258 (21%), Positives = 99/258 (38%), Gaps = 43/258 (16%)
Query: 452 KYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDAA--QGRSQ 504
+ +E++ + +GEG +G V + L VA+K ++ D + + +
Sbjct: 23 QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE 82
Query: 505 FQQEVEVLCNIRHPNMVLLLGAC----PEFGCLIY---EYMANGSLEDRLFRR---GGSP 554
F E + + HPN++ LLG C + +M G L L G
Sbjct: 83 FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK 142
Query: 555 VLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614
+P Q + +IA + +L +HRDL N +L + ++D GL++ +
Sbjct: 143 HIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKI-- 197
Query: 615 SVADSVTQYRMTSA--------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--A 664
S YR A E + KSDV++ G+ + +I T
Sbjct: 198 ---YSGDYYRQGRIAKMPVKWIA-------IESLADRVYTSKSDVWAFGVTMWEIATRGM 247
Query: 665 KPPMGLA-HQVERSIENG 681
P G+ H++ + +G
Sbjct: 248 TPYPGVQNHEMYDYLLHG 265
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 469 RKIGEGGYGPVYKSYLDHT---PVAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVL 522
K+G GG VY + D VAIK + + +F++EV + H N+V
Sbjct: 17 DKLGGGGMSTVYLAE-DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 523 LLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
++ E C L+ EY+ +L + + G L +I + H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA-GTFCYIDPEY 639
+VHRD+KP NIL+D N KI D G+A+ + S+TQ T+ GT Y PE
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQ---TNHVLGTVQYFSPEQ 183
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKPP 667
+ +D+YS+GI+L +++ +PP
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 19/217 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHP 518
E++ IG G YG K D + K L + + EV +L ++HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 519 NMVLLLGACPEFG----CLIYEYMANGSLEDRL--FRRGGSPVLPWQIRFRIAAEIATAL 572
N+V + ++ EY G L + + + + R+ ++ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL-RVMTQLTLAL 124
Query: 573 LFLHQTKPEPL--VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
H+ +HRDLKP N+ LD K+ D GLAR++ + + G
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL------NHDTSFAKTFVG 178
Query: 631 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
T Y+ PE KSD++SLG LL ++ PP
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIK---VLRPDAAQGRSQFQQEVEVLCNIRH 517
NF +KIG G + VY+ LD PVA+K + A+ R+ +E+++L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 518 PNMVLLLGACPEFGCL-IY-EYMANGSLEDRL--FRRGGSPVLPWQIRFRIAAEIATALL 573
PN++ + E L I E G L + F++ + + + ++ +AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW-KYFVQLCSALE 150
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
+H + ++HRD+KP N+ + V K+ D+GL R S S GT
Sbjct: 151 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSLVGTPY 201
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Y+ PE KSD++SLG LL ++ + P
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 71/284 (25%), Positives = 116/284 (40%), Gaps = 57/284 (20%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNM 520
++GE +G VYK +L VAIK L+ A R +F+ E + ++HPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 521 VLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR-------------IA 565
V LLG + +I+ Y ++G L + L R + R +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM 625
A+IA + +L +VH+DL N+L+ KISD+GL R V + Y++
Sbjct: 135 AQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV-----YAADYYKL 186
Query: 626 TSA--------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAHQ-V 674
A PE G + SD++S G++L ++ + +P G ++Q V
Sbjct: 187 LGNSLLPIRWMA-------PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 675 ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
I N + L D P + L ++C RP
Sbjct: 240 VEMIRNR---QVLPCP-DDCPAW----VYALMIECWNEFPSRRP 275
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 66/255 (25%), Positives = 107/255 (41%), Gaps = 66/255 (25%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
R++GEG +G V+ + D VA+K L+ R FQ+E E+L N++H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 522 LLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR-------------IAA 566
G C + +++EYM +G L L G ++ + R IA+
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+IA+ +++L VHRDL N L+ N + KI D G++R V
Sbjct: 141 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDV-------------- 183
Query: 627 SAAGTFCYIDPEY--QQTGMLGVK---------------SDVYSLGILLLQIIT--AKPP 667
Y Y ML ++ SDV+S G++L +I T +P
Sbjct: 184 -------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 668 MGLAH-QVERSIENG 681
L++ +V I G
Sbjct: 237 FQLSNTEVIECITQG 251
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 65/260 (25%), Positives = 97/260 (37%), Gaps = 71/260 (27%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPN 519
+ +G G +G V ++ VA+K+L+P A R E++VL + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 520 MVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIR---------------F 562
+V LLGAC G +I EY G L + L R+ S +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
+ ++A + FL +HRDL NILL ++KI D GLAR +
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI---------- 195
Query: 623 YRMTSAAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQIIT-A 664
D Y L VK SDV+S GI L ++ +
Sbjct: 196 -----------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 665 KPP---MGLAHQVERSIENG 681
P M + + + I+ G
Sbjct: 245 SSPYPGMPVDSKFYKMIKEG 264
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 469 RKIGEGGYGPVYKSYLDHT---PVAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVL 522
+G GG V+ + D VA+KVLR D A+ +F++E + + HP +V
Sbjct: 18 EILGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 523 LL--GACPEFGCLIY----EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
+ G + EY+ +L D + G + + + A+ AL F H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH 133
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA-GTFCYI 635
Q ++HRD+KP NI++ K+ D G+AR + S SVTQ T+A GT Y+
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQ---TAAVIGTAQYL 186
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
PE + + +SDVYSLG +L +++T +PP
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-32
Identities = 67/295 (22%), Positives = 114/295 (38%), Gaps = 41/295 (13%)
Query: 470 KIGEGGYGPVYKSYL----DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLL 524
++G G +G V + VAIKVL+ + +E +++ + +P +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 525 GAC-PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
G C E L+ E G L L + + +++ + +L +
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVSMGMKYLEEKN---F 457
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA--------AGTFCYI 635
VHR+L N+LL + +KISD GL++ + + Y SA A
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTARSAGKWPLKWYA------ 507
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVERSIENGTFDETLDPAVP 692
PE +SDV+S G+ + + ++ KP + +V IE G + + P
Sbjct: 508 -PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRM-ECPP 562
Query: 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASG 747
+ P E L L C + +DRPD V +LA + L
Sbjct: 563 ECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALEVA 613
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 63/241 (26%), Positives = 100/241 (41%), Gaps = 43/241 (17%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNM 520
R++G+G +G VY+ T VAIK + A + R +F E V+ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 521 VLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIR-------FRIAAEIATA 571
V LLG + +I E M G L+ L + + ++A EIA
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA--- 628
+ +L+ K VHRDL N ++ ++ KI D G+ R + YR
Sbjct: 151 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDYYRKGGKGLL 202
Query: 629 -----AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLA-HQVERSIEN 680
+ PE + G+ SDV+S G++L +I T +P GL+ QV R +
Sbjct: 203 PVRWMS-------PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 681 G 681
G
Sbjct: 256 G 256
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 68/284 (23%), Positives = 115/284 (40%), Gaps = 59/284 (20%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
++GEG +G V+ + D VA+K L+ + R FQ+E E+L ++H ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 522 LLLGACPEFG--CLIYEYMANGSLEDRLFRR--------GGSPVLPWQIRFR----IAAE 567
G C E +++EYM +G L L GG V P + +A++
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
+A +++L VHRDL N L+ + V KI D G++R + + YR+
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-----YRVGG 218
Query: 628 A--------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAH-QVER 676
PE +SDV+S G++L +I T +P L++ +
Sbjct: 219 RTMLPIRWMP-------PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271
Query: 677 SIENGTFDETLD--PAVPDWPVEEALILAKLALQCAELRRKDRP 718
I G L+ A P + + C + + R
Sbjct: 272 CITQG---RELERPRACPPE-------VYAIMRGCWQREPQQRH 305
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 21/212 (9%)
Query: 463 ENFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQQ---EVEVLCNIRH 517
E+F R +G+G +G VY + +A+KVL + Q EVE+ ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 518 PNMVLLLG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
PN++ L G LI EY G++ L + Q E+A AL +
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 125
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H + ++HRD+KP N+LL KI+D G + P + R GT Y+
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTDL-CGTLDYL 174
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
PE + M K D++SLG+L + + KPP
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 64/259 (24%), Positives = 100/259 (38%), Gaps = 70/259 (27%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPN 519
+ +G G +G V ++ VA+K+L+ A E+++L +I H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 520 MVLLLGACPEFG---CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR------------- 563
+V LLGAC + G +I E+ G+L L + V
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623
+ ++A + FL K +HRDL NILL V KI D GLAR +
Sbjct: 153 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI----------- 198
Query: 624 RMTSAAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQIIT-AK 665
Y DP+Y + L +K SDV+S G+LL +I +
Sbjct: 199 ----------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 666 PP---MGLAHQVERSIENG 681
P + + + R ++ G
Sbjct: 249 SPYPGVKIDEEFCRRLKEG 267
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 57/261 (21%), Positives = 103/261 (39%), Gaps = 37/261 (14%)
Query: 469 RKIGEGGYGPVYKSYLDHT-PVAIKV--LRPDAAQGRSQFQQEVEVLCNIRHPNM--VLL 523
++IG GG V++ + AIK L Q ++ E+ L ++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 524 LGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
++ ++ E N L L ++ PW+ + + A+ +HQ
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID--PWERK-SYWKNMLEAVHTIHQHG-- 175
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE--- 638
+VH DLKP N L+ + K+ D G+A + T S G Y+ PE
Sbjct: 176 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQ----PDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 639 --------YQQTGMLGVKSDVYSLGILLLQIITAKPP-MGLAHQVER--SIENGTFDETL 687
+ + KSDV+SLG +L + K P + +Q+ + +I +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH---- 285
Query: 688 DPAVPDWPVEEALILAKLALQ 708
+ PD P ++ + K L+
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLK 306
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 29/244 (11%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVLL 523
R +G+GG+ ++ T A K++ R + E+ + ++ H ++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 524 LG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
G +F ++ E SL + RR + + R +I +LH+ +
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEAR-YYLRQIVLGCQYLHRNR-- 135
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ 641
++HRDLK GN+ L+ + KI D GLA V + + + GT YI PE
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVL-CGTPNYIAPEVLS 188
Query: 642 TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDWPVEEA 699
+ DV+S+G ++ ++ KPP + E I+ + +P A
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------IPKHINPVA 242
Query: 700 --LI 701
LI
Sbjct: 243 ASLI 246
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 60/214 (28%), Positives = 84/214 (39%), Gaps = 25/214 (11%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNI-RH 517
++F ++G G YG V+K S D A+K + R++ EV + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 518 PNMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLP-WQIRFRIAAEIATALLF 574
P V L A E G L E SL+ G S LP Q+ + AL
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGAS--LPEAQVWG-YLRDTLLALAH 172
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR-LVPPSVADSVTQYRMTSAAGTFC 633
LH LVH D+KP NI L K+ D GL L + G
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--------GDPR 221
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Y+ PE Q G +DV+SLG+ +L++
Sbjct: 222 YMAPELLQGS-YGTAADVFSLGLTILEVACNMEL 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 69/264 (26%), Positives = 103/264 (39%), Gaps = 75/264 (28%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNM 520
+ +GEG +G V K+ +T VA+K+L+ +A+ E VL + HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 521 VLLLGACPEFG--CLIYEYMANGSLEDRLFRR---------------------GGSPVLP 557
+ L GAC + G LI EY GSL L L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 558 WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617
A +I+ + +L + K LVHRDL NIL+ KISD GL+R V
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDV----- 200
Query: 618 DSVTQYRMTSAAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQ 660
Y + Y + G + VK SDV+S G+LL +
Sbjct: 201 ----------------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 661 IIT--AKPPMGLA-HQVERSIENG 681
I+T P G+ ++ ++ G
Sbjct: 245 IVTLGGNPYPGIPPERLFNLLKTG 268
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 32/213 (15%)
Query: 469 RKIGEGGYGPVYKSYLDHT---PVAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVL 522
R +G GG G VY++ D VA+K++ + R++ Q+E ++ P++V
Sbjct: 40 RLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 523 L--LGACPEFGCLIY---EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+ G E +Y + L L R+G L I +I +AL H
Sbjct: 99 IHDFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHA 152
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA---GTFCY 634
HRD+KP NIL+ + + + D G+A + T ++T GT Y
Sbjct: 153 AG---ATHRDVKPENILVSADDFAYLVDFGIAS--------ATTDEKLTQLGNTVGTLYY 201
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+ PE ++D+Y+L +L + +T PP
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 65/259 (25%), Positives = 109/259 (42%), Gaps = 70/259 (27%)
Query: 469 RKIGEGGYGPVYKSYL---------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RH 517
+ +GEG +G V + + VA+K+L+ DA + S E+E++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 518 PNMVLLLGACPEFG--CLIYEYMANGSLEDRL-------------FRRGGSPVLPWQIRF 562
N++ LLGAC + G +I EY + G+L + L R + ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
++A + +L K +HRDL N+L+ N V KI+D GLAR +
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI---------- 207
Query: 623 YRMTSAAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQIIT-- 663
Y++T G L VK SDV+S G+L+ +I T
Sbjct: 208 -----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 664 AKPPMGLA-HQVERSIENG 681
P G+ ++ + ++ G
Sbjct: 257 GSPYPGIPVEELFKLLKEG 275
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 63/234 (26%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPN 519
+ +G G +G V ++ VA+K+L+ A A + E++++ ++ +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 520 MVLLLGACPEFG--CLIYEYMANGSLEDRLFRR-----------GGSPVLPWQIRFRIAA 566
+V LLGAC G +I EY G L + L R+ + + ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
++A + FL +HRD+ N+LL +V+KI D GLAR +
Sbjct: 172 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI-------------- 214
Query: 627 SAAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQIIT 663
D Y L VK SDV+S GILL +I +
Sbjct: 215 -------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 31/235 (13%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNM 520
R +G G +G VY+ + VA+K L Q F E ++ H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 521 VLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR----IAAEIATALLF 574
V +G + ++ E MA G L+ L P P + +A +IA +
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 575 LHQTKPEPLVHRDLKPGNILLDR---NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
L + +HRD+ N LL V+KI D G+AR + + YR
Sbjct: 156 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-----RASYYRKGG-CAM 206
Query: 632 F--CYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGLAH-QVERSIENG 681
++ PE G+ K+D +S G+LL +I + P ++ +V + +G
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 29/244 (11%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG---RSQFQQEVEVLCNIRHPNMVLL 523
R +G+GG+ ++ T A K++ R + E+ + ++ H ++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 524 LG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
G +F ++ E SL + RR + + R +I +LH+ +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEAR-YYLRQIVLGCQYLHRNR-- 161
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ 641
++HRDLK GN+ L+ + KI D GLA V + + + GT YI PE
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVL-CGTPNYIAPEVLS 214
Query: 642 TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDWPVEEA 699
+ DV+S+G ++ ++ KPP + E I+ + +P A
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------IPKHINPVA 268
Query: 700 --LI 701
LI
Sbjct: 269 ASLI 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPNMVLL 523
+G+G + VY +S VAIK++ A + Q EV++ C ++HP+++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 524 LG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
+ L+ E NG + L R P + R +I T +L+LH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEAR-HFMHQIITGMLYLHSHG-- 132
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ 641
++HRDL N+LL RN KI+D GLA + + T GT YI PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTL-CGTPNYISPEIAT 185
Query: 642 TGMLGVKSDVYSLGILLLQIITAKPP 667
G++SDV+SLG + ++ +PP
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 51/265 (19%), Positives = 105/265 (39%), Gaps = 43/265 (16%)
Query: 429 KALREAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTP 488
++++ + L L ++ + I ++ R + +G + + D+
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYIN-------DYRIIRTLNQGKFNKIILCEKDNKF 56
Query: 489 VAIKVL-----------------RPDAAQGRSQFQQEVEVLCNIRHPNMVLLLG--ACPE 529
A+K + F+ E++++ +I++ + G +
Sbjct: 57 YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD 116
Query: 530 FGCLIYEYMANGSLEDRLFRRG-----GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
+IYEYM N S+ + +P Q+ I + + ++H K +
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--IC 174
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE--YQQT 642
HRD+KP NIL+D+N K+SD G + + ++ + GT+ ++ PE ++
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNES 226
Query: 643 GMLGVKSDVYSLGILLLQIITAKPP 667
G K D++SLGI L + P
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 81/323 (25%), Positives = 125/323 (38%), Gaps = 62/323 (19%)
Query: 469 RKIGEGGYGPVYKSYLD----HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVL 522
IGEG +G V K+ + AIK ++ A F E+EVLC + HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 523 LLGACPEFG--CLIYEYMANGSLEDRL-------------FRRGGSPVLPWQIRFRIAAE 567
LLGAC G L EY +G+L D L + L Q AA+
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
+A + +L Q + +HRDL NIL+ NYV+KI+D GL+R Y +
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKT 199
Query: 628 A--------AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT--AKPPMGL-AHQVER 676
A E + SDV+S G+LL +I++ P G+ ++
Sbjct: 200 MGRLPVRWMA-------IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252
Query: 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAE 736
+ G + E + L QC + +RP +++ L + E
Sbjct: 253 KLPQG----YRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQIL----VSLNRMLE 300
Query: 737 ETMPAINLASGAGSSPSYSQVST 759
E +N + + S
Sbjct: 301 ERKTYVNTTLYEKFTYAGIDCSA 323
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 35/238 (14%), Positives = 77/238 (32%), Gaps = 35/238 (14%)
Query: 455 IEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTP-------VAIKVLRPDAAQGRSQFQQ 507
E + ++ +GEG + VY++ +KV +P Q
Sbjct: 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ 116
Query: 508 EVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRL--FRRGGSPVLPWQIRFR 563
+E L + A L+ E + G+L + + ++ V+P +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS-----------KISDVGLA--- 609
A + + +H + ++H D+KP N +L ++ + D+G +
Sbjct: 177 FAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+L P T+ T + E + D + + + ++
Sbjct: 234 KLFPKGT-------IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 463 ENFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRS---QFQQEVEVLCNIRH 517
++F R +G+G +G VY + + +A+KVL + Q ++E+E+ ++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 518 PNMVLLLG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF------RIAAEIA 569
PN++ + + L+ E+ G L L + G RF E+A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---------RFDEQRSATFMEELA 124
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
AL + H+ K ++HRD+KP N+L+ KI+D G + P + R T
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP-------SLRRRTM-C 173
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
GT Y+ PE + K D++ G+L + + PP
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 81/327 (24%), Positives = 129/327 (39%), Gaps = 87/327 (26%)
Query: 469 RKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNM 520
R IGEG +G V+++ T VA+K+L+ +A A ++ FQ+E ++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 521 VLLLGACPEFG--CLIYEYMANGSLEDRLFRR---------------------GGSPVLP 557
V LLG C CL++EYMA G L + L G P L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 558 WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617
+ IA ++A + +L + K VHRDL N L+ N V KI+D GL+R +
Sbjct: 173 CAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI----- 224
Query: 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVK---------------SDVYSLGILLLQII 662
S Y+ + ++ SDV++ G++L +I
Sbjct: 225 YSADYYKADGN--------------DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 663 T--AKPPMGLAH-QVERSIENGTFDETLD--PAVPDWPVEEALILAKLALQCAELRRKDR 717
+ +P G+AH +V + +G L P L L C DR
Sbjct: 271 SYGLQPYYGMAHEEVIYYVRDGN---ILACPENCPLE-------LYNLMRLCWSKLPADR 320
Query: 718 PDLGKVVVPKLNILRALAEETMPAINL 744
P + IL+ + E + +
Sbjct: 321 PSFCSIH----RILQRMCERAEGTVGV 343
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 66/273 (24%), Positives = 123/273 (45%), Gaps = 25/273 (9%)
Query: 432 REAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PV 489
+ ++RK LT + + ++ E+ +E +G G G V+K + +
Sbjct: 9 LDEQQRKRLEAFLTQKQKVGELKDDDFEKISE-------LGAGNGGVVFKVSHKPSGLVM 61
Query: 490 AIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIY--EYMANGSLEDR 546
A K++ + R+Q +E++VL P +V GA G + E+M GSL+
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ- 120
Query: 547 LFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606
+ ++ G +P QI +++ + L +L + ++HRD+KP NIL++ K+ D
Sbjct: 121 VLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 176
Query: 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKP 666
G++ + S+A+S GT Y+ PE Q V+SD++S+G+ L+++ +
Sbjct: 177 GVSGQLIDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
Query: 667 PMGLAHQVERSIENGTFDETLDPAVPDWPVEEA 699
P+ E + G E P P
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 65/259 (25%), Positives = 109/259 (42%), Gaps = 70/259 (27%)
Query: 469 RKIGEGGYGPVYKSYL---------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RH 517
+ +GEG +G V + + VA+K+L+ DA + S E+E++ I +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 518 PNMVLLLGACPEFG--CLIYEYMANGSLEDRL-------------FRRGGSPVLPWQIRF 562
N++ LLGAC + G +I EY + G+L + L R + ++
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
++A + +L K +HRDL N+L+ N V KI+D GLAR +
Sbjct: 207 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI---------- 253
Query: 623 YRMTSAAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQIIT-- 663
Y++T G L VK SDV+S G+L+ +I T
Sbjct: 254 -----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302
Query: 664 AKPPMGLA-HQVERSIENG 681
P G+ ++ + ++ G
Sbjct: 303 GSPYPGIPVEELFKLLKEG 321
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 27/246 (10%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG-RSQFQQEVEVLCNIRHPNMVLLL- 524
++G GG+G V + T VAIK R + + R ++ E++++ + HPN+V
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 525 -------GACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
A + L EY G L L + L + ++I++AL +LH+
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 578 TKPEPLVHRDLKPGNILLDRN---YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
+ ++HRDLKP NI+L + KI D+G A+ + T GT Y
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-------GELCTEFVGTLQY 189
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIENGTFDETLDPAV 691
+ PE + V D +S G L + IT P Q + + + +
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 692 PDWPVE 697
V+
Sbjct: 250 LTGAVK 255
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-30
Identities = 56/261 (21%), Positives = 96/261 (36%), Gaps = 44/261 (16%)
Query: 469 RKIGEGGYGPVYKSY---LDHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMV--- 521
I GG G +Y + ++ PV +K L A+ ++ E + L + HP++V
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 522 ----LLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
G ++ EY+ SL+ ++ LP EI AL +LH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS 200
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
LV+ DLKP NI+L + K+ D+G + + GT + P
Sbjct: 201 ---IGLVYNDLKPENIMLTEEQL-KLIDLGAVS--------RINSFGY--LYGTPGFQAP 246
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVE 697
E V +D+Y++G L + P NG + + L P
Sbjct: 247 E-IVRTGPTVATDIYTVGRTLAALTLDLPT-----------RNGRYVDGLPEDDPVLKTY 294
Query: 698 EALILAKLALQCAELRRKDRP 718
++ +L + + + R
Sbjct: 295 DS--YGRLLRRAIDPDPRQRF 313
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 64/265 (24%), Positives = 94/265 (35%), Gaps = 76/265 (28%)
Query: 469 RKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPN 519
+ +G G +G V + VA+K+L+ A + R E++++ + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 520 MVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR-------------- 563
+V LLGAC G LI+EY G L + L +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 564 ------IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617
A ++A + FL VHRDL N+L+ V KI D GLAR +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI----- 222
Query: 618 DSVTQYRMTSAAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQ 660
D Y L VK SDV+S GILL +
Sbjct: 223 ----------------MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 266
Query: 661 IIT-AKPP---MGLAHQVERSIENG 681
I + P + + + I+NG
Sbjct: 267 IFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 60/266 (22%), Positives = 98/266 (36%), Gaps = 31/266 (11%)
Query: 438 KAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-------DHTPVA 490
N + E +N + R +G G +G VY+ + VA
Sbjct: 46 MTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA 105
Query: 491 IKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRL 547
+K L Q F E ++ H N+V +G + ++ E MA G L+ L
Sbjct: 106 VKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 165
Query: 548 FRRGGSPVLPWQIRFR----IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYV 600
P P + +A +IA +L + +HRD+ N LL V
Sbjct: 166 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222
Query: 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTF--CYIDPEYQQTGMLGVKSDVYSLGILL 658
+KI D G+AR + YR ++ PE G+ K+D +S G+LL
Sbjct: 223 AKIGDFGMARDIY-----RAGYYRKGG-CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
Query: 659 LQIIT--AKPPMGLA-HQVERSIENG 681
+I + P + +V + +G
Sbjct: 277 WEIFSLGYMPYPSKSNQEVLEFVTSG 302
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 70/259 (27%)
Query: 469 RKIGEGGYGPVYKSYL---------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RH 517
+ +GEG +G V + T VA+K+L+ DA + S E+E++ I +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 518 PNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRR-------------GGSPVLPWQIRF 562
N++ LLGAC + G +I EY + G+L + L R L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
A ++A + +L K +HRDL N+L+ + V KI+D GLAR +
Sbjct: 195 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI---------- 241
Query: 623 YRMTSAAGTFCYIDPEYQQT--GMLGVK---------------SDVYSLGILLLQIIT-- 663
+ Y++T G L VK SDV+S G+LL +I T
Sbjct: 242 -----------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290
Query: 664 AKPPMGLA-HQVERSIENG 681
P G+ ++ + ++ G
Sbjct: 291 GSPYPGVPVEELFKLLKEG 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 59/266 (22%), Positives = 104/266 (39%), Gaps = 30/266 (11%)
Query: 443 SLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGP-VYKSYLDHTPVAIKVLRPDAAQG 501
SL D + S+ + + +F +G G G VY+ D+ VA+K + P+
Sbjct: 6 SLEQDDGDEETSVVIVGK--ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--- 60
Query: 502 RSQFQQEVEVLCNI-RHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPW 558
S +EV++L HPN++ +F + E A +L++ + ++ +
Sbjct: 61 FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLG 117
Query: 559 QIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL-----DRNYVSKISDVGLARLVP 613
+ + + L LH +VHRDLKP NIL+ + ISD GL + +
Sbjct: 118 LEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 614 PSVADSVTQYRMTSAAGTFCYIDPEY---QQTGMLGVKSDVYSLGILLLQIITA-KPPMG 669
+ R + GT +I PE D++S G + +I+ P G
Sbjct: 175 V---GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 670 LAHQVERSIENGTFDETLDPAVPDWP 695
+ Q + +I G +
Sbjct: 232 KSLQRQANILLGACS---LDCLHPEK 254
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 65/283 (22%), Positives = 107/283 (37%), Gaps = 45/283 (15%)
Query: 455 IEEIEEATENFSN----SRKIGEGGYGPVYKSY-LDHTPVAIKVLRPDAAQGRSQFQQEV 509
I I ++ N + +G G G V PVA+K + D E+
Sbjct: 3 IANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEI 59
Query: 510 EVLC-NIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAA 566
++L + HPN++ + F + E N +L+D + + S +
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 567 E----IATALLFLHQTKPEPLVHRDLKPGNILLD-------------RNYVSKISDVGLA 609
IA+ + LH K ++HRDLKP NIL+ N ISD GL
Sbjct: 119 SLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPE-------YQQTGMLGVKSDVYSLGILLLQII 662
+ + S + + + +GT + PE Q L D++S+G + I+
Sbjct: 176 KKLDSG--QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 663 TA-KPPMGLAHQVERSIENGTFD-ETLDPAVPDWPVEEA--LI 701
+ K P G + E +I G F + + + EA LI
Sbjct: 234 SKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLI 276
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 56/245 (22%), Positives = 93/245 (37%), Gaps = 36/245 (14%)
Query: 445 TVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGR 502
TV+L + + R + EGG+ VY + A+K L + +
Sbjct: 22 TVELGELRLRVR------------RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN 69
Query: 503 SQFQQEVEVLCNIR-HPNMVLLLGAC---------PEFGCLIYEYMANGSLEDRLFRRGG 552
QEV + + HPN+V A + L+ + G L + L +
Sbjct: 70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES 129
Query: 553 SPVLP-WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611
L + +I + A+ +H+ KP P++HRDLK N+LL K+ D G A
Sbjct: 130 RGPLSCDTVL-KIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
Query: 612 --VPPSVADSVTQYRMTSAAGTFC----YIDPE---YQQTGMLGVKSDVYSLGILLLQII 662
P + S + + T Y PE +G K D+++LG +L +
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 663 TAKPP 667
+ P
Sbjct: 248 FRQHP 252
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 471 IGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
+G+G YG VY +AIK + ++ +E+ + +++H N+V LG+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 529 EFGCL-IY-EYMANGSLEDRLFRRGGS-PVLPWQIRFRIAAEIATALLFLHQTKPEPLVH 585
E G + I+ E + GSL L + G I F +I L +LH + +VH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHDNQ---IVH 145
Query: 586 RDLKPGNILLD-RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE--YQQT 642
RD+K N+L++ + V KISD G ++ + + + GT Y+ PE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL------AGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 643 GMLGVKSDVYSLGILLLQIITAKPP 667
G +D++SLG ++++ T KPP
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 21/218 (9%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCN 514
E E ++ ++G G +G V++ T A+K +R + + +E+
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAG 106
Query: 515 IRHPNMVLLLGACPEFGCL-IY-EYMANGSLEDRLFRRGGSPVLP-WQIRFRIAAEIATA 571
+ P +V L GA E + I+ E + GSL L ++ G LP + + +
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGC--LPEDRALY-YLGQALEG 162
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVS-KISDVGLARLVPPSVADSVTQYRMTSAAG 630
L +LH + ++H D+K N+LL + + D G A + P + G
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK-SLLTGDYIPG 218
Query: 631 TFCYIDPE-YQQTGMLGVKSDVYSLGILLLQIITAKPP 667
T ++ PE K D++S ++L ++ P
Sbjct: 219 TETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN 519
+ ++ KIG+G G VY + T VAI+ + + E+ V+ ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L + L + EY+A GSL D + + QI + E AL FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTET--CMDEGQIAA-VCRECLQALEFLHS 134
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGL-ARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ ++HRD+K NILL + K++D G A++ P Q + ++ GT ++
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMVGTPYWMA 184
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
PE G K D++SLGI+ +++I +PP
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN 519
+ KIGEG G V + H+ VA+K++ Q R EV ++ + +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V + + L + E++ G+L D + + + QI + + AL +LH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQV--RLNEEQIAT-VCEAVLQALAYLHA 159
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGL-ARLVPPSVADSVTQYRMTSAAGTFCYID 636
++HRD+K +ILL + K+SD G A++ + S GT ++
Sbjct: 160 QG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------DVPKRKSLVGTPYWMA 209
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
PE + + D++SLGI++++++ +PP
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 56/251 (22%), Positives = 92/251 (36%), Gaps = 29/251 (11%)
Query: 462 TENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNI-R 516
T F KIG G +G V+K LD AIK + A +EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 517 HPNMVLLLGACPEFGCL-IY-EYMANGSLEDRLFRRGGSP-VLP-WQIRFRIAAEIATAL 572
H ++V A E + I EY GSL D + +++ + ++ L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-DLLLQVGRGL 128
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS------VAD--SVTQYR 624
++H LVH D+KP NI + R + + S + D VT+
Sbjct: 129 RYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 625 MT-SAAGTFCYIDPE-YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGT 682
G ++ E Q+ K+D+++L + ++ A+P Q I G
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE-IRQGR 244
Query: 683 FDETLDPAVPD 693
P +P
Sbjct: 245 L-----PRIPQ 250
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN 519
E + ++G+G +G VYK+ T A KV+ + + + E+E+L HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V LLGA G L + E+ G+++ + + QI+ + ++ AL FLH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGL-ARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ ++HRDLK GN+L+ +++D G+ A+ T + S GT ++
Sbjct: 136 KR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN-------LKTLQKRDSFIGTPYWMA 185
Query: 637 PE-----YQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
PE + K+D++SLGI L+++ +PP
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN 519
E F K+GEG YG VYK+ T VAIK + + +E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V G+ + L + EY GS+ D + R + +I I L +LH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGL-ARLVPPSVADSVTQYRMTSAAGTFCYID 636
+ +HRD+K GNILL+ +K++D G+ +L + T + + GT ++
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVAGQL-------TDTMAKRNTVIGTPFWMA 193
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
PE Q +D++SLGI +++ KPP
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 17/218 (7%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGR-SQFQQEVEVLCNIRHPN 519
+++ IG G V +Y VAIK + + Q + +E++ + HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 520 MVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFR---IAA---EIATA 571
+V + L + + ++ GS+ D + + + IA E+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
L +LH+ +HRD+K GNILL + +I+D G++ + + + R T GT
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-VGT 189
Query: 632 FCYIDPE-YQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
C++ PE +Q K+D++S GI +++ T P
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 8e-27
Identities = 46/226 (20%), Positives = 76/226 (33%), Gaps = 19/226 (8%)
Query: 502 RSQFQQEVEVLCNIRHPNMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQ 559
++ + N V L L + +L+D + RR
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 560 IRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619
+ I +IA A+ FLH L+HRDLKP NI + V K+ D GL + +
Sbjct: 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 620 VTQY------RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ 673
T GT Y+ PE K D++SLG++L +++ + +
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281
Query: 674 VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD 719
+ + N F P + +RP+
Sbjct: 282 IITDVRNLKFPLLFTQKYPQ--------EHMMVQDMLSPSPTERPE 319
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 21/79 (26%), Positives = 38/79 (48%), Gaps = 3/79 (3%)
Query: 463 ENFSNSRKIGEGGYGPVYK--SYLDHTPVAIKVLR-PDAAQGRSQFQQEVEVLCNIRHPN 519
+F + +G GG+G V++ + +D AIK +R P+ R + +EV+ L + HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 520 MVLLLGACPEFGCLIYEYM 538
+V A E ++
Sbjct: 66 IVRYFNAWLETPPEKWQEE 84
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQ-FQQEVEVLCNIRHP 518
E F+ KIG+G +G V+K + T VAIK++ + A+ + QQE+ VL P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 519 NMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
+ G+ + L I EY+ GS D L G P+ QI I EI L +LH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIAT-ILREILKGLDYLH 136
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
K +HRD+K N+LL + K++D G+A + + TQ + + GT ++
Sbjct: 137 SEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL------TDTQIKRNTFVGTPFWMA 187
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
PE + K+D++SLGI +++ +PP
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPH 219
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 470 KIGEGGYGPVYKSYLDHTP----VAIKVLRPDAA-QGRSQFQQEVEVLCN-IRHPNMVLL 523
++G G YG V K H P +A+K +R Q + + ++++ + P V
Sbjct: 14 ELGRGAYGVVEKMR--HVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 524 LGACPEFGCLIY--EYMANGSLED---RLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
GA G + E M + SL+ ++ +G +P I +IA I AL LH
Sbjct: 72 YGALFREGDVWICMELM-DTSLDKFYKQVIDKGQ--TIPEDILGKIAVSIVKALEHLHSK 128
Query: 579 KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY---- 634
++HRD+KP N+L++ K+ D G++ + VA AG Y
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-------KDIDAGCKPYMAPE 179
Query: 635 -IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
I+PE Q G VKSD++SLGI ++++ + P
Sbjct: 180 RINPELNQKGY-SVKSDIWSLGITMIELAILRFP 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 25/226 (11%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVE 510
+ + + N ++G G G V+K +A+K +R + + +++
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 511 VLCN-IRHPNMVLLLGACPEFGCLIY--EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
V+ P +V G + E M E R G +P +I ++
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG--PIPERILGKMTVA 132
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL-ARLVPPSVADSVTQYRMT 626
I AL +L + ++HRD+KP NILLD K+ D G+ RLV D +
Sbjct: 133 IVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-----DDKAK---D 182
Query: 627 SAAGTFCY-----IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+AG Y IDP +++DV+SLGI L+++ T + P
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 41/364 (11%), Positives = 86/364 (23%), Gaps = 66/364 (18%)
Query: 410 EAAQRIAELEAQKCKNVEFKALREAKERKAALNSLTVDLRYRKYS----IEEIEEATENF 465
EA ++ + + EA + AA+ + + + + +
Sbjct: 5 EAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKL 64
Query: 466 SNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRS---QFQQEVEVLCNIRHPNM 520
+ G V+ A+KV A RS + + + +
Sbjct: 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124
Query: 521 VLLLGACPEFG----------------------------CLIYEYMA-----NGSLEDRL 547
L+ + S D +
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184
Query: 548 FRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607
+ G + A++ L LVH P N+ + + + DV
Sbjct: 185 YVFRGD--EGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEY--QQTGMLGVKSDVYSLGILLLQIITAK 665
V R +++ Y E+ T + + LG+ + ++
Sbjct: 240 ALWKVGT---------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
Query: 666 PPMGLAHQVERSIENGTFDETLDPAVPDWPV-----EEALILAKLALQCAELRRKDRPDL 720
P GL + + + L L R+ R
Sbjct: 291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN---FDRRRRLLP 347
Query: 721 GKVV 724
+ +
Sbjct: 348 LEAM 351
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 46/235 (19%)
Query: 451 RKYSIEEIEEATENFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQQ- 507
RK E +F + +GEG + V + AIK+L ++
Sbjct: 25 RKKRPE-------DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV 77
Query: 508 --EVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR 563
E +V+ + HP V L E Y NG L + + G F
Sbjct: 78 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---------SFD 128
Query: 564 I------AAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSV 616
AEI +AL +LH ++HRDLKP NILL+ + ++ +I+D G A+++ P
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHI-QITDFGTAKVLSPES 184
Query: 617 ADSVTQYRMTSAAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+ +F Y+ PE SD+++LG ++ Q++ PP
Sbjct: 185 KQARAN--------SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 27/231 (11%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEV 511
+ + + F +G G YG VYK T AIKV+ + +QE+ +
Sbjct: 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINM 73
Query: 512 LCNI-RHPNMVLLLGA-----CPEFGC---LIYEYMANGSLEDRLFRRGGSPVLPWQIRF 562
L H N+ GA P L+ E+ GS+ D + G+ + I +
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
I EI L LHQ K ++HRD+K N+LL N K+ D G++ + T
Sbjct: 134 -ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTV 183
Query: 623 YRMTSAAGTFCYIDPE-----YQQTGMLGVKSDVYSLGILLLQIITAKPPM 668
R + GT ++ PE KSD++SLGI +++ PP+
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP----VAIKVLRPDAA-QGRSQFQQEVEVLC-NIR 516
E+ + +IG G YG V K H P +A+K +R + + Q +++V+ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMV--HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD 79
Query: 517 HPNMVLLLGACPEFGCLIY--EYMANGSLED--RLFRRGGSPVLPWQIRFRIAAEIATAL 572
P +V GA G E M+ S + + V+P +I +I AL
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL-ARLVPPSVADSVTQYRMTSAAGT 631
L + ++HRD+KP NILLDR+ K+ D G+ +LV DS+ + T AG
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV-----DSIAK---TRDAGC 188
Query: 632 FCYIDPEYQQTGMLG----VKSDVYSLGILLLQIITAKPP 667
Y+ PE V+SDV+SLGI L ++ T + P
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 68/259 (26%), Positives = 105/259 (40%), Gaps = 45/259 (17%)
Query: 458 IEEATENFSN----SRKIGEGGYGPVYKSYLDHT--PVAIKVL--RPDAAQGRSQFQQEV 509
I + S +K+G G YG V T AIK++ + S+ +EV
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 510 EVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIA 565
VL + HPN++ L L+ E G L D + R +F A
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM---------KFNEVDA 138
Query: 566 AE----IATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVAD 618
A + + + +LH+ +VHRDLKP N+LL +++ + KI D GL+ +
Sbjct: 139 AVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193
Query: 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--R 676
+M GT YI PE + K DV+S+G++L ++ PP G E R
Sbjct: 194 -----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
Query: 677 SIENGTFDETLDPAVPDWP 695
+E G + W
Sbjct: 248 KVEKGKYTFDSPE----WK 262
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 46/221 (20%), Positives = 81/221 (36%), Gaps = 21/221 (9%)
Query: 462 TENFSNSRKIGEG--GYGPVYKSYLDHTP----VAIKVLRPDAAQGR--SQFQQEVEVLC 513
+ IG+G V + + P V ++ + +A + Q E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLAR--YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK 81
Query: 514 NIRHPNMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLP-WQIRFRIAAEIAT 570
HPN+V L + +MA GS +D L + I + I +
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAY-ILQGVLK 139
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG-LARLVPPSVADSVTQYRMTSAA 629
AL ++H VHR +K +IL+ + +S + ++ V +
Sbjct: 140 ALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 630 GTFCYIDPEYQQTGMLG--VKSDVYSLGILLLQIITAKPPM 668
++ PE Q + G KSD+YS+GI ++ P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 46/260 (17%)
Query: 458 IEEATENFSN----SRKIGEGGYGPVYKSY--LDHTPVAIKVL---RPDAAQGRSQFQQE 508
++ +T FS+ R +G+G +G V + A+KV+ + + +E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 509 VEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RI 564
V++L + HPN++ L + L+ E G L D + R RF
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---------RFSEVD 127
Query: 565 AAE----IATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVA 617
AA + + + ++H+ K +VHRDLKP N+LL ++ +I D GL+ S
Sbjct: 128 AARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK- 183
Query: 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE-- 675
+M GT YI PE G K DV+S G++L +++ PP A++ +
Sbjct: 184 ------KMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 676 RSIENGTFDETLDPAVPDWP 695
+ +E G + L W
Sbjct: 237 KKVEKGKYTFELPQ----WK 252
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 34/307 (11%), Positives = 80/307 (26%), Gaps = 67/307 (21%)
Query: 409 AEAAQRIAELEAQKCKNVEFKALREAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNS 468
E RI + + + +++ + E+ E
Sbjct: 25 EELFNRIPQANVRTTSE------YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG 78
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVLR----------------------------PDA 498
+G+ + V
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 499 AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG----CLIYEYMA--NGSLEDRLFRRGG 552
A+ +F +++ + + M+ + + +Y M + + L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 553 -SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611
L R ++ ++ L LH LVH L+P +I+LD+ ++
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 612 VPPSVADSVTQYRMTSAAGTFCYIDPEY-----------QQTGMLGVKSDVYSLGILLLQ 660
++ + + PE + ++ D ++LG+++
Sbjct: 256 DG----------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 661 IITAKPP 667
I A P
Sbjct: 306 IWCADLP 312
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 7e-25
Identities = 38/327 (11%), Positives = 82/327 (25%), Gaps = 65/327 (19%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVLR----------------------------PDA 498
+G+ ++ + V
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 499 AQGRSQFQQEVEVLCNIRHPNMVLLLGA------CPEFGCLIYEYMANGSLEDRLFRRGG 552
A+ +F +++ + + M+ + F + + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 553 -SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611
L R ++ ++ L LH LVH L+P +I+LD+ ++
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 612 VPPSVADSVTQYRMTSAAGTFCYIDPE-----YQQTGMLGVKSDVYSLGILLLQIITAKP 666
+ + ++ D ++LG+ + I A
Sbjct: 260 ----RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 667 PMGLAHQVERSIENGTFDETLDPAVPDWPVE-EALILAKLALQCAELRRKDRPDLGKVVV 725
P G + + + P AL+ L ++DR + +
Sbjct: 316 PN------TDDAALGGSEWIF-RSCKNIPQPVRALLEGFLR-----YPKEDRLLPLQAM- 362
Query: 726 PKLNILRALAEETMPAINLASGAGSSP 752
+ L E A+ L G
Sbjct: 363 -ETPEYEQLRTELSAALPLYQTDGEPT 388
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 59/289 (20%), Positives = 107/289 (37%), Gaps = 61/289 (21%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKV-----LRPDAAQGRSQFQQEVEV 511
E + + IG+G YG V + + T AIK+ +R + + + EV +
Sbjct: 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81
Query: 512 LCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF------- 562
+ + HPN+ L ++ CL+ E G L D+L +
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 563 --------------------------RIAAE----IATALLFLHQTKPEPLVHRDLKPGN 592
++ + I +AL +LH + HRD+KP N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPEN 198
Query: 593 ILL--DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE--YQQTGMLGVK 648
L ++++ K+ D GL++ ++ Y MT+ AGT ++ PE G K
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKL--NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256
Query: 649 SDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDWP 695
D +S G+LL ++ P + + + N + P++
Sbjct: 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC--FEN--PNYN 301
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 59/247 (23%), Positives = 94/247 (38%), Gaps = 49/247 (19%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
IG G +G V + T A K + + +F+QE+E++ ++ HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 527 C--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IATALLFLHQT 578
L+ E G L +R+ + F AA + +A+ + H+
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHKL 125
Query: 579 KPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
+ HRDLKP N L + K+ D GLA P M + GT Y+
Sbjct: 126 N---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-------MMRTKVGTPYYV 175
Query: 636 DPE-----YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLD 688
P+ Y G + D +S G+++ ++ PP E I GTF
Sbjct: 176 SPQVLEGLY------GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT--FP 227
Query: 689 PAVPDWP 695
DW
Sbjct: 228 E--KDWL 232
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 58/281 (20%), Positives = 110/281 (39%), Gaps = 61/281 (21%)
Query: 449 RYRKYSIEEIEEATENFSN----SRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGR 502
+ ++++ + + S+ +G G G V ++ T VAI+++
Sbjct: 117 VFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 503 S--------QFQQEVEVLCNIRHPNMVLLLGAC-PEFGCLIYEYMANGSLEDRLFRRGGS 553
S + E+E+L + HP ++ + E ++ E M G L D++
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK-- 234
Query: 554 PVLPWQIRF--RIAAE----IATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKIS 604
R + A+ +LH+ ++HRDLKP N+LL + + + KI+
Sbjct: 235 -------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE---YQQTGMLGVKSDVYSLGILLLQI 661
D G ++++ + M + GT Y+ PE T D +SLG++L
Sbjct: 285 DFGHSKILGETS-------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337
Query: 662 ITAKPP-------MGLAHQVERSIENGTFDETLDPAVPDWP 695
++ PP + L Q I +G ++ P W
Sbjct: 338 LSGYPPFSEHRTQVSLKDQ----ITSGKYN--FIP--EVWA 370
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 37/207 (17%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
+G G + V+ T A+K ++ A S + E+ VL I+H N+V L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 527 --CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IATALLFLHQT 578
L+ + ++ G L DR+ RG + + A+ + +A+ +LH+
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHEN 125
Query: 579 KPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
+VHRDLKP N+L + N I+D GL+++ + M++A GT Y+
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--------MSTACGTPGYV 174
Query: 636 DPEYQQTGMLGVKSDVYSLG----ILL 658
PE D +S+G ILL
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 16/196 (8%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVL-RPDAAQGRSQFQQEVEVLCNIRHPNMVLLLG 525
+ +GEG YG V + + VA+K++ A ++E+ + + H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 526 --ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
L EY + G L DR+ G P Q F ++ +++LH +
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHGIG---I 126
Query: 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-YQQT 642
HRD+KP N+LLD KISD GLA + + + + + GT Y+ PE ++
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL----LNKMCGTLPYVAPELLKRR 182
Query: 643 GMLGVKSDVYSLGILL 658
DV+S GI+L
Sbjct: 183 EFHAEPVDVWSCGIVL 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVLR----PDAAQGRSQFQQEVEVLCNIRHPNMVL 522
+GEG YG V A+K+L+ G + ++E+++L +RH N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 523 L----LGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLP-WQIR--FRIAAEIATALLFL 575
L + ++ EY G E + P Q F ++ L +L
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFC---QLIDGLEYL 125
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H +VH+D+KPGN+LL KIS +G+A + P AD ++ G+ +
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT----CRTSQGSPAFQ 178
Query: 636 DPE--YQQTGMLGVKSDVYSLGILL 658
PE G K D++S G+ L
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 66/252 (26%), Positives = 99/252 (39%), Gaps = 32/252 (12%)
Query: 433 EAKERKAALNSLTVDLRYRKYSIEEIEEA------TENFSNSRKIGEGGYGPVYKSYLDH 486
E + A++ + R ++ E + FS+ R+IG G +G VY +
Sbjct: 18 ENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR 77
Query: 487 T--PVAIKVLRPDAAQGR---SQFQQEVEVLCNIRHPNMVLLLGACPEFGCL--IYEYMA 539
VAIK + Q +EV L +RHPN + G + EY
Sbjct: 78 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137
Query: 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599
GS D L P+ +I + L +LH ++HRD+K GNILL
Sbjct: 138 -GSASD-LLEVHKKPLQEVEIAA-VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPG 191
Query: 600 VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE---YQQTGMLGVKSDVYSLGI 656
+ K+ D G A + S GT ++ PE G K DV+SLGI
Sbjct: 192 LVKLGDFG--------SASIMA--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241
Query: 657 LLLQIITAKPPM 668
+++ KPP+
Sbjct: 242 TCIELAERKPPL 253
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 66/256 (25%), Positives = 110/256 (42%), Gaps = 51/256 (19%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGR--SQFQQEVEVLCNIRH 517
E ++ +G+G +G V K T A+KV+ +A+ + S +EVE+L + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 518 PNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IA 569
PN++ L ++ E G L D + +R RF AA +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVF 131
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+ + ++H+ +VHRDLKP NILL +++ KI D GL+ + +M
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-------KMK 181
Query: 627 SAAGTFCYIDPE-----YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIE 679
GT YI PE Y K DV+S G++L +++ PP ++ + + +E
Sbjct: 182 DRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
Query: 680 NGTFDETLDPAVPDWP 695
G + L W
Sbjct: 236 TGKYAFDLPQ----WR 247
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 59/259 (22%), Positives = 103/259 (39%), Gaps = 52/259 (20%)
Query: 458 IEEATENFSN----SRKIGEGGYGPVYKSYLDHT--PVAIKVLR-------------PDA 498
+ + RK+G G YG V + AIKV++ +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 499 AQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVL 556
+ + E+ +L ++ HPN++ L ++ L+ E+ G L +++ R
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH----- 141
Query: 557 PWQIRF--RIAAE----IATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVG 607
+F AA I + + +LH+ +VHRD+KP NILL + KI D G
Sbjct: 142 ----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
L+ ++ GT YI PE + K DV+S G+++ ++ PP
Sbjct: 195 LSSFFSKDY-------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
Query: 668 MGLA--HQVERSIENGTFD 684
G + + +E G +
Sbjct: 247 FGGQNDQDIIKKVEKGKYY 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 45/229 (19%), Positives = 86/229 (37%), Gaps = 34/229 (14%)
Query: 446 VDLRYRKYSIEEIEEATENFSN----SRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA 499
+ ++KY + +E + + ++G G +G V++ T K +
Sbjct: 30 YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 89
Query: 500 QGRSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLP 557
+ + E+ ++ + HP ++ L A LI E+++ G L DR+
Sbjct: 90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---- 145
Query: 558 WQIRF--RIAAE----IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS--KISDVGLA 609
L +H+ +VH D+KP NI+ + S KI D GLA
Sbjct: 146 ----MSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658
+ P + T + PE +G +D++++G+L
Sbjct: 199 TKLNPDE-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVL-RPDAAQGRSQFQQEVEVLCNIRHPNMVLLLG 525
+ +GEG YG V + + VA+K++ A ++E+ + + H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 526 --ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIR--FRIAAEIATALLFLHQTKPE 581
L EY + G L DR+ G P + F ++ +++LH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMP--EPDAQRFFH---QLMAGVVYLHGIG-- 125
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-YQ 640
+ HRD+KP N+LLD KISD GLA + + + + + GT Y+ PE +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL----LNKMCGTLPYVAPELLK 180
Query: 641 QTGMLGVKSDVYSLGILL 658
+ DV+S GI+L
Sbjct: 181 RREFHAEPVDVWSCGIVL 198
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 51/256 (19%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGR--SQFQQEVEVLCNIRH 517
E ++ +G+G +G V K T A+KV+ +A+ + S +EVE+L + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 518 PNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IA 569
PN++ L ++ E G L D + +R RF AA +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVF 131
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+ + ++H+ +VHRDLKP NILL +++ KI D GL+ + +M
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-------KMK 181
Query: 627 SAAGTFCYIDPE-----YQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIE 679
GT YI PE Y K DV+S G++L +++ PP ++ + + +E
Sbjct: 182 DRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
Query: 680 NGTFDETLDPAVPDWP 695
G + D P W
Sbjct: 236 TGKYA--FDL--PQWR 247
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 37/255 (14%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQ-FQQEVEVLCNIRHP 518
+ F RK+G G +G V+ + IK + D +Q + + E+EVL ++ HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 519 NMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IAT 570
N++ + ++ E G L +R+ AE +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMN 135
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
AL + H +VH+DLKP NIL + KI D GLA L T+
Sbjct: 136 ALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-------HSTN 185
Query: 628 AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDE 685
AAGT Y+ PE + + K D++S G+++ ++T P E + +
Sbjct: 186 AAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244
Query: 686 TLDPAVPDWPV-EEA 699
++ P+ +A
Sbjct: 245 AVEC----RPLTPQA 255
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 61/249 (24%), Positives = 105/249 (42%), Gaps = 28/249 (11%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLL 524
+ IG+G + V + L VAIK++ + +EV ++ + HPN+V L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 525 G--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
+ LI EY + G + D L G + + +I +A+ + HQ +
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-YQQ 641
+VHRDLK N+LLD + KI+D G + ++ + G Y PE +Q
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-------GGKLDAFCGAPPYAAPELFQG 187
Query: 642 TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDWPVEEA 699
G + DV+SLG++L +++ P + E + G + +P + +
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR------IPFYMSTDC 241
Query: 700 LILAKLALQ 708
L K L
Sbjct: 242 ENLLKRFLV 250
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 49/229 (21%)
Query: 460 EATENFSN----SRKIGEGGYGPVYKSYLDHT--PVAIKVL---------RPDAAQGRSQ 504
+T F +G G V + T A+K++ + + R
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 505 FQQEVEVLCNI-RHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIR 561
+EV++L + HPN++ L F L+++ M G L D L +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------T 120
Query: 562 F--RIAAE----IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615
+ + + + LH+ +VHRDLKP NILLD + K++D G + + P
Sbjct: 121 LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 616 VADSVTQYRMTSAAGTFCYIDPE------YQQTGMLGVKSDVYSLGILL 658
++ GT Y+ PE G + D++S G+++
Sbjct: 178 E-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 66/319 (20%), Positives = 113/319 (35%), Gaps = 57/319 (17%)
Query: 371 HRWKLEEKQKLEDARMAEEAALA--LAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVEF 428
H ++ K E R E L ++R R++ + EA+K + +
Sbjct: 7 HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 429 KALREAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT- 487
K + D K E + + IG G V + T
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAK-------EFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 488 -PVAIKVL--------RPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGAC--PEFGCLIY 535
A+K++ + R ++E +L + HP+++ L+ + F L++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 536 EYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IATALLFLHQTKPEPLVHRDLK 589
+ M G L D L + + + A+ FLH +VHRDLK
Sbjct: 180 DLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLK 227
Query: 590 PGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE------YQQTG 643
P NILLD N ++SD G + + P ++ GT Y+ PE +
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGE-------KLRELCGTPGYLAPEILKCSMDETHP 280
Query: 644 MLGVKSDVYSLG----ILL 658
G + D+++ G LL
Sbjct: 281 GYGKEVDLWACGVILFTLL 299
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 42/220 (19%)
Query: 462 TENFSN----SRKIGEGGYGPVYKSYLDHT--PVAIKVL--RPDAAQGRSQFQQEVEVLC 513
+ FS+ ++G+G + V + T A K++ + +A+ + ++E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 514 NIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE-- 567
++HPN+V L + F L+++ + G L + + R + A+
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCI 111
Query: 568 --IATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQ 622
I ++ + H +VHR+LKP N+LL + K++D GLA V
Sbjct: 112 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-------S 161
Query: 623 YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLG----ILL 658
AGT Y+ PE + D+++ G ILL
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 96.9 bits (240), Expect = 7e-22
Identities = 44/195 (22%), Positives = 67/195 (34%), Gaps = 47/195 (24%)
Query: 461 ATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLR---PDAAQGRSQ-----FQQEVEVL 512
TE KIGEG +G V+++ DHTPVAIK++ PD G Q E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 513 CNI---------RHPNMVLLL------GACPEFGCLIYEYMA--NGSLEDRL-------- 547
+ R + L G+ P +++ GS DR
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 548 -----FRRGGSP-------VLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595
F GG + I ++ +L HRDL GN+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLL 195
Query: 596 DRNYVSKISDVGLAR 610
+ + K+ +
Sbjct: 196 KKTSLKKLHYTLNGK 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 42/223 (18%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRS--------QFQQE 508
+ + + S+ +G G G V ++ T VAIK++ S + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 509 VEVLCNIRHPNMVLLLGAC-PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIA 565
+E+L + HP ++ + E ++ E M G L D++ R
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK---------RLKEATC 116
Query: 566 AE----IATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVAD 618
+ A+ +LH+ ++HRDLKP N+LL + + + KI+D G ++++
Sbjct: 117 KLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---- 169
Query: 619 SVTQYRMTSAAGTFCYIDPE---YQQTGMLGVKSDVYSLGILL 658
M + GT Y+ PE T D +SLG++L
Sbjct: 170 ---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-22
Identities = 54/298 (18%), Positives = 108/298 (36%), Gaps = 37/298 (12%)
Query: 371 HRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVEFKA 430
H ++ + + + + + + K A+ +R+ +
Sbjct: 8 HSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIP 67
Query: 431 LREAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--P 488
A + + + Y++ + E +G G +G V+K T
Sbjct: 68 APPAPFDHRIVTAKQGAVN-SFYTVSKTEI----------LGGGRFGQVHKCEETATGLK 116
Query: 489 VAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDR 546
+A K+++ + + + + E+ V+ + H N++ L A L+ EY+ G L DR
Sbjct: 117 LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR 176
Query: 547 LFRRGGSPVLPWQIRFRIAAE----IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS- 601
+ + + I + +HQ ++H DLKP NIL
Sbjct: 177 IIDESYN------LTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQ 227
Query: 602 -KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658
KI D GLAR P ++ GT ++ PE + +D++S+G++
Sbjct: 228 IKIIDFGLARRYKPRE-------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 471 IGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGAC 527
+GEG + V T A+K++ RS+ +EVE+L + H N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 528 PEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IATALLFLHQTK 579
E L++E M GS+ + +R F A+ +A+AL FLH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHNKG 131
Query: 580 PEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPP-SVADSVTQYRMTSAAGTFCYI 635
+ HRDLKP NIL ++ KI D L + ++ + + G+ Y+
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 636 DPE-----YQQTGMLGVKSDVYSLGILL 658
PE ++ + + D++SLG++L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 49/246 (19%), Positives = 95/246 (38%), Gaps = 37/246 (15%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKV-----LRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
IG+G + V + T A+K+ ++E + ++HP++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 522 LLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IATALL 573
LL G +++E+M L + +R + + +A+ I AL
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-----VYSEAVASHYMRQILEALR 144
Query: 574 FLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
+ H ++HRD+KP +LL + + K+ G+A + S G
Sbjct: 145 YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES------GLVAGGRVG 195
Query: 631 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP-MGLAHQVERSIENGTFDETLDP 689
T ++ PE + G DV+ G++L +++ P G ++ I G + ++P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK--MNP 253
Query: 690 AVPDWP 695
W
Sbjct: 254 --RQWS 257
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 49/226 (21%), Positives = 93/226 (41%), Gaps = 36/226 (15%)
Query: 450 YRKYSIEEIEEATENFSN----SRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRS 503
+++Y + +E ++ + ++G G +G V++ T A K + +
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 504 QFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIR 561
++E++ + +RHP +V L A +IYE+M+ G L +++
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-------- 251
Query: 562 F--RIAAE----IATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLV 612
A E + L +H+ VH DLKP NI+ N + K+ D GL +
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHL 307
Query: 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658
P + GT + PE + +G +D++S+G+L
Sbjct: 308 DPKQ-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 41/204 (20%), Positives = 79/204 (38%), Gaps = 27/204 (13%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVL--------RPDAAQGRSQFQQEVEVLCNIRHP 518
+G G +G V+ + + V +K + + E+ +L + H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 519 NMVLLLG--ACPEFGCLIYEYMANGS-LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
N++ +L F L+ E +G L + R L + I ++ +A+ +L
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYL 146
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
++HRD+K NI++ ++ K+ D G A + + GT Y
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-------GKLFYTFCGTIEYC 196
Query: 636 DPE-YQQTGMLGVKSDVYSLGILL 658
PE G + +++SLG+ L
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTL 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 58/253 (22%), Positives = 97/253 (38%), Gaps = 44/253 (17%)
Query: 433 EAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVY--KSYLDHTPVA 490
E + K L D + + + + F + +G G +G V K A
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 491 IKVLRPDAAQGRSQFQ---QEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLED 545
+K+L Q + E +L + P +V L + ++ EY+A G +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 546 RLFRRGGSPVLPWQIRFR------IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN- 598
L R G RF AA+I +LH L++RDLKP N+L+D+
Sbjct: 131 HLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQG 178
Query: 599 YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC----YIDPEYQQTGMLGVKSDVYSL 654
Y+ +++D G A+ V T T C + PE + D ++L
Sbjct: 179 YI-QVTDFGFAKRV-----KGRTW--------TLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 655 GILLLQIITAKPP 667
G+L+ ++ PP
Sbjct: 225 GVLIYEMAAGYPP 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 62/250 (24%), Positives = 94/250 (37%), Gaps = 41/250 (16%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVL------RPDAAQGRSQFQQEVEVLCNIRH--P 518
+G GG+G VY D+ PVAIK + ++ EV +L +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 519 NMVLLLG--ACPEFGCLIYEYMAN-GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
++ LL P+ LI E L D + RG L ++ ++ A+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHC 165
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVS-KISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
H ++HRD+K NIL+D N K+ D G L+ +V T GT Y
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--------YTDFDGTRVY 214
Query: 635 IDPEY-QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD 693
PE+ + G + V+SLGILL ++ P + + I G
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVF------FRQ 264
Query: 694 WPVEEA--LI 701
E LI
Sbjct: 265 RVSSECQHLI 274
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 42/226 (18%)
Query: 456 EEIEEATENFSNS----RKIGEGGYGPVYKSYLDHT--PVAIKVL--RPDAAQGRSQFQQ 507
E + A+ FS++ ++G+G + V + T A K++ + +A+ + ++
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 508 EVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--R 563
E + ++HPN+V L + F L+++ + G L + + R +
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEA 128
Query: 564 IAAE----IATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSV 616
A+ I ++ + H +VHR+LKP N+LL + K++D GLA V S
Sbjct: 129 DASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185
Query: 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLG----ILL 658
AGT Y+ PE + D+++ G ILL
Sbjct: 186 -------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-21
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 43/221 (19%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLR------PDAAQGRSQFQQEVEVLC 513
+++ ++G G + V K T A K ++ R + ++EV +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 514 NIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE-- 567
IRHPN++ L LI E ++ G L D L + A +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQFL 114
Query: 568 --IATALLFLHQTKPEPLVHRDLKPGNILL-DRNYVS---KISDVGLARLVPPSVADSVT 621
I + +LH + + H DLKP NI+L D+N + K+ D G+A +
Sbjct: 115 KQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----- 166
Query: 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLG----ILL 658
+ GT ++ PE LG+++D++S+G ILL
Sbjct: 167 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-21
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 37/216 (17%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVL--RPDAAQGRSQFQQEVEVLCNIRH 517
TE + ++G+G + V + A ++ + +A+ + ++E + ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 518 PNMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IA 569
PN+V L + E G LI++ + G L + + R + A+ I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQIL 120
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
A+L HQ +VHR+LKP N+LL + K++D GLA V Q
Sbjct: 121 EAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE------QQAWF 171
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLG----ILL 658
AGT Y+ PE + G D+++ G ILL
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 43/221 (19%)
Query: 462 TENFSN----SRKIGEGGYGPVYKSYLDHT--PVAIKVLR------PDAAQGRSQFQQEV 509
EN + ++G G + V K T A K ++ R ++EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 510 EVLCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIA 565
+L I+HPN++ L LI E +A G L D L + A
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------SLTEEEA 116
Query: 566 AE----IATALLFLHQTKPEPLVHRDLKPGNILL-DRNYVS---KISDVGLARLVPPSVA 617
E I + +LH + + H DLKP NI+L DRN KI D GLA +
Sbjct: 117 TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 172
Query: 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658
+ GT ++ PE LG+++D++S+G++
Sbjct: 173 ------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 78/351 (22%), Positives = 136/351 (38%), Gaps = 44/351 (12%)
Query: 374 KLEEKQKLEDARMAEEAALALAEKER---AKCKRAIEAAEAAQRIAELEAQKCKNVEFKA 430
+ + L ++ + E R C + +E EL + +
Sbjct: 98 RKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAP 157
Query: 431 LREAKERKAALNSLTVDLRYRKYSIEEIEEAT-ENFSNSRKIGEGGYGPVYKSYLDHTPV 489
+ + S+ + R+ ++ E + T F R +G+GG+G V + T
Sbjct: 158 FADYLD------SIYFN-RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGK 210
Query: 490 --AIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNMVLLLGA--CPEFGCLIYEYMANGS 542
A K L + R E ++L + +V L A + CL+ M G
Sbjct: 211 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 270
Query: 543 LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVS 601
L+ ++ G + + F AAEI L LH+ + +V+RDLKP NILLD + ++
Sbjct: 271 LKFHIYHMGQAGFPEARAVF-YAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHI- 325
Query: 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQI 661
+ISD+GLA VP + GT Y+ PE + D ++LG LL ++
Sbjct: 326 RISDLGLAVHVPEGQ-------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 662 ITAKPP------MGLAHQVERSIENGTFDETLDPAVPDWPVEEAL-ILAKL 705
I + P +VER ++ + +A + ++L
Sbjct: 379 IAGQSPFQQRKKKIKREEVERLVKEV------PEEYSERFSPQARSLCSQL 423
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 44/212 (20%), Positives = 84/212 (39%), Gaps = 31/212 (14%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIR 516
+E E + + +G G +G V++ + K ++ + ++E+ +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIAR 59
Query: 517 HPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----I 568
H N++ L + E +I+E+++ + +R+ R +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--------LNEREIVSYVHQV 111
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILL--DRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
AL FLH + H D++P NI+ R+ KI + G AR + P
Sbjct: 112 CEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-------NFR 161
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658
Y PE Q ++ +D++SLG L+
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 54/216 (25%), Positives = 80/216 (37%), Gaps = 31/216 (14%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVL------RPDAAQGRSQFQQEVEVL----CNIR 516
+G+GG+G V+ + D VAIKV+ EV +L
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 517 HPNMVLLLG--ACPEFGCLIYEYMANGS-LEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
HP ++ LL E L+ E L D + +G L ++ A+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQ 153
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVS-KISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
H +VHRD+K NIL+D K+ D G L+ T GT
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--------YTDFDGTR 202
Query: 633 CYIDPEYQQTGM-LGVKSDVYSLGILLLQIITAKPP 667
Y PE+ + + V+SLGILL ++ P
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-20
Identities = 77/408 (18%), Positives = 147/408 (36%), Gaps = 72/408 (17%)
Query: 343 RLELRQTMDM-YSAACKEALAAKQK-ARELHRWKLEEKQKLEDARMAEEAALA---LAEK 397
LR+++D+ + C +Q + L + L ++ A + +
Sbjct: 47 CEALRESLDLGFEGMC-----LEQPIGKRLFQQFLRTHEQHGPALQLWKDIEDYDTADDA 101
Query: 398 ERAKCKRAI-------EAAEAAQRIAELEAQKCKNVEFKALREAKERKAA---------- 440
R + +A+ +A + + + L + R
Sbjct: 102 LRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQE 161
Query: 441 -LNSLTVDLRYRKYSIEEIEEAT-ENFSNSRKIGEGGYGPVYKSYLDHTPV--AIKVLRP 496
L+SL R+ ++ E + + F + R +G GG+G V+ + T A K L
Sbjct: 162 FLDSLYFL-RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK 220
Query: 497 DAAQGRSQFQ---QEVEVLCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRG 551
+ R +Q E ++L + +V L A CL+ M G + ++
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD 280
Query: 552 -GSPVLP-WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGL 608
+P + F A+I + L LHQ +++RDLKP N+LLD + V +ISD+GL
Sbjct: 281 EDNPGFQEPRAIF-YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNV-RISDLGL 335
Query: 609 ARLVPPSVADSVTQYRMTSAAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITA 664
A + + T+ + ++ PE D ++LG+ L ++I A
Sbjct: 336 AVELKAG--QTKTK--------GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 665 KPP------MGLAHQVERSIENGTFDETLDPAVPDWPVEEAL-ILAKL 705
+ P ++++ + PD + L
Sbjct: 386 RGPFRARGEKVENKELKQRVLEQ------AVTYPDKFSPASKDFCEAL 427
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 53/198 (26%), Positives = 98/198 (49%), Gaps = 21/198 (10%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPNMVLL 523
+G G +G V + L VA+K+L + + + ++E++ L RHP+++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 524 LG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
+ P ++ EY++ G L D + + G + R+ +I +A+ + H+
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRHM-- 131
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-YQ 640
+VHRDLKP N+LLD + +KI+D GL+ ++ ++ TS G+ Y PE
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRTS-CGSPNYAAPEVIS 183
Query: 641 QTGMLGVKSDVYSLGILL 658
G + D++S G++L
Sbjct: 184 GRLYAGPEVDIWSCGVIL 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
++G G VY+ T P A+KVL + + E+ VL + HPN++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 527 C--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IATALLFLHQT 578
P L+ E + G L DR+ +G + R AA+ I A+ +LH+
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHEN 167
Query: 579 KPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
+VHRDLKP N+L + KI+D GL+++V V M + GT Y
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-------LMKTVCGTPGYC 217
Query: 636 DPEYQQTGMLGVKSDVYSLG----ILL 658
PE + G + D++S+G ILL
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILL 244
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 53/222 (23%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQGRSQFQ---QEVEVLCNIRH 517
++F R IG+G +G V + T A+K + R++ + +E++++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 518 PNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI------AAEIA 569
P +V L + E ++ + + G L L + F+ E+
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---------HFKEETVKLFICELV 125
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSA 628
AL +L + ++HRD+KP NILLD + +V I+D +A ++P ++T+
Sbjct: 126 MALDYLQNQR---IIHRDMKPDNILLDEHGHV-HITDFNIAAMLPRET-------QITTM 174
Query: 629 AGTFCYIDPE-YQQTGMLGVKSDV--YSLGILLLQIITAKPP 667
AGT Y+ PE + G V +SLG+ +++ + P
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 57/261 (21%), Positives = 99/261 (37%), Gaps = 48/261 (18%)
Query: 458 IEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNI 515
+ + + +GEG + K + A+K++ + Q+E+ L
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLC 62
Query: 516 R-HPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE--- 567
HPN+V L L+ E + G L +R+ ++ F A+
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMR 113
Query: 568 -IATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQY 623
+ +A+ +H +VHRDLKP N+L + N KI D G ARL PP
Sbjct: 114 KLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD------NQ 164
Query: 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP---------MGLAHQV 674
+ + T Y PE D++SLG++L +++ + P A ++
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI 224
Query: 675 ERSIENGTFDETLDPAVPDWP 695
+ I+ G F + W
Sbjct: 225 MKKIKKGDFS--FEG--EAWK 241
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 39/220 (17%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLR------PDAAQGRSQFQQEVE 510
++ + + ++G G + V K T A K ++ R + ++EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 511 VLCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAA 566
+L + H N++ L LI E ++ G L D L ++ A
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118
Query: 567 E----IATALLFLHQTKPEPLVHRDLKPGNILL----DRNYVSKISDVGLARLVPPSVAD 618
I + +LH K + H DLKP NI+L K+ D GLA + V
Sbjct: 119 SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658
+ GT ++ PE LG+++D++S+G++
Sbjct: 174 -----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 62/260 (23%), Positives = 103/260 (39%), Gaps = 31/260 (11%)
Query: 421 QKCKNVEFKALREAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVY 480
+C N + + E T ++ + E +F + IG G +G V
Sbjct: 39 DECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHRE-------DFEILKVIGRGAFGEVA 91
Query: 481 --KSYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLGA--CPEFGCL 533
K A+K+L R++ F++E +VL N + L A L
Sbjct: 92 VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151
Query: 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNI 593
+ +Y G L L + RF AE+ A+ +HQ VHRD+KP NI
Sbjct: 152 VMDYYVGGDLLTLLSKFEDRLPEEM-ARF-YLAEMVIAIDSVHQLH---YVHRDIKPDNI 206
Query: 594 LLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-----YQQTGMLGV 647
L+D N ++ +++D G + + + A GT YI PE G G
Sbjct: 207 LMDMNGHI-RLADFGSCLKLMED-----GTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260
Query: 648 KSDVYSLGILLLQIITAKPP 667
+ D +SLG+ + +++ + P
Sbjct: 261 ECDWWSLGVCMYEMLYGETP 280
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 39/220 (17%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLR------PDAAQGRSQFQQEVE 510
++ + + ++G G + V K T A K ++ R + ++EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 511 VLCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAA 566
+L + HPN++ L LI E ++ G L D L ++ A
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118
Query: 567 E----IATALLFLHQTKPEPLVHRDLKPGNILL----DRNYVSKISDVGLARLVPPSVAD 618
I + +LH K + H DLKP NI+L K+ D GLA +
Sbjct: 119 SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---- 171
Query: 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658
+ GT ++ PE LG+++D++S+G++
Sbjct: 172 ---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 22/163 (13%)
Query: 461 ATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG------RSQFQQEVEVL 512
++ F K+G G Y VYK T VA+K ++ D+ +G R E+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-----EISLM 57
Query: 513 CNIRHPNMVLLLGACPEFGC--LIYEYMAN---GSLEDRLFRRGGSPVLPWQIRFRIAAE 567
++H N+V L L++E+M N ++ R + ++ +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQ 116
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+ L F H+ K ++HRDLKP N+L+++ K+ D GLAR
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 44/223 (19%)
Query: 463 ENFSNSRKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQ---QEVEVLCNIRH 517
++F R +G G +G V+ +S + A+KVL+ + Q + E +L + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 518 PNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI------AAEIA 569
P ++ + G + +I +Y+ G L L + RF AAE+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVC 116
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSA 628
AL +LH +++RDLKP NILLD+N ++ KI+D G A+ V VT
Sbjct: 117 LALEYLHSKD---IIYRDLKPENILLDKNGHI-KITDFGFAKYV-----PDVTY------ 161
Query: 629 AGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
T C YI PE T D +S GIL+ +++ P
Sbjct: 162 --TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 64/288 (22%), Positives = 113/288 (39%), Gaps = 56/288 (19%)
Query: 432 REAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PV 489
+ L L +KY++ + + ++ + +G G G V + + T
Sbjct: 3 HHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSK-----QVLGLGVNGKVLECFHRRTGQKC 57
Query: 490 AIKVLRPDAAQGRSQFQQEVEVLC-NIRHPNMVLLLGA------CPEFGCLIYEYMANGS 542
A+K+L + +QEV+ P++V +L +I E M G
Sbjct: 58 ALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE 112
Query: 543 LEDRLFRRGGSPVLPWQIRF--RIAAE----IATALLFLHQTKPEPLVHRDLKPGNILL- 595
L R+ RG F R AAE I TA+ FLH + HRD+KP N+L
Sbjct: 113 LFSRIQERG-------DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYT 162
Query: 596 --DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYS 653
+++ V K++D G A+ + + + T Y+ PE D++S
Sbjct: 163 SKEKDAVLKLTDFGFAKETTQNA--------LQTPCYTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 654 LGILLLQIITAKPP------MGLAHQVERSIENGTFDETLDPAVPDWP 695
LG+++ ++ PP ++ ++R I G + P+W
Sbjct: 215 LGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG--FPN--PEWS 258
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 61/261 (23%), Positives = 99/261 (37%), Gaps = 31/261 (11%)
Query: 421 QKCKNVEFKALREAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVY 480
Q+ E + + + V L+ + + +F + IG G + V
Sbjct: 26 QELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRD-------DFEILKVIGRGAFSEVA 78
Query: 481 KSYLDHTP--VAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLGA--CPEFGCL 533
+ T A+K++ R + F++E +VL N + L A + L
Sbjct: 79 VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138
Query: 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNI 593
+ EY G L L + G RF AEI A+ +H+ VHRD+KP NI
Sbjct: 139 VMEYYVGGDLLTLLSKFGERIPAEM-ARF-YLAEIVMAIDSVHRLG---YVHRDIKPDNI 193
Query: 594 LLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVY- 652
LLDR +++D G + + R A GT Y+ PE Q G + Y
Sbjct: 194 LLDRCGHIRLADFGSCLKL-----RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG 248
Query: 653 ------SLGILLLQIITAKPP 667
+LG+ ++ + P
Sbjct: 249 PECDWWALGVFAYEMFYGQTP 269
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG------RSQFQQEVEVLCN 514
E + K+GEG Y VYK T VA+K +R + +G R EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-----EVSLLKD 56
Query: 515 IRHPNMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
++H N+V L L++EY+ + L+ + G+ + ++ ++ L
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYL-DKDLK-QYLDDCGNIINMHNVK-LFLFQLLRGL 113
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+ H+ K ++HRDLKP N+L++ K++D GLAR
Sbjct: 114 AYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 66/258 (25%), Positives = 109/258 (42%), Gaps = 35/258 (13%)
Query: 425 NVEFKALREAKERKAALN---SLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVY- 480
+++F ALR+ K L+ +R + E ++ + IG G +G V
Sbjct: 35 DLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAE-------DYEVVKVIGRGAFGEVQL 87
Query: 481 -KSYLDHTPVAIKVLRPDAAQGRSQ---FQQEVEVLCNIRHPNMVLLLGA--CPEFGCLI 534
+ A+K+L RS F +E +++ P +V L A + ++
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147
Query: 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNIL 594
EYM G L L P W RF AE+ AL +H +HRD+KP N+L
Sbjct: 148 MEYMPGGDLV-NLMSNYDVPE-KW-ARF-YTAEVVLALDAIHSMG---FIHRDVKPDNML 200
Query: 595 LDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-YQQTGML---GVKS 649
LD++ ++ K++D G + R +A GT YI PE + G G +
Sbjct: 201 LDKSGHL-KLADFGTCMKMNKEGMV-----RCDTAVGTPDYISPEVLKSQGGDGYYGREC 254
Query: 650 DVYSLGILLLQIITAKPP 667
D +S+G+ L +++ P
Sbjct: 255 DWWSVGVFLYEMLVGDTP 272
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 53/233 (22%), Positives = 106/233 (45%), Gaps = 37/233 (15%)
Query: 450 YRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQ 506
Y Y +E +++ RK+G G Y V+++ ++ V +K+L+P + + +
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 78
Query: 507 QEVEVLCNIR-HPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQIR 561
+E+++L N+R PN++ L + L++E+ + + F++ + + IR
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLTDYDIR 133
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARLVPPSVADSV 620
F + EI AL + H ++HRD+KP N+++D + ++ D GLA P
Sbjct: 134 FYMY-EILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---- 185
Query: 621 TQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKPPM 668
+ + PE ++ + D++SLG +L +I K P
Sbjct: 186 ---EYNVRVASRYFKGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 36/274 (13%)
Query: 407 EAAEAAQRIAE-LEAQKCKNVEFKALREAKERKAALNSLTVDLRYRKYSIEEIEEATENF 465
E A Q +A+ L+ Q ++F++ + A +++ + ++ F
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN-------EF 150
Query: 466 SNSRKIGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQGRSQFQQ---EVEVLCNIRHPNM 520
+ +G+G +G V T A+K+L+ + + + E VL N RHP +
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 521 VLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLP-WQIRFRIAAEIATALLFLHQ 577
L + + C + EY G L L R V + RF AEI +AL +LH
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARF-YGAEIVSALDYLHS 266
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC---- 633
K +V+RDLK N++LD++ KI+D GL + + D T TFC
Sbjct: 267 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGAT-------MKTFCGTPE 314
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Y+ PE + G D + LG+++ +++ + P
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 62/245 (25%), Positives = 102/245 (41%), Gaps = 54/245 (22%)
Query: 454 SIEEIEEATENFSNSRK-----------IGEGGYGPVY---KSYLDHTPV--AIKVLRPD 497
SI+EI K +G+G +G V+ K A+KVL+
Sbjct: 4 SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63
Query: 498 AAQGRSQFQQEVE--VLCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGS 553
+ R + + ++E +L + HP +V L A LI +++ G L RL +
Sbjct: 64 TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-- 121
Query: 554 PVLPWQIRFRI------AAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDV 606
F AE+A AL LH +++RDLKP NILLD ++ K++D
Sbjct: 122 -------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHI-KLTDF 170
Query: 607 GLARLVPPSVADSVTQYRMTSAAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQII 662
GL++ S+ + +FC Y+ PE +D +S G+L+ +++
Sbjct: 171 GLSKE-------SIDHEKKAY---SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
Query: 663 TAKPP 667
T P
Sbjct: 221 TGTLP 225
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQGRSQFQ---QEVEVL---CN 514
+FS R IG GG+G VY T A+K L + + E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 515 IRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
P +V + A P+ I + M G L L + G +RF AAEI L
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRF-YAAEIILGL 305
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
+H +V+RDLKP NILLD + +ISD+GLA + ++ GT
Sbjct: 306 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTH 354
Query: 633 CYIDPEYQQTGMLGVKS-DVYSLGILLLQIITAKPP 667
Y+ PE Q G+ S D +SLG +L +++ P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 22/198 (11%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPNMVLL 523
+GEG +G V Y VA+K + + + ++E+ L +RHP+++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 524 LG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPE 581
P ++ EY A G L D + + + R +I A+ + H+ K
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 582 PLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-YQ 640
+VHRDLKP N+LLD N KI+D GL+ ++ + ++ G+ Y PE
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-------NFLKTSCGSPNYAAPEVIN 180
Query: 641 QTGMLGVKSDVYSLGILL 658
G + DV+S GI+L
Sbjct: 181 GKLYAGPEVDVWSCGIVL 198
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 29/207 (14%), Positives = 55/207 (26%), Gaps = 50/207 (24%)
Query: 469 RKIGEGGYGPVYKSYLDHT---PVAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMVL 522
G +++ D VA+ + P + L I P +
Sbjct: 37 IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 523 LL--GACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
+L G ++ E++ GSL++ SPV R +A A H+
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-DTSPSPVG----AIRAMQSLAAAADAAHR--- 147
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ 640
+ P + +S G L +
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVVL------------------AYPATMPDA-- 179
Query: 641 QTGMLGVKSDVYSLGILLLQIITAKPP 667
+ D+ +G L ++ + P
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWP 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 53/229 (23%)
Query: 455 IEEIEEATENFSN----SRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQE 508
++++ + F++ IG G Y + T A+K++ +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EE 65
Query: 509 VEVLC-NIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--R 563
+E+L +HPN++ L ++ ++ E M G L D++ R+ F R
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---------FFSER 116
Query: 564 IAAE----IATALLFLHQTKPEPLVHRDLKPGNILL----DRNYVSKISDVGLARLVPPS 615
A+ I + +LH +VHRDLKP NIL +I D G A+ +
Sbjct: 117 EASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA- 172
Query: 616 VADSVTQYRMTSAAGTFCYIDPE------YQQTGMLGVKSDVYSLGILL 658
+ + T ++ PE Y D++SLG+LL
Sbjct: 173 -----ENGLLMTPCYTANFVAPEVLERQGY------DAACDIWSLGVLL 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG--RSQFQQEVEVLCNIRHP 518
E + KIGEG YG V+K T VAIK + +E+ +L ++HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 519 NMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V LL L++EY + ++ R V ++ I + A+ F H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVL-HELDRYQRGVPEHLVK-SITWQTLQAVNFCH 119
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+ +HRD+KP NIL+ ++ V K+ D G AR
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 54/233 (23%), Positives = 85/233 (36%), Gaps = 34/233 (14%)
Query: 443 SLTVDLRYRKYSIEEIEEATENFS-NSRKIGEGGYGPVYKSYLDHT--PVAIKVL--RPD 497
S VDL + +E + S+++G G + V + T A K L R
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 498 AAQGRSQFQQEVEVLCNIRH-PNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSP 554
R++ E+ VL + P ++ L LI EY A G +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE- 126
Query: 555 VLPWQIRF--RIAAE----IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS---KISD 605
I + +LHQ +VH DLKP NILL Y KI D
Sbjct: 127 ------MVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILL 658
G++R + + + GT Y+ PE + +D++++GI+
Sbjct: 178 FGMSRKIGHAC-------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 1e-18
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 23/159 (14%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQ-G------RSQFQQEVEVLC 513
E + KIGEG YG VYK+ ++ A+K +R + G R E+ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-----EISILK 55
Query: 514 NIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
++H N+V L L++E++ + L+ +L + + ++
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLK-KLLDVCEGGLESVTAK-SFLLQLLNG 112
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+ + H + ++HRDLKP N+L++R KI+D GLAR
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 70/250 (28%), Positives = 104/250 (41%), Gaps = 58/250 (23%)
Query: 443 SLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVY---KSYLDHTPV--AIKVLRPD 497
+V+ K E F R +G+GGYG V+ K +T A+KVL+
Sbjct: 4 ETSVNRGPEKIRPE-------CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKA 56
Query: 498 AAQGRSQFQQEVE-------VLCNIRHPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLF 548
++ +L ++HP +V L+ A LI EY++ G L +L
Sbjct: 57 MIVRN---AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE 113
Query: 549 RRGGSPVLPWQIRFRI------AAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVS 601
R G F AEI+ AL LHQ +++RDLKP NI+L+ +V
Sbjct: 114 REG---------IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHV- 160
Query: 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFC----YIDPEYQQTGMLGVKSDVYSLGIL 657
K++D GL + S+ D TFC Y+ PE D +SLG L
Sbjct: 161 KLTDFGLCKE---SIHDGTV-------THTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210
Query: 658 LLQIITAKPP 667
+ ++T PP
Sbjct: 211 MYDMLTGAPP 220
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG--RSQFQQEVEVLCNIRHP 518
E + N +GEG YG V K T VAIK + +E+++L +RH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 519 NMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V LL C + L++E++ + ++ + + ++ + +I + F H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFV-DHTIL-DDLELFPNGLDYQVVQ-KYLFQIINGIGFCH 141
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+HRD+KP NIL+ ++ V K+ D G AR
Sbjct: 142 SHNI---IHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 55/252 (21%), Positives = 103/252 (40%), Gaps = 50/252 (19%)
Query: 468 SRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLL 524
S+ +G G G V + + T A+K+L+ + ++EVE+ + P++V ++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 121
Query: 525 GACPEFGC------LIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IATAL 572
++ E + G L R+ RG F R A+E I A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAI 174
Query: 573 LFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
+LH + HRD+KP N+L N + K++D G A+ +T+
Sbjct: 175 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-------SLTTPC 224
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP------MGLAHQVERSIENGTF 683
T Y+ PE D++SLG+++ ++ PP + ++ ++ I G +
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 684 DETLDPAVPDWP 695
+ P+W
Sbjct: 285 E--FPN--PEWS 292
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 21/197 (10%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLL--L 524
+ IG G +G + L VA+K + A Q+E+ ++RHPN+V +
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 525 GACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
P +I EY + G L +R+ G + F+ ++ + + + H + +
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ---QLLSGVSYCHSMQ---IC 138
Query: 585 HRDLKPGNILLDRNYVS--KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE-YQQ 641
HRDLK N LLD + KI D G ++ SV + S GT YI PE +
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 642 TGMLGVKSDVYSLGILL 658
G +DV+S G+ L
Sbjct: 192 QEYDGKIADVWSCGVTL 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 25/200 (12%)
Query: 469 RKIGEGGYGPVYKSYLDHTP----VAIKVL---RPDAAQGRSQFQQEVEVLCNIRHPNMV 521
+G G +G V H VA+K+L + + + ++E++ L RHP+++
Sbjct: 22 DTLGVGTFGKVKVGK--HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 522 LLLG--ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
L + P ++ EY++ G L D + + G + F+ +I + + + H+
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ---QILSGVDYCHRHM 136
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPE- 638
+VHRDLKP N+LLD + +KI+D GL+ ++ + ++ G+ Y PE
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-------EFLRTSCGSPNYAAPEV 186
Query: 639 YQQTGMLGVKSDVYSLGILL 658
G + D++S G++L
Sbjct: 187 ISGRLYAGPEVDIWSSGVIL 206
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 55/232 (23%), Positives = 106/232 (45%), Gaps = 51/232 (21%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHT-PVAIKVLRPDAA-QGRSQFQQEVEVLCNIR 516
E+ ++N + IG G +G V+++ L + VAIK + D + R E++++ ++
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-----ELQIMRIVK 90
Query: 517 HPNMVLLL------GACPEFGC--LIYEYMANGSLED-----RLFRRGGSPVLPWQIRFR 563
HPN+V L G + L+ EY+ E R + + + I+
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLY 146
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLAR-LVP--PSVADS 619
+ ++ +L ++H + HRD+KP N+LLD V K+ D G A+ L+ P+V+
Sbjct: 147 MY-QLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202
Query: 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
++Y Y PE + G + D++S G ++ +++ +P
Sbjct: 203 CSRY----------YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQF---QQEVEVLCNIRH 517
+F + +G+G +G V T A+K+LR + + + E VL N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 518 PNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI------AAEIA 569
P + L A + C + EY G L L R F AEI
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIV 115
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSA 628
+AL +LH +V+RD+K N++LD++ ++ KI+D GL + ++D T
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHI-KITDFGLCKE---GISDGAT------- 161
Query: 629 AGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
TFC Y+ PE + G D + LG+++ +++ + P
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 48/225 (21%)
Query: 469 RKIGEGGYGPVY--KSYLDHTPVAIKVL---------------RPDAAQGRS-------- 503
+IG+G YG V + D+T A+KVL P +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 504 ---QFQQEVEVLCNIRHPNMVLLL----GACPEFGCLIYEYMANGSLEDRLFRRGGSPVL 556
Q QE+ +L + HPN+V L+ + +++E + G + + + S
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 557 PWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616
F+ ++ + +LH K ++HRD+KP N+L+ + KI+D G++ S
Sbjct: 139 ARFY-FQ---DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 617 ADSVTQYRMTSAAGTFCYIDPE---YQQTGMLGVKSDVYSLGILL 658
A +++ GT ++ PE + G DV+++G+ L
Sbjct: 192 A------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 22/159 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQ-G------RSQFQQEVEVLC 513
+ + KIGEG YG V+K+ T VA+K +R D G R E+ +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-----EICLLK 56
Query: 514 NIRHPNMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
++H N+V L L++E+ + L+ + F + P ++ ++
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLK-KYFDSCNGDLDPEIVK-SFLFQLLKG 113
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
L F H ++HRDLKP N+L++RN K+++ GLAR
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 21/159 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQ-G------RSQFQQEVEVLC 513
ENF KIGEG YG VYK+ T VA+K +R D G R E+ +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-----EISLLK 57
Query: 514 NIRHPNMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
+ HPN+V LL L++E++ + L+ + + + I+ ++
Sbjct: 58 ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQG 115
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
L F H + ++HRDLKP N+L++ K++D GLAR
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 23/159 (14%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQ-G------RSQFQQEVEVLC 513
E + K+GEG YG VYK+ D VA+K +R DA G R E+ +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIR-----EISLLK 74
Query: 514 NIRHPNMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
+ HPN+V L+ C L++E+M L+ ++ + + QI+ ++
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLK-KVLDENKTGLQDSQIK-IYLYQLLRG 131
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+ HQ + ++HRDLKP N+L++ + K++D GLAR
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 85.7 bits (211), Expect = 3e-17
Identities = 92/710 (12%), Positives = 210/710 (29%), Gaps = 241/710 (33%)
Query: 77 QVDNQAKELFVPFR-CFCTRKEIKCKEIVLEDTD---IAKALIDYV--SSHTIE------ 124
+ Q K++ F F CK++ +D ++K ID++ S +
Sbjct: 13 EHQYQYKDILSVFEDAF--VDNFDCKDV--QDMPKSILSKEEIDHIIMSKDAVSGTLRLF 68
Query: 125 TLVLGAASRTGFVKRF-KTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVRASP 183
+L V++F + +Y +
Sbjct: 69 WTLLSKQEEM--VQKFVEEVL--------RINYKFLM----------------------- 95
Query: 184 GSQLQSQSRQPSHSSDSYESAMTNSQSSRVAISAAERTPPTTSSLINDDVPIKSPFLRGK 243
S ++++ RQPS + Y I +R +V P+L+ +
Sbjct: 96 -SPIKTEQRQPSMMTRMY-------------IEQRDRLYNDNQVFAKYNVSRLQPYLKLR 141
Query: 244 GSIPKYEPSLPESDISFVS------SGRPS-------TDRMIYDMDFGMTPWLSTGSDYE 290
++ + P+ V SG+ + ++ MDF + WL+ +
Sbjct: 142 QALLELRPA------KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNS 194
Query: 291 SSSFVS-LQSGSRSIDRNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLE---- 345
+ + LQ ID N ++ S SS+ + ++ E+RRL
Sbjct: 195 PETVLEMLQKLLYQIDPN--------WTSRS--DHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 346 -----LR-----QTMDMYSAACK-------EALAAKQKARELHRWKLEEKQKLEDARMAE 388
L + + ++ +CK + + A L+ +
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT----LTP 300
Query: 389 EAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVEF------KALREAKERKAALN 442
+ +L K R +L + +++R+ +
Sbjct: 301 DEVKSLL----LKY--------LDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT---WD 345
Query: 443 SLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGR 502
++ + +++ E+ N + E K + +++
Sbjct: 346 ------NWKHVNCDKLTTIIESSLNVLEPAE-----YRKMFDR---LSV----------- 380
Query: 503 SQFQQEVEVLCNIRHPNMVL------LLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVL 556
F +I P ++L ++ + ++ + SL ++ + +
Sbjct: 381 --FPPSA----HI--PTILLSLIWFDVIKSDVM---VVVNKLHKYSLVEKQPKESTISIP 429
Query: 557 PWQIRFRIAAEIATALLFLHQT------KPEPLVHRDLKP-----------G-------- 591
+ ++ E A LH++ P+ DL P G
Sbjct: 430 SIYLELKVKLENEYA---LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH 486
Query: 592 --------NILLDRNYV-SKISDVGLARLVPPSVADSVTQ---YRMTSAAGTFCYI---D 636
+ LD ++ KI A S+ +++ Q Y+ YI D
Sbjct: 487 PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP--------YICDND 538
Query: 637 PEYQQ------TGMLGVKSDVYSLGIL-LLQIITAKPPMGLAHQVERSIE 679
P+Y++ + ++ ++ LL+I + + + ++
Sbjct: 539 PKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 2e-09
Identities = 67/557 (12%), Positives = 151/557 (27%), Gaps = 187/557 (33%)
Query: 8 KQEEAVAVAIDKDKGSQYALR--W-------AVDHLLSRGQNLTLLHVKQRVSSVPNPSG 58
K A+ V + + + W + + +L Q L L + +S + S
Sbjct: 163 KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL-LYQIDPNWTSRSDHSS 221
Query: 59 N-SVAISKVNNEVARIYKQQ--------VDN-QAKELFVPFRCFCTRKEIKCKEIVL-ED 107
N + I + E+ R+ K + + N Q + + F + CK ++
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF-------NLSCKILLTTRF 274
Query: 108 TDIAKALIDYVSSH-TIETLVLG---AASRTGFVK--RFKTADIPSNVSKGAPDYCNVYV 161
+ L ++H +++ + ++ +K + D+P V P + +
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS--I 332
Query: 162 IGKGKISSVRSATASVPVRASPGSQLQSQSRQPSHSSDSYESAMTNSQSSRVAISAAERT 221
I S+ R + D+++ + ++ + S
Sbjct: 333 IA-----------ESI--------------RDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 222 PPTTS------SLINDDVPIKSPFLRGKGSIPKYEPSLPESDISFVSSGRPSTDRMIYDM 275
P S+ I + L +
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILL------------------------------SLI-- 395
Query: 276 DFGMTPWLSTGSDYESSSFVSLQSGSRSIDRNSSPDEFSSYSQESGRTSSSSQSQSVEEV 335
W + V+ +++ S S
Sbjct: 396 ------WFD-VIKSDVMVVVNKLHKYSLVEKQPKESTISIPS------------------ 430
Query: 336 EVEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALA-- 393
+ LEL+ ++ LHR + + + +++
Sbjct: 431 ------IYLELKVKLE--------------NEYALHR-SIVDHYNIPKTFDSDDLIPPYL 469
Query: 394 -------LAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVEF--KALRE---AKERKAAL 441
+ ++ E +R+ + F + +R A ++
Sbjct: 470 DQYFYSHIG--------HHLKNIEHPERMTLFR-MVFLDFRFLEQKIRHDSTAWNASGSI 520
Query: 442 NSLTVDLR-YRKY------SIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTP-VAIKV 493
+ L+ Y+ Y E + A +F KI E + S +T + I +
Sbjct: 521 LNTLQQLKFYKPYICDNDPKYERLVNAILDF--LPKIEEN----LICS--KYTDLLRIAL 572
Query: 494 LRPDAA---QGRSQFQQ 507
+ D A + Q Q+
Sbjct: 573 MAEDEAIFEEAHKQVQR 589
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQ--------EVEVL 512
+ + +GEG + VYK+ +T VAIK ++ RS+ + E+++L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 513 CNIRHPNMVLLLGACPEFGC--LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIAT 570
+ HPN++ LL A L++++M LE + + + P I+
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLE-VIIKDNSLVLTPSHIK-AYMLMTLQ 123
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
L +LHQ ++HRDLKP N+LLD N V K++D GLA+
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQF---QQEVEVL-CNIR 516
E+F + +G+G +G V+ + T AIK L+ D E VL
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 517 HPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
HP + + E + EY+ G L + + + F AAEI L F
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATF-YAAEIILGLQF 133
Query: 575 LHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
LH +V+RDLK NILLD++ ++ KI+D G+ + +++ T+ TFC
Sbjct: 134 LHSKG---IVYRDLKLDNILLDKDGHI-KIADFGMCK-------ENMLGDAKTN---TFC 179
Query: 634 ----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
YI PE D +S G+LL +++ + P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 48/237 (20%)
Query: 456 EEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQ----QEV 509
E + + F R G+G +G V T VAIK + D +F+ Q +
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIM 70
Query: 510 EVLCNIRHPNMVLLL-----GACPEFG----CLIYEYMANGSLED-----RLFRRGGSPV 555
+ L + HPN+V L + ++ EY+ + R + R
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAP 126
Query: 556 LPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARLVPP 614
P I+ + ++ ++ LH + HRD+KP N+L++ + K+ D G A+ + P
Sbjct: 127 PPILIKVFLF-QLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
S + + Y PE + G + D++S+G + +++ +P
Sbjct: 185 SEP-------NVAYICSRYYRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 51/227 (22%), Positives = 98/227 (43%), Gaps = 46/227 (20%)
Query: 462 TENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHP 518
++++++ IG G +G VY++ L + VAIK + D + R E++++ + H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHC 107
Query: 519 NMVLLL------GACPEFGCL--IYEYMANGSLED-----RLFRRGGSPVLPWQIRFRIA 565
N+V L G + L + +Y+ E R + R + ++ +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYR 624
++ +L ++H + HRD+KP N+LLD + V K+ D G A+ +
Sbjct: 164 -QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP------- 212
Query: 625 MTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
S + Y PE + G DV+S G +L +++ +P
Sbjct: 213 NVSYICSRYYRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 72/309 (23%), Positives = 126/309 (40%), Gaps = 45/309 (14%)
Query: 417 ELEAQKCKNVEFKALREAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGY 476
++ + + +E K A+N+ ++ +F R IG G Y
Sbjct: 13 DIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ-------DFDLLRVIGRGSY 65
Query: 477 GPVYKSYLDHTPV--AIKVLRPDAAQGRSQF---QQEVEVLCNI-RHPNMVLLLGAC--- 527
V L T A++V++ + Q E V HP +V L +C
Sbjct: 66 AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQT 124
Query: 528 PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI-AAEIATALLFLHQTKPEPLVHR 586
+ EY+ G L + R+ LP + R +AEI+ AL +LH+ +++R
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQR---KLP-EEHARFYSAEISLALNYLHERG---IIYR 177
Query: 587 DLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC----YIDPEYQQT 642
DLK N+LLD K++D G+ + + + TS TFC YI PE +
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTS---TFCGTPNYIAPEILRG 227
Query: 643 GMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIENGTFDETL--DPAVPDW-PV 696
G D ++LG+L+ +++ + P +G + +++ E+ F L +P V
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 287
Query: 697 EEALILAKL 705
+ A +L
Sbjct: 288 KAASVLKSF 296
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 58/251 (23%), Positives = 105/251 (41%), Gaps = 58/251 (23%)
Query: 443 SLTVDLRYRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIK-VLRPDA 498
SL + K + + E + + + +G G YG V + + VAIK + RP
Sbjct: 3 SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-- 60
Query: 499 AQGRSQFQQ---------EVEVLCNIRHPNMVLLL------GACPEFGC--LIYEYMANG 541
FQ E+ +L +++H N++ LL + F L+ +M
Sbjct: 61 ------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM--- 111
Query: 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601
+ L + G +I++ + ++ L ++H +VHRDLKPGN+ ++ +
Sbjct: 112 --QTDLQKIMGLKFSEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCEL 165
Query: 602 KISDVGLARLVPPSVADSV-TQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLG 655
KI D GLAR + V T++ Y PE +L D++S+G
Sbjct: 166 KILDFGLARHADAEMTGYVVTRW----------YRAPEV----ILSWMHYNQTVDIWSVG 211
Query: 656 ILLLQIITAKP 666
++ +++T K
Sbjct: 212 CIMAEMLTGKT 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQF---QQEVEVL-CNIR 516
+F+ +G+G +G V S T A+K+L+ D E VL +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 517 HPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR------IAAEI 568
P + L + + EY+ G L + + G RF+ AAEI
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEI 130
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTS 627
A L FL +++RDLK N++LD ++ KI+D G+ + +++ T
Sbjct: 131 AIGLFFLQSKG---IIYRDLKLDNVMLDSEGHI-KIADFGMCK-------ENIWDGVTTK 179
Query: 628 AAGTFC----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
TFC YI PE G D ++ G+LL +++ + P
Sbjct: 180 ---TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 70/268 (26%), Positives = 117/268 (43%), Gaps = 48/268 (17%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQGRSQF---QQEVEVLCNI-R 516
++F R IG G Y V L T A+KV++ + Q E V
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 517 HPNMVLLLGAC---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI-AAEIATAL 572
HP +V L +C + EY+ G L + R+ LP + R +AEI+ AL
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLP-EEHARFYSAEISLAL 123
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
+LH+ +++RDLK N+LLD ++ K++D G+ + + + TS T
Sbjct: 124 NYLHERG---IIYRDLKLDNVLLDSEGHI-KLTDYGMCK-------EGLRPGDTTS---T 169
Query: 632 FC----YIDPE---YQQTGMLGVKS-DVYSLGILLLQIITAKPP---MGLAHQVERSIEN 680
FC YI PE + G S D ++LG+L+ +++ + P +G + +++ E+
Sbjct: 170 FCGTPNYIAPEILRGEDYG----FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225
Query: 681 GTFDETL--DPAVPDW-PVEEALILAKL 705
F L +P V+ A +L
Sbjct: 226 YLFQVILEKQIRIPRSLSVKAASVLKSF 253
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 42/216 (19%)
Query: 471 IGEGGYGPVYKSYLDHTPV--AIKVLRPDAAQGRSQF---QQEVEVLC-NIRHPNMVLLL 524
IG+G +G V + V A+KVL+ A + + E VL N++HP +V L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 525 GA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI------AAEIATALLFLH 576
+ + + +Y+ G L L R F AAEIA+AL +LH
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLH 156
Query: 577 QTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC-- 633
+V+RDLKP NILLD ++ ++D GL + +++ TS TFC
Sbjct: 157 SLN---IVYRDLKPENILLDSQGHI-VLTDFGLCK-------ENIEHNSTTS---TFCGT 202
Query: 634 --YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Y+ PE D + LG +L +++ PP
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQF---QQEVEVLCNI-R 516
+NF R +G+G +G V + + T A+KVL+ D E +L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 517 HPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
HP + L P+ + E++ G L + + + RF AAEI +AL+F
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA--RARF-YAAEIISALMF 139
Query: 575 LHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
LH +++RDLK N+LLD + K++D G+ + + + T+ TFC
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHC-KLADFGMCK-------EGICNGVTTA---TFC 185
Query: 634 ----YIDPE---YQQTGMLGVKS-DVYSLGILLLQIITAKPP 667
YI PE G + D +++G+LL +++ P
Sbjct: 186 GTPDYIAPEILQEMLYG----PAVDWWAMGVLLYEMLCGHAP 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 53/195 (27%), Positives = 79/195 (40%), Gaps = 28/195 (14%)
Query: 432 REAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PV 489
L + T S + + + K+GEG YG VYK+ T V
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 490 AIKVLRPDAAQ-G------RSQFQQEVEVLCNIRHPNMVLLLGACPEFGC--LIYEYMAN 540
AIK +R + + G R EV +L ++H N++ L LI+EY N
Sbjct: 63 AIKRIRLEHEEEGVPGTAIR-----EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV 600
L+ + + V I+ ++ + F H + +HRDLKP N+LL +
Sbjct: 118 -DLKKYMDKNP--DVSMRVIK-SFLYQLINGVNFCHSRRC---LHRDLKPQNLLLSVSDA 170
Query: 601 S-----KISDVGLAR 610
S KI D GLAR
Sbjct: 171 SETPVLKIGDFGLAR 185
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 7e-16
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTP--VAIKVLRPDAAQGRSQFQQ---EVEVL-CNIR 516
+F+ +G+G +G V S T A+K+L+ D + E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 517 HPNMVLLLGA--CPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
P + L + + EY+ G L + + G F AAEIA L F
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP--HAVF-YAAEIAIGLFF 457
Query: 575 LHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
L +++RDLK N++LD ++ KI+D G+ + +++ T TFC
Sbjct: 458 LQSKG---IIYRDLKLDNVMLDSEGHI-KIADFGMCK-------ENIWDGVTTK---TFC 503
Query: 634 ----YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
YI PE G D ++ G+LL +++ + P
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 47/230 (20%)
Query: 463 ENFSNSRKIGEGGYGPVY---KSYLDHTPV--AIKVLRPDA----AQGRSQFQQEVEVLC 513
ENF + +G G YG V+ K T A+KVL+ A+ + E +VL
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 514 NIRHPNMVLLLGAC---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRI------ 564
+IR ++ L LI +Y+ G L L +R RF
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---------RFTEHEVQIY 164
Query: 565 AAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQY 623
EI AL LH+ +++RD+K NILLD N +V ++D GL++ +
Sbjct: 165 VGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHV-VLTDFGLSKEFVADETER---- 216
Query: 624 RMTSAAGTFC----YIDPEYQQTGMLGVKSDV--YSLGILLLQIITAKPP 667
A FC Y+ P+ + G G V +SLG+L+ +++T P
Sbjct: 217 -----AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQ-G-RSQFQQEVEVLCNIRHP 518
+ KIG+G +G V+K+ T VA+K + + + G +E+++L ++H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 519 NMVLLLGACPEFGC----------LIYEYMANGSLED--RLFRRGGSPVLPWQIRFRIAA 566
N+V L+ C L++++ + D L +I+ R+
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIK-RVMQ 131
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+ L ++H+ K ++HRD+K N+L+ R+ V K++D GLAR S+A + R T
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYT 186
Query: 627 SAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
+ T Y PE +LG + D++ G ++ ++ T P
Sbjct: 187 NRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWTRSP 227
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 59/246 (23%), Positives = 88/246 (35%), Gaps = 48/246 (19%)
Query: 449 RYRKYSI-EEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQ- 504
+ E+ ++ R I G YG V D PVAIK + + GR+
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVN 65
Query: 505 -FQQ---------EVEVLCNIRHPNMVLLL-----GACPEFGC--LIYEYMANGSLED-- 545
E+ +L + HPN++ L P L+ E M D
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLA 121
Query: 546 RLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISD 605
++ + P I++ I L LH+ +VHRDL PGNILL N I D
Sbjct: 122 QVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177
Query: 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQ 660
LAR + T Y Y PE ++ K D++S G ++ +
Sbjct: 178 FNLAREDTAD--ANKTHYVTHRW-----YRAPEL----VMQFKGFTKLVDMWSAGCVMAE 226
Query: 661 IITAKP 666
+ K
Sbjct: 227 MFNRKA 232
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 50/167 (29%), Positives = 72/167 (43%), Gaps = 22/167 (13%)
Query: 461 ATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQ-GRSQFQQ----EVEVL- 512
AT + +IG G YG VYK+ H+ VA+K +R G EV +L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 513 --CNIRHPNMVLLLGACPEFGC-------LIYEYMANGSLEDRLFRRGGSPVLPWQIRFR 563
HPN+V L+ C L++E++ L L + + I+
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-D 124
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+ + L FLH +VHRDLKP NIL+ K++D GLAR
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 26/161 (16%)
Query: 470 KIGEGGYGPVYKSYLDHTP----VAIKVLRPDAAQGRSQF-QQEVEVLCNIRHPNMVLLL 524
K+G G YG VYK+ A+K + G S +E+ +L ++HPN++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQ 84
Query: 525 GACPEFG----CLIYEYMAN------GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
L+++Y + + + ++ + +I + +
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK-SLLYQILDGIHY 143
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVS----KISDVGLARL 611
LH ++HRDLKP NIL+ KI+D+G ARL
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 7e-15
Identities = 58/280 (20%), Positives = 113/280 (40%), Gaps = 53/280 (18%)
Query: 412 AQRIAELEAQKCKNVEFKALREAKERKAALNSLTVDLRYRKYSIEEIE-EATENFSNSRK 470
++ +++ C+ + + + ++ VD ++ + + + + N +
Sbjct: 10 SEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKP 69
Query: 471 IGEGGYGPVYKSYLDHT--PVAIK-VLRPDAAQGRSQFQQ---------EVEVLCNIRHP 518
IG G G V +Y VAIK + RP FQ E+ ++ + H
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRP--------FQNQTHAKRAYRELVLMKCVNHK 121
Query: 519 NMVLLLGA-CPEFGC-------LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIAT 570
N++ LL P+ L+ E M + L + + ++ + + ++
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLY-QMLC 175
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
+ LH ++HRDLKP NI++ + KI D GLAR S +T Y +T
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-- 228
Query: 631 TFCYIDPEYQQTGMLGVK----SDVYSLGILLLQIITAKP 666
Y PE +LG+ D++S+G ++ +++ K
Sbjct: 229 ---YRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 33/162 (20%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLG 525
+ +G G G V + + T A+K+L+ + ++EVE+ + P++V ++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVD 78
Query: 526 AC------PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF--RIAAE----IATALL 573
+ ++ E + G L R+ RG F R A+E I A+
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQ 131
Query: 574 FLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLV 612
+LH + HRD+KP N+L N + K++D G A+
Sbjct: 132 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 55/243 (22%), Positives = 97/243 (39%), Gaps = 53/243 (21%)
Query: 449 RYRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIK-VLRPDAAQGRSQ 504
+ I + + + N + IG G G V +Y VAIK + RP
Sbjct: 10 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------- 61
Query: 505 FQQ---------EVEVLCNIRHPNMVLLLGA-CPEFGC-------LIYEYMANGSLEDRL 547
FQ E+ ++ + H N++ LL P+ ++ E M + L
Sbjct: 62 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANL 116
Query: 548 FRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607
+ + ++ + + ++ + LH ++HRDLKP NI++ + KI D G
Sbjct: 117 CQVIQMELDHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVK----SDVYSLGILLLQIIT 663
LAR S +T Y +T Y PE +LG+ D++S+G ++ ++I
Sbjct: 173 LARTAGTS--FMMTPYVVTRY-----YRAPEV----ILGMGYKENVDIWSVGCIMGEMIK 221
Query: 664 AKP 666
Sbjct: 222 GGV 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 59/242 (24%), Positives = 93/242 (38%), Gaps = 63/242 (26%)
Query: 460 EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQ---------E 508
+ +F +GEG YG V + T VAIK + P F + E
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLRE 59
Query: 509 VEVLCNIRHPNMVLLLGACPEFGC-------LIYEYM--------ANGSLEDRLFRRGGS 553
+++L + +H N++ + +I E M + L D +
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ---- 115
Query: 554 PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613
+Q R A+ LH + ++HRDLKP N+L++ N K+ D GLAR++
Sbjct: 116 -YFIYQT-LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 614 PSVADSVTQYR----MTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITA 664
S AD+ M T Y PE ML DV+S G +L ++
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 665 KP 666
+P
Sbjct: 220 RP 221
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 34/170 (20%)
Query: 463 ENFSNSRKIGEGGYGPVYK---SYLDHTPVAIKVLRPDAAQG-------RSQFQQEVEVL 512
+ + +IGEG YG V+K VA+K +R + R EV VL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-----EVAVL 65
Query: 513 CNIR---HPNMVLLLGACPEFGC-------LIYEYMANGSLED--RLFRRGGSPVLPWQI 560
++ HPN+V L C L++E++ D + P +P +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTET 121
Query: 561 RFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+ ++ L FLH + +VHRDLKP NIL+ + K++D GLAR
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 62/238 (26%)
Query: 460 EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQ---------E 508
+ ++N IGEG YG V +Y + VAIK + P F+ E
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLRE 75
Query: 509 VEVLCNIRHPNMVLLL-----GACPEFGC--LIYEYM--------ANGSLEDRLFRRGGS 553
+++L RH N++ + + ++ + M L +
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC---- 131
Query: 554 PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613
+QI R L ++H ++HRDLKP N+LL+ KI D GLAR+
Sbjct: 132 -YFLYQI-LR-------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAKP 666
P D +T T Y PE ML K D++S+G +L ++++ +P
Sbjct: 180 P---DHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 50/262 (19%), Positives = 99/262 (37%), Gaps = 78/262 (29%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQ-EVEVLCNI 515
E +++ +S + +G G +G V + + + A+K + D +++ E++++ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVL 57
Query: 516 RHPNMVLLL----------GACPEFGC------------------------------LIY 535
H N++ L+ P+ +I
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 536 EYMANGSLED-----RLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKP 590
EY+ + + F R G + I I ++ A+ F+H + HRD+KP
Sbjct: 118 EYVP----DTLHKVLKSFIRSGRSIPMNLISIYIY-QLFRAVGFIHSLG---ICHRDIKP 169
Query: 591 GNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS 649
N+L++ K+ D G A+ + PS + + Y PE MLG
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEP-------SVAYICSRFYRAPEL----MLGATE 218
Query: 650 -----DVYSLGILLLQIITAKP 666
D++S+G + ++I KP
Sbjct: 219 YTPSIDLWSIGCVFGELILGKP 240
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 71/251 (28%)
Query: 450 YRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIK-VLRPDAAQGRSQF 505
+ + + + E + + + +G G YG V + T VAIK + RP F
Sbjct: 11 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--------F 62
Query: 506 QQ---------EVEVLCNIRHPNMVLLL------GACPEFGC--LIYEYM--------AN 540
Q E+ +L ++RH N++ LL +F L+ +M +
Sbjct: 63 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122
Query: 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV 600
L + + L +Q+ + L ++H ++HRDLKPGN+ ++ +
Sbjct: 123 EKLGEDRIQ-----FLVYQM-LK-------GLRYIHAAG---IIHRDLKPGNLAVNEDCE 166
Query: 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLG 655
KI D GLAR +T Y +T Y PE +L D++S+G
Sbjct: 167 LKILDFGLAR----QADSEMTGYVVTRW-----YRAPEV----ILNWMRYTQTVDIWSVG 213
Query: 656 ILLLQIITAKP 666
++ ++IT K
Sbjct: 214 CIMAEMITGKT 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 44/238 (18%), Positives = 98/238 (41%), Gaps = 52/238 (21%)
Query: 463 ENFSNSR-----KIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI 515
E + ++R K+G G + V+ + +++T VA+K++R + E+++L +
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRV 72
Query: 516 R-----------HPNMVLLL------GACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPW 558
+++ LL G +++E + +L + + +
Sbjct: 73 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLI 131
Query: 559 QIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS------KISDVGLARLV 612
++ +I+ ++ L ++H + ++H D+KP N+L++ KI+D+G A
Sbjct: 132 YVK-QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVK----SDVYSLGILLLQIITAKP 666
+ T T Y PE +LG +D++S L+ ++IT
Sbjct: 189 D----EHYTNSIQTRE-----YRSPEV----LLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 49/256 (19%), Positives = 88/256 (34%), Gaps = 71/256 (27%)
Query: 449 RYRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIK-VLRPDAAQGRSQ 504
R Y +N+ IG G YG VY +Y +T VAIK V R
Sbjct: 11 RENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------- 62
Query: 505 FQQ---------EVEVLCNIRHPNMVLLLGACP-----EFGC--LIYEYM---------A 539
F+ E+ +L ++ ++ L +F ++ E
Sbjct: 63 FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT 122
Query: 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599
L + + + + + F+H++ ++HRDLKP N LL+++
Sbjct: 123 PIFLTEEHIK-----TILYNL-LL-------GENFIHESG---IIHRDLKPANCLLNQDC 166
Query: 600 VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG------------MLGV 647
K+ D GLAR + ++ + + + Q T +L
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 648 KS-----DVYSLG-IL 657
++ D++S G I
Sbjct: 227 ENYTKSIDIWSTGCIF 242
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 37/205 (18%), Positives = 69/205 (33%), Gaps = 40/205 (19%)
Query: 460 EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQ----EVEVLC 513
+ + + IG G YG V ++Y VAIK + + E+ +L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILN 107
Query: 514 NIRHPNMVLLL-----GACPEFGC--LIYEYM---------ANGSLEDRLFRRGGSPVLP 557
+ H ++V +L +F ++ E L + + L
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-----TLL 162
Query: 558 WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617
+ + + ++H ++HRDLKP N L++++ K+ D GLAR V
Sbjct: 163 YNL-LV-------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 618 DSVTQYRMTSAAGTFCYIDPEYQQT 642
+ P +
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNL 236
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 48/241 (19%), Positives = 92/241 (38%), Gaps = 59/241 (24%)
Query: 460 EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIK------------VLRPDAAQGRSQF 505
+ + + + +G GG G V+ + + VAIK LR
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR---------- 57
Query: 506 QQEVEVLCNIRHPNMVLLLGA-CPEFGCLIYEYMANGSLED-------------RLFRRG 551
E++++ + H N+V + P L + + L + +G
Sbjct: 58 --EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG 115
Query: 552 GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-RNYVSKISDVGLAR 610
P+L R ++ L ++H ++HRDLKP N+ ++ + V KI D GLAR
Sbjct: 116 --PLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLGILLLQIITAK 665
++ P + ++ T Y P +L + D+++ G + +++T K
Sbjct: 170 IMDP---HYSHKGHLSEGLVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
Query: 666 P 666
Sbjct: 223 T 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 71/251 (28%)
Query: 450 YRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIK-VLRPDAAQGRSQF 505
+ + + + E E + N +G G YG V ++ T VA+K + RP F
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--------F 66
Query: 506 QQ---------EVEVLCNIRHPNMVLLL------GACPEFGC--LIYEYM--------AN 540
Q E+ +L +++H N++ LL + EF L+ M
Sbjct: 67 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 126
Query: 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV 600
L D + L +QI R L ++H ++HRDLKP N+ ++ +
Sbjct: 127 QKLTDDHVQ-----FLIYQI-LR-------GLKYIHSAD---IIHRDLKPSNLAVNEDCE 170
Query: 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKS-----DVYSLG 655
KI D GLAR AD +T Y T Y PE ML D++S+G
Sbjct: 171 LKILDFGLAR----HTADEMTGYVATRW-----YRAPEI----MLNWMHYNQTVDIWSVG 217
Query: 656 ILLLQIITAKP 666
++ +++T +
Sbjct: 218 CIMAELLTGRT 228
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 12/109 (11%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCN 514
+ + +G G +G V ++ VA+K+L+ A E+++L +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 515 I-RHPNMVLLLGACPEFG---CLIYEYMANGSLEDRLFRRGGSPVLPWQ 559
I H N+V LLGAC + G +I E+ G+L L + V
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 130
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 36/124 (29%), Positives = 56/124 (45%), Gaps = 13/124 (10%)
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623
+ ++A + FL K +HRDL NILL V KI D GLAR + Y
Sbjct: 198 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI-----YKDPDY 249
Query: 624 RMTSAAGT-FCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPP---MGLAHQVERSI 678
A ++ PE + ++SDV+S G+LL +I + P + + + R +
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
Query: 679 ENGT 682
+ GT
Sbjct: 310 KEGT 313
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 57/249 (22%), Positives = 94/249 (37%), Gaps = 67/249 (26%)
Query: 460 EATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIK-VLRPDAAQGRSQFQQ--------- 507
+ +K+G+G YG V+KS T VA+K + FQ
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDAQRTFR 57
Query: 508 EVEVLCNIR-HPNMVLLLGAC--PEFGC--LIYEYM--------ANGSLEDRLFRRGGSP 554
E+ +L + H N+V LL L+++YM LE +
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ----- 112
Query: 555 VLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614
+ +Q+ + + +LH L+HRD+KP NILL+ K++D GL+R
Sbjct: 113 YVVYQL-IK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTG------------MLGVKS-----DVYSLGIL 657
++ T + D + T +LG D++SLG +
Sbjct: 162 I-RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220
Query: 658 LLQIITAKP 666
L +I+ KP
Sbjct: 221 LGEILCGKP 229
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 28/158 (17%)
Query: 469 RKIGEGGYGPVYKSYLDH---TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH------PN 519
+ IG+G +G V K+Y DH VA+K++R + Q +E+ +L ++R N
Sbjct: 103 KVIGKGSFGQVVKAY-DHKVHQHVALKMVRNEKRF-HRQAAEEIRILEHLRKQDKDNTMN 160
Query: 520 MVLLLGACPEFG-----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
++ +L F C+ +E ++ +L + + + +R + A I L
Sbjct: 161 VIHMLEN---FTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR-KFAHSILQCLDA 215
Query: 575 LHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLA 609
LH+ + ++H DLKP NILL R+ + K+ D G +
Sbjct: 216 LHKNR---IIHCDLKPENILLKQQGRSGI-KVIDFGSS 249
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 40/199 (20%), Positives = 79/199 (39%), Gaps = 24/199 (12%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-----HPNMV 521
RK+G G + V+ S+ VA+KV++ A E+ +L ++R PN
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 522 LLLGACPEF------G---CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
+++ +F G C+++E + + L + + + ++ +I ++ L
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVK-KIIQQVLQGL 159
Query: 573 LFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
+LH ++H D+KP NILL ++ ++ + + A
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 630 GTFCYIDPEYQQTGMLGVK 648
G F E + L VK
Sbjct: 218 GNFLVNPLEPKNAEKLKVK 236
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 453 YSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT---PVAIKVLRPDAAQGRSQFQQEV 509
Y ++ E+ + + IG+G +G V K+Y D VAIK+++ A +Q Q EV
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY-DRVEQEWVAIKIIKNKKAF-LNQAQIEV 101
Query: 510 EVLCNIRHP------NMVLLLGACPEFG-----CLIYEYMANGSLEDRLFRRGGSPVLPW 558
+L + +V L F CL++E ++ +L D L V
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRH---FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLN 157
Query: 559 QIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLA 609
R + A ++ TALLFL + ++H DLKP NILL R+ + KI D G +
Sbjct: 158 LTR-KFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAI-KIVDFGSS 208
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 41/165 (24%), Positives = 64/165 (38%), Gaps = 34/165 (20%)
Query: 464 NFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH---- 517
NF +KIG G +G + + VAIK+ + Q E +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGI 67
Query: 518 PNMVLLLGACPEFGCLIYEYMANG-SLEDRLFRRGGSPVLPWQIRF------RIAAEIAT 570
P V G C ++ ++ E + G SLED LF F IA ++ +
Sbjct: 68 PQ-VYYFGPCGKYNAMVLELL--GPSLED-LFDLCDR-------TFSLKTVLMIAIQLIS 116
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSK-----ISDVGLAR 610
+ ++H L++RD+KP N L+ R I D LA+
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 53/231 (22%), Positives = 84/231 (36%), Gaps = 47/231 (20%)
Query: 469 RKIGEGGYGPVYKSYLDH---TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH-----PNM 520
RK+G+G +G V A+KV+R + E ++L I++ N+
Sbjct: 41 RKMGDGTFGRVLLCQ-HIDNKKYYAVKVVRNIKKY-TRSAKIEADILKKIQNDDINNNNI 98
Query: 521 VLLLGACPEFG-----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
V G F CLI+E + SL + + R + I+ EI AL +L
Sbjct: 99 VKYHGK---FMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIK-LYCIEILKALNYL 153
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA------ 629
+ L H DLKP NILL + L + + + YR S
Sbjct: 154 RKMS---LTHTDLKPENILL----DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 630 GTFCYID---PEYQQT-------GMLGVK----SDVYSLGILLLQIITAKP 666
G + T +L + SD++S G +L ++ T
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 44/183 (24%), Positives = 71/183 (38%), Gaps = 33/183 (18%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH----PNMVL 522
RKIG G +G +Y VAIK+ Q E ++ ++ P +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPT-IR 71
Query: 523 LLGACPEFGCLIYEYMANG-SLEDRLFRRGGSPVLPWQIRF------RIAAEIATALLFL 575
GA ++ ++ E + G SLED LF +F +A ++ + + ++
Sbjct: 72 WCGAEGDYNVMVMELL--GPSLED-LFNFCSR-------KFSLKTVLLLADQMISRIEYI 121
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSK---ISDVGLARLVPPSVADSVTQYR-MTSAAGT 631
H +HRD+KP N L+ I D GLA+ + YR + GT
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 632 FCY 634
Y
Sbjct: 179 ARY 181
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 34/160 (21%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH----PNMVL 522
R+IGEG +G +++ L++ VAIK + Q + E + PN V
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPN-VY 72
Query: 523 LLGACPEFGCLIYEYMANG-SLEDRLFRRGGSPVLPWQIRF------RIAAEIATALLFL 575
G L+ + + G SLED L G +F A ++ + +
Sbjct: 73 YFGQEGLHNVLVIDLL--GPSLED-LLDLCGR-------KFSVKTVAMAAKQMLARVQSI 122
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSK-----ISDVGLAR 610
H+ LV+RD+KP N L+ R + D G+ +
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 25/157 (15%)
Query: 469 RKIGEGGYGPVYKSYLDH----TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHP------ 518
+GEG +G V + DH + VA+K++R R + E+ VL I+
Sbjct: 25 GNLGEGTFGKVVECL-DHARGKSQVALKIIRNVGKY-REAARLEINVLKKIKEKDKENKF 82
Query: 519 NMVLLLGACPEFG-----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
VL+ F C+ +E + + + L P +R +A ++ AL
Sbjct: 83 LCVLMSDW---FNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVR-HMAYQLCHALR 137
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
FLH+ + L H DLKP NIL + + + +
Sbjct: 138 FLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 27/171 (15%), Positives = 47/171 (27%), Gaps = 38/171 (22%)
Query: 469 RKIGEGGYGPVY----------KSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHP 518
G +Y S ++K+ D + E P
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKP 102
Query: 519 NMVLLLGACPEFGCL----IYEYMANG-------------SLEDRLFRRGGSPVLPWQIR 561
V L + + SL+ VL +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQS-ALDVSPKHVLSERSV 161
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI--SDVGLAR 610
++A + AL FLH+ + VH ++ NI +D S++ + G A
Sbjct: 162 LQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 Length = 175 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 18/140 (12%)
Query: 13 VAVAID---------KDKGSQYALRWAVDHLLSRGQN---LTLLHVKQRVSSVPNPSGNS 60
V VA++ + A W ++ ++ + + LLHV+ V +
Sbjct: 8 VMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQ----VVDEDGFDD 63
Query: 61 VAISKVNNEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSS 120
V + E R +Q + L F C + C+ + D + V
Sbjct: 64 VDSIYASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKR 122
Query: 121 HTIETLVLGAASRTGFVKRF 140
+ LV+G+ F ++
Sbjct: 123 VRPDFLVVGSRGLGRF-QKV 141
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 25/157 (15%)
Query: 469 RKIGEGGYGPVYKSYLDH----TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHP------ 518
+GEG +G V + DH VA+K+++ + E++VL ++
Sbjct: 20 DTLGEGAFGKVVECI-DHKAGGRHVAVKIVKNVDRY-CEAARSEIQVLEHLNTTDPNSTF 77
Query: 519 NMVLLLGACPEFG-----CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
V +L F C+++E + S D + G P IR ++A +I ++
Sbjct: 78 RCVQMLEW---FEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIR-KMAYQICKSVN 132
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
FLH K L H DLKP NIL ++ ++ + + R
Sbjct: 133 FLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} Length = 138 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 22/129 (17%), Positives = 48/129 (37%), Gaps = 15/129 (11%)
Query: 13 VAVAIDKDKGSQYALRWAVDHL-LSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVA 71
+ AID + + A ++ +D LTL+HV +A
Sbjct: 4 LLFAIDDTEACERAAQYILDMFGKDADCTLTLIHV---KPEFMLYGEAVLAAYDE----- 55
Query: 72 RIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAA 131
+ + + +AK L F F T K I ++ E + + +++ + L++G++
Sbjct: 56 --IEMKEEEKAKLLTQKFSTFFTEKGINPFVVIKEG-EPVEMVLEE--AKDYNLLIIGSS 110
Query: 132 SRTGFVKRF 140
+ +
Sbjct: 111 ENSFL-NKI 118
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 28/166 (16%), Positives = 59/166 (35%), Gaps = 31/166 (18%)
Query: 469 RKIGEGGYGPVYK--SYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
+KIG GG+G +Y A V++ + Q E++ + + +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 527 CPEFGCL-IYEYMANG-------------------SLEDRLFRRGGSPVLPWQIRFRIAA 566
+ L I + +G L+ + + G+ ++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK-ISGQNGT--FKKSTVLQLGI 158
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI--SDVGLAR 610
+ L ++H+ + VH D+K N+LL ++ +D GL+
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 40/151 (26%), Positives = 64/151 (42%), Gaps = 18/151 (11%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH----PNMVL 522
RKIG G +G +Y + VAIK+ Q E ++ ++ PN V
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPN-VR 69
Query: 523 LLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEP 582
G ++ L+ + + SLED LF L + +A ++ + F+H
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLED-LFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 583 LVHRDLKPGNILLDRNYVSK---ISDVGLAR 610
+HRD+KP N L+ + I D GLA+
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 30/167 (17%), Positives = 61/167 (36%), Gaps = 30/167 (17%)
Query: 469 RKIGEGGYGPVY-------KSYLDHTPVAIKVLRPDAAQGRSQFQ-----QEVEVLCNIR 516
IG+GG+G +Y +S P +KV D ++ + + E +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 517 HPNMVLLLGACPEFGCLIYEYMANG-----------SLEDRLFRRGGSPVLPWQIRFRIA 565
+ LG +G +++ L+ ++ + +++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKR-FSRKTVLQLS 158
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI--SDVGLAR 610
I L ++H+ + VH D+K N+LL+ ++ D GLA
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 16/82 (19%), Positives = 35/82 (42%), Gaps = 13/82 (15%)
Query: 326 SSQSQSVEEVEV-----EMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQK 380
+ + +E E E +R RL+ D S ++ K K ++L W + ++
Sbjct: 75 AQADRLTQEPESIRKWREEQRKRLQEL---DAASKVMEQEWREKAK-KDLEEWNQRQSEQ 130
Query: 381 LE----DARMAEEAALALAEKE 398
+E + R+A++A + +
Sbjct: 131 VEKNKINNRIADKAFYQQPDAD 152
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 2e-04
Identities = 16/78 (20%), Positives = 30/78 (38%), Gaps = 13/78 (16%)
Query: 359 EALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRA--IEAAEAAQRIA 416
E++ +K RE R +L+E E A + E +++ +E + RIA
Sbjct: 85 ESI---RKWREEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSEQVEKNKINNRIA 141
Query: 417 ELEAQKCKNVEFKALREA 434
+ + F +A
Sbjct: 142 D-K-------AFYQQPDA 151
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 41.3 bits (96), Expect = 3e-04
Identities = 15/83 (18%), Positives = 32/83 (38%), Gaps = 16/83 (19%)
Query: 362 AAKQKARE---LHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAEL 418
A + +E + +W+ E+Q+ R+ E L + + E +A + + E
Sbjct: 76 QADRLTQEPESIRKWR--EEQR---KRLQE-----LDAASKVMEQEWRE--KAKKDLEEW 123
Query: 419 EAQKCKNVEFKALREAKERKAAL 441
++ + VE K + A
Sbjct: 124 NQRQSEQVE-KNKINNRIADKAF 145
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} Length = 319 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 21/126 (16%), Positives = 39/126 (30%), Gaps = 8/126 (6%)
Query: 15 VAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIY 74
V ID ++ Q ALR AV + G + +S + + + V
Sbjct: 12 VVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQK 71
Query: 75 KQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRT 134
+ QA+ I+ V+ +A+I+ V + + L+ A
Sbjct: 72 TAWIKQQARYY--------LEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHD 123
Query: 135 GFVKRF 140
Sbjct: 124 KLGSLI 129
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* Length = 268 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 21/174 (12%), Positives = 54/174 (31%), Gaps = 8/174 (4%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
+ +A D ++ A A LT+L V + + A++ +
Sbjct: 3 ILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRT 62
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
++ + + + + R + + ++ E +A++ + + LVLG +
Sbjct: 63 ELERALALRGEAVLERVRQSALAAGVAVEAVLEEG-VPHEAILRR--ARAADLLVLGRSG 119
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGKISSVRSATASVPVRASPGSQ 186
V + +P V + + + + AS +
Sbjct: 120 EAHGDGFGGLGSTADRVLRASP--VPVLLAPGEPVELEGAL---LGYDASESAV 168
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 Length = 162 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 18/130 (13%), Positives = 48/130 (36%), Gaps = 6/130 (4%)
Query: 15 VAIDKDKGSQYALRWAVDHLLSRGQNLTLLHV----KQRVSSVPNPSGNSVAISKVNNEV 70
D + ++ AL+ + + + LLHV + + + + ++K E
Sbjct: 10 YPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEF 69
Query: 71 ARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGA 130
K ++ +AK + K K+I++ + ++ ++ +++G+
Sbjct: 70 ENELKNKLTEEAKNKMENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGS 128
Query: 131 ASRTGFVKRF 140
+T K
Sbjct: 129 HGKTNL-KEI 137
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* Length = 150 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 8e-05
Identities = 18/124 (14%), Positives = 41/124 (33%), Gaps = 13/124 (10%)
Query: 15 VAIDKDKGSQYALRWAVDHLLSRGQNLTLLHV--KQRVSSVPNPSGNSVAISKVNNEVAR 72
+A+D ++ + G L+L+HV + P + + + +
Sbjct: 11 LAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLD 70
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
+ KQ++ L I L + + +I ++ +V+G+
Sbjct: 71 VEKQKLSQIGNTL-----------GIDPAHRWLVWGEPREEIIRIAEQENVDLIVVGSHG 119
Query: 133 RTGF 136
R G
Sbjct: 120 RHGL 123
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 9e-05
Identities = 23/160 (14%), Positives = 46/160 (28%), Gaps = 8/160 (5%)
Query: 312 EFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEAL----AAKQKA 367
+ S RT + Q +E+ + + L Q
Sbjct: 639 DVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEARGRLERQKILDQSE 698
Query: 368 RELHRWKLEEKQKLEDARMAEEA----ALALAEKERAKCKRAIEAAEAAQRIAELEAQKC 423
E R +L E + + A + A + AE R + + ++ A+ + +E +
Sbjct: 699 AEKARKELLELEAMSMAVESTGNAKAEAESRAEAARIEGEGSVLQAKLKAQALAIETEAE 758
Query: 424 KNVEFKALREAKERKAALNSLTVDLRYRKYSIEEIEEATE 463
K A L V + ++E +
Sbjct: 759 LERVKKVREMELIYARAQLELEVSKAQQLANVEAKKFKEM 798
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 30/174 (17%), Positives = 53/174 (30%), Gaps = 3/174 (1%)
Query: 291 SSSFVSLQSGSRSIDRNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQTM 350
S +F S I R + S T + + ++++
Sbjct: 585 SVTFDDFHKNSARIIRMAVFGFEMSEDTGPDGTLLPKARDQAVFPQNGLVVSSVDVQSVE 644
Query: 351 DMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAE 410
+ + Q A E+ E K E R+ +EA ER K EA +
Sbjct: 645 PVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEAR---GRLERQKILDQSEAEK 701
Query: 411 AAQRIAELEAQKCKNVEFKALREAKERKAALNSLTVDLRYRKYSIEEIEEATEN 464
A + + ELEA + E +A + + + ++ A E
Sbjct: 702 ARKELLELEAMSMAVESTGNAKAEAESRAEAARIEGEGSVLQAKLKAQALAIET 755
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A Length = 137 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 15/122 (12%), Positives = 39/122 (31%), Gaps = 15/122 (12%)
Query: 15 VAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIY 74
+A D + ++ A A + G L ++H VP+ G +
Sbjct: 7 LAYDGSEHARRAAEVAKAEAEAHGARLIVVHA---YEPVPDYLG-EPFFEEALRRRLERA 62
Query: 75 KQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRT 134
+ ++ + ++ +L + A+A++ + + +V+G
Sbjct: 63 EGVLEEARALT-----------GVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLG 111
Query: 135 GF 136
Sbjct: 112 AL 113
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* Length = 309 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 21/125 (16%), Positives = 40/125 (32%), Gaps = 9/125 (7%)
Query: 12 AVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVA 71
+ V ID +Q A+RWA R LTL+H S + V +
Sbjct: 21 GIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVH----AVSPEVATWLEVPLPPGVLRWQ 76
Query: 72 RIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAA 131
+ + + + + A ++ + + L+D S +V+G
Sbjct: 77 QDHGRHLIDDALKVVEQASLRAGPPTV---HSEIVPAAAVPTLVDM--SKDAVLMVVGCL 131
Query: 132 SRTGF 136
+
Sbjct: 132 GSGRW 136
|
| >2qag_C Septin-7; cell cycle, cell division, GTP-binding, nucleotide-binding, phosphorylation, acetylation, alternative splicing, coiled coil; HET: GDP GTP; 4.00A {Homo sapiens} Length = 418 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 23/123 (18%), Positives = 43/123 (34%), Gaps = 2/123 (1%)
Query: 306 RNSSPDEFSSYSQESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQ 365
+ + + + ++ + + E +M+++ +E+ Q +M + L K
Sbjct: 298 VTYNGVDNNKNKGQLTKSPLAQMEEERREHVAKMKKMEMEMEQVFEMKVKEKVQKL--KD 355
Query: 366 KARELHRWKLEEKQKLEDARMAEEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKN 425
EL R + K+ LE E E E+A + E LE K K
Sbjct: 356 SEAELQRRHEQMKKNLEAQHKELEEKRRQFEDEKANWEAQQRILEQQNSSRTLEKNKKKG 415
Query: 426 VEF 428
F
Sbjct: 416 KIF 418
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} Length = 147 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 24/128 (18%), Positives = 47/128 (36%), Gaps = 9/128 (7%)
Query: 15 VAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIY 74
V +D KG+ AL V G L +L V + S ++S E I
Sbjct: 7 VPVDGSKGAVKALEKGVGLQQLTGAELYILCV------FKHHSLLEASLSMARPEQLDIP 60
Query: 75 KQQVDNQAKELFVPFRCFCTRKEIKCKEI--VLEDTDIAKALIDYVSSHTIETLVLGAAS 132
+ + A E+ V + T + ++ ++ ++ ++ + + +V+GA
Sbjct: 61 DDALKDYATEIAVQAKTRATELGVPADKVRAFVKGGRPSRTIVRFARKRECDLVVIGAQG 120
Query: 133 RTGFVKRF 140
G K
Sbjct: 121 TNGD-KSL 127
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 Length = 141 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 6e-04
Identities = 20/122 (16%), Positives = 39/122 (31%), Gaps = 12/122 (9%)
Query: 15 VAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIY 74
VA+D + S L+ AV L+++HV V + I + +
Sbjct: 7 VAVDLSEESPILLKKAVGIAKRHDAKLSIIHV-----DVNFSDLYTGLIDVNMSSMQDRI 61
Query: 75 KQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRT 134
+ +L + E + D+ + L D + + ++ LV G
Sbjct: 62 STETQKALLDL-------AESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDF 114
Query: 135 GF 136
Sbjct: 115 WS 116
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 28/165 (16%), Positives = 65/165 (39%), Gaps = 14/165 (8%)
Query: 319 ESGRTSSSSQSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEK 378
+ + ++ + + +E+ + M +L + + + + E + + K
Sbjct: 975 QLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLK 1034
Query: 379 QKLEDARMAEEAALALAEKERAKCKRAI-----EAAEAAQRIAELEAQKC--------KN 425
K E E L EK R + ++ E+++ ++IAEL+AQ K
Sbjct: 1035 NKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKE 1094
Query: 426 VEFKALR-EAKERKAALNSLTVDLRYRKYSIEEIEEATENFSNSR 469
E +A ++ + N+ +R + I +++E E+ +R
Sbjct: 1095 EELQAALARLEDETSQKNNALKKIRELESHISDLQEDLESEKAAR 1139
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 768 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.85 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.85 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.84 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.83 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.83 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.83 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.82 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.82 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.82 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.81 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.81 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.77 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.74 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.72 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.71 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.69 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.69 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.66 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.66 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.65 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.61 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.45 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.68 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.54 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.52 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.16 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.99 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.56 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.99 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.97 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.48 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.26 | |
| 3a2k_A | 464 | TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, | 88.77 | |
| 1wy5_A | 317 | TILS, hypothetical UPF0072 protein AQ_1887; N-type | 84.24 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.91 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.42 | |
| 2xry_A | 482 | Deoxyribodipyrimidine photolyase; DNA damage, DNA | 82.38 | |
| 2iel_A | 138 | Hypothetical protein TT0030; TT0030,thermus thermo | 80.56 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=440.91 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=201.9
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~ 538 (768)
.++|.+.+.||+|+||+||+|.+.+ .||||+++.. .....+.|.+|+.+|++++|||||+++|+|.+ ..|||||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~ 113 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWC 113 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcC
Confidence 3578889999999999999999765 5999999744 33456779999999999999999999999844 459999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
+||+|.++|..... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.......
T Consensus 114 ~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~- 187 (307)
T 3omv_A 114 EGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG- 187 (307)
T ss_dssp SSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc-
Confidence 99999999976543 4999999999999999999999998 99999999999999999999999999987643211
Q ss_pred ccccccccCCCCCCCCCCcccccC---CCCCccccHHHHHHHHHHHHhCCCCCCCh---HHHHHHHHcCCccccCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQIITAKPPMGLA---HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltg~~Pf~~~---~~~~~~i~~~~~~~~ld~~~~ 692 (768)
.......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||... ..+...+..+.. .|..+
T Consensus 188 ---~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~----~p~~~ 260 (307)
T 3omv_A 188 ---SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA----SPDLS 260 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC----CCCST
T ss_pred ---ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----CCCcc
Confidence 122356789999999998864 45899999999999999999999999643 233344444432 23333
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..++..+.+|+.+||+.+|.+|||+.+|+.
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 334445567999999999999999999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=442.70 Aligned_cols=247 Identities=28% Similarity=0.426 Sum_probs=206.3
Q ss_pred cCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
++|.+.+.||+|+||.||+|.+. ++.||||+++.......+.|.+|+++|++++|||||+++|+|.+ ..||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999863 56799999987776777889999999999999999999999954 4599
Q ss_pred EEEeccCCChHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 534 IYEYMANGSLEDRLFRRG----------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
|||||++|+|.++|...+ ....++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 2346999999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHc
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIEN 680 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~ 680 (768)
+|||+|+.+..... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||... ..+...+..
T Consensus 170 ~DFGla~~~~~~~~----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp CCCSCHHHHTGGGC----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred CCcccceecCCCCc----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999987633211 111234579999999999999999999999999999999999 89999643 344455666
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
+... ..|..++..+.+|+.+||+.||.+|||+.+|+
T Consensus 246 ~~~~--------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 246 GRVL--------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCC--------CCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 5432 12223345699999999999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=448.99 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=203.1
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
++|++++.||+|+||.||+|.+ +++.||||+++.. .......+.+|+.+|++|+|||||+++++|.+ ..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999998 5789999999754 23446679999999999999999999999854 4599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
||+||+|.++|..... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 9999999999976543 34789999999999999999999999 999999999999999999999999999876321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
.......+||+.|||||++.+..|+.++||||||||||||+||++||.... .+...+..+.+.. .
T Consensus 179 -----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--------~ 245 (350)
T 4b9d_A 179 -----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP--------V 245 (350)
T ss_dssp -----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------C
T ss_pred -----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--------C
Confidence 112345689999999999999999999999999999999999999996443 3344555554321 1
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+...+..+.+||.+||+.||.+||++.+++. +|+
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 280 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence 2223356999999999999999999999986 555
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=446.81 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=208.6
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
..|++.++||+|+||.||+|.+ +++.||||++........+.+.+|+.+|+.++|||||+++++|.+ ..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5689999999999999999998 577899999976655556678999999999999999999999844 459999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
+||+|.+++.+. .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 999999988753 3999999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
......+||+.|||||++.+..|+.++||||||||||||++|++||..... ....+..+. .+.... +.
T Consensus 225 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-----~~~~~~-~~ 294 (346)
T 4fih_A 225 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-----PPRLKN-LH 294 (346)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-----CCCCSC-GG
T ss_pred ----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----CCCCCc-cc
Confidence 123567999999999999999999999999999999999999999965433 333444332 122211 22
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+..+.+||.+||+.||.+|||+.+++. +|+
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 34456999999999999999999999986 555
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=442.42 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=201.2
Q ss_pred cCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
++|.+.++||+|+||.||+|.+. ++.||||+++.......+.|.+|+++|++++|||||+++|+|.+ ..||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778889999999999999863 56799999987777777889999999999999999999999955 4599
Q ss_pred EEEeccCCChHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 534 IYEYMANGSLEDRLFRRGG------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
|||||++|+|.++|..... ...++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 235899999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSI 678 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i 678 (768)
||+|||+++.+..... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||... ..+...+
T Consensus 198 Ki~DFGla~~~~~~~~----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp EECCCC--------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred EEcccccceeccCCCc----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999987643221 112245689999999999999999999999999999999999 89999643 3344455
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
..+... ..|..++..+.+|+.+||+.||.+|||+.+|+..
T Consensus 274 ~~g~~~--------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 274 TQGREL--------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHTCCC--------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HcCCCC--------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 555321 1222334569999999999999999999999743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=438.89 Aligned_cols=244 Identities=26% Similarity=0.360 Sum_probs=207.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|++.+.||+|+||+||++.+ +++.||||++.+.. ......+.+|+++|+.++|||||+++++|.+ ..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999998 56789999997542 2234578999999999999999999999855 449999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||+||+|.+++.+.+ .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999998765 3999999999999999999999999 999999999999999999999999999987433
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.. .....+.+||+.|||||++.+..|+.++|||||||+||||+||++||... ..+...+..+.+.
T Consensus 186 ~~----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------- 252 (311)
T 4aw0_A 186 SK----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD--------- 252 (311)
T ss_dssp TT----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred CC----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 21 22345679999999999999999999999999999999999999999644 3444555555431
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+|...+..+.+||.+||+.||.+||++.+++.
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 12223456899999999999999999999753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=438.72 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=204.0
Q ss_pred cCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
.++++.++||+|+||.||+|.+ +++.||||+++... ....+.|.+|+.+|++++|||||+++|+|.+ ..|
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4567788999999999999986 34679999997543 2345679999999999999999999999954 459
Q ss_pred eEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 035604 533 LIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 599 (768)
||||||++|+|.++|..... ...++|..+++|+.||+.||.|||+.+ ||||||||+||||+.++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975431 235899999999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHH
Q 035604 600 VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVER 676 (768)
Q Consensus 600 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~ 676 (768)
.+||+|||+++.+.... .........||+.|||||++.++.|+.++|||||||+||||+| |..||... ..+..
T Consensus 183 ~~Ki~DFGlar~~~~~~----~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAAD----YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CEEECCSCCBCGGGGGG----CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CEEECCcccceeccCCC----ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999998663221 1122345689999999999999999999999999999999998 89999643 34445
Q ss_pred HHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 677 ~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+... ..|..++..+.+|+.+||+.||.+||++.+|+.
T Consensus 259 ~i~~~~~~--------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 259 MIRNRQVL--------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp HHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCC--------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 56555432 122233456999999999999999999999873
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=428.37 Aligned_cols=244 Identities=26% Similarity=0.406 Sum_probs=199.3
Q ss_pred CCccceecccCceeEEEEEEC--CccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC------CceeE
Q 035604 465 FSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------FGCLI 534 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~lV 534 (768)
|++.++||+|+||.||+|.+. +..||+|++... .......|.+|+.+|++++|||||+++++|.+ ..|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356778999999999999984 568999999654 33445679999999999999999999998843 34899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCcEEEeecccccccC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARLVP 613 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~vKL~DFGla~~~~ 613 (768)
||||+||+|.+++.+.. .+++..++.|+.||+.||.|||+++ .+||||||||+||||+. +|.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999998765 4999999999999999999999976 35999999999999974 7999999999998653
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh---HHHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA---HQVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~---~~~~~~i~~~~~~~~ld~~ 690 (768)
.. .....+||+.|||||++.+ .|+.++|||||||+||||+||++||... ..+...+..+.....++.
T Consensus 184 ~~--------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~- 253 (290)
T 3fpq_A 184 AS--------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK- 253 (290)
T ss_dssp TT--------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG-
T ss_pred CC--------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCc-
Confidence 22 1245689999999998865 6999999999999999999999999543 233344444432221111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+..+.+||.+||+.||.+|||+.+++. +|+
T Consensus 254 ------~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 254 ------VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp ------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ------cCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 12245899999999999999999999986 454
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=448.11 Aligned_cols=247 Identities=24% Similarity=0.328 Sum_probs=208.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
+.|++.+.||+|+||.||+|.+ +++.||||++........+.+.+|+.+|+.++|||||+++++|. +..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999998 46789999998765555667899999999999999999999984 4559999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
+||+|.+++.... +++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 231 EGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp TTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 9999999886543 899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCCCCH
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
......+||+.|||||++.+..|+.++||||||||||||++|++||..... ....+..+.. +.... +.
T Consensus 302 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----~~~~~-~~ 371 (423)
T 4fie_A 302 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-----PRLKN-LH 371 (423)
T ss_dssp ----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCCSC-TT
T ss_pred ----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----CCCcc-cc
Confidence 223567999999999999999999999999999999999999999965433 3334444321 11111 11
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+..+.+||.+||..||.+||++.+++. +|+
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 23356999999999999999999999986 555
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=438.41 Aligned_cols=256 Identities=19% Similarity=0.244 Sum_probs=204.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.+.|.+.++||+|+||.||+|.+ +++.||||+++.... +.+|+.+|+.++|||||+++++|.+ ..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35688889999999999999998 467899999975432 2479999999999999999999854 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeecccccccCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVPPSV 616 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFGla~~~~~~~ 616 (768)
|+||+|.++|...+ .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999998765 4999999999999999999999999 99999999999999987 69999999999875432
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
.. .........+||+.|||||++.+..|+.++|||||||+||||+||++||.... .+...+..+... ....
T Consensus 206 ~~-~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------~~~~ 278 (336)
T 4g3f_A 206 LG-KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP------IREI 278 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG------GGGS
T ss_pred cc-cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC------chhc
Confidence 11 11112234689999999999999999999999999999999999999995332 223334333211 1122
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALA 735 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~ 735 (768)
+...+..+.+||.+||+.||.+|||+.|++..+...+....
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 23334569999999999999999999999876666655543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=422.20 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=192.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|++.+.||+|+||.||+|.+ +++.||||++++.. ......+.+|+.+|+.++|||||++++++.+ ..|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999997 57899999997543 2234578999999999999999999999854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||| +|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 789999998765 4999999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~ 691 (768)
. ......+||+.|||||++.+..| +.++|||||||++|+|+||++||... ..+...+..+.+.
T Consensus 165 ~-------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~------- 230 (275)
T 3hyh_A 165 G-------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT------- 230 (275)
T ss_dssp -----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------
T ss_pred C-------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 2 12345789999999999998876 68999999999999999999999644 3334455555421
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+|...+..+.+|+.+||+.||.+|||+.+++. +|+
T Consensus 231 --~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 231 --LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 12223456899999999999999999999986 665
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=435.98 Aligned_cols=265 Identities=27% Similarity=0.387 Sum_probs=215.6
Q ss_pred CCHHHHHHHhcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCch-hhHHHHHHHHHHHhhcCC-Cceeee
Q 035604 453 YSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRH-PNMVLL 523 (768)
Q Consensus 453 ~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~H-pnIv~l 523 (768)
|+..+++...++|++.+.||+|+||.||+|.+.+ +.||||+++.... .....|.+|+.+|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4445555556889999999999999999998743 4699999976543 345679999999999965 999999
Q ss_pred eccccC---CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 035604 524 LGACPE---FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRD 587 (768)
Q Consensus 524 ~g~~~~---~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrD 587 (768)
+|+|.+ ..|||||||++|+|.++|..... ...+++..++.|+.||+.||.|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 999843 35899999999999999975321 245899999999999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCC
Q 035604 588 LKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKP 666 (768)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~ 666 (768)
|||+||||+.++.+||+|||+|+.+..... .......+||+.|||||++.+..|+.++|||||||+||||+| |+.
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCC----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 999999999999999999999987643321 122345689999999999999999999999999999999998 999
Q ss_pred CCCCh---HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 667 PMGLA---HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 667 Pf~~~---~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
||... ..+...+..+... .. |..++..+.+|+.+||+.||.+|||+.+|+..+.+.|+
T Consensus 287 Pf~~~~~~~~~~~~i~~g~~~-----~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 287 PYPGVKIDEEFCRRLKEGTRM-----RA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp SSTTCCCSHHHHHHHHHTCCC-----CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCC-----CC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 99543 3455556655421 12 22234569999999999999999999999876555554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=428.77 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=197.3
Q ss_pred cCCCccceecccCceeEEEEEE-----CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
++|++.+.||+|+||+||+|.. .++.||||++++.. ......+.+|+++|++++|||||+++++|.+ ..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999986 34579999997643 2234468899999999999999999999854 4599
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|||||+||+|.++|.+.+ .+++..+..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998765 4999999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
... ......+||+.|||||++.+..|+.++|||||||+||||+||++||.... .+...+..+.+.
T Consensus 178 ~~~------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------- 244 (304)
T 3ubd_A 178 DHE------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG------- 244 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred CCC------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-------
Confidence 221 22356789999999999999999999999999999999999999996443 344455554321
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCCh-----hhhhh-HHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDL-----GKVVV-PKL 728 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~-----~evl~-~~l 728 (768)
.|...+..+.+|+.+||+.||.+||++ ++++. +|.
T Consensus 245 --~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 245 --MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred --CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 122234569999999999999999995 45654 443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=424.78 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=195.4
Q ss_pred cCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC------CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~lV~E 536 (768)
.+|.+.+.||+|+||.||+|.++++.||||+++..... ...++.|+.++..++|||||+++|+|.+ ..|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 45778899999999999999999999999999754322 2233456667788999999999999853 2489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK-----PEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
||++|+|.++|.... ++|..+++++.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999997643 899999999999999999999871 22499999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCC------CCCccccHHHHHHHHHHHHhCCCCCCCh--------------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG------MLGVKSDVYSLGILLLQIITAKPPMGLA-------------- 671 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDvwSlGvil~elltg~~Pf~~~-------------- 671 (768)
....... ........+||+.|||||++.+. .|+.++|||||||+||||+||.+||...
T Consensus 158 ~~~~~~~--~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 158 HDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EETTTTE--ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccCCCCc--eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 6433211 11122346899999999998764 3678999999999999999998876421
Q ss_pred ---HHHHHHHHcCCccccCCCCCCCC--CHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 672 ---HQVERSIENGTFDETLDPAVPDW--PVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 672 ---~~~~~~i~~~~~~~~ld~~~~~~--~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
..+...+.. ..++|.++.. +.+....+.+|+.+||+.||.+|||+.+|+..
T Consensus 236 ~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 112222222 2334444432 23456679999999999999999999999854
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=420.64 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=192.7
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC----------
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---------- 529 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---------- 529 (768)
++|++.+.||+|+||.||+|.+ +++.||||+++... ....+.+.+|+.+|++++|||||+++++|.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999998 47799999996543 3445678999999999999999999998732
Q ss_pred ----CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEee
Q 035604 530 ----FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISD 605 (768)
Q Consensus 530 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~D 605 (768)
+.|||||||++|+|.+++.........++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 14899999999999999987665444667778899999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCcc------ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--
Q 035604 606 VGLARLVPPSVADSV------TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS-- 677 (768)
Q Consensus 606 FGla~~~~~~~~~~~------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~-- 677 (768)
||+|+.+........ .....+..+||+.|||||++.+..|+.++|||||||+||||++ ||.........
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999998754322111 1123355789999999999999999999999999999999996 88655433222
Q ss_pred -HHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 678 -IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 678 -i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+....+ +.........+.+|+.+||+.||.+||++.+++. +|+
T Consensus 239 ~~~~~~~--------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 239 DVRNLKF--------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp HHHTTCC--------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHhcCCC--------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 222221 2222234455788999999999999999999985 443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=414.05 Aligned_cols=260 Identities=22% Similarity=0.269 Sum_probs=202.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
.++|++++.||+|+||+||+|.+ +++.||||+++... ......+.+|+.+|+.++|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999998 57799999997542 3345678899999999999999999998742
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..|||||||+ |+|.+++...+ .+++..+..|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 3499999995 67999887654 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--CCcc
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--GTFD 684 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~~~~ 684 (768)
+.+..... .........+||+.|+|||++.+. .|+.++||||||||+|||++|++||....... ..|.. +...
T Consensus 206 ~~~~~~~~--~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPA--EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp BCC---------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccCcc--ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 87643221 122334678999999999988775 57999999999999999999999996543322 22221 1111
Q ss_pred ccCCC---------------CCCCCC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 685 ETLDP---------------AVPDWP-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 685 ~~ld~---------------~~~~~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
..... .....+ ...+..+.+||.+||..||.+|||+.+++. +|+..
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 11000 000001 112356889999999999999999999987 66643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=398.34 Aligned_cols=198 Identities=24% Similarity=0.343 Sum_probs=165.1
Q ss_pred HhcCCCccceecccCceeEEEEEEC-----CccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeecccc--CCce
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD-----HTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACP--EFGC 532 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~~~ 532 (768)
..++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+|+++|+.+ +|||||+++++|. +..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3578999999999999999999862 45799999875532 34678999999998 6999999999984 4558
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeecccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARL 611 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DFGla~~ 611 (768)
||||||+||+|.+++. .+++..+..++.||+.||.|||+.| ||||||||+||||+.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999883 2899999999999999999999999 9999999999999876 8999999999987
Q ss_pred cCCCCCCcc----------------------ccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCC
Q 035604 612 VPPSVADSV----------------------TQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPM 668 (768)
Q Consensus 612 ~~~~~~~~~----------------------~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf 668 (768)
......... .....+..+||+.|+|||++.+. .|+.++||||+|||+|||++|++||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 643221100 11123456899999999988775 5899999999999999999999999
Q ss_pred C
Q 035604 669 G 669 (768)
Q Consensus 669 ~ 669 (768)
.
T Consensus 248 ~ 248 (361)
T 4f9c_A 248 Y 248 (361)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=418.28 Aligned_cols=240 Identities=28% Similarity=0.330 Sum_probs=196.2
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHH---HHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQ---QEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~---~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
++|.+.+.||+|+||.||++.+ +++.||||++.+... .....+. .++.+++.++|||||+++++|.+ ..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 6799999999999999999998 567899999975421 1122233 44667778899999999999854 459
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
||||||+||+|.++|.+.+ .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999998765 4999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChH-----HHHHHHHcCCcccc
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAH-----QVERSIENGTFDET 686 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~-----~~~~~i~~~~~~~~ 686 (768)
... ...+.+||+.|||||++.+ ..|+.++||||||||||||++|++||.... .+...+....+
T Consensus 343 ~~~--------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~--- 411 (689)
T 3v5w_A 343 SKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 411 (689)
T ss_dssp SSC--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC---
T ss_pred CCC--------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC---
Confidence 432 2346799999999999864 579999999999999999999999995422 22333333221
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPD-----LGKVVV 725 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~ 725 (768)
.+|...+..+.+||.+||+.||.+|++ +.+|+.
T Consensus 412 ------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 122233456999999999999999998 577764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=420.07 Aligned_cols=247 Identities=20% Similarity=0.343 Sum_probs=207.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++..........+.+|+.+|+.++|||||+++++|.+ ..||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999998 567899999987766667789999999999999999999999855 44899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC--CCcEEEeecccccccCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR--NYVSKISDVGLARLVPPS 615 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~--~~~vKL~DFGla~~~~~~ 615 (768)
|+||+|.++|..... .+++..+..|+.||+.||.|||+++ |+||||||+||||+. .+.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999865432 4999999999999999999999999 999999999999975 489999999999987433
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
. .....+||+.|||||++.+..|+.++||||||||||||++|++||.... .....+..+.+. ...+....
T Consensus 311 ~-------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~ 382 (573)
T 3uto_A 311 Q-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-MDDSAFSG 382 (573)
T ss_dssp S-------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-CCSGGGTT
T ss_pred C-------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC-CCcccccC
Confidence 1 2345689999999999999999999999999999999999999996543 334455554321 11111112
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+..+.+||.+||..||.+||++.+++.
T Consensus 383 ----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 383 ----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2345889999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=374.17 Aligned_cols=272 Identities=36% Similarity=0.603 Sum_probs=223.0
Q ss_pred CCHHHHHHHhcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--
Q 035604 453 YSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-- 529 (768)
Q Consensus 453 ~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-- 529 (768)
+.+.++...+++|.+.+.||+|+||.||+|.+ ++..||||++..........+.+|+.+++.++||||++++++|.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44445556789999999999999999999997 467999999987766667789999999999999999999999854
Q ss_pred CceeEEEeccCCChHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGG-SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 45999999999999998865432 235899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH---------HHHHHHH
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH---------QVERSIE 679 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~---------~~~~~i~ 679 (768)
++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......
T Consensus 186 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 186 SKKGTELDQ----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CEECSSSSC----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ccccccccc----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 986532211 111234568999999999998999999999999999999999999995321 1112333
Q ss_pred cCCccccCCCCCC-CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 680 NGTFDETLDPAVP-DWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 680 ~~~~~~~ld~~~~-~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
.+.+...+++... ..+...+..+.+++.+||+.+|.+||++.+++..+...+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 4555566665553 456788889999999999999999999999986555444
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=369.04 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=207.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++..........+.+|+.+++.++||||++++++|. +..|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999986 56789999997665555677899999999999999999999884 445999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++|+|.+++.... +++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 99 ~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 99999999987653 899999999999999999999999 99999999999999999999999999987643321
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld~~~~~~~ 695 (768)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+........ ..+
T Consensus 172 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~ 239 (297)
T 3fxz_A 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL------QNP 239 (297)
T ss_dssp ------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC------SCG
T ss_pred ------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------CCc
Confidence 23456899999999999999999999999999999999999999965543322 1211111111 112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
...+..+.+|+.+||+.||.+||++.+++. +|++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence 334456999999999999999999999986 5553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=372.84 Aligned_cols=271 Identities=37% Similarity=0.596 Sum_probs=220.6
Q ss_pred cccCCHHHHHHHhcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccc
Q 035604 450 YRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGAC 527 (768)
Q Consensus 450 ~~~~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~ 527 (768)
...|++.++....++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+++.++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 46789999999999999999999999999999987 578999999976532 2234689999999999999999999998
Q ss_pred cC--CceeEEEeccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEe
Q 035604 528 PE--FGCLIYEYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 604 (768)
Q Consensus 528 ~~--~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~ 604 (768)
.+ ..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 44 4599999999999999997653 33459999999999999999999999921229999999999999999999999
Q ss_pred ecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH-----------
Q 035604 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ----------- 673 (768)
Q Consensus 605 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~----------- 673 (768)
|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 177 Dfg~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 177 DFGLAKLMDYKDT-----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp CCSSCEECCSSSS-----CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred cCccccccCcccc-----cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999987643221 123445699999999999988999999999999999999999999963221
Q ss_pred HHHHHHcCCccccCCCCC-CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 674 VERSIENGTFDETLDPAV-PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 674 ~~~~i~~~~~~~~ld~~~-~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+....+....+... ...+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 304 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence 111112233334444433 2567788889999999999999999999999983
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.27 Aligned_cols=269 Identities=38% Similarity=0.648 Sum_probs=225.0
Q ss_pred ccccCCHHHHHHHhcCCCcc------ceecccCceeEEEEEECCccEEEEEEcCCc----hhhHHHHHHHHHHHhhcCCC
Q 035604 449 RYRKYSIEEIEEATENFSNS------RKIGEGGYGPVYKSYLDHTPVAIKVLRPDA----AQGRSQFQQEVEVLCNIRHP 518 (768)
Q Consensus 449 ~~~~~~~~ei~~~~~~y~~~------~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~Hp 518 (768)
.+..|+..++..++++|... +.||+|+||.||+|.++++.||||++.... ......+.+|+.+++.++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 45778999999999999877 899999999999999999999999996532 23456789999999999999
Q ss_pred ceeeeeccccC--CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 035604 519 NMVLLLGACPE--FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD 596 (768)
Q Consensus 519 nIv~l~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~ 596 (768)
||+++++++.+ ..++||||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 99999999854 45999999999999999986555556999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH----
Q 035604 597 RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH---- 672 (768)
Q Consensus 597 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~---- 672 (768)
.++.+||+|||+++....... ........||+.|+|||.+.+ .++.++|||||||++|+|++|.+||....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQ----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSS----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred CCCcEEEeecccccccccccc----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 999999999999987643221 111234579999999998765 58899999999999999999999996332
Q ss_pred --HHHHHHHc--CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 673 --QVERSIEN--GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 673 --~~~~~i~~--~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+...+.. ..+...++......+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22222222 224445566667778888889999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=367.73 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=199.3
Q ss_pred HhcCCCccceecccCceeEEEEEECCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
..++|.+.+.||+|+||.||++.+.++.||||++.... ......+.+|+.+|++++||||++++++|.+ ..++|||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 35689999999999999999999999999999997653 3345678999999999999999999999854 4599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++|+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999976543334899999999999999999999986 359999999999999999999999999997643221
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 694 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+...... ...
T Consensus 194 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------~~~ 260 (309)
T 3p86_A 194 ------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------LEI 260 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-------CCC
T ss_pred ------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------CCC
Confidence 12245679999999999999999999999999999999999999997544322 222211111 112
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHH
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVVPKLN 729 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~ 729 (768)
+...+..+.+|+.+||..+|.+||++.+++..+..
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22334569999999999999999999999844333
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=370.83 Aligned_cols=246 Identities=25% Similarity=0.366 Sum_probs=206.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++.. ..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 56899999999999999999997 6789999999654 23445678899999999999999999999854 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999998765 3899999999999999999999999 999999999999999999999999999866432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCC-ccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLG-VKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~ 692 (768)
......+||+.|+|||++.+..+. .++|||||||++|+|++|++||... ......+..+.+.
T Consensus 168 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------- 232 (328)
T 3fe3_A 168 -------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-------- 232 (328)
T ss_dssp -------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred -------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 123456899999999999888764 8999999999999999999999644 3344455555431
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
.|...+..+.+|+.+||..||.+|||+.+++. +|++
T Consensus 233 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 233 -IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp -CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred -CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 11123356899999999999999999999986 5553
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=369.54 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=200.8
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccCC------ceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF------GCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~lV~ 535 (768)
.++|.+.+.||+|+||.||+|.+.++.||||++..... ....+..|+.+|++++|||||+++++|.+. .++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 46799999999999999999999999999999975433 334566799999999999999999998542 38999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeCCCCCCCeEEcCCCcEEEee
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT----------KPEPLVHRDLKPGNILLDRNYVSKISD 605 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~~~~iiHrDLKp~NILl~~~~~vKL~D 605 (768)
||+++|+|.+++.... +++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999997643 99999999999999999999998 8 99999999999999999999999
Q ss_pred cccccccCCCCCCccccccccCCCCCCCCCCcccccC-----CCCCccccHHHHHHHHHHHHhCCCCCCChH--------
Q 035604 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQIITAKPPMGLAH-------- 672 (768)
Q Consensus 606 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltg~~Pf~~~~-------- 672 (768)
||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 175 Fg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 175 FGLALKFEAGKS----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp CTTCEEECTTSC----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred CCcccccccccC----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 999987654321 112344679999999999886 356778999999999999999999995321
Q ss_pred ----------HHHHHHHcCCccccCCCCCCCC--CHHHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 673 ----------QVERSIENGTFDETLDPAVPDW--PVEEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 673 ----------~~~~~i~~~~~~~~ld~~~~~~--~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
.....+.... ..+..+.. ....+..+.+|+.+||+.||.+|||+.+|+..+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 313 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1111222211 12222221 224556799999999999999999999997433
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=364.01 Aligned_cols=249 Identities=29% Similarity=0.464 Sum_probs=199.3
Q ss_pred cCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccCCceeEEEeccCCC
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFGCLIYEYMANGS 542 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~lV~E~~~~gs 542 (768)
++|.+.+.||+|+||.||++.+.++.||||++.... ....+.+|+.+|++++||||+++++++.+..++||||+++|+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 568889999999999999999999999999997543 456789999999999999999999999988999999999999
Q ss_pred hHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc-EEEeecccccccCCCCCCccc
Q 035604 543 LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV-SKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 543 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-vKL~DFGla~~~~~~~~~~~~ 621 (768)
|.+++........+++..++.++.||+.||.|||+.++.+|+||||||+|||++.++. +||+|||++..+...
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------ 159 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------ 159 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------
Confidence 9999987655455889999999999999999999943334999999999999988886 799999999755321
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH----HHHHHHHcCCccccCCCCCCCCCHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH----QVERSIENGTFDETLDPAVPDWPVE 697 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~----~~~~~i~~~~~~~~ld~~~~~~~~~ 697 (768)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+.... ....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~---- 228 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP----LIKN---- 228 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC----CBTT----
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC----cccc----
Confidence 233468999999999999999999999999999999999999996331 1222233332111 1112
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
.+..+.+|+.+||..+|.+||++.+++..+...
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 234589999999999999999999998544433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.85 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=203.4
Q ss_pred hcCCCccceecccCceeEEEEEE------CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc----CCc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP----EFG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~ 531 (768)
.++|++.+.||+|+||.||++.+ +++.||||++..........+.+|+.+|+.++||||++++++|. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36799999999999999999984 46789999998776666778999999999999999999999873 346
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 899999999999999977543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH-HHHcCCcc------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER-SIENGTFD------ 684 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~-~i~~~~~~------ 684 (768)
+..... .........++..|+|||.+.+..++.++|||||||++|+|++|..||........ .+......
T Consensus 164 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 164 LPQDKE---FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccCCcc---eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 643221 11122345677889999999999999999999999999999999999965432211 11110000
Q ss_pred ---ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 685 ---ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 685 ---~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
..........+..++..+.+|+.+||..+|.+||++.+++..+.+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 000000111222334569999999999999999999999865554443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.15 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=203.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||++.+ ++..||+|++..........+.+|+.+++.++||||++++++|.+ ..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 36789999999999999999998 467899999977666777889999999999999999999999844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999987443 4999999999999999999999999 99999999999999999999999999987644322
Q ss_pred Ccc--------ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--------HHHHHHcC
Q 035604 618 DSV--------TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--------VERSIENG 681 (768)
Q Consensus 618 ~~~--------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--------~~~~i~~~ 681 (768)
... .........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--
Confidence 110 01112256899999999999999999999999999999999999999853211 111111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
....+. + +..+.+|+.+||+.+|.+||++.+++. +++.++
T Consensus 242 ---~~~~~~---~----~~~l~~li~~~l~~dP~~Rps~~~l~~-~L~~l~ 281 (310)
T 3s95_A 242 ---RYCPPN---C----PPSFFPITVRCCDLDPEKRPSFVKLEH-WLETLR 281 (310)
T ss_dssp ---HTCCTT---C----CTTHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred ---ccCCCC---C----CHHHHHHHHHHccCChhhCcCHHHHHH-HHHHHH
Confidence 011111 1 234899999999999999999999875 444443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=370.52 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=206.8
Q ss_pred hcCCCccceecccCceeEEEEEEC---------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 529 (768)
.++|.+.+.||+|+||.||+|.+. +..||||+++... ......+.+|+.+|+.+ +|||||+++++|.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367899999999999999999862 2369999997653 34456789999999999 89999999999854
Q ss_pred -CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
..|+||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 45999999999999999986532 234889999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--H
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--H 672 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~ 672 (768)
+.++.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCT----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCCEEEccccCCcccCcccc----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999987643221 112234567889999999999999999999999999999999 99999533 3
Q ss_pred HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 673 QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 673 ~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
.+...+..+... ..+..++..+.+|+.+||..+|.+||++.+++..+.+.+
T Consensus 313 ~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 313 ELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp GHHHHHHTTCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 333444444321 122233456999999999999999999999986555444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=363.35 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=211.0
Q ss_pred ccCCHHHHHHHhcC----------CCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCC
Q 035604 451 RKYSIEEIEEATEN----------FSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHP 518 (768)
Q Consensus 451 ~~~~~~ei~~~~~~----------y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp 518 (768)
..++.+++..+++. |...+.||+|+||.||+|.+ +++.||||++..........+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45666777666654 77788999999999999998 5789999999876656667789999999999999
Q ss_pred ceeeeecccc--CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc
Q 035604 519 NMVLLLGACP--EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD 596 (768)
Q Consensus 519 nIv~l~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~ 596 (768)
||++++++|. ...++||||+++|+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 9999999884 4559999999999999988643 3899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--
Q 035604 597 RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV-- 674 (768)
Q Consensus 597 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~-- 674 (768)
.++.+||+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCCcEEEeeeeeeeecccCcc------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999987643221 124568999999999999999999999999999999999999999644332
Q ss_pred HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 675 ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 675 ~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
...+..... +... .+...+..+.+|+.+||..+|.+||++.+++. +|.
T Consensus 250 ~~~~~~~~~-----~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 250 MKRLRDSPP-----PKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp HHHHHHSSC-----CCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHhcCCC-----CCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 223333221 1111 11223456999999999999999999999986 443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=366.81 Aligned_cols=243 Identities=26% Similarity=0.322 Sum_probs=202.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.. +++.||||++++.. ......+.+|+.+|+.++||||++++++|.+ ..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 36799999999999999999998 46789999997542 2234568899999999999999999999854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||++||+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999997754 4899999999999999999999999 99999999999999999999999999985422
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~ 692 (768)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|++||.... .....+..+.+
T Consensus 158 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------- 222 (337)
T 1o6l_A 158 DG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--------- 222 (337)
T ss_dssp TT------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred CC------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 11 12345689999999999999999999999999999999999999996443 33344443322
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
.+|...+..+.+|+.+||..+|.+|| ++.+++.
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11222345699999999999999999 8888875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=366.09 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=204.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC---------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------- 529 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||+++... ......+.+|+.+|++++|||||+++++|.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46799999999999999999998 57789999997543 3345678999999999999999999998722
Q ss_pred --------------------------------------------------CceeEEEeccCCChHHHHhhcCCCCCCCHH
Q 035604 530 --------------------------------------------------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQ 559 (768)
Q Consensus 530 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 559 (768)
..++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 158999999999999999887665557777
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc------cccccCCCCCCC
Q 035604 560 IRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT------QYRMTSAAGTFC 633 (768)
Q Consensus 560 ~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~------~~~~~~~~gt~~ 633 (768)
.++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+......... ........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 999999999999999999999999999887543211110 112345679999
Q ss_pred CCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcC
Q 035604 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELR 713 (768)
Q Consensus 634 Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~ 713 (768)
|+|||++.+..++.++|||||||++|+|++|..|+.........+..+.+ +.........+.+|+.+||+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~ 313 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKF--------PLLFTQKYPQEHMMVQDMLSPS 313 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCC--------CHHHHHHCHHHHHHHHHHHCSS
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCC--------CcccccCChhHHHHHHHHccCC
Confidence 99999999999999999999999999999999887544444444443322 1122334456899999999999
Q ss_pred ccCCCChhhhhh
Q 035604 714 RKDRPDLGKVVV 725 (768)
Q Consensus 714 P~~RPs~~evl~ 725 (768)
|.+||++.+++.
T Consensus 314 p~~Rps~~~~l~ 325 (332)
T 3qd2_B 314 PTERPEATDIIE 325 (332)
T ss_dssp GGGSCCHHHHHH
T ss_pred CCcCCCHHHHhh
Confidence 999999999985
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=363.20 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=202.1
Q ss_pred hcCCCccceecccCceeEEEEEEC-----CccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-----HTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
.++|.+.+.||+|+||.||+|.+. +..||||+++.. .......+.+|+.+|+.++||||++++++|.+ ..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357899999999999999999983 235999999765 34445679999999999999999999999854 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999965432 4999999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~ 690 (768)
.... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||... ..+...+..+...
T Consensus 203 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 273 (325)
T 3kul_A 203 DDPD---AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL------ 273 (325)
T ss_dssp -------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC------
T ss_pred cCcc---ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC------
Confidence 4321 1112234456888999999999999999999999999999999 99999543 3333444443211
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLN 729 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~ 729 (768)
..+..++..+.+|+..||..+|.+||++.+++..+..
T Consensus 274 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 274 --PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1122233569999999999999999999999854433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=365.80 Aligned_cols=278 Identities=17% Similarity=0.195 Sum_probs=212.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.+++.+ +||||+++++++.. ..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 677899999975432 24588999999999 99999999998744 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc-----EEEeecccccc
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV-----SKISDVGLARL 611 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-----vKL~DFGla~~ 611 (768)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 999999997653 25999999999999999999999999 999999999999998887 99999999987
Q ss_pred cCCCCCCccc-cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH-----HHHHHHHcCCccc
Q 035604 612 VPPSVADSVT-QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH-----QVERSIENGTFDE 685 (768)
Q Consensus 612 ~~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~-----~~~~~i~~~~~~~ 685 (768)
+......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6443221111 112346789999999999999999999999999999999999999996421 1122222221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhhcCcchhccccCCCCCC
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLASGAGSSP 752 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~~~~~~~~~~~~~~~~p 752 (768)
........+ + .+.+|+..||..+|.+||++.+++..+.+.+...........++.....++|
T Consensus 240 ~~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~p 301 (330)
T 2izr_A 240 PIEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTP 301 (330)
T ss_dssp CHHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTSCCCCC
T ss_pred CHHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCCCcCCC
Confidence 100011112 2 6999999999999999999999987666666555544444455544333333
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=365.19 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=205.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh------hHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ------GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|.+.+.||+|+||.||++.+ ++..||+|++...... ....+.+|+.+|+.++||||++++++|.+ ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 56899999999999999999998 4678999999764322 24678999999999999999999999855 44
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----cEEEeecc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY----VSKISDVG 607 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~vKL~DFG 607 (768)
++||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999997644 4999999999999999999999999 99999999999998776 79999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDE 685 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~ 685 (768)
++..+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.... .....+..+.+.-
T Consensus 165 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 165 LAHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237 (361)
T ss_dssp SCEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred CceEcCCCC-------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 998764321 2345679999999999999999999999999999999999999996443 3334454443211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
++. .....+..+.+||.+||..||.+||++.+++. +|+
T Consensus 238 --~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 238 --DEE---FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp --CHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred --Cch---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 100 00112345899999999999999999999985 444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=369.53 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=197.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~l 533 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++++.. ......+.+|..+|..+ +||||++++++|.+ ..||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999998 46789999997542 22345578899999988 69999999999854 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||++||+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999998765 3999999999999999999999999 9999999999999999999999999998542
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|++||.... .+...+..+.+. .
T Consensus 176 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------~ 243 (353)
T 3txo_A 176 CN------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV------Y 243 (353)
T ss_dssp C---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------C
T ss_pred cC------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------C
Confidence 21 122345689999999999999999999999999999999999999996443 344455544321 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCCh------hhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDL------GKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~------~evl~ 725 (768)
|...+..+.+|+.+||..+|.+||++ .+++.
T Consensus 244 ---p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 ---PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 12233458999999999999999998 66664
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=374.48 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=207.4
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV 534 (768)
..++|.+.+.||+|+||.||++.+ ++..||+|++.... ......+.+|+.+|+.++|||||+++++|.+. .|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999987 57789999997543 33456789999999999999999999998554 4899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCcEEEeecccccc
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD---RNYVSKISDVGLARL 611 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~vKL~DFGla~~ 611 (768)
|||+++|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999998764 4999999999999999999999999 99999999999998 468899999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDP 689 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~ 689 (768)
+.... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||... ......+..+.+.. ..+
T Consensus 163 ~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~ 235 (444)
T 3soa_A 163 VEGEQ------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF-PSP 235 (444)
T ss_dssp CCTTC------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-CTT
T ss_pred ecCCC------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC-Ccc
Confidence 64321 1234568999999999999999999999999999999999999999543 34445565554321 112
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
....+ +..+.+|+.+||..||.+||++.+++. +|+..
T Consensus 236 ~~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 236 EWDTV----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ccccC----CHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 22222 345899999999999999999999986 55543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=364.41 Aligned_cols=251 Identities=23% Similarity=0.388 Sum_probs=206.0
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--cee
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCL 533 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~l 533 (768)
...++|.+.+.||+|+||.||++.+ ++..||+|++.... ......+.+|+.+++.++|||||+++++|.+. .|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3457899999999999999999998 46789999997542 33456788999999999999999999998553 489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CcEEEeeccccc
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN---YVSKISDVGLAR 610 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~vKL~DFGla~ 610 (768)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999887654 4899999999999999999999999 9999999999999764 469999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCC
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLD 688 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld 688 (768)
.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|++||... ......+..+.+... .
T Consensus 180 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-~ 251 (362)
T 2bdw_A 180 EVNDSE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-S 251 (362)
T ss_dssp CCTTCC-------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-T
T ss_pred EecCCc-------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-c
Confidence 764321 124568999999999999999999999999999999999999999644 334445555543211 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+ .| ...+..+.+|+.+||..||.+||++.+++. +|+
T Consensus 252 ~---~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 252 P---EW-DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp T---GG-GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred c---cc-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 1 11 122356899999999999999999999986 454
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=365.16 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=202.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||+++++++.+ ..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999998 667899999964321 223468899999999999999999999854 44899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 789999887765 3999999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .+...+......
T Consensus 161 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~ 226 (336)
T 3h4j_B 161 GN-------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------NLFKKVNSCVYV 226 (336)
T ss_dssp SB-------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-------TCBCCCCSSCCC
T ss_pred Cc-------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCCCC
Confidence 21 2345689999999999988776 78999999999999999999999643210 111111111112
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
.|...+..+.+|+.+||..||.+|||+.+++. +|.+
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 23334456899999999999999999999997 6664
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=361.47 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=199.4
Q ss_pred cCCCccceecccCceeEEEEEEC--Ccc----EEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTP----VAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~----vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 534 (768)
++|.+.+.||+|+||.||+|.+. +.. ||+|++.... ......+.+|+.+++.++||||++++++|.+ ..++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 57899999999999999999973 333 7888875432 2333457789999999999999999999854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999876432 4899999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~ 691 (768)
... ........||..|+|||++.+..++.++|||||||++|+|++ |..||... ..+...+..+.....
T Consensus 168 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 238 (325)
T 3kex_A 168 DDK----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ----- 238 (325)
T ss_dssp CTT----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC-----
T ss_pred ccc----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC-----
Confidence 321 112345578889999999999999999999999999999999 99999643 344444554432111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
+..++..+.+|+.+||..+|.+||++.+++..+...
T Consensus 239 ---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 239 ---PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp ---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred ---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111223488899999999999999999998544433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.20 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=193.9
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~ 538 (768)
.++|.+.+.||+|+||.||+|.+.+ .||+|+++.. .......+.+|+.+|+.++||||+++++++.. ..++||||+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~ 101 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 101 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEec
Confidence 4679999999999999999998765 5999999754 33445678999999999999999999998744 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 174 (289)
T 3og7_A 102 EGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-- 174 (289)
T ss_dssp CEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred CCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc--
Confidence 9999999986543 24899999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCCh---HHHHHHHHcCCccccCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLA---HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~---~~~~~~i~~~~~~~~ld~~~~ 692 (768)
.........||+.|+|||++. +..++.++|||||||++|+|++|+.||... ..+...+..+.+...+.
T Consensus 175 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 248 (289)
T 3og7_A 175 --GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS---- 248 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT----
T ss_pred --ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh----
Confidence 112234457999999999886 667899999999999999999999999643 33444455554333222
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.....++..+.+|+.+||..+|.+||++.+++.
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 222333456999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=366.15 Aligned_cols=255 Identities=19% Similarity=0.296 Sum_probs=204.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-----hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-----AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++.... ......+.+|+.+++.++|||||+++++|.+ ..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45799999999999999999988 56789999986432 1235678999999999999999999999854 458
Q ss_pred eEEEeccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc---EEEeeccc
Q 035604 533 LIYEYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV---SKISDVGL 608 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~---vKL~DFGl 608 (768)
+||||+++|+|.+.+.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886532 2335899999999999999999999999 999999999999976554 99999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH-HHHHHHHcCCccccC
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH-QVERSIENGTFDETL 687 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~-~~~~~i~~~~~~~~l 687 (768)
++.+.... .......||+.|+|||++.+..++.++|||||||++|+|++|++||.... .....+..+.+....
T Consensus 180 a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 180 AIQLGESG------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNP 253 (351)
T ss_dssp CEECCTTS------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCH
T ss_pred eeEecCCC------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCc
Confidence 98764321 11245689999999999999999999999999999999999999996543 333344444321100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
..... .+..+.+|+.+||..||.+||++.+++. +|+..
T Consensus 254 -~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 254 -RQWSH----ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp -HHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred -ccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 00011 2346899999999999999999999986 56543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=365.47 Aligned_cols=266 Identities=27% Similarity=0.388 Sum_probs=212.2
Q ss_pred cCCHHHHHHHhcCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceee
Q 035604 452 KYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVL 522 (768)
Q Consensus 452 ~~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~ 522 (768)
.+....+....++|.+.+.||+|+||.||+|.+ +++.||||+++... ......+.+|+.++..+ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344555556678999999999999999999984 23579999997653 33456789999999999 7999999
Q ss_pred eeccccC---CceeEEEeccCCChHHHHhhcCC-----------------------------------------------
Q 035604 523 LLGACPE---FGCLIYEYMANGSLEDRLFRRGG----------------------------------------------- 552 (768)
Q Consensus 523 l~g~~~~---~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------- 552 (768)
++++|.+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999854 35899999999999999976532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 553 ----------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 553 ----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999999 9999999999999999999999999998664322
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh---HHHHHHHHcCCccccCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA---HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~---~~~~~~i~~~~~~~~ld~~~~ 692 (768)
. ........||+.|+|||++.+..++.++|||||||++|||++ |..||... ..+...+..+....
T Consensus 248 ~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------- 316 (359)
T 3vhe_A 248 D----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------- 316 (359)
T ss_dssp T----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-------
T ss_pred c----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-------
Confidence 1 122345678899999999999999999999999999999998 99999643 33334444432211
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
.+...+..+.+|+.+||..+|.+||++.+++..+.+.+.
T Consensus 317 -~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 317 -APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 112223469999999999999999999999865555543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.41 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=196.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh--------------------------hHHHHHHHHHHHh
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ--------------------------GRSQFQQEVEVLC 513 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~--------------------------~~~~~~~E~~il~ 513 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++...... ..+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999987 5678999999754311 1346889999999
Q ss_pred hcCCCceeeeeccccC----CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 035604 514 NIRHPNMVLLLGACPE----FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLK 589 (768)
Q Consensus 514 ~l~HpnIv~l~g~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLK 589 (768)
.++||||+++++++.+ ..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999854 34899999999999875432 24999999999999999999999999 9999999
Q ss_pred CCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCC---CCccccHHHHHHHHHHHHhCCC
Q 035604 590 PGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM---LGVKSDVYSLGILLLQIITAKP 666 (768)
Q Consensus 590 p~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltg~~ 666 (768)
|+|||++.++.+||+|||+++.+.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEECCCCCEEEecCCCcccccccc------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 999999999999999999998764321 1224568999999999987765 4789999999999999999999
Q ss_pred CCCChHH--HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 667 PMGLAHQ--VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 667 Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
||..... ....+..+.+.. +..+.++ ..+.+|+.+||..||.+||++.+++. +|.
T Consensus 239 pf~~~~~~~~~~~~~~~~~~~---~~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALEF---PDQPDIA----EDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCCC---CSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred CCCCccHHHHHHHHhcccCCC---CCccccC----HHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 9965432 233343333211 1112233 45899999999999999999999986 554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=361.42 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=195.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--c---
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--G--- 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~--- 531 (768)
.++|.+.+.||+|+||.||++.+ +++.||||+++... ......+.+|+.+++.++||||+++++++... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999997 56789999997653 23345688999999999999999999987432 2
Q ss_pred -eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 532 -CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 532 -~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
|+||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 89999999999999997765 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCccccCC
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTFDETLD 688 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~~~~ld 688 (768)
.+..... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+.......
T Consensus 165 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--- 238 (311)
T 3ork_A 165 AIADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--- 238 (311)
T ss_dssp --------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---
T ss_pred ccccccc---ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC---
Confidence 7643221 11122345789999999999999999999999999999999999999975543322 222211100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
+. ......+..+.+|+.+||+.||.+||+..+++...+
T Consensus 239 ~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 239 PS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp HH--HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cc--cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 00 001112345999999999999999999888886433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=356.52 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=196.4
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhh--cCCCceeeeeccccC------Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCN--IRHPNMVLLLGACPE------FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~------~~~l 533 (768)
.++|.+.+.||+|+||.||+|.++++.||||++.... ...+..|.+++.. ++||||+++++++.. ..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4689999999999999999999999999999997542 3456667777766 799999999998632 2489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCCeEEcCCCcEEEee
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH--------QTKPEPLVHRDLKPGNILLDRNYVSKISD 605 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~iiHrDLKp~NILl~~~~~vKL~D 605 (768)
||||+++|+|.+++... .+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999543 4999999999999999999999 777 99999999999999999999999
Q ss_pred cccccccCCCCCCccccccccCCCCCCCCCCcccccCC------CCCccccHHHHHHHHHHHHhC----------CCCCC
Q 035604 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG------MLGVKSDVYSLGILLLQIITA----------KPPMG 669 (768)
Q Consensus 606 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDvwSlGvil~elltg----------~~Pf~ 669 (768)
||+++........ .........||+.|+|||++.+. .++.++|||||||++|||++| ..||.
T Consensus 157 fg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ--LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CTTCEEEETTTTE--EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCeeeccccccc--ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999866433211 11122345899999999998876 456799999999999999999 88884
Q ss_pred Ch-------HHHHHHHHcCCccccCCCCCCC--CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 670 LA-------HQVERSIENGTFDETLDPAVPD--WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 670 ~~-------~~~~~~i~~~~~~~~ld~~~~~--~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. ......+... ...+..+. .+...+..+.+|+.+||+.+|.+||++.+|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22 1122222111 11222221 23356778999999999999999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=370.94 Aligned_cols=267 Identities=19% Similarity=0.184 Sum_probs=203.4
Q ss_pred hcCCCccceeccc--CceeEEEEEEC--CccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEG--GYGPVYKSYLD--HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G--~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
.++|.+.+.||+| +||.||++.+. ++.||||++.... ......+.+|+.+|+.++|||||+++++|.+ ..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4789999999999 99999999984 7789999997543 3345678899999999999999999999844 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|||||++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999876532 24899999999999999999999999 9999999999999999999999999987553
Q ss_pred CCCCC-ccccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCC
Q 035604 614 PSVAD-SVTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLD 688 (768)
Q Consensus 614 ~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld 688 (768)
..... ...........||+.|+|||++.+ ..++.++|||||||++|+|++|++||....... ..+..+.+...++
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 22110 011111234578999999999887 579999999999999999999999995432211 1111111111100
Q ss_pred C-------------------------------------CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 689 P-------------------------------------AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 689 ~-------------------------------------~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
. ....++...+..+.+|+.+||+.||.+||++.+++. +|++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0 000122334556999999999999999999999986 66655
Q ss_pred HH
Q 035604 731 LR 732 (768)
Q Consensus 731 l~ 732 (768)
+.
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 44
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=370.30 Aligned_cols=238 Identities=25% Similarity=0.337 Sum_probs=195.8
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~l 533 (768)
.++|.+.+.||+|+||.||++.+. ++.||||++++.. ......+..|..+|.++ +|||||+++++|.+ ..||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357999999999999999999984 5689999997643 22334578999999887 89999999999854 4599
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998765 3999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh-----------HHHHHHHHcCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA-----------HQVERSIENGT 682 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~-----------~~~~~~i~~~~ 682 (768)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|++||... ..+...+..+.
T Consensus 205 ~~------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 205 RP------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp CT------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred cC------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 21 11235678999999999999999999999999999999999999999532 11233333332
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCCh
Q 035604 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 683 ~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
+ .+|...+..+.+||.+||+.||.+||++
T Consensus 279 ~---------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 I---------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp C---------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred c---------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 1222334568999999999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=352.30 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=195.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC---chhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ .+..||+|++... .......+.+|+.+++.++||||+++++++.+. .++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999987 5678999998543 234456789999999999999999999998554 4899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999998765 4899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHH--HcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSI--ENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i--~~~~~~~~ld~~~~ 692 (768)
.. ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........+ ..+.......
T Consensus 164 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 234 (294)
T 4eqm_A 164 TS-----LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT---- 234 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHH----
T ss_pred cc-----ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcch----
Confidence 21 112234579999999999999999999999999999999999999997654433222 2222111111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
..+...+..+.+++.+||+.+|.+||+..+.+
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l 266 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHH
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHH
Confidence 11222335699999999999999999544444
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=358.55 Aligned_cols=243 Identities=27% Similarity=0.367 Sum_probs=202.8
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.. +++.||+|++++... .....+.+|+.+++.++||||+++++++.+ ..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 36799999999999999999998 577899999975422 234567899999999999999999999854 44899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998754 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~ 692 (768)
. ....+||+.|+|||++.+..++.++|||||||++|||++|++||.... .....+..+.+
T Consensus 159 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------- 220 (318)
T 1fot_A 159 V---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------- 220 (318)
T ss_dssp C---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------
T ss_pred c---------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 1 234689999999999999999999999999999999999999996443 23334444332
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh-HHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRP-----DLGKVVV-PKL 728 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~-~~l 728 (768)
.+|...+..+.+|+.+||..+|.+|| ++.+++. +|.
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 11222335699999999999999999 8888875 443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=362.16 Aligned_cols=237 Identities=25% Similarity=0.338 Sum_probs=196.8
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 534 (768)
++|.+.+.||+|+||.||++.+. ++.||||++++.. ......+.+|..++..+ +|||||+++++|.+ ..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999984 6789999997542 23345678999999987 89999999999854 45999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999997754 3899999999999999999999999 99999999999999999999999999985422
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh-----------HHHHHHHHcCCc
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA-----------HQVERSIENGTF 683 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~-----------~~~~~~i~~~~~ 683 (768)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|++||... ......+..+.+
T Consensus 163 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 163 PG------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp TT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred CC------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 11 1234568999999999999999999999999999999999999999531 122333333321
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCCh
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDL 720 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~ 720 (768)
.+|...+..+.+|+.+||..||.+||++
T Consensus 237 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ---------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1222334569999999999999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=355.03 Aligned_cols=257 Identities=23% Similarity=0.289 Sum_probs=206.8
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC----CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV 534 (768)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+++|+.++||||+++++++.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357999999999999999999984 6789999997543 2335667899999999999999999998743 34899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----cCCCcEEEeeccccc
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL----DRNYVSKISDVGLAR 610 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~vKL~DFGla~ 610 (768)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655455999999999999999999999999 9999999999999 888899999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCccccc--------CCCCCccccHHHHHHHHHHHHhCCCCCCCh------HHHHH
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ--------TGMLGVKSDVYSLGILLLQIITAKPPMGLA------HQVER 676 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~ksDvwSlGvil~elltg~~Pf~~~------~~~~~ 676 (768)
.+.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||... .....
T Consensus 165 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 165 ELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp ECCTTC-------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred ecCCCC-------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 764332 123457999999999876 577899999999999999999999999421 12222
Q ss_pred HHHcCCcccc----------------CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 677 SIENGTFDET----------------LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 677 ~i~~~~~~~~----------------ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
.+..+..... ..+.....+...+..+.+|+.+||+.||.+||++.+++....
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2222211100 001112345677888999999999999999999999985433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=346.31 Aligned_cols=248 Identities=27% Similarity=0.465 Sum_probs=203.4
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.++|.+.+.||+|+||.||++.+ ++..||+|++..... ....+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35789999999999999999998 667899999986543 34578999999999999999999999855 348999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 160 (269)
T 4hcu_A 88 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 160 (269)
T ss_dssp TTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc--
Confidence 99999999976443 4899999999999999999999999 9999999999999999999999999998663321
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
........+|+.|+|||++.+..++.++|||||||++|+|++ |++||.... .....+..+.. ... +
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~-----~~~---~ 229 (269)
T 4hcu_A 161 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----LYK---P 229 (269)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----CCC---C
T ss_pred ---cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc-----CCC---C
Confidence 112334567888999999999999999999999999999999 999996443 23333443311 111 1
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
...+..+.+|+.+||+.+|.+||++.+++..+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 122356999999999999999999999984433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.20 Aligned_cols=249 Identities=20% Similarity=0.308 Sum_probs=204.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||++.+ ++..||+|++.... .....+.+|+.+|+.++||||++++++|.+ ..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46899999999999999999998 46789999997543 334568899999999999999999999844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC--CCcEEEeecccccccCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR--NYVSKISDVGLARLVPPS 615 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~--~~~vKL~DFGla~~~~~~ 615 (768)
+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999986543 24899999999999999999999999 999999999999987 789999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
. ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.... .....+..+.+... ....+.
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~ 229 (321)
T 1tki_A 158 D-------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-EEAFKE 229 (321)
T ss_dssp C-------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-HHHHTT
T ss_pred C-------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC-hhhhcc
Confidence 1 1234578999999999999889999999999999999999999996443 33344444432110 000011
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+..+.+|+.+||..||.+||++.+++. +|+
T Consensus 230 ----~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 230 ----ISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 2346899999999999999999999986 554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.87 Aligned_cols=244 Identities=24% Similarity=0.282 Sum_probs=201.8
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--Cce
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~ 532 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++++.. ......+..|..+|..+ +||||+++++++.+ ..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 457899999999999999999998 46789999997542 22345677899999876 89999999999854 458
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
+||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999998754 3899999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPA 690 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~ 690 (768)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|++||.... .+...+..+.. .
T Consensus 169 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------~ 236 (345)
T 1xjd_A 169 MLGD------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------F 236 (345)
T ss_dssp CCTT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------C
T ss_pred ccCC------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC------C
Confidence 3211 12345689999999999999999999999999999999999999996443 33344444321 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChh-hhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLG-KVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~-evl~ 725 (768)
.+ ...+..+.+|+.+||..+|.+||++. +++.
T Consensus 237 ~p---~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 YP---RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CC---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC---cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 12 22335689999999999999999998 7763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=366.13 Aligned_cols=255 Identities=28% Similarity=0.457 Sum_probs=193.5
Q ss_pred hcCCCccceecccCceeEEEEEEC-----CccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-----HTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
.++|.+.+.||+|+||.||+|.+. +..||||+++.. .......|.+|+.+|++++||||++++++|.+ ..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999864 457999999765 33445679999999999999999999999854 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999976542 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~ 690 (768)
..... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||... ..+...+..+... +.
T Consensus 199 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~----~~ 271 (373)
T 2qol_A 199 DDPEA---AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL----PP 271 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC----CC
T ss_pred cCCcc---ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----CC
Confidence 32211 111223356788999999999999999999999999999998 99999533 2333444443211 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
+..++..+.+|+.+||+.+|.+||++.+|+..+...++
T Consensus 272 ----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 272 ----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 12233569999999999999999999999865444443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.37 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=198.7
Q ss_pred cCCCccceecccCceeEEEEEE--CCc----cEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHT----PVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 534 (768)
++|.+.+.||+|+||.||+|.+ ++. .||+|.++... ......+.+|+.++++++||||++++++|.+ ..++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 5799999999999999999987 333 36888876432 3445678999999999999999999999854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|+|+.+|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999987543 4899999999999999999999999 99999999999999999999999999987644
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~ 691 (768)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ..+...+..+...
T Consensus 170 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------- 238 (327)
T 3poz_A 170 EEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------- 238 (327)
T ss_dssp TCC-----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------
T ss_pred Ccc----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-------
Confidence 321 122234567889999999999999999999999999999999 99999643 3344444444311
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
..+..++..+.+|+.+||+.+|.+||++.+++..+...+
T Consensus 239 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 239 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 112223346999999999999999999999986544443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=363.26 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=199.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E 536 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+|+.+++.++|||||++++++.+. .|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 47899999999999999999988 467899999965432 3345688999999999999999999998554 489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999886543 4899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChHH---HHHHHHcCCccccCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQ---VERSIENGTFDETLDPAVP 692 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~~---~~~~i~~~~~~~~ld~~~~ 692 (768)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ....+..... ... .
T Consensus 160 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~-~-- 230 (323)
T 3tki_A 160 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLN-P-- 230 (323)
T ss_dssp ----EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TST-T--
T ss_pred ----cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCC-c--
Confidence 1122345689999999999887765 7899999999999999999999964322 1222222111 111 1
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
....+..+.+|+.+||..||.+||++.+++. +|.
T Consensus 231 --~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 231 --WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 1123355889999999999999999999986 554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=363.28 Aligned_cols=240 Identities=23% Similarity=0.319 Sum_probs=202.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ ++..||||++.+... .....+.+|+.+|+.++||||+++++++.+ ..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 36799999999999999999998 467899999975422 234568899999999999999999999854 44999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+..
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999998765 3899999999999999999999999 99999999999999999999999999987632
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~ 692 (768)
. ....+||+.|+|||++.+..++.++|||||||++|||++|++||.... .....+..+.+.
T Consensus 194 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------- 256 (350)
T 1rdq_E 194 R---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-------- 256 (350)
T ss_dssp C---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred C---------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 2 234689999999999999999999999999999999999999996443 334455554321
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPD-----LGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~ 725 (768)
+|...+..+.+|+.+||+.||.+||+ +.+++.
T Consensus 257 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 -FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 12223356999999999999999998 777774
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=358.82 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=201.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch------hhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA------QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|.+.+.||+|+||.||++.+ ++..||+|++..... .....+.+|+.+|+.++||||++++++|.+ ..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45799999999999999999998 467899999975432 135678999999999999999999999854 45
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----cEEEeecc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY----VSKISDVG 607 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~vKL~DFG 607 (768)
++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 89999999999999986543 4899999999999999999999999 99999999999998877 89999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDE 685 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~ 685 (768)
+++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+....+..
T Consensus 164 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 164 LAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp TCEECCTTS-------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred CCeECCCCC-------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 998764321 12346799999999999999999999999999999999999999964432 223333322110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...... ..+..+.+|+.+||..+|.+||++.+++.
T Consensus 237 -~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 -EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -Cccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000001 12345899999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=360.32 Aligned_cols=250 Identities=30% Similarity=0.459 Sum_probs=204.0
Q ss_pred HhcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--C
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--F 530 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~ 530 (768)
..++|.+.+.||+|+||.||++.+.+ +.||||+++... ......+.+|+.+++.++||||++++++|.+ .
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 35789999999999999999999854 679999997653 3445678999999999999999999999854 4
Q ss_pred ceeEEEeccCCChHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG---------------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLK 589 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLK 589 (768)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 5999999999999999976431 145899999999999999999999999 9999999
Q ss_pred CCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCC
Q 035604 590 PGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPM 668 (768)
Q Consensus 590 p~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf 668 (768)
|+|||++.++.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGC----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cceEEECCCCeEEEeecCCCcccccCcc----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999986632211 112234578899999999999999999999999999999999 99999
Q ss_pred CChH--HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 669 GLAH--QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 669 ~~~~--~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.... .....+..+.... .+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNILA--------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTSCHHHHHHHHHTTCCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCChHHHHHHHhCCCcCC--------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6443 3334455543321 12223346999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=345.28 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=201.6
Q ss_pred hcCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E~~ 538 (768)
.++|.+.+.||+|+||.||++.+.+ ..||+|++..... ....+.+|+.+++.++||||++++++|.+. .++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4679999999999999999998855 4799999976543 345689999999999999999999998554 48999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp TTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred CCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence 99999999977542 4899999999999999999999999 99999999999999999999999999987643321
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHHH--HHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQV--ERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||...... ...+..+.. ... +
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~------~ 227 (268)
T 3sxs_A 160 ----VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR--LYR------P 227 (268)
T ss_dssp ----EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCC------C
T ss_pred ----hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC--CCC------C
Confidence 12234566788999999999899999999999999999999 99999654332 233333321 111 1
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+|+.+||..+|.+||++.+++.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112346999999999999999999999983
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=365.48 Aligned_cols=247 Identities=17% Similarity=0.298 Sum_probs=204.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||+|.+ ++..||+|++..........+.+|+.+|+.++|||||+++++|.+ ..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 56899999999999999999998 467899999987665556678999999999999999999999854 44899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC--CCcEEEeecccccccCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR--NYVSKISDVGLARLVPPS 615 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~--~~~vKL~DFGla~~~~~~ 615 (768)
+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999887543 24899999999999999999999999 999999999999974 578999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 693 (768)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+..+.+. .++..
T Consensus 205 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~-- 273 (387)
T 1kob_A 205 E-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE--FDEDA-- 273 (387)
T ss_dssp S-------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC--CCSST--
T ss_pred c-------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCccc--
Confidence 1 12334799999999999999999999999999999999999999975443 22334333321 11111
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+..+.+|+.+||..||.+||++.+++.
T Consensus 274 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 -FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1122345899999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=349.61 Aligned_cols=245 Identities=28% Similarity=0.492 Sum_probs=199.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhh-------HHHHHHHHHHHhhcCCCceeeeeccccCCce
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQG-------RSQFQQEVEVLCNIRHPNMVLLLGACPEFGC 532 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 532 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++....... ...+.+|+.+++.++||||+++++++.+..+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 36799999999999999999998 56789999986543211 1578899999999999999999999988889
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc-----EEEeecc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV-----SKISDVG 607 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-----vKL~DFG 607 (768)
+||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 99999999999998876543 5899999999999999999999986 35999999999999988776 9999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccc--cCCCCCccccHHHHHHHHHHHHhCCCCCCChH----HHHHHHHcC
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ--QTGMLGVKSDVYSLGILLLQIITAKPPMGLAH----QVERSIENG 681 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~----~~~~~i~~~ 681 (768)
+++.... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||.... .....+...
T Consensus 175 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 175 LSQQSVH---------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp TCBCCSS---------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred ccccccc---------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 9975422 12446799999999988 44567899999999999999999999996332 112222222
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..... .+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 246 ~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 GLRPT-------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22211 22233456999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=356.98 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=193.6
Q ss_pred hcCCCccceecccCceeEEEEEECCc-----cEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccCC--c-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHT-----PVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--G- 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-----~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~- 531 (768)
.++|.+.+.||+|+||.||+|.+... .||||+++.. .......+.+|+.+++.++||||+++++++... .
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46899999999999999999987432 6999999764 334456789999999999999999999988432 2
Q ss_pred -----eeEEEeccCCChHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 532 -----CLIYEYMANGSLEDRLFRRG---GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 532 -----~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 89999999999999986532 1224899999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHc
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIEN 680 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~ 680 (768)
+|||+++.+..... ........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||... ......+..
T Consensus 179 ~Dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 179 ADFGLSRKIYSGDY----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CCCCC---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred eecccccccccccc----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 99999987643221 111234456888999999999999999999999999999999 99999643 233333433
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
+... ..+...+..+.+|+.+||..+|.+||++.+++..+.+.+..
T Consensus 255 ~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 255 GNRL--------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp TCCC--------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCC--------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 3211 11122234699999999999999999999998666655544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=366.28 Aligned_cols=274 Identities=18% Similarity=0.223 Sum_probs=207.1
Q ss_pred hcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCchhh-----------HHHHHHHHHHHhhcCCCceeee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDAAQG-----------RSQFQQEVEVLCNIRHPNMVLL 523 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l 523 (768)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 458999999999999999999873 3679999987654221 1123456667778899999999
Q ss_pred eccccCC------ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-
Q 035604 524 LGACPEF------GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD- 596 (768)
Q Consensus 524 ~g~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~- 596 (768)
++++... .||||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998432 58999999 999999997753 24999999999999999999999999 99999999999998
Q ss_pred -CCCcEEEeecccccccCCCCCCc-cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH-
Q 035604 597 -RNYVSKISDVGLARLVPPSVADS-VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ- 673 (768)
Q Consensus 597 -~~~~vKL~DFGla~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~- 673 (768)
.++.+||+|||+++.+....... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998764322111 111122455699999999999999999999999999999999999999963211
Q ss_pred --HHHHHH---cCCccccCCCCC--CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhhcCcchhccc
Q 035604 674 --VERSIE---NGTFDETLDPAV--PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPAINLA 745 (768)
Q Consensus 674 --~~~~i~---~~~~~~~ld~~~--~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~~~~~~~~~~ 745 (768)
...... ...+...+++.+ ...+ ..+.+|+..||..+|.+||++.+++..+.+.+...........++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS 342 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence 111011 011111111111 1222 4599999999999999999999998877777777665555555543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=345.16 Aligned_cols=245 Identities=30% Similarity=0.503 Sum_probs=192.6
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCch----hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAA----QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.++|.+.+.||+|+||.||++.+.++.||||+++.... .....+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 36789999999999999999999999999999875432 224578899999999999999999999854 459999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC--------CCcEEEeecc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR--------NYVSKISDVG 607 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~--------~~~vKL~DFG 607 (768)
||+++++|.+++... .+++..++.++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999988533 4899999999999999999999988556889999999999986 7889999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDE 685 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~ 685 (768)
++..+.... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||....... ..+.......
T Consensus 162 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3dtc_A 162 LAREWHRTT--------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233 (271)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC
T ss_pred ccccccccc--------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC
Confidence 998653321 124578999999999999999999999999999999999999997544332 2223222211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. .+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 234 ~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 234 P-------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 12223356999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=367.30 Aligned_cols=242 Identities=22% Similarity=0.352 Sum_probs=198.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ +++.||+|++.... ......+.+|+.+|+.++|||||+++++|.+ ..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999998 45679999997542 2234568899999999999999999999854 45999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+.||+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999997654 4999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccC---CCCCccccHHHHHHHHHHHHhCCCCCCCh-----HHHHHHHHcCCcccc
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQIITAKPPMGLA-----HQVERSIENGTFDET 686 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltg~~Pf~~~-----~~~~~~i~~~~~~~~ 686 (768)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ......+.....
T Consensus 168 ~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 237 (384)
T 4fr4_A 168 E-------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--- 237 (384)
T ss_dssp T-------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC---
T ss_pred C-------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc---
Confidence 2 12356789999999998864 45899999999999999999999999532 122222222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC-hhhhhh
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPD-LGKVVV 725 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs-~~evl~ 725 (768)
.++...+..+.+|+.+||..+|.+||+ +.++..
T Consensus 238 ------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 122223356999999999999999999 666653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=367.63 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=202.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||+++... ......|.+|+.+|+.++|||||+++++|.+ ..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 46789999999999999999998 47789999997543 2334568899999999999999999999854 4599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++|+|.+++...+. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999976542 3899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
. ........+++.|+|||.+.+..++.++|||||||++|||++ |..||.... .....+..+... .
T Consensus 268 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----~--- 335 (377)
T 3cbl_A 268 Y----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-----P--- 335 (377)
T ss_dssp E----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC-----C---
T ss_pred e----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----C---
Confidence 1 111122345778999999998899999999999999999998 999996443 333444444211 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
.+..++..+.+|+.+||+.+|.+||++.+++..+.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 11222346899999999999999999999975433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=347.02 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=201.9
Q ss_pred hcCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E~~ 538 (768)
.++|.+.+.||+|+||.||++.+.+ ..||||++..... ....+.+|+.+++.++||||++++++|.+. .++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 4679999999999999999999854 4799999986543 245789999999999999999999998553 48999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 102 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 174 (283)
T 3gen_A 102 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-- 174 (283)
T ss_dssp TTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH--
T ss_pred CCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc--
Confidence 99999999976332 4899999999999999999999999 9999999999999999999999999998663321
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||..... ....+..+.. ...+
T Consensus 175 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----~~~~--- 243 (283)
T 3gen_A 175 ---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----LYRP--- 243 (283)
T ss_dssp ---HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-----CCCC---
T ss_pred ---cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC-----CCCC---
Confidence 112234567788999999998899999999999999999998 9999964432 3333443321 1111
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
...+..+.+|+.+||+.+|.+||++.+++..+.+.+
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 112345999999999999999999999986665554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=373.36 Aligned_cols=256 Identities=25% Similarity=0.286 Sum_probs=203.5
Q ss_pred HHhcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchh---hHHHHHHHHHHHhhcCCCceeeeeccccCC--ce
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQ---GRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GC 532 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~ 532 (768)
...++|.+.++||+|+||.||++.+. ++.||||++++.... ....+.+|+.++..++|||||+++++|.+. .|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34678999999999999999999984 568999999753222 223488999999999999999999998554 48
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
||||||+||+|.+++..... .+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 99999999999999976432 4999999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCCCccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccc
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDE 685 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~ 685 (768)
.... .......+||+.|+|||++. ...|+.++|||||||++|||++|++||..... ....+......-
T Consensus 226 ~~~~-----~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 226 MEDG-----TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp CTTS-----CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred ccCC-----CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 4321 11234568999999999887 56789999999999999999999999964432 333333221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccC--CCChhhhhh-HHHH
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKD--RPDLGKVVV-PKLN 729 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~--RPs~~evl~-~~l~ 729 (768)
.+...... .+..+.+||.+||..+|++ ||++.+++. +|..
T Consensus 301 ~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 301 QFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp CCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred cCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 11111122 2345899999999888888 999999986 5553
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=349.18 Aligned_cols=266 Identities=19% Similarity=0.225 Sum_probs=207.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ....+.+|+.+++.+ +||||+++++++.+ ..++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 67899999986543 234578999999999 79999999998844 4489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc-----EEEeecccccc
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV-----SKISDVGLARL 611 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-----vKL~DFGla~~ 611 (768)
|+ +++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999976543 4899999999999999999999999 999999999999987765 99999999987
Q ss_pred cCCCCCCcccc-ccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh-----HHHHHHHHcCCccc
Q 035604 612 VPPSVADSVTQ-YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA-----HQVERSIENGTFDE 685 (768)
Q Consensus 612 ~~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~-----~~~~~~i~~~~~~~ 685 (768)
+.......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ......+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 75432211111 1235668999999999999999999999999999999999999999642 11112222211111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhhcCc
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETM 739 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~~~~ 739 (768)
........+ +..+.+|+.+||+.+|.+||++.+|+..+.+.++.+.....
T Consensus 241 ~~~~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~ 290 (298)
T 1csn_A 241 PLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 290 (298)
T ss_dssp CHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred cHHHHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence 111111122 34599999999999999999999998766666665544433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=347.46 Aligned_cols=254 Identities=27% Similarity=0.365 Sum_probs=196.0
Q ss_pred hcCCCccceecccCceeEEEEEECC-----ccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 534 (768)
.++|.+.+.||+|+||.||+|.+.. ..||+|++... .......+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 4679999999999999999998732 35999998754 33445678999999999999999999999844 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999976542 4899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~ 691 (768)
.. ........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||... ......+..+....
T Consensus 169 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~------ 237 (281)
T 1mp8_A 169 ST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------ 237 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC------
T ss_pred cc-----ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC------
Confidence 21 112234467789999999998999999999999999999997 99999643 33334444443211
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
.+...+..+.+|+.+||..+|.+||++.+++..+.+.++.
T Consensus 238 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 --MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1222335699999999999999999999998655555543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=371.26 Aligned_cols=242 Identities=29% Similarity=0.434 Sum_probs=202.1
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC---CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~lV~E~~ 538 (768)
.++|.+.+.||+|+||.||+|.+.++.||||+++... ....|.+|+.+|++++|||||+++++|.+ ..+|||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 3578889999999999999999999999999998654 45679999999999999999999998733 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 99999999987643 34789999999999999999999999 999999999999999999999999999854221
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.....++..|+|||++.+..++.++|||||||++|||++ |..||... ..+...+..+... ..+
T Consensus 343 ------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------~~p 408 (450)
T 1k9a_A 343 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--------DAP 408 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC--------CCC
T ss_pred ------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------CCC
Confidence 122367889999999999999999999999999999998 99999533 3344455554311 112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
..++..+.+|+.+||..+|.+||++.+++..
T Consensus 409 ~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~ 439 (450)
T 1k9a_A 409 DGCPPAVYDVMKNCWHLDAATRPTFLQLREQ 439 (450)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2234569999999999999999999999743
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.08 Aligned_cols=255 Identities=25% Similarity=0.295 Sum_probs=196.0
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E 536 (768)
.++|.+.+.||+|+||.||++.+ +++.||+|++..... .....+.+|+.+|+.++||||+++++++.+. .++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 57899999999999999999998 677899999975432 2345688999999999999999999998554 489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|++ |+|.+.+..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 100 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCS-EEHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCC-CCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 997 578887766442 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHc--CCcccc-----
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIEN--GTFDET----- 686 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~--~~~~~~----- 686 (768)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... ....+.. +.....
T Consensus 174 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 174 ------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 12344578999999998876 5689999999999999999999999953321 1111111 100000
Q ss_pred ---------CCCCCCC-----CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 687 ---------LDPAVPD-----WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 687 ---------ld~~~~~-----~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
....... .....+..+.+|+.+||+.||.+|||+.+++. +|.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 0000000 01122346889999999999999999999986 444
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=356.10 Aligned_cols=246 Identities=29% Similarity=0.376 Sum_probs=193.2
Q ss_pred hcCCCccceecccCceeEEEEEE-----CCccEEEEEEcCCc----hhhHHHHHHHHHHHhhcCCCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA----AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~ 530 (768)
.++|.+.+.||+|+||.||++.. .++.||+|+++... ......+.+|+.+|+.++||||++++++|.+ .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999986 56789999997642 2234457889999999999999999999854 4
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.|+||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 599999999999999998755 3889999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCC
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLD 688 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld 688 (768)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+.+
T Consensus 170 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----- 238 (327)
T 3a62_A 170 ESIHDG------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL----- 238 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred ccccCC------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----
Confidence 542211 12245689999999999999999999999999999999999999996443 23333433322
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh-HHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRP-----DLGKVVV-PKL 728 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~-~~l 728 (768)
..+...+..+.+|+.+||..+|.+|| ++.+++. ++.
T Consensus 239 ----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 239 ----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred ----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 11222335689999999999999999 6777765 443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.78 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=207.9
Q ss_pred hcCCCccceecccCceeEEEEEECC---------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH---------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 529 (768)
.++|.+.+.||+|+||.||+|.+.+ ..||||+++... ......+.+|+++++.+ +|||||+++++|.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4789999999999999999998632 469999997653 34456789999999999 99999999999854
Q ss_pred -CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 45899999999999999987542 235899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--H
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--H 672 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~ 672 (768)
+.++.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCT----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCCCcEEEcccCcccccccccc----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999986643211 112244567889999999999999999999999999999999 99999643 3
Q ss_pred HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 673 QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 673 ~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
.+...+..+.... .+..++..+.+|+.+||+.+|.+||++.+++..+...+.
T Consensus 301 ~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 ELFKLLKEGHRMD--------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHHHTTCCCC--------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCC--------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 3444444443211 112233469999999999999999999999865554443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=356.91 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=196.2
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHH--HhhcCCCceeeeecccc-----C--Cce
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEV--LCNIRHPNMVLLLGACP-----E--FGC 532 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~g~~~-----~--~~~ 532 (768)
.++|.+.+.||+|+||.||+|.++++.||||++.... ...+..|.++ +..++||||+++++.+. . ..+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 4689999999999999999999999999999997543 2334444444 55689999999997542 1 238
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT---------KPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
+||||+++|+|.+++.... +++..++.++.||+.||.|||+. + |+||||||+||||+.++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 9999999999999997654 68999999999999999999998 7 999999999999999999999
Q ss_pred eecccccccCCCCCCc--cccccccCCCCCCCCCCcccccC-------CCCCccccHHHHHHHHHHHHhCCCCCCCh---
Q 035604 604 SDVGLARLVPPSVADS--VTQYRMTSAAGTFCYIDPEYQQT-------GMLGVKSDVYSLGILLLQIITAKPPMGLA--- 671 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~elltg~~Pf~~~--- 671 (768)
+|||+++.+....... ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998765432111 11122345679999999999887 45678999999999999999997765211
Q ss_pred -----------------HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 672 -----------------HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 672 -----------------~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
......+........+...... ....+..+.+|+.+||..||.+||++.+++..+.+.+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc-ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1111112222211111111111 2346677999999999999999999999986555554333
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=361.57 Aligned_cols=243 Identities=23% Similarity=0.275 Sum_probs=200.8
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhc-CCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~l 533 (768)
.++|.+.+.||+|+||.||++.+. ++.||||++++... .....+..|..+|..+ +||||+++++++.+ ..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999985 46799999975422 2345678899999987 79999999999854 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||++||+|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999998755 3899999999999999999999999 9999999999999999999999999998542
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
... ......+||+.|+|||++.+..++.++|||||||++|||++|++||.... .+...+..+.+.
T Consensus 173 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------- 239 (353)
T 2i0e_A 173 WDG------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA------- 239 (353)
T ss_dssp CTT------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred cCC------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-------
Confidence 211 12345689999999999999999999999999999999999999996443 334445444321
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCCh-----hhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDL-----GKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~-----~evl~ 725 (768)
+|...+..+.+|+.+||..+|.+||+. .+++.
T Consensus 240 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 122234569999999999999999964 66653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=364.05 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=202.0
Q ss_pred hcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|.+.+.||+|+||.||+|.+. +..||||++... .......+.+|+.+++.++|||||+++++|.+ ..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999853 347999999754 34445578899999999999999999999854 45
Q ss_pred eeEEEeccCCChHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC---cEEEe
Q 035604 532 CLIYEYMANGSLEDRLFRRGG----SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY---VSKIS 604 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~vKL~ 604 (768)
++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999987532 235899999999999999999999999 99999999999998554 59999
Q ss_pred ecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcC
Q 035604 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENG 681 (768)
Q Consensus 605 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~ 681 (768)
|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++ |.+||.... .+...+..+
T Consensus 227 DFG~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 227 DFGMARDIYRAG----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp CCHHHHHHHHHS----SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred CCcccccccccc----ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999997542211 1111234567899999999999999999999999999999998 999996443 333444444
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
.... .+..++..+.+|+.+||+.+|.+||++.+++..+.
T Consensus 303 ~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 303 GRMD--------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp CCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC--------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 3211 11222345999999999999999999999985443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=369.88 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=202.8
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccCC--ce
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GC 532 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~ 532 (768)
...++|.+.+.||+|+||.||++.+ +++.||+|++++... .....+.+|+.+++.++|||||+++++|.+. .|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3467899999999999999999998 456899999975322 1233478999999999999999999998554 48
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
|||||++||+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+
T Consensus 146 lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 999999999999988654 3899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCC----CCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCcccc
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM----LGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDET 686 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ 686 (768)
.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|++||.... .....+..+... .
T Consensus 219 ~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~ 292 (410)
T 3v8s_A 219 NKEG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-L 292 (410)
T ss_dssp CTTS-----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-C
T ss_pred ccCC-----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc-c
Confidence 4321 12234678999999999988765 8899999999999999999999996443 233344332211 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccC--CCChhhhhh-HHH
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKD--RPDLGKVVV-PKL 728 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~--RPs~~evl~-~~l 728 (768)
..+....+ +..+.+||.+||..+|.+ ||++.+++. +|.
T Consensus 293 ~~p~~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 293 TFPDDNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp CCCTTCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred cCCCcccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 11111122 245899999999999988 999999985 444
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.86 Aligned_cols=244 Identities=21% Similarity=0.331 Sum_probs=199.3
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC----CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~ 535 (768)
.++|.+.+.||+|+||.||+|.++++.||||++.... ......+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 3679999999999999999999999999999997653 3445679999999999999999999999854 348999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+......
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 99999999999976443 35899999999999999999999875 3599999999999999999999999998754321
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCc---cccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGV---KSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPA 690 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~ 690 (768)
....||+.|+|||++.+..++. ++|||||||++|+|++|+.||....... ..+.......
T Consensus 166 ----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 230 (271)
T 3kmu_A 166 ----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP----- 230 (271)
T ss_dssp ----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-----
T ss_pred ----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-----
Confidence 2347899999999988765544 7999999999999999999996543322 2222222111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+...+..+.+|+..||+.+|.+||++.+++.
T Consensus 231 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 --TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112223356999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=349.06 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=194.1
Q ss_pred cCCCccceecccCceeEEEEEE-CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
++|.+.+.||+|+||.||++.+ .++.||+|++..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999998 467899999975432 224578899999999999999999999844 45999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++ +|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 975 89888876432 4899999999999999999999999 9999999999999999999999999998764221
Q ss_pred CccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCccc-------
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTFDE------- 685 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~~~------- 685 (768)
.......||+.|+|||++.+. .++.++|||||||++|+|++|++||........ .+.. +....
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 122345789999999988764 589999999999999999999999965433221 1111 10000
Q ss_pred ---cCCCCCC--------CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 ---TLDPAVP--------DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 ---~ld~~~~--------~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..++... ......+..+.+|+.+||..||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0011110 011123456899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.96 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=204.9
Q ss_pred cCCCccceecccCceeEEEEEE------CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--C--Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--E--FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~--~~~ 532 (768)
++|.+.+.||+|+||.||++.+ .+..||||++..........+.+|+.++++++||||+++++++. + ..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6799999999999999999984 45689999998777666778999999999999999999999873 2 348
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
+||||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999976432 3899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH-----------------H
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV-----------------E 675 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~-----------------~ 675 (768)
..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 178 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 178 PLDKD---YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp CTTCS---EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred ccCCc---cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 44321 111234457888999999999999999999999999999999999999644321 1
Q ss_pred HHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 676 RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 676 ~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
..+..+. ....+...+..+.+|+.+||+.+|.+||++.+++..+.
T Consensus 255 ~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 255 ELLEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp HHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111 11122233456999999999999999999999984433
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.06 Aligned_cols=247 Identities=22% Similarity=0.313 Sum_probs=198.2
Q ss_pred cceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEeccCCCh
Q 035604 468 SRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMANGSL 543 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 543 (768)
.+.||+|+||.||+|.+ ++..||+|+++.........+.+|+.+|++++|||||+++++|.+ ..+|||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999987 567899999987766667789999999999999999999999854 44999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE--cCCCcEEEeecccccccCCCCCCccc
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL--DRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl--~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 174 ~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----- 243 (373)
T 2x4f_A 174 FDRIIDESY--NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----- 243 (373)
T ss_dssp HHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----
Confidence 998876432 4899999999999999999999999 9999999999999 667899999999998764322
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVEEA 699 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~~ 699 (768)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+....+. ........ .+
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~----~~ 316 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-LEDEEFQD----IS 316 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-SCSGGGTT----SC
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CChhhhcc----CC
Confidence 123457999999999999999999999999999999999999999654332 2333333221 11111112 23
Q ss_pred HHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 700 LILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 700 ~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
..+.+|+.+||..+|.+||++.+++. +|+...
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 46999999999999999999999987 676544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=350.34 Aligned_cols=255 Identities=28% Similarity=0.375 Sum_probs=206.9
Q ss_pred hcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|.+.+.||+|+||.||++.+. +..||||++.... ......+.+|+.+|+.++||||++++++|.+ ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467999999999999999999862 3679999997643 3445678999999999999999999999854 45
Q ss_pred eeEEEeccCCChHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 035604 532 CLIYEYMANGSLEDRLFRRGG---------------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKP 590 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp 590 (768)
++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999986542 124889999999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCC
Q 035604 591 GNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMG 669 (768)
Q Consensus 591 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~ 669 (768)
+|||++.++.+||+|||+++.+..... ........+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDS----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSC----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred heEEEcCCCCEEEcccccccccccccc----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987643221 112234567889999999999899999999999999999999 999996
Q ss_pred Ch--HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 670 LA--HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 670 ~~--~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
.. ..+...+..+... ..+...+..+.+|+.+||..+|.+||++.+++..+.+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRM--------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp TCCGGGHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcC--------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 43 3344444444321 112223356999999999999999999999986555444
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.88 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=198.2
Q ss_pred cCCCccceecccCceeEEEEEECC------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
++|.+.+.||+|+||.||+|.+.. ..||||+++... ......+.+|+.+++.++||||+++++++.+ ..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567788999999999999998743 249999997653 3345578999999999999999999999854 4489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999976532 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~ 690 (768)
.... .........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||... ..+...+..+... +
T Consensus 199 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~----~- 270 (333)
T 1mqb_A 199 DDPE---ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL----P- 270 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----C-
T ss_pred cccc---cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC----C-
Confidence 3221 1111233456788999999999999999999999999999999 99999543 3333444444211 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
.+...+..+.+|+.+||..+|.+||++.+++..+.+.++.
T Consensus 271 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 271 ---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1122335699999999999999999999998655544443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=363.40 Aligned_cols=240 Identities=26% Similarity=0.308 Sum_probs=190.4
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHH-HhhcCCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEV-LCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~~--~~~l 533 (768)
.++|.+.+.||+|+||.||++.+. +..||||++++... .....+..|..+ ++.++|||||+++++|.+ ..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999984 56899999976532 223446677776 577899999999999854 4599
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||++||+|.+++.+.. .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999998754 3889999999999999999999999 9999999999999999999999999998542
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|.+||.... .....+..+.+.
T Consensus 191 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------- 257 (373)
T 2r5t_A 191 EH------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ------- 257 (373)
T ss_dssp CC------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC-------
T ss_pred cC------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC-------
Confidence 21 112345689999999999999999999999999999999999999996443 333444443221
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGK 722 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~e 722 (768)
++...+..+.+|+.+||..+|.+||++.+
T Consensus 258 --~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 --LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11122345899999999999999999853
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=356.31 Aligned_cols=257 Identities=28% Similarity=0.387 Sum_probs=203.3
Q ss_pred HhcCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE-- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 529 (768)
..++|.+.+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+|+++ +||||++++++|..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999986 23479999997542 33456789999999999 89999999999854
Q ss_pred CceeEEEeccCCChHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGS--------------------PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLK 589 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLK 589 (768)
..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 459999999999999999765421 24799999999999999999999999 9999999
Q ss_pred CCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCC
Q 035604 590 PGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPM 668 (768)
Q Consensus 590 p~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf 668 (768)
|+||||+.++.+||+|||++..+..... ........||+.|+|||++.+..++.++|||||||++|+|+| |..||
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSN----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCcc----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999986633211 112234567889999999999999999999999999999998 99999
Q ss_pred CCh---HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 669 GLA---HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 669 ~~~---~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
... ......+..+.. .. .+...+..+.+|+.+||..+|.+||++.+++..+...+.
T Consensus 276 ~~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFK-----MD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp TTCCCSHHHHHHHHTTCC-----CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ccCCcHHHHHHHHhcCCC-----CC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 643 233344443321 11 111223569999999999999999999999865544443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.72 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=205.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~ 535 (768)
.++|.+.+.||+|+||.||++.+ ++..||+|++.... ......+.+|+.+++.++||||+++++++.+. .++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999988 46789999996542 33456788999999999999999999998554 48999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc---EEEeeccccccc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV---SKISDVGLARLV 612 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~---vKL~DFGla~~~ 612 (768)
||+++++|.+.+.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999887764 4899999999999999999999999 999999999999976654 999999999866
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPA 690 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~ 690 (768)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+.+.. ..+.
T Consensus 159 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~ 230 (284)
T 3kk8_A 159 NDSE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-PSPE 230 (284)
T ss_dssp CSSC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-CTTT
T ss_pred ccCc-------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC-Cchh
Confidence 4321 1234679999999999999999999999999999999999999995443 3334444443321 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
...+ +..+.+|+.+||+.+|.+||++.+++. +|+.
T Consensus 231 ~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (284)
T 3kk8_A 231 WDTV----TPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266 (284)
T ss_dssp TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred hccc----CHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence 1222 345899999999999999999999997 5553
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.56 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=205.3
Q ss_pred hcCCCccceecccCceeEEEEEECC--ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||++.+.+ ..||+|++..........+.+|+++++.++||||++++++|.+. .++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 5679999999999999999999854 57999999766555567899999999999999999999998554 4899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCcEEEeecccccccCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~vKL~DFGla~~~~~ 614 (768)
+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..+..
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999987754 3899999999999999999999999 9999999999999 7889999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~ 692 (768)
.. ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.... .....+..+.+.... ....
T Consensus 162 ~~-------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 232 (277)
T 3f3z_A 162 GK-------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE-KDWL 232 (277)
T ss_dssp TS-------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH-HHHT
T ss_pred cc-------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-hhhh
Confidence 22 22445799999999988654 8999999999999999999999996543 333344444321100 0000
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
..+..+.+|+.+||+.+|.+||++.+++. +|...
T Consensus 233 ----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 233 ----NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ----cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 12356999999999999999999999987 56543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=347.78 Aligned_cols=254 Identities=24% Similarity=0.309 Sum_probs=195.6
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999998 46789999997543 2334678899999999999999999999844 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++ +|.+.+..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 56665554332 4999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCC-CCccccHHHHHHHHHHHHhCCCCC-CChH--HHHHHHHc--CCccccC---
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQIITAKPPM-GLAH--QVERSIEN--GTFDETL--- 687 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltg~~Pf-~~~~--~~~~~i~~--~~~~~~l--- 687 (768)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..|| .... .....+.. +......
T Consensus 156 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred ------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 1234567899999999987765 899999999999999999988885 3221 11111111 1000000
Q ss_pred ---------------CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 688 ---------------DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 688 ---------------d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
...........+..+.+|+.+||+.||.+|||+.+++. +|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 00001111234456899999999999999999999986 443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=354.28 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=197.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCcc----EEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC-Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTP----VAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~----vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~l 533 (768)
.++|.+.+.||+|+||.||+|.+ ++.. ||+|.+... .......+.+|+.+++.++||||++++++|.. ..++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 36799999999999999999997 3443 577777543 23445678999999999999999999999854 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||+|+.+|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999977543 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~ 690 (768)
.... ........+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||... ..+...+..+....
T Consensus 169 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----- 239 (327)
T 3lzb_A 169 AEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP----- 239 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----
T ss_pred Cccc----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 3221 122234567889999999999999999999999999999999 99999643 33444444433111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
.+...+..+.+|+.+||..+|.+||++.+++..+...+
T Consensus 240 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 240 ---QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11223345999999999999999999999986444443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=360.03 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=187.4
Q ss_pred HhcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
..++|.+.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.+|++++||||++++++|.+ ..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999984 5689999997543 34568899999999999999999999854 4489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCcEEEeecccccccC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYVSKISDVGLARLVP 613 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~vKL~DFGla~~~~ 613 (768)
|+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999987654 4899999999999999999999999 999999999999975 8999999999998653
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH---HHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ---VERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~---~~~~i~~~~~~~~ld~~ 690 (768)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.+. ...+
T Consensus 203 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-~~~~- 273 (349)
T 2w4o_A 203 HQV-------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-FISP- 273 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-CCTT-
T ss_pred ccc-------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-cCCc-
Confidence 321 12346799999999999999999999999999999999999999954332 33344443321 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+....+..+.+|+.+||..||.+||++.+++.
T Consensus 274 ---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 ---WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12223456899999999999999999999885
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.57 Aligned_cols=260 Identities=24% Similarity=0.295 Sum_probs=204.0
Q ss_pred ccCCHHHHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-----CCceeee
Q 035604 451 RKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-----HPNMVLL 523 (768)
Q Consensus 451 ~~~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l 523 (768)
..|++.+.....++|.+.+.||+|+||.||+|.+ +++.||||+++... .....+..|+.+++.+. |||||++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 4455555556678999999999999999999998 66789999997543 33456788999999986 9999999
Q ss_pred ecccc--CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC----
Q 035604 524 LGACP--EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---- 597 (768)
Q Consensus 524 ~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---- 597 (768)
+++|. +..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99884 4458999999 9999999977543 24899999999999999999999999 999999999999975
Q ss_pred ---------------------CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHH
Q 035604 598 ---------------------NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGI 656 (768)
Q Consensus 598 ---------------------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGv 656 (768)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC---------CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 789999999999865321 23467899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCChHHHH--HHHHc--CCcc-------------ccCCC--CCCCCCH--------------------H
Q 035604 657 LLLQIITAKPPMGLAHQVE--RSIEN--GTFD-------------ETLDP--AVPDWPV--------------------E 697 (768)
Q Consensus 657 il~elltg~~Pf~~~~~~~--~~i~~--~~~~-------------~~ld~--~~~~~~~--------------------~ 697 (768)
++|+|++|++||....... ..+.. +.+. ..+.. ....|+. .
T Consensus 248 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 327 (360)
T 3llt_A 248 VLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327 (360)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred HHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence 9999999999996443221 11111 0000 00000 0000110 0
Q ss_pred HHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 698 EALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 698 ~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+.+|+.+||+.||.+|||+.+++.
T Consensus 328 ~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 328 KHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1145889999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=366.84 Aligned_cols=253 Identities=25% Similarity=0.287 Sum_probs=201.1
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++++... .....+.+|+.+|..++||||++++++|.+ ..||
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 457899999999999999999998 577999999975322 223347899999999999999999999855 4489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||++||+|.+++.+.+. .+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|++||+|||+++.+.
T Consensus 139 VmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheecc
Confidence 9999999999999987542 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCccccc-------CCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCcc
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQ-------TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFD 684 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~ 684 (768)
.... ......+||+.|+|||++. +..|+.++|||||||++|||++|++||..... ....+......
T Consensus 214 ~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 214 ADGT-----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp TTSC-----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred CCCc-----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 3211 1224568999999999887 45789999999999999999999999964432 22333322100
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCC---CChhhhhh-HHH
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDR---PDLGKVVV-PKL 728 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~R---Ps~~evl~-~~l 728 (768)
. ..+..+...+..+.+||.+||. +|.+| |++.+++. ++.
T Consensus 289 -~---~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 289 -L---SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp -C---CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred -c---CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 0 0111112233569999999999 99998 68988875 444
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=352.45 Aligned_cols=257 Identities=26% Similarity=0.363 Sum_probs=186.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||+++.... .....+.+|+.+|+.++|||||++++++.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46799999999999999999987 467899999975432 234578899999999999999999999854 4499999
Q ss_pred eccCCChHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 537 YMANGSLEDRLFRRG---GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|++ |+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886532 1234899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--CCccccC-
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--GTFDETL- 687 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~~~~~~l- 687 (768)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||....... ..+.+ +......
T Consensus 160 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPV------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCC------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred CCc------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 321 12245578999999998876 468999999999999999999999996543322 12211 1100000
Q ss_pred ---------CCCCCC-------------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 688 ---------DPAVPD-------------WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 688 ---------d~~~~~-------------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+.... .+...+..+.+|+.+||+.||.+||++.+++. +|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 000000 00112346999999999999999999999986 555
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.53 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=206.5
Q ss_pred hcCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCch-hhHHHHHHHHHHHhhc-CCCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 530 (768)
.++|.+.+.||+|+||.||++.+ .+..||||+++.... .....+.+|+.+++++ +||||++++++|.+ .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999985 335899999976533 3456789999999999 99999999999854 4
Q ss_pred ceeEEEeccCCChHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG---------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 5999999999999999986542 124899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh---
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--- 671 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--- 671 (768)
+.++.+||+|||++..+..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cCCCCEEEcccccccccccccc----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 9999999999999987644321 111234567889999999999999999999999999999999 99999643
Q ss_pred HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 672 HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 672 ~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
......+..+. .... +...+..+.+|+.+||..+|.+||++.+++..+.+.+.
T Consensus 255 ~~~~~~~~~~~-~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 255 SKFYKMIKEGF-RMLS-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHHHHTC-CCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHhccCC-CCCC-------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 23333333332 1111 11223469999999999999999999999865555543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.12 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=202.6
Q ss_pred hcCCCccceecccCceeEEEEEECC-----ccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 534 (768)
.++|.+.+.||+|+||.||+|.+.+ ..||+|++... .......+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 4679999999999999999998633 24999999765 33456678999999999999999999999854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999976543 4899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCC--hHHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGL--AHQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~--~~~~~~~i~~~~~~~~ld~~~ 691 (768)
.. ........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.. .......+..+....
T Consensus 166 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~------ 234 (281)
T 3cc6_A 166 ED-----YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP------ 234 (281)
T ss_dssp ------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC------
T ss_pred cc-----ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC------
Confidence 21 112234567889999999998999999999999999999998 9999953 233344444432111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
.+...+..+.+|+.+||..+|.+||++.+++..+.+.+
T Consensus 235 --~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 235 --KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11122345999999999999999999999986554443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.94 Aligned_cols=245 Identities=30% Similarity=0.436 Sum_probs=200.0
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV 534 (768)
.++|.+.+.||+|+||.||++.+. +..||+|++..... .....+.+|+.+++.++||||++++++|.+. .++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999884 45799999865321 2245688999999999999999999998554 4899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999997764 3899999999999999999999999 99999999999999999999999999865432
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~ 692 (768)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+..... ..
T Consensus 162 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~- 226 (279)
T 3fdn_A 162 S--------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------TF- 226 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------CC-
T ss_pred c--------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC------CC-
Confidence 2 12345789999999999999999999999999999999999999975432 2233333221 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
+...+..+.+|+.+||..+|.+||++.+++. +|+.
T Consensus 227 --~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~ 262 (279)
T 3fdn_A 227 --PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262 (279)
T ss_dssp --CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred --CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence 1222345899999999999999999999996 5553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=361.97 Aligned_cols=246 Identities=22% Similarity=0.375 Sum_probs=191.8
Q ss_pred hcCCCcc-ceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHh-hcCCCceeeeeccccC------Cc
Q 035604 462 TENFSNS-RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLC-NIRHPNMVLLLGACPE------FG 531 (768)
Q Consensus 462 ~~~y~~~-~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~------~~ 531 (768)
.++|.+. +.||+|+||.||++.+ ++..||||++... ..+.+|+.++. ..+||||++++++|.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567666 7899999999999998 4678999999632 35678888874 4589999999998743 35
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCcEEEeeccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYVSKISDVGL 608 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~vKL~DFGl 608 (768)
|||||||+||+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999976432 35899999999999999999999999 999999999999987 78999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH------HHHHHHHcCC
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH------QVERSIENGT 682 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~------~~~~~i~~~~ 682 (768)
++..... ......+||+.|+|||++.+..++.++||||||||+|+|++|+.||.... .....+..+.
T Consensus 211 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 211 AKETTSH-------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp CEECC------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred ccccCCC-------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 9865322 12345688999999999999999999999999999999999999996432 1334444444
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 683 ~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+... .+.... .+..+.+||.+||..||.+||++.+++. +|+
T Consensus 284 ~~~~-~~~~~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 284 YEFP-NPEWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp CCCC-TTTTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ccCC-Cccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 3211 111122 2345899999999999999999999986 554
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=348.05 Aligned_cols=240 Identities=23% Similarity=0.395 Sum_probs=194.4
Q ss_pred hcCCCccceecccCceeEEEEEECC---------ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH---------TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~ 530 (768)
.++|.+.+.||+|+||.||+|.+.. ..||+|++..........+.+|+.+++.++||||++++++|.+ .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578999999999999999998743 4599999977666667789999999999999999999999854 4
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc--------EE
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV--------SK 602 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--------vK 602 (768)
.++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 5899999999999999976542 3899999999999999999999999 999999999999988887 99
Q ss_pred EeecccccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhC-CCCCCChHHHHH-HHH
Q 035604 603 ISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITA-KPPMGLAHQVER-SIE 679 (768)
Q Consensus 603 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg-~~Pf~~~~~~~~-~i~ 679 (768)
|+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||........ .+.
T Consensus 162 l~Dfg~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLPK----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSCH----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eccCcccccccCc----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 9999998754221 22357889999999887 6799999999999999999995 556643332221 111
Q ss_pred cCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 680 NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 680 ~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
... ..+.... +..+.+|+.+||+.+|.+||++.+++.
T Consensus 232 ~~~--~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 232 EDR--HQLPAPK-------AAELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp HTT--CCCCCCS-------SCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcc--CCCCCCC-------CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 1111111 234889999999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=355.68 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=191.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++..... ....+.+|+.+++.++|||||+++++|.+ ..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46899999999999999999998 567899999975433 23568899999999999999999999854 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc--EEEeecccccccCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV--SKISDVGLARLVPPS 615 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--vKL~DFGla~~~~~~ 615 (768)
+++|+|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999997655 3999999999999999999999999 999999999999987765 999999999743221
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCcc-ccHHHHHHHHHHHHhCCCCCCChH------HHHHHHHcCCccccCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVK-SDVYSLGILLLQIITAKPPMGLAH------QVERSIENGTFDETLD 688 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDvwSlGvil~elltg~~Pf~~~~------~~~~~i~~~~~~~~ld 688 (768)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... .....+....+..
T Consensus 172 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--- 241 (361)
T 3uc3_A 172 -------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI--- 241 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC---
T ss_pred -------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC---
Confidence 12244579999999999988887655 899999999999999999996432 1222222222111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+....+ +..+.+|+.+||..+|.+||++.+++. +|.
T Consensus 242 ~~~~~~----s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 242 PDDIRI----SPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp CTTSCC----CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred CCcCCC----CHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 111112 245899999999999999999999987 555
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.32 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=207.4
Q ss_pred cCCCccc-eecccCceeEEEEEE----CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEE
Q 035604 463 ENFSNSR-KIGEGGYGPVYKSYL----DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~-~LG~G~fG~Vy~~~~----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~ 535 (768)
++|.+.+ .||+|+||.||+|.+ .+..||||+++... ......+.+|+.+++.++||||+++++++.. ..++||
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 4566665 999999999999986 45679999998653 3456678999999999999999999999844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp ECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999986543 24899999999999999999999999 999999999999999999999999999877433
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~ 692 (768)
.. .........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||... ......+..+...
T Consensus 164 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~-------- 232 (287)
T 1u59_A 164 DS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------- 232 (287)
T ss_dssp SC---EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--------
T ss_pred cc---eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC--------
Confidence 21 1111234467899999999998889999999999999999998 99999643 3333444444321
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALA 735 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~ 735 (768)
..+...+..+.+|+.+||..+|.+||++.+++..+.+.+....
T Consensus 233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1122334569999999999999999999999876665554443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=371.59 Aligned_cols=246 Identities=31% Similarity=0.487 Sum_probs=202.7
Q ss_pred HhcCCCccceecccCceeEEEEEEC-CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEec
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD-HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYM 538 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~ 538 (768)
..++|.+.+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|+.++|||||++++++.. ..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeec
Confidence 3567899999999999999999985 5689999998654 345689999999999999999999999853 459999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 265 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-- 338 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-- 338 (454)
T ss_dssp TTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH--
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc--
Confidence 99999999975421 13789999999999999999999999 9999999999999999999999999998764311
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
........+|..|+|||++.+..++.++|||||||+||||+| |+.||... ..+...+..+... + .+
T Consensus 339 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----~----~~ 407 (454)
T 1qcf_A 339 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----P----RP 407 (454)
T ss_dssp ---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC----C----CC
T ss_pred ---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----C----CC
Confidence 111234456788999999998999999999999999999999 99999643 3334445444211 1 12
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
..++..+.+|+.+||..+|.+||++.+|+
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~ 436 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQ 436 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 22335699999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=372.32 Aligned_cols=247 Identities=25% Similarity=0.303 Sum_probs=194.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++.... ......+.+|+.+|+.++||||++++++|.+ ..|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999997 56789999997532 2234457789999999999999999999854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997755 48999999999999999999998 88 9999999999999999999999999997543
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+..+.+.
T Consensus 301 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------- 367 (446)
T 4ejn_A 301 KD------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR------- 367 (446)
T ss_dssp C-----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred CC------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-------
Confidence 22 122345789999999999999999999999999999999999999995443 333344433221
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh-HHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRP-----DLGKVVV-PKLN 729 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~-~~l~ 729 (768)
.+...+..+.+|+.+||..||.+|| ++.+++. ++..
T Consensus 368 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~ 409 (446)
T 4ejn_A 368 --FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409 (446)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred --CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence 1222335699999999999999999 9999885 4443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.46 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=203.9
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV 534 (768)
.++|.+.+.||+|+||.||++.+. ++.||+|++.... ......+.+|+.+++.++||||+++++++.+. .++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999984 5689999986542 33456788999999999999999999998554 4899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999887654 4899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~ 692 (768)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+.+
T Consensus 168 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 232 (294)
T 2rku_A 168 DG------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------- 232 (294)
T ss_dssp TT------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------
T ss_pred Cc------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---------
Confidence 21 1123457899999999999999999999999999999999999999754332 223333321
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+...+..+.+|+.+||..+|.+||++.+++. ++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 111222346899999999999999999999996 443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=370.22 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=205.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||+++++++.+ ..|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 36799999999999999999998 578999999975422 234568899999999999999999999854 45999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++|+|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999987644 4899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... .....+..+.+. .
T Consensus 169 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------~ 235 (476)
T 2y94_A 169 GE-------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY------T 235 (476)
T ss_dssp TC-------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC------C
T ss_pred cc-------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC------C
Confidence 21 2345689999999999988765 789999999999999999999996443 344455555321 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
+...+..+.+|+.+||..||.+||++.+++. +|+.
T Consensus 236 ---p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 236 ---PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred ---CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 1122345899999999999999999999986 5553
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.11 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=204.3
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCC---chhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV 534 (768)
.++|.+.+.||+|+||.||++.+. +..||+|++... .......+.+|+.+++.++||||++++++|.+. .++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999984 568999998654 234456788999999999999999999998554 4899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999887654 4899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~ 692 (768)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.+. .
T Consensus 194 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------~- 260 (335)
T 2owb_A 194 DG------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------I- 260 (335)
T ss_dssp TT------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------C-
T ss_pred Cc------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC------C-
Confidence 21 112346799999999999999999999999999999999999999975432 22333333221 1
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+...+..+.+|+.+||..||.+||++.+++. +|.
T Consensus 261 --~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 261 --PKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1122345899999999999999999999996 444
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=352.41 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=202.1
Q ss_pred CCccceecccCceeEEEEEE------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC----Ccee
Q 035604 465 FSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCL 533 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~l 533 (768)
|.+.+.||+|+||.||++.+ +++.||||+++... ......+.+|+.+|+.++||||+++++++.+ ..++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999998865 45689999998653 3445678999999999999999999999854 3489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|.+++.... +++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999987653 899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH-----------------HH
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV-----------------ER 676 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~-----------------~~ 676 (768)
.... .........+|..|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 186 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 186 EGHE---YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp TTCS---EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccc---ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 4321 111234456888999999999989999999999999999999999999654321 11
Q ss_pred HHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 677 ~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
.+..+.. ...+..++..+.+|+.+||+.+|.+||++.+++..+...+..+
T Consensus 263 ~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 LLERGER--------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcccC--------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1222211 1122233456999999999999999999999985444444433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=364.85 Aligned_cols=248 Identities=17% Similarity=0.171 Sum_probs=194.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC---chhhHHHHHHHH---HHHhhcCCCceeeeeccc------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD---AAQGRSQFQQEV---EVLCNIRHPNMVLLLGAC------ 527 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~E~---~il~~l~HpnIv~l~g~~------ 527 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+ .+|+.++|||||++++.|
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999996 5789999999743 333456789999 556666899999998443
Q ss_pred -cC-------------------CceeEEEeccCCChHHHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 035604 528 -PE-------------------FGCLIYEYMANGSLEDRLFRRGGS----PVLPWQIRFRIAAEIATALLFLHQTKPEPL 583 (768)
Q Consensus 528 -~~-------------------~~~lV~E~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 583 (768)
.+ ..||||||+ +|+|.+++...... ..+++..++.|+.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 22 258999999 68999999764321 12335888899999999999999999 9
Q ss_pred eeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCC-----------CCCccccHH
Q 035604 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-----------MLGVKSDVY 652 (768)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDvw 652 (768)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 9999999999999999999999999985422 2234567 999999999887 899999999
Q ss_pred HHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 653 SLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 653 SlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
||||++|||++|+.||...... ..+... ......++ ..+.+|+.+||..||.+||++.+++. +|.+.+
T Consensus 298 SlG~il~elltg~~Pf~~~~~~------~~~~~~-~~~~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAAL------GGSEWI-FRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHHHHSSCCC------------CCSGGG-GSSCCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHHHCCCCCcccccc------cchhhh-hhhccCCC----HHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9999999999999999543321 111111 11222333 45899999999999999999999997 777776
Q ss_pred HHH
Q 035604 732 RAL 734 (768)
Q Consensus 732 ~~~ 734 (768)
+..
T Consensus 367 ~~~ 369 (377)
T 3byv_A 367 RTE 369 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=352.75 Aligned_cols=256 Identities=28% Similarity=0.368 Sum_probs=196.9
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-----hhhHHHHHHHHHHHhhcC---CCceeeeeccccC-
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-----AQGRSQFQQEVEVLCNIR---HPNMVLLLGACPE- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~- 529 (768)
..++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++ ||||++++++|..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999996 66789999986432 111345677888877765 9999999999843
Q ss_pred ------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 530 ------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 530 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
..++||||+. |+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 2489999996 699998876543 34899999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc-
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN- 680 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~- 680 (768)
+|||+++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|++||....... ..+..
T Consensus 162 ~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 162 ADFGLARIYSYQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp CSCSCTTTSTTCC-------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred eeCccccccCCCc-------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999998664322 1245678999999999999999999999999999999999999996443322 12211
Q ss_pred -CCcccc------------CCCCCC----CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 681 -GTFDET------------LDPAVP----DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 681 -~~~~~~------------ld~~~~----~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+..... +.+..+ ......+..+.+|+.+||+.||.+|||+.+++. +|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 110000 000000 000123356899999999999999999999986 444
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=355.45 Aligned_cols=241 Identities=23% Similarity=0.355 Sum_probs=178.8
Q ss_pred cceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccccCC--ceeEEEeccCCC
Q 035604 468 SRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPEF--GCLIYEYMANGS 542 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~--~~lV~E~~~~gs 542 (768)
.+.||+|+||.||++.+ +++.||||++... ....+.+|+.+++.+. ||||++++++|.+. .|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999998 4678999999643 3456789999999997 99999999998554 489999999999
Q ss_pred hHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC---cEEEeecccccccCCCCCCc
Q 035604 543 LEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY---VSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 543 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~vKL~DFGla~~~~~~~~~~ 619 (768)
|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--- 163 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--- 163 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC---
Confidence 999998754 4999999999999999999999999 99999999999997665 89999999998664321
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH---------HHHHHHHcCCccccCCCC
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH---------QVERSIENGTFDETLDPA 690 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~---------~~~~~i~~~~~~~~ld~~ 690 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+.+...
T Consensus 164 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~---- 236 (325)
T 3kn6_A 164 ---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE---- 236 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC----
T ss_pred ---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC----
Confidence 12345678999999999999999999999999999999999999996432 23334444432110
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.......+..+.+|+.+||..||.+||++.+++. +|+
T Consensus 237 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 237 -GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp -SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred -cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 0000123456999999999999999999999986 454
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=370.17 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=193.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccCC-------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF------- 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------- 530 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++... .......+.+|+.+|+.++|||||+++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999987 5678999999754 233456788999999999999999999998432
Q ss_pred -ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 531 -GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 531 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
.||||||++++ |...+.. .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 38999999754 6565532 2889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCc--
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTF-- 683 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~-- 683 (768)
+..... ......+||+.|+|||++.+..|+.++||||||||+|||++|++||........ .+.. |..
T Consensus 212 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 212 RTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp -----C-------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred eecCCC-------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 866432 123456899999999999999999999999999999999999999965433221 1110 000
Q ss_pred -------------------------cccCC----CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 684 -------------------------DETLD----PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 684 -------------------------~~~ld----~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
...+. +.........+..+.+|+.+||..||.+|||+.+++. +|++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 00000 0000011122567999999999999999999999986 5443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=368.98 Aligned_cols=263 Identities=19% Similarity=0.262 Sum_probs=186.8
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeecccc-------CC
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP-------EF 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-------~~ 530 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++|||||+++++|. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999987 5678999999653 3344567889999999999999999999883 23
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 49999998 578998886543 4999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCcc---------------------ccccccCCCCCCCCCCcccc-cCCCCCccccHHHHHHHHHHHHh-----
Q 035604 611 LVPPSVADSV---------------------TQYRMTSAAGTFCYIDPEYQ-QTGMLGVKSDVYSLGILLLQIIT----- 663 (768)
Q Consensus 611 ~~~~~~~~~~---------------------~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~ellt----- 663 (768)
.+........ .....+..+||++|+|||++ .+..|+.++||||||||||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7743221100 01234567899999999975 56679999999999999999999
Q ss_pred ------CCCCCCChHHH----------------------HHHHH--cCC--------------------ccccCCCCCCC
Q 035604 664 ------AKPPMGLAHQV----------------------ERSIE--NGT--------------------FDETLDPAVPD 693 (768)
Q Consensus 664 ------g~~Pf~~~~~~----------------------~~~i~--~~~--------------------~~~~ld~~~~~ 693 (768)
|+++|...... ...+. .|. +..........
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 67777432210 00000 000 00000000000
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.....+..+.+|+.+||..||.+|||+.+++. +|+..+
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 01122456899999999999999999999987 666544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=352.94 Aligned_cols=240 Identities=28% Similarity=0.415 Sum_probs=195.6
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
+.|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|+.++|||||+++++|.+ ..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999996 57789999997542 2334578899999999999999999999843 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+. |+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 134 e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9996 678887765432 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPA 690 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~ 690 (768)
.....||+.|+|||++. +..++.++|||||||++|||++|++||....... ..+..+......
T Consensus 207 ---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 274 (348)
T 1u5q_A 207 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--- 274 (348)
T ss_dssp ---------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC---
T ss_pred ---------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Confidence 13457999999999874 5678999999999999999999999996543322 222222211111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...++ ..+.+|+.+||+.+|.+||++.+++.
T Consensus 275 ~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 275 SGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCC----HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11233 45899999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=357.23 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=201.7
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccCC--ceeEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPEF--GCLIY 535 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~--~~lV~ 535 (768)
..++|.+.+.||+|+||.||++.+ ++..||||++..... .+.+|+++|.++ +||||++++++|.+. .|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 356799999999999999999998 467899999975532 245788888887 799999999998554 48999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC----CcEEEeecccccc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN----YVSKISDVGLARL 611 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~----~~vKL~DFGla~~ 611 (768)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+..+ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999997654 4899999999999999999999999 9999999999998432 3599999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCC-----hHHHHHHHHcCCcccc
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGL-----AHQVERSIENGTFDET 686 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~-----~~~~~~~i~~~~~~~~ 686 (768)
+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.. ...+...+..+.+...
T Consensus 170 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 243 (342)
T 2qr7_A 170 LRAEN------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243 (342)
T ss_dssp CBCTT------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred CcCCC------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence 64321 123456899999999999888899999999999999999999999963 2344455655553211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
. ..+...+..+.+|+.+||..||.+||++.+++. +|+.
T Consensus 244 -~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 244 -G----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp -S----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred -c----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 1 111223356899999999999999999999987 6663
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.18 Aligned_cols=247 Identities=25% Similarity=0.362 Sum_probs=194.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E 536 (768)
.++|.+.+.||+|+||.||++.. .+..||+|++.... ......+.+|+.+|+.++||||++++++|.+. .++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35799999999999999999997 46789999997543 23456789999999999999999999998553 489999
Q ss_pred eccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCcEEEeeccccccc
Q 035604 537 YMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLV 612 (768)
Q Consensus 537 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~vKL~DFGla~~~ 612 (768)
|+++|+|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988653 11235999999999999999999999999 9999999999999 55688999999999865
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPA 690 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~ 690 (768)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||..... ....+...... ....
T Consensus 178 ~~~~-------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 247 (285)
T 3is5_A 178 KSDE-------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN--YAVE 247 (285)
T ss_dssp ----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCC-
T ss_pred CCcc-------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc--cccc
Confidence 4321 124557899999999875 5689999999999999999999999964432 22222222111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.... +..+.+|+.+||+.||.+||++.+++.
T Consensus 248 ~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 CRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112 245889999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=357.48 Aligned_cols=242 Identities=21% Similarity=0.323 Sum_probs=199.2
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--------hhHHHHHHHHHHHhhcCCCceeeeeccccCC
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--------QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF 530 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 530 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+|+.+|+.++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999987 567899999976531 1233577899999999999999999998554
Q ss_pred --ceeEEEeccCC-ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 531 --GCLIYEYMANG-SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 531 --~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
.++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 48999999776 9999887654 4999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCcccc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDET 686 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ 686 (768)
+++.+.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ...
T Consensus 176 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~ 240 (335)
T 3dls_A 176 SAAYLERGK-------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------EAA 240 (335)
T ss_dssp TCEECCTTC-------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------TTC
T ss_pred cceECCCCC-------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------hhc
Confidence 998764322 1234579999999999988876 889999999999999999999996533211 011
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.. .+...+..+.+|+.+||..+|.+||++.+++. +|+
T Consensus 241 ~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 241 IH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp CC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred cC-----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 11 11112346999999999999999999999986 454
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.90 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=197.7
Q ss_pred HHHHHhcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhh--cCCCceeeeeccccC-----
Q 035604 457 EIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCN--IRHPNMVLLLGACPE----- 529 (768)
Q Consensus 457 ei~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~----- 529 (768)
......++|.+.+.||+|+||.||+|.+.++.||||++.... ...+..|.+++.. ++||||+++++++..
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 334456789999999999999999999999999999996432 2344556666555 489999999998743
Q ss_pred -CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeeCCCCCCCeEEcCCCc
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT--------KPEPLVHRDLKPGNILLDRNYV 600 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~~~~iiHrDLKp~NILl~~~~~ 600 (768)
..++||||+++|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+||||+.++.
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred CceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence 358999999999999999654 389999999999999999999998 7 999999999999999999
Q ss_pred EEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCcc------ccHHHHHHHHHHHHhC----------
Q 035604 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVK------SDVYSLGILLLQIITA---------- 664 (768)
Q Consensus 601 vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k------sDvwSlGvil~elltg---------- 664 (768)
+||+|||+++.+...... .........||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 181 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNE--VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp EEECCCTTCEECC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEEEeCCCceeecccccc--ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999876433211 1112235689999999999988776665 9999999999999999
Q ss_pred CCCCCCh-------HHHHHHHHcCCccccCCCCCCC-C-CHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHH
Q 035604 665 KPPMGLA-------HQVERSIENGTFDETLDPAVPD-W-PVEEALILAKLALQCAELRRKDRPDLGKVVVPKLN 729 (768)
Q Consensus 665 ~~Pf~~~-------~~~~~~i~~~~~~~~ld~~~~~-~-~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~ 729 (768)
..||... ......+... .+.+..+. + +..++..+.+|+.+||+.+|.+||++.+++..+..
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 6777421 1222222221 12222221 1 23677789999999999999999999999854443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=352.53 Aligned_cols=259 Identities=28% Similarity=0.402 Sum_probs=208.0
Q ss_pred CCHHHHHHHhcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeee
Q 035604 453 YSIEEIEEATENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLL 524 (768)
Q Consensus 453 ~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~ 524 (768)
+..+++....++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444555556788999999999999999999864 4679999997543 34455789999999999999999999
Q ss_pred ccccC--CceeEEEeccCCChHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 525 GACPE--FGCLIYEYMANGSLEDRLFRRG-------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 525 g~~~~--~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
+++.+ ..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99854 4589999999999999987532 1134789999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH-- 672 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~-- 672 (768)
+.++.+||+|||+++.+.... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGG----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred cCCCeEEECcCcccccccccc----ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 999999999999997653211 1112234567889999999999999999999999999999999 899996443
Q ss_pred HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 673 QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 673 ~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
.....+..+.+.. .+...+..+.+|+.+||..+|.+||++.+++..
T Consensus 248 ~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 248 QVLRFVMEGGLLD--------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHTTCCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCcCC--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3334444443211 122233459999999999999999999999843
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.07 Aligned_cols=252 Identities=30% Similarity=0.436 Sum_probs=204.1
Q ss_pred hcCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEecc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMA 539 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~ 539 (768)
.++|.+.+.||+|+||.||+|.+.+ ..||||++..... ....+.+|+++++.++||||+++++++.+ ..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCC
Confidence 4679999999999999999999854 5899999976532 35678999999999999999999998854 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 91 ~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 164 (279)
T 1qpc_A 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-- 164 (279)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE--
T ss_pred CCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc--
Confidence 9999999865321 13899999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......++..|+|||++.+..++.++|||||||++|+|++ |+.||.... .....+..+... . .+.
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----~---~~~ 233 (279)
T 1qpc_A 165 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-----V---RPD 233 (279)
T ss_dssp ---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----C---CCT
T ss_pred ---ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC-----C---Ccc
Confidence 11234467889999999998899999999999999999999 999996433 333344443211 1 112
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
..+..+.+|+.+||..+|.+||++.+++..+.+.+
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 22356999999999999999999999885444443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=361.18 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=209.1
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC----CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV 534 (768)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+++|+.++||||+++++++.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357999999999999999999984 6789999997543 2335667899999999999999999998843 34899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----cCCCcEEEeeccccc
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL----DRNYVSKISDVGLAR 610 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~vKL~DFGla~ 610 (768)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999977554445999999999999999999999999 9999999999999 788889999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccC--------CCCCccccHHHHHHHHHHHHhCCCCCCC------hHHHHH
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT--------GMLGVKSDVYSLGILLLQIITAKPPMGL------AHQVER 676 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDvwSlGvil~elltg~~Pf~~------~~~~~~ 676 (768)
.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ......
T Consensus 165 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 165 ELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp ECCCGG-------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred EccCCC-------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 764321 2245679999999998765 5678899999999999999999999942 222333
Q ss_pred HHHcCCcccc----------------CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 677 SIENGTFDET----------------LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 677 ~i~~~~~~~~----------------ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
.+..+..... ..+.....+......+.+++.+||+.||.+||++.+++..+.+.|.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 3333321110 0011123456778889999999999999999999998765555543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=344.16 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=201.8
Q ss_pred hcCCCccceecccCceeEEEEEECC-----ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc---CCce
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP---EFGC 532 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~---~~~~ 532 (768)
..+|.+.+.||+|+||.||+|.+.. ..||+|.+.... ......+.+|+.++++++||||++++++|. ...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568889999999999999998632 258999997543 344567899999999999999999999863 3458
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999997543 34899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDP 689 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~ 689 (768)
..... ..........+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||.... .....+..+... ..
T Consensus 179 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~- 253 (298)
T 3f66_A 179 YDKEY--YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--LQ- 253 (298)
T ss_dssp SCGGG--CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC--CC-
T ss_pred cccch--hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC--CC-
Confidence 43221 11122345577889999999999999999999999999999999 667775332 233333333211 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
+...+..+.+|+.+||..+|.+||++.+++..+...+..+
T Consensus 254 -----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 254 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1112345999999999999999999999986666555443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=355.41 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=201.4
Q ss_pred HHHHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC-----chhhHHHHHHHHHHHhhcCCCceeeeeccc
Q 035604 455 IEEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD-----AAQGRSQFQQEVEVLCNIRHPNMVLLLGAC 527 (768)
Q Consensus 455 ~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 527 (768)
...+....++|.+.+.||+|+||.||++.+ ++..||+|++... .......+.+|+.+|+.++|||||+++++|
T Consensus 18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 344556678999999999999999999988 4568999998643 223456789999999999999999999999
Q ss_pred cCC--ceeEEEeccCCChHHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHH
Q 035604 528 PEF--GCLIYEYMANGSLEDRLFRRG-------------------------------------GSPVLPWQIRFRIAAEI 568 (768)
Q Consensus 528 ~~~--~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi 568 (768)
.+. .++||||+++|+|.+++.... ....+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 554 489999999999999885210 01124577788999999
Q ss_pred HHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC--cEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC--CC
Q 035604 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNY--VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT--GM 644 (768)
Q Consensus 569 ~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~ 644 (768)
+.||.|||+.+ |+||||||+||||+.++ .+||+|||+++.+..... ..........||+.|+|||++.+ ..
T Consensus 178 ~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 178 FSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN--GEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC--C--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCc--cccccccccCCCccccCchhhccCCCC
Confidence 99999999999 99999999999998766 899999999986532211 11122345679999999998875 67
Q ss_pred CCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhh
Q 035604 645 LGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGK 722 (768)
Q Consensus 645 ~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~e 722 (768)
++.++|||||||++|+|++|+.||...... ...+..+... ...+... ..+..+.+|+.+||+.+|.+||++.+
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-FENPNYN----VLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-TTSGGGG----GSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-cCCcccc----cCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 899999999999999999999999644332 2223322211 1111111 12356999999999999999999999
Q ss_pred hhh-HHHH
Q 035604 723 VVV-PKLN 729 (768)
Q Consensus 723 vl~-~~l~ 729 (768)
++. +|++
T Consensus 328 ~l~hp~~~ 335 (345)
T 3hko_A 328 ALQHPWIS 335 (345)
T ss_dssp HHHSHHHH
T ss_pred HhcChhhc
Confidence 986 5554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.78 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=201.1
Q ss_pred cCCCccceecccCceeEEEEEE------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC----Cc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FG 531 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 531 (768)
.+|++.+.||+|+||.||++.+ .++.||||++.... ......+.+|+.+|+.++||||++++++|.+ ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588999999999999999984 56789999997543 2334678999999999999999999999844 34
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999966543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH-----------------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV----------------- 674 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~----------------- 674 (768)
+..... .........||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 176 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 176 IETDKE---YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CCTTCC---EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred ccCCCc---ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 754321 112234567888999999999999999999999999999999999987533221
Q ss_pred HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHH
Q 035604 675 ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLN 729 (768)
Q Consensus 675 ~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~ 729 (768)
...+..+. ....+...+..+.+|+.+||+.+|.+||++.+++..+.+
T Consensus 253 ~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 253 VNTLKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11122221 111222334569999999999999999999999854443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=336.66 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=202.7
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.++|.+.+.||+|+||.||++.+ ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 35788999999999999999998 566899999986543 34678999999999999999999999854 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--- 157 (267)
T 3t9t_A 86 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--- 157 (267)
T ss_dssp TTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH---
T ss_pred CCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc---
Confidence 99999999976532 4899999999999999999999999 999999999999999999999999999866321
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.........++..|+|||++.+..++.++||||||+++|+|++ |++||.... .....+..+... .. +
T Consensus 158 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~-----~~---~ 227 (267)
T 3t9t_A 158 --QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-----YK---P 227 (267)
T ss_dssp --HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----CC---C
T ss_pred --cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC-----CC---C
Confidence 1112234567889999999998899999999999999999999 899996443 333344443211 11 1
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
...+..+.+|+.+||..+|.+||++.+++..+
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 12234699999999999999999999988433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.30 Aligned_cols=265 Identities=27% Similarity=0.394 Sum_probs=211.4
Q ss_pred CCHHHHHHHhcCCCccceecccCceeEEEEEE-------CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeee
Q 035604 453 YSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLL 523 (768)
Q Consensus 453 ~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l 523 (768)
+.........++|.+.+.||+|+||.||++.+ .++.||||++.... ......+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34444445568899999999999999999985 23679999997653 33456789999999999 79999999
Q ss_pred eccccC---CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 035604 524 LGACPE---FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRD 587 (768)
Q Consensus 524 ~g~~~~---~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrD 587 (768)
+++|.. ..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 999844 36899999999999999976543 123889999999999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCC
Q 035604 588 LKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKP 666 (768)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~ 666 (768)
|||+|||++.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CccceEEECCCCCEEECCCccccccccCcc----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999986643221 122344567889999999999999999999999999999998 999
Q ss_pred CCCCh---HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 667 PMGLA---HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 667 Pf~~~---~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
||... ......+..+.... . +...+..+.+++.+||..+|.+||++.+++..+.+.+.
T Consensus 250 p~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 250 PYPGVKIDEEFCRRLKEGTRMR-----A---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp SSTTCCCSHHHHHHHHHTCCCC-----C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccchhHHHHHHhccCccCC-----C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99643 33444444443211 1 11123459999999999999999999999866555553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.20 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=206.9
Q ss_pred hcCCCccc-eecccCceeEEEEEE----CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC-Ccee
Q 035604 462 TENFSNSR-KIGEGGYGPVYKSYL----DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCL 533 (768)
Q Consensus 462 ~~~y~~~~-~LG~G~fG~Vy~~~~----~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~l 533 (768)
.++|.+.+ .||+|+||.||+|.+ .+..||||+++... ......+.+|+.+++.++||||+++++++.. ..++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l 94 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML 94 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence 35678777 999999999999965 24679999997543 2335678999999999999999999999844 4489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 95 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999997754 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~ 690 (768)
.... .........+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.... .+...+..+...
T Consensus 169 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------ 239 (291)
T 1xbb_A 169 ADEN---YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------ 239 (291)
T ss_dssp TTCS---EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------
T ss_pred cCCC---cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 4321 1111233456788999999998889999999999999999999 999996433 333444444321
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhhcC
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEET 738 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~~~ 738 (768)
..+...+..+.+|+.+||..+|.+||++.+++..+.+.+.....++
T Consensus 240 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 240 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 1122334569999999999999999999999877776666655443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.00 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=192.9
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCC--CceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRH--PNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++... .......+.+|+.+|+.++| |||+++++++.+ ..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45699999999999999999987 5668999999754 33445678999999999986 999999999854 44899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||+ .+|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+..
T Consensus 88 ~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp ECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 994 5889999998754 4899999999999999999999999 99999999999997 67899999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccC-----------CCCCccccHHHHHHHHHHHHhCCCCCCChHHH-H--HHHHc
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQT-----------GMLGVKSDVYSLGILLLQIITAKPPMGLAHQV-E--RSIEN 680 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~-~--~~i~~ 680 (768)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... . ..+..
T Consensus 160 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 160 DTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccc----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 221 112245689999999998865 67899999999999999999999999643221 1 11211
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
... .. .++...+..+.+|+.+||..+|.+||++.+++. +|..
T Consensus 236 ~~~----~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 236 PNH----EI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp TTS----CC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCc----cc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 111 11 112222345899999999999999999999986 5553
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=343.45 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=202.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||++.+ +++.||+|++..........+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 46799999999999999999998 5778999999866544556788999999999999999999998543 4899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCcEEEeecccccccCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~vKL~DFGla~~~~~ 614 (768)
+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999987654 3899999999999999999999999 9999999999999 7889999999999975432
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~ 692 (768)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+.+. ...+...
T Consensus 162 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~ 232 (304)
T 2jam_A 162 G--------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-FESPFWD 232 (304)
T ss_dssp B--------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-CCTTTTT
T ss_pred C--------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCccccc
Confidence 1 1233468999999999999999999999999999999999999996433 333445554321 1111112
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
. .+..+.+|+.+||..+|.+||++.+++. +++
T Consensus 233 ~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 233 D----ISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp T----SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred c----CCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 2 3356999999999999999999999986 554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.59 Aligned_cols=241 Identities=25% Similarity=0.288 Sum_probs=191.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.++||+|+||+||+|.+ +++.||||++.... ......+..|+..+..+ +||||++++++|.+ ..||||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999998 47799999986542 23334455666665555 89999999999854 348999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+ +++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 7799998877543 4999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..||....... .+..+.....+ +
T Consensus 211 ~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~~-------~ 274 (311)
T 3p1a_A 211 G-------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-QLRQGYLPPEF-------T 274 (311)
T ss_dssp -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-HHTTTCCCHHH-------H
T ss_pred C-------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-HHhccCCCccc-------c
Confidence 1 1234579999999998876 78999999999999999999977765544332 33333222111 1
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 122356999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=352.48 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=202.0
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|.+.+.||+|+||.||++.+. +..||+|++... .......+.+|+.+|+.++||||++++++|.+ ..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999985 678999999765 33445678999999999999999999998844 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||+|||++..+..
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 999999999998765 389999999999999999999996 8 99999999999999999999999999975421
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc---CCc-------
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN---GTF------- 683 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~---~~~------- 683 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.. +..
T Consensus 185 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp -------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred -------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 12234589999999999999999999999999999999999999996433211 11100 000
Q ss_pred ---------------------------cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 684 ---------------------------DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 684 ---------------------------~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.....+..+ ....+..+.+|+.+||..||.+|||+.+++. +|+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000000010 1112446999999999999999999999997 777654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=341.91 Aligned_cols=240 Identities=25% Similarity=0.408 Sum_probs=201.2
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC---------
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--------- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------- 529 (768)
..++|.+.+.||+|+||.||++.+ +++.||+|++.... ..+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 356799999999999999999998 47899999997543 346789999999999999999998732
Q ss_pred ---------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc
Q 035604 530 ---------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV 600 (768)
Q Consensus 530 ---------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 600 (768)
..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 24899999999999999976432 24899999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc
Q 035604 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN 680 (768)
Q Consensus 601 vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~ 680 (768)
+||+|||++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........+..
T Consensus 161 ~kl~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD 233 (284)
T ss_dssp EEECCCTTCEESSCCS-------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHT
T ss_pred EEECcchhheeccccc-------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhc
Confidence 9999999998764322 123457999999999999999999999999999999999999998655444444444
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
+.+.. .+ +..+.+|+.+||..+|.+||++.+++..
T Consensus 234 ~~~~~-------~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~ 268 (284)
T 2a19_B 234 GIISD-------IF----DKKEKTLLQKLLSKKPEDRPNTSEILRT 268 (284)
T ss_dssp TCCCT-------TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccc-------cC----CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33211 12 2458899999999999999999998743
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=348.55 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=206.6
Q ss_pred hcCCCccceecccCceeEEEEEEC---------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 529 (768)
.++|.+.+.||+|+||.||+|.+. +..||||+++... ......+.+|+.+++.+ +||||++++++|.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 3579999997653 34456789999999999 89999999999854
Q ss_pred -CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 45899999999999999976532 124889999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--H
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--H 672 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~ 672 (768)
+.++.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||... .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSS----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCCCCEEEcccccccccccccc----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999987643221 112234567889999999998899999999999999999999 99999643 2
Q ss_pred HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 673 QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 673 ~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
.+...+..+.... .+...+..+.+|+.+||..+|.+||++.+++..+.+.+..
T Consensus 267 ~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 267 ELFKLLKEGHRMD--------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHHHHHTCCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCC--------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3333444433111 1122334699999999999999999999998655555443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=347.32 Aligned_cols=256 Identities=24% Similarity=0.349 Sum_probs=196.1
Q ss_pred hcCCCcc-ceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNS-RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~-~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.+.|.+. +.||+|+||.||++.+ +++.||||++..........+.+|+.+|.++ +||||+++++++.+ ..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3568774 7899999999999987 5779999999766555567789999999985 79999999999844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc---EEEeeccccccc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV---SKISDVGLARLV 612 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~---vKL~DFGla~~~ 612 (768)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++..+
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999998764 4899999999999999999999999 999999999999988765 999999999866
Q ss_pred CCCCC-CccccccccCCCCCCCCCCcccccC-----CCCCccccHHHHHHHHHHHHhCCCCCCCh---------------
Q 035604 613 PPSVA-DSVTQYRMTSAAGTFCYIDPEYQQT-----GMLGVKSDVYSLGILLLQIITAKPPMGLA--------------- 671 (768)
Q Consensus 613 ~~~~~-~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltg~~Pf~~~--------------- 671 (768)
..... ............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 0111112334579999999998875 55889999999999999999999999643
Q ss_pred --HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 672 --HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 672 --~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+...+..+.+.-. ...... .+..+.+|+.+||..||.+||++.+++. +|+
T Consensus 245 ~~~~~~~~i~~~~~~~~-~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFP-DKDWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp HHHHHHHHHHHCCCCCC-HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred HHHHHHHHHhccCcccC-chhccc----CCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 223334444432100 000011 2346999999999999999999999985 444
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=340.41 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=203.7
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch------hhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA------QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|.+.+.||+|+||.||++.+. ++.||+|++..... .....+.+|+.+++.++||||++++++|.+ ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999984 67999999875422 135678999999999999999999999854 44
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----cEEEeecc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY----VSKISDVG 607 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~vKL~DFG 607 (768)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 89999999999999997654 4899999999999999999999999 99999999999998877 89999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDE 685 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~ 685 (768)
++..+.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ....+......
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 229 (283)
T 3bhy_A 158 IAHKIEAGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD- 229 (283)
T ss_dssp TCEECC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-
T ss_pred cceeccCCC-------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC-
Confidence 998764321 12345789999999999999999999999999999999999999965433 22333333211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHH
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRA 733 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~ 733 (768)
... ..+...+..+.+|+.+||..+|.+||++.+++. ++++.++.
T Consensus 230 -~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 230 -FDE---EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp -CCH---HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred -Ccc---hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 000 000112345899999999999999999999997 77766644
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=349.25 Aligned_cols=260 Identities=23% Similarity=0.291 Sum_probs=186.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeecccc--------C-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACP--------E- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~--------~- 529 (768)
..+|.+.+.||+|+||.||++.+ +++.||||++..........+.+|+.++.++. ||||+++++++. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45799999999999999999998 67799999997666666678899999999996 999999998872 1
Q ss_pred -CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccc
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGL 608 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGl 608 (768)
..++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 1389999995 799998876433345999999999999999999999875 3599999999999999999999999999
Q ss_pred ccccCCCCCCccc------cccccCCCCCCCCCCcccc---cCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH
Q 035604 609 ARLVPPSVADSVT------QYRMTSAAGTFCYIDPEYQ---QTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE 679 (768)
Q Consensus 609 a~~~~~~~~~~~~------~~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~ 679 (768)
++.+......... ........||+.|+|||++ .+..++.++|||||||++|+|++|+.||....... +.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~ 262 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--IV 262 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--hh
Confidence 9876543211100 0111245689999999988 56678999999999999999999999996443321 11
Q ss_pred cCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 680 NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 680 ~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
.+.+... .....+ ..+.+|+.+||+.+|.+||++.+++..+.....
T Consensus 263 ~~~~~~~---~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 263 NGKYSIP---PHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---CCCC---TTCCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcccCC---cccccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 111111 348899999999999999999999865544443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=359.12 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=191.3
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcC-CCceeeeeccccC----Cc
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE----FG 531 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~----~~ 531 (768)
..++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.+. |||||+++++|.. ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 467899999999999999999987 5678999998643 3344556789999999997 9999999999842 35
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
|+|||||+ |+|..++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999996 6898888763 3899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCC---------------ccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH
Q 035604 612 VPPSVAD---------------SVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE 675 (768)
Q Consensus 612 ~~~~~~~---------------~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~ 675 (768)
+...... .......+..+||+.|+|||++.+ ..++.++||||||||+|||++|++||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 6431100 001122455789999999998876 679999999999999999999999996543322
Q ss_pred H--HHHc-CCccc--c---C-------------------CCCCCCC-------------CHHHHHHHHHHHHHhhhcCcc
Q 035604 676 R--SIEN-GTFDE--T---L-------------------DPAVPDW-------------PVEEALILAKLALQCAELRRK 715 (768)
Q Consensus 676 ~--~i~~-~~~~~--~---l-------------------d~~~~~~-------------~~~~~~~l~~Li~~cl~~~P~ 715 (768)
. .+.. ..... . + ....... +...+..+.+|+.+||..||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 1 1110 00000 0 0 0000000 001234689999999999999
Q ss_pred CCCChhhhhh-HHHHH
Q 035604 716 DRPDLGKVVV-PKLNI 730 (768)
Q Consensus 716 ~RPs~~evl~-~~l~~ 730 (768)
+|||+.+++. +++..
T Consensus 319 ~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 319 KRISANDALKHPFVSI 334 (388)
T ss_dssp GSCCHHHHTTSTTTTT
T ss_pred cCCCHHHHhCCHHHHH
Confidence 9999999986 66543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=356.43 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=195.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccCC-------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF------- 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------- 530 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999997 5678999999643 233456788999999999999999999998432
Q ss_pred -ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 531 -GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 531 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
.|+||||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 38999999 88999988763 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCc-
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTF- 683 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~- 683 (768)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||........ .+.. +..
T Consensus 176 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 176 RQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp EECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccc---------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 875321 245688999999998877 6799999999999999999999999965433221 1110 110
Q ss_pred -------------------cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 684 -------------------DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 684 -------------------~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
..........+....+..+.+|+.+||..||.+|||+.+++. ++.+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000011111112223456999999999999999999999986 565443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=371.01 Aligned_cols=242 Identities=23% Similarity=0.348 Sum_probs=200.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++.+... .....+.+|+.+|+.++|||||+++++|.+ ..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999998 477899999975432 234568899999999999999999999854 45999
Q ss_pred EEeccCCChHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 535 YEYMANGSLEDRLFRRGG-SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|||++||+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999876432 345999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh------HHHHHHHHcCCccccC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA------HQVERSIENGTFDETL 687 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~------~~~~~~i~~~~~~~~l 687 (768)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||... ..+...+..+..
T Consensus 341 ~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~---- 410 (543)
T 3c4z_A 341 AGQT------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV---- 410 (543)
T ss_dssp TTCC------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC----
T ss_pred CCCc------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc----
Confidence 3221 123458999999999999999999999999999999999999999643 233344433321
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChh
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLG 721 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~ 721 (768)
.+|...+..+.+|+.+||..+|.+||++.
T Consensus 411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 -----TYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred -----CCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 12223345699999999999999999763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=365.47 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=202.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~ 535 (768)
.++|.+.+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+|+.++|||||+++++|.+. .|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45799999999999999999998 46689999997543 23356789999999999999999999998554 48999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCcEEEeeccccccc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYVSKISDVGLARLV 612 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~vKL~DFGla~~~ 612 (768)
|||++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999887765 3899999999999999999999999 999999999999976 456999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPA 690 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~ 690 (768)
... ......+||+.|+|||++. ..++.++|||||||++|+|++|.+||.... .+...+..+.+... .+.
T Consensus 190 ~~~-------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~ 260 (494)
T 3lij_A 190 ENQ-------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD-SPE 260 (494)
T ss_dssp BTT-------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-SGG
T ss_pred CCC-------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-chh
Confidence 432 1234568999999999876 468999999999999999999999996443 34455555543211 111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
... .+..+.+|+.+||..+|.+|||+.+++. +|+...
T Consensus 261 ~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 261 WKN----VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp GTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ccc----CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 122 2345899999999999999999999997 777654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=339.26 Aligned_cols=244 Identities=26% Similarity=0.406 Sum_probs=202.8
Q ss_pred cCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|.+.+.||+|+||.||++.+. +..||||++..... .....+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999984 56799999965421 224568899999999999999999999854 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999998764 3899999999999999999999999 999999999999999999999999999765321
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 693 (768)
......|++.|+|||++.+..++.++|||||||++|+|++|..||..... ....+..... .
T Consensus 168 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~ 230 (284)
T 2vgo_A 168 --------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---------K 230 (284)
T ss_dssp --------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------C
T ss_pred --------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---------C
Confidence 12345789999999999999999999999999999999999999965433 2233333221 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
++...+..+.+|+.+||..+|.+||++.+++. +|..
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 12223346899999999999999999999987 5553
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=342.14 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=200.8
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc---cCCceeEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC---PEFGCLIY 535 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~---~~~~~lV~ 535 (768)
..++|.+.+.||+|+||.||+|.+ .++.||||++..... ...+.+|+.+++.++|++++..++.| ....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 667899998765432 23578999999999999888777665 33458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCcEEEeeccccccc
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLV 612 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~vKL~DFGla~~~ 612 (768)
||+ +++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999875433 4899999999999999999999999 9999999999999 78999999999999876
Q ss_pred CCCCCCccc-cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH-----HHHHHHHcCCcccc
Q 035604 613 PPSVADSVT-QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH-----QVERSIENGTFDET 686 (768)
Q Consensus 613 ~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~-----~~~~~i~~~~~~~~ 686 (768)
......... ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... .....+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543221111 112345689999999999999999999999999999999999999996321 11111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhh
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAE 736 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~ 736 (768)
.......+ +..+.+|+..||+.+|.+||++.+++..+.+.+.....
T Consensus 239 ~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 10011122 24699999999999999999999998766666555543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=341.51 Aligned_cols=263 Identities=20% Similarity=0.285 Sum_probs=203.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc---cCCceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC---PEFGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~---~~~~~lV~E 536 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.+++.++|++++..++.+ ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999996 678999999875432 24688999999999999877776665 334589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCcEEEeecccccccC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVP 613 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~vKL~DFGla~~~~ 613 (768)
|+ +++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999975432 4999999999999999999999999 9999999999999 588999999999998765
Q ss_pred CCCCCcccc-ccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH-----HHHHHHHcCCccccC
Q 035604 614 PSVADSVTQ-YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH-----QVERSIENGTFDETL 687 (768)
Q Consensus 614 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~-----~~~~~i~~~~~~~~l 687 (768)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 432211111 12345689999999999999999999999999999999999999996421 111222211111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhh
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAE 736 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~ 736 (768)
......++ ..+.+|+.+||+.+|.+||++.+++..+.+.+.....
T Consensus 240 ~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 240 EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00111222 4599999999999999999999998655555544443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=370.07 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=203.5
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||+|.+. +..||||+++.... ....|.+|+.+|++++|||||+++++|.+ ..+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 467889999999999999999985 67899999976543 35679999999999999999999999854 45999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 298 ~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred cCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 999999999976443 34899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
........+++.|+|||++.+..++.++|||||||+||||++ |..||... ..+...+..+... ..
T Consensus 373 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~ 440 (495)
T 1opk_A 373 ----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--------ER 440 (495)
T ss_dssp ----EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--------CC
T ss_pred ----eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------CC
Confidence 111234456788999999999999999999999999999999 99999533 3344444443211 11
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+..++..+.+|+.+||+.+|.+||++.+++.
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 2223356999999999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.88 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=203.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh------hHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ------GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|.+.+.||+|+||.||++.+ ++..||+|++...... ....+.+|+.+++.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999998 4678999999754321 35678999999999999999999999854 34
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----cEEEeecc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY----VSKISDVG 607 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~vKL~DFG 607 (768)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 89999999999999997643 4899999999999999999999999 99999999999999887 79999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDE 685 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~ 685 (768)
++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+..+.+.
T Consensus 165 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~- 236 (321)
T 2a2a_A 165 LAHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD- 236 (321)
T ss_dssp TCEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-
T ss_pred cceecCccc-------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc-
Confidence 998764321 12345799999999999999999999999999999999999999964432 23333333211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.++. .+...+..+.+|+.+||..+|.+||++.+++. +|+
T Consensus 237 -~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 237 -FDEE---FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp -CCHH---HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred -cChh---hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 1100 00112345899999999999999999999985 443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=367.30 Aligned_cols=245 Identities=32% Similarity=0.461 Sum_probs=197.1
Q ss_pred hcCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEecc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMA 539 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~ 539 (768)
.++|.+.+.||+|+||.||+|.+.+ ..||||+++.... ..+.|.+|+.+|++++||||+++++++.+ ..+|||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhc
Confidence 4678899999999999999999965 5799999986542 35679999999999999999999999854 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 262 ~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 335 (452)
T 1fmk_A 262 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 335 (452)
T ss_dssp TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce--
Confidence 9999999975321 24899999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||... ..+...+..+... ..+.
T Consensus 336 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------~~~~ 404 (452)
T 1fmk_A 336 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------PCPP 404 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------CCCT
T ss_pred ---ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------CCCC
Confidence 11233456788999999999999999999999999999999 99999643 3344445444211 1122
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
.++..+.+|+.+||..+|.+||++.+++
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~ 432 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQ 432 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 2335699999999999999999999887
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.62 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=197.6
Q ss_pred HhcCCCccceecccCceeEEEEEECC-----ccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccCC---
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--- 530 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--- 530 (768)
..++|.+.+.||+|+||.||+|.+.. ..||+|++... .......+.+|+.+++.++||||++++++|.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 35679999999999999999998632 37999998754 234456789999999999999999999998442
Q ss_pred ----ceeEEEeccCCChHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 531 ----GCLIYEYMANGSLEDRLFRR---GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 531 ----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
.++||||+++|+|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 38999999999999998542 22345999999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHc
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIEN 680 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~ 680 (768)
+|||+++.+..... ........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||... ......+..
T Consensus 189 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 189 ADFGLSKKIYSGDY----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp CSCSCC--------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred eecCcceecccccc----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 99999986643211 111234467889999999999999999999999999999999 99999543 333344444
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
+... ..+...+..+.+|+.+||..+|.+||++.+++..+.+.+..+
T Consensus 265 ~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 265 GHRL--------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp TCCC--------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCC--------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 3211 112223346999999999999999999999986665555443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.24 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=194.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC---chhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD---AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.. ++..||||++... .......+.+|+.+++.++||||++++++|.+ ..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999997 5789999999753 23445678999999999999999999999843 45899
Q ss_pred EEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 535 YEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|||+++|+|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998652 12235899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH----HHHHHHHcCCccccCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH----QVERSIENGTFDETLDP 689 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~----~~~~~i~~~~~~~~ld~ 689 (768)
... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.... .....+..+.+.....
T Consensus 188 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 260 (310)
T 2wqm_A 188 SKT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS- 260 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT-
T ss_pred CCC------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc-
Confidence 321 11234578999999999999999999999999999999999999995332 3333444443322111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
..+ +..+.+|+.+||..||.+||++.+++. .++.+.+.
T Consensus 261 --~~~----~~~l~~li~~~l~~dp~~Rps~~~il~-~l~~l~~~ 298 (310)
T 2wqm_A 261 --DHY----SEELRQLVNMCINPDPEKRPDVTYVYD-VAKRMHAC 298 (310)
T ss_dssp --TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHHHH
T ss_pred --ccc----CHHHHHHHHHHcCCChhhCCCHHHHHH-HHHHHHHh
Confidence 122 345999999999999999999999874 34444443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.08 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=196.6
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC------Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~ 532 (768)
..|.+.+.||+|+||.||+|.+ ++..||+|++... .......+.+|+.+|+.++||||++++++|.. ..+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3478888999999999999998 4557999998654 23445678999999999999999999998743 248
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCcEEEeecccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-RNYVSKISDVGLARL 611 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~vKL~DFGla~~ 611 (768)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999997754 3899999999999999999999976 3599999999999997 789999999999976
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH---HHHHHHcCCccccCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ---VERSIENGTFDETLD 688 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~---~~~~i~~~~~~~~ld 688 (768)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ....+..+......+
T Consensus 182 ~~~~~--------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 182 KRASF--------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp CCTTS--------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred ccccc--------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence 53321 234578999999998764 589999999999999999999999964332 223333332221111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. ..+..+.+|+.+||..+|.+||++.+++.
T Consensus 253 ~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 253 K-------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G-------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 12245999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=340.86 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=179.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ ++..||||++..... .....+.+|+.+++.++||||+++++++.+. .++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999997 677899999965422 2235688999999999999999999998554 4899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999987643 25899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +...... +. ..
T Consensus 165 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~---~~---~~ 231 (278)
T 3cok_A 165 PHE------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLA---DY---EM 231 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS---CC---CC
T ss_pred CCC------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhc---cc---CC
Confidence 211 12345789999999999999999999999999999999999999964322111 1111000 11 12
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2233456899999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=339.91 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=208.3
Q ss_pred HhcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
..++|.+.+.||+|+||.||+|.+. +..||+|++.... .....+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 3578999999999999999999985 6789999997654 345678999999999999999999999854 4489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999976443 35899999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
. .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||... ......+..+... .
T Consensus 166 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------~ 232 (288)
T 3kfa_A 166 Y-----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--------E 232 (288)
T ss_dssp S-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--------C
T ss_pred c-----ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC--------C
Confidence 1 12234567889999999999999999999999999999999 99999633 2333344333211 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
.+...+..+.+|+.+||..+|.+||++.+++..+...+..
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1122235699999999999999999999998655555444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=357.47 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=193.7
Q ss_pred cCCCccceecccCceeEEEEEE-CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcC--CCceeeeecccc--CCceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIR--HPNMVLLLGACP--EFGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~--~~~~lV~ 535 (768)
.+|.+.+.||+|+||.||++.+ .++.||||++... .......+.+|+.+|+.++ |||||++++++. ...||||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999987 4678999999654 3344567899999999996 599999998874 3458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56899999998754 4889999999999999999999999 99999999999995 588999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccC-----------CCCCccccHHHHHHHHHHHHhCCCCCCChHH---HHHHHHcC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQT-----------GMLGVKSDVYSLGILLLQIITAKPPMGLAHQ---VERSIENG 681 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDvwSlGvil~elltg~~Pf~~~~~---~~~~i~~~ 681 (768)
.. .......+||+.|+|||++.+ ..++.++||||||||||||++|++||..... ....+...
T Consensus 208 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 208 TT----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred Cc----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 11 112345689999999998865 4689999999999999999999999964321 11222222
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.. ....+.++ +..+.+|+.+||..+|.+||++.+++. +|.
T Consensus 284 ~~----~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 284 NH----EIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp TS----CCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cc----cCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 21 11222322 345899999999999999999999986 444
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=347.29 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=205.4
Q ss_pred cCCCccceecccCceeEEEEEE------CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC----Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL------DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~ 532 (768)
++|.+.+.||+|+||.||++.+ ++..||||++..........+.+|+.+++.++||||+++++++.. ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5689999999999999999984 467899999987766667789999999999999999999998743 458
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
+||||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 121 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999977543 4899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH-HHHHHHcCCc--------
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ-VERSIENGTF-------- 683 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~-~~~~i~~~~~-------- 683 (768)
...... ........++..|+|||.+.+..++.++|||||||++|+|+||..||..... ....+.....
T Consensus 196 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 196 PQDKEY---YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp CSSCSE---EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccccc---cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 443211 1112344677889999999988899999999999999999999999864421 1111100000
Q ss_pred cccC-CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 684 DETL-DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 684 ~~~l-d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
.+.+ .......+..++..+.+|+.+||..+|.+||++.+++..+.+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000 000011122334569999999999999999999999865444433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.08 Aligned_cols=258 Identities=25% Similarity=0.356 Sum_probs=196.7
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.++|.+.+.||+|+||.||++.+. ++.||||++.... ......+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999984 6789999986543 2335568899999999999999999999854 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999988876544 3899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc------------
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN------------ 680 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~------------ 680 (768)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........ .+..
T Consensus 156 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 S------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 1 11234578999999998876 6689999999999999999999999965433221 1110
Q ss_pred ---CCccc-cCCCCCCCC-C-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 681 ---GTFDE-TLDPAVPDW-P-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 681 ---~~~~~-~ld~~~~~~-~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
..+.. ...+..... + ...+..+.+|+.+||..||.+|||+.+++. +|.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 00000 000100000 0 123345899999999999999999999986 665444
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.93 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=191.3
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+|+.+++.++||||+++++++.. ..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999997 467899999975432 234678899999999999999999999844 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999998754 4899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~~ 691 (768)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+.... .. ..
T Consensus 186 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~-~~--- 255 (309)
T 2h34_A 186 DEK-----LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI-PR-PS--- 255 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC-CC-GG---
T ss_pred ccc-----cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC-CC-cc---
Confidence 321 11223457899999999999999999999999999999999999999755432 22222221 11 00
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCC-ChhhhhhHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRP-DLGKVVVPKL 728 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RP-s~~evl~~~l 728 (768)
..+...+..+.+|+.+||..+|.+|| ++.+++..+.
T Consensus 256 -~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 256 -TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp -GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 11112224589999999999999999 7887774443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=349.34 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=204.5
Q ss_pred HhcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE-- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 529 (768)
..++|.+.+.||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+|+.+ +||||++++++|.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35789999999999999999999743 369999997653 34456789999999999 89999999999854
Q ss_pred CceeEEEeccCCChHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGG-----------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN 598 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 598 (768)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 45999999999999999875421 235899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh---HHH
Q 035604 599 YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA---HQV 674 (768)
Q Consensus 599 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~---~~~ 674 (768)
+.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||... ...
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSN----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTT----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CeEEECccccccccccccc----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 9999999999986533211 112234567889999999999999999999999999999998 99999643 223
Q ss_pred HHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 675 ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 675 ~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
...+..+. .. ..+ ...+..+.+|+..||..+|.+||++.+++..+.+.+.
T Consensus 277 ~~~~~~~~-~~----~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 277 YKLVKDGY-QM----AQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHTC-CC----CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCC-CC----CCC---CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 33333332 11 111 1123458999999999999999999999865444443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=373.22 Aligned_cols=247 Identities=28% Similarity=0.378 Sum_probs=204.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++.+.. ......+.+|+.+|+.++|||||+++++|.+ ..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999998 57799999996542 2234567899999999999999999999854 45999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||++||+|.+++..... ..+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999876543 34899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh------HHHHHHHHcCCccccCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA------HQVERSIENGTFDETLD 688 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~------~~~~~~i~~~~~~~~ld 688 (768)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|++||... ..+...+.....
T Consensus 339 ~~-------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~----- 406 (576)
T 2acx_A 339 GQ-------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----- 406 (576)
T ss_dssp TC-------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-----
T ss_pred Cc-------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-----
Confidence 21 123458999999999999999999999999999999999999999643 233333433221
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh-HHH
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRP-----DLGKVVV-PKL 728 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~-~~l 728 (768)
.++...+..+.+||.+||..||.+|| ++.+++. +|.
T Consensus 407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF 448 (576)
T 2acx_A 407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448 (576)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGG
T ss_pred ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhh
Confidence 12223345699999999999999999 6788875 444
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=357.58 Aligned_cols=258 Identities=27% Similarity=0.355 Sum_probs=194.6
Q ss_pred cCCCccceecccCceeEEEEEEC---C--ccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeecccc---CCcee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD---H--TPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP---EFGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~---~--~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~---~~~~l 533 (768)
..|.+.+.||+|+||.||+|.+. + ..||+|.++.. .......|.+|+.+|++++||||++++++|. ...++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34777889999999999999862 2 35899998654 3345677999999999999999999999863 34589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999975433 4889999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~ 690 (768)
..... .........+|+.|+|||.+.+..++.++|||||||++|||+| |.+||.... .....+..+... .
T Consensus 244 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~--~--- 316 (373)
T 3c1x_A 244 DKEFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--L--- 316 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC--C---
T ss_pred ccccc--cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC--C---
Confidence 32111 1112234567889999999999999999999999999999999 788885332 233344444311 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALA 735 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~ 735 (768)
.+..++..+.+|+.+||..+|.+||++.+++..+...+..+.
T Consensus 317 ---~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111223469999999999999999999999866665555443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=340.62 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=198.2
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
+.|.....||+|+||.||+|.+ ++..||||++..........+.+|+.+++.++||||++++++|.+ ..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455666899999999999998 567899999987665556779999999999999999999999854 448999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCcEEEeecccccccCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~vKL~DFGla~~~~~~~~ 617 (768)
++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++..+....
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999987655445789999999999999999999999 999999999999987 8999999999998764321
Q ss_pred CccccccccCCCCCCCCCCcccccCCC--CCccccHHHHHHHHHHHHhCCCCCCChHHHHHH-HHcCCccccCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQIITAKPPMGLAHQVERS-IENGTFDETLDPAVPDW 694 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~-i~~~~~~~~ld~~~~~~ 694 (768)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......... ...+.. ...+ ..
T Consensus 178 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~---~~ 247 (295)
T 2clq_A 178 -----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHP---EI 247 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCC---CC
T ss_pred -----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccc---cc
Confidence 1123457899999999887654 889999999999999999999999543221111 111100 0111 12
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+...+..+.+|+.+||..+|.+||++.+++. +++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 2233456899999999999999999999986 444
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.82 Aligned_cols=258 Identities=26% Similarity=0.317 Sum_probs=204.1
Q ss_pred CCCccceecccCceeEEEEEE--CCc---cEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc-eeE
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHT---PVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG-CLI 534 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~---~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~-~lV 534 (768)
.|...+.||+|+||.||+|.+ ++. .||+|++.... ......+.+|+.+++.++||||++++++|.+ .. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 466778999999999999986 222 69999997543 3445678999999999999999999999843 23 899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997643 34899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhC-CCCCCCh--HHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA-KPPMGLA--HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg-~~Pf~~~--~~~~~~i~~~~~~~~ld~~~ 691 (768)
... ..........+|+.|+|||.+.+..++.++|||||||++|+|++| .+||... ......+..+....
T Consensus 177 ~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~------ 248 (298)
T 3pls_A 177 REY--YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP------ 248 (298)
T ss_dssp GGG--GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC------
T ss_pred Ccc--cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC------
Confidence 211 111223455788999999999999999999999999999999995 5555422 33334444433111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAE 736 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~ 736 (768)
.+...+..+.+|+.+||..+|.+||++.+++..+.+.+..+..
T Consensus 249 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 249 --QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred --CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 1112234699999999999999999999998777666666543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=340.31 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=198.3
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhc-CCCceeeeecccc--CCcee
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNI-RHPNMVLLLGACP--EFGCL 533 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~~~l 533 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++... .......+.+|+.++..+ +||||+++++++. ...++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 356799999999999999999998 4789999999754 233456788999999999 9999999999984 34589
Q ss_pred EEEeccCCChHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---------------
Q 035604 534 IYEYMANGSLEDRLFRRGG-SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR--------------- 597 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~--------------- 597 (768)
||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976421 134899999999999999999999999 999999999999984
Q ss_pred ----CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChH
Q 035604 598 ----NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAH 672 (768)
Q Consensus 598 ----~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~ 672 (768)
.+.+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred ccCCceEEEEcccccccccCCc----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 447999999999876432 234689999999998766 56789999999999999999998886554
Q ss_pred HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 673 QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 673 ~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. ..+..+.+. ..+...+..+.+|+.+||..||.+||++.+++.
T Consensus 236 ~~-~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 QW-HEIRQGRLP--------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH-HHHHTTCCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHcCCCC--------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 43 334443322 112223356999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=376.88 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=200.8
Q ss_pred CCCccc-eecccCceeEEEEEEC----CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEE
Q 035604 464 NFSNSR-KIGEGGYGPVYKSYLD----HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYE 536 (768)
Q Consensus 464 ~y~~~~-~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E 536 (768)
+|.+.+ .||+|+||.||+|.+. +..||||+++... ......|.+|+.+|+.++|||||+++++|.. ..+||||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E 415 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 415 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEE
Confidence 344444 7999999999999873 3469999997653 3346789999999999999999999999854 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 416 ~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp CCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred eCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999997543 35999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.. ........+|+.|+|||++.+..++.++|||||||+||||++ |+.||... ..+...+..+... .
T Consensus 491 ~~---~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--------~ 559 (613)
T 2ozo_A 491 SY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--------E 559 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC--------C
T ss_pred ce---eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------C
Confidence 10 111223456789999999999999999999999999999998 99999643 3444556555421 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRAL 734 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~ 734 (768)
.+..++..+.+|+..||..+|.+||++.+|+..+...+...
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 12223356999999999999999999999986555554444
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=352.93 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=192.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
.++|.+.+.||+|+||.||+|.+ .++.||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999987 5678999999753 23345668899999999999999999998843
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..|+||||++ |+|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 3489999996 578777742 3889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHcCCc----
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIENGTF---- 683 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~~~~---- 683 (768)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+.....
T Consensus 175 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 175 RTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred cccccc-------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 865322 122456899999999999999999999999999999999999999965443221 1211100
Q ss_pred -----------------------------cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 684 -----------------------------DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 684 -----------------------------~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.....+.....+...+..+.+|+.+||..||.+|||+.+++. +|++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 000000000111233667999999999999999999999987 77643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=340.50 Aligned_cols=241 Identities=29% Similarity=0.435 Sum_probs=194.4
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC---CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~lV~E~~ 538 (768)
.++|.+.+.||+|+||.||++.+.++.||||+++... ..+.+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4679999999999999999999999999999997553 34578999999999999999999998632 459999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999999976432 23789999999999999999999999 999999999999999999999999999755322
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.....+++.|+|||.+.+..++.++|||||||++|+|++ |..||... ......+..+.. . ..+
T Consensus 171 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----~---~~~ 236 (278)
T 1byg_A 171 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----M---DAP 236 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-----C---CCC
T ss_pred ------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----C---CCc
Confidence 123467889999999999999999999999999999998 99999643 233333433321 1 112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+|+.+||..+|.+||++.+++.
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 223356999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=367.01 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=204.0
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV 534 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++.... ......+.+|+.+|+.++|||||+++++|.+. .|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 356799999999999999999998 46789999986432 22356788999999999999999999998554 4899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCcEEEeecccccc
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD---RNYVSKISDVGLARL 611 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~vKL~DFGla~~ 611 (768)
|||+.+|+|.+.+.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999987765 3899999999999999999999999 99999999999994 456899999999986
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDP 689 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~ 689 (768)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|++||.... .+...+..+.+....
T Consensus 174 ~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-- 243 (486)
T 3mwu_A 174 FQQNT-------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-- 243 (486)
T ss_dssp BCCC-----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS--
T ss_pred CCCCC-------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence 64321 2345679999999999876 58999999999999999999999996443 344455555432211
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
+.| ...+..+.+|+.+||..+|.+|||+.+++. +|+..
T Consensus 244 --~~~-~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 244 --PQW-RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp --GGG-GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred --ccc-CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 111 123356899999999999999999999986 66543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=351.25 Aligned_cols=253 Identities=24% Similarity=0.316 Sum_probs=189.1
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
...++|.+.+.||+|+||.||++.+ +++.||||+++.... .....+.+|+.+|+.++||||+++++++.+ ..+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999987 567899999975532 224467899999999999999999999844 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-----cCCCcEEEeeccc
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL-----DRNYVSKISDVGL 608 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl-----~~~~~vKL~DFGl 608 (768)
||||++ |+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 59999987764 3899999999999999999999999 9999999999999 4556699999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCc
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTF 683 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~ 683 (768)
++.+.... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||........ .+.. +..
T Consensus 184 a~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 184 ARAFGIPI------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp HHHHC-----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccccCCcc------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 98764321 123445789999999998774 489999999999999999999999965543322 1111 110
Q ss_pred cccCC----------CCCCC---CC------HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 684 DETLD----------PAVPD---WP------VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 684 ~~~ld----------~~~~~---~~------~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..... ...+. .. ...+..+.+|+.+||+.||.+||++.+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00000 00 013356899999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=340.48 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=201.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeecccc----CCcee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACP----EFGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~l 533 (768)
.++|.+.+.||+|+||.||++.+ +++.||+|++.... ......+.+|+.+++.++||||++++++|. ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46799999999999999999998 56789999997542 344567899999999999999999999872 34589
Q ss_pred EEEeccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 534 IYEYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTK--PEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997632 2335899999999999999999999976 2359999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCC
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLD 688 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld 688 (768)
.+.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .+...+..+.+..
T Consensus 165 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--- 235 (279)
T 2w5a_A 165 ILNHDT------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--- 235 (279)
T ss_dssp HC---C------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---
T ss_pred eecccc------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---
Confidence 764321 11123468999999999999999999999999999999999999996543 3344555554321
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 236 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 236 -----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11223356999999999999999999999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=361.29 Aligned_cols=256 Identities=14% Similarity=0.094 Sum_probs=185.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhc--CCCceeeeecccc------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNI--RHPNMVLLLGACP------ 528 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l--~HpnIv~l~g~~~------ 528 (768)
..+|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+++.| +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34589999999999999999997 567899999987542 3345677885555444 6999888653331
Q ss_pred --------------------CCceeEEEeccCCChHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 035604 529 --------------------EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIR------FRIAAEIATALLFLHQTKPEP 582 (768)
Q Consensus 529 --------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~~ 582 (768)
...||||||++ |+|.+++...+. .+++..+ +.++.||+.||.|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 23599999998 899999987532 2566666 788899999999999999
Q ss_pred eeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHH
Q 035604 583 LVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQ 660 (768)
Q Consensus 583 iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~e 660 (768)
|+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+|||
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE---------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC---------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 999999999999999999999999999865321 113456799999999987 679999999999999999
Q ss_pred HHhCCCCCCChHHHHH-HHHcCCccccC--CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHH
Q 035604 661 IITAKPPMGLAHQVER-SIENGTFDETL--DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRA 733 (768)
Q Consensus 661 lltg~~Pf~~~~~~~~-~i~~~~~~~~l--d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~ 733 (768)
|++|+.||........ .+......... ....+. +...+..+.+|+.+||+.||.+||++.+++. +|...+..
T Consensus 286 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp HHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred HHhCCCCCCCcCcccccchhhhhhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 9999999965422110 00000000000 011111 1123456999999999999999999999997 77776644
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.55 Aligned_cols=261 Identities=23% Similarity=0.371 Sum_probs=206.1
Q ss_pred CHHHHHHHhcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhh--cCCCceeeeeccccC--
Q 035604 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCN--IRHPNMVLLLGACPE-- 529 (768)
Q Consensus 454 ~~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~-- 529 (768)
.+.-.....++|.+.+.||+|+||.||+|.++++.||||++... ....+.+|.+++.. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 34444556788999999999999999999999999999999743 23467789999887 789999999999843
Q ss_pred ----CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCCeEEcC
Q 035604 530 ----FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH--------QTKPEPLVHRDLKPGNILLDR 597 (768)
Q Consensus 530 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~iiHrDLKp~NILl~~ 597 (768)
..++||||+++|+|.+++... .+++..++.++.||+.||.||| +.+ |+||||||+||||+.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 458999999999999999764 3899999999999999999999 777 999999999999999
Q ss_pred CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCC------CCccccHHHHHHHHHHHHhC-------
Q 035604 598 NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM------LGVKSDVYSLGILLLQIITA------- 664 (768)
Q Consensus 598 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~s~ksDvwSlGvil~elltg------- 664 (768)
++.+||+|||++........ ..........||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATD--TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp TSCEEECCCTTCEEEETTTT--EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCEEEEECCCceecccccc--ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999987643221 1111234568999999999987762 34789999999999999999
Q ss_pred ---CCCCCCh-------HHHHHHHHcCCccccCCCCCCC-C-CHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 665 ---KPPMGLA-------HQVERSIENGTFDETLDPAVPD-W-PVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 665 ---~~Pf~~~-------~~~~~~i~~~~~~~~ld~~~~~-~-~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
..||... ......+.... +.+..+. + .......+.+|+.+||..+|.+||++.+|+..+.+.
T Consensus 261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCccccCcCcccHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 7888532 22223332222 2233322 1 235667799999999999999999999998544433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=341.72 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=201.8
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.+.|.+.+.||+|+||.||+|.+ .++.||||++.... ......+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35699999999999999999987 46789999997543 3345678999999999999999999999843 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999988643 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 694 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+... ..
T Consensus 174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~ 239 (303)
T 3a7i_A 174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP--------TL 239 (303)
T ss_dssp ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------CC
T ss_pred ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC--------CC
Confidence 12245678999999999999999999999999999999999999996543322 233332211 11
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1122345999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.52 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=198.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc------CCcee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP------EFGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~~~~l 533 (768)
.++|.+.+.||+|+||.||++.. +++.||||++..........+.+|+.+++.++||||+++++++. ...++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999997 67799999997666666778999999999999999999999884 14489
Q ss_pred EEEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 534 IYEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
||||+++|+|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998762 22345999999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCCCcc---ccccccCCCCCCCCCCcccccCCC---CCccccHHHHHHHHHHHHhCCCCCCChH----HHHHHHHcCC
Q 035604 613 PPSVADSV---TQYRMTSAAGTFCYIDPEYQQTGM---LGVKSDVYSLGILLLQIITAKPPMGLAH----QVERSIENGT 682 (768)
Q Consensus 613 ~~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltg~~Pf~~~~----~~~~~i~~~~ 682 (768)
........ .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... .....+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~- 263 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ- 263 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-
Confidence 32111000 001112346799999999887654 6899999999999999999999995321 122222221
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 683 ~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. .+..+.+ +..+.+|+.+||+.+|.+||++.+++.
T Consensus 264 ~~---~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 299 (317)
T 2buj_A 264 LS---IPQSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLS 299 (317)
T ss_dssp -----CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC---CCccccC----CHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 11 1111222 346999999999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.72 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=197.1
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.++|.+.+.||+|+||.||++.+. ++.||||++.... ......+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999984 6789999986543 2335567899999999999999999999854 348999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988765544 3899999999999999999999999 999999999999999999999999999865332
Q ss_pred CCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HH--cC---------
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IE--NG--------- 681 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~--~~--------- 681 (768)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|++||......... +. .+
T Consensus 178 ~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 178 G------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 1 122345789999999988775 7899999999999999999999999654332211 10 00
Q ss_pred -----CccccCCCCCCC-CC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 682 -----TFDETLDPAVPD-WP-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 682 -----~~~~~ld~~~~~-~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
.+.....+.... .+ ...+..+.+|+.+||..||.+||++.+++. +|.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~ 311 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence 001111111110 01 123456999999999999999999999997 5654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=367.07 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=207.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++.... ......+.+|+.+|+.++|||||+++++|.+. .++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46799999999999999999998 56789999996542 23456789999999999999999999998554 4899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCcEEEeecccccc
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARL 611 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~vKL~DFGla~~ 611 (768)
|||+.+|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999987654 4899999999999999999999999 9999999999999 5678999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDP 689 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~ 689 (768)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.... .....+..+.+...
T Consensus 179 ~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 247 (484)
T 3nyv_A 179 FEASK-------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE--- 247 (484)
T ss_dssp BCCCC-------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred ccccc-------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 64332 1234579999999998876 68999999999999999999999996543 33445555543211
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.+.| ...+..+.+|+.+||..+|.+|||+.+++. +|+...
T Consensus 248 -~~~~-~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 248 -LPQW-KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp -SGGG-GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred -Cccc-ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 1111 123456999999999999999999999997 676543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.64 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=200.0
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc----hhhHHHHHHHHHHHhhcCCCceeeeeccc--cC--C
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA----AQGRSQFQQEVEVLCNIRHPNMVLLLGAC--PE--F 530 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~--~ 530 (768)
..++|.+.+.||+|+||.||++.+ ++..||+|+++... ......+.+|+.+++.++||||+++++++ .+ .
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999998 45689999997542 23356789999999999999999999987 22 4
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.++||||++++ |.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 59999999876 7777765432 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCC--CCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCcccc
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM--LGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDET 686 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ 686 (768)
.+..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... .....+..+.+.
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-- 231 (305)
T 2wtk_C 158 ALHPFAA----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA-- 231 (305)
T ss_dssp ECCTTCS----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--
T ss_pred ccCcccc----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC--
Confidence 7643221 11234567999999999887654 4789999999999999999999996543 333344444321
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+...+..+.+|+.+||..||.+||++.+++. +|.
T Consensus 232 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 232 -------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp -------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred -------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 11223346899999999999999999999986 444
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=343.44 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=196.9
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||+|.+. +..||+|++..........+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999984 67899999987665566789999999999999999999998844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 169 (302)
T 2j7t_A 98 CPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--- 169 (302)
T ss_dssp CTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH---
T ss_pred CCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc---
Confidence 999999998876443 4899999999999999999999999 99999999999999999999999999754311
Q ss_pred CccccccccCCCCCCCCCCcccc-----cCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQ-----QTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPA 690 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld~~ 690 (768)
.........||+.|+|||++ .+..++.++|||||||++|+|++|..||....... ..+..+.....
T Consensus 170 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 242 (302)
T 2j7t_A 170 ---TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL---- 242 (302)
T ss_dssp ---HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----
T ss_pred ---cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc----
Confidence 01112345789999999987 46678999999999999999999999997544322 22222221111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+...+..+.+|+.+||..+|.+||++.+++.
T Consensus 243 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 --LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 112223356999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=363.36 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=203.0
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-------------hhHHHHHHHHHHHhhcCCCceeeeec
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-------------QGRSQFQQEVEVLCNIRHPNMVLLLG 525 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-------------~~~~~~~~E~~il~~l~HpnIv~l~g 525 (768)
..++|.+.++||+|+||.||+|.+ .+..||||++..... .....+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 467899999999999999999998 456899999975431 22456889999999999999999999
Q ss_pred cccCC--ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC---c
Q 035604 526 ACPEF--GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY---V 600 (768)
Q Consensus 526 ~~~~~--~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~ 600 (768)
+|.+. .|+|||||++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 98554 489999999999999997765 3999999999999999999999999 99999999999998776 6
Q ss_pred EEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHH
Q 035604 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSI 678 (768)
Q Consensus 601 vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i 678 (768)
+||+|||+++.+.... ......||+.|+|||++. +.++.++|||||||++|+|++|.+||... ..+...+
T Consensus 188 ~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 259 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259 (504)
T ss_dssp EEECCCTTCEECCTTS-------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC-------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999998764321 234567999999999887 46899999999999999999999999644 3344555
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
..+.+..... .... .+..+.+|+.+||..+|.+|||+.+++. +|+..
T Consensus 260 ~~~~~~~~~~-~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 260 EKGKYYFDFN-DWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHCCCCCCHH-HHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HcCCCCCCcc-ccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 5554321110 0011 2346999999999999999999999987 66643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.39 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=198.8
Q ss_pred HhcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
..++|.+.+.||+|+||.||+|.+. ++.||||++.... ....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3567999999999999999999984 6789999997543 34568899999999999999999998844 4599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 105 ~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999875432 4899999999999999999999999 9999999999999999999999999998664321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHcCCccccCCCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IENGTFDETLDPAVPDW 694 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~~~~~~~ld~~~~~~ 694 (768)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +..... +.. ..
T Consensus 180 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~-~~ 247 (314)
T 3com_A 180 ------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-----PTF-RK 247 (314)
T ss_dssp ------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCC-SS
T ss_pred ------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-----ccc-CC
Confidence 1223457899999999999999999999999999999999999999755443322 222111 111 11
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
+...+..+.+|+.+||..+|.+||++.+++. +++.
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 2223356999999999999999999999986 5543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=362.16 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=193.1
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--------hhHHHHHHHHHHHhhcCCCceeeeeccccC-
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--------QGRSQFQQEVEVLCNIRHPNMVLLLGACPE- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 529 (768)
..++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|++++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 457899999999999999999998 456899999975321 112347899999999999999999999844
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CcEEEeec
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN---YVSKISDV 606 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~vKL~DF 606 (768)
..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred ceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 4589999999999998886544 4899999999999999999999999 9999999999999654 45999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccC---CCCCccccHHHHHHHHHHHHhCCCCCCCh---HHHHHHHHc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQIITAKPPMGLA---HQVERSIEN 680 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltg~~Pf~~~---~~~~~~i~~ 680 (768)
|+++.+... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||... ......+..
T Consensus 287 G~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~ 359 (419)
T 3i6u_A 287 GHSKILGET-------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359 (419)
T ss_dssp STTTSCC------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred ccceecCCC-------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence 999876432 12245679999999998753 56889999999999999999999999633 233444544
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+.+... +......+..+.+|+.+||..+|.+||++.+++. +|.
T Consensus 360 ~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 360 GKYNFI-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp TCCCCC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCCCCC-----chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 432211 0000112356999999999999999999999986 444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.51 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=192.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh-hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ-GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.+|+.++||||+++++++.+ ..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999998 4678999999754322 12245679999999999999999999844 45999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
++ |+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 96 589888876543 5899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--CCccccCCCC--
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--GTFDETLDPA-- 690 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~~~~~~ld~~-- 690 (768)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|++||....... ..+.. +.......+.
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 155 -----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 12234578999999998876 568999999999999999999999996543322 11111 1100000000
Q ss_pred ---------CCC--------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 691 ---------VPD--------WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 691 ---------~~~--------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.+. .....+..+.+|+.+||+.||.+|||+.+++. +|...+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 000 00122356899999999999999999999987 666443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=376.85 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=198.2
Q ss_pred ceecccCceeEEEEEE----CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYL----DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~----~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~g 541 (768)
+.||+|+||.||+|.+ .++.||||+++.... .....+.+|+.+|+.++|||||+++++|.. ..+|||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 4799999999999976 235799999976432 335679999999999999999999999954 348999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|.+++.... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+..... .
T Consensus 455 ~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~---~ 525 (635)
T 4fl3_A 455 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---Y 525 (635)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc---c
Confidence 9999997654 4899999999999999999999999 99999999999999999999999999987743321 1
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCCHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ..+...+..+... ..+..+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--------~~p~~~ 597 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------GCPAGC 597 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------CCCTTC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------CCCCCC
Confidence 112234467889999999999999999999999999999998 99999644 3444555555321 112233
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
+..+.+|+..||..+|.+||++.+|+..+.+.+.+
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 45699999999999999999999998655554443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.65 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=203.2
Q ss_pred HHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--------hhHHHHHHHHHHHhhc-CCCceeeeec
Q 035604 457 EIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--------QGRSQFQQEVEVLCNI-RHPNMVLLLG 525 (768)
Q Consensus 457 ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l-~HpnIv~l~g 525 (768)
......++|.+.+.||+|+||.||+|.+ +++.||||+++.... .....+.+|+.+++.+ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3445567899999999999999999998 478999999975431 1244678999999999 7999999999
Q ss_pred cccC--CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 526 ACPE--FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 526 ~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
+|.. ..|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9854 4589999999999999997654 4899999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccC------CCCCccccHHHHHHHHHHHHhCCCCCCChHH--HH
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT------GMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VE 675 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~ 675 (768)
+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ..
T Consensus 242 ~DfG~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 314 (365)
T 2y7j_A 242 SDFGFSCHLEPGE-------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML 314 (365)
T ss_dssp CCCTTCEECCTTC-------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCcccccCCCc-------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999998764321 2245689999999998763 3588999999999999999999999964432 23
Q ss_pred HHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 676 RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 676 ~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+... .+.... .+..+.+|+.+||..+|.+||++.+++.
T Consensus 315 ~~i~~~~~~~~-~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RMIMEGQYQFS-SPEWDD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHTCCCCC-HHHHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhCCCCCC-Cccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 34444432111 000011 2345899999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=357.28 Aligned_cols=254 Identities=17% Similarity=0.272 Sum_probs=189.9
Q ss_pred hcCCCccceecccCceeEEEEEEC-----CccEEEEEEcCCchh-----------hHHHHHHHHHHHhhcCCCceeeeec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-----HTPVAIKVLRPDAAQ-----------GRSQFQQEVEVLCNIRHPNMVLLLG 525 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~l~~~~~~-----------~~~~~~~E~~il~~l~HpnIv~l~g 525 (768)
.++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999984 468999998765321 1223667889999999999999999
Q ss_pred cccC------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC
Q 035604 526 ACPE------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY 599 (768)
Q Consensus 526 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 599 (768)
++.. ..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 8743 349999999 999999987654 4899999999999999999999999 99999999999998877
Q ss_pred --cEEEeecccccccCCCCCC-ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHH
Q 035604 600 --VSKISDVGLARLVPPSVAD-SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQV 674 (768)
Q Consensus 600 --~vKL~DFGla~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~ 674 (768)
.+||+|||+++.+...... ...........||+.|+|||++.+..++.++|||||||++|||++|+.||... ...
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 11112234568999999999999999999999999999999999999999431 111
Q ss_pred -HHHHHcC---CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 675 -ERSIENG---TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 675 -~~~i~~~---~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
....... .+...+....+ ....+..+.+|+..||..+|.+||++.+|+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 320 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALK 320 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHHhhcccccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 1111111 01110000000 002234699999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.34 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=199.8
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 356799999999999999999998 46789999996443 3345678999999999999999999999854 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999886543 4899999999999999999999999 999999999999999999999999999865322
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChHH---HHHHHHcCCccccCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQ---VERSIENGTFDETLDPAV 691 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~~---~~~~i~~~~~~~~ld~~~ 691 (768)
. .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ....+...... . +.
T Consensus 159 ~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~-~~- 230 (276)
T 2yex_A 159 N----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--L-NP- 230 (276)
T ss_dssp T----EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--S-TT-
T ss_pred c----chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--c-Cc-
Confidence 1 1112345678999999999887765 7899999999999999999999964322 22222222110 1 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+..+.+|+.+||..+|.+||++.+++.
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ---WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1122346899999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=350.07 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=199.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+|+.+|+.++||||++++++|..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999998 567899999865432 224567899999999999999999998843
Q ss_pred --CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 --FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..++||||+++ +|.+.+..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 24899999974 77777765432 4899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--CC
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--GT 682 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~~ 682 (768)
+++.+...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... ..+.. +.
T Consensus 170 ~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 170 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp TCEECCCCSSS--SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hcccccccccc--cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99877533221 2223456688999999998876 458999999999999999999999996543322 12211 11
Q ss_pred ccccCCCCCC--------------CCCHH-------HHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 683 FDETLDPAVP--------------DWPVE-------EALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 683 ~~~~ld~~~~--------------~~~~~-------~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+.....+... ..... .+..+.+|+.+||..||.+||++.+++. +|.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 1111111100 00000 1345889999999999999999999986 444
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=351.69 Aligned_cols=263 Identities=17% Similarity=0.219 Sum_probs=200.9
Q ss_pred cCCCccceecccCceeEEEEEEC----------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeee---------
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD----------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLL--------- 523 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~----------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l--------- 523 (768)
++|.+.+.||+|+||.||+|.+. +..||||++... ..+.+|+.++++++|||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 67999999999999999999884 578999999754 357899999999999999984
Q ss_pred ------eccc---cCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 035604 524 ------LGAC---PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNIL 594 (768)
Q Consensus 524 ------~g~~---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NIL 594 (768)
++++ ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 3333 23448999999 999999998652 124999999999999999999999999 999999999999
Q ss_pred EcCCC--cEEEeecccccccCCCCCCc-cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh
Q 035604 595 LDRNY--VSKISDVGLARLVPPSVADS-VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA 671 (768)
Q Consensus 595 l~~~~--~vKL~DFGla~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~ 671 (768)
++.++ .+||+|||+++.+....... ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 99999999998764322110 1111224458999999999999999999999999999999999999999643
Q ss_pred H----HHHHHHH--cCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHhhc
Q 035604 672 H----QVERSIE--NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737 (768)
Q Consensus 672 ~----~~~~~i~--~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~~~ 737 (768)
. .+..... ............ .+ ...+..+.+|+.+||..+|.+||++.+++..+.+.+......
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCG-HW-IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTS-CE-ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CcCHHHHHHHHHhccCChhhhhhhcc-cc-CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 2 1111111 111111111110 00 012245999999999999999999999987666666555433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=352.28 Aligned_cols=264 Identities=23% Similarity=0.255 Sum_probs=196.7
Q ss_pred HHHHHHHhcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCch-----------hhHHHHHHHHHHHhhcCCCceee
Q 035604 455 IEEIEEATENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA-----------QGRSQFQQEVEVLCNIRHPNMVL 522 (768)
Q Consensus 455 ~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~-----------~~~~~~~~E~~il~~l~HpnIv~ 522 (768)
+.++....++|.+.+.||+|+||.||+|.+ .+..||||++..... .....+.+|+.+|+.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456677789999999999999999999987 567899999864321 12367899999999999999999
Q ss_pred eecccc-----C--CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 523 LLGACP-----E--FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 523 l~g~~~-----~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
++++|. . ..|+||||+. |+|.+.+.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999872 1 2489999997 68888876543 35899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHH
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQV 674 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~ 674 (768)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA-------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp CTTCCEEECCTTC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cCCCCEEEEecCccccccccc-------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999997543221 2244578999999998876 67899999999999999999999999654321
Q ss_pred H--HHHHc-----------------------CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 675 E--RSIEN-----------------------GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 675 ~--~~i~~-----------------------~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
. ..+.. ..+...........+...+..+.+|+.+||+.+|.+||++.+++. +|.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 1 11110 000000000000011122456899999999999999999999986 666
Q ss_pred HHH
Q 035604 729 NIL 731 (768)
Q Consensus 729 ~~l 731 (768)
+.+
T Consensus 321 ~~~ 323 (362)
T 3pg1_A 321 ESL 323 (362)
T ss_dssp TTT
T ss_pred hhc
Confidence 443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.30 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=194.8
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 46799999999999999999998 478999999965422 234578899999999999999999999854 45899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999997764 3899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
.. ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... .....+..+...
T Consensus 164 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 229 (276)
T 2h6d_A 164 GE-------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY------- 229 (276)
T ss_dssp --------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred Cc-------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc-------
Confidence 21 1234578999999999988765 689999999999999999999996443 333344443221
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+...+..+.+|+.+||+.+|.+||++.+++. +|+
T Consensus 230 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 230 --IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred --CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 11122346899999999999999999999986 444
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=348.97 Aligned_cols=257 Identities=26% Similarity=0.325 Sum_probs=193.5
Q ss_pred HHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh-----hHHHHHHHHHHHhhcCCCceeeeeccccC--C
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ-----GRSQFQQEVEVLCNIRHPNMVLLLGACPE--F 530 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~ 530 (768)
...++|.+.+.||+|+||.||++.+ +++.||||++...... ....+.+|+.+++.++||||++++++|.+ .
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999998 4678999998753221 12467899999999999999999999844 4
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.++||||+++ +|..++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 5999999975 8888876543 35889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCccc
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTFDE 685 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~~~ 685 (768)
.+.... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||........ .+.. +....
T Consensus 161 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 161 SFGSPN------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234 (346)
T ss_dssp TTTSCC------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred eccCCc------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 764321 123456789999999988664 589999999999999999999999965443221 1111 11100
Q ss_pred cCCC------------CCCCCC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 686 TLDP------------AVPDWP-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 686 ~ld~------------~~~~~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
...+ ..+..+ ...+..+.+|+.+||..||.+||++.+++. +|.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 0000 011111 122356999999999999999999999986 444
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=352.37 Aligned_cols=244 Identities=27% Similarity=0.362 Sum_probs=196.3
Q ss_pred hcCCCccceecccCceeEEEEEE-----CCccEEEEEEcCCc----hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA----AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE-- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 529 (768)
.++|.+.+.||+|+||.||++.. .++.||||+++... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 56789999997532 12344577899999999 69999999998844
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..+|||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 4589999999999999998764 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCCCCCh------HHHHHHHHcC
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPPMGLA------HQVERSIENG 681 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~Pf~~~------~~~~~~i~~~ 681 (768)
+.+.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ..+...+...
T Consensus 207 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 207 KEFVADE-----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281 (355)
T ss_dssp EECCGGG-----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eecccCC-----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence 8653221 122345679999999999886 34789999999999999999999999532 1222222221
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP-----DLGKVVV 725 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~ 725 (768)
. +.++...+..+.+|+.+||..||.+|| ++.+++.
T Consensus 282 ~---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 282 E---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp C---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 1 112223345689999999999999999 8888875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=376.86 Aligned_cols=243 Identities=23% Similarity=0.275 Sum_probs=202.4
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--Ccee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~l 533 (768)
.++|.+.+.||+|+||.||++.+. ++.||||++++.. ......+..|..+|..+ +||||+.+++++.+ ..||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999984 5679999997542 22345678899999987 79999999999855 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||++||+|.+++...+ .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|++||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999998765 3999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|++||.... .+...|..+.+
T Consensus 494 ~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------- 559 (674)
T 3pfq_A 494 WDG------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-------- 559 (674)
T ss_dssp CTT------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC--------
T ss_pred cCC------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 221 12356789999999999999999999999999999999999999996443 34445554432
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCCh-----hhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDL-----GKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~-----~evl~ 725 (768)
.+|...+..+.+||.+||+.||.+||++ .+|+.
T Consensus 560 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1222334569999999999999999998 66653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=349.07 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=195.8
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--------hhHHHHHHHHHHHhhcCCCceeeeeccccC-
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--------QGRSQFQQEVEVLCNIRHPNMVLLLGACPE- 529 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 529 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 356799999999999999999998 457899999975421 122347899999999999999999999844
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc---EEEeec
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV---SKISDV 606 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~---vKL~DF 606 (768)
..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4599999999999999886543 4899999999999999999999999 999999999999987654 999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHhCCCCCCChH---HHHHHHHc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIITAKPPMGLAH---QVERSIEN 680 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltg~~Pf~~~~---~~~~~i~~ 680 (768)
|+++.+.... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.... .....+..
T Consensus 162 g~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (322)
T 2ycf_A 162 GHSKILGETS-------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234 (322)
T ss_dssp TTCEECCCCH-------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH
T ss_pred ccceeccccc-------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh
Confidence 9998764321 123456899999999864 5678999999999999999999999996432 23344444
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 681 ~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+.+... +......+..+.+|+.+||..||.+||++.+++.
T Consensus 235 ~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKYNFI-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCCCCC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccC-----chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 432110 0000112346899999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.46 Aligned_cols=252 Identities=30% Similarity=0.465 Sum_probs=198.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCcc--EEEEEEcCC-chhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTP--VAIKVLRPD-AAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~--vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 534 (768)
++|.+.+.||+|+||.||++.+ ++.. ||+|.+... .......+.+|+.+++++ +||||+++++++.+ ..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5799999999999999999987 4443 599998753 233456789999999999 89999999999844 45899
Q ss_pred EEeccCCChHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 535 YEYMANGSLEDRLFRRG-------------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 2235899999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSI 678 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i 678 (768)
||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ....+
T Consensus 182 kL~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp EECCTTCEESSCEE-------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EEcccCcCcccccc-------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 99999999743211 11234467889999999998889999999999999999998 9999964432 33333
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
..+.. . ..+...+..+.+|+.+||..+|.+||++.+++..+.+.+.
T Consensus 255 ~~~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 255 PQGYR-----L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp GGTCC-----C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCC-----C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 33311 1 1122233569999999999999999999999865555443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.23 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=185.4
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.++|.+.+.||+|+||.||++.+ +++.||||+++.... .....+..+..+++.++||||+++++++.+ ..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999998 677899999975422 223334555566888999999999999844 459999
Q ss_pred EeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 536 EYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 536 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||++ |+|.+++... .....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 5887777541 2223599999999999999999999998 8 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccc----cCCCCCccccHHHHHHHHHHHHhCCCCCCChHH----HHHHHHcCCccc
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQ----QTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ----VERSIENGTFDE 685 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~----~~~~i~~~~~~~ 685 (768)
... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||..... ....+.... ..
T Consensus 162 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~ 233 (290)
T 3fme_A 162 DDV-------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQ 233 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-CC
T ss_pred ccc-------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-CC
Confidence 322 12334799999999985 566789999999999999999999999964221 122222221 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.. +...+..+.+|+.+||+.+|.+||++.+++. +|....
T Consensus 234 ~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 LP-------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CC-------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cc-------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 11 1122345999999999999999999999987 666543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=345.26 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=198.4
Q ss_pred HHHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccC---
Q 035604 456 EEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--- 529 (768)
Q Consensus 456 ~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--- 529 (768)
.++....++|.+.+.||+|+||.||+|.+ +++.||||++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33444578899999999999999999998 678999999975432 346788999999999 79999999999832
Q ss_pred -----CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEe
Q 035604 530 -----FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 604 (768)
Q Consensus 530 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~ 604 (768)
..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 45899999999999999976432 24899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccCCCCCCccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--H
Q 035604 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--S 677 (768)
Q Consensus 605 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~ 677 (768)
|||++..+.... .......||+.|+|||++. +..++.++|||||||++|+|++|..||........ .
T Consensus 172 Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (326)
T 2x7f_A 172 DFGVSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245 (326)
T ss_dssp CCTTTC-------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred eCcCceecCcCc------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 999998653321 1123457899999999887 56789999999999999999999999965443322 2
Q ss_pred HHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 678 IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 678 i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+.......... ..++ ..+.+|+.+||..+|.+||++.+++. +++
T Consensus 246 ~~~~~~~~~~~---~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 246 IPRNPAPRLKS---KKWS----KKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp HHHSCCCCCSC---SCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred hhcCccccCCc---cccC----HHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 22222211111 1233 45999999999999999999999986 444
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.88 Aligned_cols=250 Identities=13% Similarity=0.142 Sum_probs=195.8
Q ss_pred hcCCCccceecccCceeEEEEE-------ECCccEEEEEEcCCchhhHHHHHHHHHHHhhcC---CCceeeeecccc--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSY-------LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR---HPNMVLLLGACP--E 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~-------~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~--~ 529 (768)
.++|.+.+.||+|+||.||+|. ..++.||||++.... ...+..|+.++..++ |+||+.+++++. +
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4679999999999999999994 256789999998654 335777888888776 999999999974 4
Q ss_pred CceeEEEeccCCChHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC----------
Q 035604 530 FGCLIYEYMANGSLEDRLFRRG--GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---------- 597 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---------- 597 (768)
..||||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccc
Confidence 5599999999999999997532 2345999999999999999999999999 999999999999988
Q ss_pred -CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH
Q 035604 598 -NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER 676 (768)
Q Consensus 598 -~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~ 676 (768)
++.+||+|||+++.+.... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--- 290 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFP----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG--- 290 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSC----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET---
T ss_pred ccCCEEEeeCchhhhhhccC----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC---
Confidence 8999999999997553211 11234567899999999999999999999999999999999999999943321
Q ss_pred HHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCCh-hhhhhHHHHHHH
Q 035604 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDL-GKVVVPKLNILR 732 (768)
Q Consensus 677 ~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~-~evl~~~l~~l~ 732 (768)
+. ..+.......+ ....+.+++..|++.+|.+||+. .++...+.+.+.
T Consensus 291 ----~~--~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 291 ----GE--CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----TE--EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----Cc--eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 10 01111122212 13458899999999999999654 444434444443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=344.07 Aligned_cols=265 Identities=20% Similarity=0.293 Sum_probs=184.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 536 (768)
.++|.+.+.||+|+||.||++.+ ++..||||++.... ......+.+|+.+++.++||||+++++++. +..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 57899999999999999999987 67799999986543 233556889999999999999999999884 45589999
Q ss_pred eccCCChHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 537 YMANGSLEDRLFRR-----GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 537 ~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
|+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 99999999998641 12235899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCccccCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLD 688 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~~~ld 688 (768)
+...... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .....+.......
T Consensus 171 ~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 171 LATGGDI-TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp CC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eccCCCc-cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 6432111 11111234579999999998876 568999999999999999999999996433221 1111211111100
Q ss_pred C-CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 689 P-AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 689 ~-~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
. .........+..+.+|+.+||..+|.+||++.+++. +|...
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 0 000111122346899999999999999999999986 55443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=359.81 Aligned_cols=200 Identities=23% Similarity=0.322 Sum_probs=163.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-------C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~ 530 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 47899999999999999999998 4568999999753 33445678999999999999999999998843 3
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.|+||||+. |+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 599999995 69999887643 4999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCcc----------------ccccccCCCCCCCCCCcccc-cCCCCCccccHHHHHHHHHHHHhCCCCC
Q 035604 611 LVPPSVADSV----------------TQYRMTSAAGTFCYIDPEYQ-QTGMLGVKSDVYSLGILLLQIITAKPPM 668 (768)
Q Consensus 611 ~~~~~~~~~~----------------~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltg~~Pf 668 (768)
.+........ .....+..+||++|+|||++ ....++.++||||||||+|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 7754321100 01224677899999999975 5667999999999999999999854433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=370.44 Aligned_cols=247 Identities=32% Similarity=0.459 Sum_probs=202.8
Q ss_pred HhcCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEec
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYM 538 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~ 538 (768)
..++|.+.+.||+|+||.||+|.+.+ ..||||+++.... ..+.|.+|+.+|+.++|||||+++++|.+ ..||||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence 34678899999999999999999965 5799999986543 35679999999999999999999999854 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.++|..... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 344 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 417 (535)
T 2h8h_A 344 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 417 (535)
T ss_dssp TTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--
T ss_pred cCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--
Confidence 99999999975321 24899999999999999999999999 9999999999999999999999999998763211
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
........++..|+|||++.+..++.++|||||||+||||++ |+.||... ..+...+..+.... .+
T Consensus 418 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------~~ 486 (535)
T 2h8h_A 418 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------CP 486 (535)
T ss_dssp ---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC--------CC
T ss_pred ---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------CC
Confidence 111234457788999999999999999999999999999999 99999643 33444555443111 11
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..++..+.+|+.+||..+|.+||++.+|+.
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 223346999999999999999999998873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.42 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=198.8
Q ss_pred HHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-------
Q 035604 459 EEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------- 529 (768)
Q Consensus 459 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 529 (768)
+...++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+|+.+|+.++|||||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999987 567999999875432 23479999999999999999998721
Q ss_pred ---------------------------------CceeEEEeccCCChHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 035604 530 ---------------------------------FGCLIYEYMANGSLEDRLFRR-GGSPVLPWQIRFRIAAEIATALLFL 575 (768)
Q Consensus 530 ---------------------------------~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~L 575 (768)
+.++||||++ |+|.+.+... .....+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1479999997 5777776541 1223599999999999999999999
Q ss_pred HhCCCCCeeeCCCCCCCeEEc-CCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHH
Q 035604 576 HQTKPEPLVHRDLKPGNILLD-RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYS 653 (768)
Q Consensus 576 H~~~~~~iiHrDLKp~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwS 653 (768)
|+.+ |+||||||+|||++ .++.+||+|||+++.+.... ......||+.|+|||++.+. .++.++||||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-------PSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-------CCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 9999 99999999999998 68999999999998764322 12455789999999988765 4899999999
Q ss_pred HHHHHHHHHhCCCCCCChHHHHH---HHH-------------cCCccccCCCCCC--C----CCHHHHHHHHHHHHHhhh
Q 035604 654 LGILLLQIITAKPPMGLAHQVER---SIE-------------NGTFDETLDPAVP--D----WPVEEALILAKLALQCAE 711 (768)
Q Consensus 654 lGvil~elltg~~Pf~~~~~~~~---~i~-------------~~~~~~~ld~~~~--~----~~~~~~~~l~~Li~~cl~ 711 (768)
|||++|+|++|++||........ .+. ...+....-+... . .+...+..+.+|+.+||.
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 99999999999999975433221 111 0111111111111 1 122234569999999999
Q ss_pred cCccCCCChhhhhh-HHHHHHHH
Q 035604 712 LRRKDRPDLGKVVV-PKLNILRA 733 (768)
Q Consensus 712 ~~P~~RPs~~evl~-~~l~~l~~ 733 (768)
.+|.+|||+.+++. +|.+.++.
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHHHHH
T ss_pred CChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999999997 88877765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=336.24 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=191.4
Q ss_pred hcCCCccceecccCceeEEEEEEC---Cc--cEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC-Cce
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD---HT--PVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGC 532 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~---~~--~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 532 (768)
.++|.+.+.||+|+||.||+|.+. ++ .||||+++... ......+.+|+.+++.++||||+++++++.+ ..+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 357999999999999999999862 22 58999987542 2345678999999999999999999999854 458
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
+||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999976532 4899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDP 689 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~ 689 (768)
..... .........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||..... ....+....... +
T Consensus 172 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 245 (291)
T 1u46_A 172 PQNDD---HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---P 245 (291)
T ss_dssp CC-CC---EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---C
T ss_pred ccccc---chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC---C
Confidence 44321 1111234567888999999998889999999999999999999 9999964432 223333322111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
. +...+..+.+|+.+||..+|.+||++.+++.
T Consensus 246 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 246 R----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1 1223356999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.27 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=195.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccccC----CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE----FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~----~~~lV 534 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+|+.++ ||||+++++++.+ ..++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999987 56799999997543 356889999999997 9999999999854 34899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeecccccccC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVP 613 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFGla~~~~ 613 (768)
|||+.+++|.+++.. +++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+.
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999988743 889999999999999999999999 99999999999999776 89999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHH----------------HHH
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQ----------------VER 676 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~----------------~~~ 676 (768)
... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...
T Consensus 183 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 183 PGQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TTC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCC-------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 332 1244578999999998877 6789999999999999999999999932211 111
Q ss_pred HHHcCCc------------------cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 677 SIENGTF------------------DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 677 ~i~~~~~------------------~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+..... ...... ..+...+..+.+|+.+||+.||.+|||+.+++. +|.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHS---ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCT---TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhccccccchhhhhhhccccchhhhccc---cccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 1111110 000000 111123456999999999999999999999986 444
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=355.21 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=194.2
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--------Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--------FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~~~ 532 (768)
.+|.+.+.||+|+||.||+|.+ ++..||||++..... .+.+|+++|+.++|||||+++++|.. +.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4699999999999999999998 477899999865432 23479999999999999999988721 247
Q ss_pred eEEEeccCCChHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-CcEEEeeccccc
Q 035604 533 LIYEYMANGSLEDRLFR-RGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLAR 610 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~vKL~DFGla~ 610 (768)
+||||+++ +|.+.+.. ......+++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 56555543 122235999999999999999999999999 9999999999999965 678999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHHH-------
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIE------- 679 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i~------- 679 (768)
.+.... ......||+.|+|||++.+. .++.++||||||||||||++|++||....... ..+.
T Consensus 206 ~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 206 QLVRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp ECCTTC-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred hcccCC-------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 764321 12456889999999988765 79999999999999999999999996543222 1111
Q ss_pred ------cCCccccCCCCCCC--C----CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 680 ------NGTFDETLDPAVPD--W----PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 680 ------~~~~~~~ld~~~~~--~----~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
...+.....+.+.. | +...+..+.+|+.+||..||.+||++.+++. +|.+.+
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 11111111121111 1 1123456999999999999999999999986 666544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.02 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=198.7
Q ss_pred hcCCCccceecccCceeEEEEEE-------CCccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|.+.+.||+|+||.||+|.+ .+..||||++... .......+.+|+.+++.++||||+++++++.+ ..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 3457999999754 33445678999999999999999999999854 45
Q ss_pred eeEEEeccCCChHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCcEEEe
Q 035604 532 CLIYEYMANGSLEDRLFRRGG----SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYVSKIS 604 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~vKL~ 604 (768)
|+||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999987542 134889999999999999999999999 999999999999984 4569999
Q ss_pred ecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcC
Q 035604 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENG 681 (768)
Q Consensus 605 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~ 681 (768)
|||++..+..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.... .....+..+
T Consensus 186 Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 186 DFGMARDIYRASY----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp CCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred ccccccccccccc----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 9999976532211 111234567899999999999999999999999999999998 999996443 333344443
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
.... .+...+..+.+|+.+||..+|.+||++.+++..+.
T Consensus 262 ~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 262 GRMD--------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp CCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC--------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 3211 11222346999999999999999999999985443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.00 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=201.6
Q ss_pred HHHHhcCCCcc-ceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcC-CCceeeeeccccCC-
Q 035604 458 IEEATENFSNS-RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIR-HPNMVLLLGACPEF- 530 (768)
Q Consensus 458 i~~~~~~y~~~-~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~- 530 (768)
.+...++|.+. +.||+|+||.||++.+ +++.||||++..... .....+.+|+.++..+. ||||++++++|.+.
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 44556778887 8999999999999998 477999999975432 33567889999999995 69999999998554
Q ss_pred -ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCcEEEeec
Q 035604 531 -GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYVSKISDV 606 (768)
Q Consensus 531 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~vKL~DF 606 (768)
.++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 489999999999999885532 235899999999999999999999999 999999999999987 789999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHcCCcc
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFD 684 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~~~~~ 684 (768)
|+++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+......
T Consensus 179 g~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 179 GMSRKIGHAC-------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251 (327)
T ss_dssp GGCEEC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred ccccccCCcc-------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence 9998764321 1234579999999999999999999999999999999999999996544322 233332211
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 685 ~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
....... ..+..+.+|+.+||..+|.+||++.+++. +|+
T Consensus 252 -~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 252 -YSEETFS----SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp -CCTTTTT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred -cCchhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 1111112 23345899999999999999999999986 554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=352.83 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=182.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999987 5678999999653 23345678899999999999999999998743
Q ss_pred CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 530 FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 530 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
..|+||||+ +++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 348999999 78999888652 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCcc
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTFD 684 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~~ 684 (768)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||........ .+.. |...
T Consensus 180 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 180 RHTADE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred cccccc---------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 865321 245689999999998877 6799999999999999999999999965443221 1111 1100
Q ss_pred ----------------ccCCCCCCCCC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 685 ----------------ETLDPAVPDWP-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 685 ----------------~~ld~~~~~~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
..+ +..+..+ ...+..+.+|+.+||..||.+||++.+++. +++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 251 AELLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTS-CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHhhhHHHHHHHhcc-CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 000 0011111 112346899999999999999999999987 66543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=349.87 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=198.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC--------CCceeeeecccc---
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR--------HPNMVLLLGACP--- 528 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~--------HpnIv~l~g~~~--- 528 (768)
.++|.+.+.||+|+||.||++.+ +++.||||+++... .....+.+|+.+|+.++ ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999987 46789999997543 34567889999999985 788999999874
Q ss_pred ---CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCC-----
Q 035604 529 ---EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNY----- 599 (768)
Q Consensus 529 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~----- 599 (768)
...|+||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+. + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 2458999999 6677777765432 3489999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------cEEEeecccccccCCCCCCccccccccCCCCCCCCC
Q 035604 600 --------------------------------------------VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635 (768)
Q Consensus 600 --------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~ 635 (768)
.+||+|||+++..... .....||+.|+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---------~~~~~gt~~y~ 260 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---------SCSCCSCGGGC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---------CccCCCCCccc
Confidence 7999999999876322 24457899999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH---------HHHHHH-----------HcCCccc----------
Q 035604 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH---------QVERSI-----------ENGTFDE---------- 685 (768)
Q Consensus 636 aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~---------~~~~~i-----------~~~~~~~---------- 685 (768)
|||++.+..++.++|||||||+||+|++|+.||.... .....+ ..+.+..
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9999999999999999999999999999999995321 111110 0111100
Q ss_pred -cCCC----------CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 -TLDP----------AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 -~ld~----------~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.... ....++...+..+.+|+.+||+.||.+||++.+++.
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000 011356777888999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.72 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=201.9
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---------hhhHHHHHHHHHHHhhcC-CCceeeeecccc
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---------AQGRSQFQQEVEVLCNIR-HPNMVLLLGACP 528 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---------~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~ 528 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999998 46789999997542 122456789999999996 999999999985
Q ss_pred CC--ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeec
Q 035604 529 EF--GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606 (768)
Q Consensus 529 ~~--~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DF 606 (768)
+. .++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 43 489999999999999997754 4899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCccccc------CCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHH
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQ------TGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSI 678 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i 678 (768)
|++..+.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||..... ....+
T Consensus 169 g~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 241 (298)
T 1phk_A 169 GFSCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241 (298)
T ss_dssp TTCEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cchhhcCCCc-------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence 9998764321 123457899999999875 45689999999999999999999999964432 33344
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+.+... .+.. ...+..+.+|+.+||..+|.+||++.+++.
T Consensus 242 ~~~~~~~~-~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGNYQFG-SPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTCCCCC-TTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCCcccC-cccc----cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 44432211 1111 123456999999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=335.03 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=192.5
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc----------
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP---------- 528 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~---------- 528 (768)
..++|.+.+.||+|+||.||+|.+ +++.||||++... ......+.+|+.+++.++||||++++++|.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356799999999999999999997 5778999999643 334567899999999999999999998863
Q ss_pred -----CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEE
Q 035604 529 -----EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKI 603 (768)
Q Consensus 529 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL 603 (768)
...++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 23489999999999999997644 24788999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCCCc--------cccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHH-
Q 035604 604 SDVGLARLVPPSVADS--------VTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQ- 673 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~- 673 (768)
+|||++..+....... ..........||+.|+|||++.+. .++.++|||||||++|+|++ ||.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999998764321100 001223456799999999998764 68999999999999999998 5643322
Q ss_pred --HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 674 --VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 674 --~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+..... .+. +.++...+..+.+|+.+||..||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSI--EFP---PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTC--CCC---TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccccc--ccC---ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 2233333221 111 1233344456899999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.94 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=199.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-------Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~ 531 (768)
.++|.+.+.||+|+||.||++.+ ++..||||++.... ......+.+|+.+|+.++||||+++++++.. ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999987 46689999997543 3344678899999999999999999998743 34
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
|+||||+. |+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 89999996 6899988654 3899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHc--CCcc--
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIEN--GTFD-- 684 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~--~~~~-- 684 (768)
...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... ....+.. +...
T Consensus 178 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHD---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGC---BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred cCCCCC---ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 643211 1112345689999999997654 4589999999999999999999999964321 1111110 0000
Q ss_pred ---------------ccCCCCCCCC---CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 685 ---------------ETLDPAVPDW---PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 685 ---------------~~ld~~~~~~---~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.........| ....+..+.+|+.+||..||.+||++.+++. +|+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 0000000000 1122356899999999999999999999986 66543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=358.27 Aligned_cols=260 Identities=21% Similarity=0.290 Sum_probs=199.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeee-c--cccCCceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLL-G--ACPEFGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~-g--~~~~~~~lV~E 536 (768)
.++|.+.++||+|+||.||+|.+ ++..||||++...... .++.+|+++++.++|++++..+ . ...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999997 4789999998754332 3578999999999875444333 3 33556699999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---cCCCcEEEeecccccccC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVP 613 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~vKL~DFGla~~~~ 613 (768)
|+ +++|.+++..... .+++..++.|+.||+.||.|||+.+ ||||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999975433 4999999999999999999999999 9999999999999 688999999999998775
Q ss_pred CCCCCccc-cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH-----HHHHHHHcCCccccC
Q 035604 614 PSVADSVT-QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH-----QVERSIENGTFDETL 687 (768)
Q Consensus 614 ~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~-----~~~~~i~~~~~~~~l 687 (768)
........ ........||+.|+|||++.+..++.++||||||||||||++|+.||.... .....+....+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43221111 112236789999999999999999999999999999999999999996421 111222221111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHH
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~ 733 (768)
......++ ..+.+|+..||..+|.+||++.+|+..+.+.+..
T Consensus 238 ~~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 238 EALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 11111222 4599999999999999999999998655555543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.83 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=192.7
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc-----------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP----------- 528 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----------- 528 (768)
.++|.+.+.||+|+||.||+|.+. ++.||||++..........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999984 6789999998776666778999999999999999999998763
Q ss_pred -----CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCcEE
Q 035604 529 -----EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-RNYVSK 602 (768)
Q Consensus 529 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~vK 602 (768)
...++||||+. |+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 23489999997 6999988542 4899999999999999999999999 99999999999997 567999
Q ss_pred EeecccccccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHH
Q 035604 603 ISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIE 679 (768)
Q Consensus 603 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~ 679 (768)
|+|||+++.+..... .........+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .+.
T Consensus 162 l~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYS---HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EccCccccccCCCcc---cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999987643211 1112234567999999998765 6789999999999999999999999975543221 111
Q ss_pred cCC-c-------------c-----ccCCCCC--CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 680 NGT-F-------------D-----ETLDPAV--PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 680 ~~~-~-------------~-----~~ld~~~--~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
... . . ....+.. .......+..+.+|+.+||+.||.+||++.+++. +|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 100 0 0 0000000 0001123456999999999999999999999986 555
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=341.70 Aligned_cols=254 Identities=22% Similarity=0.268 Sum_probs=200.6
Q ss_pred hcCCCccceecccCceeEEEEEE---CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCc------eeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL---DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN------MVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~g~~~~--~ 530 (768)
.++|.+.+.||+|+||.||++.+ ++..||||+++... .....+.+|+.+++.++|+| |+++++++.+ .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 46789999997543 34567889999999987664 8999998844 4
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-------------
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR------------- 597 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~------------- 597 (768)
.|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 59999999 8999999876543 34889999999999999999999999 999999999999987
Q ss_pred ------CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh
Q 035604 598 ------NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA 671 (768)
Q Consensus 598 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~ 671 (768)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH---------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC---------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCceEeeCcccccCccc---------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999865322 23457899999999999999999999999999999999999999644
Q ss_pred HHHH--HHHHc--CCccc----------cCCC-----------------------CCCCCCHHHHHHHHHHHHHhhhcCc
Q 035604 672 HQVE--RSIEN--GTFDE----------TLDP-----------------------AVPDWPVEEALILAKLALQCAELRR 714 (768)
Q Consensus 672 ~~~~--~~i~~--~~~~~----------~ld~-----------------------~~~~~~~~~~~~l~~Li~~cl~~~P 714 (768)
.... ..+.. +.+.. .... .....+..++..+.+|+.+||..||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 3221 11110 00000 0000 0001123456779999999999999
Q ss_pred cCCCChhhhhh-HHHHH
Q 035604 715 KDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 715 ~~RPs~~evl~-~~l~~ 730 (768)
.+||++.+++. +|++.
T Consensus 318 ~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 318 AKRITLREALKHPFFDL 334 (339)
T ss_dssp TTSCCHHHHTTSGGGGG
T ss_pred ccccCHHHHhcCHHHHH
Confidence 99999999986 66543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=344.73 Aligned_cols=260 Identities=25% Similarity=0.292 Sum_probs=198.1
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-------Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~ 531 (768)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 578999999999999999999984 7789999997543 3345568899999999999999999998743 34
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
++||||+. |+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 89999996 6899888763 3899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCcc----ccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HH--cCC
Q 035604 612 VPPSVADSV----TQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IE--NGT 682 (768)
Q Consensus 612 ~~~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~--~~~ 682 (768)
+........ .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||......... +. .+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 754321111 1112334678999999997654 67899999999999999999999999655432211 10 010
Q ss_pred cc--ccC--------------CCCCCC-----CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 683 FD--ETL--------------DPAVPD-----WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 683 ~~--~~l--------------d~~~~~-----~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
.. ... .+..+. .....+..+.+|+.+||..||.+||++.+++. +|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00 000 000000 01123456899999999999999999999986 5553
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=349.09 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=194.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccCC-------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF------- 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------- 530 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+++.++||||++++++|...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999987 4679999999754 233356788999999999999999999998432
Q ss_pred -ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 531 -GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 531 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
.|+||||+. ++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 289999996 688776632 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HH-Hc-CCcc
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SI-EN-GTFD 684 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i-~~-~~~~ 684 (768)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+ .. +...
T Consensus 192 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 192 RHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccC---------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 865322 234678999999998877 6799999999999999999999999965432221 11 10 0000
Q ss_pred -----------------ccCCCCCCC---CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 685 -----------------ETLDPAVPD---WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 685 -----------------~~ld~~~~~---~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
......... .....+..+.+|+.+||+.||.+||++.+++. +|.+.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000000000 11122456999999999999999999999987 666433
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=346.21 Aligned_cols=263 Identities=20% Similarity=0.261 Sum_probs=189.5
Q ss_pred HHHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC----
Q 035604 456 EEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---- 529 (768)
Q Consensus 456 ~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 529 (768)
.......++|.+.+.||+|+||.||+|.+ ++..||||++..... ....+.+++..+..++||||++++++|..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34556678999999999999999999998 467899999865432 23456788888999999999999998732
Q ss_pred -----CceeEEEeccCCChHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeCCCCCCCeEEcC-CCc
Q 035604 530 -----FGCLIYEYMANGSLEDRLFR-RGGSPVLPWQIRFRIAAEIATALLFLH--QTKPEPLVHRDLKPGNILLDR-NYV 600 (768)
Q Consensus 530 -----~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~~iiHrDLKp~NILl~~-~~~ 600 (768)
+.++||||+++ +|...+.. ......+++..++.++.|++.||.||| +.+ |+||||||+||||+. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 15799999976 45444432 233345899999999999999999999 888 999999999999996 899
Q ss_pred EEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HH
Q 035604 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RS 677 (768)
Q Consensus 601 vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~ 677 (768)
+||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||....... ..
T Consensus 171 ~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE-------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp EEECCCTTCBCCCTTS-------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEeeCCCceecCCCC-------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 9999999998764322 12345789999999988665 48999999999999999999999996543221 11
Q ss_pred HHc--CC--------------ccccCCCC-------CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 678 IEN--GT--------------FDETLDPA-------VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 678 i~~--~~--------------~~~~ld~~-------~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
+.. +. ........ .+..+...+..+.+|+.+||+.||.+||++.+++. +|...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 111 00 00000000 11112224567999999999999999999999986 66543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.90 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=202.5
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhh-----------------HHHHHHHHHHHhhcCCCceeeee
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQG-----------------RSQFQQEVEVLCNIRHPNMVLLL 524 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~-----------------~~~~~~E~~il~~l~HpnIv~l~ 524 (768)
.++|.+.+.||+|+||.||++.+++..||||++....... ...+.+|+.+++.++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4689999999999999999999989999999997432211 16789999999999999999999
Q ss_pred ccccC--CceeEEEeccCCChHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEE
Q 035604 525 GACPE--FGCLIYEYMANGSLEDR------LFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 525 g~~~~--~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl 595 (768)
+++.+ ..++||||+++|+|.++ +... ....+++..++.++.||+.||.|||+ .+ |+||||||+|||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 99854 44899999999999988 4432 13469999999999999999999999 88 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCc-cccHHHHHHHHHHHHhCCCCCCCh--
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGV-KSDVYSLGILLLQIITAKPPMGLA-- 671 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-ksDvwSlGvil~elltg~~Pf~~~-- 671 (768)
+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||...
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cCCCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999875322 23456799999999999887 6666 999999999999999999999644
Q ss_pred -HHHHHHHHcCCccccCCCC--C--------CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 672 -HQVERSIENGTFDETLDPA--V--------PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 672 -~~~~~~i~~~~~~~~ld~~--~--------~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
......+..+......... . .......+..+.+|+.+||+.+|.+||++.+++.
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3344445444322111000 0 0000223456999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.48 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=194.2
Q ss_pred HhcCCCccceecccCceeEEEEEECCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
..++|.+.+.||+|+||.||+|.+.+ .||+|+++... ......+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 35789999999999999999999865 59999987542 2233457889999999999999999999854 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999986643 35899999999999999999999999 99999999999998 6799999999987653211
Q ss_pred CCccccccccCCCCCCCCCCcccccC---------CCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccc
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQT---------GMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDE 685 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~---------~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~ 685 (768)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .....+..+....
T Consensus 184 ~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 184 AG-RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cc-ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 11 11122344578999999998864 457899999999999999999999996443 2333444443222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..... ++ ..+.+|+.+||..+|.+||++.+++.
T Consensus 263 ~~~~~---~~----~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 LSQIG---MG----KEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCSS---CC----TTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCcCC---CC----HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22111 22 34899999999999999999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=355.37 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=197.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhc------CCCceeeeecccc--CCc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI------RHPNMVLLLGACP--EFG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~g~~~--~~~ 531 (768)
..+|.+.+.||+|+||.||+|.+ .++.||||+++... .....+.+|+.+++.+ +||||++++++|. ...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45799999999999999999988 45789999997643 3345677888888887 5789999999884 455
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc--EEEeecccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV--SKISDVGLA 609 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--vKL~DFGla 609 (768)
|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 89999995 689998876543 24899999999999999999999999 999999999999999887 999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCc--
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTF-- 683 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~-- 683 (768)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||........ .+.. +..
T Consensus 250 ~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 250 CYEHQR---------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp EETTCC---------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eecCCc---------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 764322 2346899999999999999999999999999999999999999965433211 1110 000
Q ss_pred ---------cccCC---------------------------------CCCCCC----CHHHHHHHHHHHHHhhhcCccCC
Q 035604 684 ---------DETLD---------------------------------PAVPDW----PVEEALILAKLALQCAELRRKDR 717 (768)
Q Consensus 684 ---------~~~ld---------------------------------~~~~~~----~~~~~~~l~~Li~~cl~~~P~~R 717 (768)
...++ +....| +...+..+.+|+.+||+.||.+|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 00000 000001 00113568999999999999999
Q ss_pred CChhhhhh-HHHH
Q 035604 718 PDLGKVVV-PKLN 729 (768)
Q Consensus 718 Ps~~evl~-~~l~ 729 (768)
||+.+++. +|+.
T Consensus 401 pta~e~L~Hpw~~ 413 (429)
T 3kvw_A 401 MTPGQALRHPWLR 413 (429)
T ss_dssp CCHHHHHTSTTTC
T ss_pred CCHHHHhCChhhc
Confidence 99999986 5653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=340.73 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=199.3
Q ss_pred HhcCCCccceecccCceeEEEEEE---CCccEEEEEEcCCch--hhHHHHHHHHHHHhhc---CCCceeeeecccc----
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL---DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNI---RHPNMVLLLGACP---- 528 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~---~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~---- 528 (768)
+.++|.+.+.||+|+||.||++.+ +++.||+|++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 357899999999999999999987 356899999864322 1223566788887776 8999999999874
Q ss_pred ---CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEee
Q 035604 529 ---EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISD 605 (768)
Q Consensus 529 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~D 605 (768)
...++||||+. |+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 23489999997 699999876543 24899999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--C
Q 035604 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--G 681 (768)
Q Consensus 606 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~ 681 (768)
||+++.+... .......||+.|+|||++.+..++.++|||||||++|+|++|++||....... ..+.. +
T Consensus 164 fg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CcccccccCC-------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999865321 12345688999999999999999999999999999999999999996543322 11211 0
Q ss_pred C-----ccc-----------cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 682 T-----FDE-----------TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 682 ~-----~~~-----------~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
. +.. .............+..+.+|+.+||..+|.+||++.+++. +++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 301 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence 0 000 0000001111223456899999999999999999999986 5553
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=348.65 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=193.8
Q ss_pred hcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--------Cce
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--------FGC 532 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~~~ 532 (768)
..+|.+.+.||+|+||.||++.+ .+..||+|.+..... ...+|+.+|+.++|||||+++++|.. +.+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 35799999999999999999998 445699998864432 22479999999999999999998821 147
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCcEEEeecccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-RNYVSKISDVGLARL 611 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~vKL~DFGla~~ 611 (768)
+||||++++.+............+++..++.++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999977654443332222345999999999999999999999999 99999999999999 799999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH---HHH--------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER---SIE-------- 679 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~---~i~-------- 679 (768)
+.... ......||+.|+|||++.+. .++.++|||||||++|||++|++||........ .+.
T Consensus 192 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 192 LIAGE-------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp CCTTC-------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccCCC-------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 64322 12456789999999988765 589999999999999999999999965433221 111
Q ss_pred -----cCCccccCCCCCCC------CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 680 -----NGTFDETLDPAVPD------WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 680 -----~~~~~~~ld~~~~~------~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
...+....-+.... ++...+..+.+|+.+||..||.+||++.+++. +|.+.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00111111111111 11123456999999999999999999999986 665443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.80 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=199.6
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-----------CCceeeeecccc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-----------HPNMVLLLGACP 528 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~g~~~ 528 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... .....+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36799999999999999999997 57789999997543 33456889999999886 899999999884
Q ss_pred C------CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEc-----
Q 035604 529 E------FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLD----- 596 (768)
Q Consensus 529 ~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~----- 596 (768)
. ..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+. + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 3 458999999 8999999876443 2489999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH---
Q 035604 597 -RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--- 672 (768)
Q Consensus 597 -~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--- 672 (768)
..+.+||+|||+++.+... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCcceEEEcccccccccCCC---------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999876322 234578999999999999999999999999999999999999996332
Q ss_pred ------HHHHHHH-cCCcc---------------------ccCC----------CCCCCCCHHHHHHHHHHHHHhhhcCc
Q 035604 673 ------QVERSIE-NGTFD---------------------ETLD----------PAVPDWPVEEALILAKLALQCAELRR 714 (768)
Q Consensus 673 ------~~~~~i~-~~~~~---------------------~~ld----------~~~~~~~~~~~~~l~~Li~~cl~~~P 714 (768)
.+...+. .+.+. .... ......+...+..+.+|+.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 1111110 01000 0000 00113456777889999999999999
Q ss_pred cCCCChhhhhh-HHHH
Q 035604 715 KDRPDLGKVVV-PKLN 729 (768)
Q Consensus 715 ~~RPs~~evl~-~~l~ 729 (768)
.+||++.+++. +|..
T Consensus 323 ~~Rpt~~ell~hp~f~ 338 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLK 338 (373)
T ss_dssp TTCBCHHHHHTCGGGT
T ss_pred cccCCHHHHhhChhhh
Confidence 99999999987 5654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.85 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=202.5
Q ss_pred HhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++.... ......+.+|+.++++++||||+++++++.+ ..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 456899999999999999999998 56789999996542 2345678999999999999999999999854 44899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC---CcEEEeecccccc
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN---YVSKISDVGLARL 611 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~vKL~DFGla~~ 611 (768)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999887654 3899999999999999999999999 9999999999999654 4799999999986
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDP 689 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~ 689 (768)
..... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.... .....+..+.+.... +
T Consensus 174 ~~~~~-------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 244 (287)
T 2wei_A 174 FQQNT-------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-P 244 (287)
T ss_dssp BCCCS-------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-G
T ss_pred ecCCC-------ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-h
Confidence 64321 12234688999999988764 8999999999999999999999996443 333445555432111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.... .+..+.+|+.+||..+|.+||++.+++. +++..
T Consensus 245 ~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 245 QWRT----ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp GGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred hhhh----cCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 1112 2345899999999999999999999986 55543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=334.98 Aligned_cols=258 Identities=26% Similarity=0.351 Sum_probs=178.6
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc-hhhHHHHHHHHH-HHhhcCCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA-AQGRSQFQQEVE-VLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.++|.+.+.||+|+||.||++.+. ++.||||++.... ......+..|+. +++.++||||+++++++.+ ..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367999999999999999999984 7789999997653 233445556666 7778899999999999844 458999
Q ss_pred EeccCCChHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 536 EYMANGSLEDRLFR--RGGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 536 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
||+++ +|.+++.. ......+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 78777653 11223589999999999999999999998 8 999999999999999999999999999866
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccc----cCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQ----QTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLD 688 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld 688 (768)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.........+.... ....
T Consensus 177 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~ 247 (327)
T 3aln_A 177 VDSI-------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV--KGDP 247 (327)
T ss_dssp ------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC--CSCC
T ss_pred cccc-------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh--cCCC
Confidence 4321 12334789999999998 466789999999999999999999999975443322221111 1111
Q ss_pred CCCC-CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHH
Q 035604 689 PAVP-DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILR 732 (768)
Q Consensus 689 ~~~~-~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~ 732 (768)
+..+ ......+..+.+|+.+||..+|.+||++.+++. +++....
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 1111 111123356999999999999999999999987 6665543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.14 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=195.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccCC-------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF------- 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------- 530 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999997 46799999997542 23356788999999999999999999988542
Q ss_pred -ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 531 -GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 531 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
.|+||||+. |+|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 389999996 688776532 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--CC--
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--GT-- 682 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~~-- 682 (768)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..+.. +.
T Consensus 174 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 174 RHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp TC-----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred cCCCCC---------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 865321 234578999999998877 678999999999999999999999996443221 11110 00
Q ss_pred ------------------ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 683 ------------------FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 683 ------------------~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
+...............+..+.+|+.+||..||.+||++.+++. +|..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 0001111122222334566999999999999999999999986 6654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=366.23 Aligned_cols=254 Identities=27% Similarity=0.363 Sum_probs=203.1
Q ss_pred HhcCCCccceecccCceeEEEEEECC-----ccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC-Ccee
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCL 533 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~l 533 (768)
..++|.+.+.||+|+||.||+|.+.. ..||||.+... .......+.+|+.+|+.++|||||++++++.+ ..++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~l 467 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEE
Confidence 34679999999999999999998732 36999998754 33445678999999999999999999999854 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 468 v~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999976532 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChH--HHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAH--QVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~--~~~~~i~~~~~~~~ld~~ 690 (768)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |.+||.... .....+..+....
T Consensus 543 ~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~----- 612 (656)
T 2j0j_A 543 DST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----- 612 (656)
T ss_dssp C---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC-----
T ss_pred CCc-----ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 321 112234567889999999998999999999999999999997 999996443 3334444443211
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
.+..++..+.+|+.+||..+|.+||++.+++..+.+.+.
T Consensus 613 ---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 ---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 122233569999999999999999999999865555543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=349.80 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=179.5
Q ss_pred cCCCc-cceecccCceeEEEEEEC----CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc----cCCcee
Q 035604 463 ENFSN-SRKIGEGGYGPVYKSYLD----HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC----PEFGCL 533 (768)
Q Consensus 463 ~~y~~-~~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~----~~~~~l 533 (768)
+.|.+ .++||+|+||.||+|.+. +..||||++..... ...+.+|+.+|+.++|||||+++++| ....||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34665 568999999999999963 56899999975432 24678999999999999999999998 234589
Q ss_pred EEEeccCCChHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----cCCCcEEE
Q 035604 534 IYEYMANGSLEDRLFRRG------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL----DRNYVSKI 603 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~vKL 603 (768)
||||+. |+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 57877775321 1224899999999999999999999999 9999999999999 77899999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHH---------
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQ--------- 673 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~--------- 673 (768)
+|||+++.+..... ........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 174 ADMGFARLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp CCTTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EECCCceecCCCCc---ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999987643211 11223456899999999988874 589999999999999999999999953321
Q ss_pred ---HHHHHHc-CCccccCCCCC------------------CCCCH---------HHHHHHHHHHHHhhhcCccCCCChhh
Q 035604 674 ---VERSIEN-GTFDETLDPAV------------------PDWPV---------EEALILAKLALQCAELRRKDRPDLGK 722 (768)
Q Consensus 674 ---~~~~i~~-~~~~~~ld~~~------------------~~~~~---------~~~~~l~~Li~~cl~~~P~~RPs~~e 722 (768)
+...+.. |.........+ ..+.. ..+..+.+|+.+||..||.+|||+.+
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111110 10000000000 00000 00345889999999999999999999
Q ss_pred hhh-HHH
Q 035604 723 VVV-PKL 728 (768)
Q Consensus 723 vl~-~~l 728 (768)
++. +|.
T Consensus 331 ~L~hp~f 337 (405)
T 3rgf_A 331 AMQDPYF 337 (405)
T ss_dssp HHTSGGG
T ss_pred HhcChhh
Confidence 986 555
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.94 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=172.5
Q ss_pred hcCCCccc-eecccCceeEEEEEEC--CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC------Cce
Q 035604 462 TENFSNSR-KIGEGGYGPVYKSYLD--HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------FGC 532 (768)
Q Consensus 462 ~~~y~~~~-~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~ 532 (768)
.++|.+.+ .||+|+||.||++.+. ++.||||++..... ........++.+.||||+++++++.. ..+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 57899855 6999999999999984 77999999975421 12223334667799999999998843 258
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCcEEEeecccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYVSKISDVGLA 609 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~vKL~DFGla 609 (768)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999986543 35999999999999999999999999 999999999999975 456999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH------HHHHcCCc
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE------RSIENGTF 683 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~------~~i~~~~~ 683 (768)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+.+
T Consensus 179 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 179 KETTQN--------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp EEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred eecccc--------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 865322 1234578999999999988899999999999999999999999995433211 11111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 684 DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 684 ~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
. ...+.. ...+..+.+|+.+||..+|.+||++.+++. +|++
T Consensus 251 ~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 292 (336)
T 3fhr_A 251 G-FPNPEW----SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292 (336)
T ss_dssp C-CCTTTS----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred c-cCchhh----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 0 011111 123356999999999999999999999986 5553
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.61 Aligned_cols=240 Identities=26% Similarity=0.399 Sum_probs=192.6
Q ss_pred HHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh------hHHHHHHHHHHHhhc----CCCceeeeecc
Q 035604 459 EEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ------GRSQFQQEVEVLCNI----RHPNMVLLLGA 526 (768)
Q Consensus 459 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l----~HpnIv~l~g~ 526 (768)
....++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999987 5678999999754321 223456799999998 89999999999
Q ss_pred cc--CCceeEEEe-ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCcEE
Q 035604 527 CP--EFGCLIYEY-MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-RNYVSK 602 (768)
Q Consensus 527 ~~--~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~vK 602 (768)
+. +..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 84 355899999 78999999998755 3899999999999999999999999 99999999999999 889999
Q ss_pred EeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcC
Q 035604 603 ISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENG 681 (768)
Q Consensus 603 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~ 681 (768)
|+|||++..+... ......||..|+|||++.+..+ +.++|||||||++|+|++|+.||........ .
T Consensus 181 l~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~ 248 (312)
T 2iwi_A 181 LIDFGSGALLHDE--------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE----A 248 (312)
T ss_dssp ECCCSSCEECCSS--------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----T
T ss_pred EEEcchhhhcccC--------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh----h
Confidence 9999999876432 1245579999999998877666 4589999999999999999999976544322 1
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.. .++...+..+.+|+.+||..+|.+||++.+++.
T Consensus 249 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 EL---------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CC---------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cc---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111223346899999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.17 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=192.1
Q ss_pred HhcCCCccceecccCceeEEEEEE-CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcC--CCceeeeeccccC--Ccee
Q 035604 461 ATENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIR--HPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 461 ~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~--~~~l 533 (768)
..++|.+.+.||+|+||.||++.+ +++.||||++... .......+.+|+.++..++ ||||+++++++.+ ..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 457799999999999999999987 4678999999654 3345567899999999997 5999999998844 4489
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999 55889999998754 4899999999999999999999999 99999999999996 4899999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccC-----------CCCCccccHHHHHHHHHHHHhCCCCCCChHHH---HHHHH
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQT-----------GMLGVKSDVYSLGILLLQIITAKPPMGLAHQV---ERSIE 679 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~---~~~i~ 679 (768)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...+.
T Consensus 178 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (313)
T 3cek_A 178 PDTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253 (313)
T ss_dssp ----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred Cccc----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence 3211 111234578999999998875 46889999999999999999999999643221 11222
Q ss_pred cCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 680 NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 680 ~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.... ....+.. .+..+.+|+.+||..+|.+||++.+++. +|.
T Consensus 254 ~~~~----~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 254 DPNH----EIEFPDI---PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp CTTS----CCCCCCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred hccc----ccCCccc---chHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 2111 1111111 2346899999999999999999999986 554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=330.79 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=181.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++..... .....+..+..+++.++||||+++++++.+ ..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 46799999999999999999998 477999999976532 222334455567888899999999999854 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||+ ++.+..++.... ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++..+..
T Consensus 104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 555655554432 2489999999999999999999995 8 99999999999999999999999999976533
Q ss_pred CCCCccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChH---HHHHHHHcCCcccc
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAH---QVERSIENGTFDET 686 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~---~~~~~i~~~~~~~~ 686 (768)
.. ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.... .....+..+....
T Consensus 178 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~- 249 (318)
T 2dyl_A 178 DK-------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL- 249 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-
T ss_pred Cc-------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-
Confidence 21 123457899999999884 5568999999999999999999999996422 2222332222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHH
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRA 733 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~ 733 (768)
.+....++ ..+.+|+.+||..+|.+||++.+++. ++++....
T Consensus 250 -~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 250 -LPGHMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp -CCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred -CCccCCCC----HHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 11111223 45899999999999999999999997 77766544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=338.69 Aligned_cols=259 Identities=26% Similarity=0.335 Sum_probs=199.7
Q ss_pred HHHHHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CC-----ceeeeecc
Q 035604 455 IEEIEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HP-----NMVLLLGA 526 (768)
Q Consensus 455 ~~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~g~ 526 (768)
+.......++|.+.+.||+|+||.||+|.+ +++.||||+++... .....+..|+.++..++ |+ +|+.++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 334445578999999999999999999988 46789999997543 33456788999988885 55 48999888
Q ss_pred cc--CCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeeCCCCCCCeEEc--CCCc
Q 035604 527 CP--EFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ--TKPEPLVHRDLKPGNILLD--RNYV 600 (768)
Q Consensus 527 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~~~~iiHrDLKp~NILl~--~~~~ 600 (768)
|. ...||||||+. |+|.+++..... ..+++..++.++.||+.||.|||. .+ |+||||||+||||+ .++.
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCC
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCc
Confidence 74 45599999995 699999876542 248999999999999999999994 56 99999999999994 5788
Q ss_pred EEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHH
Q 035604 601 SKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSI 678 (768)
Q Consensus 601 vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i 678 (768)
+||+|||+++.+... .....||+.|+|||++.+..++.++|||||||++|||++|++||....... ..+
T Consensus 200 ~kL~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i 270 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR---------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270 (382)
T ss_dssp EEECCCTTCEETTCC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEEeccCceecccc---------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999876322 235688999999999999999999999999999999999999997543322 111
Q ss_pred Hc--CCcc---------------ccCC-----------------C---------------------CCCCCCHHHHHHHH
Q 035604 679 EN--GTFD---------------ETLD-----------------P---------------------AVPDWPVEEALILA 703 (768)
Q Consensus 679 ~~--~~~~---------------~~ld-----------------~---------------------~~~~~~~~~~~~l~ 703 (768)
.. +... ...+ + ........+...+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (382)
T 2vx3_A 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350 (382)
T ss_dssp HHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHH
T ss_pred HHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHH
Confidence 11 0000 0000 0 00011233456799
Q ss_pred HHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 704 KLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 704 ~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+|+.+||+.||.+|||+.+++. +|+
T Consensus 351 dli~~mL~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 351 DLILRMLDYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred HHHHHhcCCChhhCCCHHHHhcCccc
Confidence 9999999999999999999986 554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=334.14 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=197.8
Q ss_pred hcCCCccceecccCceeEEEEEEC--C-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCc------eeeeecccc--CC
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--H-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN------MVLLLGACP--EF 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~g~~~--~~ 530 (768)
.++|.+.+.||+|+||.||++.+. + ..||||+++... .....+.+|+.+++.++|++ ++.+++++. ..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999973 3 579999997543 34567889999999997766 888888774 45
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---------------
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL--------------- 595 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl--------------- 595 (768)
.|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 58999999 6777777766432 34899999999999999999999999 9999999999999
Q ss_pred ----cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh
Q 035604 596 ----DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA 671 (768)
Q Consensus 596 ----~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~ 671 (768)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH---------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCcEEEeecCcccccccc---------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999864322 23457999999999999999999999999999999999999999654
Q ss_pred HHHHH--HHHc--CCccc----------cC---------------------CC--CCCCCCHHHHHHHHHHHHHhhhcCc
Q 035604 672 HQVER--SIEN--GTFDE----------TL---------------------DP--AVPDWPVEEALILAKLALQCAELRR 714 (768)
Q Consensus 672 ~~~~~--~i~~--~~~~~----------~l---------------------d~--~~~~~~~~~~~~l~~Li~~cl~~~P 714 (768)
..... .+.. +.+.. .. .+ ........++..+.+|+.+||..||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 32211 1111 10000 00 00 0001122345679999999999999
Q ss_pred cCCCChhhhhh-HHHHH
Q 035604 715 KDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 715 ~~RPs~~evl~-~~l~~ 730 (768)
.+||++.+++. +|...
T Consensus 323 ~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAG 339 (355)
T ss_dssp TTSCCHHHHTTSGGGGG
T ss_pred hhCcCHHHHhcChhhcC
Confidence 99999999986 56543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.41 Aligned_cols=244 Identities=27% Similarity=0.383 Sum_probs=198.1
Q ss_pred HHHHhcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchh------hHHHHHHHHHHHhhcC--CCceeeeeccc
Q 035604 458 IEEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ------GRSQFQQEVEVLCNIR--HPNMVLLLGAC 527 (768)
Q Consensus 458 i~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~--HpnIv~l~g~~ 527 (768)
.....++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344567899999999999999999987 5678999999754321 2245678999999996 59999999998
Q ss_pred cC--CceeEEEeccC-CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCcEEE
Q 035604 528 PE--FGCLIYEYMAN-GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-RNYVSKI 603 (768)
Q Consensus 528 ~~--~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~vKL 603 (768)
.+ ..++|||++.+ ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+ .++.+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 54 45899999976 89999998754 4899999999999999999999999 99999999999999 7899999
Q ss_pred eecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCC
Q 035604 604 SDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGT 682 (768)
Q Consensus 604 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~ 682 (768)
+|||+++.+... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ +.
T Consensus 192 ~Dfg~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~ 259 (320)
T 3a99_A 192 IDFGSGALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR----GQ 259 (320)
T ss_dssp CCCTTCEECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----CC
T ss_pred eeCccccccccc--------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc----cc
Confidence 999999876432 1234579999999998887665 7889999999999999999999976543321 21
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 683 ~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
. .... .+ +..+.+|+.+||..+|.+||++.+++. +|+
T Consensus 260 ~--~~~~---~~----~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 260 V--FFRQ---RV----SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp C--CCSS---CC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred c--cccc---cC----CHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 1 1111 22 245899999999999999999999986 443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=358.10 Aligned_cols=266 Identities=24% Similarity=0.289 Sum_probs=206.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC--------C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--------F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~ 530 (768)
.++|.+.+.||+|+||.||++.+ ++..||||+++.. .......+.+|+.+|+.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999987 5678999998764 34446678999999999999999999998633 3
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCc---EEEeecc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYV---SKISDVG 607 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~---vKL~DFG 607 (768)
.++||||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 4899999999999999987665556999999999999999999999999 999999999999987664 8999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--------HH
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--------IE 679 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--------i~ 679 (768)
++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..
T Consensus 170 ~a~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE-------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC-------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccc-------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 998764321 124568999999999999999999999999999999999999999643221110 00
Q ss_pred cCCccccC---------CCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHHHhhc
Q 035604 680 NGTFDETL---------DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRALAEE 737 (768)
Q Consensus 680 ~~~~~~~l---------d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~~~~~ 737 (768)
........ .+.........+..+.+|+..||..||.+||++.+++. ++...+..+...
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000000 01112344556778999999999999999999999876 677777665543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=344.75 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=186.5
Q ss_pred cCCCccceecccCceeEE-EEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccCC--ceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVY-KSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPEF--GCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy-~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~--~~lV~E~~ 538 (768)
+.|...+.||+|+||+|| .+..+++.||||++.... .+.+.+|+.+|..+ +|||||++++++.+. .|||||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445667889999999996 455588999999986532 34578999999876 899999999998543 48999999
Q ss_pred cCCChHHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCC-------------CcE
Q 035604 539 ANGSLEDRLFRRGGSP----VLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-------------YVS 601 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~-------------~~v 601 (768)
. |+|.+++....... ..++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999997654211 1133345789999999999999999 9999999999999654 489
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC-------CCCCccccHHHHHHHHHHHHh-CCCCCCChHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT-------GMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ 673 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~ 673 (768)
||+|||+++.+...... .........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 168 kL~DFG~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSS--FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EECCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEcccccceecCCCCcc--ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 99999999877543211 1111235689999999998875 668999999999999999999 9999975544
Q ss_pred HHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 674 VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 674 ~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+..+.+... ..........+..+.+|+.+||+.+|.+||++.+++.
T Consensus 246 ~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESNIIRGIFSLD--EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHTCCCCC--CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHHhcCCCCcc--cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 4444444432211 1111123456678999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.54 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=186.9
Q ss_pred cCCCccceecccCcee-EEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGP-VYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~-Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
.+|.+.+.||+|+||+ ||++..+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+ ..|||||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4688889999999998 556777899999999975432 2356899999999 79999999999854 348999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-----CCcEEEeecccccccC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-----NYVSKISDVGLARLVP 613 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-----~~~vKL~DFGla~~~~ 613 (768)
. |+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++.+.
T Consensus 101 ~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 5 699999876543 2555566789999999999999999 999999999999943 3467899999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCccccc---CCCCCccccHHHHHHHHHHHHh-CCCCCCChHHHHHHHHcCCccccCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQ---TGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQVERSIENGTFDETLDP 689 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~~~~~i~~~~~~~~ld~ 689 (768)
.... .........||+.|+|||++. +..++.++|||||||++|||++ |.+||+........+..+....
T Consensus 175 ~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---- 247 (432)
T 3p23_A 175 VGRH---SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL---- 247 (432)
T ss_dssp --------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC----
T ss_pred CCCc---ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc----
Confidence 3211 112234568999999999987 4567889999999999999999 9999965544333332222111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.....+...+..+.+|+.+||+.||.+||++.+++.
T Consensus 248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111112345566899999999999999999999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.49 Aligned_cols=247 Identities=17% Similarity=0.155 Sum_probs=185.8
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCch---hhHHHHHHHHHHHhhcCC-Ccee--------------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRH-PNMV-------------- 521 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~H-pnIv-------------- 521 (768)
+.+|...+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+.+++.++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 355788899999999999999984 78999999974432 235678999999999987 2221
Q ss_pred -ee------ecccc-------CCceeEEEeccCCChHHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 035604 522 -LL------LGACP-------EFGCLIYEYMANGSLEDRLFR----RGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583 (768)
Q Consensus 522 -~l------~g~~~-------~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 583 (768)
.+ +..+. ...+++|+++ +++|.+++.. ......+++..++.++.||+.||.|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11 11111 1225666655 7899988842 112234788899999999999999999999 9
Q ss_pred eeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccc----------cCCCCCccccHHH
Q 035604 584 VHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ----------QTGMLGVKSDVYS 653 (768)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~ksDvwS 653 (768)
|||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++||||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 99999999999999999999999999865321 345577 999999988 5666899999999
Q ss_pred HHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHH
Q 035604 654 LGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILR 732 (768)
Q Consensus 654 lGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~ 732 (768)
|||++|||++|+.||...... ..+...+. .....+ ..+.+|+.+||+.+|.+||++.+++. ++.+.+.
T Consensus 303 lGvil~elltg~~Pf~~~~~~------~~~~~~~~-~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAAL------GGSEWIFR-SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGG------SCSGGGGS-SCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCcchh------hhHHHHHh-hcccCC----HHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 999999999999999654321 11111111 122333 45999999999999999999999986 6665554
Q ss_pred H
Q 035604 733 A 733 (768)
Q Consensus 733 ~ 733 (768)
.
T Consensus 372 ~ 372 (413)
T 3dzo_A 372 T 372 (413)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=356.39 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=191.9
Q ss_pred hcCCCccceecccCceeEEEEEE---CCccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC--C-----
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL---DHTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--F----- 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~---~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~----- 530 (768)
.++|.+.+.||+|+||.||++.+ +++.||||++... .......+.+|+.+|+.++|||||+++++|.. .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 36899999999999999999987 4678999998654 33445678899999999999999999999843 2
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.||||||++|++|.+++.. .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 4899999999999887643 4899999999999999999999999 9999999999999875 89999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCC
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPA 690 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~ 690 (768)
.+... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.... ...+...
T Consensus 230 ~~~~~----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~-----------~~~~~~~ 287 (681)
T 2pzi_A 230 RINSF----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY-----------VDGLPED 287 (681)
T ss_dssp ETTCC----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE-----------CSSCCTT
T ss_pred hcccC----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc-----------ccccccc
Confidence 76332 3457999999999887654 899999999999999999999985321 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHHHHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNILRAL 734 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l~~~ 734 (768)
......+..+.+|+.+||..+|.+||+..+++. .+...++..
T Consensus 288 --~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 288 --DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp --CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred --ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 001123456999999999999999997666665 555555443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=311.61 Aligned_cols=227 Identities=22% Similarity=0.366 Sum_probs=177.9
Q ss_pred hcCCCcc-ceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHH-hhcCCCceeeeeccccC------Cc
Q 035604 462 TENFSNS-RKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVL-CNIRHPNMVLLLGACPE------FG 531 (768)
Q Consensus 462 ~~~y~~~-~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~g~~~~------~~ 531 (768)
.++|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++ +.++||||++++++|.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4667776 7899999999999998 5678999999642 3567888888 56699999999998743 34
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCcEEEeeccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYVSKISDVGL 608 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~vKL~DFGl 608 (768)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 899999999999999987543 35899999999999999999999999 999999999999988 78999999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCC
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLD 688 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld 688 (768)
+.... +..++.++|||||||++|+|++|+.||......... ... ...+.
T Consensus 167 a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~-~~~~~ 215 (299)
T 3m2w_A 167 AKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGM-KTRIR 215 (299)
T ss_dssp CEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCS-CCSSC
T ss_pred ccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--HHH-HHHHh
Confidence 87531 234678999999999999999999999655432211 111 11111
Q ss_pred CCCCCCC----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 689 PAVPDWP----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 689 ~~~~~~~----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
......+ ...+..+.+|+.+||..+|.+||++.+++. +|+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 1111122 123456999999999999999999999986 555
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=323.64 Aligned_cols=236 Identities=18% Similarity=0.207 Sum_probs=183.0
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCCch--------hhHHHHHHHHHHHhhcC---------CCceeee-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAA--------QGRSQFQQEVEVLCNIR---------HPNMVLL- 523 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~---------HpnIv~l- 523 (768)
.++|.+.+.||+|+||.||+|.++++.||||++..... .....+.+|+.+|+.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 36789999999999999999999999999999975421 22367889999999886 5555554
Q ss_pred ----------------eccc---------------cCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 035604 524 ----------------LGAC---------------PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572 (768)
Q Consensus 524 ----------------~g~~---------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL 572 (768)
+++| ....||||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 4443 2455999999999977766644 2489999999999999999
Q ss_pred HHHH-hCCCCCeeeCCCCCCCeEEcCCC--------------------cEEEeecccccccCCCCCCccccccccCCCCC
Q 035604 573 LFLH-QTKPEPLVHRDLKPGNILLDRNY--------------------VSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631 (768)
Q Consensus 573 ~~LH-~~~~~~iiHrDLKp~NILl~~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt 631 (768)
.||| +.+ |+||||||+||||+.++ .+||+|||+++.+.. ...+||
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----------~~~~gt 240 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----------GIVVFC 240 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------TEEECC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------CcEEEe
Confidence 9999 899 99999999999999887 899999999987632 134799
Q ss_pred CCCCCcccccCCCCCccccHHHHHHH-HHHHHhCCCCCCChHH---HHHHHHcC-CccccCCCCCCCCCHHHHHHHHHHH
Q 035604 632 FCYIDPEYQQTGMLGVKSDVYSLGIL-LLQIITAKPPMGLAHQ---VERSIENG-TFDETLDPAVPDWPVEEALILAKLA 706 (768)
Q Consensus 632 ~~Y~aPE~~~~~~~s~ksDvwSlGvi-l~elltg~~Pf~~~~~---~~~~i~~~-~~~~~ld~~~~~~~~~~~~~l~~Li 706 (768)
+.|+|||++.+.. +.++||||||++ .+++++|..||..... ....+... .+.. ......+...+..+.+|+
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT---KCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS---CCCSHHHHHHHHHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc---ccchhhhhhcCHHHHHHH
Confidence 9999999998776 899999998777 7889999999954322 22222211 1111 111122345778899999
Q ss_pred HHhhhcCccCCCChhhhh
Q 035604 707 LQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 707 ~~cl~~~P~~RPs~~evl 724 (768)
.+||+.+ |+.+++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999976 888887
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=316.78 Aligned_cols=219 Identities=12% Similarity=0.072 Sum_probs=172.0
Q ss_pred hcCCCccceecccCceeEEEEEEC--CccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 534 (768)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.++..++||||+++++++.+ ..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999984 6799999997653 2334678999999999999999999999844 45999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||++|++|.+++... .....+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999998432 345567889999999999999999 9999999999999999999998544
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCccccCCCCCC--
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVP-- 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ld~~~~-- 692 (768)
|++ .++.++|||||||++|+|+||+.||......... . .....+.....
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-~--~~~~~~~~~~~~~ 225 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-A--PAERDTAGQPIEP 225 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-E--ECCBCTTSCBCCH
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-H--HHHHHhccCCCCh
Confidence 233 3688999999999999999999999644321100 0 00000000000
Q ss_pred -CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 -DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 -~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
......+..+.+|+.+||+.||.+| |+.+++.
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 0111233569999999999999999 9998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-29 Score=289.06 Aligned_cols=182 Identities=15% Similarity=0.124 Sum_probs=126.6
Q ss_pred ecccCceeEEEEE--ECCccEEEEEEcCCc----------hhhHHHHHHHHHHHhhc-CCCceeeeeccccCC--ceeEE
Q 035604 471 IGEGGYGPVYKSY--LDHTPVAIKVLRPDA----------AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPEF--GCLIY 535 (768)
Q Consensus 471 LG~G~fG~Vy~~~--~~~~~vAvK~l~~~~----------~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~--~~lV~ 535 (768)
.+.|++|.+..++ +-|..||+|++.+.. .....+|.+|+++|+++ .|+||+++++++.+. .||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666555432 368899999997542 23345699999999999 699999999999654 49999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||++|++|.++|...+ .++.. +|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999998765 35554 58899999999999999 999999999999999999999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf 668 (768)
. ....+.+||+.|+|||++.+ .+..++|+||+|+++++|+++..||
T Consensus 393 ~------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 C------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred C------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 12345689999999998876 4677899999999988876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=267.94 Aligned_cols=188 Identities=16% Similarity=0.157 Sum_probs=146.6
Q ss_pred CCccceecccCceeEEEEEECCccEEEEEEcCCch--------hhHHHHHHHHHHHhhcCCCcee--eeeccccCCceeE
Q 035604 465 FSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAA--------QGRSQFQQEVEVLCNIRHPNMV--LLLGACPEFGCLI 534 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv--~l~g~~~~~~~lV 534 (768)
+...++||+|+||.||++...+..+++|....... ...+.+.+|+++|++++||||+ .+++...+..|||
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ----------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 34567899999999999988999999998754321 1234588999999999999999 7777777788999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|||++|++|.+++.. ++.++.||+.||.|||+.+ |+||||||+|||++. .+||+|||+++.+..
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998865 4579999999999999999 999999999999998 999999999998743
Q ss_pred CCCCcccc-ccccCCCCCCCCCCcccccC--CCCCccccHHHHHHHHHHHHhCCCCC
Q 035604 615 SVADSVTQ-YRMTSAAGTFCYIDPEYQQT--GMLGVKSDVYSLGILLLQIITAKPPM 668 (768)
Q Consensus 615 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltg~~Pf 668 (768)
........ .......||+.|+|||++.. ..|+..+|+|+.++-.++-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21100000 01235689999999999887 56888999999999998888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6e-23 Score=217.35 Aligned_cols=161 Identities=14% Similarity=0.083 Sum_probs=125.2
Q ss_pred HHHHhcCCCccceecccCceeEEEEEE-CCccEEEEEEcCCch------------------hhHHHHHHHHHHHhhcCCC
Q 035604 458 IEEATENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA------------------QGRSQFQQEVEVLCNIRHP 518 (768)
Q Consensus 458 i~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~------------------~~~~~~~~E~~il~~l~Hp 518 (768)
+......|.+.+.||+|+||.||+|.+ +++.||||+++.... .....+.+|+.+|++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 334455677789999999999999998 567999999974321 134568899999999994
Q ss_pred ceeeeeccc-cCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC
Q 035604 519 NMVLLLGAC-PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR 597 (768)
Q Consensus 519 nIv~l~g~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~ 597 (768)
+++++++ ....|+||||++||+|.+ +. . .....++.||+.||.|||+.+ |+||||||+||||+
T Consensus 164 --~~v~~~~~~~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 --LAVPKVYAWEGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS- 227 (282)
T ss_dssp --SSSCCEEEEETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred --CCcCeEEeccceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence 5555544 234599999999999987 41 1 224479999999999999999 99999999999999
Q ss_pred CCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccC----------CCCCccccHHHH
Q 035604 598 NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT----------GMLGVKSDVYSL 654 (768)
Q Consensus 598 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----------~~~s~ksDvwSl 654 (768)
++.+||+|||+|+. +..|+|||++.. ..|+..+|+|.+
T Consensus 228 ~~~vkl~DFG~a~~-------------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 228 EEGIWIIDFPQSVE-------------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp TTEEEECCCTTCEE-------------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CCcEEEEECCCCeE-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999999999863 345789998753 345666676653
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=187.43 Aligned_cols=149 Identities=13% Similarity=0.175 Sum_probs=114.3
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCC-----CCCCCC-CCCcc-cccccCHHHHHHHHHhhhHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRV-----SSVPNP-SGNSV-AISKVNNEVARIYKQQVDNQA 82 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~-----~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 82 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+++. ...... .+..+ + ........+.+...+.+
T Consensus 5 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 81 (162)
T 1mjh_A 5 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNK---SVEEFENELKNKLTEEA 81 (162)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC--------------------CHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCcccccccccccccccccccc---chhhhHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999753 110000 00000 0 00011223445566778
Q ss_pred HHhHHHHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEE
Q 035604 83 KELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162 (768)
Q Consensus 83 ~~~l~~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV 162 (768)
++.|+.+.+.+...|+++.. .+..|+|+++|+++|++.++||||||+||++++.+.+ .|||+.+|+++++ |||+||
T Consensus 82 ~~~l~~~~~~~~~~g~~~~~-~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~-~GSv~~~vl~~~~--~pVlvv 157 (162)
T 1mjh_A 82 KNKMENIKKELEDVGFKVKD-IIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEIL-LGSVTENVIKKSN--KPVLVV 157 (162)
T ss_dssp HHHHHHHHHHHHHTTCEEEE-EEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCS-SCHHHHHHHHHCC--SCEEEE
T ss_pred HHHHHHHHHHHHHcCCceEE-EEcCCCHHHHHHHHHHHcCCCEEEEcCCCCCCccceE-ecchHHHHHHhCC--CCEEEE
Confidence 88899998888888998554 4667999999999999999999999999997666544 4599999999998 999999
Q ss_pred eCC
Q 035604 163 GKG 165 (768)
Q Consensus 163 ~k~ 165 (768)
+.+
T Consensus 158 ~~~ 160 (162)
T 1mjh_A 158 KRK 160 (162)
T ss_dssp CCC
T ss_pred eCC
Confidence 754
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=183.27 Aligned_cols=140 Identities=22% Similarity=0.185 Sum_probs=115.7
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+++...... . .........+...+.+++.|+.+
T Consensus 5 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~------~----~~~~~~~~~~~~~~~~~~~l~~~ 74 (146)
T 3s3t_A 5 YTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTP------A----LDPVLSELLDAEAAHAKDAMRQR 74 (146)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCG------G----GHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccc------c----cccccHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999999999989999999999987532211 0 00122344566677888899999
Q ss_pred HHHhhhcCc-eeEEEEEecCCHHHHHHH-HHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 90 RCFCTRKEI-KCKEIVLEDTDIAKALID-YVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 90 ~~~~~~~gv-~~~~~~v~~G~~a~~Iv~-~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
.+.+...|+ .+ +..+..|+|+++|++ +|++.++||||||+||++++.+.++ ||++.+|+++++ ||||||+
T Consensus 75 ~~~~~~~g~~~~-~~~~~~g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvV~ 146 (146)
T 3s3t_A 75 QQFVATTSAPNL-KTEISYGIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAV-GSTTSYVVDHAP--CNVIVIR 146 (146)
T ss_dssp HHHHTTSSCCCC-EEEEEEECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSS-CHHHHHHHHHCS--SEEEEEC
T ss_pred HHHHHhcCCcce-EEEEecCChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEE-cchHHHHhccCC--CCEEEeC
Confidence 999988899 74 455667999999999 9999999999999999977765554 599999999999 9999984
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.2e-21 Score=177.71 Aligned_cols=135 Identities=21% Similarity=0.269 Sum_probs=110.5
Q ss_pred cEEEEEecCCcCcHHHHHHHHHhh-cCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhh-HHHHHhHHH
Q 035604 11 EAVAVAIDKDKGSQYALRWAVDHL-LSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVD-NQAKELFVP 88 (768)
Q Consensus 11 ~~IlVavDgS~~S~~Al~~A~~~a-~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~ 88 (768)
++||||+|+|+.|..|++||+.+| ...+++|++|||+++...... . ........+..+ +.+++.++.
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~------~-----~~~~~~~~~~~~~~~~~~~l~~ 70 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGE------A-----VLAAYDEIEMKEEEKAKLLTQK 70 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHH------H-----HHHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccc------c-----ccCcHHHHHHHHHHHHHHHHHH
Confidence 689999999999999999999999 899999999999976432110 0 011123345555 778889999
Q ss_pred HHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 89 FRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 89 ~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
+.+.+...|+++. ..+..|+|+++|+++|+ ++||||||+||++++.+ ++ ||++.+|+++++ ||||||+
T Consensus 71 ~~~~~~~~g~~~~-~~v~~g~~~~~I~~~a~--~~dliV~G~~~~~~~~~-~~-Gs~~~~vl~~~~--~pVlvv~ 138 (138)
T 3idf_A 71 FSTFFTEKGINPF-VVIKEGEPVEMVLEEAK--DYNLLIIGSSENSFLNK-IF-ASHQDDFIQKAP--IPVLIVK 138 (138)
T ss_dssp HHHHHHTTTCCCE-EEEEESCHHHHHHHHHT--TCSEEEEECCTTSTTSS-CC-CCTTCHHHHHCS--SCEEEEC
T ss_pred HHHHHHHCCCCeE-EEEecCChHHHHHHHHh--cCCEEEEeCCCcchHHH-Hh-CcHHHHHHhcCC--CCEEEeC
Confidence 9999988899854 55667999999999999 99999999999977664 55 799999999999 9999984
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=181.38 Aligned_cols=138 Identities=14% Similarity=0.224 Sum_probs=112.0
Q ss_pred CcEEEEEec--CCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHH
Q 035604 10 EEAVAVAID--KDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFV 87 (768)
Q Consensus 10 ~~~IlVavD--gS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 87 (768)
.++||||+| +|+.|..|++||+.+|...+++|++|||+++...... . . .. ....+...+.+++.|+
T Consensus 15 ~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~--~-~-----~~----~~~~~~~~~~~~~~l~ 82 (156)
T 3fg9_A 15 YRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIF--D-S-----LT----PSKIQAKRKHVEDVVA 82 (156)
T ss_dssp CC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCC--C-S-----SH----HHHHHHHHHHHHHHHH
T ss_pred CceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCcccc--c-c-----CC----HHHHHHHHHHHHHHHH
Confidence 789999999 9999999999999999999999999999987532111 1 0 11 1233556677888899
Q ss_pred HHHHHhhhcCceeEEEEEec-CCHHHHHHHH-HHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 88 PFRCFCTRKEIKCKEIVLED-TDIAKALIDY-VSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 88 ~~~~~~~~~gv~~~~~~v~~-G~~a~~Iv~~-a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
.+.+.+...|+...+..+.. |+|+++|+++ |++.++||||||+||++++. ++ .||++.+|+++++ ||||||+
T Consensus 83 ~~~~~~~~~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~-~~-~Gs~~~~vl~~a~--~PVlvV~ 156 (156)
T 3fg9_A 83 EYVQLAEQRGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHS-KI-AGAIGPRLARKAP--ISVIVVR 156 (156)
T ss_dssp HHHHHHHHHTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTS-SS-CSCHHHHHHHHCS--SEEEEEC
T ss_pred HHHHHHHHcCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccc-ee-ecchHHHHHHhCC--CCEEEeC
Confidence 99888888898423445555 9999999999 99999999999999998885 55 5599999999999 9999984
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.4e-21 Score=182.64 Aligned_cols=143 Identities=15% Similarity=0.203 Sum_probs=97.7
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+++........+...+.. ..+ +.+...+.+++.|+.+
T Consensus 6 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~l~~~ 79 (150)
T 3tnj_A 6 YHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLD--TET----TYDAMLDVEKQKLSQI 79 (150)
T ss_dssp CSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSS--SCC----CHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcC--HHH----HHHHHHHHHHHHHHHH
Confidence 7999999999999999999999999999999999999976432100011100000 001 1133344555556555
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
.+. .|+......+..|+|+++|+++|+++++||||||+||++++. . +.||++.+|+++++ |||+||+..
T Consensus 80 ~~~---~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~-~-~~Gs~~~~vl~~~~--~pVlvv~~~ 148 (150)
T 3tnj_A 80 GNT---LGIDPAHRWLVWGEPREEIIRIAEQENVDLIVVGSHGRHGLA-L-LLGSTANSVLHYAK--CDVLAVRLR 148 (150)
T ss_dssp HHH---HTCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEEEC----------CCCHHHHHHHHCS--SEEEEEECC
T ss_pred HHH---cCCCcceEEEecCCHHHHHHHHHHHcCCCEEEEecCCCCCcC-e-EecchHHHHHHhCC--CCEEEEeCC
Confidence 443 366533456677999999999999999999999999997776 4 45599999999999 999999753
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-21 Score=185.65 Aligned_cols=143 Identities=20% Similarity=0.237 Sum_probs=111.1
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCC-CCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVS-SVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVP 88 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 88 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+++.. ......... ......+.+..++.+++.++.
T Consensus 2 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~ 74 (147)
T 3hgm_A 2 FNRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMAR-------PEQLDIPDDALKDYATEIAVQ 74 (147)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCC-------CGGGCCCTTHHHHHHHHHHHH
T ss_pred CceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccC-------hhhhhhHHHHHHHHHHHHHHH
Confidence 479999999999999999999999999999999999997642 100000000 000001123445667788888
Q ss_pred HHHHhhhcCcee--EEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEE
Q 035604 89 FRCFCTRKEIKC--KEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162 (768)
Q Consensus 89 ~~~~~~~~gv~~--~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV 162 (768)
+.+.+...|+.+ .+..+..|+|+++|+++|+++++||||||+||++++.+.++ ||++.+|+++++ |||+||
T Consensus 75 ~~~~~~~~g~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 75 AKTRATELGVPADKVRAFVKGGRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLL-GSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp HHHHHHHTTCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCC-CHHHHHHHHHCS--SCEEEC
T ss_pred HHHHHHhcCCCccceEEEEecCCHHHHHHHHHHHhCCCEEEEeCCCCccccceee-ccHHHHHHhhCC--CCEEEC
Confidence 888888889875 13566779999999999999999999999999977775555 599999999999 999997
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.82 E-value=9.3e-21 Score=184.52 Aligned_cols=152 Identities=12% Similarity=0.035 Sum_probs=110.9
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCH-HHHHHHHHhhhHHHHHhHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNN-EVARIYKQQVDNQAKELFVP 88 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~ 88 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+++........+ ++.....+ .....+.+...+.+++.|+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 82 (170)
T 2dum_A 5 FRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDG--YSFFYDNAEIELKDIKEKLKEEASRKLQE 82 (170)
T ss_dssp CSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC--------------CCTTSHHHHHHHHHHHHHH
T ss_pred cceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccc--cccccccccccHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999999999999999999999876421100000 00000000 00001123445566778888
Q ss_pred HHHHhhhcCceeEE-EEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCCc
Q 035604 89 FRCFCTRKEIKCKE-IVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKGK 166 (768)
Q Consensus 89 ~~~~~~~~gv~~~~-~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~~ 166 (768)
+.+.+...|+.+.. ..+..|+|+++|+++|+++++||||||+||++++.+.+ .|||+.+|+++++ ||||||+.+.
T Consensus 83 ~~~~~~~~g~~~~~~~~~~~g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~-~Gsv~~~vl~~~~--~PVlvv~~~~ 158 (170)
T 2dum_A 83 KAEEVKRAFRAKNVRTIIRFGIPWDEIVKVAEEENVSLIILPSRGKLSLSHEF-LGSTVMRVLRKTK--KPVLIIKEVD 158 (170)
T ss_dssp HHHHHHHHTTCSEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCCCC--TTC-CCHHHHHHHHHCS--SCEEEECCCC
T ss_pred HHHHHHHcCCceeeeeEEecCChHHHHHHHHHHcCCCEEEECCCCCCccccce-echHHHHHHHhCC--CCEEEEccCC
Confidence 88888778888543 25567999999999999999999999999997766555 4599999999998 9999998644
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=182.02 Aligned_cols=140 Identities=18% Similarity=0.188 Sum_probs=106.1
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEE--EeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLL--HVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFV 87 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~ll--HV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 87 (768)
.++||||+|+|+.|..|++||+.+|. .+++|+|| ||+++.... . +..+ . ...+.+...+.+++.|+
T Consensus 17 ~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~-~--~~~~-----~---~~~~~~~~~~~~~~~l~ 84 (163)
T 1tq8_A 17 YKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDAR-A--ADIL-----K---DESYKVTGTAPIYEILH 84 (163)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC-------------------------------CCTHHHHHH
T ss_pred CCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccc-c--cccc-----c---cHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999999 99999999 887653210 0 0000 0 11122334556778888
Q ss_pred HHHHHhhhcCce-eEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 88 PFRCFCTRKEIK-CKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 88 ~~~~~~~~~gv~-~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
.+.+.+...|++ +.. .+..|+|+++|+++|++.++||||||+||++++.+.++ |||+.+|+++++ |||+||+..
T Consensus 85 ~~~~~~~~~gv~~v~~-~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~l-GSva~~vl~~a~--~PVlvV~~~ 159 (163)
T 1tq8_A 85 DAKERAHNAGAKNVEE-RPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLL-GSVPANVSRRAK--VDVLIVHTT 159 (163)
T ss_dssp HHHHHHHTTTCCEEEE-EEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHT-BBHHHHHHHHTT--CEEEEECCC
T ss_pred HHHHHHHHcCCCeEEE-EEecCCHHHHHHHHHHhcCCCEEEECCCCCCcccceee-ccHHHHHHHhCC--CCEEEEeCC
Confidence 888888888887 554 45679999999999999999999999999977765555 599999999999 999999753
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.82 E-value=3.3e-20 Score=181.56 Aligned_cols=148 Identities=20% Similarity=0.276 Sum_probs=106.1
Q ss_pred CcEEEEEecCCc---------CcHHHHHHHHHhhcC---CCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHh
Q 035604 10 EEAVAVAIDKDK---------GSQYALRWAVDHLLS---RGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQ 77 (768)
Q Consensus 10 ~~~IlVavDgS~---------~S~~Al~~A~~~a~~---~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (768)
.++||||||+|+ .|..|++||+.+|.. .+++|+||||+++........+.. .........+.+.
T Consensus 5 ~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 80 (175)
T 2gm3_A 5 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSI----YASPEDFRDMRQS 80 (175)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CC----CCSHHHHHHHTTS
T ss_pred ccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccc----cCCHHHHHHHHHH
Confidence 689999999999 999999999998754 589999999986532110000000 0112333333344
Q ss_pred hhHHHHHhHHHHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCce
Q 035604 78 VDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYC 157 (768)
Q Consensus 78 ~~~~~~~~l~~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C 157 (768)
..+.+++.|+.+.+.+...|+.+. ..+..|+|+++|+++|+++++||||||+||++++.+.++ |||+.+|+++++ |
T Consensus 81 ~~~~~~~~l~~~~~~~~~~g~~~~-~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~-Gsva~~vl~~a~--~ 156 (175)
T 2gm3_A 81 NKAKGLHLLEFFVNKCHEIGVGCE-AWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFV-GTVSAFCVKHAE--C 156 (175)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCEEE-EEEEESCHHHHHHHHHHHHCCSEEEEEECCCC---------CHHHHHHHHCS--S
T ss_pred HHHHHHHHHHHHHHHHHHCCCceE-EEEecCCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhc-CchHHHHHhCCC--C
Confidence 455677888888888888899854 456679999999999999999999999999977765555 599999999998 9
Q ss_pred eEEEEeCC
Q 035604 158 NVYVIGKG 165 (768)
Q Consensus 158 ~VlvV~k~ 165 (768)
|||||+.+
T Consensus 157 pVlvv~~~ 164 (175)
T 2gm3_A 157 PVMTIKRN 164 (175)
T ss_dssp CEEEEECC
T ss_pred CEEEEcCC
Confidence 99999754
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.1e-20 Score=173.61 Aligned_cols=138 Identities=11% Similarity=0.149 Sum_probs=100.3
Q ss_pred cEEEEEecCCcC--cHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHH
Q 035604 11 EAVAVAIDKDKG--SQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVP 88 (768)
Q Consensus 11 ~~IlVavDgS~~--S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 88 (768)
++||||+|+|+. |..|++||+.+|...+++|++|||+++...... .+..+ . .. .+..++..++.++.
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~-~~~~~-----~-~~----~~~~~~~~~~~~~~ 70 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYAS-LGMAY-----T-AE----LPGMDELREGSETQ 70 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC---------------------------CHHHHHHHHHHH
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCccccc-ccccc-----c-ch----hhhHHHHHHHHHHH
Confidence 789999999999 999999999999989999999999987532211 11000 0 00 12223344455556
Q ss_pred HHHHhhhcCcee--EEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 89 FRCFCTRKEIKC--KEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 89 ~~~~~~~~gv~~--~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
+.+.+.+.|+.. .+..+..|+|+++|+++|+++++||||||+|| +++.+.+ .||++.+|+++++ ||||||+
T Consensus 71 l~~~~~~~~~~~~~v~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~-~~~~~~~-~Gs~~~~v~~~~~--~pVlvv~ 143 (143)
T 3fdx_A 71 LKEIAKKFSIPEDRMHFHVAEGSPKDKILALAKSLPADLVIIASHR-PDITTYL-LGSNAAAVVRHAE--CSVLVVR 143 (143)
T ss_dssp HHHHHTTSCCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEEESSC-TTCCSCS-SCHHHHHHHHHCS--SEEEEEC
T ss_pred HHHHHHHcCCCCCceEEEEEecChHHHHHHHHHHhCCCEEEEeCCC-CCCeeee-eccHHHHHHHhCC--CCEEEeC
Confidence 666666665431 34556779999999999999999999999996 6766544 5599999999999 9999984
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-20 Score=174.61 Aligned_cols=135 Identities=18% Similarity=0.212 Sum_probs=101.6
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+++... .. .. + .++ .+.+...+.+++.|+.+
T Consensus 2 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~-~~--~~-~-----~~~---~~~~~~~~~~~~~l~~~ 69 (137)
T 2z08_A 2 FKTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPD-YL--GE-P-----FFE---EALRRRLERAEGVLEEA 69 (137)
T ss_dssp CSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC--------------------------CHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCc-cc--cc-c-----chH---HHHHHHHHHHHHHHHHH
Confidence 4789999999999999999999999988999999999975321 00 00 0 001 12233344566666666
Q ss_pred HHHhhhcCc-eeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 90 RCFCTRKEI-KCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 90 ~~~~~~~gv-~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
.+. .|+ .+.. .+..|+|+++|+++|+++++||||||+||++++.+.++ ||++.+|+++++ |||+||+
T Consensus 70 ~~~---~g~~~~~~-~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvv~ 137 (137)
T 2z08_A 70 RAL---TGVPKEDA-LLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFL-GSQSQRVVAEAP--CPVLLVR 137 (137)
T ss_dssp HHH---HCCCGGGE-EEEESSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSS-CHHHHHHHHHCS--SCEEEEC
T ss_pred HHH---cCCCccEE-EEEecCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhh-ccHHHHHHhcCC--CCEEEeC
Confidence 554 577 6443 45579999999999999999999999999977765555 599999999998 9999984
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4.3e-20 Score=177.43 Aligned_cols=130 Identities=18% Similarity=0.211 Sum_probs=108.1
Q ss_pred CcEEEEEecC-CcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHH
Q 035604 10 EEAVAVAIDK-DKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVP 88 (768)
Q Consensus 10 ~~~IlVavDg-S~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 88 (768)
.++||||+|+ |+.|..|++||+.+|...+++|++|||++.... . . +...+.+++.|+.
T Consensus 24 ~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~--~-----------~--------~~~~~~~~~~l~~ 82 (155)
T 3dlo_A 24 YMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGR--T-----------K--------DEDIIEAKETLSW 82 (155)
T ss_dssp CCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT--S-----------C--------HHHHHHHHHHHHH
T ss_pred cCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc--c-----------c--------HHHHHHHHHHHHH
Confidence 6899999999 999999999999999999999999999975311 0 0 2233456777888
Q ss_pred HHHHhhhcCceeEE-EEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 89 FRCFCTRKEIKCKE-IVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 89 ~~~~~~~~gv~~~~-~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
+.+.+...|+.+.. ..+..|+|+++|+++|++.++||||||+||++++.+.++ ||++.+|+++++ ||||||+
T Consensus 83 ~~~~~~~~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~l-GSv~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 83 AVSIIRKEGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIF-GSVARDVILKAN--KPVICIK 155 (155)
T ss_dssp HHHHHHHTTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEEC-CHHHHHHHHHCS--SCEEEEC
T ss_pred HHHHHHhcCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEe-ccHHHHHHHhCC--CCEEEeC
Confidence 88888888887543 345679999999999999999999999999977765555 599999999999 9999984
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=189.30 Aligned_cols=135 Identities=19% Similarity=0.145 Sum_probs=106.3
Q ss_pred CCccceecccCceeEEEEEE--CCcc--EEEEEEcCCchh------------------------hHHHHHHHHHHHhhcC
Q 035604 465 FSNSRKIGEGGYGPVYKSYL--DHTP--VAIKVLRPDAAQ------------------------GRSQFQQEVEVLCNIR 516 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~--~~~~--vAvK~l~~~~~~------------------------~~~~~~~E~~il~~l~ 516 (768)
|.+.+.||+|+||.||+|.+ +++. ||||+++..... ....+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999998 7888 999997643211 1135789999999998
Q ss_pred CCce--eeeeccccCCceeEEEeccC-C----ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCC
Q 035604 517 HPNM--VLLLGACPEFGCLIYEYMAN-G----SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH-QTKPEPLVHRDL 588 (768)
Q Consensus 517 HpnI--v~l~g~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~iiHrDL 588 (768)
|++| ..+++ ....+|||||+.+ | +|.+.... +++.....++.|++.||.||| ..+ ||||||
T Consensus 129 ~~~i~~p~~~~--~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYT--YMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHADL 197 (258)
T ss_dssp HTTCCCCCEEE--EETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSC
T ss_pred hCCCCCCeEEE--cCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 8764 33333 2466999999942 4 67665432 234567789999999999999 888 999999
Q ss_pred CCCCeEEcCCCcEEEeeccccccc
Q 035604 589 KPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 589 Kp~NILl~~~~~vKL~DFGla~~~ 612 (768)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 9999999999754
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.77 E-value=4.1e-19 Score=167.06 Aligned_cols=138 Identities=15% Similarity=0.206 Sum_probs=103.0
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+++...... +. .......+.+...+.+++.|+.+
T Consensus 2 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~--~~-------~~~~~~~~~~~~~~~~~~~l~~~ 72 (141)
T 1jmv_A 2 YKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYT--GL-------IDVNMSSMQDRISTETQKALLDL 72 (141)
T ss_dssp CSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCC--CC-------EEHHHHHHTTCCCCHHHHHHHHH
T ss_pred CceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhc--cc-------cccchHHHHHHHHHHHHHHHHHH
Confidence 4789999999999999999999999988999999999854211000 10 00112222233344556666665
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
.+ ..|+.+....+..|+|+++|+++|++.++||||||+| ++++. ++ ||++.+|+++++ ||||||+.+
T Consensus 73 ~~---~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~-~l--gs~~~~vl~~~~--~pVlvv~~~ 139 (141)
T 1jmv_A 73 AE---SVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHH-QDFWS-KL--MSSTRQVMNTIK--IDMLVVPLR 139 (141)
T ss_dssp HH---HSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEEC-CCCHH-HH--HHHHHHHHTTCC--SEEEEEECC
T ss_pred HH---HcCCCceEEEEecCCHHHHHHHHHHhcCCCEEEEeCC-Cchhh-hh--cchHHHHHhcCC--CCEEEeeCC
Confidence 44 3577653456677999999999999999999999999 86655 43 499999999999 999999754
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.3e-18 Score=180.56 Aligned_cols=145 Identities=16% Similarity=0.127 Sum_probs=114.6
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+++...... + .........+.+...+.+++.|+.+
T Consensus 7 ~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~~l~~~ 78 (319)
T 3olq_A 7 YQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMT--T------LLSPDERNAMRKGVINQKTAWIKQQ 78 (319)
T ss_dssp SCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCT--T------TSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhc--c------ccChhhHHHHHHHHHHHHHHHHHHH
Confidence 7999999999999999999999999999999999999865321111 0 0122333344455566777888888
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
.+.+...|+.+...+...|+|+++|+++|++.++||||||++|++++.+.++ ||++..|+++++ ||||||+.+
T Consensus 79 ~~~~~~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~-Gs~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 79 ARYYLEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIF-TPLDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp HHHHHHTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBC-CHHHHHHHHHCS--SCEEEEESS
T ss_pred HHHHhhcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccc-cccHHHHHhcCC--CCEEEecCc
Confidence 8888888998655444389999999999999999999999999977665545 599999999999 999999864
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.1e-17 Score=154.80 Aligned_cols=131 Identities=14% Similarity=0.133 Sum_probs=98.0
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEee-cC-CCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVK-QR-VSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFV 87 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 87 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+ +. +....... ..++ ..... .+...+.+++.|+
T Consensus 4 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~-~~~~---~~~~~----~~~~~~~~~~~l~ 75 (138)
T 1q77_A 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVT-FGLP---FPPEI----KEESKKRIERRLR 75 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHH-HCCC---CCTHH----HHHHHHHHHHHHH
T ss_pred ccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccc-cCCC---CChHH----HHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999998 53 10000000 0000 00122 2344455667777
Q ss_pred HHHHH--hhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 88 PFRCF--CTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 88 ~~~~~--~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
.+ +. +...| .+. ..+..|+|+++|+++|++.++||||||+||+ ||+.+|+++++ ||||||+
T Consensus 76 ~~-~~~~~~~~~-~~~-~~~~~g~~~~~I~~~a~~~~~dliV~G~~g~----------sv~~~vl~~a~--~PVlvv~ 138 (138)
T 1q77_A 76 EV-WEKLTGSTE-IPG-VEYRIGPLSEEVKKFVEGKGYELVVWACYPS----------AYLCKVIDGLN--LASLIVK 138 (138)
T ss_dssp HH-HHHHHSCCC-CCC-EEEECSCHHHHHHHHHTTSCCSEEEECSCCG----------GGTHHHHHHSS--SEEEECC
T ss_pred HH-HHHhhccCC-cce-EEEEcCCHHHHHHHHHHhcCCCEEEEeCCCC----------chHHHHHHhCC--CceEeeC
Confidence 77 65 34556 533 3466799999999999999999999999987 89999999999 9999984
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=176.25 Aligned_cols=137 Identities=12% Similarity=0.118 Sum_probs=102.8
Q ss_pred CCcEEEEEecCCcC-------cHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHH
Q 035604 9 QEEAVAVAIDKDKG-------SQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQ 81 (768)
Q Consensus 9 ~~~~IlVavDgS~~-------S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (768)
..++||||+|+|+. |..|++||+.+|...+++|+||||+++...... . . .. .+.+..++.
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~-----~-----~-~~--~~~~~~~~~ 199 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSA-----D-----P-TF--QLSETIEAR 199 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC--------------------CH--HHHHHHHHH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccccc-----C-----c-hh--HHHHHHHHH
Confidence 36899999999998 999999999999999999999999976432110 0 0 00 222333444
Q ss_pred HHHhHHHHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEE
Q 035604 82 AKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYV 161 (768)
Q Consensus 82 ~~~~l~~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~Vlv 161 (768)
.++.++.+.+ +.|+......+..|+|+++|+++|+++++||||||+||++++.+.++ |||+.+|+++++ |||||
T Consensus 200 ~~~~l~~~~~---~~g~~~~~~~v~~g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~-Gsv~~~vl~~~~--~pVLv 273 (290)
T 3mt0_A 200 YREACRTFQA---EYGFSDEQLHIEEGPADVLIPRTAQKLDAVVTVIGTVARTGLSGALI-GNTAEVVLDTLE--SDVLV 273 (290)
T ss_dssp HHHHHHHHHH---HHTCCTTTEEEEESCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCS-CHHHHHHHTTCS--SEEEE
T ss_pred HHHHHHHHHH---HcCCCcceEEEeccCHHHHHHHHHHhcCCCEEEECCCCCcCCcceec-chHHHHHHhcCC--CCEEE
Confidence 5555555443 34664334556779999999999999999999999999977775555 599999999999 99999
Q ss_pred EeC
Q 035604 162 IGK 164 (768)
Q Consensus 162 V~k 164 (768)
|+.
T Consensus 274 v~~ 276 (290)
T 3mt0_A 274 LKP 276 (290)
T ss_dssp ECC
T ss_pred ECC
Confidence 974
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.9e-17 Score=174.48 Aligned_cols=141 Identities=16% Similarity=0.167 Sum_probs=111.7
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||++.........+. ...+ +.+..++.+++.|+.+
T Consensus 22 ~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~------~~~~----~~~~~~~~~~~~l~~~ 91 (294)
T 3loq_A 22 SNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGI------DIDH----YIDEMSEKAEEVLPEV 91 (294)
T ss_dssp TCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CC------CTTH----HHHHHHHHHHHHHHHH
T ss_pred hccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccc------cHHH----HHHHHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999765322111110 1112 2345566778888999
Q ss_pred HHHhhhcCceeEEEEEe-cCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 90 RCFCTRKEIKCKEIVLE-DTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~-~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
.+.+...|+.+....+. .|+|+++| ++++.++||||||++|++++.+.++ ||++.+|+++++ |||+||+.+
T Consensus 92 ~~~~~~~g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~-Gs~~~~vl~~~~--~PVlvv~~~ 163 (294)
T 3loq_A 92 AQKIEAAGIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILL-GSVSEGVLHDSK--VPVYIFKHD 163 (294)
T ss_dssp HHHHHHTTCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHH-CCHHHHHHHHCS--SCEEEECCC
T ss_pred HHHHHHcCCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceee-ccHHHHHHhcCC--CCEEEecCc
Confidence 88888889985541344 79999999 9999999999999999977665554 599999999999 999999753
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.6e-17 Score=173.76 Aligned_cols=145 Identities=15% Similarity=0.083 Sum_probs=108.5
Q ss_pred cEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCC-CCCCCcccccccCHHH---HHHHHHhhhHHHHHhH
Q 035604 11 EAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVP-NPSGNSVAISKVNNEV---ARIYKQQVDNQAKELF 86 (768)
Q Consensus 11 ~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l 86 (768)
++||||+|+|+.|..|++||+.+|...+++|++|||+++..... ...+. . ....+. .....+...+.+++.+
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~l 76 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDF--G--ALTVPVPVLRTELERALALRGEAVL 76 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-----------CHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCc--h--HHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 57999999999999999999999999999999999986532100 00000 0 000000 0111234456677888
Q ss_pred HHHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCC-CceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 87 VPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRT-GFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 87 ~~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~-g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
+.+.+.+...|+++. ..+..|+|+++|+++ +.++||||||+||++ ++.+.++ ||++.+|+++++ |||+||+.+
T Consensus 77 ~~~~~~~~~~g~~~~-~~~~~g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~-Gs~~~~v~~~a~--~PVlvv~~~ 150 (268)
T 3ab8_A 77 ERVRQSALAAGVAVE-AVLEEGVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGL-GSTADRVLRASP--VPVLLAPGE 150 (268)
T ss_dssp HHHHHHHHHTTCCEE-EEEEEECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSC-CHHHHHHHHHCS--SCEEEECSS
T ss_pred HHHHHHHHhCCCCeE-EEEecCCHHHHHHhh--ccCCCEEEEeccCCCcccccccc-chhHHHHHHhCC--CCEEEECCC
Confidence 999888888898854 455679999999999 789999999999997 6665554 599999999999 999999753
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-16 Score=170.75 Aligned_cols=139 Identities=18% Similarity=0.217 Sum_probs=107.5
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.|..|++||+.+|...+++|++|||+++... ..+.+ . ...+. .+...+.+++.|+.+
T Consensus 19 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~-~~~~~-~-----~~~~~----~~~~~~~~~~~l~~~ 87 (309)
T 3cis_A 19 SLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVA-TWLEV-P-----LPPGV----LRWQQDHGRHLIDDA 87 (309)
T ss_dssp TTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCC-CTTCC-C-----CCHHH----HHHHHHHHHHHHHHH
T ss_pred CCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCccc-ccccC-C-----CCchh----hHHHHHHHHHHHHHH
Confidence 6899999999999999999999999989999999999874321 11111 1 11122 233445667777777
Q ss_pred HHHhhhc-----CceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeC
Q 035604 90 RCFCTRK-----EIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGK 164 (768)
Q Consensus 90 ~~~~~~~-----gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k 164 (768)
.+.+... |+.+. ..+..|+|+++|+++|+ ++||||||++|++++.+.+ .||++.+|+++++ |||+||+.
T Consensus 88 ~~~~~~~~~~~~~~~~~-~~~~~g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~-~Gs~~~~vl~~~~--~PVlvv~~ 161 (309)
T 3cis_A 88 LKVVEQASLRAGPPTVH-SEIVPAAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRL-LGSVSSGLLRHAH--CPVVIIHD 161 (309)
T ss_dssp HHHHHHHCSSSCCSCEE-EEEESSCHHHHHHHHGG--GEEEEEEESSCTTCCTTCC-SCHHHHHHHHHCS--SCEEEECT
T ss_pred HHHHHHhcccCCCceEE-EEEecCCHHHHHHHHhc--CCCEEEECCCCCccccccc-cCcHHHHHHHhCC--CCEEEEcC
Confidence 7777655 88854 45667999999999986 7999999999997766544 4599999999998 99999975
Q ss_pred C
Q 035604 165 G 165 (768)
Q Consensus 165 ~ 165 (768)
+
T Consensus 162 ~ 162 (309)
T 3cis_A 162 E 162 (309)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=169.31 Aligned_cols=122 Identities=13% Similarity=0.073 Sum_probs=100.6
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.+..|++||+.+|...+++|++|||.++ . ..++.|+.+
T Consensus 7 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~-----~-------------------------~~~~~l~~~ 56 (290)
T 3mt0_A 7 IRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKR-----R-------------------------DHSAALNDL 56 (290)
T ss_dssp CCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSS-----S-------------------------CCHHHHHHH
T ss_pred hceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCc-----H-------------------------HHHHHHHHH
Confidence 7999999999999999999999999999999999999862 0 112233344
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGK 164 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k 164 (768)
.+.+...|+.+...+...|+|+++|+++|++.++||||||++|++++.+.++ ||++..|+++++ ||||||+.
T Consensus 57 ~~~~~~~~~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~-gs~~~~vl~~~~--~PVlvv~~ 128 (290)
T 3mt0_A 57 AQELREEGYSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAIL-TPDDWKLLRFAP--CPVLMTKT 128 (290)
T ss_dssp HHHHHHTTCCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSC-CHHHHHHHHHCS--SCEEEECC
T ss_pred HHHHhhCCCeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhccc-CHHHHHHHhcCC--CCEEEecC
Confidence 4445567888655555578999999999999999999999999977665554 599999999999 99999974
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.2e-16 Score=169.39 Aligned_cols=141 Identities=13% Similarity=0.150 Sum_probs=106.1
Q ss_pred CcEEEEEecCCcC-------cHHHHHHHHHhhcCC--CCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhH
Q 035604 10 EEAVAVAIDKDKG-------SQYALRWAVDHLLSR--GQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDN 80 (768)
Q Consensus 10 ~~~IlVavDgS~~-------S~~Al~~A~~~a~~~--~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (768)
.++||||+|+|+. |..|++||+.+|... +++|+||||+++...... .+ . +... ...+.+...+
T Consensus 156 ~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~-~~--~--~~~~---~~~~~~~~~~ 227 (319)
T 3olq_A 156 YGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIA-IE--L--PDFD---PNLYNNALRG 227 (319)
T ss_dssp TCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCC-TT--C--TTCC---HHHHHHHHHH
T ss_pred CCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhh-cc--C--Cccc---HHHHHHHHHH
Confidence 6899999999994 699999999999988 999999999977532211 00 0 0011 1223344455
Q ss_pred HHHHhHHHHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEE
Q 035604 81 QAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVY 160 (768)
Q Consensus 81 ~~~~~l~~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~Vl 160 (768)
...+.|+.+.+ +.|+......+..|+|+++|+++|++.++||||||+||++++.+.++| ||+.+|+++++ ||||
T Consensus 228 ~~~~~l~~~~~---~~~~~~~~~~v~~g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~G-sv~~~vl~~~~--~pVL 301 (319)
T 3olq_A 228 QHLIAMKELRQ---KFSIPEEKTHVKEGLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLG-NTAEQLIDHIK--CDLL 301 (319)
T ss_dssp HHHHHHHHHHH---HTTCCGGGEEEEESCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHH-HHHHHHHTTCC--SEEE
T ss_pred HHHHHHHHHHH---HhCCCcccEEEecCCcHHHHHHHHHHhCCCEEEEeccCccCCcccccc-HHHHHHHhhCC--CCEE
Confidence 55566655543 445543344566799999999999999999999999999888766655 99999999999 9999
Q ss_pred EEeC
Q 035604 161 VIGK 164 (768)
Q Consensus 161 vV~k 164 (768)
||+.
T Consensus 302 vv~~ 305 (319)
T 3olq_A 302 AIKP 305 (319)
T ss_dssp EECC
T ss_pred EECC
Confidence 9965
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.5e-16 Score=167.31 Aligned_cols=134 Identities=18% Similarity=0.204 Sum_probs=99.9
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.|..|++||+.+|...+++|+||||+++...... . ... . +...+..++.++.+
T Consensus 171 ~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~--~------~~~---~----~~~~~~~~~~l~~~ 235 (309)
T 3cis_A 171 QAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVSEW--P------GID---W----PATQSMAEQVLAER 235 (309)
T ss_dssp CCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTTC--S------SCC---H----HHHHHHHHHHHHHH
T ss_pred CCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeecccccCC--C------ccc---H----HHHHHHHHHHHHHH
Confidence 5789999999999999999999999989999999999875422100 0 001 1 11222333444444
Q ss_pred HHHhhh--cCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeC
Q 035604 90 RCFCTR--KEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGK 164 (768)
Q Consensus 90 ~~~~~~--~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k 164 (768)
.+.+.. .|+.+. ..+..|+|+++|+++|+ ++||||||++|++++.+.++ |||+.+|+++++ |||+||+.
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~-Gsv~~~vl~~~~--~pVlvv~~ 306 (309)
T 3cis_A 236 LAGWQERYPNVAIT-RVVVRDQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLV-GSVGETVAQLAR--TPVIVARE 306 (309)
T ss_dssp HTTHHHHCTTSCEE-EEEESSCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSS-CHHHHHHHHHCS--SCEEEECC
T ss_pred HHHHHhhCCCCcEE-EEEEcCCHHHHHHHhhC--CCCEEEECCCCCCCcccccc-CcHHHHHHhcCC--CCEEEeCC
Confidence 443332 477744 45667999999999997 89999999999977765555 599999999999 99999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.5e-16 Score=170.69 Aligned_cols=136 Identities=13% Similarity=0.107 Sum_probs=95.4
Q ss_pred CCCccceecccCceeEEEEEE-CCccEEEEEEcCCchh--------------hHHHH--------HHHHHHHhhcCCCce
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQ--------------GRSQF--------QQEVEVLCNIRHPNM 520 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~--------------~~~~~--------~~E~~il~~l~HpnI 520 (768)
-|.+...||.|+||.||+|.. +|+.||||+++..... ..... .+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 499999999999999999987 6789999998643110 01112 234445555533332
Q ss_pred eeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-
Q 035604 521 VLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY- 599 (768)
Q Consensus 521 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~- 599 (768)
....-+.....+|||||++|+.|..+. .......++.||+.+|.+||..| ||||||||.||||+.+|
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 111111112347999999988875432 11233568899999999999999 99999999999998776
Q ss_pred ---------cEEEeecccccc
Q 035604 600 ---------VSKISDVGLARL 611 (768)
Q Consensus 600 ---------~vKL~DFGla~~ 611 (768)
.+.|+||+-+--
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997753
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.5e-16 Score=163.95 Aligned_cols=122 Identities=19% Similarity=0.230 Sum_probs=101.8
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.+..|++||+.+|...+++|+||||.++.. .++.++.+
T Consensus 170 ~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~------------------------------~~~~l~~~ 219 (294)
T 3loq_A 170 FDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD------------------------------KTADLRVM 219 (294)
T ss_dssp TSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC------------------------------CHHHHHHH
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch------------------------------HHHHHHHH
Confidence 689999999999999999999999988899999999986521 12233444
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
.+.+.+.|+++ ...+..|+++++|+++|++.++||||||++|++++.+.++| |++..|+++++ ||||||+.+
T Consensus 220 ~~~l~~~~~~~-~~~~~~g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~G-s~~~~vl~~~~--~pvLvv~~~ 291 (294)
T 3loq_A 220 EEVIGAEGIEV-HVHIESGTPHKAILAKREEINATTIFMGSRGAGSVMTMILG-STSESVIRRSP--VPVFVCKRG 291 (294)
T ss_dssp HHHHHHTTCCE-EEEEECSCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHH-CHHHHHHHHCS--SCEEEECSC
T ss_pred HHHHHHcCCcE-EEEEecCCHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeC-cHHHHHHhcCC--CCEEEECCC
Confidence 55555678884 45667799999999999999999999999999777755555 99999999999 999999764
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=6e-14 Score=146.51 Aligned_cols=115 Identities=15% Similarity=0.160 Sum_probs=93.2
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
.++||||+|+|+.|..|+++|..++...+++|+||||+++. + ..++.++.+
T Consensus 154 ~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~------------------~-----------~~~~~l~~~ 204 (268)
T 3ab8_A 154 LEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDP------------------A-----------RAEAWALEA 204 (268)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSH------------------H-----------HHHHHHHHH
T ss_pred CCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcH------------------H-----------HHHHHHHHH
Confidence 58999999999999999999999998889999999997531 1 123344555
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
.+.+...|+.+. ..+..|+|+++|+++|+++ ||||||+ ++.+.+ .||++.+|+++++ ||||||+
T Consensus 205 ~~~l~~~~~~~~-~~~~~g~~~~~i~~~a~~~--dliV~G~----~~~~~~-~Gs~~~~vl~~~~--~pvlvv~ 268 (268)
T 3ab8_A 205 EAYLRDHGVEAS-ALVLGGDAADHLLRLQGPG--DLLALGA----PVRRLV-FGSTAERVIRNAQ--GPVLTAR 268 (268)
T ss_dssp HHHHHHTTCCEE-EEEECSCHHHHHHHHCCTT--EEEEEEC----CCSCCS-SCCHHHHHHHHCS--SCEEEEC
T ss_pred HHHHHHcCCceE-EEEeCCChHHHHHHHHHhC--CEEEECC----cccccE-eccHHHHHHhcCC--CCEEEeC
Confidence 556666788844 4556799999999999988 9999999 444444 4599999999999 9999984
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=8.2e-12 Score=129.69 Aligned_cols=143 Identities=15% Similarity=0.124 Sum_probs=110.1
Q ss_pred HHhcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccccC--CceeEEE
Q 035604 460 EATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 460 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~E 536 (768)
.....|.+...+|.|+.+.||+....+..+++|+...........+.+|+.+|+.+. +.++.++++++.+ ..|+|||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 445678888889999999999998888899999987532223345889999999885 5667777777644 3489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK------------------------------------- 579 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------- 579 (768)
|++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999877531 11223468889999999999821
Q ss_pred -------------------CCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 580 -------------------PEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 580 -------------------~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
+..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999876667899999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=3e-10 Score=123.66 Aligned_cols=141 Identities=16% Similarity=0.223 Sum_probs=106.1
Q ss_pred ccceecccCceeEEEEEECCccEEEEEEc--CCc-hhhHHHHHHHHHHHhhcC--CCceeeeeccccCC-----ceeEEE
Q 035604 467 NSRKIGEGGYGPVYKSYLDHTPVAIKVLR--PDA-AQGRSQFQQEVEVLCNIR--HPNMVLLLGACPEF-----GCLIYE 536 (768)
Q Consensus 467 ~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~--~~~-~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~-----~~lV~E 536 (768)
..+.|+.|.++.||+....+..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. .++|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 35679999999999998888889999876 332 123346889999999987 44567788777554 589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK------------------------------------- 579 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------- 579 (768)
|++|..+.+.. ...++...+..++.+++..|..||...
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99988774321 123678888899999999999999841
Q ss_pred ------------------CCCeeeCCCCCCCeEEcCCCc--EEEeeccccccc
Q 035604 580 ------------------PEPLVHRDLKPGNILLDRNYV--SKISDVGLARLV 612 (768)
Q Consensus 580 ------------------~~~iiHrDLKp~NILl~~~~~--vKL~DFGla~~~ 612 (768)
+..++|+|++|.|||++.++. +.|+||+.+..-
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245999999999999987653 699999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=3.4e-10 Score=116.60 Aligned_cols=134 Identities=16% Similarity=0.126 Sum_probs=94.8
Q ss_pred cCCCccceecccCceeEEEEEEC-CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce--eeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM--VLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI--v~l~g~~~~--~~~lV~E~ 537 (768)
..|.+....+.|..+.||+.... +..+++|+.... ....+.+|+.+++.+.+.++ .++++++.. ..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 34444333345566999998763 568999998654 22457889999998865444 457766644 34999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK-------------------------------------- 579 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------- 579 (768)
++|.+|. ... .. ...++.+++..|..||...
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 110 11 1256777888888888753
Q ss_pred -----------------CCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 580 -----------------PEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 580 -----------------~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
+..++|+|++|.|||++.++.+.|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887777899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=4.7e-10 Score=119.25 Aligned_cols=181 Identities=19% Similarity=0.197 Sum_probs=122.5
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCc--eeeeeccccC-----CceeEEEecc
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPN--MVLLLGACPE-----FGCLIYEYMA 539 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-Hpn--Iv~l~g~~~~-----~~~lV~E~~~ 539 (768)
.+.++.|.+..||+.. ..+++|+.... .....+.+|..+|+.+. +.. +.+++..... ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999853 67999987533 33457889999998873 322 2333333321 2378999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK---------------------------------------- 579 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------- 579 (768)
|..|.+.... .++..++..++.+++..|..||+..
T Consensus 100 G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9888764432 2677788888999999999998621
Q ss_pred ---------------CCCeeeCCCCCCCeEEcC--CCcEEEeecccccccCCCCCCccccccccCCCCCCCC---CCccc
Q 035604 580 ---------------PEPLVHRDLKPGNILLDR--NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY---IDPEY 639 (768)
Q Consensus 580 ---------------~~~iiHrDLKp~NILl~~--~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y---~aPE~ 639 (768)
+..++|+|++|.|||++. ++.+.|+||+.+..-+...+ . .....+ ..|+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D--l--------~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND--F--------ISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH--H--------HTTCCTTTSCCHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH--H--------HHHHhhccccCHHH
Confidence 134899999999999988 56679999999875432110 0 000011 23331
Q ss_pred ccC-----CC---------CCccccHHHHHHHHHHHHhCCCCC
Q 035604 640 QQT-----GM---------LGVKSDVYSLGILLLQIITAKPPM 668 (768)
Q Consensus 640 ~~~-----~~---------~s~ksDvwSlGvil~elltg~~Pf 668 (768)
... +. .....+.|++|.++|.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 110 00 112358999999999999999887
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.4e-06 Score=92.51 Aligned_cols=134 Identities=20% Similarity=0.210 Sum_probs=92.5
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCC---ceeeeeccc---cCCceeEEEeccCC
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHP---NMVLLLGAC---PEFGCLIYEYMANG 541 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~g~~---~~~~~lV~E~~~~g 541 (768)
.+.++.|....||+. +..+++|+... ......+.+|..+|..+.+. .+.+.+.++ ....++||+|++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456888888899987 67899998532 23345788999999998642 233344333 22358999999998
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK------------------------------------------ 579 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------------ 579 (768)
.+...... .++......++.+++..|..||+..
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88764322 1445555556666666666666432
Q ss_pred ---------------CCCeeeCCCCCCCeEEcC---CCc-EEEeecccccc
Q 035604 580 ---------------PEPLVHRDLKPGNILLDR---NYV-SKISDVGLARL 611 (768)
Q Consensus 580 ---------------~~~iiHrDLKp~NILl~~---~~~-vKL~DFGla~~ 611 (768)
+..++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 234799999999999987 354 58999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.7e-06 Score=93.60 Aligned_cols=77 Identities=6% Similarity=-0.015 Sum_probs=51.9
Q ss_pred ccee-cccCceeEEEEEEC--------CccEEEEEEcCCc---hhhHHHHHHHHHHHhhcC-C--CceeeeeccccCC--
Q 035604 468 SRKI-GEGGYGPVYKSYLD--------HTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIR-H--PNMVLLLGACPEF-- 530 (768)
Q Consensus 468 ~~~L-G~G~fG~Vy~~~~~--------~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~-H--pnIv~l~g~~~~~-- 530 (768)
.+.| +.|....+|+.... +..+++|+..... ......+.+|+.+|+.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999987765 6789999875432 111245778888888774 2 2455666665443
Q ss_pred ---ceeEEEeccCCChH
Q 035604 531 ---GCLIYEYMANGSLE 544 (768)
Q Consensus 531 ---~~lV~E~~~~gsL~ 544 (768)
.++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 47999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=7.7e-06 Score=89.94 Aligned_cols=74 Identities=19% Similarity=0.243 Sum_probs=51.1
Q ss_pred cceecccCceeEEEEEE--CCccEEEEEEcCCch-------hhHHHHHHHHHHHhhcCC--Cc-eeeeeccccCCceeEE
Q 035604 468 SRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-------QGRSQFQQEVEVLCNIRH--PN-MVLLLGACPEFGCLIY 535 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-------~~~~~~~~E~~il~~l~H--pn-Iv~l~g~~~~~~~lV~ 535 (768)
.+.||.|.++.||++.. .+..|+||...+... .....+..|.++|+.+.. |. +.+++.+..+..++||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 56799999999999964 457899998754321 123456789999887742 33 3456665566679999
Q ss_pred EeccCC
Q 035604 536 EYMANG 541 (768)
Q Consensus 536 E~~~~g 541 (768)
|++++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=2e-05 Score=81.55 Aligned_cols=131 Identities=17% Similarity=0.145 Sum_probs=89.6
Q ss_pred eecccCce-eEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccc--cCCceeEEEeccCCCh
Q 035604 470 KIGEGGYG-PVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGAC--PEFGCLIYEYMANGSL 543 (768)
Q Consensus 470 ~LG~G~fG-~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~--~~~~~lV~E~~~~gsL 543 (768)
.+..|..| .||+... .+..+++|+-... ....+.+|..+|+.+. +--+-++++++ .+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 35555554 6898765 4567999987533 3446788999998874 21234455554 3345999999999888
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-------------------------------------------
Q 035604 544 EDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP------------------------------------------- 580 (768)
Q Consensus 544 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~------------------------------------------- 580 (768)
.+..... ......++.+++..|..||...+
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7755321 12233566677777777775421
Q ss_pred ------------CCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 581 ------------EPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 581 ------------~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 138999999999999988777899999885
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=1.7e-05 Score=84.78 Aligned_cols=138 Identities=19% Similarity=0.228 Sum_probs=78.9
Q ss_pred ceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-----CCceeeee-c----cccCCceeEEEec
Q 035604 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-----HPNMVLLL-G----ACPEFGCLIYEYM 538 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~-g----~~~~~~~lV~E~~ 538 (768)
+.|+.|..+.||+....+..+++|+..... ..+..|..++..|. .|.++... | ......++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 456667789999988877779999997532 23445555555442 34444311 1 1233458999999
Q ss_pred cCCChH--------------HHHhhc-CCC--C--------CCCHHHHH-------------------------------
Q 035604 539 ANGSLE--------------DRLFRR-GGS--P--------VLPWQIRF------------------------------- 562 (768)
Q Consensus 539 ~~gsL~--------------~~l~~~-~~~--~--------~l~~~~~~------------------------------- 562 (768)
+|..+. ..+... ... + ...|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986442 111111 000 0 11222110
Q ss_pred HHHHHHHHHHHHHHh----------CCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 563 RIAAEIATALLFLHQ----------TKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 563 ~i~~qi~~aL~~LH~----------~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.+...+..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666663 123469999999999999888899999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.86 E-value=4.4e-05 Score=84.62 Aligned_cols=73 Identities=14% Similarity=0.166 Sum_probs=46.1
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCch---------hhHHHHHHHHHHHh-hcCCCceeeeeccccCCceeEEEe
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAA---------QGRSQFQQEVEVLC-NIRHPNMVLLLGACPEFGCLIYEY 537 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~---------~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~~~~lV~E~ 537 (768)
.+.||.|..+.||+....+..++||...+... .....+..|+..+. ......+.+++.+.....++||||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~~~~~~lv~e~ 118 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFDRTMALIGMRY 118 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEETTTTEEEECC
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEECCCccEEEEee
Confidence 46789999999999987778899995332110 12223334433322 122334556666666677999999
Q ss_pred c-cC
Q 035604 538 M-AN 540 (768)
Q Consensus 538 ~-~~ 540 (768)
+ ++
T Consensus 119 l~~g 122 (420)
T 2pyw_A 119 LEPP 122 (420)
T ss_dssp CCTT
T ss_pred cCCc
Confidence 9 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00015 Score=76.39 Aligned_cols=138 Identities=14% Similarity=0.160 Sum_probs=78.3
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-eeeeccccCCceeEEEec-cCCChHH
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-VLLLGACPEFGCLIYEYM-ANGSLED 545 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~-~~gsL~~ 545 (768)
.+.|+.|....+|+. ..+++|+....... .-...+|..+++.+..-++ .++++.+.+..++++||+ +|.++..
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l~~ 97 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTMSP 97 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEECCH
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccCCH
Confidence 678999999999998 77999988653211 1123568777777642222 456666777789999999 6544432
Q ss_pred H---------------Hhh-cCCCCCCC-----HHHHHHHHH--------------HHHHHHH----HHHh-CCCCCeee
Q 035604 546 R---------------LFR-RGGSPVLP-----WQIRFRIAA--------------EIATALL----FLHQ-TKPEPLVH 585 (768)
Q Consensus 546 ~---------------l~~-~~~~~~l~-----~~~~~~i~~--------------qi~~aL~----~LH~-~~~~~iiH 585 (768)
. |.+ +.....+. +.....+.. .+...+. .|.. ..+..++|
T Consensus 98 ~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~H 177 (301)
T 3dxq_A 98 EKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAACH 177 (301)
T ss_dssp HHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEEC
T ss_pred hhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceeec
Confidence 1 111 00000011 111111110 0111111 1111 22345899
Q ss_pred CCCCCCCeEEcCCCcEEEeecccccc
Q 035604 586 RDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
+|+.|.||+ ..++.+.|+||..+..
T Consensus 178 gDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 178 CDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp SCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred cCCCcCCEE-ECCCCEEEEecccccC
Confidence 999999999 5566789999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00021 Score=74.63 Aligned_cols=77 Identities=21% Similarity=0.194 Sum_probs=55.1
Q ss_pred CCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCC--C-ceeeeeccccCCceeEEEeccC
Q 035604 465 FSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH--P-NMVLLLGACPEFGCLIYEYMAN 540 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--p-nIv~l~g~~~~~~~lV~E~~~~ 540 (768)
..-...+|.|..+.||+... +|+.|.+|+...........|..|...|+.|.- + .+.+++++ +..++||||+++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~~lv~e~l~~ 94 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETTEEEEECCCC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCceEEEEeecc
Confidence 44467799999999999987 678999998765444444568899999988742 1 23344443 345899999987
Q ss_pred CCh
Q 035604 541 GSL 543 (768)
Q Consensus 541 gsL 543 (768)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00053 Score=72.61 Aligned_cols=158 Identities=13% Similarity=0.209 Sum_probs=88.9
Q ss_pred ccCCHHHHHHHhcCCCc-----cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCc--eeee
Q 035604 451 RKYSIEEIEEATENFSN-----SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN--MVLL 523 (768)
Q Consensus 451 ~~~~~~ei~~~~~~y~~-----~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l 523 (768)
...+.+++......|.+ .+.|+.|....+|+....+..+++|+..... ....+..|+.++..+...+ +.++
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 34556666666666654 2456678888999988766689999987531 2234667777777664211 2222
Q ss_pred ecc--------ccCCceeEEEeccCCChH-----------H---HHhhcC---CCCC---C---CHHHHHH---------
Q 035604 524 LGA--------CPEFGCLIYEYMANGSLE-----------D---RLFRRG---GSPV---L---PWQIRFR--------- 563 (768)
Q Consensus 524 ~g~--------~~~~~~lV~E~~~~gsL~-----------~---~l~~~~---~~~~---l---~~~~~~~--------- 563 (768)
+.. .....+++|+|++|..+. . .+.... ..+. . .|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 221 123347899999875431 0 111111 0000 1 1221110
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 564 ---IAAEIATALLFLHQT----KPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 564 ---i~~qi~~aL~~LH~~----~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
+...+...+.+++.. .+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455556532 23469999999999999887666899999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00025 Score=75.28 Aligned_cols=136 Identities=18% Similarity=0.239 Sum_probs=86.5
Q ss_pred cceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcC---CCceeeeecccc--CCceeEEEeccCCC
Q 035604 468 SRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR---HPNMVLLLGACP--EFGCLIYEYMANGS 542 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~--~~~~lV~E~~~~gs 542 (768)
.+.|+.|....+|+...++..+++|+.... ....+..|...|+.|. ...+.+++.++. ...++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 467899999999999888888999987643 2456888999888874 244566665553 34599999999875
Q ss_pred hH--------HH---HhhcCCCC-------------------CCCHHHHH---HHH----------------HHHHHHH-
Q 035604 543 LE--------DR---LFRRGGSP-------------------VLPWQIRF---RIA----------------AEIATAL- 572 (768)
Q Consensus 543 L~--------~~---l~~~~~~~-------------------~l~~~~~~---~i~----------------~qi~~aL- 572 (768)
+. .. |....... .-+|...+ ++. ..++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 42 11 22211100 01343321 111 1112112
Q ss_pred HHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 573 LFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 573 ~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..|.. ..++.+||+|+.+.|++++.++ +.|+||+
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23322 2235699999999999999887 8899984
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0011 Score=70.61 Aligned_cols=141 Identities=12% Similarity=0.061 Sum_probs=73.7
Q ss_pred ceecccCcee-EEEEEEC-CccEEEEEEcCCchhhHHHHHHHHHHHhhcCC--CceeeeeccccCCceeEEEeccCCChH
Q 035604 469 RKIGEGGYGP-VYKSYLD-HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH--PNMVLLLGACPEFGCLIYEYMANGSLE 544 (768)
Q Consensus 469 ~~LG~G~fG~-Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~lV~E~~~~gsL~ 544 (768)
+.|+.|+... +|+.... +..+++|....... ..+..|+.++..+.. -.+.+++.+..+..+++||++.+..+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFT 100 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchH
Confidence 3465554444 6677664 67787776543321 234566776666532 123455555555668999999776665
Q ss_pred HHHhhcC-----------------------CCCCCCHHHHH-------H-H------------HHHHHHHHHHHH---hC
Q 035604 545 DRLFRRG-----------------------GSPVLPWQIRF-------R-I------------AAEIATALLFLH---QT 578 (768)
Q Consensus 545 ~~l~~~~-----------------------~~~~l~~~~~~-------~-i------------~~qi~~aL~~LH---~~ 578 (768)
+.+.... ..+.+...... . + ...+...+..|. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 4332110 01112111100 0 0 001112222221 12
Q ss_pred CCCCeeeCCCCCCCeEEcCC----CcEEEeeccccccc
Q 035604 579 KPEPLVHRDLKPGNILLDRN----YVSKISDVGLARLV 612 (768)
Q Consensus 579 ~~~~iiHrDLKp~NILl~~~----~~vKL~DFGla~~~ 612 (768)
.+..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 34569999999999999874 68899999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00044 Score=76.82 Aligned_cols=71 Identities=15% Similarity=0.203 Sum_probs=48.4
Q ss_pred cceecccCceeEEEEEEC---------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-eeeeccccCCceeEEEe
Q 035604 468 SRKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-VLLLGACPEFGCLIYEY 537 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~ 537 (768)
.+.|+.|-...||+.... +..+++|+...... ...+.+|..++..|...++ .++++.+.+ .+||+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~--g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--CEEEEE
Confidence 356888888999998864 36799999853211 1345579998888753333 466666654 489999
Q ss_pred ccCCC
Q 035604 538 MANGS 542 (768)
Q Consensus 538 ~~~gs 542 (768)
++|..
T Consensus 154 l~G~~ 158 (429)
T 1nw1_A 154 IPSRP 158 (429)
T ss_dssp CCEEE
T ss_pred eCCcc
Confidence 98643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0011 Score=74.07 Aligned_cols=73 Identities=16% Similarity=0.135 Sum_probs=48.2
Q ss_pred cceecccCceeEEEEEECC--ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-eeeeccccCCceeEEEeccCCCh
Q 035604 468 SRKIGEGGYGPVYKSYLDH--TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-VLLLGACPEFGCLIYEYMANGSL 543 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~--~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~~~gsL 543 (768)
.+.|+.|-...+|+....+ ..+++|+....... .-+..+|..++..|...++ .++++.+. ..+||||++|..|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--NGRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--TEEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--CeEEEEeeCCccC
Confidence 4568888889999998866 78999987543211 1112588899988865444 46677664 3469999987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0074 Score=63.84 Aligned_cols=159 Identities=14% Similarity=0.138 Sum_probs=88.0
Q ss_pred ccccCCHHHHHHHhcCCCc-----cceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCC--ce
Q 035604 449 RYRKYSIEEIEEATENFSN-----SRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHP--NM 520 (768)
Q Consensus 449 ~~~~~~~~ei~~~~~~y~~-----~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp--nI 520 (768)
.+...+.+.+......|.+ ...|+ |....||+... ++..+++|+.++.. .....+..|..++..+... .+
T Consensus 7 ~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 7 TFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 3455566666555555532 34566 77889998776 45689999997432 1234567788888777421 23
Q ss_pred eeeecc-------ccCCceeEEEeccCCChH-----H------H---Hhhc----C--CCCCCCHHHH----HHH-----
Q 035604 521 VLLLGA-------CPEFGCLIYEYMANGSLE-----D------R---LFRR----G--GSPVLPWQIR----FRI----- 564 (768)
Q Consensus 521 v~l~g~-------~~~~~~lV~E~~~~gsL~-----~------~---l~~~----~--~~~~l~~~~~----~~i----- 564 (768)
.+++.. .....++||+|++|..+. . . +... . ..+.+++... ..+
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 334332 112236799999875431 1 1 1110 0 0111222111 001
Q ss_pred ----------HHHHHHHHHHHHhC----CCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 565 ----------AAEIATALLFLHQT----KPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 565 ----------~~qi~~aL~~LH~~----~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
...+-..+..+... .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 234589999999999998 4 899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00079 Score=72.95 Aligned_cols=72 Identities=18% Similarity=0.193 Sum_probs=43.7
Q ss_pred cceecccCceeEEEEEECC----------ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-eeeeccccCCceeEEE
Q 035604 468 SRKIGEGGYGPVYKSYLDH----------TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-VLLLGACPEFGCLIYE 536 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~----------~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E 536 (768)
.+.|+.|..-.+|+....+ ..+++|+....... ......|..+++.+...++ .++++.+ ..++||+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~~~v~e 114 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NGGRIEE 114 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CCcEEEE
Confidence 3567778888999988754 57888887643221 1124578888887753333 3555544 3578999
Q ss_pred eccCCC
Q 035604 537 YMANGS 542 (768)
Q Consensus 537 ~~~~gs 542 (768)
|++|..
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0013 Score=71.62 Aligned_cols=140 Identities=19% Similarity=0.230 Sum_probs=81.5
Q ss_pred ceecccCceeEEEEEEC---------CccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccccCCceeEEEec
Q 035604 469 RKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPEFGCLIYEYM 538 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~lV~E~~ 538 (768)
+.|..|-...+|+.... +..|++|+.-.. ......+.+|..+++.|. +.-..++++.+.+ .+||||+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g~v~e~i 132 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--GRLEQYI 132 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--EEEEECC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--ccEEEEe
Confidence 45766777889988763 367899986332 223455678999988874 2222456666665 3999999
Q ss_pred cCCChH--------------HHHhhcCC-----CCCC--CHHHHHHHHHHHHH-------------------HHHHH---
Q 035604 539 ANGSLE--------------DRLFRRGG-----SPVL--PWQIRFRIAAEIAT-------------------ALLFL--- 575 (768)
Q Consensus 539 ~~gsL~--------------~~l~~~~~-----~~~l--~~~~~~~i~~qi~~-------------------aL~~L--- 575 (768)
+|..|. ..|.+-.. .... -+.++.++..++-. .+.+|
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 875542 11111000 1111 23445555544322 22333
Q ss_pred -HhC-CCCCeeeCCCCCCCeEEcCC----CcEEEeecccccc
Q 035604 576 -HQT-KPEPLVHRDLKPGNILLDRN----YVSKISDVGLARL 611 (768)
Q Consensus 576 -H~~-~~~~iiHrDLKp~NILl~~~----~~vKL~DFGla~~ 611 (768)
... .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 23459999999999999876 7899999998863
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0084 Score=59.36 Aligned_cols=100 Identities=16% Similarity=0.100 Sum_probs=65.8
Q ss_pred CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 541 GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 541 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
-+|.++|...+. +++++++|-++.|.+.+|.-+-. ..+ ..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~~---~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQP---RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCC---CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcccC---CceecCCcceEEecCCceeccc-cccc---------
Confidence 379999987764 69999999999999999877622 221 1223447899999999987764 2110
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCC
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAK 665 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~ 665 (768)
.....+.+||... ...+.+.=|||||+++|.-+--.
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122466888653 34467889999999999987633
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.99 E-value=0.022 Score=60.83 Aligned_cols=32 Identities=28% Similarity=0.324 Sum_probs=28.3
Q ss_pred CCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 581 ~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
..++|+|+.+.|||++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999988653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.48 E-value=0.013 Score=64.67 Aligned_cols=140 Identities=12% Similarity=0.147 Sum_probs=82.6
Q ss_pred cceecccCceeEEEEEEC---------CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCc-eeeeeccccCCceeEEEe
Q 035604 468 SRKIGEGGYGPVYKSYLD---------HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN-MVLLLGACPEFGCLIYEY 537 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~lV~E~ 537 (768)
.+.|..|-...+|+.... +..|++|+....... .-+..+|..+++.+..-+ ..++++.+ ..++||+|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~~~I~ef 151 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PEGRIEEF 151 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEEC
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CCCEEEEE
Confidence 345766777889988875 578999986543211 112357888888774222 33455444 35889999
Q ss_pred ccCCChHH--------------HHhh-----c-----C---CCCCCCHHHHHHHHHHH-------------------HHH
Q 035604 538 MANGSLED--------------RLFR-----R-----G---GSPVLPWQIRFRIAAEI-------------------ATA 571 (768)
Q Consensus 538 ~~~gsL~~--------------~l~~-----~-----~---~~~~l~~~~~~~i~~qi-------------------~~a 571 (768)
++|..|.. .|.+ . . ...+..+..+.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99865321 1110 0 0 11111244443443222 222
Q ss_pred HHHHHh---------------------CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 572 LLFLHQ---------------------TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 572 L~~LH~---------------------~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
+.+|.. ..+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333321 12345899999999999 7888999999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.26 E-value=0.32 Score=52.95 Aligned_cols=29 Identities=28% Similarity=0.410 Sum_probs=25.1
Q ss_pred eeeCCCCCCCeEE------cCCCcEEEeecccccc
Q 035604 583 LVHRDLKPGNILL------DRNYVSKISDVGLARL 611 (768)
Q Consensus 583 iiHrDLKp~NILl------~~~~~vKL~DFGla~~ 611 (768)
++|+|+.+.|||+ +.+..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998864
|
| >3a2k_A TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, ligase/RNA complex; 3.65A {Geobacillus kaustophilus} | Back alignment and structure |
|---|
Probab=88.77 E-value=0.95 Score=50.31 Aligned_cols=97 Identities=15% Similarity=0.224 Sum_probs=66.6
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
..+|+||+-|-..|..++.++.++....+-.|+++||..... + . ...+..+.+
T Consensus 18 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~~~v~avhvdhglr------g----------~-----------~s~~~~~~v 70 (464)
T 3a2k_A 18 GAAVIVGVSGGPDSLALLHVFLSLRDEWKLQVIAAHVDHMFR------G----------R-----------ESEEEMEFV 70 (464)
T ss_dssp SSBEEEECCSSHHHHHHHHHHHHHHHTTTCBCEEEEEECTTC------T----------H-----------HHHHHHHHH
T ss_pred CCEEEEEEcCcHHHHHHHHHHHHHHHHcCCeEEEEEEECCCC------c----------c-----------ccHHHHHHH
Confidence 578999999999999988888777666688999999963210 0 0 111223455
Q ss_pred HHHhhhcCceeEEEEEec-------C-CH--------HHHHHHHHHhcCCCEEEeecCCC
Q 035604 90 RCFCTRKEIKCKEIVLED-------T-DI--------AKALIDYVSSHTIETLVLGAASR 133 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~-------G-~~--------a~~Iv~~a~~~~aDlIVmGs~g~ 133 (768)
...|...||++....+.. | .+ ...+.++|.+.+++.|++|.|..
T Consensus 71 ~~~~~~lgi~~~v~~~~~~~~~~~~~~~~e~~aR~~Ry~~l~~~a~~~g~~~IatgH~~d 130 (464)
T 3a2k_A 71 KRFCVERRILCETAQIDVPAFQRSAGLGAQEAARICRYRFFAELMEKHQAGYVAVGHHGD 130 (464)
T ss_dssp HHHHHHTTCEEEEEECCCHHHHTTTTCCSHHHHHHHHHHHHHHHHHTTTCCEEECCCCHH
T ss_pred HHHHHHcCCcEEEEEechhhhhhccCCCHHHHHHHHHHHHHHHHHHHcCcCEEEEeCChH
Confidence 667788899865544431 1 11 14556788889999999999854
|
| >1wy5_A TILS, hypothetical UPF0072 protein AQ_1887; N-type ATP-ppase, structural genomics, translation, NPPSFA; 2.42A {Aquifex aeolicus} SCOP: c.26.2.5 d.229.1.1 PDB: 2e21_A* 2e89_A* | Back alignment and structure |
|---|
Probab=84.24 E-value=2.2 Score=44.64 Aligned_cols=96 Identities=13% Similarity=0.044 Sum_probs=62.1
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCe-EEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQN-LTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVP 88 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~-l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 88 (768)
.++|+||+-|-..|..++..+.+.....|-. |+++||..... . . ..+..+.
T Consensus 24 ~~~vlva~SGG~DS~~Ll~ll~~~~~~~g~~~v~av~vd~g~r---~-------------~------------s~~~~~~ 75 (317)
T 1wy5_A 24 ERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR---E-------------S------------AERDEEF 75 (317)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS---T-------------H------------HHHHHHH
T ss_pred CCEEEEEecchHHHHHHHHHHHHHHHHcCCCEEEEEEEECCCC---c-------------c------------cHHHHHH
Confidence 5789999999999998888777665555777 99999963210 0 0 1111234
Q ss_pred HHHHhhhcCceeEEEEEec-------C-CH---H-----HHHHHHHHhcCCCEEEeecCCC
Q 035604 89 FRCFCTRKEIKCKEIVLED-------T-DI---A-----KALIDYVSSHTIETLVLGAASR 133 (768)
Q Consensus 89 ~~~~~~~~gv~~~~~~v~~-------G-~~---a-----~~Iv~~a~~~~aDlIVmGs~g~ 133 (768)
+...|...||++..+.+.. | ++ + ..+.++|.+.+++.|++|.|..
T Consensus 76 v~~~a~~lgi~~~v~~~~~~~~~~~~~~~~e~~ar~~Ry~~l~~~a~~~g~~~i~~Gh~~d 136 (317)
T 1wy5_A 76 CKEFAKERNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (317)
T ss_dssp HHHHHHHHTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred HHHHHHHcCCcEEEEEEechhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEeCchh
Confidence 4556667788754443321 1 11 1 2455778889999999999853
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.91 E-value=1.9 Score=42.60 Aligned_cols=115 Identities=13% Similarity=0.105 Sum_probs=72.8
Q ss_pred CCCceeeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeCCCCCCCeE
Q 035604 516 RHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL-FLHQTKPEPLVHRDLKPGNIL 594 (768)
Q Consensus 516 ~HpnIv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~~~iiHrDLKp~NIL 594 (768)
.||++-.-+..-.+...+.|+.-+++.-...+. .++...+++++.+|+.... +++. -+|-=|.|+||+
T Consensus 48 ~~~~f~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCIVRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSSEEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCCCeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 577773333333333444455443443333342 2778999999999888665 4443 578889999999
Q ss_pred EcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 035604 595 LDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMG 669 (768)
Q Consensus 595 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~ 669 (768)
++.++.++|.-.|+-..+++-. +.+| -=+-.+=|++..++.++..|.
T Consensus 117 f~~~~~p~i~hRGi~~~lpP~e------------------~~ee----------~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESLPPDE------------------WDDE----------RLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTTBSSCS------------------CCHH----------HHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCcccCCCCC------------------CCHH----------HHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999888754332110 1112 112356678888888888773
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.42 E-value=1.9 Score=42.44 Aligned_cols=115 Identities=12% Similarity=0.072 Sum_probs=72.6
Q ss_pred CCCceeeeeccccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 516 RHPNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 516 ~HpnIv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
.||+++.. ..-.+..-+++.|-...+...+-.-. .++...+++++.+|+....+++. =+|-=|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 57877744 22222234444443333222222111 27788999999999987755543 4788899999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCC
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM 668 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf 668 (768)
+.++.++|.-.|+-..+++. .++...=+-.+=|++..+++++..|
T Consensus 113 ~~~~~p~i~~RGik~~l~P~----------------------------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVDPL----------------------------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CTTSCEEESCCEETTTBSCC----------------------------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred cCCCCEEEEEccCccCCCCC----------------------------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999988875433211 1111122335668888999999888
|
| >2xry_A Deoxyribodipyrimidine photolyase; DNA damage, DNA repair; HET: FAD; 1.50A {Methanosarcina mazei} PDB: 2xrz_A* | Back alignment and structure |
|---|
Probab=82.38 E-value=3.6 Score=45.82 Aligned_cols=87 Identities=11% Similarity=0.041 Sum_probs=60.1
Q ss_pred CcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHHHHHhhhcCceeE
Q 035604 22 GSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCK 101 (768)
Q Consensus 22 ~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~gv~~~ 101 (768)
.-..||..|++.+...+..|+.|.|+++.... . ... -..-..+-|..+.+.+++.|+.
T Consensus 50 ~DN~aL~~A~~~a~~~~~~v~~vfi~dp~~~~---~---------~~~--------r~~Fl~~sL~~L~~~L~~~G~~-- 107 (482)
T 2xry_A 50 EDNWALLFSRAIAKEANVPVVVVFCLTDEFLE---A---------GIR--------QYEFMLKGLQELEVSLSRKKIP-- 107 (482)
T ss_dssp SSCHHHHHHHHHHHHHTSCEEEEEEECTTGGG---S---------CHH--------HHHHHHHHHHHHHHHHHHTTCC--
T ss_pred cccHHHHHHHHHHHHcCCcEEEEEEeChhhhc---c---------CHH--------HHHHHHHHHHHHHHHHHHcCCc--
Confidence 34568888887765557789999999764211 0 001 1112345566666677778887
Q ss_pred EEEEecCCHHHHHHHHHHhcCCCEEEeecC
Q 035604 102 EIVLEDTDIAKALIDYVSSHTIETLVLGAA 131 (768)
Q Consensus 102 ~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~ 131 (768)
.++..|++.++|.+++++++++.|+.-..
T Consensus 108 -L~v~~g~~~~~l~~l~~~~~~~~V~~~~~ 136 (482)
T 2xry_A 108 -SFFLRGDPGEKISRFVKDYNAGTLVTDFS 136 (482)
T ss_dssp -EEEEESCHHHHHHHHHHHTTCSEEEEECC
T ss_pred -EEEEeCCHHHHHHHHHHHcCCCEEEEecc
Confidence 34556999999999999999999998554
|
| >2iel_A Hypothetical protein TT0030; TT0030,thermus thermophilus, structural genomics, PSI, protein structure initiative; 1.60A {Thermus thermophilus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=80.56 E-value=4 Score=36.76 Aligned_cols=81 Identities=16% Similarity=0.138 Sum_probs=62.1
Q ss_pred hhHHHHHhHHHHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcC--CCEEEeecCCCCCceeccccCCCcccccccCCC
Q 035604 78 VDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHT--IETLVLGAASRTGFVKRFKTADIPSNVSKGAPD 155 (768)
Q Consensus 78 ~~~~~~~~l~~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~--aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~ 155 (768)
.++.+++.|+.....++..|+.+.+..+.+++|-.+|.+.....+ +|=||+-+.-+ ...+. |.-+++++.-+ .-
T Consensus 52 a~~~A~~~l~~sl~aL~~~G~~a~~G~v~d~~Pl~AL~~~v~~~~~~~deiIV~T~Ph-~vs~~-fh~DwasrAr~-~g- 127 (138)
T 2iel_A 52 VRRRAEEEAAAAKRALEAQGIPVEEAKAGDISPLLAIEEELLAHPGAYQGIVLSTLPP-GLSRW-LRLDVHTQAER-FG- 127 (138)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCCCSEEEEEESSHHHHHHHHHHHSTTSCSEEEEEECCT-TTCHH-HHTTHHHHGGG-GS-
T ss_pred HHHHHHHHHHHHHHHHHHcCCcccccccCCCChHHHHHHHHHhcCCCCceEEEEcCCc-hHHHH-HhccHHHHHHh-cC-
Confidence 445566777777777788899977466777999999999999999 99999999877 55544 44488887766 44
Q ss_pred ceeEEEEe
Q 035604 156 YCNVYVIG 163 (768)
Q Consensus 156 ~C~VlvV~ 163 (768)
.||+-+-
T Consensus 128 -vPVlhl~ 134 (138)
T 2iel_A 128 -LPVIHVI 134 (138)
T ss_dssp -SCEEEEE
T ss_pred -CCEEEEe
Confidence 7887664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 768 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d2gm3a1 | 171 | c.26.2.4 (A:5-175) Putative ethylene-responsive pr | 9e-09 | |
| d1mjha_ | 160 | c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archa | 1e-05 | |
| d2z3va1 | 135 | c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 { | 2e-05 | |
| d1tq8a_ | 147 | c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobac | 8e-05 | |
| d1q77a_ | 138 | c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex | 1e-04 | |
| d1jmva_ | 140 | c.26.2.4 (A:) Universal stress protein A, UspA {Ha | 5e-04 | |
| d1f5na1 | 300 | a.114.1.1 (A:284-583) Interferon-induced guanylate | 8e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 1e-66
Identities = 73/294 (24%), Positives = 125/294 (42%), Gaps = 28/294 (9%)
Query: 456 EEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDA--AQGRSQFQQEVEVLC 513
++ E + ++IG G +G VYK H VA+K+L A Q F+ EV VL
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 514 NIRHPNMVLLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
RH N++L +G ++ ++ SL L IA + A +
Sbjct: 60 KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
+LH + ++HRDLK NI L + KI D GLA + ++ +G+
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS----RWSGSHQFEQLSGSI 170
Query: 633 CYIDPEY---QQTGMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIENGTFDET 686
++ PE Q +SDVY+ GI+L +++T + P + Q+ + G
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMP 740
L + P + +L +C + +R +RP ++ L + LA ++P
Sbjct: 231 LSKVRSNCPKA----MKRLMAECLKKKRDERPLFPQI----LASIELLA-RSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-59
Identities = 77/264 (29%), Positives = 113/264 (42%), Gaps = 17/264 (6%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
E ++G G +G V+ Y HT VA+K L+ + F E ++ ++H +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 522 LLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP 580
L + +I EYM NGSL D L G L +AA+IA + F+ +
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE--- 127
Query: 581 EPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQ 640
+HRDL+ NIL+ KI+D GLARL+ + A + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-----EYTAREGAKFPIKWTAPEAI 182
Query: 641 QTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEAL 700
G +KSDV+S GILL +I+T I+N + PD EE
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--LERGYRMVRPDNCPEE-- 238
Query: 701 ILAKLALQCAELRRKDRPDLGKVV 724
L +L C + R +DRP +
Sbjct: 239 -LYQLMRLCWKERPEDRPTFDYLR 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-57
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 458 IEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG-RSQFQQEVEVLCN 514
+E ++F ++G G G V+K + +A K++ + R+Q +E++VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 515 IRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
P +V GA G + E+M GSL+ L + G +P QI +++ + L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
+L + ++HRD+KP NIL++ K+ D G++ + S S GT
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTR 167
Query: 633 CYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
Y+ PE Q V+SD++S+G+ L+++ + P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 7e-57
Identities = 67/265 (25%), Positives = 108/265 (40%), Gaps = 23/265 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVL 522
+ + IG+G +G V VA+K ++ DA F E V+ +RH N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 523 LLGACPEFG---CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
LLG E ++ EYMA GSL D L RG S L + + ++ A+ +L
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG-- 121
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
VHRDL N+L+ + V+K+SD GL + + + + PE
Sbjct: 122 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPEA 171
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEA 699
+ KSDV+S GILL +I + ++ + ++ PD
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VEKGYKMDAPDGCPPA- 228
Query: 700 LILAKLALQCAELRRKDRPDLGKVV 724
+ ++ C L RP ++
Sbjct: 229 --VYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-56
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 23/277 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
+ ++IG G +G V+ Y + VAIK +R A F +E EV+ + HP +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 522 LLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
L G C E CL++E+M +G L D + R + + + ++ + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
++HRDL N L+ N V K+SD G+ R V T + PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWASPEV 173
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEA 699
KSDV+S G+L+ ++ + +E+ P
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--ISTGFRLYKPRLASTH- 230
Query: 700 LILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAE 736
+ ++ C + R +DRP ++ L L +AE
Sbjct: 231 --VYQIMNHCWKERPEDRPAFSRL----LRQLAEIAE 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 1e-55
Identities = 73/290 (25%), Positives = 117/290 (40%), Gaps = 30/290 (10%)
Query: 453 YSIEEIEEATENFSNS---------RKIGEGGYGPVYKSYLDHT-----PVAIKVLRPDA 498
++ E+ EA F+ + IG G +G V +L VAIK L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 499 -AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPV 555
+ R F E ++ HPN++ L G + +I E+M NGSL+ L + G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 556 LPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615
+ IA + +L VHRDL NIL++ N V K+SD GL+R +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQV 674
+D T + PE Q SDV+S GI++ ++++ + P
Sbjct: 182 TSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 675 ERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+ + P++ L +L L C + R RP G++V
Sbjct: 241 D------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-55
Identities = 83/305 (27%), Positives = 128/305 (41%), Gaps = 28/305 (9%)
Query: 445 TVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT-PVAIKVLRPDAAQGRS 503
T L + I E+ K+G+G +G V+ + T VAIK L+P
Sbjct: 4 TQGLAKDAWEIPR-----ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 57
Query: 504 QFQQEVEVLCNIRHPNMVLLLGAC-PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRF 562
F QE +V+ +RH +V L E ++ EYM+ GSL D L G +
Sbjct: 58 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLV 116
Query: 563 RIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQ 622
+AA+IA+ + ++ + VHRDL+ NIL+ N V K++D GLARL+ +
Sbjct: 117 DMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EY 168
Query: 623 YRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIE 679
A + PE G +KSDV+S GILL ++ T + +V +E
Sbjct: 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228
Query: 680 NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETM 739
G + P P+ L L QC ++RP + + + +
Sbjct: 229 RG-YRMPCPPECPES-------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
Query: 740 PAINL 744
P NL
Sbjct: 281 PGENL 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-55
Identities = 58/265 (21%), Positives = 108/265 (40%), Gaps = 19/265 (7%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
++ + +++G G +G V VAIK+++ + +F +E +V+ N+ H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 522 LLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
L G C + +I EYMANG L + L Q + ++ A+ +L
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
+ +HRDL N L++ V K+SD GL+R V + + PE
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEV 172
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEA 699
KSD+++ G+L+ +I + + E+ + L P E+
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLASEK- 229
Query: 700 LILAKLALQCAELRRKDRPDLGKVV 724
+ + C + +RP ++
Sbjct: 230 --VYTIMYSCWHEKADERPTFKILL 252
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-55
Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 26/279 (9%)
Query: 456 EEIEEATENFS-NSRKIGEGGYGPVYKSYL----DHTPVAIKVLRPDAAQG-RSQFQQEV 509
+++ +N ++G G +G V + VAIKVL+ + + +E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 510 EVLCNIRHPNMVLLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEI 568
+++ + +P +V L+G C L+ E G L L + +P + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQV 118
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
+ + +L + + VHRDL N+LL + +KISD GL++ + D ++
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAG 172
Query: 629 AGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA-KPPMGLAHQVE--RSIENGTFDE 685
+ PE +SDV+S G+ + + ++ + P E IE G
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-- 230
Query: 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
P+ P E L L C + +DRPD V
Sbjct: 231 --MECPPECPPE----LYALMSDCWIYKWEDRPDFLTVE 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (480), Expect = 5e-55
Identities = 79/314 (25%), Positives = 125/314 (39%), Gaps = 47/314 (14%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQG-RSQF 505
+ +E N R IGEG +G V+++ T VA+K+L+ +A+ ++ F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 506 QQEVEVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRG------------ 551
Q+E ++ +PN+V LLG C CL++EYMA G L + L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 552 ---------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSK 602
G P L + IA ++A + +L + K VHRDL N L+ N V K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVK 180
Query: 603 ISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQII 662
I+D GL+R + + + A ++ PE +SDV++ G++L +I
Sbjct: 181 IADFGLSRNIYSADYYKAD----GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 663 TAKPPMGLAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGK 722
+ E D + P L L L C DRP
Sbjct: 237 SYGLQPYYGMAHEE-----VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 723 VVVPKLNILRALAE 736
+ IL+ + E
Sbjct: 292 IH----RILQRMCE 301
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-54
Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 48/295 (16%)
Query: 444 LTVDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA-- 499
++ D R+ K+ +IG G + VYK T VA L+
Sbjct: 4 MSNDGRFLKFD--------------IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 49
Query: 500 QGRSQFQQEVEVLCNIRHPNMVLLLGACPEFG------CLIYEYMANGSLEDRLFRRGGS 553
R +F++E E+L ++HPN+V + L+ E M +G+L+ L R
Sbjct: 50 SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-- 107
Query: 554 PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL-DRNYVSKISDVGLARLV 612
V+ ++ +I L FLH P P++HRDLK NI + KI D+GLA L
Sbjct: 108 -VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165
Query: 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP---MG 669
S A +V GT ++ PE + DVY+ G+ +L++ T++ P
Sbjct: 166 RASFAKAV--------IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ 216
Query: 670 LAHQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
A Q+ R + +G + D + ++ C + +R + ++
Sbjct: 217 NAAQIYRRVTSGVKPASFDKVAIPE-------VKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 8e-54
Identities = 67/275 (24%), Positives = 108/275 (39%), Gaps = 27/275 (9%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHP 518
E++ IG G YG K D + K L + + EV +L ++HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 519 NMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGS-PVLPWQIRFRIAAEIATALL 573
N+V + ++ EY G L + + L + R+ ++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 574 FLHQ--TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
H+ ++HRDLKP N+ LD K+ D GLAR++ + GT
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH------DTSFAKAFVGT 177
Query: 632 FCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDP 689
Y+ PE KSD++SLG LL ++ PP Q E I G F
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----R 232
Query: 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+P +E L ++ + L+ RP + +++
Sbjct: 233 RIPYRYSDE---LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 1e-53
Identities = 70/292 (23%), Positives = 125/292 (42%), Gaps = 23/292 (7%)
Query: 451 RKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQE 508
+ ++ E + + K+G G YG VY+ VA+K L+ D + +F +E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 509 VEVLCNIRHPNMVLLLGACPEFGCLI--YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAA 566
V+ I+HPN+V LLG C E+M G+L D L + + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMAT 122
Query: 567 EIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMT 626
+I++A+ +L + + +HRDL N L+ N++ K++D GL+RL+ T
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHA 174
Query: 627 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDET 686
A + PE +KSDV++ G+LL +I T + + E ++
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--LEKD 232
Query: 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEET 738
P+ E+ + +L C + DRP ++ + +E+
Sbjct: 233 YRMERPEGCPEK---VYELMRACWQWNPSDRPSFAEIH----QAFETMFQES 277
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 60/301 (19%), Positives = 113/301 (37%), Gaps = 43/301 (14%)
Query: 469 RKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP 528
IG+G +G V++ VA+K+ + + E+ +RH N++ + A
Sbjct: 9 ESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 529 EFG------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ----- 577
+ L+ +Y +GSL D L R + + ++A A+ L LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
+ HRDLK NIL+ +N I+D+GLA + GT Y+ P
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA--TDTIDIAPNHRVGTKRYMAP 181
Query: 638 EYQQTGM------LGVKSDVYSLGILLLQIITAKPPMG-------------LAHQVERSI 678
E + ++D+Y++G++ +I G + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 679 ENGTFDETLDPAVPDW--PVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAE 736
++ L P +P+ E ++AK+ +C R ++ L L++
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK----KTLSQLSQ 297
Query: 737 E 737
+
Sbjct: 298 Q 298
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 77/316 (24%), Positives = 128/316 (40%), Gaps = 30/316 (9%)
Query: 441 LNSLTVDLRYR-KYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT-----PVAIKVL 494
L++L +L ++ + +F+ IG G +G VY L A+K L
Sbjct: 6 LSALNPELVQAVQHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63
Query: 495 RPDAAQG-RSQFQQEVEVLCNIRHPNMVLLLGACPEFG---CLIYEYMANGSLEDRLFRR 550
G SQF E ++ + HPN++ LLG C ++ YM +G L + +
Sbjct: 64 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 551 GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+P + I F + + + VHRDL N +LD + K++D GLAR
Sbjct: 124 THNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA-KPPMG 669
+ DSV T A ++ E QT KSDV+S G+LL +++T PP
Sbjct: 179 DMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 670 LAHQVE--RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPK 727
+ + + G P++ + L ++ L+C + + RP ++V
Sbjct: 237 DVNTFDITVYLLQGR-----RLLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRI 288
Query: 728 LNILRALAEETMPAIN 743
I E +N
Sbjct: 289 SAIFSTFIGEHYVHVN 304
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-53
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 38/289 (13%)
Query: 446 VDLRYRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT----PVAIKVLRPDAAQG 501
V L + ++E+ +++G G +G V K Y VA+K+L+ +A
Sbjct: 1 VYLDRKLLTLED-----------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 49
Query: 502 --RSQFQQEVEVLCNIRHPNMVLLLGAC-PEFGCLIYEYMANGSLEDRLFRRGGSPVLPW 558
+ + E V+ + +P +V ++G C E L+ E G L L + +
Sbjct: 50 ALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH---VKD 106
Query: 559 QIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618
+ + +++ + +L + VHRDL N+LL + +KISD GL++ + D
Sbjct: 107 KNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA---D 160
Query: 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAK--PPMGL-AHQVE 675
T + PE KSDV+S G+L+ + + P G+ +V
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220
Query: 676 RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+E G P E + L C ++RP V
Sbjct: 221 AMLEKG-----ERMGCPAGCPRE---MYDLMNLCWTYDVENRPGFAAVE 261
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-52
Identities = 71/277 (25%), Positives = 113/277 (40%), Gaps = 24/277 (8%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLDHT------PVAIKVLRPDAAQG-RSQFQQEV 509
EI + + IG G +G VYK L + PVAIK L+ + R F E
Sbjct: 3 EIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 510 EVLCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAE 567
++ H N++ L G ++ +I EYM NG+L+ L + G +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRG 118
Query: 568 IATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
IA + +L VHRDL NIL++ N V K+SD GL+R++ D Y +
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED---DPEATYTTSG 172
Query: 628 AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETL 687
+ PE SDV+S GI++ +++T ++
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-----IN 227
Query: 688 DPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
D P++ + +L +QC + R RP +V
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-52
Identities = 63/261 (24%), Positives = 105/261 (40%), Gaps = 28/261 (10%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
++G+G +G VYK+ T A KV+ + + + E+++L + HPN+V LL A
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 527 CPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLV 584
++ E+ A G+++ + L + + AL +LH K ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNK---II 132
Query: 585 HRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM 644
HRDLK GNIL + K++D G++ T R S GT ++ PE
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTR------TIQRRDSFIGTPYWMAPEVVMCET 186
Query: 645 L-----GVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDWPVE 697
K+DV+SLGI L+++ +PP + + I P W
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP--SRWSSN 244
Query: 698 EALILAKLALQCAELRRKDRP 718
+C E R
Sbjct: 245 ----FKDFLKKCLEKNVDARW 261
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-52
Identities = 64/271 (23%), Positives = 109/271 (40%), Gaps = 21/271 (7%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT-----PVAIKVLRPDAA---QGRSQFQQEVEVLCN 514
++ K+G+G +G V + D VA+K L+PD + F +EV + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 515 IRHPNMVLLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
+ H N++ L G ++ E GSL DRL + G R A ++A +
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMG 125
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFC 633
+L + +HRDL N+LL + KI D GL R +P + V Q F
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ---EHRKVPFA 179
Query: 634 YIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD 693
+ PE +T SD + G+ L ++ T + + + + P D
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 694 WPVEEALILAKLALQCAELRRKDRPDLGKVV 724
P + + + +QC + +DRP +
Sbjct: 240 CPQD----IYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-51
Identities = 63/277 (22%), Positives = 114/277 (41%), Gaps = 27/277 (9%)
Query: 454 SIEEIEEATENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEV 511
SI + + + ++ KIG+G G VY + VAI+ + + E+ V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 512 LCNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIA 569
+ ++PN+V L + ++ EY+A GSL D + + E
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
AL FLH + ++HRD+K NILL + K++D G + + Q + ++
Sbjct: 127 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI------TPEQSKRSTMV 177
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIENGTFDET 686
GT ++ PE G K D++SLGI+ +++I +PP + NGT +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKV 723
+ I +C ++ + R ++
Sbjct: 238 NPEKLSA-------IFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-51
Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 39/283 (13%)
Query: 451 RKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDA---AQGRSQF 505
R++++E +F R +G+G +G VY + + +A+KVL A Q
Sbjct: 1 RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 506 QQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFR 563
++EVE+ ++RHPN++ L G LI EY G++ L + Q
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTAT 110
Query: 564 IAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQY 623
E+A AL + H + ++HRD+KP N+LL KI+D G + P S
Sbjct: 111 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 159
Query: 624 RMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENG 681
R T+ GT Y+ PE + M K D++SLG+L + + KPP E + I
Sbjct: 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
Query: 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+ PD+ E A L + + RP L +V+
Sbjct: 220 ------EFTFPDFVTEGA---RDLISRLLKHNPSQRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-50
Identities = 60/262 (22%), Positives = 101/262 (38%), Gaps = 20/262 (7%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPN 519
E++ + +GEG YG V + T VA+K++ A ++E+ + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 520 MVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V G L EY + G L DR+ G +P R ++ +++LH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
+ HRD+KP N+LLD KISD GLA + + + + + GT Y+ P
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL----LNKMCGTLPYVAP 174
Query: 638 EYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWPV 696
E + DV+S GI+L ++ + P + + +T
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 697 EEALILAKLALQCAELRRKDRP 718
L + R
Sbjct: 235 A----PLALLHKILVENPSARI 252
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-50
Identities = 69/288 (23%), Positives = 112/288 (38%), Gaps = 37/288 (12%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQG-RSQFQQEVEVLCN 514
S + +G G +G V ++ VA+K+L+P A R E++VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 515 I-RHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPV---------------L 556
+ H N+V LLGAC G +I EY G L + L R+ S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 557 PWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616
+ + ++A + FL + +HRDL NILL ++KI D GLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK--- 196
Query: 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER 676
+ +A ++ PE + +SDV+S GI L ++ + V+
Sbjct: 197 -NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
E P+ E + + C + RP ++V
Sbjct: 256 KFYK-MIKEGFRMLSPEHAPAE---MYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (443), Expect = 1e-49
Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 31/270 (11%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQG---RSQFQQEVEVLC 513
++ + FS+ R+IG G +G VY + + VAIK + Q +EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 514 NIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATA 571
+RHPN + G L+ EY + + + L +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQG 127
Query: 572 LLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGT 631
L +LH ++HRD+K GNILL + K+ D G A ++ P S GT
Sbjct: 128 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----------ANSFVGT 174
Query: 632 FCYIDPEY---QQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLD 688
++ PE G K DV+SLGI +++ KPP+ + + ++ + +E+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA 233
Query: 689 PAVPDWPVEEALILAKLALQCAELRRKDRP 718
W C + +DRP
Sbjct: 234 LQSGHWSEY----FRNFVDSCLQKIPQDRP 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-49
Identities = 79/302 (26%), Positives = 123/302 (40%), Gaps = 40/302 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT----PVAIKVLRPDAA-QGRSQFQQEVEVLCNI-R 516
+ IGEG +G V K+ + AIK ++ A+ F E+EVLC +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 517 HPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRR-------------GGSPVLPWQIR 561
HPN++ LLGAC + L EY +G+L D L + + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621
AA++A + +L Q + +HRDL NIL+ NYV+KI+D GL+R V
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----- 181
Query: 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENG 681
+ T ++ E + SDV+S G+LL +I++ E
Sbjct: 182 --KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK- 238
Query: 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEETMPA 741
+ P +E + L QC + +RP ++ L L + EE
Sbjct: 239 -LPQGYRLEKPLNCDDE---VYDLMRQCWREKPYERPSFAQI----LVSLNRMLEERKTY 290
Query: 742 IN 743
+N
Sbjct: 291 VN 292
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 4e-49
Identities = 71/293 (24%), Positives = 111/293 (37%), Gaps = 42/293 (14%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT-------PVAIKVLRPDAAQG-RSQFQQEVEVLCN 514
EN + +G G +G V + VA+K+L+ A R E++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 515 I-RHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGS------------------ 553
+ H N+V LLGAC G LI+EY G L + L +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 554 --PVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611
VL ++ A ++A + FL + VHRDL N+L+ V KI D GLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA 671
+ +A ++ PE G+ +KSDV+S GILL +I +
Sbjct: 214 IMS----DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 672 HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
V+ + P + EE + + C + RP +
Sbjct: 270 IPVDANFYK-LIQNGFKMDQPFYATEE---IYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 29/289 (10%)
Query: 453 YSIEEIEEATENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQG-RSQ 504
Y +E E A E + SR++G+G +G VY+ T VAIK + A+ R +
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 505 FQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGS-------PV 555
F E V+ ++V LLG + +I E M G L+ L +
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 556 LPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615
++A EIA + +L+ VHRDL N ++ ++ KI D G+ R +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-- 184
Query: 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE 675
++ + ++ PE + G+ SDV+S G++L +I T E
Sbjct: 185 --ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 676 RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
+ + ++ + D P +L +L C + K RP +++
Sbjct: 243 QVLRF-----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 7e-48
Identities = 75/291 (25%), Positives = 113/291 (38%), Gaps = 34/291 (11%)
Query: 457 EIEEATENFSNSRKIGEGGYGPVYKSYLDHT-----PVAIKVLRPDAAQG-RSQFQQEVE 510
EI+ E R IGEG +G V++ VAIK + + R +F QE
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 511 VLCNIRHPNMVLLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIA 569
+ HP++V L+G E +I E G L L R S L A +++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLS 118
Query: 570 TALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAA 629
TAL +L + VHRD+ N+L+ N K+ D GL+R + S T Y+ +
Sbjct: 119 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGK 170
Query: 630 GTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQVE--RSIENGTFDET 686
++ PE SDV+ G+ + +I+ P + IENG
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--- 227
Query: 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737
P P+ P L L +C RP ++ L + EE
Sbjct: 228 -LPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELK----AQLSTILEE 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 8e-47
Identities = 62/273 (22%), Positives = 107/273 (39%), Gaps = 28/273 (10%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT------PVAIKVLRPDA-AQGRSQFQQEVEVLCNI 515
F + +G G +G VYK PVAIK LR + + E V+ ++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 516 RHPNMVLLLGACPEFG-CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
+P++ LLG C LI + M G L D + + Q +IA + +
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNY 126
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
L LVHRDL N+L+ KI+D GLA+L+ +Y +
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA----EEKEYHAEGGKVPIKW 179
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGL--AHQVERSIENGTFDETLDPAV 691
+ E + +SDV+S G+ + +++T P A ++ +E G
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------- 231
Query: 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
P + + + ++C + RP +++
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 4e-46
Identities = 51/264 (19%), Positives = 106/264 (40%), Gaps = 25/264 (9%)
Query: 463 ENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM 520
+++ ++G G +G V++ A K + + ++E++ + +RHP +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 521 VLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
V L A + +IYE+M+ G L +++ + ++ L +H+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 143
Query: 579 KPEPLVHRDLKPGNILL--DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
VH DLKP NI+ R+ K+ D GL + P + + GT +
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-------KQSVKVTTGTAEFAA 193
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPDW 694
PE + +G +D++S+G+L +++ P G + E R++++ ++ D A
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-DSAFSGI 252
Query: 695 PVEEALILAKLALQCAELRRKDRP 718
+ + R
Sbjct: 253 SED----GKDFIRKLLLADPNTRM 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-45
Identities = 66/265 (24%), Positives = 105/265 (39%), Gaps = 28/265 (10%)
Query: 463 ENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAA---QGRSQFQQEVEVLCNIRH 517
E+F + +GEG + V + AIK+L +E +V+ + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 518 PNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
P V L E Y NG L + + G AEI +AL +L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H + ++HRDLKP NILL+ + +I+D G A+++ P Q R S GT Y+
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP----ESKQARANSFVGTAQYV 177
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPD 693
PE SD+++LG ++ Q++ PP ++ + I +D P+
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD------FPE 231
Query: 694 WPVEEALILAKLALQCAELRRKDRP 718
+A L + L R
Sbjct: 232 KFFPKAR---DLVEKLLVLDATKRL 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (406), Expect = 5e-45
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 35/274 (12%)
Query: 462 TENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRS---QFQQEVEVLCNIR 516
++ + +G GG V+ + H VA+KVLR D A+ S +F++E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 517 HPNMVLLLGACPEFG------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIAT 570
HP +V + ++ EY+ +L D + G + + + A+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
AL F HQ ++HRD+KP NI++ K+ D G+AR + + + + G
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAAVIG 176
Query: 631 TFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP------MGLAHQVERSIENGTFD 684
T Y+ PE + + +SDVYSLG +L +++T +PP + +A+Q R E+
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPP 234
Query: 685 ETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
+ L + L+ ++R
Sbjct: 235 SARHEGLSAD-------LDAVVLKALAKNPENRY 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 160 bits (405), Expect = 8e-45
Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 40/278 (14%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA---------QGRSQFQQEVEV 511
EN+ +G G V + T A+K++ + R +EV++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 512 LCNIR-HPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEI 568
L + HPN++ L L+++ M G L D L + L + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
+ LH+ +VHRDLKP NILLD + K++D G + + P ++
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-------EKLREV 169
Query: 629 AGTFCYIDPEYQQTGML------GVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN 680
GT Y+ PE + M G + D++S G+++ ++ PP Q+ R I +
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229
Query: 681 GTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
G + P D+ + L + ++ + R
Sbjct: 230 GNYQFG-SPEWDDYSDT----VKDLVSRFLVVQPQKRY 262
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 158 bits (400), Expect = 2e-43
Identities = 51/281 (18%), Positives = 105/281 (37%), Gaps = 29/281 (10%)
Query: 450 YRKYSIEEIEEATENFSNS----RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRS 503
++KY + +E + + ++G G +G V++ T K + +
Sbjct: 12 WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 504 QFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIR 561
+ E+ ++ + HP ++ L A LI E+++ G L DR+ +
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEV 129
Query: 562 FRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS--KISDVGLARLVPPSVADS 619
+ L +H+ +VH D+KP NI+ + S KI D GLA + P
Sbjct: 130 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP----- 181
Query: 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RS 677
+ T + PE +G +D++++G+L +++ P +E ++
Sbjct: 182 --DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239
Query: 678 IENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
++ + E + A E + + R
Sbjct: 240 VKRCDW-EFDEDAFSSVSPE----AKDFIKNLLQKEPRKRL 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 5e-43
Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 28/273 (10%)
Query: 456 EEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG-RSQFQQEVEVL 512
++ E+ + + +G G + V + T VAIK + A +G + E+ VL
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 513 CNIRHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIAT 570
I+HPN+V L G LI + ++ G L DR+ +G + R+ ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLD 118
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILL---DRNYVSKISDVGLARLVPPSVADSVTQYRMTS 627
A+ +LH +VHRDLKP N+L D + ISD GL+++ P +++
Sbjct: 119 AVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-------SVLST 168
Query: 628 AAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDE 685
A GT Y+ PE D +S+G++ ++ PP + + I + E
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-E 227
Query: 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
P D E + R
Sbjct: 228 FDSPYWDDISDS----AKDFIRHLMEKDPEKRF 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 7e-43
Identities = 52/268 (19%), Positives = 104/268 (38%), Gaps = 26/268 (9%)
Query: 459 EEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIR 516
+E E + + +G G +G V++ + K ++ + ++E+ +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59
Query: 517 HPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
H N++ L + E +I+E+++ + +R+ L + ++ AL F
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQF 117
Query: 575 LHQTKPEPLVHRDLKPGNILLD--RNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
LH + H D++P NI+ R+ KI + G AR + P
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-------DNFRLLFTAP 167
Query: 633 CYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPA 690
Y PE Q ++ +D++SLG L+ +++ P + +I N + + A
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-EEA 226
Query: 691 VPDWPVEEALILAKLALQCAELRRKDRP 718
+ +E + RK R
Sbjct: 227 FKEISIE----AMDFVDRLLVKERKSRM 250
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 71/288 (24%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL---------DHTPVAIKVLRPDAAQ-GRSQFQQEVEVL 512
+ + +GEG +G V + T VA+K+L+ DA + S E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 513 CNI-RHPNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPV-------------L 556
I +H N++ LLGAC + G +I EY + G+L + L R + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 557 PWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616
+ A ++A + +L + +HRDL N+L+ + V KI+D GLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER 676
T ++ PE + +SDV+S G+LL +I T VE
Sbjct: 190 YYKKTTNGR----LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724
F + D P L + C RP ++V
Sbjct: 246 -----LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 73/300 (24%), Positives = 120/300 (40%), Gaps = 44/300 (14%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL-------DHTPVAIKVLRPDAAQG-RSQFQQEVEVLCN 514
+ + +G G +G V ++ VA+K+L+ A E+++L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 515 IRH-PNMVLLLGACPEFG---CLIYEYMANGSLEDRLFRRGGSPV-------------LP 557
I H N+V LLGAC + G +I E+ G+L L + V L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 558 WQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617
+ + ++A + FL +HRDL NILL V KI D GLAR +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY---- 185
Query: 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP----MGLAHQ 673
R A ++ PE + ++SDV+S G+LL +I + + + +
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 674 VERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRA 733
R ++ GT PD+ E + + L C RP ++V N+L+A
Sbjct: 246 FCRRLKEGT-----RMRAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 9e-42
Identities = 66/266 (24%), Positives = 100/266 (37%), Gaps = 31/266 (11%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA---QGRSQFQQEVEVL-CNIR 516
E+F + +G+G +G V+ + T AIK L+ D E VL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 517 HPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
HP + + E + EY+ G L + AAEI L F
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
LH +V+RDLK NILLD++ KI+D G+ + + + GT Y
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG------DAKTNTFCGTPDY 169
Query: 635 IDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVP 692
I PE D +S G+LL +++ + P + E SI +P P
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYP 223
Query: 693 DWPVEEALILAKLALQCAELRRKDRP 718
W +EA L ++ + R
Sbjct: 224 RWLEKEA---KDLLVKLFVREPEKRL 246
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 5e-40
Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 26/242 (10%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA---QGRSQFQQEVEVLCNIRH 517
++F R +G G +G V+ H A+KVL+ + + E +L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 518 PNMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
P ++ + G + + I +Y+ G L L + P + AAE+ AL +L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYL 120
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H + +++RDLKP NILLD+N KI+D G A+ VP + GT YI
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VTYTLCGTPDYI 168
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENG--TFDETLDPAV 691
PE T D +S GIL+ +++ P ++ ++ I N F + V
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228
Query: 692 PD 693
D
Sbjct: 229 KD 230
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-40
Identities = 63/275 (22%), Positives = 106/275 (38%), Gaps = 14/275 (5%)
Query: 460 EATENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQG-RSQFQQEVEVLCNIR 516
+ ++N IGEG YG V +Y ++ VAIK + P Q + +E+++L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 517 HPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLF 574
H N++ + P + Y+ + L++ + L +I L +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 575 LHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCY 634
+H ++HRDLKP N+LL+ KI D GLAR+ P D +T T Y
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP---DHDHTGFLTEYVATRWY 178
Query: 635 IDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPD 693
PE D++S+G +L ++++ +P H ++ N P+ D
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQED 236
Query: 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728
L L + L K
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 9e-40
Identities = 52/270 (19%), Positives = 90/270 (33%), Gaps = 26/270 (9%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGA 526
RKIG G +G +Y VAIK+ Q E ++ ++ + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 527 CPEFG---CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPL 583
C G ++ E + + F + +A ++ + + ++H
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 584 VHRDLKPGNIL---LDRNYVSKISDVGLARLVPPSVADSVTQY-RMTSAAGTFCYIDPEY 639
+HRD+KP N L + + I D GLA+ + Y + GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 640 QQTGMLGVKSDVYSLGILLLQIITAKP--PMGLAHQVERSIENGTFDETLDPA---VPDW 694
+ D+ SLG +L+ A + E + + P +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 695 PVEEALILAKLALQCAELRRKDRPDLGKVV 724
P E A C LR D+PD +
Sbjct: 245 PSE----FATYLNFCRSLRFDDKPDYSYLR 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (363), Expect = 5e-39
Identities = 50/292 (17%), Positives = 95/292 (32%), Gaps = 34/292 (11%)
Query: 463 ENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM 520
++ R+IGEG +G +++ L++ VAIK + Q + E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 521 VLLLGACPEFG---CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+ + + G L+ + + G + L G + A ++ + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE 119
Query: 578 TKPEPLVHRDLKPGNILLDRNYVS-----KISDVGLARLVPPSVADSVTQY-RMTSAAGT 631
LV+RD+KP N L+ R + D G+ + V Y + +GT
Sbjct: 120 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 632 FCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAK------PPMGLAHQVERSIENGTFDE 685
Y+ + D+ +LG + + + + ER I
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQST 235
Query: 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALAEE 737
L +P E K L PD + + + E
Sbjct: 236 PLRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQ----GLFSKVLER 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 8e-39
Identities = 68/275 (24%), Positives = 107/275 (38%), Gaps = 29/275 (10%)
Query: 461 ATENFSNSRKIGEGGYGPVYKSY---LDHTPVAIKVLRPDAAQG--RSQFQQEVEVLCNI 515
A + + +IGEG YG V+K+ VA+K +R + +EV VL ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 516 ---RHPNMVLLLGACPEFG-------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIA 565
HPN+V L C L++E++ +P + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 122
Query: 566 AEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRM 625
++ L FLH +VHRDLKP NIL+ + K++D GLAR+ Q +
Sbjct: 123 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-------QMAL 172
Query: 626 TSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDE 685
TS T Y PE D++S+G + ++ KP + D
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF--RGSSDVDQLGKILDV 230
Query: 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDL 720
P DWP + AL + A+ K D+
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (367), Expect = 8e-39
Identities = 76/263 (28%), Positives = 110/263 (41%), Gaps = 26/263 (9%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA---QGRSQFQQEVEV---LCN 514
+FS R IG GG+G VY T A+K L QG + E + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 515 IRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATAL 572
P +V + A P+ I + M G L L + G +RF AAEI L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRF-YAAEIILGL 120
Query: 573 LFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
+H +V+RDLKP NILLD + +ISD+GLA + ++ GT
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTH 169
Query: 633 CYIDPEYQQTGM-LGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAV 691
Y+ PE Q G+ +D +SLG +L +++ P H+ + E T+ +
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVEL 228
Query: 692 PDWPVEEALILAKLALQCAELRR 714
PD E L + LQ RR
Sbjct: 229 PDSFSPELRSLLEGLLQRDVNRR 251
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 9e-38
Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 26/246 (10%)
Query: 463 ENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHP 518
ENF KIGEG YG VYK+ L VA+K +R D S +E+ +L + HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 519 NMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V LL L++E++ + +P + ++ L F H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
++HRDLKP N+L++ K++D GLAR V T T Y
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF------GVPVRTYTHEVVTLWYRA 170
Query: 637 PE-YQQTGMLGVKSDVYSLGILLLQIITAKPP------MGLAHQVERSIENGTFDETLDP 689
PE D++SLG + +++T + + ++ R++ GT DE + P
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTPDEVVWP 228
Query: 690 AVPDWP 695
V P
Sbjct: 229 GVTSMP 234
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 44/215 (20%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 464 NFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMV 521
++++++ IG G +G VY++ L + VAIK + D + +E++++ + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 522 LLLGACPEFG--------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALL 573
L G L+ +Y+ LP ++ +L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 574 FLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTF 632
++H + HRD+KP N+LLD + V K+ D G A+ + + ++ +
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSRY 187
Query: 633 CYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
DV+S G +L +++ +P
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-36
Identities = 55/269 (20%), Positives = 105/269 (39%), Gaps = 39/269 (14%)
Query: 468 SRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQGRSQFQQEVEVLCNI-RHPNMVLLL 524
S+ +G G G V + + T A+K+L+ + ++EVE+ + P++V ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 71
Query: 525 GACPEFG------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT 578
++ E + G L R+ RG + I I A+ +LH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHSI 130
Query: 579 KPEPLVHRDLKPGNILLDR---NYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
+ HRD+KP N+L N + K++D G A+ +T+ T Y+
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-------HNSLTTPCYTPYYV 180
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPP------MGLAHQVERSIENGTFDETLDP 689
PE D++SLG+++ ++ PP + ++ ++ I G + E +P
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNP 239
Query: 690 AVPDWPVEEALILAKLALQCAELRRKDRP 718
+ E + L + R
Sbjct: 240 EWSEVSEE----VKMLIRNLLKTEPTQRM 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 59/285 (20%), Positives = 107/285 (37%), Gaps = 40/285 (14%)
Query: 450 YRKYSIEEIEEATENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG------ 501
+R+ ++++ + ++G G + V K T A K ++ +
Sbjct: 3 FRQENVDD------YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS 56
Query: 502 RSQFQQEVEVLCNIRHPNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQ 559
R ++EV +L I+HPN++ L LI E +A G L D L + L +
Sbjct: 57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEE 113
Query: 560 IRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS----KISDVGLARLVPPS 615
+I + +LH + H DLKP NI+L V KI D GLA +
Sbjct: 114 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE 675
+ GT ++ PE LG+++D++S+G++ +++ P + E
Sbjct: 171 -------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
Query: 676 --RSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRP 718
++ + E D + + K R
Sbjct: 224 TLANVSAVNY-EFEDEYFSNTSAL----AKDFIRRLLVKDPKKRM 263
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-36
Identities = 63/264 (23%), Positives = 97/264 (36%), Gaps = 40/264 (15%)
Query: 469 RKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQG------RSQFQQEVEVL--CNIRHP 518
+G GG+G VY D+ PVAIK + D ++ EV +L +
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 519 NMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
++ LL P+ LI E G+ L ++ ++ A+ H
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCH 127
Query: 577 QTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
++HRD+K NIL+D N K+ D G L+ + T GT Y
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--------VYTDFDGTRVYS 176
Query: 636 DPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDW 694
PE+ + G + V+SLGILL ++ P ++ R F + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--QVFFRQRVSSECQH- 233
Query: 695 PVEEALILAKLALQCAELRRKDRP 718
L C LR DRP
Sbjct: 234 ----------LIRWCLALRPSDRP 247
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 135 bits (340), Expect = 6e-36
Identities = 56/267 (20%), Positives = 101/267 (37%), Gaps = 20/267 (7%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT-PVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPN 519
E + KIGEG YG VYK+ ++ A+K +R + S +E+ +L ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 520 MVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+V L L++E++ + GG L ++ + + H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDP 637
+ ++HRDLKP N+L++R KI+D GLAR + +
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPD 170
Query: 638 EYQQTGMLGVKSDVYSLGILLLQIITAKPP---MGLAHQVERSIE-NGTFDETLDPAVPD 693
+ D++S+G + +++ P + A Q+ R GT + P V +
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 694 WPVEEALILAKLALQCAELRRKDRPDL 720
P + L +
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESG 257
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 7e-36
Identities = 60/261 (22%), Positives = 111/261 (42%), Gaps = 27/261 (10%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG--RSQFQQEVEVLCNIRHP 518
+ KIG+G +G V+K+ T VA+K + + + +E+++L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 519 NMVLLLGACPEFG----------CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEI 568
N+V L+ C L++++ + R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 569 ATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSA 628
L ++H+ K ++HRD+K N+L+ R+ V K++D GLAR S+A + R T+
Sbjct: 127 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYTNR 181
Query: 629 AGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPM---GLAHQVERSIE-NGTF 683
T Y PE G D++ G ++ ++ T P M HQ+ + G+
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 684 DETLDPAVPDWPVEEALILAK 704
+ P V ++ + E L L K
Sbjct: 242 TPEVWPNVDNYELYEKLELVK 262
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 9e-35
Identities = 59/237 (24%), Positives = 94/237 (39%), Gaps = 24/237 (10%)
Query: 469 RKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAAQG-----RSQFQQEVEVLCNIRHPNMV 521
+GEG + VYK+ +T VAIK ++ +E+++L + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 522 LLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK 579
LL A L++++M L L +LHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQ-- 118
Query: 580 PEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEY 639
++HRDLKP N+LLD N V K++D GLA+ T T Y PE
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS------PNRAYTHQVVTRWYRAPEL 171
Query: 640 QQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLDPAVPDWP 695
+ GV D++++G +L +++ P L + F+ P WP
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPF--LPGDSDLDQLTRIFETLGTPTEEQWP 226
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 56/299 (18%), Positives = 106/299 (35%), Gaps = 32/299 (10%)
Query: 450 YRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAA--QGRSQ 504
+ + + + E + + + +G G YG V + VAIK L +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 505 FQQEVEVLCNIRHPNMVLLLGACPEFG--------CLIYEYMANGSLEDRLFRRGGSPVL 556
+E+ +L ++RH N++ LL L+ +M G+ +L + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK---L 118
Query: 557 PWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616
+ ++ L ++H HRDLKPGN+ ++ + KI D GLAR +
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEM 175
Query: 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER 676
V + D++S+G ++ ++IT K + ++
Sbjct: 176 TGYVVT--------RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD- 226
Query: 677 SIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPK-LNILRAL 734
T P ++ EL +KD + P +N+L +
Sbjct: 227 -QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 61/242 (25%), Positives = 96/242 (39%), Gaps = 23/242 (9%)
Query: 463 ENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGR---SQFQQEVEVLCNIRH 517
+F + +G+G +G V A+K+LR + + + E VL N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 518 PNMVLLLGACPEFG--CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
P + L A C + EY G L L R V + AEI +AL +L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYL 121
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H +V+RD+K N++LD++ KI+D GL + M + GT Y+
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------DGATMKTFCGTPEYL 172
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENG--TFDETLDPAV 691
PE + G D + LG+++ +++ + P I F TL P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 692 PD 693
Sbjct: 233 KS 234
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 6e-34
Identities = 56/261 (21%), Positives = 99/261 (37%), Gaps = 30/261 (11%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYLDHT--PVAIKVLRPDAA---QGRSQFQQEVEVLCNIRH 517
+ F + +G G +G V + A+K+L + E +L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 518 PNMVLLLGACPEFGCL--IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFL 575
P +V L + + L + EY+A G + L R G AA+I +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 576 HQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYI 635
H L++RDLKP N+L+D+ +++D G A+ + R + GT +
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLCGTPEAL 205
Query: 636 DPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIENGTFDETLDPAVPD 693
PE + D ++LG+L+ ++ PP ++ I +G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPS 259
Query: 694 WPVEEALILAKLALQCAELRR 714
+ L + LQ +R
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKR 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 56/269 (20%), Positives = 101/269 (37%), Gaps = 22/269 (8%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHP 518
+ + KIGEG YG V+K+ H VA+K +R D S +E+ +L ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 519 NMVLLLGACPE--FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLH 576
N+V L L++E+ + G +I ++ L F H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 577 QTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYID 636
++HRDLKP N+L++RN K+++ GLAR + +
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEVVTLWYRPP 170
Query: 637 PEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN-----GTFDETLDPAV 691
+ D++S G + ++ A P+ + V+ ++ GT E P++
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 692 PDWPVEEALILAKLALQCAELRRKDRPDL 720
P + + + K
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATG 259
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (305), Expect = 6e-31
Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 449 RYRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQF 505
Y Y +E +++ RK+G G Y V+++ ++ V +K+L+P + +
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKI 76
Query: 506 QQEVEVLCNIR-HPNMVLLLGACPEFG----CLIYEYMANGSLEDRLFRRGGSPVLPWQI 560
++E+++L N+R PN++ L + L++E++ N + L
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYD 130
Query: 561 RFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVGLARLVPPSVADS 619
EI AL + H ++HRD+KP N+++D + ++ D GLA P
Sbjct: 131 IRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--- 184
Query: 620 VTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPP 667
+ + PE + D++SLG +L +I K P
Sbjct: 185 ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 9e-31
Identities = 44/229 (19%), Positives = 87/229 (37%), Gaps = 25/229 (10%)
Query: 450 YRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAA--QGRSQ 504
+ + + + E E + N +G G YG V ++ VA+K L +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 505 FQQEVEVLCNIRHPNMVLLLGAC------PEFGCLIYEYMANGSLEDRLFRRGGSPVLPW 558
+E+ +L +++H N++ LL EF + G+ + + + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTD 120
Query: 559 QIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618
+ +I L ++H ++HRDLKP N+ ++ + KI D GLAR
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------- 169
Query: 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
A + D++S+G ++ +++T +
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 69/274 (25%), Positives = 105/274 (38%), Gaps = 28/274 (10%)
Query: 463 ENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRP----DAAQGRSQFQQEVEVLC 513
ENF + +G G YG V+ A+KVL+ A+ + E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 514 NIRH-PNMVLLLGAC--PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIAT 570
+IR P +V L A LI +Y+ G L L +R EI
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 571 ALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAG 630
AL LH+ +++RD+K NILLD N ++D GL++ + R G
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-----VADETERAYDFCG 192
Query: 631 TFCYIDPEYQQTGMLGV--KSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDETLD 688
T Y+ P+ + G G D +SLG+L+ +++T P + + E +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252
Query: 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGK 722
P P A L + K R G
Sbjct: 253 PPYPQEMSALA---KDLIQRLLMKDPKKRLGCGP 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-29
Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 29/232 (12%)
Query: 449 RYRKYSIEEIE-EATENFSNSRKIGEGGYGPVYKSY--LDHTPVAIKVLRPDAA--QGRS 503
++ + + + + N + IG G G V +Y + VAIK L
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 504 QFQQEVEVLCNIRHPNMVLLLGACPEFG--------CLIYEYMANGSLEDRLFRRGGSPV 555
+ +E+ ++ + H N++ LL L+ E M +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----- 116
Query: 556 LPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615
+ + ++ + LH +HRDLKP NI++ + KI D GLAR S
Sbjct: 117 -DHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
+ MT T Y PE D++S+G ++ +++ K
Sbjct: 173 -------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 9e-26
Identities = 40/228 (17%), Positives = 89/228 (39%), Gaps = 30/228 (13%)
Query: 463 ENFSNSR-----KIGEGGYGPVYKSY--LDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNI 515
E + ++R K+G G + V+ + +++T VA+K++R D + E+++L +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRV 66
Query: 516 RHPNMVLLLGAC---------------PEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQI 560
+ P ++ + G L ++ +P
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 561 RFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRN-YVSKISDVGLARLVPPSVADS 619
+I+ ++ L ++H+ ++H D+KP N+L++ + + +A L
Sbjct: 127 VKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN----AC 180
Query: 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP 667
T++ T Y PE G +D++S L+ ++IT
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 2e-20
Identities = 22/153 (14%), Positives = 42/153 (27%), Gaps = 19/153 (12%)
Query: 469 RKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRS----------QFQQEVEVLCNIRH 517
+ +GEG V+ Y +K + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 518 PNMVLLLGACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ 577
+ L G +Y + N L + + + V + I + +
Sbjct: 66 RALQKLQGLAV---PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYH 121
Query: 578 TKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610
+VH DL N+L+ + I D +
Sbjct: 122 ---RGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 171 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 53.3 bits (127), Expect = 9e-09
Identities = 26/159 (16%), Positives = 52/159 (32%), Gaps = 14/159 (8%)
Query: 13 VAVAID---------KDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAI 63
V VA++ + A W ++ ++ + + + V V + V
Sbjct: 4 VMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLH-VQVVDEDGFDDVDS 62
Query: 64 SKVNNEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTI 123
+ E R +Q + L F C + C+ ++ D + V
Sbjct: 63 IYASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCE-AWIKTGDPKDVICQEVKRVRP 121
Query: 124 ETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162
+ LV+G+ F ++ + + K A C V I
Sbjct: 122 DFLVVGSRGLGRF-QKVFVGTVSAFCVKHAE--CPVMTI 157
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} Length = 160 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Score = 43.8 bits (102), Expect = 1e-05
Identities = 23/152 (15%), Positives = 55/152 (36%), Gaps = 8/152 (5%)
Query: 15 VAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQ----RVSSVPNPSGNSVAISKVNNEV 70
D + ++ AL+ + + + LLHV + + + ++K E
Sbjct: 8 YPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEF 67
Query: 71 ARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGA 130
K ++ +AK + K K+I++ + ++ ++ +++G+
Sbjct: 68 ENELKNKLTEEAKNKMENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGS 126
Query: 131 ASRTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162
+T K + NV K + V V+
Sbjct: 127 HGKTNL-KEILLGSVTENVIKKSN--KPVLVV 155
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} Length = 135 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Score = 42.9 bits (100), Expect = 2e-05
Identities = 18/150 (12%), Positives = 47/150 (31%), Gaps = 18/150 (12%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
+ +A D + ++ A A + G L ++H + V
Sbjct: 4 ILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEP--------------- 48
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
+++ + + + + ++ +L + A+A++ + + +V+G
Sbjct: 49 FFEEALRRRLERAEGVLEEARALTGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRG 108
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162
V AP C V ++
Sbjct: 109 LGAL-GSLFLGSQSQRVVAEAP--CPVLLV 135
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} Length = 147 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 41.5 bits (96), Expect = 8e-05
Identities = 22/150 (14%), Positives = 40/150 (26%), Gaps = 13/150 (8%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
V V D S A+ A + + + +
Sbjct: 8 VVVGTDGSDSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADILKD----------E 57
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
YK E+ + K E AL++ + LV+G
Sbjct: 58 SYKVTGTAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVG 117
Query: 133 RTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162
+ +P+NVS+ A +V ++
Sbjct: 118 LSTI-AGRLLGSVPANVSRRAK--VDVLIV 144
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} Length = 138 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 19/137 (13%), Positives = 49/137 (35%), Gaps = 7/137 (5%)
Query: 15 VAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIY 74
V D + A+ +AV+ G L +L V + V ++ + E+
Sbjct: 9 VLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTF--GLPFPPEIKEES 66
Query: 75 KQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRT 134
K++++ + +E++ ++ + +++ + +V E +V
Sbjct: 67 KKRIERRLREVWEKLTGSTEIPGVEYRIG-----PLSEEVKKFVEGKGYELVVWACYPSA 121
Query: 135 GFVKRFKTADIPSNVSK 151
K ++ S + K
Sbjct: 122 YLCKVIDGLNLASLIVK 138
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} Length = 140 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Score = 38.8 bits (89), Expect = 5e-04
Identities = 22/124 (17%), Positives = 40/124 (32%), Gaps = 12/124 (9%)
Query: 13 VAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVAR 72
+ VA+D + S L+ AV L+++HV N S + VN +
Sbjct: 5 ILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHV------DVNFSDLYTGLIDVNMSSMQ 58
Query: 73 IYKQQVDNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAAS 132
+A + E + D+ + L D + + ++ LV G
Sbjct: 59 DRISTETQKA------LLDLAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQ 112
Query: 133 RTGF 136
Sbjct: 113 DFWS 116
|
| >d1f5na1 a.114.1.1 (A:284-583) Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 300 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain superfamily: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain family: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain domain: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (92), Expect = 8e-04
Identities = 22/106 (20%), Positives = 43/106 (40%), Gaps = 4/106 (3%)
Query: 328 QSQSVEEVEVEMRRLRLELRQTMDMYSAACKEALAAKQKARELHRWKLEEKQKLEDARMA 387
Q+ + +E E+E+ R++ E Q E ++ E +E K +M
Sbjct: 197 QTLTEKEKEIEVERVKAESAQASAKML---HEMQRKNEQMMEQKERSYQEHLKQLTEKME 253
Query: 388 EEAALALAEKERAKCKRAIEAAEAAQRIAELEAQKCKNVEFKALRE 433
+ L E+ER + E + + + E++ KN E + L+
Sbjct: 254 NDRVQLLKEQERTLALKLQEQEQLLKEGFQKESRIMKN-EIQDLQT 298
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 768 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.87 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.86 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.84 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.8 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.75 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.52 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.46 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.15 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 89.35 | |
| d1np7a2 | 204 | Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: | 86.09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=421.32 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=202.4
Q ss_pred hcCCCccceecccCceeEEEEEECCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEec
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYM 538 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~ 538 (768)
.++|.+.+.||+|+||.||+|.+.+ .||||+++.. .....+.|.+|+.+|++++|||||+++|++.+ ..+||||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence 4679999999999999999998765 5999999754 34456789999999999999999999999854 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.......
T Consensus 86 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~- 159 (276)
T d1uwha_ 86 EGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG- 159 (276)
T ss_dssp CEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC-
Confidence 99999999976543 4999999999999999999999999 99999999999999999999999999987643211
Q ss_pred ccccccccCCCCCCCCCCcccccC---CCCCccccHHHHHHHHHHHHhCCCCCCCh---HHHHHHHHcCCccccCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQIITAKPPMGLA---HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltg~~Pf~~~---~~~~~~i~~~~~~~~ld~~~~ 692 (768)
........||+.|+|||++.+ ..|+.++|||||||+||||+||+.||... ..+...+..+... +...
T Consensus 160 ---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----p~~~ 232 (276)
T d1uwha_ 160 ---SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS----PDLS 232 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC----CCGG
T ss_pred ---cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----Ccch
Confidence 122356689999999998864 35899999999999999999999999643 2333444444322 2222
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
..+..++..+.+|+.+||+.+|.+|||+.+|+..+.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 223334456999999999999999999999985443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=415.74 Aligned_cols=243 Identities=31% Similarity=0.455 Sum_probs=205.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~ 535 (768)
++|++.+.||+|+||.||+|.+ +++.||||++.+.. ......+.+|+.+|+.++|||||++++++.+. .||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4699999999999999999998 46789999996532 22355788999999999999999999998554 48999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||++|+|.+++.... .+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999998765 3999999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
......||+.|+|||++.+..|+.++|||||||+||||++|++||.... .....+..+.+.
T Consensus 160 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------- 222 (263)
T d2j4za1 160 --------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------- 222 (263)
T ss_dssp --------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------
T ss_pred --------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 1244689999999999999999999999999999999999999996443 334445444321
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.|...+..+.+|+.+||+.||.+|||+.+++. +|+
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 12223456999999999999999999999986 665
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=421.17 Aligned_cols=246 Identities=26% Similarity=0.417 Sum_probs=206.7
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 538 (768)
++|++.+.||+|+||+||+|.+ +++.||||+++.......+.+.+|+.+|+.++|||||+++++|. +..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999997 57899999997665555677999999999999999999999984 4458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
+||+|.+++.+. .+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 999999987654 3899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i~~~~~~~~ld~~~~~~~ 695 (768)
......+||+.|+|||++.+..|+.++|||||||++|+|+||++||....... ..+..+... . ..+
T Consensus 171 ----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------~-~~~ 239 (293)
T d1yhwa1 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE------L-QNP 239 (293)
T ss_dssp ----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC------C-SSG
T ss_pred ----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC------C-CCc
Confidence 12345689999999999999999999999999999999999999996543322 222222211 1 112
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
...+..+.+|+.+||+.||.+|||+.+++. +|+
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 333456999999999999999999999986 555
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=420.08 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=198.8
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
.++|++.+.||+|+||+||+|.+ +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+ ..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999998 46789999997553 2334568999999999999999999999854 4489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
||++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999886543 4999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChHH---HHHHHHcCCccccCCCCCC
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQ---VERSIENGTFDETLDPAVP 692 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~~---~~~~i~~~~~~~~ld~~~~ 692 (768)
........+||+.|+|||++.+..+ +.++|||||||+||||+||++||..... ....+...... .+.
T Consensus 158 ----~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---~~~-- 228 (271)
T d1nvra_ 158 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---LNP-- 228 (271)
T ss_dssp ----EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---STT--
T ss_pred ----ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---CCc--
Confidence 1122356789999999999988776 6789999999999999999999954322 11222222111 011
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
....+..+.+|+.+||+.||.+|||+.+++.
T Consensus 229 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122356889999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=417.45 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=196.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC----CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE----FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV 534 (768)
++|++.+.||+|+||.||+|.+ +++.||||++.... ....+.+.+|+++|++++|||||+++++|.+ ..|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999998 46789999997653 3345678999999999999999999998832 34899
Q ss_pred EEeccCCChHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 535 YEYMANGSLEDRLFRRG-GSPVLPWQIRFRIAAEIATALLFLHQTKP--EPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~--~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
||||++|+|.+++.+.. ....+++..++.++.||+.||.|||+.++ .+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986531 22359999999999999999999998752 3599999999999999999999999999997
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCC
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDP 689 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~ 689 (768)
+.... .......||+.|+|||++.+..|+.++|||||||++|||+||++||... ..+...+..+.+..
T Consensus 164 ~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---- 233 (269)
T d2java1 164 LNHDT------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---- 233 (269)
T ss_dssp C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----
T ss_pred cccCC------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence 74321 1234568999999999999999999999999999999999999999643 33445555554322
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.+...+..+.+|+.+||+.||.+|||+.+++.
T Consensus 234 ----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12223456999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=416.87 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=205.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEec
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYM 538 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 538 (768)
+.|++.+.||+|+||.||+|.+ ++..||||++........+.+.+|+++|++++|||||+++++|.+ ..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5689999999999999999998 466899999987666666789999999999999999999999844 458999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~---- 162 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---- 162 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH----
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC----
Confidence 99999998876543 4999999999999999999999999 99999999999999999999999999975421
Q ss_pred ccccccccCCCCCCCCCCccccc-----CCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQ-----TGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
.........||+.|+|||++. +..|+.++|||||||+||||+||++||.... .....+..+.....
T Consensus 163 --~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~----- 235 (288)
T d2jfla1 163 --TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL----- 235 (288)
T ss_dssp --HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-----
T ss_pred --CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 112235678999999999874 4568999999999999999999999996433 33334444332111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+...+..+.+|+.+||+.||.+|||+.+++. +|+
T Consensus 236 -~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 236 -AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp -SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred -CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 122334456999999999999999999999985 444
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=407.36 Aligned_cols=246 Identities=27% Similarity=0.452 Sum_probs=194.1
Q ss_pred cCCCccceecccCceeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeEEEecc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLIYEYMA 539 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 539 (768)
++|.+.+.||+|+||.||+|.+ ++..||||+++... ...++|.+|++++++++|||||+++|+|. +..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999998 45689999997654 33567999999999999999999999984 45699999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-- 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-- 156 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc--
Confidence 999999887654 35899999999999999999999999 99999999999999999999999999987643221
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......||+.|+|||++.+..|+.++|||||||++|||+| |++||... ..+...+..+.. +. .|.
T Consensus 157 ---~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-----~~---~p~ 225 (263)
T d1sm2a_ 157 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----LY---KPR 225 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-----CC---CCT
T ss_pred ---eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-----CC---Ccc
Confidence 12234578999999999999999999999999999999999 56666533 234445555421 11 122
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
.++..+.+|+.+||+.||.+||++.+|+..+
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 2345699999999999999999999998543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=406.51 Aligned_cols=241 Identities=27% Similarity=0.411 Sum_probs=196.9
Q ss_pred CCccceecccCceeEEEEEEC--CccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccC------CceeE
Q 035604 465 FSNSRKIGEGGYGPVYKSYLD--HTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------FGCLI 534 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~lV 534 (768)
|++.++||+|+||+||+|.+. +..||+|++... .....+.|.+|+++|++++|||||+++++|.+ ..|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999984 568999998654 33445678999999999999999999998742 24899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc-CCCcEEEeecccccccC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD-RNYVSKISDVGLARLVP 613 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~vKL~DFGla~~~~ 613 (768)
||||++|+|.+++.+.. .+++..++.++.||+.||.|||+.+ .+||||||||+||||+ .++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999998765 4899999999999999999999876 4599999999999996 57999999999998653
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh---HHHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA---HQVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~---~~~~~~i~~~~~~~~ld~~ 690 (768)
.. .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... ..+...+..+.....++
T Consensus 167 ~~--------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~-- 235 (270)
T d1t4ha_ 167 AS--------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-- 235 (270)
T ss_dssp TT--------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--
T ss_pred CC--------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccC--
Confidence 32 1235689999999998875 5999999999999999999999999643 33344444443222211
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
...+..+.+|+.+||+.||++|||+.|++.
T Consensus 236 -----~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 -----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 122345899999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-48 Score=414.76 Aligned_cols=255 Identities=28% Similarity=0.414 Sum_probs=194.5
Q ss_pred cCCCccceecccCceeEEEEEECC--c---cEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeecccc--CCceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH--T---PVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~--~---~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV 534 (768)
++|++.++||+|+||+||+|.+.. . .||||.+... .....+.|.+|+.+|++++|||||+++|+|. ...++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457778999999999999999732 2 5899998754 3345567999999999999999999999984 455999
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||||++|+|.+++..... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998876443 4999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~ 691 (768)
.... ..........||+.|+|||++.++.++.++|||||||+||||+| |++||... ..+...+..+...
T Consensus 181 ~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------- 252 (299)
T d1jpaa_ 181 DTSD-PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL------- 252 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------
T ss_pred CCCc-ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 3221 11112234568999999999999999999999999999999998 89999643 3344455544321
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
..+..++..+.+|+.+||+.+|.+||++.+|+..+.+.+
T Consensus 253 -~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 253 -PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 112233456999999999999999999999985544443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=422.13 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=202.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E 536 (768)
.++|++.+.||+|+||+||+|.+ ++..||+|+++... ......+.+|+.+|+.++|||||+++++|.+. .|||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46899999999999999999998 46789999997653 33456789999999999999999999999554 599999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQT-KPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+||+|.+++.+.+ .+++..++.++.||+.||.|||+. + |+||||||+||||+.+|.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 999999999998765 389999999999999999999974 8 99999999999999999999999999986532
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHH-----cCCcccc----
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIE-----NGTFDET---- 686 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~-----~~~~~~~---- 686 (768)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........... .+.....
T Consensus 158 -------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 158 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp -------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred -------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 123456899999999999999999999999999999999999999953321110000 0000000
Q ss_pred ---------------------------CCCCCCCCC-HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 687 ---------------------------LDPAVPDWP-VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 687 ---------------------------ld~~~~~~~-~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.....+..+ ...+.++.+|+.+||..||.+|||+.+++. +|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000001 112356899999999999999999999997 67654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=409.84 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=205.9
Q ss_pred cCCCccc-eecccCceeEEEEEEC----CccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeecccc-CCceeEE
Q 035604 463 ENFSNSR-KIGEGGYGPVYKSYLD----HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACP-EFGCLIY 535 (768)
Q Consensus 463 ~~y~~~~-~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~ 535 (768)
++|.+.+ +||+|+||.||+|.+. +..||||+++... ....+.|.+|+++|++++|||||+++|+|. +..||||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 4566666 4999999999999763 3469999997653 344677999999999999999999999985 4558999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||++|+|.+++..... .+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+...
T Consensus 88 E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999998865432 4999999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~ 692 (768)
.. .........||+.|+|||++.++.++.++|||||||++|||+| |++||... ..+...+..+....
T Consensus 163 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~------- 232 (285)
T d1u59a_ 163 DS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME------- 232 (285)
T ss_dssp SC---EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC-------
T ss_pred cc---ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 21 1122345678999999999999999999999999999999998 99999643 34455666654321
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
.|..++..+.+|+.+||+.+|.+||++.+|+..+...
T Consensus 233 -~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1222335699999999999999999999987544333
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=414.36 Aligned_cols=244 Identities=26% Similarity=0.366 Sum_probs=202.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|++.+.||+|+||+||+|.+ +++.||||++.+.. ......+.+|+++|++++|||||+++++|.+ ..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999998 46789999997542 2234568999999999999999999999854 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||+||+|.+++...+ .+++..++.++.|++.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999988765 3999999999999999999999999 999999999999999999999999999877432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.. .......+||+.|+|||++.+..|+.++|||||||+||||++|++||.... .+...+..+.+.
T Consensus 162 ~~----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--------- 228 (288)
T d1uu3a_ 162 SK----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--------- 228 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---------
T ss_pred Cc----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC---------
Confidence 21 122345689999999999999999999999999999999999999996443 334455554321
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+|...+..+.+||.+||+.||.+|||+.|++.
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 12223456899999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=410.12 Aligned_cols=246 Identities=31% Similarity=0.456 Sum_probs=202.2
Q ss_pred hcCCCccceecccCceeEEEEEEC-CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEecc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMA 539 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~ 539 (768)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ...+.|.+|+.+|++++|||||+++|+|.+ ..+|||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCC
Confidence 367889999999999999999985 5689999997654 335679999999999999999999999854 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--- 163 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--- 163 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC---
T ss_pred CCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc---
Confidence 9999998765432 23899999999999999999999999 9999999999999999999999999999875322
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhC-CCCCCCh--HHHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA-KPPMGLA--HQVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg-~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
........||+.|+|||++.++.++.++|||||||++|||+|| .+||... ..+...+..+.. +..+ .
T Consensus 164 --~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-----~~~p---~ 233 (272)
T d1qpca_ 164 --YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-----MVRP---D 233 (272)
T ss_dssp --EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----CCCC---T
T ss_pred --cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----CCCc---c
Confidence 1223456799999999999999999999999999999999995 5555432 334445554421 1111 2
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+|+.+||+.+|.+|||+.+|+.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 23346999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=405.82 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=198.4
Q ss_pred ceecccCceeEEEEEEC----CccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEeccCC
Q 035604 469 RKIGEGGYGPVYKSYLD----HTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMANG 541 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~----~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~g 541 (768)
++||+|+||.||+|.+. ++.||||+++... ....+.|.+|+.+|++++|||||+++|+|.+ ..+||||||++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 57999999999999863 2479999997542 2335679999999999999999999999954 458999999999
Q ss_pred ChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCccc
Q 035604 542 SLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADSVT 621 (768)
Q Consensus 542 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 621 (768)
+|.+++.... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+..... .
T Consensus 93 ~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~---~ 163 (277)
T d1xbba_ 93 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---Y 163 (277)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS---E
T ss_pred cHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc---c
Confidence 9999987654 4999999999999999999999999 99999999999999999999999999987744321 1
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCCHHH
Q 035604 622 QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWPVEE 698 (768)
Q Consensus 622 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~~~~ 698 (768)
........||+.|+|||.+.+..++.++|||||||++|||+| |++||... ..+...+..+... ..|..+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--------~~p~~~ 235 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------GCPAGC 235 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------CCCTTC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC--------CCCccc
Confidence 122345678999999999999999999999999999999998 89999643 3444556555321 122233
Q ss_pred HHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 699 ALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 699 ~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
+..+.+|+.+||+.||.+||++.+|+..+.+..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 456999999999999999999999875444433
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-48 Score=409.14 Aligned_cols=246 Identities=28% Similarity=0.413 Sum_probs=203.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||+++.+.. ..++|.+|+.+|++++|||||+++|+|.+ ..+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 46789999999999999999998 467899999976543 35679999999999999999999999854 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
|++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.....
T Consensus 95 ~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 999999999876543 35999999999999999999999999 99999999999999999999999999987644321
Q ss_pred CccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCC-CC--hHHHHHHHHcCCccccCCCCCCCC
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPM-GL--AHQVERSIENGTFDETLDPAVPDW 694 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf-~~--~~~~~~~i~~~~~~~~ld~~~~~~ 694 (768)
.......||+.|+|||++.+..|+.++|||||||++|||++|..|| .. ...+...+..+.. +..
T Consensus 171 -----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~-----~~~--- 237 (287)
T d1opja_ 171 -----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-----MER--- 237 (287)
T ss_dssp -----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-----CCC---
T ss_pred -----eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-----CCC---
Confidence 1234456899999999999999999999999999999999976665 32 2333344444321 111
Q ss_pred CHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 695 PVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 695 ~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+...+..+.+|+.+||+.||.+|||+.+|+.
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2223356999999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=409.12 Aligned_cols=243 Identities=26% Similarity=0.392 Sum_probs=199.5
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
..|+.++.||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.+|++++|||||+++++|.+ ..||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3599999999999999999997 46789999997653 2334568899999999999999999999844 458999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||++|+|..++.... .+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999977665543 4999999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCccccccccCCCCCCCCCCcccccC---CCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCccccCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQT---GMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDETLDPA 690 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ld~~ 690 (768)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ...+..+.......
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 236 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-- 236 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC--
T ss_pred ---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC--
Confidence 234689999999998864 45899999999999999999999999644332 22333333222211
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
..+ +..+.+|+.+||+.||.+|||+.+++. +|+
T Consensus 237 -~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 237 -GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp -TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred -CCC----CHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 122 345999999999999999999999986 444
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=408.37 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=188.9
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch-hhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA-QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E 536 (768)
.+.|++.+.||+|+||+||+|.+ +++.||||++..... .....+.+|+.+|+.++|||||++++++.+. .|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46799999999999999999998 467899999976532 2345678999999999999999999998554 489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCcEEEeecccccccC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD---RNYVSKISDVGLARLVP 613 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~vKL~DFGla~~~~ 613 (768)
||+||+|.+++...+ .+++..+..++.||+.||.|||+.+ ||||||||+|||+. .++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999997654 4999999999999999999999999 99999999999994 57899999999998663
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAV 691 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~ 691 (768)
... .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.... .....+..+.+.. ..+..
T Consensus 162 ~~~-------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~ 233 (307)
T d1a06a_ 162 PGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-DSPYW 233 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC-CTTTT
T ss_pred CCC-------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-CCccc
Confidence 321 2345689999999999999999999999999999999999999996443 3444555544221 11111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
+. .+..+.+|+.+||..||.+|||+.+++.
T Consensus 234 ~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 234 DD----ISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 22 3346899999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=397.07 Aligned_cols=247 Identities=24% Similarity=0.377 Sum_probs=206.6
Q ss_pred cCCCccceecccCceeEEEEEEC-CccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEecc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD-HTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEYMA 539 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 539 (768)
++|++.++||+|+||+||+|.+. ++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+ ..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999994 55899999986543 35679999999999999999999999854 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|..++..... .+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-- 155 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-- 155 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--
T ss_pred CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc--
Confidence 9999998766543 4889999999999999999999999 99999999999999999999999999987643321
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||... .++...+..+... .. |.
T Consensus 156 ---~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-----~~---p~ 224 (258)
T d1k2pa_ 156 ---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-----YR---PH 224 (258)
T ss_dssp ---CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----CC---CT
T ss_pred ---eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----CC---cc
Confidence 12345678999999999999999999999999999999998 89999644 3444556554321 11 12
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhhHHH
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVVPKL 728 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l 728 (768)
..+..+.+|+.+||+.+|.+|||+.+++..++
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 23356999999999999999999999986543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=402.16 Aligned_cols=247 Identities=29% Similarity=0.459 Sum_probs=194.2
Q ss_pred cCCCccceecccCceeEEEEEECC------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Ccee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 533 (768)
+.|...++||+|+||.||+|.+.+ ..||||+++... ......|.+|+.+|++++|||||+++|+|.+ ..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 568889999999999999998743 369999997653 3345578999999999999999999999854 4589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
|||||.+|++.+++..... .+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999998876543 4999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCC-CC--ChHHHHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP-MG--LAHQVERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~P-f~--~~~~~~~~i~~~~~~~~ld~~ 690 (768)
.... .........||+.|+|||++.++.++.++|||||||++|||++|..| |. ....+...+..+...
T Consensus 162 ~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------ 232 (283)
T d1mqba_ 162 DDPE---ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL------ 232 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------
T ss_pred CCCc---cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC------
Confidence 4321 11223445789999999999999999999999999999999996555 43 233444555554321
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 233 --~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 --PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 122233456999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.4e-47 Score=411.42 Aligned_cols=247 Identities=20% Similarity=0.336 Sum_probs=206.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|++.+.||+|+||.||+|.+ +++.||||++........+.+.+|+.+|++++|||||+++++|.+ ..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999998 477999999987766667789999999999999999999999844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc--CCCcEEEeecccccccCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD--RNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~--~~~~vKL~DFGla~~~~~~ 615 (768)
|+||+|.+++....+ .+++..++.|+.||+.||.|||+.+ ||||||||+||||+ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999865432 4999999999999999999999999 99999999999995 4689999999999877433
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
. ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.... .....+..+.+.. .. .
T Consensus 180 ~-------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~~---~ 247 (350)
T d1koaa2 180 Q-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM--DD---S 247 (350)
T ss_dssp S-------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS--CC---G
T ss_pred c-------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--Cc---c
Confidence 2 1245689999999999999999999999999999999999999996443 3334444443211 11 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.....+..+.+||.+||..||.+|||+.+++.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122346899999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9e-47 Score=410.02 Aligned_cols=247 Identities=17% Similarity=0.295 Sum_probs=207.0
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|++.+.||+|+||.||+|.+ +++.||||+++.........+.+|+.+|++++|||||+++++|.+ ..||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46799999999999999999998 577899999987766666788999999999999999999999854 44899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc--CCCcEEEeecccccccCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD--RNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~--~~~~vKL~DFGla~~~~~~ 615 (768)
|+||+|.+++..... .+++..++.|+.||+.||.|||+.| ||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999988765442 4999999999999999999999999 99999999999997 5789999999999887543
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 693 (768)
. ......||+.|+|||++.+..|+.++|||||||+||+|+||++||..... ....+..+.+.. .....+
T Consensus 183 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~- 253 (352)
T d1koba_ 183 E-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF-DEDAFS- 253 (352)
T ss_dssp S-------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC-CSSTTT-
T ss_pred C-------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-Cccccc-
Confidence 2 12446899999999999999999999999999999999999999965433 334455544321 111112
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+||.+||+.||.+|||+.+++.
T Consensus 254 ---~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 254 ---SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23345899999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=408.79 Aligned_cols=242 Identities=26% Similarity=0.322 Sum_probs=204.6
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~ 535 (768)
++|++++.||+|+||.||+|.+ +++.||||++++.. ......+.+|+.+|+.++|||||+++++|.+. .|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6799999999999999999997 57799999997542 22346688999999999999999999999554 48999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||+||+|.+++.+.+ .+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999998766 3899999999999999999999999 999999999999999999999999999865332
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.... .+...+..+.+ .
T Consensus 159 ~------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~---------~ 223 (337)
T d1o6la_ 159 G------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------R 223 (337)
T ss_dssp T------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------C
T ss_pred C------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC---------C
Confidence 1 22356789999999999999999999999999999999999999996443 33444554432 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPD-----LGKVVV 725 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~ 725 (768)
+|...+..+.+||.+||++||.+||+ +.+++.
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 22233456899999999999999995 777765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=407.46 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=200.0
Q ss_pred hcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCC-chhhHHHHHHHHHHHhhc-CCCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPD-AAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 530 (768)
.++|++.+.||+|+||+||+|.+.+ ..||+|.+... .......+.+|+.+|.++ +|||||+++++|.+ .
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3679999999999999999998733 25999998654 334456789999999998 89999999999854 4
Q ss_pred ceeEEEeccCCChHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 035604 531 GCLIYEYMANGSLEDRLFRRGG--------------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKP 590 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp 590 (768)
.+||||||++|+|.++|..... ...+++..++.|+.||+.||.|||+.+ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 5899999999999999976432 235899999999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCC
Q 035604 591 GNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMG 669 (768)
Q Consensus 591 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~ 669 (768)
+|||++.++.+||+|||+|+....... ........||+.|+|||++.+..|+.++|||||||+||||+| |++||.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSN----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred hccccccCCeEEEeeccccccccCCCc----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999999999999999986543221 112345678999999999999999999999999999999998 899996
Q ss_pred Ch---HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 670 LA---HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 670 ~~---~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
.. ..+...+..+.. + +.|...+..+.+|+.+||+.+|.+|||+.+|+..
T Consensus 269 ~~~~~~~~~~~~~~~~~-----~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFK-----M---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHTTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCC-----C---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 43 233344444321 1 1222234569999999999999999999999743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=396.90 Aligned_cols=252 Identities=27% Similarity=0.368 Sum_probs=196.8
Q ss_pred cCCCccceecccCceeEEEEEECC-----ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~ 535 (768)
++|++.+.||+|+||.||+|.+.. ..||||.++... ......|.+|+.+|++++|||||+++|+|.+ ..++||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 579999999999999999998732 358889886543 3445679999999999999999999999854 559999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.+...
T Consensus 87 E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp ECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999998766543 4899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~ 692 (768)
. ........||+.|+|||++.+..++.++|||||||++|||+| |.+||... ..+...+..+....
T Consensus 162 ~-----~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~------- 229 (273)
T d1mp8a_ 162 T-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------- 229 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------
T ss_pred c-----ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 1 122345678999999999999999999999999999999998 89999633 34555566554321
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
.+...+..+.+|+.+||..||.+|||+.+|+..+.+.+.
T Consensus 230 -~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 230 -MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122233569999999999999999999999866554443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=397.54 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=204.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch------hhHHHHHHHHHHHhhcCCCceeeeeccccCC--c
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA------QGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--G 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~ 531 (768)
.++|++.+.||+|+||+||+|.+ +++.||||++.+... ...+.+.+|+.+|++++|||||+++++|.+. .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999998 467999999965321 2356799999999999999999999999554 4
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC----cEEEeecc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY----VSKISDVG 607 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~vKL~DFG 607 (768)
|||||||++|+|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 89999999999999998765 4999999999999999999999999 99999999999998776 59999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDE 685 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~ 685 (768)
+++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+..+.+..
T Consensus 163 ~a~~~~~~~-------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 163 LAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp TCEECTTSC-------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred hhhhcCCCc-------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 998764321 2345689999999999999999999999999999999999999996443 3334444443211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
. + ..+...+..+.+||.+||+.||.+|||+.+++. +|+
T Consensus 236 ~--~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 236 E--D---EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp C--H---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred C--c---hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0 0 001122346899999999999999999999975 444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=402.61 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=202.4
Q ss_pred cCCCccceecccCceeEEEEEEC--Cc----cEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccCC-ceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLD--HT----PVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF-GCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~--~~----~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~lV 534 (768)
++|+++++||+|+||+||+|.+. ++ .||+|.++.. .....+.|.+|+.+|++++|||||+++|+|.+. .+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 46999999999999999999874 32 5899988654 334566799999999999999999999999554 4889
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
|+|+.+|+|.+.+..... .+++..+++|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+..
T Consensus 89 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 999999999998876543 5999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--HHHHHHHHcCCccccCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--HQVERSIENGTFDETLDPAV 691 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~~~~~~i~~~~~~~~ld~~~ 691 (768)
... ........||+.|+|||++.++.|+.++|||||||++|||+| |.+||... ..+...+..+...
T Consensus 164 ~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~------- 232 (317)
T d1xkka_ 164 EEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------- 232 (317)
T ss_dssp TCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-------
T ss_pred ccc----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 321 112234578999999999999999999999999999999998 89999643 4455566655321
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHH
Q 035604 692 PDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNI 730 (768)
Q Consensus 692 ~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~ 730 (768)
..|..++..+.+|+.+||..+|.+|||+.+++..+...
T Consensus 233 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11223335699999999999999999999998654433
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-46 Score=401.98 Aligned_cols=242 Identities=27% Similarity=0.370 Sum_probs=203.4
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 535 (768)
++|++.+.||+|+||+||+|.+ +++.||||++++.. ....+.+.+|+.+|+.++|||||++++++.+ ..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999997 47799999997542 2234678899999999999999999999854 448999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
|||+||+|..++..... +++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998877653 889999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.... .....+..+.+.
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~--------- 219 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--------- 219 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---------
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---------
Confidence 245689999999999999999999999999999999999999996443 333445444321
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh-HHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRP-----DLGKVVV-PKL 728 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~-~~l 728 (768)
+|...+..+.+++.+||..+|.+|| ++.+++. +|.
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 1122234589999999999999996 8888875 444
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-46 Score=398.50 Aligned_cols=249 Identities=31% Similarity=0.458 Sum_probs=203.7
Q ss_pred hcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccC--Cc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 531 (768)
.++|++.+.||+|+||+||+|.+.+ +.||||+++... ......|.+|+++|++++||||++++++|.+ ..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 4689999999999999999998743 579999997653 3345679999999999999999999999854 45
Q ss_pred eeEEEeccCCChHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 035604 532 CLIYEYMANGSLEDRLFRRGG---------------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKP 590 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp 590 (768)
++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ ||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 999999999999999965321 234889999999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCC-CCCC
Q 035604 591 GNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAK-PPMG 669 (768)
Q Consensus 591 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~-~Pf~ 669 (768)
+||||+.++.+||+|||+++.+.... .....+...||+.|+|||++.+..|+.++|||||||++|||++|. +||.
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGG----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEECCCCcEEEccchhheeccCCc----cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 99999999999999999998664321 112234567899999999999999999999999999999999985 6785
Q ss_pred ChH--HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 670 LAH--QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 670 ~~~--~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
... .+...+.++... ..|..++..+.+|+.+||+.+|.+|||+.+|+.
T Consensus 245 ~~~~~e~~~~v~~~~~~--------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCC--------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 443 344556665432 222233356999999999999999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=398.50 Aligned_cols=245 Identities=32% Similarity=0.444 Sum_probs=195.5
Q ss_pred hcCCCccceecccCceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC-CceeEEEecc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-FGCLIYEYMA 539 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~ 539 (768)
.++|++.+.||+|+||.||+|.+.+ +.||||+++... ...+.|.+|+.+|++++|||||+++|+|.+ ..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecC
Confidence 4679999999999999999999855 579999997554 345679999999999999999999999854 4589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|..++..... ..++|..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-- 168 (285)
T d1fmka3 95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 168 (285)
T ss_dssp TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc--
Confidence 9999988865432 24999999999999999999999999 99999999999999999999999999987643221
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCC-CCCh--HHHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPP-MGLA--HQVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~P-f~~~--~~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.......||+.|+|||++.++.++.++|||||||++|||+||..| |... ..+...+..+... . .+.
T Consensus 169 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-----~---~~~ 237 (285)
T d1fmka3 169 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----P---CPP 237 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----C---CCT
T ss_pred ---eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-----C---CCc
Confidence 223456789999999999999999999999999999999996555 4332 2333444444311 1 122
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
.++..+.+|+.+||+.+|++||++.+|+
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~ 265 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQ 265 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 2335699999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4e-46 Score=392.20 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=196.3
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF------ 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------ 530 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||+++... ......|.+|+.+|+.++|||||++++++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999997 57799999997653 23345689999999999999999999987432
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.||||||++||+|.+++...+ .+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.++|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 489999999999999887765 3899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHHHcCCccccC
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSIENGTFDETL 687 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i~~~~~~~~l 687 (768)
....... ........+||+.|+|||++.+..++.++|||||||++|||+||++||....... ..+..+.....
T Consensus 160 ~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 235 (277)
T d1o6ya_ 160 AIADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS- 235 (277)
T ss_dssp ECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG-
T ss_pred hhccccc---cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc-
Confidence 6643221 1223456789999999999999999999999999999999999999997544332 22333221110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhcCccCCC-ChhhhhhHHH
Q 035604 688 DPAVPDWPVEEALILAKLALQCAELRRKDRP-DLGKVVVPKL 728 (768)
Q Consensus 688 d~~~~~~~~~~~~~l~~Li~~cl~~~P~~RP-s~~evl~~~l 728 (768)
...+++ +..+.+|+.+||+.||.+|| ++.+++..+.
T Consensus 236 -~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 -ARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp -GTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -hhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 011122 24599999999999999999 6776665544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=391.53 Aligned_cols=240 Identities=29% Similarity=0.438 Sum_probs=195.9
Q ss_pred cCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC---CceeEEEecc
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---FGCLIYEYMA 539 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~lV~E~~~ 539 (768)
++|++.+.||+|+||.||+|.+.++.||||+++.+. ..+.|.+|+++|++++|||||+++|+|.+ ..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 568889999999999999999999999999997653 34678999999999999999999998832 3589999999
Q ss_pred CCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCCc
Q 035604 540 NGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVADS 619 (768)
Q Consensus 540 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 619 (768)
+|+|.++|..... ..+++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999976432 24899999999999999999999999 999999999999999999999999999865322
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCC--hHHHHHHHHcCCccccCCCCCCCCCH
Q 035604 620 VTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGL--AHQVERSIENGTFDETLDPAVPDWPV 696 (768)
Q Consensus 620 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~--~~~~~~~i~~~~~~~~ld~~~~~~~~ 696 (768)
.....+|..|+|||++.+..++.++|||||||++|||+| |++||.. ...+...+.++...+ . +.
T Consensus 157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~-----~---~~ 223 (262)
T d1byga_ 157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-----A---PD 223 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC-----C---CT
T ss_pred -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----C---Cc
Confidence 233468899999999999999999999999999999998 7888854 334555565543222 1 22
Q ss_pred HHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 697 EEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 697 ~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
..+..+.+|+.+||..||.+|||+.+++.
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22356899999999999999999998874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=396.44 Aligned_cols=261 Identities=27% Similarity=0.381 Sum_probs=198.5
Q ss_pred HHHHHHhcCCCccceecccCceeEEEEEECC-------ccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeecc
Q 035604 456 EEIEEATENFSNSRKIGEGGYGPVYKSYLDH-------TPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGA 526 (768)
Q Consensus 456 ~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~ 526 (768)
..++...++|.+.+.||+|+||.||+|.+.+ +.||||+++... ......+.+|..++.++ +|||||.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3333334689999999999999999998632 479999997543 33455677888888776 68999999998
Q ss_pred ccC---CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 035604 527 CPE---FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKP 590 (768)
Q Consensus 527 ~~~---~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp 590 (768)
+.+ ..++|||||++|+|.+++..... ...+++..++.++.||+.||.|||+.+ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 743 35899999999999999975421 235899999999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhC-CCCCC
Q 035604 591 GNILLDRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA-KPPMG 669 (768)
Q Consensus 591 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg-~~Pf~ 669 (768)
+||||+.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+|| .+||.
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTT----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cceeECCCCcEEEccCcchhhcccccc----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999999987643321 1223456899999999999999999999999999999999986 56785
Q ss_pred Ch---HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 670 LA---HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 670 ~~---~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
.. ..+...+..+.... . +...+..+.+|+.+||+.||.+|||+.+++..+.+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRMR-----A---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp TCCCSHHHHHHHHHTCCCC-----C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCC-----C---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 33 34445555554221 1 2223346999999999999999999999986655544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=389.51 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=192.1
Q ss_pred cCCCccceecccCceeEEEEEECC-----ccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC-cee
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF-GCL 533 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~l 533 (768)
++|++.+.||+|+||.||+|.+.+ ..||||++++.. ....+.|.+|+.+|++++|||||+++|+|.+. .++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 568999999999999999998632 268999987542 23356789999999999999999999999654 589
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccC
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVP 613 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~ 613 (768)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998876543 4999999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCChHH--HHHHHHcCCccccCCCC
Q 035604 614 PSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLAHQ--VERSIENGTFDETLDPA 690 (768)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~~~--~~~~i~~~~~~~~ld~~ 690 (768)
..... ........|+..|+|||++.+..++.++|||||||++|||+| |++||..... ....+....... +.
T Consensus 163 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~---~~ 236 (273)
T d1u46a_ 163 QNDDH---YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---PR 236 (273)
T ss_dssp C-CCE---EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---CC
T ss_pred cCCCc---ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC---CC
Confidence 43221 122334567889999999999999999999999999999998 8999964433 223443332211 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhh
Q 035604 691 VPDWPVEEALILAKLALQCAELRRKDRPDLGKVV 724 (768)
Q Consensus 691 ~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl 724 (768)
...++ ..+.+|+.+||..||++|||+.+|+
T Consensus 237 ~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 237 PEDCP----QDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccccc----HHHHHHHHHHcCCChhHCcCHHHHH
Confidence 12333 4599999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-46 Score=402.88 Aligned_cols=242 Identities=23% Similarity=0.314 Sum_probs=203.7
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHhhcCCCceeeeeccccCC--ceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF--GCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~ 535 (768)
++|++++.||+|+||.||+|.+ +++.||||++.+.. ......+.+|+.+|+.++|||||++++++.+. .++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999998 47799999996532 22345688999999999999999999998554 48999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPS 615 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 615 (768)
||+.+|+|..++.+.+ .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999998765 3999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
.....||+.|+|||++.+..|+.++|||||||+||||+||++||.... .....+..+.+.
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~--------- 256 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--------- 256 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC---------
Confidence 235689999999999999999999999999999999999999996543 333445444321
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCC-----Chhhhhh-HHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRP-----DLGKVVV-PKL 728 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RP-----s~~evl~-~~l 728 (768)
.+...+..+.+|+.+||..||.+|+ ++.+++. +|.
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 1112234589999999999999994 8998875 443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-45 Score=385.30 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=204.7
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---------hhHHHHHHHHHHHhhcC-CCceeeeeccccC
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---------QGRSQFQQEVEVLCNIR-HPNMVLLLGACPE 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---------~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~ 529 (768)
.++|++.+.||+|+||+||+|.+ +++.||||++..... ...+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999998 678999999965421 12345889999999997 9999999999965
Q ss_pred C--ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 F--GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 ~--~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
. .|||||||++|+|.++|...+ .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 4 499999999999999997765 4999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccC------CCCCccccHHHHHHHHHHHHhCCCCCCChHH--HHHHHH
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQT------GMLGVKSDVYSLGILLLQIITAKPPMGLAHQ--VERSIE 679 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDvwSlGvil~elltg~~Pf~~~~~--~~~~i~ 679 (768)
+++.+.... ......||+.|+|||++.+ ..++.++||||+||+||+|++|+.||..... ....+.
T Consensus 156 ~a~~~~~~~-------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~ 228 (277)
T d1phka_ 156 FSCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228 (277)
T ss_dssp TCEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred heeEccCCC-------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence 998774432 1245689999999998753 3478899999999999999999999965543 333455
Q ss_pred cCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 680 NGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 680 ~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+.+. ...+.. ...+.++.+|+.+||+.+|.+||++.+|+. +|+
T Consensus 229 ~~~~~-~~~~~~----~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 229 SGNYQ-FGSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp HTCCC-CCTTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred hCCCC-CCCccc----ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 55432 111111 223456999999999999999999999986 554
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=396.74 Aligned_cols=246 Identities=24% Similarity=0.295 Sum_probs=202.9
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc---hhhHHHHHHHHHHHh-hcCCCceeeeeccccCC--ceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA---AQGRSQFQQEVEVLC-NIRHPNMVLLLGACPEF--GCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~~--~~lV 534 (768)
++|.+.+.||+|+||+||+|.+ +++.||||++++.. ......+..|..++. .++|||||++++++.+. .|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999998 56789999997542 223345667777765 68999999999998554 5899
Q ss_pred EEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCC
Q 035604 535 YEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPP 614 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 614 (768)
||||++|+|.+++..... +++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999987653 899999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCCh--HHHHHHHHcCCccccCCCCCC
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLA--HQVERSIENGTFDETLDPAVP 692 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~--~~~~~~i~~~~~~~~ld~~~~ 692 (768)
.. .......||+.|+|||++.+..|+.++|||||||++|||+||+.||... ..+...+..+.. ..
T Consensus 156 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------~~- 222 (320)
T d1xjda_ 156 GD------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------FY- 222 (320)
T ss_dssp TT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------CC-
T ss_pred cc------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------CC-
Confidence 21 2234568999999999999999999999999999999999999999643 334445554432 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCccCCCChh-hhhh-HHHH
Q 035604 693 DWPVEEALILAKLALQCAELRRKDRPDLG-KVVV-PKLN 729 (768)
Q Consensus 693 ~~~~~~~~~l~~Li~~cl~~~P~~RPs~~-evl~-~~l~ 729 (768)
|...+..+.+|+.+||..||.+||++. +++. +|.+
T Consensus 223 --p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 223 --PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred --CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence 222345699999999999999999996 6754 5543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=392.98 Aligned_cols=249 Identities=20% Similarity=0.308 Sum_probs=204.2
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.++|.+.+.||+|+||+||+|.+ ++..||||+++..... ...+.+|+++|+.++|||||+++++|.+ ..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 57899999999999999999998 4678999999866433 4568899999999999999999999844 45999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC--CCcEEEeecccccccCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR--NYVSKISDVGLARLVPPS 615 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~--~~~vKL~DFGla~~~~~~ 615 (768)
|+||+|.+++...+. .+++..++.|+.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999876542 4899999999999999999999999 999999999999975 458999999999876432
Q ss_pred CCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCCCCCC
Q 035604 616 VADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDPAVPD 693 (768)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 693 (768)
. ......||+.|+|||.+.+..|+.++|||||||++|+|++|++||.... .+...+..+.+.-. ....+.
T Consensus 158 ~-------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~ 229 (321)
T d1tkia_ 158 D-------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-EEAFKE 229 (321)
T ss_dssp C-------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-HHHHTT
T ss_pred C-------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-hhhccC
Confidence 1 1234578999999999999999999999999999999999999996443 33444544432110 000011
Q ss_pred CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 694 WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 694 ~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.+..+.+|+.+||..||.+||++.+++. +|+
T Consensus 230 ----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 230 ----ISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 2345899999999999999999999986 554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=399.20 Aligned_cols=249 Identities=21% Similarity=0.331 Sum_probs=196.7
Q ss_pred hcCCCccc-eecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhh-cCCCceeeeeccccC------Cc
Q 035604 462 TENFSNSR-KIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCN-IRHPNMVLLLGACPE------FG 531 (768)
Q Consensus 462 ~~~y~~~~-~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~------~~ 531 (768)
.++|.+.. .||+|+||.||+|.+ +++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46888775 699999999999997 5678999999642 357789998765 489999999998743 35
Q ss_pred eeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC---CCcEEEeeccc
Q 035604 532 CLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR---NYVSKISDVGL 608 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~vKL~DFGl 608 (768)
|||||||+||+|.++|...+. ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 999999999999999976543 35999999999999999999999999 999999999999975 56799999999
Q ss_pred ccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHH--HHHHHcCCcccc
Q 035604 609 ARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQV--ERSIENGTFDET 686 (768)
Q Consensus 609 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~--~~~i~~~~~~~~ 686 (768)
|+...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||++||...... ...+.......
T Consensus 161 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~- 232 (335)
T d2ozaa1 161 AKETTSHN-------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG- 232 (335)
T ss_dssp CEECCCCC-------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC-
T ss_pred eeeccCCC-------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC-
Confidence 98764332 234568999999999999999999999999999999999999999543321 11111111100
Q ss_pred CCCCCCC-CCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 687 LDPAVPD-WPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 687 ld~~~~~-~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
....+. .....+..+.+|+.+||+.||.+||++.+++. +|.
T Consensus 233 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 233 -QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp -SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred -CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence 111111 11234567999999999999999999999985 444
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-45 Score=400.86 Aligned_cols=243 Identities=27% Similarity=0.306 Sum_probs=193.8
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch---hhHHHHH---HHHHHHhhcCCCceeeeeccccC--Cce
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA---QGRSQFQ---QEVEVLCNIRHPNMVLLLGACPE--FGC 532 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~---~E~~il~~l~HpnIv~l~g~~~~--~~~ 532 (768)
++|++.+.||+|+||.||+|.+ +++.||||++.+... .....+. +++.+++.++|||||+++++|.+ ..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999998 467899999964321 1222333 44677778899999999999855 459
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
||||||+||+|.++|.... .+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999998765 3889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChH--HHHHHHHcCCccccCCC
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAH--QVERSIENGTFDETLDP 689 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~--~~~~~i~~~~~~~~ld~ 689 (768)
... .....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||.... .......... . ...
T Consensus 158 ~~~--------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~--~~~ 226 (364)
T d1omwa3 158 SKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-T--MAV 226 (364)
T ss_dssp SSS--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-S--CCC
T ss_pred CCC--------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-c--CCC
Confidence 432 2345689999999998864 568999999999999999999999995432 1111111111 0 011
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh
Q 035604 690 AVPDWPVEEALILAKLALQCAELRRKDRPD-----LGKVVV 725 (768)
Q Consensus 690 ~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~ 725 (768)
..+...+..+.+||.+||..||.+||+ +.+++.
T Consensus 227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 122223456999999999999999999 577764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=386.55 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=200.3
Q ss_pred hcCCCccceecccCceeEEEEEECC---------ccEEEEEEcCCch-hhHHHHHHHHHHHhhc-CCCceeeeeccccC-
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLDH---------TPVAIKVLRPDAA-QGRSQFQQEVEVLCNI-RHPNMVLLLGACPE- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 529 (768)
.++|.+.+.||+|+||.||+|++.+ +.||||+++.+.. .....+.+|...+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3678999999999999999998632 3699999976643 4456788999999888 89999999999954
Q ss_pred -CceeEEEeccCCChHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 530 -FGCLIYEYMANGSLEDRLFRRGG-------------SPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 530 -~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
..++|||||++|+|.++|..... ...+++.+++.++.||+.||.|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 44899999999999999975431 235899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh--H
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--H 672 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--~ 672 (768)
+.++.+||+|||+++...... .........||+.|+|||.+.++.|+.++|||||||++|||++ |.+||... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHID----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCC----TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCCCCeEeccchhhccccccc----cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 999999999999998764322 1222355678999999999999999999999999999999998 79999533 3
Q ss_pred HHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHH
Q 035604 673 QVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPK 727 (768)
Q Consensus 673 ~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~ 727 (768)
.+...+..+... .. |...+..+.+|+.+||+.+|.+|||+.+|+..+
T Consensus 245 ~~~~~i~~~~~~-----~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 245 ELFKLLKEGHRM-----DK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHHHTTCCC-----CC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCC-----CC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 444555554321 11 122234699999999999999999999997533
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=390.83 Aligned_cols=251 Identities=30% Similarity=0.474 Sum_probs=199.0
Q ss_pred cCCCccceecccCceeEEEEEECC--c--cEEEEEEcCC-chhhHHHHHHHHHHHhhc-CCCceeeeeccccC--CceeE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDH--T--PVAIKVLRPD-AAQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--FGCLI 534 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~--~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 534 (768)
++|++.+.||+|+||.||+|.+.+ . .||||.++.. .....+.|.+|+++|+++ +|||||+++|+|.+ ..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999999843 3 5788888644 334556799999999998 79999999999954 34999
Q ss_pred EEeccCCChHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcE
Q 035604 535 YEYMANGSLEDRLFRR-------------GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVS 601 (768)
Q Consensus 535 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~v 601 (768)
|||+++|+|.++|... .....+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 22346999999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCC-CCCCCh--HHHHHHH
Q 035604 602 KISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAK-PPMGLA--HQVERSI 678 (768)
Q Consensus 602 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~-~Pf~~~--~~~~~~i 678 (768)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||... ..+...+
T Consensus 167 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EEccccccccccccc-------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 999999998653221 123457899999999999999999999999999999999965 567533 3333445
Q ss_pred HcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 679 ENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 679 ~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
..+.. + ..+...+..+.+||.+||+.||++||++.+|+..+.+.+
T Consensus 240 ~~~~~-----~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 240 PQGYR-----L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp GGTCC-----C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCC-----C---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 44421 1 222233456999999999999999999999986544433
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=388.15 Aligned_cols=250 Identities=27% Similarity=0.359 Sum_probs=200.2
Q ss_pred cceecccCceeEEEEEECC-----ccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeeccccC---CceeEEEec
Q 035604 468 SRKIGEGGYGPVYKSYLDH-----TPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE---FGCLIYEYM 538 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~lV~E~~ 538 (768)
.++||+|+||+||+|.+.. ..||||+++.. .......|.+|+++|++++|||||+++|+|.+ ..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999732 25899999753 44556789999999999999999999998732 348999999
Q ss_pred cCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCCC
Q 035604 539 ANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVAD 618 (768)
Q Consensus 539 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 618 (768)
++|+|.+++..... .+++..+++++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998876543 4788899999999999999999999 999999999999999999999999999877543221
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH---HHHHHHHcCCccccCCCCCCCCC
Q 035604 619 SVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH---QVERSIENGTFDETLDPAVPDWP 695 (768)
Q Consensus 619 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~---~~~~~i~~~~~~~~ld~~~~~~~ 695 (768)
.........||+.|+|||.+.+..++.++|||||||++|||+||..||.... .+...+..+... ..+.
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-----~~p~-- 257 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-----LQPE-- 257 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-----CCCT--
T ss_pred --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----CCcc--
Confidence 1122345678999999999999999999999999999999999877774332 223444444321 1121
Q ss_pred HHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHH
Q 035604 696 VEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILR 732 (768)
Q Consensus 696 ~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~ 732 (768)
.++..+.+|+.+||..||.+||++.+|+..+.+.+.
T Consensus 258 -~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 258 -YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 223469999999999999999999999866554443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=390.08 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=194.5
Q ss_pred cCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC------CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE------FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~lV~E 536 (768)
.+|.+.+.||+|+||.||+|+++++.||||+++..... ...++.|+..+..++|||||+++++|.+ ..|+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 45778889999999999999999999999999754322 2223445566678899999999999843 2489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTK-----PEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
||++|+|.++|.+.. ++|..+++++.|++.||.|||... ..+||||||||+||||+.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999997643 899999999999999999999741 13499999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCCCCCCCcccccCCC------CCccccHHHHHHHHHHHHhCCCCCCChH-------------
Q 035604 612 VPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGM------LGVKSDVYSLGILLLQIITAKPPMGLAH------------- 672 (768)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~s~ksDvwSlGvil~elltg~~Pf~~~~------------- 672 (768)
+..... ..........||+.|+|||++.+.. ++.++|||||||+||||+||.+||+...
T Consensus 158 ~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 158 HDSATD--TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EETTTT--EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccCCCc--ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 744321 1122334568999999999887643 6789999999999999999998874211
Q ss_pred HHHHHHHcCCccccCCCCCCCC--CHHHHHHHHHHHHHhhhcCccCCCChhhhhhH
Q 035604 673 QVERSIENGTFDETLDPAVPDW--PVEEALILAKLALQCAELRRKDRPDLGKVVVP 726 (768)
Q Consensus 673 ~~~~~i~~~~~~~~ld~~~~~~--~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~ 726 (768)
.....+........+.|.++.. +......+.+|+.+||..||.+|||+.+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0011111111222334444322 22345569999999999999999999998753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=389.48 Aligned_cols=250 Identities=26% Similarity=0.288 Sum_probs=190.7
Q ss_pred ccceecccCceeEEEEEE--CCccEEEEEEcCCchh-----hHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 467 NSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQ-----GRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 467 ~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
.+++||+|+||+||+|.+ +++.||||+++..... ....+.+|+.+|+.++|||||+++++|.+ ..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999997 4678999998654322 13458899999999999999999999854 45999999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+.++++..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 9888776554333 24899999999999999999999999 9999999999999999999999999998664322
Q ss_pred CccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CCcccc------
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GTFDET------ 686 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~~~~~------ 686 (768)
......+||+.|+|||++.+ ..|+.++|||||||++|||+||.+||........ .+.+ +.....
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 155 -----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp -----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred -----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 12345689999999998765 4689999999999999999999999965443322 2211 110000
Q ss_pred ------CCCCCCCCCH-----HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 687 ------LDPAVPDWPV-----EEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 687 ------ld~~~~~~~~-----~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
.....+..+. ..+..+.+|+.+||+.||.+|||+.|++. +|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 0001111111 22356999999999999999999999985 443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=387.98 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=204.3
Q ss_pred hcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCC-chhhHHHHHHHHHHHhhcCCCceeeeecccc--CCc
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPD-AAQGRSQFQQEVEVLCNIRHPNMVLLLGACP--EFG 531 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~ 531 (768)
.++|.+.+.||+|+||.||+|.+. ++.||||+++.. .......|.+|++++++++|||||+++|+|. +..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 478899999999999999999874 357999999754 3344557899999999999999999999984 456
Q ss_pred eeEEEeccCCChHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEe
Q 035604 532 CLIYEYMANGSLEDRLFRR-------GGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKIS 604 (768)
Q Consensus 532 ~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~ 604 (768)
++|||||++|+|.+++... .....+++..+++++.|++.||.|||+.+ |+||||||+||||+.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999988643 22335789999999999999999999999 9999999999999999999999
Q ss_pred ecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhC-CCCCCChH--HHHHHHHcC
Q 035604 605 DVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITA-KPPMGLAH--QVERSIENG 681 (768)
Q Consensus 605 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg-~~Pf~~~~--~~~~~i~~~ 681 (768)
|||+++.+.... .........||+.|+|||.+.+..++.++|||||||++|||+|| .+||.... .....+.++
T Consensus 176 DFGla~~~~~~~----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 176 DFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp CTTCCCGGGGGG----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred ecccceeccCCc----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 999998763321 22233455789999999999999999999999999999999998 57785443 334455555
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 682 TFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 682 ~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.... .+...+..+.+|+.+||+.+|.+|||+.+|+.
T Consensus 252 ~~~~--------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 252 GLLD--------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC--------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4321 12223356999999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=384.23 Aligned_cols=240 Identities=27% Similarity=0.380 Sum_probs=195.8
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch------hhHHHHHHHHHHHhhcC--CCceeeeeccccC--
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA------QGRSQFQQEVEVLCNIR--HPNMVLLLGACPE-- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~-- 529 (768)
.++|.+.+.||+|+||.||+|.+ +++.||||++++... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36799999999999999999998 467899999875321 12234678999999987 8999999999855
Q ss_pred CceeEEEeccC-CChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-CCcEEEeecc
Q 035604 530 FGCLIYEYMAN-GSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-NYVSKISDVG 607 (768)
Q Consensus 530 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~vKL~DFG 607 (768)
..++||||+.+ +++.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 44999999976 57777776654 4999999999999999999999999 999999999999985 4799999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCCCC-CccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHcCCcccc
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGML-GVKSDVYSLGILLLQIITAKPPMGLAHQVERSIENGTFDET 686 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~~~~~~~ 686 (768)
+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.....+. .+.+ .
T Consensus 157 ~a~~~~~~--------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~----~~~~--~ 222 (273)
T d1xwsa_ 157 SGALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQV--F 222 (273)
T ss_dssp TCEECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HCCC--C
T ss_pred cceecccc--------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh----hccc--C
Confidence 99875332 2345689999999999887765 678999999999999999999998655432 2221 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 687 LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 687 ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+.+ . .+..+.+|+.+||..||.+|||+.+++. +|+
T Consensus 223 ~~~---~----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 223 FRQ---R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp CSS---C----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CCC---C----CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 111 1 2346899999999999999999999986 554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=383.92 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=205.4
Q ss_pred hcCCCccceecccCceeEEEEEEC-------CccEEEEEEcCCc-hhhHHHHHHHHHHHhhc-CCCceeeeeccccC--C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD-------HTPVAIKVLRPDA-AQGRSQFQQEVEVLCNI-RHPNMVLLLGACPE--F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 530 (768)
.++|++.++||+|+||.||+|.+. ++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+ .
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 368899999999999999999862 2479999998653 34455789999999999 69999999999954 4
Q ss_pred ceeEEEeccCCChHHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 035604 531 GCLIYEYMANGSLEDRLFRRG---------------GSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILL 595 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl 595 (768)
.++|||||++|+|.+++.+.. ....+++..++.++.||+.||.|||+++ ||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 599999999999999997643 2235899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHh-CCCCCCCh---
Q 035604 596 DRNYVSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIIT-AKPPMGLA--- 671 (768)
Q Consensus 596 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-g~~Pf~~~--- 671 (768)
+.++.+||+|||+++.+..... ........||+.|+|||++.++.++.++|||||||++|||+| |.+||...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccCcccccccchheeccCCCc----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999987643321 122355789999999999999999999999999999999998 66666432
Q ss_pred HHHHHHHHcCCccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHH
Q 035604 672 HQVERSIENGTFDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNIL 731 (768)
Q Consensus 672 ~~~~~~i~~~~~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l 731 (768)
..+...+..+.. +..+ ...+..+.+||.+||+.||++||++.+|+..+.+.+
T Consensus 255 ~~~~~~i~~~~~-----~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 SKFYKMIKEGFR-----MLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHHHHHTCC-----CCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCC-----CCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 233444444431 1111 112345999999999999999999999985444444
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-45 Score=385.62 Aligned_cols=255 Identities=28% Similarity=0.393 Sum_probs=195.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
++|++.+.||+|+||+||+|.+ +++.||||+++.... .....+.+|+++|++++|||||+++++|.+ ..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999998 477999999965432 235678999999999999999999999854 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
|+.++ +..++..... ..+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99655 4444443322 35999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCccccccccCCCCCCCCCCcccccCCC-CCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HH-H-cCCccccCC---
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SI-E-NGTFDETLD--- 688 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i-~-~~~~~~~ld--- 688 (768)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||........ .+ . .+...+...
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 2234568999999999876655 58999999999999999999999965433221 11 1 011111100
Q ss_pred -------CCCCCC--------CHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 689 -------PAVPDW--------PVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 689 -------~~~~~~--------~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
...+.+ ....+..+.+|+.+||..||.+|||+.+++. +|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 000000 0122356899999999999999999999986 444
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=384.13 Aligned_cols=256 Identities=26% Similarity=0.356 Sum_probs=196.3
Q ss_pred hcCCCccceecccCceeEEEEEEC---CccEEEEEEcCCch--hhHHHHHHHHHHHhhc---CCCceeeeeccccC----
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYLD---HTPVAIKVLRPDAA--QGRSQFQQEVEVLCNI---RHPNMVLLLGACPE---- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~---- 529 (768)
.++|++++.||+|+||+||+|.+. ++.||||+++.... .....+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999973 45699999864322 2233466788887766 79999999998731
Q ss_pred ---CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeec
Q 035604 530 ---FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDV 606 (768)
Q Consensus 530 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DF 606 (768)
..+++|||+.++.+........ ..+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 3489999998877655444332 35899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--CC
Q 035604 607 GLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--GT 682 (768)
Q Consensus 607 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~~ 682 (768)
|+++.... ........||+.|+|||++.+..|+.++|||||||++|||++|++||....... ..+.. +.
T Consensus 161 g~~~~~~~-------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSF-------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCG-------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhhcc-------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 99876432 123456789999999999999999999999999999999999999996543322 11111 00
Q ss_pred c----------------cccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 683 F----------------DETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 683 ~----------------~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
. ..........++...+..+.+|+.+||+.||.+|||+.|++. +|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 0 000000111122233456889999999999999999999986 5553
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.6e-44 Score=377.41 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=194.2
Q ss_pred cCCCccceecccCceeEEEEEE-CCccEEEEEEcCCch--hhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA--QGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 537 (768)
++|.+.++||+|+||+||+|.+ +++.||||+++.... .....+.+|+.+|++++|||||+++++|.+ ..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999998 567899999976532 235678999999999999999999999844 45899999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSVA 617 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 617 (768)
+.++.+..+....+ .+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 97776666554333 4999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CC----------
Q 035604 618 DSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GT---------- 682 (768)
Q Consensus 618 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~---------- 682 (768)
.......|++.|+|||.+.+. .++.++|||||||++|||++|++||........ .+.. +.
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 223455789999999987654 579999999999999999999999964432221 1110 10
Q ss_pred ----ccccCCCCC----CCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 683 ----FDETLDPAV----PDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 683 ----~~~~ld~~~----~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+........ .......+..+.+|+.+||+.||++|||+.|++. +|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 000000000 0111223356899999999999999999999985 443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=380.73 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=195.8
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc-hhhHHHHHHHHHHHhhcCCCceeeeeccccCC------ce
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-AQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF------GC 532 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~ 532 (768)
+++|.++++||+|+||+||+|.+ +++.||||++++.. ....+.+.+|+.+|+.++|||||+++++|... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999997 57899999997543 34456789999999999999999999998432 24
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccccc
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLV 612 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~ 612 (768)
++++|+.+|+|.+++... .+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 566777799999998654 3999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHHHHHc----CCccc--
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVERSIEN----GTFDE-- 685 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~i~~----~~~~~-- 685 (768)
.... .........+||+.|+|||++.. ..++.++||||+||++|+|++|++||............ .....
T Consensus 160 ~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDH---DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGG---CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cCCC---ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 4322 11222456789999999998754 56799999999999999999999999644321111000 00000
Q ss_pred -------------cCCCCCCCCC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 686 -------------TLDPAVPDWP-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 686 -------------~ld~~~~~~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
...+.....+ ...+..+.+|+.+||+.||.+|||+.+++. +|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 0000000011 112245889999999999999999999986 554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=380.26 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=193.1
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCC--chhhHHHHHHHHHHHhhcCCCceeeeeccccCC-------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPD--AAQGRSQFQQEVEVLCNIRHPNMVLLLGACPEF------- 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------- 530 (768)
.++|+++++||+|+||+||+|.+ +++.||||+++.. .....+.+.+|+.+|+.++|||||+++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999998 4788999999754 233456788999999999999999999998432
Q ss_pred -ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccc
Q 035604 531 -GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLA 609 (768)
Q Consensus 531 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla 609 (768)
.||||||+ +++|..++... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 48999999 66777665443 3999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHHH--HHc--CC--
Q 035604 610 RLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVERS--IEN--GT-- 682 (768)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~~--i~~--~~-- 682 (768)
+..... .+...||+.|+|||++.+. .++.++|||||||++|+|++|++||......... +.. +.
T Consensus 169 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 169 RQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp EECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eccCCc---------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 876432 3456899999999988764 5799999999999999999999999654332211 000 00
Q ss_pred ------------------ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 683 ------------------FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 683 ------------------~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
+...............+..+.+|+.+||..||.+|||+.+++. +|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000011111111223456889999999999999999999986 666443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-43 Score=373.62 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=195.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--------
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------- 529 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 529 (768)
.++|+++++||+|+||+||+|.+ +++.||||++.... ......+.+|+.+|++++||||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999998 56789999986442 2335678899999999999999999988732
Q ss_pred --CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecc
Q 035604 530 --FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVG 607 (768)
Q Consensus 530 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFG 607 (768)
..|+||||+.++.+....... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 348999999877665443332 24889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--CC
Q 035604 608 LARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--GT 682 (768)
Q Consensus 608 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~~ 682 (768)
+++.+...... ........+||+.|+|||++.+. .|+.++|||||||++|||++|++||........ .+.. +.
T Consensus 163 ~~~~~~~~~~~--~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp TCEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeeeccccccc--ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99876543211 12223456899999999988765 689999999999999999999999965443222 1111 11
Q ss_pred ccccCCCCCC--------------CCCH-------HHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 683 FDETLDPAVP--------------DWPV-------EEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 683 ~~~~ld~~~~--------------~~~~-------~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
+......... ..+. .....+.+|+.+||+.||++|||+.+++. +|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 1111111100 0011 11335778999999999999999999985 443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-43 Score=379.75 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=193.3
Q ss_pred CCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccccC--------Ccee
Q 035604 464 NFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--------FGCL 533 (768)
Q Consensus 464 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~~~l 533 (768)
+|...++||+|+||+||+|.+ +++.||||++..... .+.+|+.+|++++|||||+++++|.. +.||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588899999999999999998 467899999976532 23479999999999999999998722 2479
Q ss_pred EEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeeccccccc
Q 035604 534 IYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLV 612 (768)
Q Consensus 534 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFGla~~~ 612 (768)
|||||++|.+..+.........+++..++.++.||+.||.|||+.| |+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655544433333346999999999999999999999999 99999999999999775 8999999999876
Q ss_pred CCCCCCccccccccCCCCCCCCCCcccccC-CCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHHc--C------
Q 035604 613 PPSVADSVTQYRMTSAAGTFCYIDPEYQQT-GMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIEN--G------ 681 (768)
Q Consensus 613 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~~--~------ 681 (768)
.... ......||+.|+|||.+.+ ..|+.++|||||||++|||++|++||........ .+.+ |
T Consensus 174 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTS-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCCc-------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 4322 2345689999999997765 5789999999999999999999999964432221 1100 0
Q ss_pred ------CccccCCCCCC------CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHHH
Q 035604 682 ------TFDETLDPAVP------DWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNIL 731 (768)
Q Consensus 682 ------~~~~~ld~~~~------~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~l 731 (768)
.+....-+... ......+..+.+|+.+||..||.+|||+.|++. +|++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00010001000 011123456899999999999999999999987 666443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-42 Score=366.56 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=190.6
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCceeeeeccc---cCCceeEEEe
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNMVLLLGAC---PEFGCLIYEY 537 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~---~~~~~lV~E~ 537 (768)
++|++.+.||+|+||.||+|.+ +++.||||++..... ...+..|+++++.++|+|+|.+++.| .+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999997 467999999876533 23578999999999988776665554 3445889999
Q ss_pred ccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEc---CCCcEEEeecccccccCC
Q 035604 538 MANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLD---RNYVSKISDVGLARLVPP 614 (768)
Q Consensus 538 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~vKL~DFGla~~~~~ 614 (768)
+ +++|.+.+..... .+++..++.++.|++.||.|||+++ ||||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5677666655432 4999999999999999999999999 99999999999985 456799999999998754
Q ss_pred CCCCccc-cccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHH--H---HHHcCCccccCC
Q 035604 615 SVADSVT-QYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--R---SIENGTFDETLD 688 (768)
Q Consensus 615 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~---~i~~~~~~~~ld 688 (768)
....... ........||+.|+|||.+.+..++.++|||||||++|||+||++||....... . ......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3322111 122356689999999999999999999999999999999999999995332211 1 111110000000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 689 PAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 689 ~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.....+ +.++.+|+..||+.+|.+||++.++..
T Consensus 239 ~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~ 271 (299)
T d1ckia_ 239 VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQ 271 (299)
T ss_dssp HHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHH
T ss_pred HhccCC----CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 011122 245899999999999999999987754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.3e-42 Score=363.53 Aligned_cols=262 Identities=19% Similarity=0.245 Sum_probs=200.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCC-CceeeeeccccC--CceeEEE
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRH-PNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~--~~~lV~E 536 (768)
.++|.+.+.||+|+||.||+|++ +++.||||++..... ...+.+|+++++.+.| +||+.+++++.+ ..++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46899999999999999999997 567899999865432 2357789999999975 899988887743 4589999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcC-----CCcEEEeecccccc
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDR-----NYVSKISDVGLARL 611 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~-----~~~vKL~DFGla~~ 611 (768)
|+ +++|.+++..... .+++..++.++.|++.||.|||+.| ||||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 7899998876543 4899999999999999999999999 999999999999964 57899999999998
Q ss_pred cCCCCCCcc-ccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChH-----HHHHHHHcCCccc
Q 035604 612 VPPSVADSV-TQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAH-----QVERSIENGTFDE 685 (768)
Q Consensus 612 ~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~-----~~~~~i~~~~~~~ 685 (768)
+........ ........+||+.|+|||++.+..++.++|||||||++|||+||+.||.... .....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 754332211 1122456789999999999999999999999999999999999999995221 1111222111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhhHHHHHHHHHh
Q 035604 686 TLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVVPKLNILRALA 735 (768)
Q Consensus 686 ~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~~~l~~l~~~~ 735 (768)
.......+.| .++.+|+..|+..+|.+||++..+...+.+.++...
T Consensus 236 ~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 236 PLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp CHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ChHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1111112233 459999999999999999999877644444444443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=361.57 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=199.1
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--CceeEEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--FGCLIYE 536 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 536 (768)
++|++++.||+|+||+||+|.+ +++.||||+++... ......+.+|+.+|+.++|||||+++++|.+ ..++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999998 56789999996543 2345678999999999999999999999854 4489999
Q ss_pred eccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeecccccccCCCC
Q 035604 537 YMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLARLVPPSV 616 (768)
Q Consensus 537 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 616 (768)
++.+++|..++...+ .+++..++.++.|++.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998888776544 4889999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCccccccccCCCCCCCCCCcccccCCC-CCccccHHHHHHHHHHHHhCCCCCCChHH---HHHHHHc--CCccc-----
Q 035604 617 ADSVTQYRMTSAAGTFCYIDPEYQQTGM-LGVKSDVYSLGILLLQIITAKPPMGLAHQ---VERSIEN--GTFDE----- 685 (768)
Q Consensus 617 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltg~~Pf~~~~~---~~~~i~~--~~~~~----- 685 (768)
. ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||..... ....+.. +....
T Consensus 156 ~------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 1 223456788999999887665 69999999999999999999999732221 1111111 10000
Q ss_pred ------c-------CCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHH
Q 035604 686 ------T-------LDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKL 728 (768)
Q Consensus 686 ------~-------ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l 728 (768)
. ............+..+.+|+.+||+.||.+|||+.|++. +|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 0 001111222334456899999999999999999999986 554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-42 Score=372.13 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=189.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC--------C
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE--------F 530 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~ 530 (768)
++|+++++||+|+||+||+|.+ +++.||||++.... ......+.+|+.+|+.++|||||+++++|.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999998 47899999997542 3344568899999999999999999999842 3
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.|+|||||.++.+ ..+.. .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 4899999976544 44422 3899999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHHHHH--HHH---------
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQVER--SIE--------- 679 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~~--~i~--------- 679 (768)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|++||...+.... .+.
T Consensus 168 ~~~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 168 TAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccc-------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 65432 223556899999999999999999999999999999999999999954332211 110
Q ss_pred -------------cCC-----------ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHHH
Q 035604 680 -------------NGT-----------FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPDLGKVVV-PKLNI 730 (768)
Q Consensus 680 -------------~~~-----------~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~~ 730 (768)
.+. +.....+.........+..+.+|+.+||..||++|||+.+++. +|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000 0000011111112345677999999999999999999999987 66654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-41 Score=363.47 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=191.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccccC----CceeEE
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGACPE----FGCLIY 535 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~----~~~lV~ 535 (768)
++|+++++||+|+||+||+|++ +++.||||+++... ...+.+|+++|+.+. ||||++++++|.. ..++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999998 47789999997543 356889999999995 9999999998742 358999
Q ss_pred EeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCC-cEEEeecccccccCC
Q 035604 536 EYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNY-VSKISDVGLARLVPP 614 (768)
Q Consensus 536 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~vKL~DFGla~~~~~ 614 (768)
|||.+|+|..+. ..+++..++.++.||+.||.|||++| ||||||||+||||+.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987643 24899999999999999999999999 99999999999998654 689999999987643
Q ss_pred CCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHH---HHH------------
Q 035604 615 SVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVE---RSI------------ 678 (768)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~---~~i------------ 678 (768)
.. ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||....... ..+
T Consensus 183 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CC-------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 32 23456899999999987765 57999999999999999999999995322111 000
Q ss_pred -HcCC------ccccCCCC--------CC-CCCHHHHHHHHHHHHHhhhcCccCCCChhhhhh
Q 035604 679 -ENGT------FDETLDPA--------VP-DWPVEEALILAKLALQCAELRRKDRPDLGKVVV 725 (768)
Q Consensus 679 -~~~~------~~~~ld~~--------~~-~~~~~~~~~l~~Li~~cl~~~P~~RPs~~evl~ 725 (768)
.... +...+... .. ......+.++.+|+.+||..||.+|||+.+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000 00 011223456899999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=365.14 Aligned_cols=246 Identities=28% Similarity=0.364 Sum_probs=196.5
Q ss_pred cCCCccceecccCceeEEEEEE-----CCccEEEEEEcCCc----hhhHHHHHHHHHHHhhcCC-CceeeeeccccC--C
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL-----DHTPVAIKVLRPDA----AQGRSQFQQEVEVLCNIRH-PNMVLLLGACPE--F 530 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~--~ 530 (768)
++|++.+.||+|+||+||+|.. +++.||||+++... ....+.+.+|+++|++++| |||+++++++.+ .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999986 35689999986532 2234567899999999977 899999999844 4
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.+++|||+.+|+|.+++..... +++...+.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 5899999999999999987763 788999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCC--CCCccccHHHHHHHHHHHHhCCCCCCChH------HHHHHHHcCC
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG--MLGVKSDVYSLGILLLQIITAKPPMGLAH------QVERSIENGT 682 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltg~~Pf~~~~------~~~~~i~~~~ 682 (768)
.+.... ........|++.|++||.+.+. .++.++|||||||+||+|++|+.||.... .+........
T Consensus 178 ~~~~~~-----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 178 EFVADE-----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252 (322)
T ss_dssp ECCGGG-----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred hhcccc-----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence 764321 2223456899999999988754 47889999999999999999999995332 2222221211
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhhcCccCCCC-----hhhhhh-HHH
Q 035604 683 FDETLDPAVPDWPVEEALILAKLALQCAELRRKDRPD-----LGKVVV-PKL 728 (768)
Q Consensus 683 ~~~~ld~~~~~~~~~~~~~l~~Li~~cl~~~P~~RPs-----~~evl~-~~l 728 (768)
+ ..+...+..+.+|+.+||..||.+||+ +.|++. +|.
T Consensus 253 ------~---~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 253 ------P---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp ------C---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ------C---CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 1 122234466999999999999999995 677765 454
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=367.43 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=194.5
Q ss_pred hcCCCccceecccCceeEEEEEE--CCccEEEEEEcCCc--hhhHHHHHHHHHHHhhcCCCceeeeeccccC-------C
Q 035604 462 TENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA--AQGRSQFQQEVEVLCNIRHPNMVLLLGACPE-------F 530 (768)
Q Consensus 462 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~ 530 (768)
.++|++.++||+|+||+||+|.+ +++.||||++.... ......+.+|+++|+.++|||||++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999997 57899999997543 3345578899999999999999999998732 2
Q ss_pred ceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 531 GCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 531 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.+++|+|+.+|+|.+++..+ .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 36778888899999988543 3999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCcccccCC-CCCccccHHHHHHHHHHHHhCCCCCCChHHHH--HHHHc--CCccc
Q 035604 611 LVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTG-MLGVKSDVYSLGILLLQIITAKPPMGLAHQVE--RSIEN--GTFDE 685 (768)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltg~~Pf~~~~~~~--~~i~~--~~~~~ 685 (768)
... .......||+.|+|||.+.+. .++.++|||||||++|+|++|++||...+... ..+.. +....
T Consensus 170 ~~~---------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 170 HTD---------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCT---------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccC---------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 542 223456899999999976665 56899999999999999999999996443221 11111 00000
Q ss_pred c---------------CCCCCCCCC-----HHHHHHHHHHHHHhhhcCccCCCChhhhhh-HHHH
Q 035604 686 T---------------LDPAVPDWP-----VEEALILAKLALQCAELRRKDRPDLGKVVV-PKLN 729 (768)
Q Consensus 686 ~---------------ld~~~~~~~-----~~~~~~l~~Li~~cl~~~P~~RPs~~evl~-~~l~ 729 (768)
. ..+..+... ...+..+.+||.+||..||.+|||+.|++. +|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 0 000011111 122356889999999999999999999986 5654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-37 Score=333.37 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=192.3
Q ss_pred cCCCccceecccCceeEEEEEE--CCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-----------CCceeeeeccccC
Q 035604 463 ENFSNSRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-----------HPNMVLLLGACPE 529 (768)
Q Consensus 463 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~g~~~~ 529 (768)
++|+++++||+|+||+||+|++ +++.||||+++..... .+.+.+|+.+++.++ |||||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999997 5789999999866433 456788999988875 5788999888733
Q ss_pred ----CceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCC-----
Q 035604 530 ----FGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNY----- 599 (768)
Q Consensus 530 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~----- 599 (768)
..+++|+++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 336777777666555555444445568999999999999999999998 77 99999999999997655
Q ss_pred -cEEEeecccccccCCCCCCccccccccCCCCCCCCCCcccccCCCCCccccHHHHHHHHHHHHhCCCCCCChHH-----
Q 035604 600 -VSKISDVGLARLVPPSVADSVTQYRMTSAAGTFCYIDPEYQQTGMLGVKSDVYSLGILLLQIITAKPPMGLAHQ----- 673 (768)
Q Consensus 600 -~vKL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltg~~Pf~~~~~----- 673 (768)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++++|++|+.||.....
T Consensus 169 ~~~kl~dfg~s~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE---------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEEEECCCTTCEETTB---------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ceeeEeeccccccccc---------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 389999999975432 22456899999999999999999999999999999999999999953211
Q ss_pred ----HHHHHH-cCCc--------------------cccCCC-----------CCCCCCHHHHHHHHHHHHHhhhcCccCC
Q 035604 674 ----VERSIE-NGTF--------------------DETLDP-----------AVPDWPVEEALILAKLALQCAELRRKDR 717 (768)
Q Consensus 674 ----~~~~i~-~~~~--------------------~~~ld~-----------~~~~~~~~~~~~l~~Li~~cl~~~P~~R 717 (768)
....+. -|.. ...+.. .....+...+..+.+|+.+||+.||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 000000 0000 000000 0112345667789999999999999999
Q ss_pred CChhhhhh-HHHH
Q 035604 718 PDLGKVVV-PKLN 729 (768)
Q Consensus 718 Ps~~evl~-~~l~ 729 (768)
||+.+++. +|.+
T Consensus 320 pta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 320 ADAGGLVNHPWLK 332 (362)
T ss_dssp BCHHHHHTCGGGT
T ss_pred cCHHHHhcCcccC
Confidence 99999986 5654
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.89 E-value=1.8e-23 Score=199.59 Aligned_cols=152 Identities=14% Similarity=0.178 Sum_probs=119.5
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCC----cccccccCHHHHHHHHHhhhHHHHHh
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGN----SVAISKVNNEVARIYKQQVDNQAKEL 85 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (768)
+++||||||+|+.|++|++||+++|...+++|+||||+++.......... ........+.....+.+...+.+++.
T Consensus 3 ~~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (160)
T d1mjha_ 3 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 82 (160)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cCeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHH
Confidence 58999999999999999999999999999999999998765332211100 00111222333445566677788899
Q ss_pred HHHHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeCC
Q 035604 86 FVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGKG 165 (768)
Q Consensus 86 l~~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k~ 165 (768)
++.+.+.+...|+.+.. .+..|+|++.|+++|+++++||||||+||++++.+.|+ ||++.+|+++++ ||||||++.
T Consensus 83 l~~~~~~~~~~gv~~~~-~~~~G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~-GS~a~~vl~~s~--~pVlvV~~~ 158 (160)
T d1mjha_ 83 MENIKKELEDVGFKVKD-IIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILL-GSVTENVIKKSN--KPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHHTTCEEEE-EEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSS-CHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHhcCCeEEE-EEEeccHHHHHhhhhhccccceEEeccCCCCccccccc-CcHHHHHHhcCC--CCEEEEcCC
Confidence 99999999999999554 56679999999999999999999999999977775555 599999999999 999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.3e-23 Score=205.06 Aligned_cols=163 Identities=14% Similarity=0.089 Sum_probs=120.7
Q ss_pred CCccceecccCceeEEEEEE-CCccEEEEEEcCCch------------------hhHHHHHHHHHHHhhcCCCceeeeec
Q 035604 465 FSNSRKIGEGGYGPVYKSYL-DHTPVAIKVLRPDAA------------------QGRSQFQQEVEVLCNIRHPNMVLLLG 525 (768)
Q Consensus 465 y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~l~~~~~------------------~~~~~~~~E~~il~~l~HpnIv~l~g 525 (768)
+.+.++||+|+||.||+|.+ +++.||||+++.... .....+.+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45678999999999999987 678999999764211 11223457889999999999998886
Q ss_pred cccCCceeEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEcCCCcEEEee
Q 035604 526 ACPEFGCLIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKPEPLVHRDLKPGNILLDRNYVSKISD 605 (768)
Q Consensus 526 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~vKL~D 605 (768)
+. ..+++|||++++.+.. ++......++.|++.+|.|||+.+ |+||||||+|||++.++ ++|+|
T Consensus 82 ~~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liD 145 (191)
T d1zara2 82 WE--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIID 145 (191)
T ss_dssp EE--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECC
T ss_pred ec--CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEE
Confidence 54 3589999998765532 445556789999999999999999 99999999999998654 89999
Q ss_pred cccccccCCCCCCccccccccCCCCCCCCCCc------ccccCCCCCccccHHHHHHHH
Q 035604 606 VGLARLVPPSVADSVTQYRMTSAAGTFCYIDP------EYQQTGMLGVKSDVYSLGILL 658 (768)
Q Consensus 606 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aP------E~~~~~~~s~ksDvwSlGvil 658 (768)
||+|........ ..|... +++ ...|+.++|+||+.--+
T Consensus 146 FG~a~~~~~~~~--------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGW--------------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTH--------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCc--------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999976532211 011111 111 35688999999975443
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.87 E-value=1.4e-22 Score=195.82 Aligned_cols=150 Identities=19% Similarity=0.271 Sum_probs=111.7
Q ss_pred cEEEEEecCCc---------CcHHHHHHHHHhhcCCCC---eEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhh
Q 035604 11 EAVAVAIDKDK---------GSQYALRWAVDHLLSRGQ---NLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQV 78 (768)
Q Consensus 11 ~~IlVavDgS~---------~S~~Al~~A~~~a~~~~a---~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (768)
.|||||||+|. .|++|++||++++.+.++ .|+++||.+........... ............+..
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 77 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDS----IYASPEDFRDMRQSN 77 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------C----CCCSHHHHHHHTTSH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccc----cccCHHHHHHHHHHH
Confidence 68999999996 799999999999988777 59999998764322111111 112334555555666
Q ss_pred hHHHHHhHHHHHHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCcee
Q 035604 79 DNQAKELFVPFRCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCN 158 (768)
Q Consensus 79 ~~~~~~~l~~~~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~ 158 (768)
.+.+.++|+.+...|...|+.+. ..+..|+|.++|+++|++.++|+||||+||++++.+.++ |||+.+|+++++ ||
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~-~~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~l-GSv~~~vi~~~~--cp 153 (171)
T d2gm3a1 78 KAKGLHLLEFFVNKCHEIGVGCE-AWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFV-GTVSAFCVKHAE--CP 153 (171)
T ss_dssp HHHHHHHHHHHHHHHHHHTCEEE-EEEEESCHHHHHHHHHHHHCCSEEEEEECCCC---------CHHHHHHHHCS--SC
T ss_pred HHHHHHHHHHHHHHHHhcCCceE-EEEEeCChHHHHHHHHhhcCCcEEEeccCCccccccCcc-CcHHHHHHhCCC--CC
Confidence 77888999999999999999854 566789999999999999999999999999977775555 599999999999 99
Q ss_pred EEEEeCCcee
Q 035604 159 VYVIGKGKIS 168 (768)
Q Consensus 159 VlvV~k~~~~ 168 (768)
|+||+.+.-.
T Consensus 154 VlvV~~~~~~ 163 (171)
T d2gm3a1 154 VMTIKRNADE 163 (171)
T ss_dssp EEEEECCGGG
T ss_pred EEEEeCCCCC
Confidence 9999865433
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.86 E-value=4.1e-22 Score=184.38 Aligned_cols=135 Identities=16% Similarity=0.198 Sum_probs=106.1
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
+++||||+|+|+.|.+|++||+++|...+++|+|+||+++...... . .......+...+.+++.++++
T Consensus 1 yk~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~---~---------~~~~~~~~~~~~~~~~~l~~~ 68 (135)
T d2z3va1 1 FKTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLG---E---------PFFEEALRRRLERAEGVLEEA 68 (135)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCC---T---------THHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCccccc---c---------chhHHHHHHHHHHHHHHHHHH
Confidence 5899999999999999999999999999999999999986432211 1 112222234445556666665
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEE
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVI 162 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV 162 (768)
.. ..|+.....++..|+|.++|+++|+++++||||||+||++++.+.++ ||++.+|+++++ |||+||
T Consensus 69 ~~---~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 69 RA---LTGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFL-GSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp HH---HHCCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSC-BHHHHHHHHHCS--SCEEEE
T ss_pred HH---hcCCCeEEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCccccccc-CcHHHHHHHhCC--CCEEeC
Confidence 54 34555455667789999999999999999999999999977775555 599999999999 999997
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.84 E-value=1.6e-21 Score=182.88 Aligned_cols=141 Identities=16% Similarity=0.118 Sum_probs=105.0
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
+++||||||+|+.|.+|++||+.+|...++.++++|+.++......... ...........+.+++.++.+
T Consensus 5 yk~ILv~vD~s~~s~~al~~A~~la~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~ 74 (147)
T d1tq8a_ 5 YKTVVVGTDGSDSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADI----------LKDESYKVTGTAPIYEILHDA 74 (147)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHTTTSEEEEEEECCC------------------------------CCTHHHHHHHH
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHhcCCCEEEEEEEeccccccccccc----------chhhhHHHHHHHHHHHHHHHH
Confidence 8999999999999999999999999765555544444433221111000 111123345556678888999
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
...+.+.|+......+..|++++.|+++++++++||||||+||++++.+.++ ||++.+|+++++ ||||||+
T Consensus 75 ~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~-Gs~~~~ll~~~~--~pVlvV~ 145 (147)
T d1tq8a_ 75 KERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLL-GSVPANVSRRAK--VDVLIVH 145 (147)
T ss_dssp HHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHT-BBHHHHHHHHTT--CEEEEEC
T ss_pred HHHHHHcCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCccccccc-ccHHHHHHHhCC--CCEEEEe
Confidence 9999888988677888899999999999999999999999999977775555 599999999998 9999996
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.80 E-value=3e-20 Score=172.63 Aligned_cols=137 Identities=15% Similarity=0.148 Sum_probs=104.4
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
+++||||+|+|+.|+.|++||+.+|+..+++|+++||++++....... .+.......+...+...+.++.+
T Consensus 2 yk~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 72 (140)
T d1jmva_ 2 YKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGL---------IDVNMSSMQDRISTETQKALLDL 72 (140)
T ss_dssp CSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCC---------EEHHHHHHTTCCCCHHHHHHHHH
T ss_pred CCeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccc---------cccchHHHHHHHHHHHHHHHHHH
Confidence 689999999999999999999999999999999999997754322111 11223233334444445555544
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEeC
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIGK 164 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~k 164 (768)
.. ..+......++..|+++++|+++++++++||||||+||+++. .+ ||++.+|+++++ ||||||+-
T Consensus 73 ~~---~~~~~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~---~l-gs~~~~li~~~~--~pVliVp~ 138 (140)
T d1jmva_ 73 AE---SVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWS---KL-MSSTRQVMNTIK--IDMLVVPL 138 (140)
T ss_dssp HH---HSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHH---HH-HHHHHHHHTTCC--SEEEEEEC
T ss_pred HH---hcCCceEEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCC---Cc-ccHHHHHHhccC--CCEEEEec
Confidence 44 445544556777899999999999999999999999998653 24 499999999999 99999974
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.75 E-value=1.4e-19 Score=167.42 Aligned_cols=135 Identities=13% Similarity=0.099 Sum_probs=97.8
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPF 89 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 89 (768)
-|+||||+|+|+.|+.|++||+++|...+++|+|+||+++........ .... ...... ..+...+.+++.++.+
T Consensus 4 mk~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~-~~~~-~~~~~~----~~e~~~~~~~~~l~~~ 77 (138)
T d1q77a_ 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERAN-VTFG-LPFPPE----IKEESKKRIERRLREV 77 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHH-HHHC-CCCCTH----HHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCcccccccc-cccc-cchhhh----hhhhhhhhccccchhh
Confidence 489999999999999999999999999999999999986431100000 0000 000112 2244455666777777
Q ss_pred HHHhhhcCceeEEEEEecCCHHHHHHHHHHhcCCCEEEeecCCCCCceeccccCCCcccccccCCCceeEEEEe
Q 035604 90 RCFCTRKEIKCKEIVLEDTDIAKALIDYVSSHTIETLVLGAASRTGFVKRFKTADIPSNVSKGAPDYCNVYVIG 163 (768)
Q Consensus 90 ~~~~~~~gv~~~~~~v~~G~~a~~Iv~~a~~~~aDlIVmGs~g~~g~~~~~~~gSVa~~V~~~Ap~~C~VlvV~ 163 (768)
.+.+...++.+ ...+..|+|++.|+++|++.++||||||+||++++.+.++| + . ||+|||+
T Consensus 78 ~~~~~~~~~~~-~~~v~~G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g-~---------~--~~~livk 138 (138)
T d1q77a_ 78 WEKLTGSTEIP-GVEYRIGPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDG-L---------N--LASLIVK 138 (138)
T ss_dssp HHHHHSCCCCC-CEEEECSCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHH-S---------S--SEEEECC
T ss_pred cccccccceeE-EEeeecchhHHHHHHhhhhccCCEEEEecCCCcHHHHHhcC-C---------C--CCEEEeC
Confidence 77777777774 44577899999999999999999999999999666654444 4 3 8888874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.52 E-value=1.6e-07 Score=94.45 Aligned_cols=147 Identities=15% Similarity=0.131 Sum_probs=98.9
Q ss_pred HHHHHHhcCCCccceecccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcC-CCceeeeeccc--cCCce
Q 035604 456 EEIEEATENFSNSRKIGEGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIR-HPNMVLLLGAC--PEFGC 532 (768)
Q Consensus 456 ~ei~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~--~~~~~ 532 (768)
.++......|...+..+.++.+.||+...++..+.+|+...........+.+|..++..+. +--+-+++.++ ....+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3455666777776665555667999998888889999986554444445778888877664 21233444443 33458
Q ss_pred eEEEeccCCChHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--------------------------------
Q 035604 533 LIYEYMANGSLEDRLFRRGGSPVLPWQIRFRIAAEIATALLFLHQTKP-------------------------------- 580 (768)
Q Consensus 533 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-------------------------------- 580 (768)
+||++++|..+...... ......++.+++..|..||+...
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999887654321 11122345556666666665321
Q ss_pred ------------------------CCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 581 ------------------------EPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 581 ------------------------~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 138999999999999987777899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=3.9e-05 Score=81.64 Aligned_cols=76 Identities=18% Similarity=0.220 Sum_probs=51.9
Q ss_pred cceecccCceeEEEEEE--CCccEEEEEEcCCc-------hhhHHHHHHHHHHHhhcC-C--CceeeeeccccCCceeEE
Q 035604 468 SRKIGEGGYGPVYKSYL--DHTPVAIKVLRPDA-------AQGRSQFQQEVEVLCNIR-H--PNMVLLLGACPEFGCLIY 535 (768)
Q Consensus 468 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~l~~~~-------~~~~~~~~~E~~il~~l~-H--pnIv~l~g~~~~~~~lV~ 535 (768)
.+.||.|....||+... .+..|+||.-.+.. .........|.+.|+.+. + ..+.+++.+..+..++||
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvm 110 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 110 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEE
Confidence 45689999999999876 35678999754321 112334567888887663 2 346677777788889999
Q ss_pred EeccCCCh
Q 035604 536 EYMANGSL 543 (768)
Q Consensus 536 E~~~~gsL 543 (768)
|++.+..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred eccCCccc
Confidence 99976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.46 E-value=0.0002 Score=70.51 Aligned_cols=138 Identities=16% Similarity=0.129 Sum_probs=76.9
Q ss_pred eecccC-ceeEEEEEECC-ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCc--eeeeeccc--cCCceeEEEeccCCCh
Q 035604 470 KIGEGG-YGPVYKSYLDH-TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPN--MVLLLGAC--PEFGCLIYEYMANGSL 543 (768)
Q Consensus 470 ~LG~G~-fG~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~--~~~~~lV~E~~~~gsL 543 (768)
.+..|. .+.||+...++ ..+++|.-..... ..+..|..+|+.+.... +.+++.++ ....++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 455555 36899888754 4688898765432 24677888887764322 34455544 3345899999987655
Q ss_pred HH--------------HHhhcCC----CCCCCH--HHHHH-----H---------------HHHHHHHHHHHHhCCC---
Q 035604 544 ED--------------RLFRRGG----SPVLPW--QIRFR-----I---------------AAEIATALLFLHQTKP--- 580 (768)
Q Consensus 544 ~~--------------~l~~~~~----~~~l~~--~~~~~-----i---------------~~qi~~aL~~LH~~~~--- 580 (768)
.. .+.+-.. ...+.. ..... + .......+..+....+
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 32 1111000 000000 00000 0 0011112233333221
Q ss_pred -CCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 581 -EPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 581 -~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 238999999999999987777899999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.88 E-value=0.0014 Score=66.78 Aligned_cols=156 Identities=10% Similarity=0.084 Sum_probs=82.4
Q ss_pred CCHHHHHHHhcCCCccceec-----ccCceeEEEEEECCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-----ee
Q 035604 453 YSIEEIEEATENFSNSRKIG-----EGGYGPVYKSYLDHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-----VL 522 (768)
Q Consensus 453 ~~~~ei~~~~~~y~~~~~LG-----~G~fG~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-----v~ 522 (768)
.+.+++.....+|.+++... .|---+.|+...++..+++|+..... ....+..|+++|..|...++ +.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 45677778888888765443 44446789988888889999986532 23455667777777642222 11
Q ss_pred ee-cc----ccCCceeEEEeccCCChH--------------HHHhhcCCC---C-C--CC------------------HH
Q 035604 523 LL-GA----CPEFGCLIYEYMANGSLE--------------DRLFRRGGS---P-V--LP------------------WQ 559 (768)
Q Consensus 523 l~-g~----~~~~~~lV~E~~~~gsL~--------------~~l~~~~~~---~-~--l~------------------~~ 559 (768)
.. |. .......++.++.+.... ..+...... . . .. ..
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 10 11 112224455555443211 011100000 0 0 00 00
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEEcCCCcEEEeeccccc
Q 035604 560 IRFRIAAEIATALLFLHQ-TKPEPLVHRDLKPGNILLDRNYVSKISDVGLAR 610 (768)
Q Consensus 560 ~~~~i~~qi~~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~ 610 (768)
.....+..+...+...+. .-+.++||+|+.++|||++.+...-|+||+.|.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222223333333322 123469999999999999988888899999885
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.76 E-value=0.0056 Score=62.49 Aligned_cols=160 Identities=16% Similarity=0.198 Sum_probs=84.0
Q ss_pred ccccCCHHHHHHHhcCCC---ccceecccCc-eeEEEEEE-CCccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce--e
Q 035604 449 RYRKYSIEEIEEATENFS---NSRKIGEGGY-GPVYKSYL-DHTPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM--V 521 (768)
Q Consensus 449 ~~~~~~~~ei~~~~~~y~---~~~~LG~G~f-G~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI--v 521 (768)
.|...+.+.|..+...+- ..+.+-=++| -.||+... +|..|++|+.++.. ....++..|...|..|..-+| +
T Consensus 4 ~f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~ 82 (325)
T d1zyla1 4 TFQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA 82 (325)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCC
Confidence 455555555554444331 1222222333 37999887 67889999998653 234567888888877742221 1
Q ss_pred eeecc-------ccCCceeEEEeccCCChH-----H---------HHhh----cC--CCCCCCH----------------
Q 035604 522 LLLGA-------CPEFGCLIYEYMANGSLE-----D---------RLFR----RG--GSPVLPW---------------- 558 (768)
Q Consensus 522 ~l~g~-------~~~~~~lV~E~~~~gsL~-----~---------~l~~----~~--~~~~l~~---------------- 558 (768)
..+.. .....+.++++++|..+. . .+.. .. ....++.
T Consensus 83 ~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~ 162 (325)
T d1zyla1 83 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 162 (325)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred CceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCc
Confidence 11111 122346788888763221 0 0110 00 0011111
Q ss_pred ---HHHHHHHHHHHHHHHHHHh----CCCCCeeeCCCCCCCeEEcCCCcEEEeecccccc
Q 035604 559 ---QIRFRIAAEIATALLFLHQ----TKPEPLVHRDLKPGNILLDRNYVSKISDVGLARL 611 (768)
Q Consensus 559 ---~~~~~i~~qi~~aL~~LH~----~~~~~iiHrDLKp~NILl~~~~~vKL~DFGla~~ 611 (768)
.....+...+...+..+.. ..+.++||+|+.|.|||++.+ ..++||+-|..
T Consensus 163 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 163 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1111122222233333332 234569999999999999743 45899998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.15 E-value=0.0032 Score=66.34 Aligned_cols=71 Identities=18% Similarity=0.277 Sum_probs=46.4
Q ss_pred ceecccCceeEEEEEECC---------ccEEEEEEcCCchhhHHHHHHHHHHHhhcCCCce-eeeeccccCCceeEEEec
Q 035604 469 RKIGEGGYGPVYKSYLDH---------TPVAIKVLRPDAAQGRSQFQQEVEVLCNIRHPNM-VLLLGACPEFGCLIYEYM 538 (768)
Q Consensus 469 ~~LG~G~fG~Vy~~~~~~---------~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~ 538 (768)
+.|+.|--=.+|+..... ..|.+++.-. . ...-...+|..+++.+.-.++ .+++++|. ..+||||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFS--GGRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--TEEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--CceEEEEe
Confidence 467777778899987632 3466776642 2 122345688889888753344 46777775 47899999
Q ss_pred cCCCh
Q 035604 539 ANGSL 543 (768)
Q Consensus 539 ~~gsL 543 (768)
+|..|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87543
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=89.35 E-value=0.49 Score=44.40 Aligned_cols=96 Identities=11% Similarity=0.026 Sum_probs=61.2
Q ss_pred CcEEEEEecCCcCcHHHHHHHHHhhcCCCC-eEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHH
Q 035604 10 EEAVAVAIDKDKGSQYALRWAVDHLLSRGQ-NLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVP 88 (768)
Q Consensus 10 ~~~IlVavDgS~~S~~Al~~A~~~a~~~~a-~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 88 (768)
.++|+||+=|-..|...|..+..+....+. .|.++||-.... . +. ....+.
T Consensus 24 ~~kv~Va~SGG~DS~~Ll~lL~~~~~~~~~~~i~~~~vdh~~r---~-------------~s------------~~~~~~ 75 (216)
T d1wy5a1 24 ERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR---E-------------SA------------ERDEEF 75 (216)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS---T-------------HH------------HHHHHH
T ss_pred CCeEEEEeCCcHHHHHHHHHHHHHHHhcCCCcEEEEEeecccc---c-------------ch------------hhhhhH
Confidence 679999999999998887777665544443 689999853210 0 10 111123
Q ss_pred HHHHhhhcCceeEEEEEec--------CCH--------HHHHHHHHHhcCCCEEEeecCCC
Q 035604 89 FRCFCTRKEIKCKEIVLED--------TDI--------AKALIDYVSSHTIETLVLGAASR 133 (768)
Q Consensus 89 ~~~~~~~~gv~~~~~~v~~--------G~~--------a~~Iv~~a~~~~aDlIVmGs~g~ 133 (768)
+...|...|+++....+.. ... ...+.++|++.++|.|++|.|..
T Consensus 76 ~~~~~~~l~i~~~i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~d 136 (216)
T d1wy5a1 76 CKEFAKERNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (216)
T ss_dssp HHHHHHHHTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred HHHHHHhhhhhhhhhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeecc
Confidence 4556667788754333221 000 24567899999999999999864
|
| >d1np7a2 c.28.1.1 (A:1-204) Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: 1143]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Cryptochrome/photolyase, N-terminal domain superfamily: Cryptochrome/photolyase, N-terminal domain family: Cryptochrome/photolyase, N-terminal domain domain: Cryptochrome species: Synechocystis sp., pcc 6803 [TaxId: 1143]
Probab=86.09 E-value=0.69 Score=42.80 Aligned_cols=86 Identities=10% Similarity=0.017 Sum_probs=54.9
Q ss_pred HHHHHHHHhhcCCCCeEEEEEeecCCCCCCCCCCCcccccccCHHHHHHHHHhhhHHHHHhHHHHHHHhhhcCceeEEEE
Q 035604 25 YALRWAVDHLLSRGQNLTLLHVKQRVSSVPNPSGNSVAISKVNNEVARIYKQQVDNQAKELFVPFRCFCTRKEIKCKEIV 104 (768)
Q Consensus 25 ~Al~~A~~~a~~~~a~l~llHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~gv~~~~~~ 104 (768)
.||..|+. .+..|+.|+|+++........+.. ..+.. -..-..+.|..+...+++.|+. .+
T Consensus 22 ~aL~~A~~----~~~~vi~vyi~dp~~~~~~~~~~~----~~~~~--------r~~fl~~sL~~L~~~L~~~g~~---L~ 82 (204)
T d1np7a2 22 EPLHRALK----SGLAITAVYCYDPRQFAQTHQGFA----KTGPW--------RSNFLQQSVQNLAESLQKVGNK---LL 82 (204)
T ss_dssp HHHHHHHH----TTSEEEEEEEECGGGGSBCTTSCB----SSCHH--------HHHHHHHHHHHHHHHHHHTTCC---EE
T ss_pred HHHHHHHh----cCCcEEEEEEECchHhcCcccccc----cccHH--------HHHHHHHHHHHHHHHHHhccch---hh
Confidence 46666653 467899999997643221111110 00111 1122445566667777778888 45
Q ss_pred EecCCHHHHHHHHHHhcCCCEEEee
Q 035604 105 LEDTDIAKALIDYVSSHTIETLVLG 129 (768)
Q Consensus 105 v~~G~~a~~Iv~~a~~~~aDlIVmG 129 (768)
+..|++.++|.+++++++++.|+.-
T Consensus 83 v~~G~~~~~l~~l~~~~~i~~V~~n 107 (204)
T d1np7a2 83 VTTGLPEQVIPQIAKQINAKTIYYH 107 (204)
T ss_dssp EEESCHHHHHHHHHHHTTEEEEEEE
T ss_pred hhhhhhHHHHHHHHHHhhhhheeee
Confidence 6679999999999999999988864
|